Secretory	O	O
immunoglobulin	O	O
A	O	O
(	O	O
SIgA	O	O
)	O	O
antibodies	O	O
reactive	O	O
with	O	O
the	O	O
pioneer	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
Streptococcus	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
biovar	I-bacteria	I-bacteria
1	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
the	O	O
late	O	O
oral	O	O
colonizer	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
and	O	O
the	O	O
pioneer	O	O
enteric	B-bacteria	B-bacteria
bacterium	I-bacteria	I-bacteria
Enterococcus	I-bacteria	I-bacteria
faecalis	E-bacteria	I-bacteria
in	O	O
saliva	O	O
samples	O	O
from	O	O
10	O	O
human	O	O
infants	O	O
from	O	O
birth	O	O
to	O	O
age	O	O
2	O	O
years	O	O
were	O	O
analyzed	O	O
.	O	O

Low	O	O
levels	O	O
of	O	O
salivary	O	O
SIgA1	O	O
and	O	O
SIgA2	O	O
antibodies	O	O
reactive	O	O
with	O	O
whole	O	O
cells	O	O
of	O	O
all	O	O
four	O	O
species	O	O
were	O	O
detected	O	O
within	O	O
the	O	O
first	O	O
month	O	O
after	O	O
birth	O	O
,	O	O
even	O	O
though	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
were	O	O
not	O	O
recovered	O	O
from	O	O
the	O	O
mouths	O	O
of	O	O
the	O	O
infants	O	O
during	O	O
the	O	O
study	O	O
period	O	O
.	O	O

Although	O	O
there	O	O
was	O	O
a	O	O
fivefold	O	O
increase	O	O
in	O	O
the	O	O
concentration	O	O
of	O	O
SIgA	O	O
between	O	O
birth	O	O
and	O	O
age	O	O
2	O	O
years	O	O
,	O	O
there	O	O
were	O	O
no	O	O
differences	O	O
between	O	O
the	O	O
concentrations	O	O
of	O	O
SIgA1	O	O
and	O	O
SIgA2	O	O
antibodies	O	O
reactive	O	O
with	O	O
the	O	O
four	O	O
species	O	O
over	O	O
this	O	O
time	O	O
period	O	O
.	O	O

When	O	O
the	O	O
concentrations	O	O
of	O	O
SIgA1	O	O
and	O	O
SIgA2	O	O
antibodies	O	O
reactive	O	O
with	O	O
all	O	O
four	O	O
species	O	O
were	O	O
normalized	O	O
to	O	O
the	O	O
concentrations	O	O
of	O	O
SIgA1	O	O
and	O	O
SIgA2	O	O
in	O	O
saliva	O	O
,	O	O
SIgA1	O	O
and	O	O
SIgA2	O	O
antibodies	O	O
reactive	O	O
with	O	O
these	O	O
bacteria	O	O
showed	O	O
a	O	O
significant	O	O
decrease	O	O
from	O	O
birth	O	O
to	O	O
2	O	O
years	O	O
of	O	O
age	O	O
.	O	O

Adsorption	O	O
of	O	O
each	O	O
infant	O	O
's	O	O
saliva	O	O
with	O	O
cells	O	O
of	O	O
one	O	O
species	O	O
produced	O	O
a	O	O
dramatic	O	O
reduction	O	O
of	O	O
antibodies	O	O
recognizing	O	O
the	O	O
other	O	O
three	O	O
species	O	O
.	O	O

Sequential	O	O
adsorption	O	O
of	O	O
saliva	O	O
samples	O	O
removed	O	O
all	O	O
SIgA	O	O
antibody	O	O
to	O	O
the	O	O
bacteria	O	O
,	O	O
indicating	O	O
that	O	O
the	O	O
SIgA	O	O
antibodies	O	O
were	O	O
directed	O	O
to	O	O
antigens	O	O
shared	O	O
by	O	O
all	O	O
four	O	O
species	O	O
.	O	O

The	O	O
induction	O	O
by	O	O
the	O	O
host	O	O
of	O	O
a	O	O
limited	O	O
immune	O	O
response	O	O
to	O	O
common	O	O
antigens	O	O
that	O	O
are	O	O
likely	O	O
not	O	O
involved	O	O
in	O	O
adherence	O	O
may	O	O
be	O	O
among	O	O
the	O	O
mechanisms	O	O
that	O	O
commensal	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
employ	O	O
to	O	O
persist	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Human	O	O
salivary	O	O
mucin	O	O
MG2	O	O
was	O	O
purified	O	O
from	O	O
submandibular/sublingual	O	O
gland	O	O
secretion	O	O
by	O	O
ultrafiltration	O	O
and	O	O
sequential	O	O
gel	O	O
filtration	O	O
chromatography	O	O
on	O	O
Sephadex	O	O
G-200	O	O
,	O	O
Superose	O	O
6	O	O
(	O	O
prepgrade	O	O
)	O	O
,	O	O
and	O	O
Superose	O	O
6	O	O
.	O	O

This	O	O
method	O	O
differs	O	O
from	O	O
earlier	O	O
procedures	O	O
in	O	O
that	O	O
all	O	O
steps	O	O
are	O	O
performed	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
4	O	O
M	O	O
guanidine	O	O
hydrochloride	O	O
and	O	O
do	O	O
not	O	O
involve	O	O
covalent	O	O
modification	O	O
of	O	O
the	O	O
mucin	O	O
molecule	O	O
.	O	O

Electrophoretic	O	O
analyses	O	O
and	O	O
Western	O	O
blotting	O	O
showed	O	O
that	O	O
purified	O	O
MG2	O	O
did	O	O
not	O	O
contain	O	O
detectable	O	O
levels	O	O
of	O	O
other	O	O
salivary	O	O
proteins	O	O
.	O	O

Amino	O	O
acid	O	O
analysis	O	O
showed	O	O
that	O	O
the	O	O
composition	O	O
of	O	O
purified	O	O
MG2	O	O
was	O	O
in	O	O
excellent	O	O
agreement	O	O
with	O	O
the	O	O
deduced	O	O
sequence	O	O
of	O	O
MG2	O	O
apomucin	O	O
encoded	O	O
in	O	O
the	O	O
MUC7	O	O
gene	O	O
.	O	O

The	O	O
yield	O	O
of	O	O
purified	O	O
MG2	O	O
was	O	O
10-15	O	O
mg	O	O
from	O	O
750	O	O
ml	O	O
of	O	O
salivary	O	O
secretion	O	O
.	O	O

Binding	O	O
of	O	O
purified	O	O
MG2	O	O
to	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
vitro	O	O
was	O	O
not	O	O
significantly	O	O
affected	O	O
by	O	O
reductive	O	O
methylation	O	O
,	O	O
but	O	O
was	O	O
nearly	O	O
abolished	O	O
by	O	O
reduction	O	O
and	O	O
alkylation	O	O
.	O	O

These	O	O
data	O	O
identified	O	O
a	O	O
functional	O	O
determinant	O	O
for	O	O
mucin-bacterial	O	O
interactions	O	O
in	O	O
the	O	O
N-terminal	O	O
region	O	O
where	O	O
the	O	O
only	O	O
two	O	O
cysteines	O	O
(	O	O
Cys45	O	O
and	O	O
Cys50	O	O
)	O	O
in	O	O
the	O	O
MG2	O	O
apomucin	O	O
occur	O	O
.	O	O

Additionally	O	O
,	O	O
purified	O	O
MG2	O	O
bound	O	O
to	O	O
four	O	O
strains	O	O
of	O	O
oral	O	O
Streptococci	B-bacteria	B-bacteria
,	O	O
indicating	O	O
that	O	O
the	O	O
binding	O	O
is	O	O
not	O	O
dependent	O	O
on	O	O
complexing	O	O
with	O	O
other	O	O
salivary	O	O
proteins	O	O
,	O	O
such	O	O
as	O	O
secretory	O	O
immunoglobulin	O	O
A	O	O
.	O	O

The	O	O
purification	O	O
procedure	O	O
described	O	O
in	O	O
this	O	O
work	O	O
will	O	O
facilitate	O	O
investigation	O	O
of	O	O
the	O	O
role	O	O
of	O	O
MG2	O	O
in	O	O
the	O	O
oral	O	O
environment	O	O
.	O	O

The	O	O
effects	O	O
of	O	O
a	O	O
magnesium	O	O
monoperoxyphthalate	O	O
(	O	O
MMPP	O	O
)	O	O
mouth-rinse	O	O
,	O	O
with	O	O
or	O	O
without	O	O
sodium	O	O
lauryl	O	O
sulphate	O	O
(	O	O
SLS	O	O
)	O	O
,	O	O
and	O	O
an	O	O
MMPP	O	O
dentifrice	O	O

,	O	O
on	O	O
salivary	O	O
counts	O	O
of	O	O
bacterial	O	O
flora	O	O
and	O	O
yeasts	O	O
,	O	O
and	O	O
on	O	O
supragingival	O	O
plaque	O	O
scores	O	O
were	O	O
investigated	O	O
in	O	O
131	O	O
healthy	O	O
oral	O	O
candida	O	O
carriers	O	O
over	O	O
a	O	O
9	O	O
week	O	O
double	O	O
blind	O	O
study	O	O
.	O	O

There	O	O
were	O	O
no	O	O
changes	O	O
in	O	O
the	O	O
salivary	O	O
counts	O	O
of	O	O
bacteria	O	O
studied	O	O
(	O	O
anaerobes	B-bacteria	B-bacteria
,	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
fusobacteria	B-bacteria	B-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
,	O	O
Viellonella	B-bacteria	B-bacteria
)	O	O
in	O	O
the	O	O
test	O	O
or	O	O
placebo	O	O
groups	O	O
.	O	O

A	O	O
significant	O	O
increase	O	O
in	O	O
salivary	O	O
candida	O	O
counts	O	O
was	O	O
seen	O	O
in	O	O
subjects	O	O
using	O	O
an	O	O
MMPP	O	O
rinse	O	O
and	O	O
dentifrice	O	O
compared	O	O
with	O	O
placebo	O	O
subjects	O	O
and	O	O
this	O	O
phenomenon	O	O
was	O	O
not	O	O
influenced	O	O
by	O	O
the	O	O
presence	O	O
of	O	O
SLS	O	O
.	O	O

A	O	O
significant	O	O
reduction	O	O
in	O	O
plaque	O	O
was	O	O
seen	O	O
in	O	O
subjects	O	O
using	O	O
an	O	O
MMPP	O	O
rinse	O	O
and	O	O
dentifrice	O	O
compared	O	O
with	O	O
placebo	O	O
subjects	O	O
.	O	O

Frank	O	O
candidosis	O	O
was	O	O
observed	O	O
in	O	O
only	O	O
2	O	O
subjects	O	O
(	O	O
1	O	O
in	O	O
the	O	O
placebo	O	O
rinse	O	O
group	O	O

and	O	O
1	O	O
in	O	O
the	O	O
MMPP	O	O
dentifrice	O	O
group	O	O
)	O	O
but	O	O
erythematous	O	O
lesions	O	O
,	O	O
with	O	O
subjective	O	O
reports	O	O
of	O	O
soreness	O	O
,	O	O
dryness	O	O
or	O	O
burning	O	O
sensation	O	O
,	O	O
were	O	O
recorded	O	O
and	O	O
observed	O	O
more	O	O
frequently	O	O
in	O	O
the	O	O
experimental	O	O
groups	O	O
than	O	O
in	O	O
the	O	O
placebos	O	O
,	O	O
especially	O	O
in	O	O
those	O	O
also	O	O
using	O	O
SLS	O	O
.	O	O

The	O	O
substantial	O	O
plaque	O	O
reduction	O	O
achieved	O	O
with	O	O
MMPP	O	O
in	O	O
the	O	O
absence	O	O
of	O	O
tooth	O	O
staining	O	O
but	O	O
with	O	O
the	O	O
increase	O	O
in	O	O
salivary	O	O
Candida	O	O
counts	O	O
suggests	O	O
that	O	O
further	O	O
studies	O	O
of	O	O
MMPP	O	O
are	O	O
warranted	O	O
.	O	O

Bacteroides	B-bacteria	B-bacteria
forsythus	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
recovered	O	O
from	O	O
cat	O	O
and	O	O
dog	O	O
bite	O	O
wound	O	O
infections	O	O
in	O	O
humans	O	O
(	O	O
n	O	O
=	O	O
3	O	O
)	O	O
,	O	O
monkey	O	O
oral	O	O
strains	O	O
(	O	O
n	O	O
=	O	O
3	O	O
)	O	O
,	O	O
and	O	O
the	O	O
human	O	O
oral	O	O
ATCC	B-bacteria	B-bacteria
43037	I-bacteria	I-bacteria
type	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
were	O	O
characterized	O	O
by	O	O
using	O	O
phenotypic	O	O
characteristics	O	O
,	O	O
enzymatic	O	O
tests	O	O
,	O	O
whole	O	O
cell	O	O
fatty	O	O
acid	O	O
analysis	O	O
,	O	O
sodium	O	O
dodecyl	O	O
sulfate-polyacrylamide	O	O
gel	O	O
electrophoresis	O	O
(	O	O
SDS-PAGE	O	O
)	O	O
analysis	O	O
,	O	O
PCR	O	O
fingerprinting	O	O
,	O	O
and	O	O
16S	O	O
rDNA	O	O
(	O	O
genes	O	O
coding	O	O
for	O	O
rRNA	O	O
)	O	O
sequencing	O	O
.	O	O

All	O	O
three	O	O
bite	O	O
wound	O	O
isolates	O	O
grew	O	O
on	O	O
brucella	O	O
agar	O	O
supplemented	O	O
with	O	O
5	O	O
%	O	O
sheep	O	O
blood	O	O
,	O	O
vitamin	O	O
K1	O	O
,	O	O
and	O	O
hemin	O	O
.	O	O

These	O	O
strains	O	O
,	O	O
unlike	O	O
the	O	O
ATCC	B-bacteria	B-bacteria
strain	E-bacteria	I-bacteria
and	O	O
previously	O	O
described	O	O
monkey	O	O
oral	O	O
and	O	O
human	O	O
clinical	O	O
strains	O	O
,	O	O
did	O	O
not	O	O
require	O	O
N-acetylmuramic	O	O
acid	O	O
supplementation	O	O
for	O	O
growth	O	O
as	O	O
pure	O	O
cultures	O	O
.	O	O

However	O	O
,	O	O
their	O	O
phenotypic	O	O
characteristics	O	O
,	O	O
except	O	O
for	O	O
catalase	O	O
production	O	O
,	O	O
were	O	O
similar	O	O
to	O	O
those	O	O
of	O	O
previously	O	O
identified	O	O
strains	O	O
.	O	O

PCR	O	O
fingerprinting	O	O
analysis	O	O
showed	O	O
differences	O	O
in	O	O
band	O	O
patterns	O	O
from	O	O
the	O	O
ATCC	B-bacteria	B-bacteria
strain	E-bacteria	I-bacteria
.	O	O

Also	O	O
,	O	O
SDS-PAGE	O	O
and	O	O
whole	O	O
cell	O	O
fatty	O	O
acid	O	O
analysis	O	O
indicated	O	O
that	O	O
the	O	O
dog	O	O
and	O	O
cat	O	O
bite	O	O
wound	O	O
strains	O	O
were	O	O
similar	O	O
but	O	O
not	O	O
identical	O	O
to	O	O
the	O	O
human	O	O
B.	B-bacteria	B-bacteria
forsythus	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
43037	I-bacteria	I-bacteria
type	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
and	O	O
the	O	O
monkey	O	O
oral	O	O
strains	O	O
.	O	O

The	O	O
rDNA	O	O
sequence	O	O
analysis	O	O
indicated	O	O
that	O	O
the	O	O
three	O	O
bite	O	O
wound	O	O
isolates	O	O
had	O	O
99.93	O	O
%	O	O
homology	O	O
with	O	O
each	O	O
other	O	O
and	O	O
98.9	O	O
and	O	O
99.22	O	O
%	O	O
homology	O	O
with	O	O
the	O	O
human	O	O
ATCC	B-bacteria	B-bacteria
43037	E-bacteria	I-bacteria
and	O	O
monkey	O	O
oral	O	O
strains	O	O
,	O	O
respectively	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
there	O	O
are	O	O
host-specific	O	O
variations	O	O
within	O	O
each	O	O
group	O	O
.	O	O

Information	O	O
about	O	O
the	O	O
total	O	O
amount	O	O
of	O	O
bacteria	O	O
in	O	O
oral	O	O
samples	O	O
contributes	O	O
to	O	O
assessment	O	O
of	O	O
an	O	O
individual	O	O
's	O	O
risk	O	O
of	O	O
contracting	O	O
dental	O	O
caries	O	O
or	O	O
developing	O	O
periodontitis	O	O
and	O	O
the	O	O
prediction	O	O
of	O	O
that	O	O
individual	O	O
's	O	O
clinical	O	O
course	O	O
.	O	O

Since	O	O
existing	O	O
techniques	O	O
are	O	O
often	O	O
time-consuming	O	O
and	O	O
expensive	O	O
,	O	O
it	O	O
seemed	O	O
attractive	O	O
to	O	O
look	O	O
for	O	O
alternative	O	O
methods	O	O
for	O	O
the	O	O
quantification	O	O
of	O	O
eubacteria	B-bacteria	B-bacteria
.	O	O

With	O	O
their	O	O
high	O	O
specificity	O	O
and	O	O
sensitivity	O	O
,	O	O
polymerase	O	O
chain-reaction	O	O
(	O	O
PCR	O	O
)	O	O
techniques	O	O
have	O	O
the	O	O
potential	O	O
of	O	O
supplying	O	O
fast	O	O
and	O	O
reliable	O	O
results	O	O
.	O	O

We	O	O
developed	O	O
a	O	O
method	O	O
of	O	O
competitive	O	O
PCR	O	O
for	O	O
the	O	O
quantification	O	O
of	O	O
eubacteria	B-bacteria	B-bacteria
.	O	O

We	O	O
designed	O	O
forward	O	O
and	O	O
reverse	O	O
PCR	O	O
primers	O	O
which	O	O
bind	O	O
to	O	O
highly	O	O
conserved	O	O
sequences	O	O
of	O	O
the	O	O
bacterial	O	O
16S	O	O
rRNA	O	O
gene	O	O
.	O	O

A	O	O
homologous	O	O
competitor	O	O
was	O	O
synthesized	O	O
with	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
16S	O	O
rDNA	O	O
as	O	O
a	O	O
template	O	O
,	O	O
with	O	O
the	O	O
reverse	O	O
primer	O	O
and	O	O
a	O	O
hybrid	O	O
primer	O	O
which	O	O
binds	O	O
67	O	O
bases	O	O
downstream	O	O
to	O	O
the	O	O
forward	O	O
primer	O	O
and	O	O
carries	O	O
the	O	O
forward	O	O
primer	O	O
sequence	O	O
at	O	O
its	O	O
5	O	O
'	O	O
end	O	O
.	O	O

Specificity	O	O
controls	O	O
with	O	O
30	O	O
different	O	O
bacterial	O	O
species	O	O
,	O	O
5	O	O
Archaea	O	O
,	O	O
3	O	O
fungi	O	O
,	O	O
human	O	O
astrocytoma	O	O
cells	O	O
,	O	O
and	O	O
rat	O	O
hepatoblastoma	O	O
cells	O	O
were	O	O
carried	O	O
out	O	O
.	O	O

Results	O	O
were	O	O
positive	O	O
for	O	O
all	O	O
eubacteria	B-bacteria	B-bacteria
and	O	O
negative	O	O
for	O	O
all	O	O
other	O	O
cells	O	O
tested	O	O
.	O	O

Calibration	O	O
curves	O	O
were	O	O
obtained	O	O
by	O	O
co-amplification	O	O
of	O	O
known	O	O
amounts	O	O
of	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
cells	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
homologous	O	O
competitor	O	O
.	O	O

The	O	O
developed	O	O
method	O	O
was	O	O
successfully	O	O
applied	O	O
to	O	O
assessment	O	O
of	O	O
the	O	O
accumulation	O	O
of	O	O
bacteria	O	O
during	O	O
an	O	O
oral	O	O
hygiene	O	O
cessation	O	O
experiment	O	O
.	O	O

The	O	O
competitive	O	O
PCR	O	O
method	O	O
proved	O	O
to	O	O
be	O	O
a	O	O
reliable	O	O
and	O	O
fast	O	O
method	O	O
for	O	O
the	O	O
quantification	O	O
of	O	O
bacterial	O	O
DNA	O	O
and	O	O
cultured	O	O
eubacteria	B-bacteria	B-bacteria
,	O	O
as	O	O
well	O	O
as	O	O
of	O	O
bacteria	O	O
in	O	O
biological	O	O
samples	O	O
.	O	O

It	O	O
may	O	O
find	O	O
further	O	O
applications	O	O
not	O	O
only	O	O
in	O	O
periodontology	O	O
and	O	O
cariology	O	O
but	O	O
also	O	O
in	O	O
other	O	O
fields	O	O
of	O	O
medical	O	O
microbiology	O	O
.	O	O

Several	O	O
publications	O	O
have	O	O
reported	O	O
an	O	O
increased	O	O
susceptibility	O	O
for	O	O
root	O	O
caries	O	O
after	O	O
periodontal	O	O
therapy	O	O
.	O	O

It	O	O
has	O	O
been	O	O
suggested	O	O
that	O	O
newly	O	O
exposed	O	O
roots	O	O
were	O	O
less	O	O
resistant	O	O
to	O	O
cariogenic	O	O
species	O	O
.	O	O

This	O	O
study	O	O
examined	O	O
the	O	O
hypothesis	O	O
that	O	O
the	O	O
increased	O	O
susceptibility	O	O
could	O	O
also	O	O
be	O	O
related	O	O
to	O	O
an	O	O
intra-oral	O	O
microbial	O	O
shift	O	O
during	O	O
the	O	O
initial	O	O
phase	O	O
of	O	O
the	O	O
periodontal	O	O
therapy	O	O
from	O	O
a	O	O
perio-pathogenic	O	O
to	O	O
a	O	O
more	O	O
cariogenic	O	O
flora	O	O
.	O	O

10	O	O
patients	O	O
with	O	O
severe	O	O
periodontitis	O	O
were	O	O
followed	O	O
for	O	O
8	O	O
months	O	O
after	O	O
thorough	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
in	O	O
combination	O	O
with	O	O
optimal	O	O
plaque	O	O
control	O	O
.	O	O

At	O	O
baseline	O	O
and	O	O
after	O	O
4	O	O
and	O	O
8	O	O
months	O	O
,	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
the	O	O
saliva	O	O
,	O	O
the	O	O
tongue	O	O
dorsum	O	O
and	O	O
the	O	O
supragingival	O	O
interdental	O	O
spaces	O	O
.	O	O

These	O	O
samples	O	O
were	O	O
cultured	O	O
both	O	O
aerobically	O	O
and	O	O
anaerobically	O	O
in	O	O
order	O	O
to	O	O
determine	O	O
the	O	O
total	O	O
number	O	O
of	O	O
colony	O	O
forming	O	O
units	O	O
(	O	O
CFU	O	O
)	O	O
per	O	O
sample	O	O
as	O	O
well	O	O
as	O	O
the	O	O
number	O	O
of	O	O
CFU	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

Oral	O	O
hygiene	O	O
parameters	O	O
were	O	O
recorded	O	O
at	O	O
the	O	O
same	O	O
visits	O	O
.	O	O

Finally	O	O
,	O	O
at	O	O
baseline	O	O
and	O	O
at	O	O
the	O	O
8	O	O
months	O	O
follow-up	O	O
,	O	O
changes	O	O
in	O	O
caries	O	O
activity	O	O
and	O	O
periodontal	O	O
health	O	O
were	O	O
registered	O	O
.	O	O

Although	O	O
the	O	O
total	O	O
number	O	O
of	O	O
aerobic	O	O
and	O	O
anaerobic	O	O
CFU	O	O
in	O	O
samples	O	O
from	O	O
the	O	O
tongue	O	O
and	O	O
the	O	O
saliva	O	O
remained	O	O
nearly	O	O
constant	O	O
over	O	O
the	O	O
entire	O	O
observation	O	O
period	O	O
(	O	O
variations	O	O
within	O	O
0.5	O	O
log	O	O
)	O	O
,	O	O
significant	O	O
(	O	O
p	O	O
<	O	O
or	O	O
=0.05	O	O
)	O	O
increases	O	O
in	O	O
the	O	O
number	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
could	O	O
be	O	O
detected	O	O
,	O	O
especially	O	O
at	O	O
month	O	O
8	O	O
.	O	O

The	O	O
significant	O	O
decrease	O	O
in	O	O
the	O	O
total	O	O
number	O	O
of	O	O
anaerobic	O	O
CFU	O	O
in	O	O
samples	O	O
from	O	O
the	O	O
teeth	O	O
was	O	O
not	O	O
associated	O	O
with	O	O
a	O	O
reduction	O	O
in	O	O
the	O	O
number	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
so	O	O
that	O	O
also	O	O
for	O	O
this	O	O
niche	O	O
the	O	O
relative	O	O
proportion	O	O
of	O	O
the	O	O
latter	O	O
increased	O	O
.	O	O

The	O	O
number	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
for	O	O
the	O	O
different	O	O
niches	O	O
showed	O	O
only	O	O
negligible	O	O
changes	O	O
(	O	O
within	O	O
0.5	O	O
log	O	O
values	O	O
)	O	O
,	O	O
except	O	O
for	O	O
samples	O	O
from	O	O
the	O	O
teeth	O	O
for	O	O
which	O	O
a	O	O
small	O	O
(	O	O
1	O	O
log	O	O
)	O	O
,	O	O
but	O	O
statistically	O	O
significant	O	O
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
,	O	O
reduction	O	O
could	O	O
be	O	O
detected	O	O
.	O	O

The	O	O
periodontal	O	O
conditions	O	O
improved	O	O
for	O	O
all	O	O
patients	O	O
,	O	O
but	O	O
the	O	O
caries	O	O
activity	O	O
could	O	O
not	O	O
be	O	O
arrested	O	O
.	O	O

These	O	O
findings	O	O
seem	O	O
to	O	O
indicate	O	O
that	O	O
the	O	O
increased	O	O
caries	O	O
susceptibility	O	O
after	O	O
periodontal	O	O
therapy	O	O
might	O	O
partially	O	O
be	O	O
explained	O	O
by	O	O
a	O	O
significant	O	O
increase	O	O
in	O	O
the	O	O
number	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
due	O	O
to	O	O
ecological	O	O
changes	O	O
within	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
clinical	O	O
consequence	O	O
of	O	O
this	O	O
observation	O	O
would	O	O
be	O	O
to	O	O
advocate	O	O
a	O	O
more	O	O
strict	O	O
caries	O	O
preventive	O	O
program	O	O
during	O	O
initial	O	O
periodontal	O	O
therapy	O	O
.	O	O

The	O	O
many	O	O
viruses	O	O
associated	O	O
with	O	O
Pagetic	O	O
osteoclasts	O	O
could	O	O
be	O	O
opportunistic	O	O
rather	O	O
than	O	O
causative	O	O
.	O	O

Some	O	O
mouth	O	O
bacteria	O	O
can	O	O
lyse	O	O
bone	O	O
.	O	O

One	O	O
(	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
)	O	O
can	O	O
grow	O	O
and	O	O
even	O	O
multiply	O	O
inside	O	O
human	O	O
cell	O	O
lines	O	O
in	O	O
culture	O	O
,	O	O
producing	O	O
osteolytic	O	O
materials	O	O
--	O	O
one	O	O
62	O	O
kDa	O	O
protein	O	O
having	O	O
a	O	O
potency	O	O
in	O	O
the	O	O
picomolar	O	O
range	O	O
.	O	O

A	O	O
small	O	O
focus	O	O
of	O	O
this	O	O
,	O	O
or	O	O
of	O	O
one	O	O
of	O	O
the	O	O
other	O	O
periodontitis-causing	O	O
bacteria	O	O
,	O	O
in	O	O
a	O	O
bone	O	O
might	O	O
gradually	O	O
spread	O	O
its	O	O
influence	O	O
to	O	O
activate	O	O
osteoclasts	O	O
--	O	O
the	O	O
first	O	O
stage	O	O
in	O	O
Paget	O	O
's	O	O
disease	O	O
.	O	O

The	O	O
focus	O	O
in	O	O
each	O	O
bone	O	O
might	O	O
be	O	O
small	O	O
and	O	O
easily	O	O
overlooked	O	O
,	O	O
as	O	O
other	O	O
intracellular	O	O
bacteria	O	O
have	O	O
been	O	O
in	O	O
the	O	O
past	O	O
.	O	O

The	O	O
reduced	O	O
susceptibility	O	O
to	O	O
phagocytosis	O	O
found	O	O
among	O	O
some	O	O
periodontopathogenic	B-bacteria	B-bacteria
anaerobes	E-bacteria	I-bacteria
may	O	O
account	O	O
for	O	O
the	O	O
differences	O	O
between	O	O
invasive	O	O
and	O	O
non-invasive	O	O
strains	O	O
.	O	O

We	O	O
applied	O	O
flow	O	O
cytometry	O	O
as	O	O
a	O	O
powerful	O	O
tool	O	O
to	O	O
analyze	O	O
and	O	O
quantify	O	O
phagocytosis	O	O
using	O	O
standardized	O	O
cultures	O	O
of	O	O
oral	O	O
anaerobes	B-bacteria	B-bacteria
(	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
Capnocytophaga	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
C.	B-bacteria	B-bacteria
ochracea	E-bacteria	I-bacteria
,	O	O
C.	B-bacteria	B-bacteria
sputigena	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
Peptostreptococcus	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
)	O	O
and	O	O
heparinized	O	O
whole	O	O
blood	O	O
.	O	O

Bacteria	O	O
were	O	O
labeled	O	O
by	O	O
a	O	O
fluorescein-methylester	O	O
and	O	O
their	O	O
esterase	O	O
activity	O	O
,	O	O
resulting	O	O
in	O	O
green	O	O
fluorescence	O	O
.	O	O

Ingested	O	O
bacteria	O	O
could	O	O
be	O	O
detected	O	O
easily	O	O
and	O	O
quantified	O	O
by	O	O
a	O	O
shift	O	O
towards	O	O
green	O	O
fluorescence	O	O
in	O	O
the	O	O
PMNL	O	O
population	O	O
involved	O	O
and	O	O
a	O	O
concomitant	O	O
decrease	O	O
in	O	O
the	O	O
bacterial	O	O
population	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
oxidative	O	O
burst	O	O
of	O	O
PMNLs	O	O
was	O	O
detected	O	O
in	O	O
parallel	O	O
assays	O	O
using	O	O
the	O	O
dye	O	O
DHR123	O	O
which	O	O
becomes	O	O
fluorescent	O	O
upon	O	O
oxidation	O	O
during	O	O
the	O	O
oxidative	O	O
burst	O	O
process	O	O
.	O	O

We	O	O
found	O	O
a	O	O
great	O	O
diversity	O	O
in	O	O
phagocytosis	O	O
susceptibility	O	O
determined	O	O
by	O	O
estimating	O	O
the	O	O
portion	O	O
of	O	O
phagocytosing	O	O
PMNLs	O	O
,	O	O
ranging	O	O
from	O	O
10.6	O	O
%	O	O
(	O	O
strain	B-bacteria	B-bacteria
W83	E-bacteria	I-bacteria
)	O	O
to	O	O
>	O	O
99.4	O	O
%	O	O
(	O	O
e.g	O	O
.	O	O

ATCC	B-bacteria	B-bacteria
33277T	E-bacteria	I-bacteria
)	O	O
in	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
from	O	O
15.9	O	O
%	O	O
(	O	O
strain	B-bacteria	B-bacteria
MH5	E-bacteria	I-bacteria
)	O	O
to	O	O
>	O	O
95	O	O
%	O	O
(	O	O
ATCC	B-bacteria	B-bacteria
33563T	E-bacteria	I-bacteria
)	O	O
in	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
.	O	O

In	O	O
contrast	O	O
,	O	O
almost	O	O
all	O	O
P.	B-bacteria	B-bacteria
intermedia	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
as	O	O
well	O	O
as	O	O
the	O	O
representatives	O	O
of	O	O
the	O	O
other	O	O
anaerobic	O	O
,	O	O
putative	O	O
periodontopathic	O	O
species	O	O
tested	O	O
showed	O	O
no	O	O
or	O	O
only	O	O
moderate	O	O
resistance	O	O
in	O	O
the	O	O
phagocytosis	O	O
assay	O	O
.	O	O

Comparison	O	O
of	O	O
clinical	O	O
data	O	O
of	O	O
patients	O	O
and	O	O
the	O	O
extent	O	O
of	O	O
phagocytosis	O	O
resistance	O	O
of	O	O
the	O	O
corresponding	O	O
P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
suggests	O	O
that	O	O
this	O	O
virulence	O	O
factor	O	O
may	O	O
contribute	O	O
to	O	O
the	O	O
clinical	O	O
outcome	O	O
.	O	O

Recent	O	O
studies	O	O
showed	O	O
the	O	O
clinical	O	O
benefits	O	O
of	O	O
a	O	O
one	O	O
stage	O	O
full-mouth	O	O
disinfection	O	O
,	O	O
when	O	O
compared	O	O
to	O	O
the	O	O
worldwide	O	O
standard	O	O
treatmen	O	O
strategy	O	O
of	O	O
consecutive	O	O
root	O	O
planings	O	O
per	O	O
quadrant	O	O
without	O	O
proper	O	O
disinfection	O	O
of	O	O
the	O	O
remaining	O	O
intraoral	O	O
niches	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
microbiological	O	O
benefits	O	O
of	O	O
such	O	O
a	O	O
one	O	O
stage	O	O
full-mouth	O	O
disinfectio	O	O
with	O	O
special	O	O
attention	O	O
to	O	O
all	O	O
intraoral	O	O
niches	O	O
for	O	O
periodontopathogens	O	O
and	O	O
to	O	O
evaluate	O	O
the	O	O
perception	O	O
by	O	O
the	O	O
patients	O	O
of	O	O
the	O	O
new	O	O
treatment	O	O
strategy	O	O
.	O	O

Sixteen	O	O
patients	O	O
with	O	O
early-onset	O	O
periodontitis	O	O
and	O	O
24	O	O
patients	O	O
with	O	O
severe	O	O
adult	O	O
periodontitis	O	O
were	O	O
randomly	O	O
assigned	O	O
to	O	O
test	O	O
and	O	O
control	O	O
groups	O	O
.	O	O

The	O	O
control	O	O
group	O	O
was	O	O
scaled	O	O
and	O	O
root	O	O
planed	O	O
,	O	O
per	O	O
quadrant	O	O
,	O	O
at	O	O
2-week	O	O
intervals	O	O
and	O	O
given	O	O
oral	O	O
hygiene	O	O
instructions	O	O
.	O	O

The	O	O
test	O	O
group	O	O
received	O	O
the	O	O
one	O	O
stage	O	O
full-mouth	O	O
disinfection	O	O
treatment	O	O
.	O	O

At	O	O
baseline	O	O
and	O	O
after	O	O
1	O	O
,	O	O
2	O	O
,	O	O
4	O	O
,	O	O
and	O	O
8	O	O
months	O	O
,	O	O
microbiological	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
all	O	O
niches	O	O
(	O	O
tongue	O	O
,	O	O
mucosa	O	O
,	O	O
saliva	O	O
,	O	O
and	O	O
pooled	O	O
samples	O	O
from	O	O
single-	O	O
and	O	O
multi-rooted	O	O
teeth	O	O
)	O	O
.	O	O

The	O	O
samples	O	O
were	O	O
cultured	O	O
on	O	O
selective	O	O
and	O	O
non-selective	O	O
media	O	O
.	O	O

Patient	O	O
perception	O	O
of	O	O
the	O	O
treatment	O	O
was	O	O
evaluated	O	O
using	O	O
a	O	O
questionnaire	O	O
.	O	O

In	O	O
comparison	O	O
to	O	O
the	O	O
standard	O	O
therapy	O	O
,	O	O
the	O	O
one	O	O
stage	O	O
full-mouth	O	O
disinfection	O	O
resulted	O	O
in	O	O
significant	O	O
additional	O	O
microbial	O	O
improvements	O	O
.	O	O

The	O	O
test	O	O
group	O	O
showed	O	O
larger	O	O
reductions	O	O
in	O	O
the	O	O
proportions	O	O
of	O	O
spirochetes	B-bacteria	B-bacteria
and	O	O
motile	O	O
organisms	O	O
in	O	O
the	O	O
subgingival	O	O
flora	O	O
,	O	O
and	O	O
more	O	O
significant	O	O
reductions	O	O
in	O	O
the	O	O
density	O	O
of	O	O
key	O	O
pathogens	O	O
,	O	O
with	O	O
even	O	O
the	O	O
eradication	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

The	O	O
beneficial	O	O
effects	O	O
in	O	O
the	O	O
other	O	O
niches	O	O
were	O	O
primarily	O	O
restricted	O	O
to	O	O
the	O	O
number	O	O
of	O	O
colony-forming	O	O
units/ml	O	O
of	O	O
black-pigmented	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
especially	O	O
on	O	O
the	O	O
mucosa	O	O
and	O	O
in	O	O
the	O	O
saliva	O	O
and	O	O
to	O	O
a	O	O
lesser	O	O
extent	O	O
on	O	O
the	O	O
tongue	O	O
.	O	O

Both	O	O
treatments	O	O
were	O	O
well	O	O
tolerated	O	O
by	O	O
the	O	O
patients	O	O
and	O	O
the	O	O
overall	O	O
severity	O	O
rating	O	O
for	O	O
both	O	O
therapies	O	O
was	O	O
comparable	O	O
,	O	O
although	O	O
4	O	O
quadrants	O	O
were	O	O
treated	O	O
within	O	O
24	O	O
hours	O	O
in	O	O
the	O	O
test	O	O
group	O	O
versus	O	O
only	O	O
1	O	O
in	O	O
the	O	O
control	O	O
group	O	O
.	O	O

The	O	O
full-mouth	O	O
disinfection	O	O
approach	O	O
resulted	O	O
more	O	O
frequently	O	O
in	O	O
a	O	O
slight	O	O
increase	O	O
of	O	O
body	O	O
temperature	O	O
,	O	O
especially	O	O
after	O	O
the	O	O
second	O	O
day	O	O
.	O	O

These	O	O
findings	O	O
support	O	O
the	O	O
benefit	O	O
of	O	O
a	O	O
one	O	O
stage	O	O
full-mouth	O	O
disinfection	O	O
in	O	O
the	O	O
treatment	O	O
of	O	O
patients	O	O
with	O	O
either	O	O
chronic	O	O
adult	O	O
or	O	O
early-onset	O	O
periodontitis	O	O
.	O	O

Ninety-one	O	O
isolates	O	O
of	O	O
nutritionally	B-bacteria	B-bacteria
variant	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
NVS	B-bacteria	B-bacteria
)	O	O
that	O	O
were	O	O
previously	O	O
isolated	O	O
from	O	O
the	O	O
human	O	O
mouth	O	O
were	O	O
regarded	O	O
as	O	O
consisting	O	O
of	O	O
7	O	O
Streptococcus	B-bacteria	B-bacteria
defectivus	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
,	O	O
78	O	O
Streptococcus	B-bacteria	B-bacteria
adjacens	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
,	O	O
and	O	O
6	O	O
Gemella	B-bacteria	B-bacteria
morbillorum	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
.	O	O

However	O	O
,	O	O
recent	O	O
references	O	O
to	O	O
the	O	O
taxonomic	O	O
reclassification	O	O
of	O	O
NVS	B-bacteria	B-bacteria
,	O	O
from	O	O
S.	B-bacteria	B-bacteria
defectivus	E-bacteria	I-bacteria
to	O	O
Abiotrophia	B-bacteria	B-bacteria
defectiva	E-bacteria	I-bacteria
and	O	O
from	O	O
S.	B-bacteria	B-bacteria
adjacens	E-bacteria	I-bacteria
to	O	O
Abiotrophia	B-bacteria	B-bacteria
adiacens	E-bacteria	I-bacteria
,	O	O
and	O	O
the	O	O
newly	O	O
introduced	O	O
species	O	O
Abiotrophia	B-bacteria	B-bacteria
elegans	E-bacteria	I-bacteria
as	O	O
a	O	O
third	O	O
Abiotrophia	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
emphasize	O	O
the	O	O
need	O	O
for	O	O
genetic	O	O
analyses	O	O
for	O	O
identification	O	O
of	O	O
NVS	B-bacteria	B-bacteria
.	O	O

When	O	O
PCR-restriction	O	O
fragment	O	O
length	O	O
polymorphism	O	O
(	O	O
RFLP	O	O
)	O	O
and	O	O
phylogenetic	O	O
distances	O	O
were	O	O
examined	O	O
based	O	O
on	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
,	O	O
the	O	O
results	O	O
indicated	O	O
that	O	O
7	O	O
of	O	O
the	O	O
91	O	O
NVS	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
were	O	O
closely	O	O
related	O	O
to	O	O
A.	B-bacteria	B-bacteria
elegans	E-bacteria	I-bacteria
.	O	O

These	O	O
seven	O	O
isolates	O	O
consisted	O	O
of	O	O
four	O	O
isolates	O	O
previously	O	O
identified	O	O
as	O	O
G.	B-bacteria	B-bacteria
morbillorum	E-bacteria	I-bacteria
and	O	O
three	O	O
isolates	O	O
previously	O	O
identified	O	O
as	O	O
S.	B-bacteria	B-bacteria
adjacens	E-bacteria	I-bacteria
.	O	O

Two	O	O
isolates	O	O
previously	O	O
identified	O	O
as	O	O
G.	B-bacteria	B-bacteria
morbillorum	E-bacteria	I-bacteria
were	O	O
related	O	O
to	O	O
A.	B-bacteria	B-bacteria
adiacens	E-bacteria	I-bacteria
.	O	O

In	O	O
biochemical	O	O
tests	O	O
,	O	O
A.	B-bacteria	B-bacteria
elegans	E-bacteria	I-bacteria
and	O	O
the	O	O
seven	O	O
isolates	O	O
related	O	O
to	O	O
it	O	O
possessed	O	O
arginine	O	O
dihydrolase	O	O
(	O	O
ADH	O	O
)	O	O
activity	O	O
but	O	O
the	O	O
other	O	O
Abiotrophia	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
did	O	O
not	O	O
.	O	O

As	O	O
a	O	O
result	O	O
,	O	O
A.	B-bacteria	B-bacteria
elegans	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
comprised	O	O
8	O	O
%	O	O
of	O	O
the	O	O
91	O	O
NVS	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
.	O	O

Our	O	O
findings	O	O
suggest	O	O
that	O	O
A.	B-bacteria	B-bacteria
elegans	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
adiacens	E-bacteria	I-bacteria
,	O	O
and	O	O
A.	B-bacteria	B-bacteria
defectiva	E-bacteria	I-bacteria
exist	O	O
in	O	O
the	O	O
human	O	O
mouth	O	O
in	O	O
proportions	O	O
of	O	O
about	O	O
1:11:1	O	O
and	O	O
that	O	O
A.	B-bacteria	B-bacteria
elegans	E-bacteria	I-bacteria
can	O	O
be	O	O
genetically	O	O
distinguished	O	O
from	O	O
the	O	O
other	O	O
two	O	O
Abiotrophia	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
by	O	O
PCR-RFLP	O	O
analysis	O	O
of	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
and	O	O
can	O	O
be	O	O
biochemically	O	O
distinguished	O	O
by	O	O
ADH	O	O
activity	O	O
.	O	O

It	O	O
is	O	O
generally	O	O
assumed	O	O
that	O	O
a	O	O
decreased	O	O
salivary	O	O
secretion	O	O
rate	O	O
will	O	O
promote	O	O
plaque	O	O
accumulation	O	O
and	O	O
increase	O	O
the	O	O
risk	O	O
for	O	O
caries	O	O
,	O	O
gingival	O	O
inflammation	O	O
,	O	O
and	O	O
mucosal	O	O
infections	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
the	O	O
effect	O	O
of	O	O
hyposalivation	O	O
on	O	O
the	O	O
oral	O	O
microflora	O	O
was	O	O
examined	O	O
.	O	O

The	O	O
following	O	O
micro-organisms	O	O
were	O	O
analyzed	O	O
in	O	O
rinsing	O	O
samples	O	O
from	O	O
14	O	O
subjects	O	O
with	O	O
hyposalivation	O	O
:	O	O
the	O	O
total	O	O
number	O	O
of	O	O
anaerobically	O	O
growing	O	O
micro-organisms	O	O
,	O	O
alpha-hemolytic	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
lactobacilli	B-bacteria	B-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia/Prevotella	I-bacteria	I-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
Candida	O	O
albicans	O	O
,	O	O
and	O	O
enterics	B-bacteria	B-bacteria
.	O	O

The	O	O
study	O	O
group	O	O
,	O	O
age	O	O
53	O	O
+/-	O	O
7	O	O
years	O	O
,	O	O
had	O	O
no	O	O
history	O	O
of	O	O
radiation	O	O
therapy	O	O
and	O	O
showed	O	O
no	O	O
signs	O	O
of	O	O
inflammation	O	O
in	O	O
their	O	O
salivary	O	O
glands	O	O
on	O	O
biopsy	O	O
.	O	O

All	O	O
were	O	O
dentate	O	O
with	O	O
a	O	O
mean	O	O
of	O	O
24	O	O
+/-	O	O
3	O	O
teeth	O	O
.	O	O

Their	O	O
salivary	O	O
secretion	O	O
rates	O	O
were	O	O
0.03	O	O
+/-	O	O
0.02	O	O
mL/min	O	O
(	O	O
unstimulated	O	O
)	O	O
and	O	O
0.84	O	O
+/-	O	O
0.65	O	O
mL/min	O	O
(	O	O
stimulated	O	O
)	O	O
.	O	O

The	O	O
control	O	O
group	O	O
was	O	O
matched	O	O
to	O	O
the	O	O
hyposalivation	O	O
group	O	O
according	O	O
to	O	O
age	O	O
,	O	O
sex	O	O
,	O	O
and	O	O
number	O	O
of	O	O
teeth	O	O
.	O	O

There	O	O
was	O	O
a	O	O
significantly	O	O
increased	O	O
number	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
,	O	O
and	O	O
a	O	O
tendency	O	O
,	O	O
not	O	O
statistically	O	O
significant	O	O
and	O	O
with	O	O
large	O	O
variations	O	O
within	O	O
the	O	O
groups	O	O
,	O	O
toward	O	O
a	O	O
higher	O	O
proportion	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
a	O	O
lower	O	O
proportion	O	O
of	O	O
alpha-hemolytic	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
in	O	O
the	O	O
hyposalivation	O	O
group	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
micro-organisms	O	O
associated	O	O
with	O	O
gingival	O	O
inflammation	O	O
and	O	O
mucosal	O	O
infections	O	O
was	O	O
comparable	O	O
with	O	O
that	O	O
in	O	O
the	O	O
healthy	O	O
controls	O	O
.	O	O

The	O	O
results	O	O
indicated	O	O
that	O	O
a	O	O
low	O	O
salivary	O	O
secretion	O	O
rate	O	O
mainly	O	O
promotes	O	O
a	O	O
flora	O	O
associated	O	O
with	O	O
the	O	O
development	O	O
of	O	O
caries	O	O
.	O	O

An	O	O
association	O	O
between	O	O
oral	O	O
conditions	O	O
such	O	O
as	O	O
periodontal	O	O
disease	O	O
and	O	O
several	O	O
respiratory	O	O
conditions	O	O
has	O	O
been	O	O
noted	O	O
.	O	O

For	O	O
example	O	O
,	O	O
recent	O	O
evidence	O	O
has	O	O
suggested	O	O
a	O	O
central	O	O
role	O	O
for	O	O
the	O	O
oral	O	O
cavity	O	O
in	O	O
the	O	O
process	O	O
of	O	O
respiratory	O	O
infection	O	O
.	O	O

Oral	O	O
periodontopathic	O	O
bacteria	O	O
can	O	O
be	O	O
aspirated	O	O
into	O	O
the	O	O
lung	O	O
to	O	O
cause	O	O
aspiration	O	O
pneumonia	O	O
.	O	O

The	O	O
teeth	O	O
may	O	O
also	O	O
serve	O	O
as	O	O
a	O	O
reservoir	O	O
for	O	O
respiratory	O	O
pathogen	O	O
colonization	O	O
and	O	O
subsequent	O	O
nosocomial	O	O
pneumonia	O	O
.	O	O

Typical	O	O
respiratory	O	O
pathogens	O	O
have	O	O
been	O	O
shown	O	O
to	O	O
colonize	O	O
the	O	O
dental	O	O
plaque	O	O
of	O	O
hospitalized	O	O
intensive	O	O
care	O	O
and	O	O
nursing	O	O
home	O	O
patients	O	O
.	O	O

Once	O	O
established	O	O
in	O	O
the	O	O
mouth	O	O
,	O	O
these	O	O
pathogens	O	O
may	O	O
be	O	O
aspirated	O	O
into	O	O
the	O	O
lung	O	O
to	O	O
cause	O	O
infection	O	O
.	O	O

Other	O	O
epidemiologic	O	O
studies	O	O
have	O	O
noted	O	O
a	O	O
relationship	O	O
between	O	O
poor	O	O
oral	O	O
hygiene	O	O
or	O	O
periodontal	O	O
bone	O	O
loss	O	O
and	O	O
chronic	O	O
obstructive	O	O
pulmonary	O	O
disease	O	O
.	O	O

Several	O	O
mechanisms	O	O
are	O	O
proposed	O	O
to	O	O
explain	O	O
the	O	O
potential	O	O
role	O	O
of	O	O
oral	O	O
bacteria	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
respiratory	O	O
infection	O	O
:	O	O
1.	O	O
aspiration	O	O
of	O	O
oral	O	O
pathogens	O	O
(	O	O
such	O	O
as	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
etc	O	O
.	O	O
)	O	O

into	O	O
the	O	O
lung	O	O
to	O	O
cause	O	O
infection	O	O
;	O	O
2.	O	O
periodontal	O	O
disease-associated	O	O
enzymes	O	O
in	O	O
saliva	O	O
may	O	O
modify	O	O
mucosal	O	O
surfaces	O	O
to	O	O
promote	O	O
adhesion	O	O
and	O	O
colonization	O	O
by	O	O
respiratory	O	O
pathogens	O	O
,	O	O
which	O	O
are	O	O
then	O	O
aspirated	O	O
into	O	O
the	O	O
lung	O	O
;	O	O
3.	O	O
periodontal	O	O
disease-associated	O	O
enzymes	O	O
may	O	O
destroy	O	O
salivary	O	O
pellicles	O	O
on	O	O
pathogenic	O	O
bacteria	O	O
to	O	O
hinder	O	O
their	O	O
clearance	O	O
from	O	O
the	O	O
mucosal	O	O
surface	O	O
;	O	O
and	O	O
4.	O	O
cytokines	O	O
originating	O	O
from	O	O
periodontal	O	O
tissues	O	O
may	O	O
alter	O	O
respiratory	O	O
epithelium	O	O
to	O	O
promote	O	O
infection	O	O
by	O	O
respiratory	O	O
pathogens	O	O
.	O	O

The	O	O
majority	O	O
of	O	O
cases	O	O
of	O	O
oral	O	O
malodour	O	O
are	O	O
thought	O	O
to	O	O
be	O	O
due	O	O
to	O	O
bacterial	O	O
activities	O	O
in	O	O
the	O	O
mouth	O	O
,	O	O
but	O	O
many	O	O
of	O	O
the	O	O
bacterial	O	O
species	O	O
responsible	O	O
have	O	O
not	O	O
been	O	O
identified	O	O
.	O	O

Volatile	O	O
sulphide	O	O
compounds	O	O
have	O	O
been	O	O
proposed	O	O
as	O	O
constituents	O	O
of	O	O
oral	O	O
malodour	O	O
.	O	O

Therefore	O	O
,	O	O
the	O	O
relation	O	O
between	O	O
intensity	O	O
of	O	O
odour	O	O
and	O	O
numbers	O	O
of	O	O
bacteria	O	O
in	O	O
the	O	O
mouth	O	O
that	O	O
are	O	O
sulphide-producing	O	O
from	O	O
sulphate	O	O
was	O	O
investigated	O	O
.	O	O

Numbers	O	O
of	O	O
such	O	O
dissimilatory	B-bacteria	B-bacteria
sulphate-reducing	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
SRB	B-bacteria	B-bacteria
)	O	O
and	O	O
sulphide	O	O
reduction	O	O
rates	O	O
were	O	O
evaluated	O	O
in	O	O
samples	O	O
from	O	O
different	O	O
oral	O	O
sites	O	O
in	O	O
relation	O	O
to	O	O
measures	O	O
of	O	O
oral	O	O
malodour	O	O
.	O	O

Results	O	O
showed	O	O
that	O	O
sulphate-reducing	O	O
bacterial	O	O
numbers	O	O
and	O	O
activities	O	O
were	O	O
negatively	O	O
correlated	O	O
with	O	O
malodour	O	O
,	O	O
as	O	O
determined	O	O
by	O	O
organoleptic	O	O
assessment	O	O
and	O	O
measurement	O	O
with	O	O
a	O	O
sulphide-monitoring	O	O
instrument	O	O
,	O	O
the	O	O
Halimeter	O	O
.	O	O

The	O	O
data	O	O
indicate	O	O
that	O	O
sulphide	O	O
produced	O	O
by	O	O
oral	O	O
SRB	B-bacteria	B-bacteria
may	O	O
not	O	O
be	O	O
an	O	O
important	O	O
contributor	O	O
to	O	O
oral	O	O
malodour	O	O
.	O	O

A	O	O
rather	O	O
poor	O	O
correlation	O	O
was	O	O
observed	O	O
between	O	O
Halimetric	O	O
and	O	O
organoleptic	O	O
values	O	O
,	O	O
indicating	O	O
that	O	O
these	O	O
methods	O	O
may	O	O
measure	O	O
different	O	O
aspects	O	O
of	O	O
oral	O	O
malodour	O	O
intensity	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
monitor	O	O
the	O	O
presence	O	O
of	O	O
sulfate-reducing	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
SRB	B-bacteria	B-bacteria
)	O	O
at	O	O
different	O	O
sites	O	O
in	O	O
the	O	O
mouths	O	O
of	O	O
both	O	O
healthy	O	O
individuals	O	O
and	O	O
periodontitis	O	O
patients	O	O
.	O	O

In	O	O
20	O	O
healthy	O	O
subjects	O	O
and	O	O
21	O	O
periodontitis	O	O
patients	O	O
,	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
the	O	O
palate	O	O
,	O	O
vestibulum	O	O
,	O	O
dorsum	O	O
of	O	O
the	O	O
tongue	O	O
,	O	O
supragingival	O	O
plaque	O	O
,	O	O
and	O	O
periodontal	O	O
pockets	O	O
.	O	O

In	O	O
order	O	O
to	O	O
demonstrate	O	O
growth	O	O
of	O	O
SRB	B-bacteria	B-bacteria
,	O	O
samples	O	O
were	O	O
incubated	O	O
in	O	O
an	O	O
anoxic	O	O
chamber	O	O
in	O	O
a	O	O
reduced	O	O
growth-medium	O	O
for	O	O
SRB	B-bacteria	B-bacteria
,	O	O
with	O	O
an	O	O
iron-indicator	O	O
for	O	O
sulfide	O	O
production	O	O
.	O	O

The	O	O
SRB	B-bacteria	B-bacteria
were	O	O
detected	O	O
throughout	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

They	O	O
were	O	O
found	O	O
on	O	O
the	O	O
mucosa	O	O
in	O	O
10	O	O
%	O	O
of	O	O
both	O	O
healthy	O	O
subjects	O	O
and	O	O
periodontitis	O	O
patients	O	O
.	O	O

On	O	O
the	O	O
tongue	O	O
and	O	O
in	O	O
supragingival	O	O
plaque	O	O
,	O	O
the	O	O
frequency	O	O
of	O	O
detection	O	O
was	O	O
slightly	O	O
higher	O	O
(	O	O
22	O	O
%	O	O
of	O	O
the	O	O
subjects	O	O
)	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
86	O	O
%	O	O
of	O	O
the	O	O
periodontitis	O	O
patients	O	O
harbored	O	O
SRB	B-bacteria	B-bacteria
in	O	O
one	O	O
or	O	O
more	O	O
pockets	O	O
.	O	O

In	O	O
1/3	O	O
of	O	O
the	O	O
patients	O	O
,	O	O
SRB	B-bacteria	B-bacteria
were	O	O
present	O	O
in	O	O
all	O	O
3	O	O
pockets	O	O
that	O	O
were	O	O
sampled	O	O
.	O	O

The	O	O
data	O	O
indicated	O	O
that	O	O
SRB	B-bacteria	B-bacteria
belong	O	O
to	O	O
the	O	O
normal	O	O
oral	O	O
microbiota	O	O
,	O	O
and	O	O
have	O	O
a	O	O
preference	O	O
for	O	O
periodontal	O	O
pockets	O	O
.	O	O

This	O	O
study	O	O
examined	O	O
and	O	O
compared	O	O
levels	O	O
of	O	O
salivary	O	O
bacteria	O	O
which	O	O
produced	O	O
volatile	O	O
sulfur	O	O
compounds	O	O
(	O	O
VSC	O	O
)	O	O
in	O	O
young	O	O
children	O	O
with	O	O
and	O	O
without	O	O
oral	O	O
malodor	O	O
.	O	O

Clinic	O	O
populations	O	O
of	O	O
children	O	O
aged	O	O
two	O	O
to	O	O
seven	O	O
years	O	O
,	O	O
whose	O	O
parents	O	O
presented	O	O
with	O	O
an	O	O
unsolicited	O	O
major	O	O
complaint	O	O
of	O	O
oral	O	O
malodor	O	O
in	O	O
their	O	O
child	O	O
(	O	O
OM+	O	O
)	O	O
,	O	O
or	O	O
aged-matched	O	O
controls	O	O
in	O	O
whom	O	O
oral	O	O
malodor	O	O
was	O	O
not	O	O
detected	O	O
by	O	O
parents	O	O
(	O	O
OM-	O	O
)	O	O
,	O	O
were	O	O
investigated	O	O
.	O	O

Saliva	O	O
specimens	O	O
were	O	O
cultured	O	O
anaerobically	O	O
on	O	O
media	O	O
that	O	O
differentiated	O	O
VSC+	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

These	O	O
were	O	O
quantified	O	O
and	O	O
identified	O	O
.	O	O

Levels	O	O
in	O	O
OM+	O	O
and	O	O
OM-	O	O
children	O	O
were	O	O
compared	O	O
and	O	O
statistically	O	O
analyzed	O	O
.	O	O

OM+	O	O
children	O	O
harbored	O	O
significantly	O	O
higher	O	O
levels	O	O
of	O	O
VSC+	O	O
isolates	O	O
in	O	O
saliva	O	O
than	O	O
OM-	O	O
children	O	O
(	O	O
OM+	O	O
=	O	O
44	O	O
%	O	O
of	O	O
total	O	O
viable	O	O
counts	O	O
,	O	O
TVC	O	O
;	O	O
OM-	O	O
=	O	O
24	O	O
%	O	O
of	O	O
TVC	O	O
;	O	O
P	O	O
=	O	O
0.0083	O	O
)	O	O
.	O	O

Types	O	O
of	O	O
recovered	O	O
bacterial	O	O
species	O	O
did	O	O
not	O	O
differ	O	O
in	O	O
the	O	O
two	O	O
groups	O	O
,	O	O
but	O	O
levels	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
were	O	O
significantly	O	O
higher	O	O
in	O	O
OM+	O	O
children	O	O
(	O	O
P	O	O
=	O	O
0.0001	O	O
)	O	O
.	O	O

Veillonella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
followed	O	O
by	O	O
P.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
were	O	O
the	O	O
predominant	O	O
VSC+	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
recovered	O	O
in	O	O
both	O	O
populations	O	O
.	O	O

VSC+	B-bacteria	B-bacteria
salivary	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
may	O	O
differ	O	O
both	O	O
in	O	O
type	O	O
and	O	O
quantity	O	O
in	O	O
young	O	O
children	O	O
with	O	O
and	O	O
without	O	O
parent-perceived	O	O
oral	O	O
malodor	O	O
.	O	O

Peptides	O	O
derived	O	O
from	O	O
the	O	O
N-terminal	O	O
domain	O	O
that	O	O
comprises	O	O
an	O	O
amphipathic	O	O
alpha-helix	O	O
in	O	O
human	O	O
lactoferrin	O	O
(	O	O
LFh	O	O
18-31	O	O
and	O	O
LFh	O	O
20-38	O	O
)	O	O
and	O	O
bovine	O	O
lactoferrin	O	O
(	O	O
LFb	O	O
17-30	O	O
and	O	O
LFb	O	O
19-37	O	O
)	O	O
were	O	O
chemically	O	O
synthesised	O	O
.	O	O

Since	O	O
many	O	O
positively	O	O
charged	O	O
amphipathic	O	O
alpha-helices	O	O
contain	O	O
antimicrobial	O	O
activity	O	O
,	O	O
the	O	O
peptides	O	O
were	O	O
tested	O	O
for	O	O
their	O	O
antimicrobial	O	O
activity	O	O
against	O	O
various	O	O
oral	O	O
pathogens	O	O
.	O	O

Both	O	O
peptides	O	O
from	O	O
bovine	O	O
lactoferrin	O	O
had	O	O
more	O	O
potent	O	O
antimicrobial	O	O
activities	O	O
than	O	O
the	O	O
human	O	O
equivalent	O	O
.	O	O

Peptide	O	O
LFb	O	O
17-30	O	O
,	O	O
containing	O	O
the	O	O
largest	O	O
number	O	O
of	O	O
positively	O	O
charged	O	O
amino	O	O
acids	O	O
,	O	O
showed	O	O
the	O	O
highest	O	O
antimicrobial	O	O
activity	O	O
to	O	O
both	O	O
Gram-positive	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

Since	O	O
native	O	O
lactoferrin	O	O
molecules	O	O
had	O	O
no	O	O
killing	O	O
activity	O	O
,	O	O
release	O	O
of	O	O
these	O	O
peptides	O	O
from	O	O
the	O	O
native	O	O
protein	O	O
should	O	O
be	O	O
investigated	O	O
to	O	O
explore	O	O
the	O	O
use	O	O
in	O	O
oral	O	O
care	O	O
products	O	O
.	O	O

Thirty	O	O
patients	O	O
with	O	O
oral	O	O
mucosal	O	O
cancer	O	O
were	O	O
studied	O	O
in	O	O
relation	O	O
to	O	O
oral	O	O
mucosal	O	O
damage	O	O
and	O	O
bacterial	O	O
translocation	O	O
to	O	O
the	O	O
regional	O	O
lymph	O	O
nodes	O	O
in	O	O
the	O	O
neck	O	O
.	O	O

All	O	O
30	O	O
patients	O	O
(	O	O
gingiva	O	O
11	O	O
,	O	O
tongue	O	O
13	O	O
,	O	O
cheek	O	O
mucosa	O	O
four	O	O
,	O	O
oral	O	O
floor	O	O
two	O	O
)	O	O
underwent	O	O
extensive	O	O
,	O	O
clean-contaminated	O	O
,	O	O
head-and-neck	O	O
surgery	O	O
(	O	O
including	O	O
neck	O	O
dissection	O	O
)	O	O
with	O	O
free	O	O
flap	O	O
reconstruction	O	O
.	O	O

A	O	O
total	O	O
of	O	O
153	O	O
lymph	O	O
nodes	O	O
was	O	O
harvested	O	O
for	O	O
microbial	O	O
and	O	O
histological	O	O
examination	O	O
.	O	O

Viable	O	O
bacteria	O	O
were	O	O
isolated	O	O
from	O	O
70	O	O
lymph	O	O
nodes	O	O
(	O	O
45.8	O	O
%	O	O
)	O	O
from	O	O
25	O	O
patients	O	O
(	O	O
83.3	O	O
%	O	O
)	O	O
.	O	O

Bacterial	O	O
cells	O	O
in	O	O
the	O	O
nodes	O	O
were	O	O
detected	O	O
by	O	O
scanning	O	O
electron	O	O
microscopy	O	O
.	O	O

Bacterial	O	O
translocation	O	O
was	O	O
found	O	O
more	O	O
often	O	O
in	O	O
metastatic	O	O
nodes	O	O
(	O	O
75.0	O	O
%	O	O
)	O	O
than	O	O
in	O	O
uninvolved	O	O
nodes	O	O
(	O	O
40.3	O	O
%	O	O
)	O	O
(	O	O
p	O	O
=	O	O
0.015	O	O
;	O	O
chi2	O	O
test	O	O
)	O	O
.	O	O

Gingival	O	O
carcinoma	O	O
yielded	O	O
56.4	O	O
%	O	O
of	O	O
bacterial	O	O
growth	O	O
in	O	O
the	O	O
regional	O	O
lymph	O	O
nodes	O	O
compared	O	O
to	O	O
tongue	O	O
(	O	O
40.3	O	O
%	O	O
)	O	O
,	O	O
oral	O	O
floor	O	O
(	O	O
40.0	O	O
%	O	O
)	O	O
and	O	O
cheek	O	O
mucosa	O	O
(	O	O
37.5	O	O
%	O	O
)	O	O
.	O	O

As	O	O
the	O	O
gingival	O	O
carcinoma	O	O
group	O	O
includes	O	O
more	O	O
T4	O	O
cases	O	O
(	O	O
11/11	O	O
;	O	O
100	O	O
%	O	O
)	O	O
than	O	O
the	O	O
other	O	O
three	O	O
groups	O	O
(	O	O
7/19	O	O
;	O	O
36.8	O	O
%	O	O
)	O	O
,	O	O
bacterial	O	O
translocation	O	O
in	O	O
uninvolved	O	O
nodes	O	O
could	O	O
be	O	O
caused	O	O
by	O	O
the	O	O
size	O	O
and	O	O
invasion	O	O
of	O	O
the	O	O
primary	O	O
oral	O	O
tumor	O	O
.	O	O

Oral	O	O
streptococci	B-bacteria	B-bacteria
(	O	O
Streptococcus	B-bacteria	B-bacteria
intermedius	E-bacteria	I-bacteria
,	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

constellatus	E-bacteria	I-bacteria
,	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

oralis	E-bacteria	I-bacteria
,	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

mitis	E-bacteria	I-bacteria
,	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

sanguis	E-bacteria	I-bacteria
,	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

salivarius	E-bacteria	I-bacteria
)	O	O
were	O	O
the	O	O
most	O	O
common	O	O
isolates	O	O
.	O	O

Aerobic	B-bacteria	B-bacteria
enteric	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
Enterococcus	B-bacteria	B-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
,	O	O
Klebsiella	B-bacteria	B-bacteria
etc	O	O
.	O	O
)	O	O

were	O	O
also	O	O
found	O	O
in	O	O
the	O	O
lymph	O	O
nodes	O	O
.	O	O

Among	O	O
the	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
Peptostreptococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

were	O	O
isolated	O	O
from	O	O
12	O	O
patients	O	O
.	O	O

Damaged	O	O
oral	O	O
mucosa	O	O
in	O	O
patients	O	O
with	O	O
oral	O	O
cancer	O	O
might	O	O
allow	O	O
the	O	O
new	O	O
bacterial	O	O
colonization	O	O
on	O	O
the	O	O
surface	O	O
and	O	O
subsequently	O	O
drain	O	O
the	O	O
bacteria	O	O
into	O	O
the	O	O
regional	O	O
lymph	O	O
nodes	O	O
as	O	O
well	O	O
as	O	O
the	O	O
general	O	O
circulation	O	O
.	O	O

Anaerobes	B-bacteria	B-bacteria
constitute	O	O
a	O	O
significant	O	O
part	O	O
of	O	O
bacterial	O	O
communities	O	O
in	O	O
human	O	O
mouths	O	O
.	O	O

Their	O	O
ability	O	O
to	O	O
colonize	O	O
and	O	O
survive	O	O
in	O	O
the	O	O
environment	O	O
,	O	O
where	O	O
remarkable	O	O
changes	O	O
occur	O	O
during	O	O
early	O	O
childhood	O	O
,	O	O
is	O	O
fundamental	O	O
for	O	O
oral	O	O
homeostasis	O	O
.	O	O

However	O	O
,	O	O
relatively	O	O
little	O	O
is	O	O
known	O	O
of	O	O
the	O	O
time	O	O
of	O	O
colonization	O	O
and	O	O
succession	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

This	O	O
article	O	O
presents	O	O
an	O	O
up-to-date	O	O
review	O	O
on	O	O
the	O	O
development	O	O
of	O	O
the	O	O
oral	O	O
anaerobic	O	O
microflora	O	O
in	O	O
respect	O	O
to	O	O
age	O	O
,	O	O
and	O	O
in	O	O
addition	O	O
,	O	O
considers	O	O
some	O	O
aspects	O	O
of	O	O
the	O	O
role	O	O
of	O	O
oral	O	O
anaerobes	B-bacteria	B-bacteria
in	O	O
health	O	O
and	O	O
disease	O	O
.	O	O

Behcet	O	O
's	O	O
disease	O	O
is	O	O
a	O	O
multisystem	O	O
disorder	O	O
of	O	O
unknown	O	O
etiology	O	O
,	O	O
affecting	O	O
predominantly	O	O
the	O	O
oral	O	O
mucosa	O	O
,	O	O
skin	O	O
,	O	O
and	O	O
eyes	O	O
.	O	O

Recurrent	O	O
and	O	O
painful	O	O
episodes	O	O
of	O	O
oral	O	O
ulcerations	O	O
interfere	O	O
with	O	O
regular	O	O
oral	O	O
hygiene	O	O
leading	O	O
to	O	O
rapid	O	O
bacterial	O	O
plaque	O	O
accumulation	O	O
.	O	O

The	O	O
aims	O	O
of	O	O
this	O	O
study	O	O
were	O	O
to	O	O
evaluate	O	O
the	O	O
periodontal	O	O
status	O	O
of	O	O
patients	O	O
with	O	O
Behcet	O	O
's	O	O
disease	O	O
and	O	O
determine	O	O
serum	O	O
antibody	O	O
responses	O	O
to	O	O
selected	O	O
oral	O	O
microorganisms	O	O
,	O	O
including	O	O
major	O	O
periodontopathogens	O	O
in	O	O
these	O	O
patients	O	O
.	O	O

Thirty-three	O	O
patients	O	O
with	O	O
Behcet	O	O
's	O	O
disease	O	O
and	O	O
15	O	O
healthy	O	O
subjects	O	O
were	O	O
included	O	O
in	O	O
the	O	O
study	O	O
.	O	O

Plaque	O	O
,	O	O
sulcular	O	O
bleeding	O	O
,	O	O
periodontal	O	O
index	O	O
scores	O	O
,	O	O
probing	O	O
depths	O	O
,	O	O
and	O	O
total	O	O
number	O	O
of	O	O
teeth	O	O
were	O	O
recorded	O	O
.	O	O

Serum	O	O
IgG	O	O
antibody	O	O
levels	O	O
to	O	O
a	O	O
panel	O	O
of	O	O
13	O	O
oral	O	O
microorganisms	O	O
were	O	O
determined	O	O
.	O	O

Significantly	O	O
higher	O	O
values	O	O
for	O	O
each	O	O
of	O	O
the	O	O
clinical	O	O
measures	O	O
were	O	O
observed	O	O
in	O	O
patients	O	O
with	O	O
Behcet	O	O
's	O	O
disease	O	O
compared	O	O
to	O	O
healthy	O	O
subjects	O	O
(	O	O
P	O	O
<	O	O
0.0001	O	O
)	O	O
.	O	O

Antibody	O	O
levels	O	O
to	O	O
selected	O	O
members	O	O
of	O	O
plaque	O	O
,	O	O
including	O	O
Actinomyces	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
Eikenella	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
,	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
,	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
were	O	O
significantly	O	O
lower	O	O
in	O	O
patients	O	O
with	O	O
Behcet	O	O
's	O	O
disease	O	O
than	O	O
in	O	O
controls	O	O
(	O	O
P	O	O
<	O	O
0.001-0.05	O	O
)	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
these	O	O
patients	O	O
exhibited	O	O
significantly	O	O
elevated	O	O
antibody	O	O
levels	O	O
to	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	I-bacteria	I-bacteria
Y4	E-bacteria	I-bacteria
compared	O	O
to	O	O
controls	O	O
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

Our	O	O
data	O	O
indicate	O	O
that	O	O
the	O	O
patients	O	O
with	O	O
Behcet	O	O
's	O	O
disease	O	O
generally	O	O
exhibit	O	O
clinical	O	O
findings	O	O
of	O	O
established	O	O
periodontal	O	O
disease	O	O
.	O	O

Decreased	O	O
antibody	O	O
responses	O	O
to	O	O
early	O	O
colonizers	O	O
of	O	O
both	O	O
supra-	O	O
and	O	O
subgingival	O	O
plaque	O	O
were	O	O
observed	O	O
along	O	O
with	O	O
the	O	O
elevation	O	O
in	O	O
antibody	O	O
levels	O	O
to	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
bacterial	O	O
plaque	O	O
ecology	O	O
and/or	O	O
immune	O	O
responses	O	O
to	O	O
these	O	O
microorganisms	O	O
may	O	O
be	O	O
affected	O	O
in	O	O
Behcet	O	O
's	O	O
disease	O	O
which	O	O
could	O	O
lead	O	O
to	O	O
changes	O	O
in	O	O
the	O	O
expression	O	O
of	O	O
periodontal	O	O
disease	O	O
.	O	O

MG2	O	O
(	O	O
the	O	O
MUC7	O	O
gene	O	O
product	O	O
)	O	O
is	O	O
a	O	O
low-molecular-mass	O	O
mucin	O	O
found	O	O
in	O	O
human	O	O
submandibular/sublingual	O	O
secretions	O	O
.	O	O

This	O	O
mucin	O	O
is	O	O
believed	O	O
to	O	O
agglutinate	O	O
a	O	O
variety	O	O
of	O	O
microbes	O	O
and	O	O
thus	O	O
is	O	O
considered	O	O
an	O	O
important	O	O
component	O	O
of	O	O
the	O	O
non-immune	O	O
host	O	O
defence	O	O
system	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

We	O	O
have	O	O
shown	O	O
that	O	O
MUC7	O	O
can	O	O
bind	O	O
to	O	O
cariogenic	O	O
strains	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
that	O	O
this	O	O
binding	O	O
requires	O	O
a	O	O
structural	O	O
determinant	O	O
in	O	O
the	O	O
N-terminal	O	O
region	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
an	O	O
expression	O	O
construct	O	O
,	O	O
pNMuc7	O	O
,	O	O
encoding	O	O
the	O	O
N-terminal	O	O
144	O	O
amino	O	O
acids	O	O
of	O	O
MUC7	O	O
was	O	O
generated	O	O
,	O	O
and	O	O
the	O	O
recombinant	O	O
protein	O	O
rNMUC7	O	O
was	O	O
expressed	O	O
in	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
.	O	O

Purified	O	O
rNMUC7	O	O
was	O	O
characterized	O	O
and	O	O
the	O	O
binding	O	O
of	O	O
this	O	O
protein	O	O
to	O	O
oral	O	O
bacteria	O	O
was	O	O
investigated	O	O
in	O	O
an	O	O
established	O	O
assay	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
that	O	O
the	O	O
recombinant	O	O
protein	O	O
bound	O	O
to	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25175	E-bacteria	I-bacteria
and	O	O
ATCC	B-bacteria	B-bacteria
33402	E-bacteria	I-bacteria
,	O	O
and	O	O
that	O	O
alkylation	O	O
of	O	O
the	O	O
two	O	O
cysteine	O	O
residues	O	O
(	O	O
Cys	O	O
(	O	O
45	O	O
)	O	O
and	O	O
Cys	O	O
(	O	O
50	O	O
)	O	O
)	O	O
resulted	O	O
in	O	O
the	O	O
complete	O	O
loss	O	O
of	O	O
bacterial	O	O
binding	O	O
.	O	O

This	O	O
suggests	O	O
that	O	O
binding	O	O
of	O	O
MUC7	O	O
to	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
occurs	O	O
between	O	O
the	O	O
N-terminal	O	O
region	O	O
of	O	O
the	O	O
mucin	O	O
molecule	O	O
and	O	O
the	O	O
bacterial	O	O
surface	O	O
,	O	O
and	O	O
that	O	O
this	O	O
interaction	O	O
is	O	O
dependent	O	O
on	O	O
a	O	O
cysteine-containing	O	O
domain	O	O
within	O	O
this	O	O
region	O	O
of	O	O
MUC7	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
killing	O	O
activity	O	O
of	O	O
rNMUC7	O	O
was	O	O
compared	O	O
with	O	O
that	O	O
of	O	O
the	O	O
candidacidal	O	O
salivary	O	O
protein	O	O
histatin	O	O
5	O	O
in	O	O
an	O	O
established	O	O
Candida	O	O
albicans	O	O
(	O	O
ATCC	O	O
44505	O	O
)	O	O
blastoconidia	O	O
killing	O	O
assay	O	O
.	O	O

It	O	O
was	O	O
found	O	O
that	O	O
the	O	O
LD	O	O
(	O	O
50	O	O
)	O	O
values	O	O
of	O	O
rNMUC7	O	O
and	O	O
histatin	O	O
5	O	O
were	O	O
comparable	O	O
,	O	O
and	O	O
that	O	O
the	O	O
recombinant	O	O
protein	O	O
displayed	O	O
significant	O	O
killing	O	O
activity	O	O
at	O	O
the	O	O
physiological	O	O
concentration	O	O
range	O	O
of	O	O
MUC7	O	O
in	O	O
whole	O	O
saliva	O	O
.	O	O

This	O	O
study	O	O
is	O	O
the	O	O
first	O	O
to	O	O
show	O	O
that	O	O
the	O	O
N-terminal	O	O
region	O	O
of	O	O
MUC7	O	O
contains	O	O
a	O	O
structural	O	O
determinant	O	O
for	O	O
bacterial	O	O
binding	O	O
and	O	O
that	O	O
this	O	O
region	O	O
exhibits	O	O
candidacidal	O	O
activity	O	O
.	O	O

The	O	O
aim	O	O
was	O	O
to	O	O
establish	O	O
defined-species	O	O
consortium	O	O
plaque	O	O
biofilms	O	O
to	O	O
investigate	O	O
enamel	O	O
and	O	O
root	O	O
caries	O	O
in	O	O
an	O	O
artificial	O	O
mouth	O	O
.	O	O

Strains	O	O
of	O	O
the	O	O
putative	O	O
enamel	O	O
and	O	O
root	O	O
caries	O	O
pathogens	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

sobrinus	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
,	O	O
were	O	O
screened	O	O
in	O	O
batch	O	O
culture	O	O
for	O	O
potential	O	O
cariogenic	O	O
properties	O	O
:	O	O
a	O	O
low	O	O
terminal	O	O
pH	O	O
,	O	O
ability	O	O
to	O	O
aggregate	O	O
,	O	O
and	O	O
catabolic	O	O
diversity	O	O
.	O	O

The	O	O
strains	O	O
selected	O	O
were	O	O
grown	O	O
as	O	O
monoculture	O	O
biofilms	O	O
and	O	O
as	O	O
consortium	O	O
plaque	O	O
biofilms	O	O
in	O	O
a	O	O
multiplaque	O	O
artificial	O	O
mouth	O	O
.	O	O

The	O	O
biofilms	O	O
were	O	O
supplied	O	O
with	O	O
a	O	O
constant	O	O
flow	O	O
of	O	O
a	O	O
simulated	O	O
oral	O	O
fluid	O	O
and	O	O
were	O	O
given	O	O
periodic	O	O
sucrose	O	O
(	O	O
and	O	O
in	O	O
some	O	O
instances	O	O
glucose	O	O
)	O	O
to	O	O
simulate	O	O
meals	O	O
.	O	O

All	O	O
the	O	O
bacteria	O	O
except	O	O
L.	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
formed	O	O
large	O	O
,	O	O
monospecies	O	O
biofilms	O	O
with	O	O
resting	O	O
pH	O	O
in	O	O
the	O	O
range	O	O
5.3-5.8	O	O
.	O	O

The	O	O
consortia	O	O
biofilms	O	O
were	O	O
larger	O	O
and	O	O
had	O	O
a	O	O
resting	O	O
pH	O	O
of	O	O
4.9-5.3	O	O
.	O	O

The	O	O
consortia	O	O
biofilms	O	O
supplied	O	O
with	O	O
8-hourly	O	O
carbohydrate	O	O
comprised	O	O
mainly	O	O
'mutans	B-bacteria	B-bacteria
'	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
58	O	O
,	O	O
SD	O	O
5.5	O	O
%	O	O
)	O	O
and	O	O
L.	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
(	O	O
42	O	O
,	O	O
SD	O	O
5.7	O	O
%	O	O
)	O	O
.	O	O

A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
characteristically	O	O
was	O	O
absent	O	O
or	O	O
present	O	O
in	O	O
a	O	O
low	O	O
percentage	O	O
(	O	O
up	O	O
to	O	O
4	O	O
%	O	O
colony-forming	O	O
units	O	O
)	O	O
.	O	O

All	O	O
biofilms	O	O
demineralized	O	O
polished	O	O
bovine	O	O
enamel	O	O
and	O	O
dentine	O	O
blocks	O	O
,	O	O
as	O	O
assessed	O	O
by	O	O
microradiography	O	O
and	O	O
enamel-surface	O	O
microhardness	O	O
measurement	O	O
.	O	O

The	O	O
consortia	O	O
also	O	O
demineralized	O	O
intact	O	O
enamel	O	O
and	O	O
tooth	O	O
roots	O	O
;	O	O
they	O	O
were	O	O
more	O	O
cariogenic	O	O
to	O	O
enamel	O	O
than	O	O
any	O	O
of	O	O
the	O	O
monoculture	O	O
biofilms	O	O
,	O	O
as	O	O
measured	O	O
by	O	O
enamel-surface	O	O
softening	O	O
,	O	O
but	O	O
variation	O	O
in	O	O
lesion	O	O
depth	O	O
was	O	O
proportional	O	O
to	O	O
biofilm	O	O
wet	O	O
weight	O	O
irrespective	O	O
of	O	O
acidogen	O	O
composition	O	O
(	O	O
r	O	O
=	O	O
0.93	O	O
,	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Enamel	O	O
lesions	O	O
had	O	O
a	O	O
well-mineralized	O	O
intact	O	O
surface	O	O
and	O	O
a	O	O
zone	O	O
of	O	O
subsurface	O	O
demineralization	O	O
,	O	O
typical	O	O
of	O	O
early	O	O
natural	O	O
lesions	O	O
.	O	O

Dentine	O	O
and	O	O
root	O	O
lesions	O	O
showed	O	O
extensive	O	O
demineralization	O	O
but	O	O
lacked	O	O
a	O	O
pronounced	O	O
surface	O	O
mineralized	O	O
zone	O	O
.	O	O

Substitution	O	O
of	O	O
glucose	O	O
for	O	O
sucrose	O	O
had	O	O
no	O	O
effect	O	O
on	O	O
the	O	O
cariogenicity	O	O
of	O	O
the	O	O
consortium	O	O
to	O	O
bovine	O	O
enamel	O	O
or	O	O
human	O	O
roots	O	O
and	O	O
had	O	O
no	O	O
major	O	O
effect	O	O
on	O	O
the	O	O
plaque	O	O
composition	O	O
.	O	O

Continuously	O	O
supplied	O	O
fluoride	O	O
(	O	O
19	O	O
parts/10	O	O
(	O	O
6	O	O
)	O	O
)	O	O
resulted	O	O
in	O	O
a	O	O
substantially	O	O
reduced	O	O
enamel	O	O
surface	O	O
softening	O	O
and	O	O
subsurface	O	O
demineralization	O	O
of	O	O
intact	O	O
roots	O	O
.	O	O

It	O	O
was	O	O
concluded	O	O
that	O	O
consortia	O	O
biofilms	O	O
of	O	O
selected	O	O
caries	O	O
pathogens	O	O
generate	O	O
realistic	O	O
caries	O	O
lesions	O	O
in	O	O
all	O	O
tooth	O	O
hard	O	O
tissues	O	O
under	O	O
controlled	O	O
growth	O	O
conditions	O	O
in	O	O
the	O	O
artificial	O	O
mouth	O	O
.	O	O

This	O	O
in	O	O
vitro	O	O
caries	O	O
experimental	O	O
model	O	O
may	O	O
prove	O	O
useful	O	O
for	O	O
the	O	O
study	O	O
of	O	O
interrelations	O	O
between	O	O
the	O	O
plaque	O	O
biofilm	O	O
,	O	O
tooth	O	O
tissues	O	O
and	O	O
the	O	O
oral	O	O
environment	O	O
,	O	O
and	O	O
for	O	O
the	O	O
development	O	O
of	O	O
procedures	O	O
to	O	O
modify	O	O
the	O	O
course	O	O
of	O	O
caries	O	O
development	O	O
.	O	O

intimate	O	O
relationship	O	O
with	O	O
bacteria	O	O
is	O	O
a	O	O
fundamental	O	O
factor	O	O
in	O	O
the	O	O
health	O	O
status	O	O
of	O	O
an	O	O
individual	O	O
.	O	O

After	O	O
birth	O	O
infants	O	O
are	O	O
exposed	O	O
to	O	O
continuous	O	O
person-to-person	O	O
and	O	O
environmental	O	O
contacts	O	O
with	O	O
microbes	O	O
,	O	O
and	O	O
the	O	O
development	O	O
of	O	O
the	O	O
indigenous	O	O
microflora	O	O
begins	O	O
on	O	O
the	O	O
surfaces	O	O
of	O	O
the	O	O
human	O	O
body	O	O
.	O	O

In	O	O
a	O	O
developing	O	O
ecosystem	O	O
microbial	O	O
colonization	O	O
may	O	O
easily	O	O
occur	O	O
because	O	O
of	O	O
the	O	O
still	O	O
inadequate	O	O
host	O	O
response	O	O
.	O	O

Adhesion	O	O
is	O	O
the	O	O
initial	O	O
event	O	O
in	O	O
the	O	O
colonization	O	O
of	O	O
bacteria	O	O
.	O	O

In	O	O
the	O	O
mouth	O	O
,	O	O
only	O	O
mucosal	O	O
surfaces	O	O
are	O	O
available	O	O
during	O	O
the	O	O
first	O	O
months	O	O
of	O	O
life	O	O
.	O	O

After	O	O
teeth	O	O
emerge	O	O
,	O	O
the	O	O
number	O	O
of	O	O
attachment	O	O
sites	O	O
and	O	O
potential	O	O
niches	O	O
increases	O	O
significantly	O	O
.	O	O

Bacteria	O	O
adhere	O	O
not	O	O
only	O	O
to	O	O
oral	O	O
surfaces	O	O
but	O	O
also	O	O
to	O	O
each	O	O
other	O	O
,	O	O
forming	O	O
multigeneric	O	O
communities	O	O
where	O	O
specific	O	O
partner	O	O
relationships	O	O
influence	O	O
their	O	O
composition	O	O
and	O	O
stability	O	O
.	O	O

Viridans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
a	O	O
strictly	O	O
anaerobic	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
are	O	O
of	O	O
interest	O	O
in	O	O
this	O	O
context	O	O
.	O	O

The	O	O
oral	O	O
colonization	O	O
pattern	O	O
differs	O	O
between	O	O
individuals	O	O
already	O	O
in	O	O
infancy	O	O
;	O	O
variable	O	O
bacterial	O	O
load	O	O
in	O	O
saliva	O	O
of	O	O
attendants	O	O
and	O	O
other	O	O
close	O	O
contacts	O	O
and	O	O
the	O	O
frequency	O	O
of	O	O
this	O	O
bacterial	O	O
exposure	O	O
may	O	O
partly	O	O
account	O	O
for	O	O
individual	O	O
differences	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
exposure	O	O
of	O	O
an	O	O
infant	O	O
to	O	O
antibiotics	O	O
affects	O	O
the	O	O
quality	O	O
of	O	O
colonizing	O	O
bacteria	O	O
.	O	O

This	O	O
article	O	O
presents	O	O
an	O	O
overview	O	O
of	O	O
the	O	O
age-related	O	O
acquisition	O	O
of	O	O
oral	O	O
bacterial	O	O
and	O	O
the	O	O
role	O	O
of	O	O
the	O	O
indigenous	O	O
oral	O	O
microflora	O	O
in	O	O
health	O	O
and	O	O
disease	O	O
.	O	O

Bacteria	O	O
are	O	O
causative	O	O
agents	O	O
of	O	O
periodontal	O	O
diseases	O	O
.	O	O

Interactions	O	O
between	O	O
oral	O	O
bacteria	O	O
and	O	O
gingival	O	O
epithelial	O	O
cells	O	O
are	O	O
essential	O	O
aspects	O	O
of	O	O
periodontal	O	O
infections	O	O
.	O	O

Using	O	O
an	O	O
in	O	O
vitro	O	O
tissue	O	O
culture	O	O
model	O	O
,	O	O
a	O	O
selected	O	O
group	O	O
of	O	O
gram-negative	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
frequently	O	O
associated	O	O
with	O	O
periodontal	O	O
diseases	O	O
,	O	O
including	O	O
Bacteroides	B-bacteria	B-bacteria
forsythus	E-bacteria	I-bacteria
,	O	O
Campylobacter	B-bacteria	B-bacteria
curvus	E-bacteria	I-bacteria
,	O	O
Eikenella	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
were	O	O
examined	O	O
for	O	O
their	O	O
ability	O	O
to	O	O
adhere	O	O
to	O	O
and	O	O
invade	O	O
primary	O	O
cultures	O	O
of	O	O
human	O	O
gingival	O	O
epithelial	O	O
cells	O	O
(	O	O
HGEC	O	O
)	O	O
.	O	O

The	O	O
effects	O	O
of	O	O
these	O	O
bacteria	O	O
on	O	O
the	O	O
production	O	O
of	O	O
interleukin-8	O	O
(	O	O
IL-8	O	O
)	O	O
,	O	O
a	O	O
proinflammatory	O	O
chemokine	O	O
,	O	O
were	O	O
also	O	O
measured	O	O
.	O	O

These	O	O
studies	O	O
provided	O	O
an	O	O
initial	O	O
demonstration	O	O
that	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
adhered	O	O
to	O	O
and	O	O
invaded	O	O
HGEC	O	O
and	O	O
that	O	O
this	O	O
was	O	O
accompanied	O	O
by	O	O
high	O	O
levels	O	O
of	O	O
IL-8	O	O
secretion	O	O
from	O	O
the	O	O
epithelial	O	O
cells	O	O
.	O	O

The	O	O
attachment	O	O
and	O	O
invasion	O	O
characteristics	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
were	O	O
also	O	O
tested	O	O
using	O	O
KB	O	O
cells	O	O
,	O	O
an	O	O
oral	O	O
epithelial	O	O
cell	O	O
line	O	O
.	O	O

The	O	O
invasion	O	O
was	O	O
verified	O	O
by	O	O
transmission	O	O
electron	O	O
microscopy	O	O
and	O	O
with	O	O
metabolic	O	O
inhibitors	O	O
.	O	O

Invasion	O	O
appeared	O	O
to	O	O
occur	O	O
via	O	O
a	O	O
``	O	O
zipping	O	O
''	O	O
mechanism	O	O
and	O	O
required	O	O
the	O	O
involvement	O	O
of	O	O
actins	O	O
,	O	O
microtubules	O	O
,	O	O
signal	O	O
transduction	O	O
,	O	O
protein	O	O
synthesis	O	O
,	O	O
and	O	O
energy	O	O
metabolism	O	O
of	O	O
the	O	O
epithelial	O	O
cell	O	O
,	O	O
as	O	O
well	O	O
as	O	O
protein	O	O
synthesis	O	O
by	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

A	O	O
spontaneous	O	O
mutant	O	O
,	O	O
lam	O	O
,	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
isolated	O	O
as	O	O
defective	O	O
in	O	O
autoagglutination	O	O
,	O	O
was	O	O
unable	O	O
to	O	O
attach	O	O
to	O	O
or	O	O
invade	O	O
HGEC	O	O
or	O	O
KB	O	O
cells	O	O
,	O	O
further	O	O
indicating	O	O
the	O	O
requirement	O	O
of	O	O
bacterial	O	O
components	O	O
in	O	O
these	O	O
processes	O	O
.	O	O

Sugar	O	O
inhibition	O	O
assays	O	O
indicated	O	O
that	O	O
lectin-like	O	O
interactions	O	O
were	O	O
involved	O	O
in	O	O
the	O	O
attachment	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
to	O	O
KB	O	O
cells	O	O
.	O	O

Investigation	O	O
of	O	O
these	O	O
new	O	O
virulence	O	O
phenotypes	O	O
should	O	O
improve	O	O
our	O	O
understanding	O	O
of	O	O
the	O	O
role	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
in	O	O
periodontal	O	O
infections	O	O
.	O	O

The	O	O
heterogeneous	O	O
group	O	O
of	O	O
oral	O	O
bacteria	O	O
within	O	O
the	O	O
sanguinis	B-bacteria	B-bacteria
(	I-bacteria	I-bacteria
sanguis	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
comprise	O	O
members	O	O
of	O	O
the	O	O
indigenous	O	O
biota	O	O
of	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
.	O	O

While	O	O
the	O	O
association	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
with	O	O
bacterial	O	O
endocarditis	O	O
is	O	O
well	O	O
described	O	O
in	O	O
the	O	O
literature	O	O
,	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
is	O	O
thought	O	O
to	O	O
play	O	O
a	O	O
benign	O	O
,	O	O
if	O	O
not	O	O
a	O	O
beneficial	O	O
,	O	O
role	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Little	O	O
is	O	O
known	O	O
,	O	O
however	O	O
,	O	O
about	O	O
the	O	O
natural	O	O
history	O	O
of	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
and	O	O
its	O	O
specific	O	O
relationship	O	O
with	O	O
other	O	O
oral	O	O
bacteria	O	O
.	O	O

As	O	O
part	O	O
of	O	O
a	O	O
longitudinal	O	O
study	O	O
concerning	O	O
the	O	O
transmission	O	O
and	O	O
acquisition	O	O
of	O	O
oral	O	O
bacteria	O	O
within	O	O
mother-infant	O	O
pairs	O	O
,	O	O
we	O	O
examined	O	O
the	O	O
initial	O	O
acquisition	O	O
of	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
and	O	O
described	O	O
its	O	O
colonization	O	O
relative	O	O
to	O	O
tooth	O	O
emergence	O	O
and	O	O
its	O	O
proportions	O	O
in	O	O
plaque	O	O
and	O	O
saliva	O	O
as	O	O
a	O	O
function	O	O
of	O	O
other	O	O
biological	O	O
events	O	O
,	O	O
including	O	O
subsequent	O	O
colonization	O	O
with	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
.	O	O

A	O	O
second	O	O
cohort	O	O
of	O	O
infants	O	O
was	O	O
recruited	O	O
to	O	O
define	O	O
the	O	O
taxonomic	O	O
affiliation	O	O
of	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
.	O	O

We	O	O
found	O	O
that	O	O
the	O	O
colonization	O	O
of	O	O
the	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
occurs	O	O
during	O	O
a	O	O
discrete	O	O
``	O	O
window	O	O
of	O	O
infectivity	O	O
''	O	O
at	O	O
a	O	O
median	O	O
age	O	O
of	O	O
9	O	O
months	O	O
in	O	O
the	O	O
infants	O	O
.	O	O

Its	O	O
colonization	O	O
is	O	O
tooth	O	O
dependent	O	O
and	O	O
correlated	O	O
to	O	O
the	O	O
time	O	O
of	O	O
tooth	O	O
emergence	O	O
;	O	O
its	O	O
proportions	O	O
in	O	O
saliva	O	O
increase	O	O
as	O	O
new	O	O
teeth	O	O
emerge	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
early	O	O
colonization	O	O
of	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
and	O	O
its	O	O
elevated	O	O
levels	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
were	O	O
correlated	O	O
to	O	O
a	O	O
significant	O	O
delay	O	O
in	O	O
the	O	O
colonization	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
.	O	O

Underpinning	O	O
this	O	O
apparent	O	O
antagonism	O	O
between	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
and	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
is	O	O
the	O	O
observation	O	O
that	O	O
after	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
colonize	O	O
the	O	O
infant	O	O
,	O	O
the	O	O
levels	O	O
of	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
decrease	O	O
.	O	O

Children	O	O
who	O	O
do	O	O
not	O	O
harbor	O	O
detectable	O	O
levels	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
have	O	O
significantly	O	O
higher	O	O
levels	O	O
of	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
in	O	O
their	O	O
saliva	O	O
than	O	O
do	O	O
children	O	O
colonized	O	O
with	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
.	O	O

Collectively	O	O
,	O	O
these	O	O
findings	O	O
suggest	O	O
that	O	O
the	O	O
colonization	O	O
of	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
may	O	O
influence	O	O
the	O	O
subsequent	O	O
colonization	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
and	O	O
this	O	O
in	O	O
turn	O	O
may	O	O
suggest	O	O
several	O	O
ecological	O	O
approaches	O	O
toward	O	O
controlling	O	O
dental	O	O
caries	O	O
.	O	O

A	O	O
novel	O	O
group	O	O
of	O	O
oral	O	O
spirochaetes	B-bacteria	B-bacteria
that	O	O
were	O	O
specifically	O	O
labeled	O	O
by	O	O
H9-2	O	O
,	O	O
a	O	O
monoclonal	O	O
antibody	O	O
against	O	O
the	O	O
37-kDa	O	O
endoflagellar	O	O
sheath	O	O
protein	O	O
of	O	O
Treponema	B-bacteria	B-bacteria
pallidum	E-bacteria	I-bacteria
,	O	O
have	O	O
earlier	O	O
been	O	O
demonstrated	O	O
in	O	O
periodontitis-associated	O	O
plaque	O	O
samples	O	O
;	O	O
two	O	O
cultivable	O	O
oral	O	O
spirochaetes	B-bacteria	B-bacteria
T.	B-bacteria	B-bacteria
vincentii	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
medium	E-bacteria	I-bacteria
displayed	O	O
cross-reactivity	O	O
with	O	O
that	O	O
monoclonal	O	O
,	O	O
but	O	O
the	O	O
molecular	O	O
basis	O	O
for	O	O
this	O	O
cross-reactivity	O	O
is	O	O
not	O	O
yet	O	O
defined	O	O
.	O	O

Here	O	O
,	O	O
the	O	O
flaA-1	O	O
genes	O	O
which	O	O
encode	O	O
the	O	O
37-kDa	O	O
sheath	O	O
protein	O	O
from	O	O
T.	B-bacteria	B-bacteria
vincentii	E-bacteria	I-bacteria
and	O	O
the	O	O
oral	O	O
spirochaetes	B-bacteria	B-bacteria
present	O	O
in	O	O
samples	O	O
from	O	O
advanced	O	O
periodontitis	O	O
were	O	O
examined	O	O
.	O	O

A	O	O
856	O	O
bp	O	O
fragment	O	O
of	O	O
the	O	O
flaA-1	O	O
gene	O	O
was	O	O
amplified	O	O
in	O	O
T.	B-bacteria	B-bacteria
pallidum	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
vincentii	E-bacteria	I-bacteria
.	O	O

The	O	O
same-size	O	O
polymerase	O	O
chain	O	O
reaction	O	O
fragments	O	O
were	O	O
also	O	O
amplified	O	O
in	O	O
two	O	O
clinical	O	O
samples	O	O
from	O	O
patients	O	O
with	O	O
advanced	O	O
periodontitis	O	O
but	O	O
not	O	O
from	O	O
samples	O	O
of	O	O
healthy	O	O
plaque	O	O
.	O	O

The	O	O
sequences	O	O
of	O	O
the	O	O
flaA-1	O	O
genes	O	O
of	O	O
the	O	O
oral	O	O
spirochaetes	B-bacteria	B-bacteria
detected	O	O
in	O	O
human	O	O
periodontal	O	O
plaque	O	O
were	O	O
closely	O	O
similar	O	O
to	O	O
those	O	O
of	O	O
T.	B-bacteria	B-bacteria
pallidum	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
vincentii	E-bacteria	I-bacteria
,	O	O
but	O	O
neither	O	O
of	O	O
these	O	O
two	O	O
organisms	O	O
could	O	O
be	O	O
detected	O	O
in	O	O
these	O	O
samples	O	O
using	O	O
rRNA-specific	O	O
primers	O	O
.	O	O

The	O	O
identity	O	O
of	O	O
the	O	O
flaA-1	B-bacteria	B-bacteria
positive	I-bacteria	I-bacteria
spirochaetes	E-bacteria	I-bacteria
associated	O	O
with	O	O
periodontitis	O	O
remains	O	O
to	O	O
be	O	O
determined	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
antibacterial	O	O
effect	O	O
of	O	O
Coptidis	O	O
Rhizoma	O	O
(	O	O
CR	O	O
)	O	O
,	O	O
a	O	O
traditional	O	O
medicinal	O	O
plant	O	O
,	O	O
on	O	O
oral	O	O
bacteria	O	O
.	O	O

CR	O	O
extract	O	O
was	O	O
prepared	O	O
by	O	O
boiling	O	O
CR	O	O
in	O	O
water	O	O
for	O	O
2	O	O
h.	O	O
Alkaloids	O	O
contained	O	O
in	O	O
CR	O	O
extract	O	O
were	O	O
assayed	O	O
by	O	O
high	O	O
performance	O	O
liquid	O	O
chromatography	O	O
(	O	O
HPLC	O	O
)	O	O
.	O	O

Antibacterial	O	O
activity	O	O
of	O	O
CR	O	O
extract	O	O
was	O	O
estimated	O	O
from	O	O
the	O	O
lowest	O	O
concentration	O	O
that	O	O
did	O	O
not	O	O
permit	O	O
bacterial	O	O
growth	O	O
(	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
,	O	O
MIC	O	O
)	O	O
and	O	O
the	O	O
concentrations	O	O
that	O	O
inhibited	O	O
50	O	O
%	O	O
of	O	O
bacterial	O	O
proteolytic	O	O
activity	O	O
(	O	O
IC50	O	O
)	O	O
.	O	O

CR	O	O
extract	O	O
inhibited	O	O
the	O	O
growth	O	O
of	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
and	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
at	O	O
MIC	O	O
of	O	O
0.031-0.25	O	O
mg	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
,	O	O
whereas	O	O
it	O	O
had	O	O
less	O	O
inhibitory	O	O
effect	O	O
(	O	O
MIC	O	O
:	O	O
0.5-2	O	O
mg	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
)	O	O
on	O	O
the	O	O
growth	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
.	O	O

The	O	O
major	O	O
active	O	O
component	O	O
of	O	O
CR	O	O
extract	O	O
was	O	O
berberine	O	O
(	O	O
Ber	O	O
)	O	O
,	O	O
an	O	O
alkaloid	O	O
,	O	O
and	O	O
its	O	O
inhibiting	O	O
specificity	O	O
to	O	O
bacterial	O	O
growth	O	O
was	O	O
similar	O	O
to	O	O
that	O	O
of	O	O
CR	O	O
extract	O	O
.	O	O

CR	O	O
extract	O	O
and	O	O
Ber	O	O
were	O	O
bacteriostatic	O	O
at	O	O
the	O	O
MICs	O	O
against	O	O
most	O	O
of	O	O
the	O	O
bacteria	O	O
,	O	O
and	O	O
bacteriocidal	O	O
at	O	O
the	O	O
concentrations	O	O
higher	O	O
than	O	O
the	O	O
MICs	O	O
.	O	O

Ber	O	O
inhibited	O	O
the	O	O
activities	O	O
of	O	O
collagenase	O	O
from	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
.	O	O

CR	O	O
extract	O	O
and	O	O
Ber	O	O
had	O	O
an	O	O
inhibitory	O	O
effect	O	O
on	O	O
periodontopathogenic	O	O
bacteria	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
the	O	O
possibility	O	O
of	O	O
their	O	O
clinical	O	O
application	O	O
for	O	O
the	O	O
treatment	O	O
of	O	O
periodontal	O	O
diseases	O	O
.	O	O

Lymphocytes	O	O
cultures	O	O
were	O	O
used	O	O
as	O	O
an	O	O
in	O	O
vitro	O	O
experimental	O	O
model	O	O
to	O	O
get	O	O
a	O	O
deeper	O	O
insight	O	O
into	O	O
immune	O	O
response	O	O
to	O	O
oral	O	O
bacteria	O	O
in	O	O
periapical	O	O
granulomas	O	O
.	O	O

Lymphocytes	O	O
isolated	O	O
from	O	O
leucocyte	O	O
concentrate	O	O
were	O	O
in	O	O
lymphocyte	O	O
cultures	O	O
stimulated	O	O
by	O	O
antigen	O	O
preparations	O	O
of	O	O
oral	O	O
bacteria	O	O
.	O	O

Lymphocyte	O	O
subsets	O	O
that	O	O
have	O	O
developed	O	O
in	O	O
lymphocyte	O	O
cultures	O	O
after	O	O
a	O	O
week	O	O
of	O	O
stimulation	O	O
were	O	O
analysed	O	O
by	O	O
flow	O	O
cytometry	O	O
.	O	O

A	O	O
significant	O	O
increase	O	O
in	O	O
expression	O	O
of	O	O
INF-gamma	O	O
molecules	O	O
in	O	O
CD3+	O	O
cells	O	O
stimulated	O	O
by	O	O
antigen	O	O
preparations	O	O
of	O	O
oral	E-bacteria	I-bacteria
streptococci	B-bacteria	B-bacteria
was	O	O
found	O	O
,	O	O
compared	O	O
with	O	O
negative	O	O
control	O	O
.	O	O

On	O	O
the	O	O
other	O	O
hand	O	O
we	O	O
observed	O	O
a	O	O
significant	O	O
increase	O	O
in	O	O
expression	O	O
of	O	O
IL-4	O	O
in	O	O
CD3+	O	O
cells	O	O
stimulated	O	O
by	O	O
antigens	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
compared	O	O
with	O	O
negative	O	O
control	O	O
.	O	O

Our	O	O
results	O	O
show	O	O
that	O	O
antigens	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
in	O	O
in	O	O
vitro	O	O
lymphocyte	O	O
cultures	O	O
induce	O	O
the	O	O
differentiation	O	O
of	O	O
T	O	O
helper	O	O
cells	O	O
into	O	O
Th2	O	O
cells	O	O
and	O	O
that	O	O
antigen	O	O
preparations	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
induce	O	O
the	O	O
differentiation	O	O
of	O	O
T	O	O
helper	O	O
cells	O	O
into	O	O
Th1	O	O
cells	O	O
.	O	O

Furthermore	O	O
,	O	O
an	O	O
increased	O	O
expression	O	O
of	O	O
HLA-DR	O	O
molecules	O	O
on	O	O
CD8+	O	O
T	O	O
cells	O	O
stimulated	O	O
by	O	O
antigens	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
was	O	O
found	O	O
,	O	O
compared	O	O
with	O	O
negative	O	O
control	O	O
.	O	O

Many	O	O
epidemiological	O	O
studies	O	O
have	O	O
identified	O	O
chronic	O	O
alcohol	O	O
consumption	O	O
as	O	O
a	O	O
significant	O	O
risk	O	O
factor	O	O
for	O	O
cancer	O	O
of	O	O
the	O	O
upper	O	O
aerodigestive	O	O
tract	O	O
(	O	O
UAT	O	O
)	O	O
in	O	O
human	O	O
.	O	O

Although	O	O
acetaldehyde	O	O
,	O	O
the	O	O
first	O	O
metabolite	O	O
from	O	O
ethanol	O	O
by	O	O
alcohol	O	O
dehydrogenase	O	O
(	O	O
ADH	O	O
)	O	O
,	O	O
is	O	O
regarded	O	O
as	O	O
a	O	O
carcinogen	O	O
,	O	O
how	O	O
systemic	O	O
production	O	O
of	O	O
acetaldehyde	O	O
particularly	O	O
affects	O	O
the	O	O
UAT	O	O
remains	O	O
unclear	O	O
.	O	O

In	O	O
our	O	O
study	O	O
,	O	O
we	O	O
searched	O	O
for	O	O
the	O	O
regional	O	O
source	O	O
of	O	O
acetaldehyde	O	O
in	O	O
UAT	O	O
,	O	O
especially	O	O
the	O	O
involvement	O	O
of	O	O
bacteria	O	O
in	O	O
the	O	O
human	O	O
normal	O	O
oral	O	O
microflora	O	O
.	O	O

Here	O	O
we	O	O
demonstrate	O	O
that	O	O
,	O	O
among	O	O
the	O	O
bacterial	O	O
species	O	O
identified	O	O
from	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
,	O	O
genus	B-bacteria	B-bacteria
Neisseria	E-bacteria	I-bacteria
had	O	O
extremely	O	O
high	O	O
ADH	O	O
activity	O	O
and	O	O
produced	O	O
significant	O	O
amounts	O	O
of	O	O
acetaldehyde	O	O
when	O	O
cultured	O	O
with	O	O
medium	O	O
containing	O	O
ethanol	O	O
in	O	O
vitro	O	O
.	O	O

The	O	O
ability	O	O
to	O	O
produce	O	O
acetaldehyde	O	O
was	O	O
more	O	O
than	O	O
100-fold	O	O
higher	O	O
than	O	O
that	O	O
produced	O	O
by	O	O
any	O	O
other	O	O
genera	O	O
we	O	O
studied	O	O
.	O	O

Furthermore	O	O
,	O	O
alcohol	O	O
ingestion	O	O
influences	O	O
the	O	O
bacterial	O	O
composition	O	O
of	O	O
the	O	O
oral	O	O
microflora	O	O
,	O	O
resulting	O	O
in	O	O
an	O	O
increased	O	O
proportion	O	O
of	O	O
Neisseria	B-bacteria	B-bacteria
.	O	O

Although	O	O
Neisseria	B-bacteria	B-bacteria
present	O	O
in	O	O
normal	O	O
oral	O	O
microflora	O	O
is	O	O
generally	O	O
non-pathogenic	O	O
,	O	O
these	O	O
findings	O	O
suggest	O	O
that	O	O
this	O	O
microbe	O	O
can	O	O
be	O	O
a	O	O
regional	O	O
source	O	O
of	O	O
carcinogenic	O	O
acetaldehyde	O	O
and	O	O
thus	O	O
potentially	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
alcohol-related	O	O
carcinogenesis	O	O
in	O	O
human	O	O
UAT	O	O
.	O	O

The	O	O
aims	O	O
of	O	O
the	O	O
present	O	O
study	O	O
were	O	O
to	O	O
screen	O	O
and	O	O
characterize	O	O
the	O	O
antimicrobial	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
which	O	O
were	O	O
isolated	O	O
from	O	O
healthy	O	O
oral	O	O
cavities	O	O
of	O	O
Thai	O	O
volunteers	O	O
,	O	O
and	O	O
to	O	O
characterize	O	O
their	O	O
inhibiting	O	O
substances	O	O
.	O	O

Among	O	O
3790	O	O
isolates	O	O
(	O	O
suspected	O	O
to	O	O
be	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
)	O	O
from	O	O
130	O	O
volunteers	O	O
,	O	O
five	O	O
showed	O	O
an	O	O
appreciable	O	O
effect	O	O
against	O	O
Sarcina	B-bacteria	B-bacteria
lutea	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
9341	E-bacteria	I-bacteria
,	O	O
Bacillus	B-bacteria	B-bacteria
cereus	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
11778	E-bacteria	I-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25922	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
6538	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
DTMU	I-bacteria	I-bacteria
1	E-bacteria	I-bacteria
,	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

salivarius	I-bacteria	I-bacteria
DTMU	I-bacteria	I-bacteria
1	E-bacteria	I-bacteria
,	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

sanguis	I-bacteria	I-bacteria
DTMU	I-bacteria	I-bacteria
1	E-bacteria	I-bacteria
,	O	O
Candida	O	O
albicans	O	O
ATCC	O	O
13803	O	O
and	O	O
C.	O	O
albicans	O	O
DTMU	O	O
2	O	O
,	O	O
as	O	O
well	O	O
as	O	O
the	O	O
oral	O	O
pathogens	O	O
.	O	O

These	O	O
antimicrobial	O	O
isolates	O	O
included	O	O
L17	B-bacteria	B-bacteria
and	O	O
N14	B-bacteria	B-bacteria
which	O	O
showed	O	O
the	O	O
antibacterial	O	O
activity	O	O
,	O	O
D14	B-bacteria	B-bacteria
which	O	O
showed	O	O
the	O	O
anticandidal	O	O
activity	O	O
,	O	O
and	O	O
D6	B-bacteria	B-bacteria
and	O	O
N8	B-bacteria	B-bacteria
which	O	O
showed	O	O
both	O	O
the	O	O
antibacterial	O	O
and	O	O
anticandidal	O	O
activities	O	O
.	O	O

The	O	O
isolates	O	O
were	O	O
later	O	O
found	O	O
to	O	O
be	O	O
facultative	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
Gram-positive	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
non-spore-forming	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
non-capsule-forming	I-bacteria	I-bacteria
and	I-bacteria	I-bacteria
catalase-negative	I-bacteria	I-bacteria
bacilli	E-bacteria	I-bacteria
.	O	O

They	O	O
could	O	O
utilize	O	O
casein	O	O
but	O	O
could	O	O
not	O	O
hydrolyse	O	O
starch	O	O
,	O	O
and	O	O
they	O	O
produced	O	O
hydrogen	O	O
peroxide	O	O
and	O	O
bacteriocins	O	O
.	O	O

Their	O	O
antimicrobial	O	O
potentials	O	O
were	O	O
found	O	O
to	O	O
be	O	O
affected	O	O
by	O	O
pH	O	O
,	O	O
catalase	O	O
,	O	O
proteolytic	O	O
enzymes	O	O
and	O	O
temperature	O	O
.	O	O

The	O	O
activity	O	O
was	O	O
partially	O	O
inactivated	O	O
after	O	O
catalase	O	O
treatment	O	O
,	O	O
significantly	O	O
declined	O	O
at	O	O
pH	O	O
>	O	O
or	O	O
=9.0	O	O
or	O	O
after	O	O
trypsin	O	O
and	O	O
pepsin	O	O
treatments	O	O
,	O	O
and	O	O
also	O	O
reduced	O	O
after	O	O
heating	O	O
at	O	O
>	O	O
or	O	O
=100	O	O
degrees	O	O
C.	O	O
However	O	O
,	O	O
the	O	O
antimicrobial	O	O
activity	O	O
of	O	O
these	O	O
five	O	O
isolates	O	O
was	O	O
somewhat	O	O
resistant	O	O
to	O	O
heat	O	O
.	O	O

When	O	O
the	O	O
isolates	O	O
were	O	O
tested	O	O
for	O	O
their	O	O
antimicrobial	O	O
sensitivity	O	O
,	O	O
they	O	O
were	O	O
shown	O	O
to	O	O
be	O	O
sensitive	O	O
to	O	O
a	O	O
number	O	O
of	O	O
antimicrobial	O	O
agents	O	O
.	O	O

The	O	O
final	O	O
identification	O	O
revealed	O	O
that	O	O
D6	B-bacteria	B-bacteria
,	O	O
D14	B-bacteria	B-bacteria
and	O	O
N14	B-bacteria	B-bacteria
were	O	O
Lactobacillus	B-bacteria	B-bacteria
paracasei	I-bacteria	I-bacteria
subsp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

paracasei	E-bacteria	I-bacteria
,	O	O
and	O	O
L17	B-bacteria	B-bacteria
and	O	O
N8	B-bacteria	B-bacteria
were	O	O
Lact	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

rhamnosus	E-bacteria	I-bacteria
.	O	O

Beta-galactosyllactose	O	O
is	O	O
a	O	O
trisaccharide	O	O
containing	O	O
the	O	O
beta-galactosidic	O	O
linkage	O	O
at	O	O
the	O	O
nonreducing	O	O
end	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
whether	O	O
certain	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
could	O	O
utilize	O	O
four	O	O
kinds	O	O
of	O	O
beta-galactosyllactoses	O	O
.	O	O

Three	O	O
of	O	O
four	O	O
beta-galactosyllactoses	O	O
were	O	O
unable	O	O
to	O	O
support	O	O
growth	O	O
of	O	O
the	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
to	O	O
be	O	O
a	O	O
substrate	O	O
for	O	O
producing	O	O
acid	O	O
from	O	O
the	O	O
cell	O	O
suspensions	O	O
and	O	O
dental	O	O
plaque	O	O
.	O	O

4'-beta-Galactosyllactose	O	O
supported	O	O
growth	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
35105	E-bacteria	I-bacteria
,	O	O
ATCC	B-bacteria	B-bacteria
49298	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
15914	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
35037	E-bacteria	I-bacteria
,	O	O
ATCC	B-bacteria	B-bacteria
10557	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
milleri	I-bacteria	I-bacteria
10707	E-bacteria	I-bacteria
and	O	O
produced	O	O
acid	O	O
from	O	O
dental	O	O
plaque	O	O
.	O	O

Although	O	O
beta-galactosidase	O	O
activities	O	O
were	O	O
observed	O	O
in	O	O
all	O	O
the	O	O
strains	O	O
,	O	O
4'-beta-galactosyllactose	O	O
could	O	O
not	O	O
be	O	O
used	O	O
as	O	O
a	O	O
carbon	O	O
source	O	O
for	O	O
the	O	O
growth	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
.	O	O

Enzymes	O	O
metabolizing	O	O
4'-beta-galactosyllactose	O	O
were	O	O
induced	O	O
when	O	O
S.	B-bacteria	B-bacteria
oralis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
10557	E-bacteria	I-bacteria
was	O	O
cultured	O	O
in	O	O
medium	O	O
containing	O	O
galactose	O	O
.	O	O

These	O	O
results	O	O
suggested	O	O
that	O	O
4'-beta-galactosyllactose	O	O
could	O	O
be	O	O
as	O	O
cariogenic	O	O
as	O	O
lactose	O	O
if	O	O
it	O	O
is	O	O
consumed	O	O
frequently	O	O
and	O	O
retained	O	O
for	O	O
a	O	O
long	O	O
period	O	O
in	O	O
the	O	O
mouth	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
adsorption	O	O
of	O	O
[	O	O
3H	O	O
]	O	O
-thymidine	O	O
labeled	O	O
oral	O	O
microorganisms	O	O
to	O	O
porous	O	O
type	O	O
calcium	O	O
carbonate	O	O
(	O	O
PCC	O	O
)	O	O
beads	O	O
in	O	O
a	O	O
buffer	O	O
containing	O	O
human	O	O
parotid	O	O
saliva	O	O
and	O	O
to	O	O
PCC	O	O
combined	O	O
chewing	O	O
gum	O	O
sheets	O	O
.	O	O

Adsorption	O	O
rates	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	I-bacteria	I-bacteria
B13	E-bacteria	I-bacteria
and	O	O
6715	B-bacteria	B-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
MT8148R	E-bacteria	I-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	I-bacteria	I-bacteria
T14V	E-bacteria	I-bacteria
with	O	O
PCC	O	O
were	O	O
significantly	O	O
higher	O	O
than	O	O
those	O	O
with	O	O
calcium	O	O
carbonate	O	O
(	O	O
CC	O	O
)	O	O
beads	O	O
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

Adsorption	O	O
rates	O	O
of	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
with	O	O
PCC	O	O
combined	O	O
chewing	O	O
gum	O	O
were	O	O
significantly	O	O
higher	O	O
than	O	O
those	O	O
with	O	O
CC	O	O
combined	O	O
chewing	O	O
gum	O	O
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

The	O	O
present	O	O
results	O	O
suggested	O	O
that	O	O
the	O	O
chewing	O	O
gum	O	O
containing	O	O
PCC	O	O
may	O	O
be	O	O
able	O	O
to	O	O
exclude	O	O
oral	O	O
bacteria	O	O
,	O	O
including	O	O
cariogenic	O	O
and	O	O
periodontopathic	O	O
bacteria	O	O
,	O	O
for	O	O
prevention	O	O
of	O	O
dental	O	O
caries	O	O
and	O	O
periodontal	O	O
disease	O	O
.	O	O

One	O	O
promising	O	O
way	O	O
of	O	O
reducing	O	O
caries	O	O
is	O	O
by	O	O
using	O	O
sucrose	O	O
substitutes	O	O
in	O	O
food	O	O
,	O	O
e.g.	O	O
,	O	O
palatinose	O	O
or	O	O
leucrose	O	O
.	O	O

Previous	O	O
experiments	O	O
addressing	O	O
cariogenic	O	O
potential	O	O
of	O	O
sucrose	O	O
substitutes	O	O
have	O	O
focused	O	O
mainly	O	O
on	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

However	O	O
,	O	O
given	O	O
the	O	O
many	O	O
other	O	O
micro-organisms	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
this	O	O
study	O	O
compared	O	O
the	O	O
acid	O	O
production	O	O
of	O	O
100	O	O
bacterial	O	O
strains	O	O
representing	O	O
44	O	O
different	O	O
species	O	O
,	O	O
by	O	O
batch	O	O
fermentation	O	O
in	O	O
a	O	O
test	O	O
tube	O	O
containing	O	O
,	O	O
as	O	O
a	O	O
sole	O	O
carbohydrate	O	O
source	O	O
,	O	O
glucose	O	O
,	O	O
sucrose	O	O
,	O	O
palatinose	O	O
,	O	O
or	O	O
leucrose	O	O
.	O	O

Selected	O	O
strains	O	O
were	O	O
further	O	O
analyzed	O	O
in	O	O
a	O	O
fermenter	O	O
.	O	O

Additionally	O	O
,	O	O
30	O	O
yeast	O	O
strains	O	O
were	O	O
tested	O	O
by	O	O
an	O	O
auxanographic	O	O
sugar	O	O
assimilation	O	O
test	O	O
.	O	O

Only	O	O
Lactobacillus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Stomatococcus	B-bacteria	B-bacteria
mucilaginosus	E-bacteria	I-bacteria
,	O	O
Leuconostoc	B-bacteria	B-bacteria
mesenteroides	E-bacteria	I-bacteria
,	O	O
and	O	O
Weissella	B-bacteria	B-bacteria
paramesenteroides	E-bacteria	I-bacteria
,	O	O
and	O	O
some	O	O
of	O	O
the	O	O
yeasts	O	O
studied-i.e.	O	O
,	O	O
Candida	O	O
albicans	O	O
,	O	O
C.	O	O
tropicalis	O	O
,	O	O
C.	O	O
parapsilosis	O	O
,	O	O
and	O	O
Saccharomyces	O	O
cerevisiae-utilized	O	O
leucrose	O	O
and/or	O	O
palatinose	O	O
well	O	O
.	O	O

Strikingly	O	O
,	O	O
Stomatococcus	O	O
mucilaginosus	O	O
produced	O	O
water-insoluble	O	O
polysaccharides	O	O
by	O	O
fermentation	O	O
of	O	O
leucrose	O	O
and	O	O
palatinose	O	O
.	O	O

In	O	O
the	O	O
fermenter	O	O
,	O	O
the	O	O
respective	O	O
sucrose	O	O
substitutes	O	O
were	O	O
not	O	O
only	O	O
cleaved	O	O
but	O	O
also	O	O
utilized	O	O
.	O	O

Thus	O	O
,	O	O
extracellular	O	O
cleavage	O	O
by	O	O
autochthonous	O	O
micro-organisms	O	O
may	O	O
produce	O	O
cariogenic	O	O
cleavage	O	O
products	O	O
(	O	O
glucose	O	O
,	O	O
fructose	O	O
)	O	O
that	O	O
can	O	O
be	O	O
used	O	O
by	O	O
other	O	O
well-characterized	O	O
cariogenic	O	O
bacteria	O	O
found	O	O
in	O	O
the	O	O
oral	O	O
flora	O	O
.	O	O

Therefore	O	O
,	O	O
the	O	O
anticariogenic	O	O
potential	O	O
of	O	O
sucrose	O	O
substitutes	O	O
in	O	O
food	O	O
might	O	O
be	O	O
limited	O	O
.	O	O

The	O	O
susceptibility	O	O
(	O	O
MIC	O	O
)	O	O
of	O	O
44	O	O
strains	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
3	O	O
standard	O	O
strains	O	O
to	O	O
statherin	O	O
and	O	O
its	O	O
C-terminal	O	O
fragments	O	O
with	O	O
sequences	O	O
QYQQYTF	O	O
,	O	O
YQQYTF	O	O
,	O	O
QQYTF	O	O
,	O	O
QYTF	O	O
and	O	O
YTF	O	O
was	O	O
determined	O	O
by	O	O
means	O	O
of	O	O
plate	O	O
dilution	O	O
technique	O	O
in	O	O
Brucella	B-bacteria	B-bacteria
agar	O	O
with	O	O
5	O	O
%	O	O
content	O	O
of	O	O
defibrinated	O	O
sheep's	O	O
blood	O	O
,	O	O
menadione	O	O
and	O	O
hemin	O	O
.	O	O

The	O	O
culture	O	O
was	O	O
anaerobic	O	O
.	O	O

As	O	O
shown	O	O
,	O	O
at	O	O
concentrations	O	O
from	O	O
12.5	O	O
to	O	O
100	O	O
microg/ml	O	O
statherin	O	O
and	O	O
its	O	O
C-terminal	O	O
fragments	O	O
inhibited	O	O
the	O	O
growth	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Peptostreptococcus	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
were	O	O
the	O	O
most	O	O
susceptible	O	O
to	O	O
statherin	O	O
and	O	O
YTF	O	O
(	O	O
MIC	O	O
<	O	O
or	O	O
=	O	O
12.5	O	O
mg/ml	O	O
)	O	O
,	O	O
whereas	O	O
the	O	O
most	O	O
susceptible	O	O
to	O	O
the	O	O
peptides	O	O
investigated	O	O
were	O	O
Fusobacterium	B-bacteria	B-bacteria
necrogenes	E-bacteria	I-bacteria
and	O	O
Fusobacterium	B-bacteria	B-bacteria
necrophorum	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
:	O	O
QYQQYTF	O	O
,	O	O
YQQYTF	O	O
,	O	O
QQYTF	O	O
,	O	O
QYTF	O	O
(	O	O
MIC	O	O
<	O	O
or	O	O
=	O	O
12.5	O	O
microg/ml	O	O
)	O	O
.	O	O

Prevotella	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
Bacteroides	B-bacteria	B-bacteria
forsythus	E-bacteria	I-bacteria
,	O	O
and	O	O
Bacteroides	B-bacteria	B-bacteria
ureolyticus	E-bacteria	I-bacteria
,	O	O
strains	O	O
exhibited	O	O
the	O	O
lowest	O	O
susceptibility	O	O
(	O	O
MIC	O	O
>	O	O
100	O	O
microg/ml	O	O
)	O	O
.	O	O

When	O	O
analysing	O	O
the	O	O
bacteriostatic	O	O
activity	O	O
of	O	O
statherin	O	O
it	O	O
should	O	O
be	O	O
pointed	O	O
out	O	O
that	O	O
the	O	O
concentrations	O	O
of	O	O
this	O	O
peptide	O	O
used	O	O
in	O	O
microbiological	O	O
investigations	O	O
are	O	O
within	O	O
the	O	O
range	O	O
of	O	O
physiological	O	O
concentrations	O	O
determined	O	O
for	O	O
whole	O	O
saliva	O	O
when	O	O
at	O	O
rest	O	O
and	O	O
stimulated	O	O
in	O	O
healthy	O	O
donors	O	O
of	O	O
19-25	O	O
years	O	O
of	O	O
age	O	O
.	O	O

Since	O	O
the	O	O
anaerobes	B-bacteria	B-bacteria
investigated	O	O
may	O	O
be	O	O
involved	O	O
in	O	O
the	O	O
diseases	O	O
of	O	O
periodontum	O	O
,	O	O
the	O	O
results	O	O
presented	O	O
seem	O	O
to	O	O
have	O	O
also	O	O
a	O	O
practical	O	O
aspect	O	O
,	O	O
i.e	O	O
.	O	O

a	O	O
possibility	O	O
to	O	O
apply	O	O
the	O	O
C-terminal	O	O
fragments	O	O
of	O	O
statherin	O	O
as	O	O
a	O	O
novel	O	O
therapeutic	O	O
agent	O	O
,	O	O
affecting	O	O
favourably	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
is	O	O
a	O	O
common	O	O
gut	O	O
inhabitant	O	O
,	O	O
but	O	O
it	O	O
is	O	O
usually	O	O
out	O	O
numbered	O	O
by	O	O
strictly	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

When	O	O
fecal	O	O
material	O	O
is	O	O
exposed	O	O
to	O	O
oxygen	O	O
,	O	O
fermentation	O	O
acids	O	O
can	O	O
be	O	O
respired	O	O
,	O	O
and	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
numbers	O	O
increase	O	O
.	O	O

E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
can	O	O
survive	O	O
for	O	O
long	O	O
periods	O	O
of	O	O
time	O	O
in	O	O
feces	O	O
,	O	O
but	O	O
subsequent	O	O
proliferation	O	O
is	O	O
dependent	O	O
on	O	O
its	O	O
ability	O	O
to	O	O
re-enter	O	O
the	O	O
gastrointestinal	O	O
tract	O	O
via	O	O
contaminated	O	O
water	O	O
and	O	O
food	O	O
.	O	O

The	O	O
oral-fecal	O	O
lifestyle	O	O
of	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
is	O	O
facilitated	O	O
by	O	O
its	O	O
ability	O	O
to	O	O
survive	O	O
the	O	O
low	O	O
pH	O	O
of	O	O
the	O	O
human	O	O
gastric	O	O
stomach	O	O
.	O	O

Most	O	O
strains	O	O
of	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
do	O	O
not	O	O
cause	O	O
human	O	O
disease	O	O
,	O	O
but	O	O
some	O	O
strains	O	O
produce	O	O
toxins	O	O
and	O	O
other	O	O
virulence	O	O
factors	O	O
.	O	O

Mature	O	O
cattle	O	O
carry	O	O
E.	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
O157	I-bacteria	I-bacteria
:	I-bacteria	I-bacteria
H7	E-bacteria	I-bacteria
without	O	O
showing	O	O
signs	O	O
of	O	O
infection	O	O
,	O	O
and	O	O
beef	O	O
can	O	O
be	O	O
contaminated	O	O
with	O	O
cattle	O	O
feces	O	O
at	O	O
slaughter	O	O
.	O	O

Cattle	O	O
manure	O	O
is	O	O
often	O	O
used	O	O
as	O	O
a	O	O
fertilizer	O	O
by	O	O
the	O	O
vegetable	O	O
industry	O	O
,	O	O
and	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
from	O	O
manure	O	O
can	O	O
migrate	O	O
through	O	O
the	O	O
soil	O	O
into	O	O
water	O	O
supplies	O	O
.	O	O

Sanitation	O	O
,	O	O
cooking	O	O
and	O	O
chlorination	O	O
have	O	O
been	O	O
used	O	O
to	O	O
combat	O	O
fecal	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
but	O	O
these	O	O
methods	O	O
are	O	O
not	O	O
always	O	O
effective	O	O
.	O	O

Recent	O	O
work	O	O
indicates	O	O
that	O	O
cattle	O	O
diets	O	O
can	O	O
be	O	O
modified	O	O
overcome	O	O
the	O	O
extreme	O	O
acid	O	O
resistance	O	O
of	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
.	O	O

When	O	O
cattle	O	O
were	O	O
fed	O	O
have	O	O
for	O	O
only	O	O
a	O	O
few	O	O
days	O	O
,	O	O
colonic	O	O
volatile	O	O
fatty	O	O
acid	O	O
concentrations	O	O
declined	O	O
,	O	O
pH	O	O
increased	O	O
,	O	O
and	O	O
the	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
were	O	O
no	O	O
longer	O	O
able	O	O
to	O	O
survive	O	O
a	O	O
pH	O	O
shock	O	O
that	O	O
mimicked	O	O
the	O	O
human	O	O
gastric	O	O
stomach	O	O
.	O	O

E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
in	O	O
stored	O	O
cattle	O	O
manure	O	O
eventually	O	O
become	O	O
highly	O	O
acid	O	O
resistant	O	O
even	O	O
if	O	O
the	O	O
cattle	O	O
were	O	O
fed	O	O
hay	O	O
,	O	O
but	O	O
these	O	O
bacteria	O	O
could	O	O
be	O	O
killed	O	O
by	O	O
sodium	O	O
carbonate	O	O
(	O	O
150	O	O
mM	O	O
,	O	O
pH	O	O
8.5	O	O
)	O	O
.	O	O

Because	O	O
the	O	O
diet	O	O
manipulations	O	O
and	O	O
carbonate	O	O
treatments	O	O
affected	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
in	O	O
general	O	O
rather	O	O
than	O	O
specific	O	O
serotypes	O	O
,	O	O
there	O	O
is	O	O
an	O	O
increased	O	O
likelihood	O	O
of	O	O
successful	O	O
field	O	O
application	O	O
.	O	O

Recent	O	O
studies	O	O
reported	O	O
significant	O	O
,	O	O
additional	O	O
clinical	O	O
and	O	O
microbiological	O	O
improvements	O	O
when	O	O
severe	O	O
adult	O	O
periodontitis	O	O
was	O	O
treated	O	O
via	O	O
the	O	O
one-stage	O	O
full-mouth	O	O
(	O	O
OSFM	O	O
)	O	O
disinfection	O	O
approach	O	O
,	O	O
instead	O	O
of	O	O
a	O	O
standard	O	O
treatment	O	O
scheme	O	O
with	O	O
staged	O	O
instrumentation	O	O
per	O	O
quadrant	O	O
.	O	O

The	O	O
OSFM	O	O
disinfection	O	O
involves	O	O
dealing	O	O
with	O	O
the	O	O
remaining	O	O
oropharyngeal	O	O
niches	O	O
such	O	O
as	O	O
tonsils	O	O
,	O	O
saliva	O	O
,	O	O
tongue	O	O
,	O	O
and	O	O
mucosa	O	O
.	O	O

The	O	O
OSFM	O	O
disinfection	O	O
procedure	O	O
involves	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
of	O	O
all	O	O
pockets	O	O
within	O	O
24	O	O
hours	O	O
in	O	O
combination	O	O
with	O	O
chlorhexidine	O	O
application	O	O
to	O	O
all	O	O
oropharyngeal	O	O
niches	O	O
(	O	O
chairside	O	O
and	O	O
at	O	O
home	O	O
for	O	O
2	O	O
months	O	O
)	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
compare	O	O
the	O	O
microbiological	O	O
shifts	O	O
with	O	O
the	O	O
OSFM	O	O
approach	O	O
versus	O	O
standard	O	O
therapy	O	O
.	O	O

Nineteen	O	O
patients	O	O
with	O	O
advanced	O	O
chronic	O	O
periodontitis	O	O
(	O	O
AP	O	O
)	O	O
and	O	O
12	O	O
patients	O	O
with	O	O
early-onset	O	O
periodontitis	O	O
(	O	O
EOP	O	O
)	O	O
were	O	O
randomly	O	O
assigned	O	O
to	O	O
the	O	O
test	O	O
and	O	O
control	O	O
groups	O	O
.	O	O

The	O	O
control	O	O
group	O	O
(	O	O
9	O	O
AP	O	O
patients	O	O
,	O	O
6	O	O
EOP	O	O
patients	O	O
)	O	O
was	O	O
scaled	O	O
and	O	O
root	O	O
planed	O	O
,	O	O
per	O	O
quadrant	O	O
,	O	O
with	O	O
2-week	O	O
intervals	O	O
.	O	O

The	O	O
test	O	O
group	O	O
(	O	O
10	O	O
AP	O	O
patients	O	O
and	O	O
6	O	O
EOP	O	O
patients	O	O
)	O	O
underwent	O	O
OSFM	O	O
disinfection	O	O
treatment	O	O
.	O	O

At	O	O
baseline	O	O
and	O	O
after	O	O
2	O	O
,	O	O
4	O	O
,	O	O
and	O	O
8	O	O
months	O	O
,	O	O
pooled	O	O
subgingival	O	O
plaque	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
single-	O	O
and	O	O
multi-rooted	O	O
teeth	O	O
.	O	O

The	O	O
presence	O	O
and	O	O
levels	O	O
of	O	O
30	O	O
subgingival	O	O
taxa	O	O
were	O	O
determined	O	O
using	O	O
whole	O	O
genomic	O	O
DNA	O	O
probes	O	O
and	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
.	O	O

Both	O	O
treatments	O	O
resulted	O	O
in	O	O
important	O	O
reductions	O	O
of	O	O
the	O	O
pathogenic	O	O
species	O	O
up	O	O
to	O	O
8	O	O
months	O	O
after	O	O
therapy	O	O
,	O	O
both	O	O
for	O	O
their	O	O
detection	O	O
level	O	O
and	O	O
frequency	O	O
.	O	O

The	O	O
OSFM	O	O
disinfection	O	O
resulted	O	O
in	O	O
an	O	O
additional	O	O
improvement	O	O
,	O	O
especially	O	O
in	O	O
the	O	O
AP	O	O
group	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
B.	B-bacteria	B-bacteria
forsythus	E-bacteria	I-bacteria
were	O	O
reduced	O	O
below	O	O
detection	O	O
level	O	O
.	O	O

The	O	O
number	O	O
of	O	O
beneficial	O	O
species	O	O
remained	O	O
nearly	O	O
unchanged	O	O
.	O	O

The	O	O
OSFM	O	O
disinfection	O	O
results	O	O
in	O	O
supplementary	O	O
reductions	O	O
of	O	O
periodontal	O	O
pathogens	O	O
even	O	O
after	O	O
8	O	O
months	O	O
in	O	O
the	O	O
treatment	O	O
of	O	O
patients	O	O
with	O	O
advanced	O	O
or	O	O
early-onset	O	O
periodontitis	O	O
.	O	O

The	O	O
frequency	O	O
of	O	O
carriage	O	O
of	O	O
antibiotic-resistant	O	O
bacteria	O	O
in	O	O
healthy	O	O
7-	O	O
and	O	O
8-year-old	O	O
children	O	O
in	O	O
Bristol	O	O
was	O	O
studied	O	O
.	O	O

Children	O	O
born	O	O
in	O	O
Avon	O	O
between	O	O
1	O	O
April	O	O
1991	O	O
and	O	O
31	O	O
December	O	O
1992	O	O
,	O	O
attending	O	O
the	O	O
Avon	O	O
Longitudinal	O	O
Study	O	O
of	O	O
Pregnancy	O	O
and	O	O
Childhood	O	O
(	O	O
ALSPAC	O	O
)	O	O
7	O	O
year	O	O
follow-up	O	O
clinic	O	O
,	O	O
formed	O	O
the	O	O
study	O	O
population	O	O
.	O	O

Carriage	O	O
was	O	O
estimated	O	O
using	O	O
mouth	O	O
and	O	O
stool	O	O
samples	O	O
.	O	O

None	O	O
of	O	O
105	O	O
children	O	O
on	O	O
whom	O	O
information	O	O
was	O	O
available	O	O
had	O	O
received	O	O
tetracycline	O	O
,	O	O
chloramphenicol	O	O
,	O	O
ciprofloxacin	O	O
or	O	O
an	O	O
extended-spectrum	O	O
cephalosporin	O	O
in	O	O
the	O	O
previous	O	O
year	O	O
.	O	O

Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
was	O	O
isolated	O	O
from	O	O
mouthwashes	O	O
from	O	O
200	O	O
(	O	O
37.1	O	O
%	O	O
)	O	O
of	O	O
539	O	O
children	O	O
sampled	O	O
.	O	O

Six	O	O
(	O	O
3	O	O
%	O	O
)	O	O
of	O	O
the	O	O
isolates	O	O
were	O	O
resistant	O	O
to	O	O
chloramphenicol	O	O
or	O	O
tetracycline	O	O
and	O	O
four	O	O
(	O	O
2	O	O
%	O	O
)	O	O
were	O	O
methicillin	O	O
resistant	O	O
.	O	O

Haemophilus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

were	O	O
isolated	O	O
from	O	O
369	O	O
(	O	O
72	O	O
%	O	O
)	O	O
of	O	O
513	O	O
samples	O	O
and	O	O
63	O	O
(	O	O
17	O	O
%	O	O
)	O	O
were	O	O
ampicillin	O	O
resistant	O	O
,	O	O
49	O	O
(	O	O
13.3	O	O
%	O	O
)	O	O
were	O	O
erythromycin	O	O
resistant	O	O
and	O	O
seven	O	O
(	O	O
1.9	O	O
%	O	O
)	O	O
were	O	O
tetracycline	O	O
resistant	O	O
.	O	O

Branhamella	B-bacteria	B-bacteria
catarrhalis	E-bacteria	I-bacteria
was	O	O
isolated	O	O
from	O	O
333	O	O
(	O	O
74	O	O
%	O	O
)	O	O
of	O	O
450	O	O
samples	O	O
.	O	O

Twenty-eight	O	O
(	O	O
8.4	O	O
%	O	O
)	O	O
were	O	O
erythromycin	O	O
resistant	O	O
and	O	O
14	O	O
(	O	O
4.2	O	O
%	O	O
)	O	O
strains	O	O
were	O	O
tetracycline	O	O
resistant	O	O
.	O	O

Group	O	O
A	O	O
beta-haemolytic	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
were	O	O
isolated	O	O
from	O	O
17	O	O
of	O	O
507	O	O
children	O	O
sampled	O	O
.	O	O

One	O	O
(	O	O
5.9	O	O
%	O	O
)	O	O
was	O	O
tetracycline	O	O
resistant	O	O
.	O	O

Stool	O	O
samples	O	O
were	O	O
returned	O	O
from	O	O
335	O	O
(	O	O
62	O	O
%	O	O
)	O	O
of	O	O
539	O	O
children	O	O
from	O	O
whom	O	O
they	O	O
were	O	O
requested	O	O
.	O	O

Eleven	O	O
per	O	O
cent	O	O
of	O	O
samples	O	O
yielded	O	O
Gram-negative	B-bacteria	B-bacteria
bacilli	E-bacteria	I-bacteria
with	O	O
high-level	O	O
resistance	O	O
to	O	O
chloramphenicol	O	O
,	O	O
which	O	O
was	O	O
frequently	O	O
linked	O	O
to	O	O
resistance	O	O
to	O	O
ampicillin	O	O
,	O	O
spectinomycin	O	O
and	O	O
streptomycin	O	O
.	O	O

Isolates	O	O
demonstrating	O	O
resistance	O	O
to	O	O
the	O	O
third-generation	O	O
cephalosporin	O	O
ceftazidime	O	O
were	O	O
recovered	O	O
from	O	O
17	O	O
subjects	O	O
(	O	O
3.2	O	O
%	O	O
)	O	O
.	O	O

Six	O	O
(	O	O
35	O	O
%	O	O
)	O	O
of	O	O
17	O	O
isolates	O	O
possessed	O	O
extended-spectrum	O	O
beta-lactamases	O	O
.	O	O

Healthy	O	O
children	O	O
carry	O	O
bacteria	O	O
resistant	O	O
to	O	O
antibiotics	O	O
to	O	O
which	O	O
children	O	O
are	O	O
not	O	O
usually	O	O
exposed	O	O
.	O	O

Resistance	O	O
to	O	O
ceftazidime	O	O
,	O	O
chloramphenicol	O	O
and	O	O
tetracycline	O	O
may	O	O
be	O	O
co-selected	O	O
by	O	O
exposure	O	O
to	O	O
other	O	O
antibiotics	O	O
used	O	O
in	O	O
children	O	O
or	O	O
may	O	O
be	O	O
acquired	O	O
from	O	O
family	O	O
members	O	O
,	O	O
pets	O	O
,	O	O
other	O	O
children	O	O
or	O	O
food	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
antibiotic-resistant	O	O
bacteria	O	O
are	O	O
widely	O	O
disseminated	O	O
and	O	O
may	O	O
be	O	O
acquired	O	O
by	O	O
children	O	O
before	O	O
exposure	O	O
to	O	O
specific	O	O
selection	O	O
pressure	O	O
.	O	O

A	O	O
total	O	O
of	O	O
eight	O	O
bacterial	O	O
isolates	O	O
belonging	O	O
to	O	O
six	O	O
species	O	O
,	O	O
and	O	O
a	O	O
select	O	O
group	O	O
of	O	O
12	O	O
oral	O	O
Candida	O	O
albicans	O	O
isolates	O	O
,	O	O
were	O	O
used	O	O
to	O	O
study	O	O
the	O	O
effect	O	O
of	O	O
bacteria	O	O
on	O	O
germ-tube	O	O
formation	O	O
.	O	O

Briefly	O	O
,	O	O
each	O	O
bacterial	O	O
suspension	O	O
(	O	O
10	O	O
(	O	O
5-6	O	O
)	O	O
cells/ml	O	O
)	O	O
was	O	O
mixed	O	O
with	O	O
a	O	O
C.	O	O
albicans	O	O
suspension	O	O
(	O	O
10	O	O
(	O	O
7	O	O
)	O	O
cells/ml	O	O
)	O	O
and	O	O
incubated	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
for	O	O
90	O	O
min	O	O
with	O	O
bovine	O	O
serum	O	O
,	O	O
and	O	O
the	O	O
percentage	O	O
germ-tube-positive	O	O
Candida	O	O
cells	O	O
was	O	O
quantified	O	O
using	O	O
a	O	O
haemocytometer	O	O
,	O	O
under	O	O
light	O	O
microscopy	O	O
.	O	O

In	O	O
general	O	O
,	O	O
out	O	O
of	O	O
eight	O	O
bacteria	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	I-bacteria	I-bacteria
SK21A	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
SK56	E-bacteria	I-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25922	E-bacteria	I-bacteria
,	O	O
and	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
OBU3	E-bacteria	I-bacteria
suppressed	O	O
germ-tube	O	O
formation	O	O
to	O	O
varying	O	O
degrees	O	O
,	O	O
with	O	O
different	O	O
C	O	O
albicans	O	O
isolates	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
Pg	O	O
50	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
7469	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	I-bacteria	I-bacteria
OBU4	E-bacteria	I-bacteria
elicited	O	O
significant	O	O
enhancement	O	O
of	O	O
germ-tube	O	O
formation	O	O
,	O	O
whereas	O	O
S.	B-bacteria	B-bacteria
sanguis	I-bacteria	I-bacteria
OBU	I-bacteria	I-bacteria
2	E-bacteria	I-bacteria
had	O	O
no	O	O
effect	O	O
.	O	O

E.	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25922	E-bacteria	I-bacteria
was	O	O
the	O	O
only	O	O
organism	O	O
to	O	O
show	O	O
statistically	O	O
significant	O	O
suppression	O	O
of	O	O
germ-tube	O	O
formation	O	O
(	O	O
p=0.0312	O	O
)	O	O
.	O	O

A	O	O
significant	O	O
increase	O	O
in	O	O
the	O	O
germ	O	O
tube	O	O
production	O	O
of	O	O
C.	O	O
albicans	O	O
isolated	O	O
from	O	O
HIV-infected	O	O
compared	O	O
with	O	O
HIV-free	O	O
individuals	O	O
was	O	O
also	O	O
noted	O	O
.	O	O

The	O	O
current	O	O
results	O	O
tend	O	O
to	O	O
suggest	O	O
that	O	O
commensal	O	O
and	O	O
transient	O	O
oral	O	O
bacterial	O	O
populations	O	O
may	O	O
selectively	O	O
influence	O	O
the	O	O
differential	O	O
expression	O	O
of	O	O
germ-tube-forming	O	O
ability	O	O
of	O	O
C.	O	O
albicans	O	O
isolates	O	O
.	O	O

The	O	O
species	O	O
of	O	O
sulfate-reducing	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
that	O	O
prevail	O	O
in	O	O
sites	O	O
affected	O	O
by	O	O
periodontal	O	O
disease	O	O
may	O	O
be	O	O
different	O	O
from	O	O
those	O	O
commonly	O	O
occurring	O	O
in	O	O
the	O	O
digestive	O	O
tracts	O	O
of	O	O
healthy	O	O
individuals	O	O
.	O	O

Ten	O	O
strains	O	O
of	O	O
mesophilic	B-bacteria	B-bacteria
sulfate-reducing	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
SRB	B-bacteria	B-bacteria
)	O	O
were	O	O
isolated	O	O
from	O	O
subgingival	O	O
plaque	O	O
in	O	O
periodontal	O	O
lesions	O	O
of	O	O
ten	O	O
patients	O	O
with	O	O
periodontitis	O	O
.	O	O

Characterization	O	O
on	O	O
the	O	O
basis	O	O
of	O	O
morphological	O	O
,	O	O
physiological	O	O
and	O	O
phylogenetic	O	O
properties	O	O
demonstrated	O	O
two	O	O
distinct	O	O
types	O	O
of	O	O
oral	O	O
SRB	B-bacteria	B-bacteria
.	O	O

One	O	O
strain	O	O
was	O	O
a	O	O
curved	O	O
rod	O	O
with	O	O
high	O	O
motility	O	O
.	O	O

For	O	O
dissimilatory	O	O
sulfate	O	O
reduction	O	O
,	O	O
lactate	O	O
or	O	O
pyruvate	O	O
was	O	O
oxidized	O	O
incompletely	O	O
to	O	O
equimolar	O	O
amounts	O	O
of	O	O
acetate	O	O
.	O	O

Desulfoviridin	O	O
and	O	O
cytochrome	O	O
c3	O	O
were	O	O
present	O	O
in	O	O
this	O	O
mesophilic	B-bacteria	B-bacteria
vibrio	E-bacteria	I-bacteria
and	O	O
the	O	O
cellular	O	O
lipid	O	O
profile	O	O
was	O	O
similar	O	O
to	O	O
that	O	O
from	O	O
members	O	O
of	O	O
the	O	O
genus	B-bacteria	B-bacteria
Desulfovibrio	E-bacteria	I-bacteria
.	O	O

The	O	O
16S	O	O
rDNA	O	O
sequence	O	O
was	O	O
similar	O	O
to	O	O
that	O	O
of	O	O
the	O	O
proposed	O	O
'Desulfovibrio	B-bacteria	B-bacteria
fairfieldensis	E-bacteria	I-bacteria
'	O	O
.	O	O

Cells	O	O
of	O	O
the	O	O
nine	O	O
other	O	O
strains	O	O
were	O	O
straight	O	O
,	O	O
rod-shaped	O	O
,	O	O
exhibited	O	O
a	O	O
low	O	O
growth	O	O
rate	O	O
and	O	O
oxidized	O	O
substrates	O	O
incompletely	O	O
to	O	O
acetate	O	O
.	O	O

These	O	O
SRB	B-bacteria	B-bacteria
,	O	O
like	O	O
members	O	O
of	O	O
the	O	O
genus	B-bacteria	B-bacteria
Desulfomicrobium	E-bacteria	I-bacteria
,	O	O
lacked	O	O
desulfoviridin	O	O
.	O	O

Analysis	O	O
of	O	O
the	O	O
16S	O	O
rDNA	O	O
sequences	O	O
of	O	O
seven	O	O
of	O	O
the	O	O
nine	O	O
isolates	O	O
showed	O	O
a	O	O
high	O	O
degree	O	O
of	O	O
similarity	O	O
among	O	O
these	O	O
oral	O	O
strains	O	O
,	O	O
forming	O	O
a	O	O
distinct	O	O
lineage	O	O
within	O	O
the	O	O
genus	B-bacteria	B-bacteria
Desulfomicrobium	E-bacteria	I-bacteria
.	O	O

The	O	O
cellular	O	O
lipid	O	O
profile	O	O
of	O	O
a	O	O
representative	O	O
oral	O	O
strain	O	O
,	O	O
NY678T	B-bacteria	B-bacteria
,	O	O
was	O	O
in	O	O
accordance	O	O
with	O	O
that	O	O
of	O	O
other	O	O
Desulfomicrobium	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
but	O	O
also	O	O
showed	O	O
dissimilar	O	O
features	O	O
.	O	O

The	O	O
phenotypic	O	O
and	O	O
phylogenetic	O	O
analyses	O	O
indicate	O	O
that	O	O
these	O	O
rod-shaped	O	O
SRB	B-bacteria	B-bacteria
from	O	O
the	O	O
oral	O	O
cavity	O	O
could	O	O
be	O	O
regarded	O	O
as	O	O
a	O	O
new	O	O
species	O	O
,	O	O
for	O	O
which	O	O
the	O	O
designation	O	O
Desulfomicrobium	B-bacteria	B-bacteria
orale	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
is	O	O
proposed	O	O
.	O	O

Transformation	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
DL1	E-bacteria	I-bacteria
by	O	O
free	O	O
DNA	O	O
was	O	O
studied	O	O
in	O	O
human	O	O
saliva	O	O
.	O	O

Competent	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
could	O	O
be	O	O
transformed	O	O
in	O	O
vitro	O	O
with	O	O
plasmid	O	O
DNA	O	O
that	O	O
had	O	O
been	O	O
taken	O	O
into	O	O
the	O	O
human	O	O
mouth	O	O
.	O	O

Transformation	O	O
also	O	O
occurred	O	O
with	O	O
a	O	O
plasmid	O	O
that	O	O
can	O	O
not	O	O
replicate	O	O
in	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
but	O	O
that	O	O
has	O	O
a	O	O
region	O	O
of	O	O
chromosomal	O	O
homology	O	O
,	O	O
by	O	O
integration	O	O
into	O	O
the	O	O
bacterial	O	O
chromosome	O	O
,	O	O
although	O	O
linearised	O	O
plasmid	O	O
DNA	O	O
gave	O	O
no	O	O
transformants	O	O
.	O	O

Linear	O	O
chromosomal	O	O
DNA	O	O
fragments	O	O
did	O	O
however	O	O
transform	O	O
S.	B-bacteria	B-bacteria
gordonii/Tn916	E-bacteria	I-bacteria
efficiently	O	O
in	O	O
saliva	O	O
when	O	O
regions	O	O
of	O	O
homology	O	O
with	O	O
the	O	O
recipient	O	O
chromosome	O	O
flanked	O	O
the	O	O
marker	O	O
gene	O	O
.	O	O

These	O	O
findings	O	O
are	O	O
discussed	O	O
in	O	O
relation	O	O
to	O	O
the	O	O
potential	O	O
for	O	O
acquisition	O	O
of	O	O
DNA	O	O
sequences	O	O
,	O	O
including	O	O
genetically	O	O
modified	O	O
DNA	O	O
,	O	O
by	O	O
gut	O	O
and	O	O
oral	O	O
bacteria	O	O
.	O	O

To	O	O
develop	O	O
a	O	O
simple	O	O
and	O	O
flexible	O	O
novel	O	O
in	O	O
vitro	O	O
model	O	O
system	O	O
to	O	O
grow	O	O
films	O	O
of	O	O
oral	O	O
bacteria	O	O
that	O	O
could	O	O
be	O	O
used	O	O
to	O	O
study	O	O
aspects	O	O
of	O	O
dental	O	O
caries	O	O
.	O	O

Standardized	O	O
suspensions	O	O
of	O	O
bacteria	O	O
were	O	O
inoculated	O	O
into	O	O
Ultrafree-CL	O	O
(	O	O
Millipore	O	O
)	O	O
ultrafiltration	O	O
units	O	O
at	O	O
various	O	O
densities	O	O
.	O	O

These	O	O
were	O	O
incubated	O	O
for	O	O
varying	O	O
time	O	O
intervals	O	O
with	O	O
a	O	O
range	O	O
of	O	O
carbon	O	O
sources	O	O
.	O	O

The	O	O
bacterial	O	O
films	O	O
reproducibly	O	O
achieved	O	O
between	O	O
107	O	O
and	O	O
108	O	O
cfu	O	O
cm-2	O	O
,	O	O
irrespective	O	O
of	O	O
the	O	O
number	O	O
inoculated	O	O
and	O	O
with	O	O
no	O	O
significant	O	O
changes	O	O
for	O	O
14	O	O
d.	O	O
However	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
grew	O	O
through	O	O
membranes	O	O
with	O	O
pores	O	O
of	O	O
diameter	O	O
greater	O	O
than	O	O
0.1	O	O
microm	O	O
after	O	O
6	O	O
d.	O	O
Culture	O	O
of	O	O
films	O	O
in	O	O
sucrose	O	O
or	O	O
water	O	O
for	O	O
6	O	O
d	O	O
led	O	O
to	O	O
a	O	O
decreased	O	O
number	O	O
of	O	O
colony-forming	O	O
units	O	O
,	O	O
but	O	O
returning	O	O
them	O	O
to	O	O
broth	O	O
reversed	O	O
this	O	O
.	O	O

Reproducible	O	O
films	O	O
of	O	O
oral	O	O
bacteria	O	O
can	O	O
be	O	O
cultured	O	O
in	O	O
Ultrafree-CL	O	O
units	O	O
.	O	O

This	O	O
study	O	O
has	O	O
shown	O	O
that	O	O
Ultrafree-CL	O	O
units	O	O
can	O	O
be	O	O
used	O	O
as	O	O
a	O	O
simple	O	O
model	O	O
system	O	O
to	O	O
grow	O	O
biofilms	O	O
that	O	O
could	O	O
be	O	O
used	O	O
for	O	O
dental	O	O
caries	O	O
research	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
compare	O	O
the	O	O
resistance	O	O
of	O	O
the	O	O
corrosion	O	O
of	O	O
dental	O	O
alloys	O	O
in	O	O
a	O	O
solution	O	O
containing	O	O
oral	O	O
bacteria	O	O
named	O	O
Actinomyces	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
(	O	O
ATCC19246	B-bacteria	B-bacteria
)	O	O
.	O	O

In	O	O
this	O	O
paper	O	O
,	O	O
we	O	O
explain	O	O
the	O	O
choice	O	O
of	O	O
this	O	O
precise	O	O
species	O	O
of	O	O
bacteria	O	O
,	O	O
then	O	O
specify	O	O
its	O	O
culture	O	O
in	O	O
artificial	O	O
saliva	O	O
and	O	O
the	O	O
experimental	O	O
precautions	O	O
needed	O	O
to	O	O
avoid	O	O
the	O	O
pollution	O	O
by	O	O
other	O	O
bacteria	O	O
.	O	O

The	O	O
electrochemical	O	O
behaviour	O	O
of	O	O
two	O	O
dental	O	O
alloys	O	O
(	O	O
Ni-Cr	O	O
alloy	O	O
and	O	O
gold-based	O	O
alloy	O	O
)	O	O
was	O	O
investigated	O	O
by	O	O
electrochemical	O	O
means	O	O
in	O	O
sterile	O	O
Fusayama	O	O
artificial	O	O
saliva	O	O
(	O	O
AS	O	O
)	O	O
,	O	O
AS	O	O
enriched	O	O
with	O	O
sterile	O	O
yeast	O	O
extract	O	O
(	O	O
YE	O	O
)	O	O
and	O	O
YE	O	O
modified	O	O
by	O	O
introducing	O	O
bacteria	O	O
(	O	O
AV	O	O
)	O	O
.	O	O

Open-circuit	O	O
potentials	O	O
,	O	O
potentiodynamic	O	O
curves	O	O
,	O	O
polarization	O	O
resistance	O	O
and	O	O
impedance	O	O
spectroscopy	O	O
are	O	O
the	O	O
electrochemical	O	O
procedures	O	O
selected	O	O
for	O	O
this	O	O
work	O	O
.	O	O

It	O	O
has	O	O
thus	O	O
been	O	O
shown	O	O
that	O	O
the	O	O
open-circuit	O	O
potential	O	O
of	O	O
the	O	O
non-precious	O	O
alloy	O	O
is	O	O
always	O	O
lower	O	O
than	O	O
that	O	O
of	O	O
the	O	O
gold	O	O
precious	O	O
alloy	O	O
,	O	O
and	O	O
the	O	O
colonization	O	O
of	O	O
metal	O	O
surface	O	O
by	O	O
bacteria	O	O
caused	O	O
a	O	O
drop	O	O
in	O	O
open	O	O
circuit	O	O
potential	O	O
.	O	O

The	O	O
electrochemical	O	O
impedance	O	O
spectroscopy	O	O
results	O	O
have	O	O
shown	O	O
that	O	O
the	O	O
electrolyte	O	O
resistance	O	O
decreased	O	O
between	O	O
the	O	O
AS	O	O
,	O	O
YE	O	O
and	O	O
AV	O	O
milieu	O	O
,	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
bacteria	O	O
a	O	O
slight	O	O
decrease	O	O
in	O	O
polarization	O	O
resistance	O	O
was	O	O
observed	O	O
with	O	O
the	O	O
precious	O	O
alloy	O	O
and	O	O
an	O	O
increase	O	O
with	O	O
the	O	O
non-precious	O	O
alloy	O	O
.	O	O

The	O	O
drop	O	O
in	O	O
the	O	O
electrolyte	O	O
resistance	O	O
can	O	O
not	O	O
explain	O	O
the	O	O
change	O	O
in	O	O
polarization	O	O
resistance	O	O
.	O	O

The	O	O
influence	O	O
of	O	O
Actinomyces	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
might	O	O
be	O	O
essentially	O	O
due	O	O
to	O	O
the	O	O
consumption	O	O
of	O	O
oxygen	O	O
at	O	O
the	O	O
metal/electrolyte	O	O
interface	O	O
of	O	O
the	O	O
specimen	O	O
.	O	O

For	O	O
the	O	O
non-precious	O	O
alloy	O	O
,	O	O
the	O	O
absence	O	O
of	O	O
oxygen	O	O
(	O	O
instigator	O	O
of	O	O
corrosion	O	O
)	O	O
led	O	O
to	O	O
an	O	O
increase	O	O
in	O	O
polarization	O	O
resistance	O	O
whereas	O	O
the	O	O
slight	O	O
decrease	O	O
for	O	O
the	O	O
precious	O	O
alloys	O	O
might	O	O
be	O	O
justified	O	O
by	O	O
the	O	O
organic	O	O
and	O	O
inorganic	O	O
metabolites	O	O
released	O	O
by	O	O
bacteria	O	O
in	O	O
to	O	O
the	O	O
electrolyte	O	O
.	O	O

The	O	O
scanning	O	O
electron	O	O
micrography	O	O
after	O	O
electrochemical	O	O
analysis	O	O
,	O	O
confirmed	O	O
the	O	O
absence	O	O
of	O	O
contaminants	O	O
.	O	O

These	O	O
preliminary	O	O
results	O	O
demonstrate	O	O
the	O	O
unquestionable	O	O
influence	O	O
of	O	O
this	O	O
bacteria	O	O
on	O	O
the	O	O
corrosion	O	O
behaviour	O	O
of	O	O
the	O	O
alloys	O	O
studied	O	O
,	O	O
however	O	O
,	O	O
further	O	O
studies	O	O
are	O	O
necessary	O	O
.	O	O

Dental	O	O
caries	O	O
and	O	O
periodontitis	O	O
,	O	O
although	O	O
generally	O	O
not	O	O
life	O	O
threatening	O	O
,	O	O
are	O	O
nevertheless	O	O
of	O	O
significant	O	O
importance	O	O
.	O	O

An	O	O
understanding	O	O
of	O	O
the	O	O
molecular	O	O
nature	O	O
of	O	O
these	O	O
diseases	O	O
could	O	O
aid	O	O
the	O	O
development	O	O
of	O	O
novel	O	O
methods	O	O
of	O	O
prevention	O	O
and	O	O
control	O	O
,	O	O
and	O	O
increase	O	O
our	O	O
knowledge	O	O
of	O	O
their	O	O
etiology	O	O
.	O	O

The	O	O
identification	O	O
of	O	O
virulence	O	O
factors	O	O
in	O	O
oral	O	O
bacteria	O	O
could	O	O
lead	O	O
to	O	O
the	O	O
development	O	O
of	O	O
vaccines	O	O
directed	O	O
against	O	O
these	O	O
organisms	O	O
,	O	O
the	O	O
design	O	O
of	O	O
inhibitors	O	O
of	O	O
biofilm	O	O
formation	O	O
,	O	O
and	O	O
the	O	O
development	O	O
of	O	O
replacement	O	O
therapy	O	O
strategies	O	O
.	O	O

The	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
are	O	O
normally	O	O
non-pathogenic	O	O
residents	O	O
of	O	O
the	O	O
human	O	O
microflora	O	O
.	O	O

There	O	O
is	O	O
substantial	O	O
evidence	O	O
that	O	O
these	O	O
bacteria	O	O
can	O	O
,	O	O
however	O	O
,	O	O
act	O	O
as	O	O
``	O	O
genetic	O	O
reservoirs	O	O
''	O	O
and	O	O
transfer	O	O
genetic	O	O
information	O	O
to	O	O
transient	O	O
bacteria	O	O
as	O	O
they	O	O
make	O	O
their	O	O
way	O	O
through	O	O
the	O	O
mouth	O	O
,	O	O
the	O	O
principal	O	O
entry	O	O
point	O	O
for	O	O
a	O	O
wide	O	O
variety	O	O
of	O	O
bacteria	O	O
.	O	O

Examples	O	O
that	O	O
are	O	O
of	O	O
particular	O	O
concern	O	O
include	O	O
the	O	O
transfer	O	O
of	O	O
antibiotic	O	O
resistance	O	O
from	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
to	O	O
Streptococcus	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
.	O	O

The	O	O
mechanisms	O	O
that	O	O
are	O	O
used	O	O
by	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
to	O	O
exchange	O	O
genetic	O	O
information	O	O
are	O	O
not	O	O
well-understood	O	O
,	O	O
although	O	O
several	O	O
species	O	O
are	O	O
known	O	O
to	O	O
enter	O	O
a	O	O
physiological	O	O
state	O	O
of	O	O
genetic	O	O
competence	O	O
.	O	O

This	O	O
state	O	O
permits	O	O
them	O	O
to	O	O
become	O	O
capable	O	O
of	O	O
natural	O	O
genetic	O	O
transformation	O	O
,	O	O
facilitating	O	O
the	O	O
acquisition	O	O
of	O	O
foreign	O	O
DNA	O	O
from	O	O
the	O	O
external	O	O
environment	O	O
.	O	O

The	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
share	O	O
many	O	O
similarities	O	O
with	O	O
two	O	O
closely	O	O
related	O	O
Gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
and	O	O
Bacillus	B-bacteria	B-bacteria
subtilis	E-bacteria	I-bacteria
.	O	O

In	O	O
these	O	O
bacteria	O	O
,	O	O
the	O	O
mechanisms	O	O
of	O	O
quorum-sensing	O	O
,	O	O
the	O	O
development	O	O
of	O	O
competence	O	O
,	O	O
and	O	O
DNA	O	O
uptake	O	O
and	O	O
integration	O	O
are	O	O
well-characterized	O	O
.	O	O

Using	O	O
this	O	O
knowledge	O	O
and	O	O
the	O	O
data	O	O
available	O	O
in	O	O
genome	O	O
databases	O	O
allowed	O	O
us	O	O
to	O	O
identify	O	O
putative	O	O
genes	O	O
involved	O	O
in	O	O
these	O	O
processes	O	O
in	O	O
the	O	O
oral	O	O
organism	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Models	O	O
of	O	O
competence	O	O
development	O	O
and	O	O
genetic	O	O
transformation	O	O
in	O	O
the	O	O
oral	O	O
streptococci	E-bacteria	I-bacteria
and	O	O
strategies	O	O
to	O	O
confirm	O	O
these	O	O
models	O	O
are	O	O
discussed	O	O
.	O	O

Future	O	O
studies	O	O
of	O	O
competence	O	O
in	O	O
oral	O	O
biofilms	O	O
,	O	O
the	O	O
natural	O	O
environment	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
will	O	O
be	O	O
discussed	O	O
.	O	O

Nested	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
was	O	O
performed	O	O
to	O	O
detect	O	O
the	O	O
presence	O	O
of	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
tongue	O	O
mucosa	O	O
in	O	O
268	O	O
patients	O	O
divided	O	O
into	O	O
four	O	O
groups	O	O
according	O	O
to	O	O
their	O	O
diagnosis	O	O
:	O	O
87	O	O
with	O	O
atrophic	O	O
glossitis	O	O
,	O	O
37	O	O
with	O	O
benign	O	O
migratory	O	O
glossitis	O	O
and	O	O
144	O	O
with	O	O
burning	O	O
mouth	O	O
syndrome	O	O
(	O	O
BMS	O	O
)	O	O
.	O	O

The	O	O
latter	O	O
group	O	O
was	O	O
subdivided	O	O
according	O	O
to	O	O
anatomic	O	O
site	O	O
of	O	O
burning	O	O
sensation	O	O
:	O	O
subgroup	O	O
A	O	O
(	O	O
54	O	O
patients	O	O
)	O	O
with	O	O
complaints	O	O
limited	O	O
to	O	O
tongue	O	O
and	O	O
subgroup	O	O
B	O	O
(	O	O
90	O	O
patients	O	O
)	O	O
with	O	O
burning	O	O
sensations	O	O
in	O	O
other	O	O
parts	O	O
of	O	O
oral	O	O
mucosa	O	O
.	O	O

H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
found	O	O
in	O	O
43	O	O
samples	O	O
(	O	O
16	O	O
%	O	O
)	O	O
.	O	O

Bacteria	O	O
were	O	O
significantly	O	O
less	O	O
present	O	O
in	O	O
tongue	O	O
mucosa	O	O
affected	O	O
with	O	O
benign	O	O
migratory	O	O
glossitis	O	O
compared	O	O
with	O	O
atrophic	O	O
glossitis	O	O
and	O	O
BMS	O	O
(	O	O
P=0.025	O	O
)	O	O
.	O	O

This	O	O
difference	O	O
was	O	O
more	O	O
obvious	O	O
when	O	O
compared	O	O
with	O	O
atrophic	O	O
glossitis	O	O
only	O	O
(	O	O
P=0.006	O	O
)	O	O
.	O	O

Mucosal	O	O
changes	O	O
in	O	O
these	O	O
conditions	O	O
might	O	O
make	O	O
the	O	O
oral	O	O
environment	O	O
more	O	O
acceptable	O	O
for	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
colonization	O	O
compared	O	O
with	O	O
normal	O	O
mucosa	O	O
,	O	O
and	O	O
this	O	O
mechanism	O	O
may	O	O
play	O	O
a	O	O
role	O	O
in	O	O
its	O	O
oro-oral	O	O
transmission	O	O
.	O	O

A	O	O
growing	O	O
body	O	O
of	O	O
information	O	O
has	O	O
provided	O	O
insights	O	O
into	O	O
the	O	O
mechanisms	O	O
by	O	O
which	O	O
the	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
maintain	O	O
their	O	O
niches	O	O
in	O	O
the	O	O
human	O	O
mouth	O	O
.	O	O

In	O	O
at	O	O
least	O	O
one	O	O
case	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
the	O	O
organism	O	O
apparently	O	O
uses	O	O
a	O	O
panel	O	O
of	O	O
proteins	O	O
to	O	O
survive	O	O
in	O	O
acidic	O	O
conditions	O	O
while	O	O
it	O	O
promotes	O	O
the	O	O
formation	O	O
of	O	O
dental	O	O
caries	O	O
.	O	O

Oral	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
which	O	O
are	O	O
not	O	O
as	O	O
inherently	O	O
resistant	O	O
to	O	O
acidification	O	O
,	O	O
use	O	O
protective	O	O
schemes	O	O
to	O	O
ameliorate	O	O
acidic	O	O
plaque	O	O
pH	O	O
values	O	O
.	O	O

Existing	O	O
information	O	O
clearly	O	O
shows	O	O
that	O	O
while	O	O
the	O	O
streptococci	B-bacteria	B-bacteria
are	O	O
highly	O	O
related	O	O
,	O	O
very	O	O
different	O	O
strategies	O	O
have	O	O
evolved	O	O
for	O	O
them	O	O
to	O	O
take	O	O
advantage	O	O
of	O	O
their	O	O
particular	O	O
location	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
picture	O	O
that	O	O
emerges	O	O
is	O	O
that	O	O
the	O	O
acid-adaptive	O	O
regulatory	O	O
mechanisms	O	O
of	O	O
the	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
differ	O	O
markedly	O	O
from	O	O
those	O	O
used	O	O
by	O	O
Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

What	O	O
future	O	O
research	O	O
must	O	O
determine	O	O
is	O	O
the	O	O
extent	O	O
and	O	O
complexity	O	O
of	O	O
the	O	O
acid-adaptive	O	O
systems	O	O
in	O	O
these	O	O
organisms	O	O
and	O	O
how	O	O
they	O	O
permit	O	O
the	O	O
organisms	O	O
to	O	O
maintain	O	O
themselves	O	O
in	O	O
the	O	O
face	O	O
of	O	O
a	O	O
low-pH	O	O
environment	O	O
and	O	O
the	O	O
microbial	O	O
competition	O	O
present	O	O
in	O	O
their	O	O
respective	O	O
niches	O	O
.	O	O

Whilst	O	O
the	O	O
diversity	O	O
of	O	O
organisms	O	O
present	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
well	O	O
accepted	O	O
,	O	O
there	O	O
remains	O	O
considerable	O	O
controversy	O	O
as	O	O
to	O	O
whether	O	O
Staphylococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

play	O	O
a	O	O
role	O	O
in	O	O
the	O	O
ecology	O	O
of	O	O
the	O	O
normal	O	O
oral	O	O
flora	O	O
.	O	O

Surprisingly	O	O
little	O	O
detailed	O	O
work	O	O
has	O	O
been	O	O
performed	O	O
on	O	O
the	O	O
quantitative	O	O
and	O	O
qualitative	O	O
aspects	O	O
of	O	O
colonisation	O	O
or	O	O
infection	O	O
either	O	O
by	O	O
coagulase-negative	B-bacteria	B-bacteria
staphylococci	E-bacteria	I-bacteria
(	O	O
CNS	O	O
)	O	O
or	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
.	O	O

The	O	O
latter	O	O
is	O	O
especially	O	O
interesting	O	O
in	O	O
the	O	O
light	O	O
of	O	O
present	O	O
difficulties	O	O
in	O	O
eradicating	O	O
carriage	O	O
of	O	O
methicillin-resistant	B-bacteria	B-bacteria
S.	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
MRSA	B-bacteria	B-bacteria
)	O	O
from	O	O
the	O	O
oropharynx	O	O
in	O	O
affected	O	O
individuals	O	O
.	O	O

This	O	O
paper	O	O
reviews	O	O
the	O	O
current	O	O
knowledge	O	O
of	O	O
staphylococcal	O	O
colonisation	O	O
and	O	O
infection	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
in	O	O
health	O	O
and	O	O
disease	O	O
.	O	O

S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
has	O	O
been	O	O
isolated	O	O
from	O	O
a	O	O
wide	O	O
range	O	O
of	O	O
infective	O	O
oral	O	O
conditions	O	O
,	O	O
such	O	O
as	O	O
angular	O	O
cheilitis	O	O
and	O	O
parotitis	O	O
.	O	O

More	O	O
recently	O	O
,	O	O
a	O	O
clinical	O	O
condition	O	O
classified	O	O
as	O	O
staphylococcal	O	O
mucositis	O	O
has	O	O
emerged	O	O
as	O	O
a	O	O
clinical	O	O
problem	O	O
in	O	O
many	O	O
debilitated	O	O
elderly	O	O
patients	O	O
and	O	O
those	O	O
with	O	O
oral	O	O
Crohn	O	O
's	O	O
disease	O	O
.	O	O

Higher	O	O
carriage	O	O
rates	O	O
of	O	O
both	O	O
CNS	B-bacteria	B-bacteria
or	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
or	O	O
both	O	O
,	O	O
in	O	O
patients	O	O
prone	O	O
to	O	O
joint	O	O
infections	O	O
raises	O	O
the	O	O
interesting	O	O
possibility	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
serving	O	O
as	O	O
a	O	O
potential	O	O
source	O	O
for	O	O
bacteraemic	O	O
spread	O	O
to	O	O
compromised	O	O
joint	O	O
spaces	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
there	O	O
is	O	O
a	O	O
surprising	O	O
paucity	O	O
of	O	O
knowledge	O	O
regarding	O	O
the	O	O
role	O	O
of	O	O
oral	O	O
staphylococci	B-bacteria	B-bacteria
in	O	O
both	O	O
health	O	O
and	O	O
disease	O	O
.	O	O

Further	O	O
work	O	O
in	O	O
this	O	O
area	O	O
may	O	O
lead	O	O
to	O	O
benefits	O	O
,	O	O
such	O	O
as	O	O
improved	O	O
decolonisation	O	O
regimens	O	O
for	O	O
eradication	O	O
of	O	O
MRSA	B-bacteria	B-bacteria
and	O	O
acknowledgement	O	O
of	O	O
the	O	O
mouth	O	O
as	O	O
a	O	O
source	O	O
of	O	O
bacteraemic	B-bacteria	B-bacteria
staphylococci	E-bacteria	I-bacteria
.	O	O

To	O	O
study	O	O
the	O	O
effect	O	O
of	O	O
a	O	O
new	O	O
Triclosan-containing	O	O
mouthrinse	O	O
--	O	O
LIBO	O	O
Anti-plaque	O	O
mouth	O	O
rinse	O	O
on	O	O
oral	O	O
infection	O	O
.	O	O

1	O	O
.	O	O

Before	O	O
and	O	O
after	O	O
the	O	O
use	O	O
of	O	O
triclosan	O	O
mouthrinse	O	O
:	O	O
the	O	O
gingival	O	O
data	O	O
were	O	O
checked	O	O
and	O	O
secorded	O	O
;	O	O
plaque	O	O
sausples	O	O
were	O	O
collected	O	O
,	O	O
cultured	O	O
in	O	O
selective	O	O
and	O	O
non-selective	O	O
media	O	O
,	O	O
bacteria	O	O
were	O	O
isolated	O	O
,	O	O
sounted	O	O
,	O	O
and	O	O
compased	O	O
.	O	O

2	O	O
.	O	O

With	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
Gingivalis	E-bacteria	I-bacteria
as	O	O
experimental	O	O
bacteria	O	O
,	O	O
triclosan	O	O
and	O	O
chlorhexidine	O	O
(	O	O
CHX	O	O
)	O	O
mouthrinses	O	O
anti-bacterium	O	O
substance	O	O
,	O	O
the	O	O
minimum	O	O
inhibitory	O	O
concentrations	O	O
(	O	O
MICs	O	O
)	O	O
of	O	O
the	O	O
two	O	O
rinses	O	O
were	O	O
compared	O	O
.	O	O

3	O	O
.	O	O

Smooth	O	O
plates	O	O
with	O	O
the	O	O
film	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
C	E-bacteria	I-bacteria
were	O	O
set	O	O
in	O	O
different	O	O
mouthrinses	O	O
and	O	O
water	O	O
.	O	O

Observing	O	O
the	O	O
exfoliation	O	O
of	O	O
bacteria	O	O
film	O	O
from	O	O
the	O	O
plates	O	O
in	O	O
three	O	O
agents	O	O
.	O	O

1	O	O
.	O	O

Triclosan	O	O
mouthrinse	O	O
was	O	O
effective	O	O
to	O	O
decrease	O	O
the	O	O
plaque	O	O
index	O	O
(	O	O
PLI	O	O
)	O	O
and	O	O
supragingival	O	O
bleeding	O	O
index	O	O
(	O	O
SBI	O	O
)	O	O
.	O	O

2	O	O
.	O	O

The	O	O
bacteria	O	O
count	O	O
obtained	O	O
after	O	O
use	O	O
of	O	O
triclosan	O	O
mouthrinse	O	O
was	O	O
lower	O	O
than	O	O
that	O	O
before	O	O
using	O	O
it	O	O
.	O	O

3	O	O
.	O	O

The	O	O
minimum	O	O
inhibitory	O	O
concentrations	O	O
of	O	O
triclosan	O	O
mouthrinse	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
C	E-bacteria	I-bacteria
was	O	O
much	O	O
lower	O	O
than	O	O
that	O	O
of	O	O
chlorhexidine	O	O
mouthrinse	O	O
.	O	O

4	O	O
.	O	O

In	O	O
triclosan	O	O
mouthrinse	O	O
,	O	O
the	O	O
bacterial	O	O
films	O	O
were	O	O
most	O	O
easily	O	O
exfoliated	O	O
from	O	O
the	O	O
plate	O	O
.	O	O

Triclosan	O	O
mouthrinse	O	O
has	O	O
strongest	O	O
anti-adhesion	O	O
effect	O	O
among	O	O
the	O	O
three	O	O
tested	O	O
agents	O	O
.	O	O

Triclosan	O	O
mouthrinse	O	O
has	O	O
continuous	O	O
disinfecting	O	O
effect	O	O
and	O	O
help	O	O
control	O	O
the	O	O
formation	O	O
and	O	O
adhesion	O	O
of	O	O
dental	O	O
plaque	O	O
.	O	O

Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
is	O	O
capable	O	O
of	O	O
colonizing	O	O
mucosa	O	O
and	O	O
dental	O	O
plaque	O	O
and	O	O
plays	O	O
an	O	O
important	O	O
role	O	O
in	O	O
periodontal	O	O
disease	O	O
in	O	O
young	O	O
peoples	O	O
and	O	O
adult	O	O
.	O	O

Adherence	O	O
mechanisms	O	O
on	O	O
epithelial	O	O
cells	O	O
,	O	O
tooth	O	O
or	O	O
oral	O	O
bacteria	O	O
and	O	O
gingival	O	O
invasion	O	O
probably	O	O
are	O	O
the	O	O
initial	O	O
steps	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
gingivitis	O	O
or	O	O
periodontitis	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
the	O	O
adherence	O	O
of	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
on	O	O
oral	O	O
epithelial	O	O
cells	O	O
following	O	O
subculturing	O	O
were	O	O
examined	O	O
.	O	O

The	O	O
adherence	O	O
on	O	O
oral	O	O
epithelial	O	O
cells	O	O
showed	O	O
high	O	O
in	O	O
all	O	O
the	O	O
isolates	O	O
values	O	O
but	O	O
with	O	O
differences	O	O
among	O	O
them	O	O
and	O	O
at	O	O
each	O	O
time	O	O
of	O	O
subculturing	O	O
.	O	O

The	O	O
adherence	O	O
of	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	I-bacteria	I-bacteria
FDC	I-bacteria	I-bacteria
Y4	E-bacteria	I-bacteria
was	O	O
stable	O	O
in	O	O
each	O	O
of	O	O
the	O	O
subcultures	O	O
.	O	O

However	O	O
,	O	O
adhesion	O	O
values	O	O
of	O	O
all	O	O
the	O	O
tested	O	O
isolates	O	O
were	O	O
different	O	O
except	O	O
for	O	O
strains	O	O
#	O	O
1	O	O
,	O	O
#	O	O
38	O	O
and	O	O
Y4	O	O
,	O	O
suggesting	O	O
a	O	O
heterogenicity	O	O
within	O	O
this	O	O
microbial	O	O
group	O	O
.	O	O

Morphologic	O	O
variations	O	O
were	O	O
observed	O	O
in	O	O
extracellular	O	O
structures	O	O
of	O	O
the	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
tested	O	O
.	O	O

The	O	O
adhesion	O	O
process	O	O
on	O	O
oral	O	O
epithelial	O	O
cells	O	O
of	O	O
this	O	O
organism	O	O
can	O	O
be	O	O
influenced	O	O
by	O	O
subcultures	O	O
,	O	O
but	O	O
additional	O	O
studies	O	O
are	O	O
necessary	O	O
to	O	O
verify	O	O
the	O	O
influence	O	O
of	O	O
subculturing	O	O
on	O	O
adherence	O	O
or	O	O
other	O	O
virulence	O	O
factors	O	O
.	O	O

AIMS	O	O
AND	O	O
Currently	O	O
,	O	O
as	O	O
a	O	O
preventive	O	O
measure	O	O
against	O	O
air	O	O
contamination	O	O
caused	O	O
by	O	O
dental	O	O
procedures	O	O
,	O	O
dust-collecting	O	O
aspirators	O	O
such	O	O
as	O	O
an	O	O
extra-oral	O	O
vacuum	O	O
aspirator	O	O
(	O	O
EOVA	O	O
)	O	O
are	O	O
coming	O	O
into	O	O
general	O	O
use	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
tested	O	O
the	O	O
ability	O	O
of	O	O
a	O	O
modified	O	O
EOVA	O	O
that	O	O
uses	O	O
a	O	O
household	O	O
vacuum	O	O
machine	O	O
.	O	O

The	O	O
study	O	O
was	O	O
conducted	O	O
in	O	O
two	O	O
parts	O	O
.	O	O

First	O	O
,	O	O
the	O	O
modified	O	O
EOVA	O	O
was	O	O
tested	O	O
for	O	O
its	O	O
ability	O	O
to	O	O
eliminate	O	O
an	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
aerosol	O	O
generated	O	O
in	O	O
a	O	O
manikin	O	O
.	O	O

Second	O	O
,	O	O
the	O	O
device	O	O
was	O	O
tested	O	O
for	O	O
its	O	O
ability	O	O
to	O	O
remove	O	O
the	O	O
aerosol	O	O
generated	O	O
by	O	O
dental	O	O
treatment	O	O
procedures	O	O
,	O	O
scaling	O	O
and	O	O
drilling	O	O
a	O	O
tooth	O	O
,	O	O
on	O	O
human	O	O
subjects	O	O
.	O	O

There	O	O
was	O	O
a	O	O
statistically	O	O
significant	O	O
reduction	O	O
in	O	O
both	O	O
the	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
aerosol	O	O
and	O	O
the	O	O
oral	O	O
bacterial	O	O
aerosol	O	O
during	O	O
dental	O	O
treatment	O	O
procedures	O	O
.	O	O

The	O	O
modified	O	O
EOVA	O	O
machine	O	O
is	O	O
highly	O	O
effective	O	O
in	O	O
preventing	O	O
air	O	O
contamination	O	O
by	O	O
dental	O	O
procedures	O	O
.	O	O

Its	O	O
main	O	O
advantages	O	O
are	O	O
that	O	O
it	O	O
can	O	O
easily	O	O
be	O	O
modified	O	O
for	O	O
use	O	O
with	O	O
any	O	O
dental	O	O
unit	O	O
and	O	O
it	O	O
is	O	O
relatively	O	O
inexpensive	O	O
.	O	O

Black-pigmented	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
such	O	O
as	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
are	O	O
amongst	O	O
the	O	O
predominant	O	O
bacteria	O	O
in	O	O
periodontal	O	O
pockets	O	O
and	O	O
have	O	O
been	O	O
implicated	O	O
in	O	O
periodontal	O	O
diseases	O	O
.	O	O

To	O	O
elucidate	O	O
the	O	O
roles	O	O
of	O	O
gingival	O	O
keratinocytes	O	O
,	O	O
which	O	O
are	O	O
the	O	O
first	O	O
cells	O	O
encountered	O	O
by	O	O
oral	O	O
bacteria	O	O
in	O	O
periodontal	O	O
diseases	O	O
,	O	O
human	O	O
gingival	O	O
keratinocytes	O	O
in	O	O
primary	O	O
culture	O	O
were	O	O
stimulated	O	O
with	O	O
cell-surface	O	O
components	O	O
of	O	O
P	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Pr	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

intermedia	E-bacteria	I-bacteria
.	O	O

A	O	O
glycoprotein	O	O
fraction	O	O
from	O	O
Pr	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

intermedia	E-bacteria	I-bacteria
(	O	O
PGP	O	O
)	O	O
clearly	O	O
augmented	O	O
the	O	O
release	O	O
of	O	O
interleukin-8	O	O
,	O	O
granulocyte	O	O
colony-stimulating	O	O
factor	O	O
and	O	O
granulocyte-macrophage	O	O
colony-stimulating	O	O
factor	O	O
,	O	O
as	O	O
determined	O	O
by	O	O
enzyme-linked	O	O
immunosorbent	O	O
assay	O	O
.	O	O

This	O	O
PGP	O	O
also	O	O
induced	O	O
expression	O	O
of	O	O
intercellular	O	O
adhesion	O	O
molecule-1	O	O
(	O	O
ICAM-1	O	O
)	O	O
,	O	O
as	O	O
determined	O	O
by	O	O
flow	O	O
cytometry	O	O
.	O	O

The	O	O
augmentation	O	O
of	O	O
mRNA	O	O
expression	O	O
for	O	O
these	O	O
molecules	O	O
was	O	O
also	O	O
confirmed	O	O
by	O	O
reverse	O	O
transcription	O	O
PCR	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
lipopolysaccharide	O	O
(	O	O
LPS	O	O
)	O	O
from	O	O
Pr	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

intermedia	E-bacteria	I-bacteria
and	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
was	O	O
completely	O	O
inactive	O	O
in	O	O
these	O	O
assays	O	O
.	O	O

LPS	O	O
fraction	O	O
and	O	O
purified	O	O
fimbriae	O	O
from	O	O
P	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
exhibited	O	O
weak	O	O
activities	O	O
.	O	O

Cytokine	O	O
production	O	O
and	O	O
ICAM-1	O	O
expression	O	O
by	O	O
gingival	O	O
keratinocytes	O	O
might	O	O
cause	O	O
accumulation	O	O
and	O	O
activation	O	O
of	O	O
neutrophils	O	O
in	O	O
the	O	O
epithelium	O	O
and	O	O
,	O	O
therefore	O	O
,	O	O
may	O	O
be	O	O
involved	O	O
in	O	O
the	O	O
initiation	O	O
and	O	O
development	O	O
of	O	O
inflammation	O	O
in	O	O
periodontal	O	O
tissues	O	O
.	O	O

Novel	O	O
isolates	O	O
,	O	O
strains	B-bacteria	B-bacteria
HM-7	E-bacteria	I-bacteria
,	O	O
HM-6	B-bacteria	B-bacteria
,	O	O
HH-31	B-bacteria	B-bacteria
,	O	O
P9a-hT	B-bacteria	B-bacteria
and	O	O
UJB13-d	B-bacteria	B-bacteria
,	O	O
which	O	O
were	O	O
isolated	O	O
from	O	O
tongue	O	O
plaque	O	O
and	O	O
necrotic	O	O
dental	O	O
pulp	O	O
,	O	O
were	O	O
studied	O	O
taxonomically	O	O
and	O	O
phylogenetically	O	O
.	O	O

These	O	O
organisms	O	O
were	O	O
anaerobic	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
non-spore-forming	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
gram-positive	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
rod-shaped	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
that	O	O
were	O	O
inert	O	O
in	O	O
most	O	O
of	O	O
the	O	O
conventional	O	O
biochemical	O	O
tests	O	O
and	O	O
phenotypically	O	O
resemble	O	O
Mogibacterium	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
or	O	O
asaccharolytic	B-bacteria	B-bacteria
Eubacterium	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
.	O	O

The	O	O
G+C	O	O
contents	O	O
of	O	O
the	O	O
DNAs	O	O
from	O	O
the	O	O
novel	O	O
isolates	O	O
ranged	O	O
from	O	O
41	O	O
to	O	O
42	O	O
mol	O	O
%	O	O
.	O	O

DNA-DNA	O	O
hybridization	O	O
studies	O	O
demonstrated	O	O
that	O	O
these	O	O
strains	O	O
might	O	O
be	O	O
assigned	O	O
to	O	O
the	O	O
genus	B-bacteria	B-bacteria
Mogibacterium	E-bacteria	I-bacteria
but	O	O
not	O	O
to	O	O
the	O	O
previously	O	O
described	O	O
species	O	O
.	O	O

It	O	O
was	O	O
also	O	O
apparent	O	O
that	O	O
strain	B-bacteria	B-bacteria
HM-7	E-bacteria	I-bacteria
belonged	O	O
to	O	O
the	O	O
same	O	O
species	O	O
as	O	O
strains	B-bacteria	B-bacteria
HM-6	E-bacteria	I-bacteria
and	O	O
HH-31	B-bacteria	B-bacteria
,	O	O
and	O	O
that	O	O
strains	B-bacteria	B-bacteria
P9a-hT	E-bacteria	I-bacteria
and	O	O
UJB13-d	B-bacteria	B-bacteria
belonged	O	O
to	O	O
a	O	O
second	O	O
species	O	O
.	O	O

The	O	O
levels	O	O
of	O	O
DNA-DNA	O	O
relatedness	O	O
to	O	O
asaccharolytic	B-bacteria	B-bacteria
Eubacterium	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
,	O	O
including	O	O
Eubacterium	B-bacteria	B-bacteria
brachy	E-bacteria	I-bacteria
,	O	O
Eubacterium	B-bacteria	B-bacteria
nodatum	E-bacteria	I-bacteria
,	O	O
Eubacterium	B-bacteria	B-bacteria
saphenum	E-bacteria	I-bacteria
and	O	O
the	O	O
more	O	O
recently	O	O
proposed	O	O
Eubacterium	B-bacteria	B-bacteria
minutum	E-bacteria	I-bacteria
and	O	O
Eubacterium	B-bacteria	B-bacteria
exiguum	E-bacteria	I-bacteria
(	O	O
reclassified	O	O
as	O	O
Slackia	B-bacteria	B-bacteria
exigua	E-bacteria	I-bacteria
)	O	O
,	O	O
are	O	O
less	O	O
than	O	O
2	O	O
%	O	O
.	O	O

The	O	O
results	O	O
of	O	O
16S	O	O
rDNA	O	O
sequence	O	O
comparisons	O	O
revealed	O	O
that	O	O
these	O	O
organisms	O	O
represent	O	O
novel	O	O
lineages	O	O
distinct	O	O
from	O	O
all	O	O
previously	O	O
described	O	O
species	O	O
of	O	O
gram-positive	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
rod-shaped	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

On	O	O
the	O	O
basis	O	O
of	O	O
phenotypic	O	O
characteristics	O	O
,	O	O
DNA-DNA	O	O
hybridization	O	O
data	O	O
and	O	O
phylogenetic	O	O
analysis	O	O
with	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
data	O	O
,	O	O
new	O	O
species	O	O
are	O	O
proposed	O	O
,	O	O
namely	O	O
Mogibacterium	B-bacteria	B-bacteria
diversum	E-bacteria	I-bacteria
(	O	O
for	O	O
strains	B-bacteria	B-bacteria
HM-7	E-bacteria	I-bacteria
,	O	O
HM-6	B-bacteria	B-bacteria
and	O	O
HH-31	B-bacteria	B-bacteria
)	O	O
and	O	O
Mogibacterium	B-bacteria	B-bacteria
neglectum	E-bacteria	I-bacteria
(	O	O
for	O	O
strains	B-bacteria	B-bacteria
P9a-hT	E-bacteria	I-bacteria
and	O	O
UJB13-d	B-bacteria	B-bacteria
)	O	O
.	O	O

HM-7T	B-bacteria	B-bacteria
(	O	O
=	O	O
ATCC	B-bacteria	B-bacteria
700923T	E-bacteria	I-bacteria
=	O	O
JCM	B-bacteria	B-bacteria
11205T	E-bacteria	I-bacteria
)	O	O
is	O	O
the	O	O
type	O	O
strain	O	O
of	O	O
the	O	O
former	O	O
and	O	O
P9a-hT	B-bacteria	B-bacteria
(	O	O
=	O	O
ATCC	B-bacteria	B-bacteria
700924T	E-bacteria	I-bacteria
=	O	O
JCM	B-bacteria	B-bacteria
11204T	B-bacteria	B-bacteria
)	O	O
is	O	O
the	O	O
type	O	O
strain	O	O
for	O	O
the	O	O
latter	O	O
.	O	O

The	O	O
ability	O	O
of	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
to	O	O
produce	O	O
bacteriocin	O	O
has	O	O
rarely	O	O
been	O	O
reported	O	O
.	O	O

antagonistic	O	O
substance	O	O
production	O	O
may	O	O
confer	O	O
an	O	O
important	O	O
ecological	O	O
advantage	O	O
for	O	O
the	O	O
producer	O	O
microorganisms	O	O
,	O	O
especially	O	O
in	O	O
a	O	O
competitive	O	O
ecosystem	O	O
such	O	O
as	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
75	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
human	O	O
patients	O	O
with	O	O
periodontal	O	O
disease	O	O
,	O	O
periodontally	O	O
healthy	O	O
subjects	O	O
and	O	O
marmosets	O	O
,	O	O
as	O	O
well	O	O
as	O	O
two	O	O
reference	O	O
strains	O	O
(	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
29523	E-bacteria	I-bacteria
and	O	O
FDC	B-bacteria	B-bacteria
Y4	B-bacteria	B-bacteria
)	O	O
were	O	O
evaluated	O	O
for	O	O
auto-	O	O
,	O	O
iso-	O	O
,	O	O
and	O	O
heteroantagonistic	O	O
activity	O	O
.	O	O

Fifty-one	O	O
(	O	O
68.00	O	O
%	O	O
)	O	O
strains	O	O
exhibited	O	O
antagonistic	O	O
activity	O	O
;	O	O
heteroantagonism	O	O
was	O	O
observed	O	O
more	O	O
often	O	O
than	O	O
isoantagonism	O	O
.	O	O

Isolated	O	O
strains	O	O
antagonized	O	O
17	O	O
different	O	O
species	O	O
of	O	O
gram-positive	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
gram-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
from	O	O
the	O	O
oral	O	O
and	O	O
nonoral	O	O
microbiota	O	O
.	O	O

Sensitivity	O	O
to	O	O
heat	O	O
and	O	O
to	O	O
proteolytic	O	O
enzymes	O	O
constituted	O	O
strong	O	O
evidence	O	O
that	O	O
the	O	O
antagonistic	O	O
substance	O	O
has	O	O
a	O	O
proteic	O	O
nature	O	O
.	O	O

Taken	O	O
together	O	O
,	O	O
our	O	O
data	O	O
enabled	O	O
us	O	O
to	O	O
confirm	O	O
that	O	O
the	O	O
antagonistic	O	O
substance	O	O
detected	O	O
was	O	O
a	O	O
bacteriocin	O	O
.	O	O

The	O	O
wide	O	O
spectrum	O	O
of	O	O
activity	O	O
indicates	O	O
the	O	O
possibility	O	O
that	O	O
more	O	O
than	O	O
one	O	O
antagonistic	O	O
substance	O	O
is	O	O
produced	O	O
and	O	O
that	O	O
these	O	O
substances	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
ecological	O	O
balance	O	O
of	O	O
the	O	O
oral	O	O
ecosystem	O	O
.	O	O

For	O	O
more	O	O
than	O	O
100	O	O
years	O	O
,	O	O
investigators	O	O
have	O	O
tried	O	O
to	O	O
identify	O	O
the	O	O
bacteria	O	O
responsible	O	O
for	O	O
dental	O	O
caries	O	O
formation	O	O
and	O	O
to	O	O
determine	O	O
whether	O	O
their	O	O
role	O	O
is	O	O
one	O	O
of	O	O
specificity	O	O
.	O	O

Frequent	O	O
association	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
with	O	O
caries	O	O
activity	O	O
gave	O	O
credence	O	O
to	O	O
their	O	O
being	O	O
specific	O	O
cariogens	O	O
.	O	O

However	O	O
,	O	O
dental	O	O
caries	O	O
occurrence	O	O
in	O	O
their	O	O
absence	O	O
,	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
other	O	O
bacteria	O	O
able	O	O
to	O	O
produce	O	O
substantial	O	O
amounts	O	O
of	O	O
acid	O	O
from	O	O
fermentable	O	O
carbohydrate	O	O
,	O	O
provided	O	O
arguments	O	O
for	O	O
non-specificity	O	O
.	O	O

In	O	O
the	O	O
1940s	O	O
,	O	O
Stephan	O	O
found	O	O
that	O	O
the	O	O
mixed	O	O
bacteria	O	O
in	O	O
dental	O	O
plaque	O	O
produced	O	O
a	O	O
rapid	O	O
drop	O	O
in	O	O
pH	O	O
following	O	O
a	O	O
sugar	O	O
rinse	O	O
and	O	O
a	O	O
slow	O	O
pH	O	O
return	O	O
toward	O	O
baseline	O	O
.	O	O

This	O	O
response	O	O
became	O	O
a	O	O
cornerstone	O	O
of	O	O
plaque	O	O
and	O	O
mixed-bacterial	O	O
involvement	O	O
in	O	O
dental	O	O
caries	O	O
causation	O	O
when	O	O
Stephan	O	O
showed	O	O
that	O	O
the	O	O
pH	O	O
decrease	O	O
was	O	O
inversely	O	O
and	O	O
clearly	O	O
related	O	O
to	O	O
caries	O	O
activity	O	O
.	O	O

Detailed	O	O
examination	O	O
of	O	O
the	O	O
pH	O	O
(	O	O
acid-base	O	O
)	O	O
metabolisms	O	O
of	O	O
oral	O	O
pure	O	O
cultures	O	O
,	O	O
dental	O	O
plaque	O	O
,	O	O
and	O	O
salivary	O	O
sediment	O	O
identified	O	O
the	O	O
main	O	O
bacteria	O	O
and	O	O
metabolic	O	O
processes	O	O
responsible	O	O
for	O	O
the	O	O
pH	O	O
metabolism	O	O
of	O	O
dental	O	O
plaque	O	O
.	O	O

It	O	O
was	O	O
discovered	O	O
that	O	O
this	O	O
metabolism	O	O
in	O	O
different	O	O
individuals	O	O
,	O	O
in	O	O
plaque	O	O
in	O	O
different	O	O
dentition	O	O
locations	O	O
within	O	O
individuals	O	O
,	O	O
and	O	O
in	O	O
individuals	O	O
of	O	O
different	O	O
levels	O	O
of	O	O
caries	O	O
activity	O	O
could	O	O
be	O	O
described	O	O
in	O	O
terms	O	O
of	O	O
a	O	O
relatively	O	O
small	O	O
number	O	O
of	O	O
acid-base	O	O
metabolic	O	O
processes	O	O
.	O	O

This	O	O
led	O	O
to	O	O
an	O	O
overall	O	O
bacterial	O	O
metabolic	O	O
vector	O	O
concept	O	O
for	O	O
dental	O	O
plaque	O	O
,	O	O
and	O	O
helped	O	O
unravel	O	O
the	O	O
bacterial	O	O
involvement	O	O
in	O	O
the	O	O
degradation	O	O
of	O	O
the	O	O
carbohydrate	O	O
and	O	O
nitrogenous	O	O
substrates	O	O
that	O	O
produce	O	O
the	O	O
acids	O	O
and	O	O
alkali	O	O
that	O	O
affect	O	O
the	O	O
pH	O	O
and	O	O
favor	O	O
and	O	O
inhibit	O	O
dental	O	O
caries	O	O
production	O	O
,	O	O
respectively	O	O
.	O	O

A	O	O
central	O	O
role	O	O
of	O	O
oral	O	O
arginolytic	O	O
and	O	O
non-arginolytic	O	O
acidogens	O	O
in	O	O
the	O	O
production	O	O
of	O	O
the	O	O
Stephan	O	O
pH	O	O
curve	O	O
was	O	O
discovered	O	O
.	O	O

The	O	O
non-arginolytics	O	O
could	O	O
produce	O	O
only	O	O
the	O	O
pH	O	O
fall	O	O
part	O	O
of	O	O
this	O	O
curve	O	O
,	O	O
whereas	O	O
the	O	O
arginolytics	O	O
could	O	O
produce	O	O
both	O	O
the	O	O
fall	O	O
and	O	O
the	O	O
rise	O	O
.	O	O

The	O	O
net	O	O
result	O	O
of	O	O
the	O	O
latter	O	O
was	O	O
a	O	O
less	O	O
acidic	O	O
Stephan	O	O
pH	O	O
curve	O	O
.	O	O

Both	O	O
kinds	O	O
of	O	O
bacteria	O	O
are	O	O
numerous	O	O
in	O	O
dental	O	O
plaque	O	O
.	O	O

By	O	O
varying	O	O
their	O	O
ratios	O	O
,	O	O
we	O	O
were	O	O
easily	O	O
able	O	O
to	O	O
produce	O	O
Stephan	O	O
pH	O	O
curves	O	O
indicative	O	O
of	O	O
different	O	O
levels	O	O
of	O	O
caries	O	O
activity	O	O
.	O	O

This	O	O
and	O	O
substantial	O	O
related	O	O
metabolic	O	O
and	O	O
microbial	O	O
data	O	O
indicated	O	O
that	O	O
it	O	O
is	O	O
the	O	O
proportions	O	O
and	O	O
numbers	O	O
of	O	O
acid-base-producing	O	O
bacteria	O	O
that	O	O
are	O	O
at	O	O
the	O	O
core	O	O
of	O	O
dental	O	O
caries	O	O
activity	O	O
.	O	O

The	O	O
elimination	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
as	O	O
with	O	O
a	O	O
vaccine	O	O
,	O	O
was	O	O
considered	O	O
to	O	O
have	O	O
little	O	O
chance	O	O
of	O	O
success	O	O
in	O	O
preventing	O	O
dental	O	O
caries	O	O
in	O	O
humans	O	O
,	O	O
since	O	O
,	O	O
in	O	O
most	O	O
cases	O	O
,	O	O
this	O	O
would	O	O
simply	O	O
make	O	O
more	O	O
room	O	O
for	O	O
one	O	O
or	O	O
more	O	O
of	O	O
the	O	O
many	O	O
acidogens	O	O
remaining	O	O
.	O	O

An	O	O
understanding	O	O
of	O	O
mixed-bacterial	O	O
metabolism	O	O
,	O	O
knowledge	O	O
of	O	O
how	O	O
to	O	O
manipulate	O	O
and	O	O
work	O	O
with	O	O
mixed	O	O
bacteria	O	O
,	O	O
and	O	O
the	O	O
use	O	O
of	O	O
a	O	O
bacterial	O	O
metabolic	O	O
vector	O	O
approach	O	O
as	O	O
described	O	O
in	O	O
this	O	O
article	O	O
have	O	O
led	O	O
to	O	O
(	O	O
1	O	O
)	O	O
a	O	O
more	O	O
ecological	O	O
focus	O	O
for	O	O
dealing	O	O
with	O	O
dental	O	O
caries	O	O
,	O	O
and	O	O
(	O	O
2	O	O
)	O	O
new	O	O
means	O	O
of	O	O
developing	O	O
and	O	O
evaluating	O	O
anti-caries	O	O
agents	O	O
directed	O	O
toward	O	O
microbial	O	O
mixtures	O	O
that	O	O
counter	O	O
excess	O	O
acid	O	O
accumulation	O	O
and	O	O
tooth	O	O
demineralization	O	O
.	O	O

Bacterial	O	O
invasion	O	O
of	O	O
dentinal	O	O
tubules	O	O
commonly	O	O
occurs	O	O
when	O	O
dentin	O	O
is	O	O
exposed	O	O
following	O	O
a	O	O
breach	O	O
in	O	O
the	O	O
integrity	O	O
of	O	O
the	O	O
overlying	O	O
enamel	O	O
or	O	O
cementum	O	O
.	O	O

Bacterial	O	O
products	O	O
diffuse	O	O
through	O	O
the	O	O
dentinal	O	O
tubule	O	O
toward	O	O
the	O	O
pulp	O	O
and	O	O
evoke	O	O
inflammatory	O	O
changes	O	O
in	O	O
the	O	O
pulpo-dentin	O	O
complex	O	O
.	O	O

These	O	O
may	O	O
eliminate	O	O
the	O	O
bacterial	O	O
insult	O	O
and	O	O
block	O	O
the	O	O
route	O	O
of	O	O
infection	O	O
.	O	O

Unchecked	O	O
,	O	O
invasion	O	O
results	O	O
in	O	O
pulpitis	O	O
and	O	O
pulp	O	O
necrosis	O	O
,	O	O
infection	O	O
of	O	O
the	O	O
root	O	O
canal	O	O
system	O	O
,	O	O
and	O	O
periapical	O	O
disease	O	O
.	O	O

While	O	O
several	O	O
hundred	O	O
bacterial	O	O
species	O	O
are	O	O
known	O	O
to	O	O
inhabit	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
a	O	O
relatively	O	O
small	O	O
and	O	O
select	O	O
group	O	O
of	O	O
bacteria	O	O
is	O	O
involved	O	O
in	O	O
the	O	O
invasion	O	O
of	O	O
dentinal	O	O
tubules	O	O
and	O	O
subsequent	O	O
infection	O	O
of	O	O
the	O	O
root	O	O
canal	O	O
space	O	O
.	O	O

Gram-positive	O	O
organisms	O	O
dominate	O	O
the	O	O
tubule	O	O
microflora	O	O
in	O	O
both	O	O
carious	O	O
and	O	O
non-carious	O	O
dentin	O	O
.	O	O

The	O	O
relatively	O	O
high	O	O
numbers	O	O
of	O	O
obligate	B-bacteria	B-bacteria
anaerobes	E-bacteria	I-bacteria
present-such	O	O
as	O	O
Eubacterium	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Propionibacterium	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Bifidobacterium	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Peptostreptococcus	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
,	O	O
and	O	O
Veillonella	B-bacteria	B-bacteria
spp.-suggest	E-bacteria	I-bacteria
that	O	O
the	O	O
environment	O	O
favors	O	O
growth	O	O
of	O	O
these	O	O
bacteria	O	O
.	O	O

Gram-negative	B-bacteria	B-bacteria
obligate	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
rods	E-bacteria	I-bacteria
,	O	O
e.g.	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
are	O	O
less	O	O
frequently	O	O
recovered	O	O
.	O	O

Streptococci	B-bacteria	B-bacteria
are	O	O
among	O	O
the	O	O
most	O	O
commonly	O	O
identified	O	O
bacteria	O	O
that	O	O
invade	O	O
dentin	O	O
.	O	O

Recent	O	O
evidence	O	O
suggests	O	O
that	O	O
streptococci	B-bacteria	B-bacteria
may	O	O
recognize	O	O
components	O	O
present	O	O
within	O	O
dentinal	O	O
tubules	O	O
,	O	O
such	O	O
as	O	O
collagen	O	O
type	O	O
I	O	O
,	O	O
which	O	O
stimulate	O	O
bacterial	O	O
adhesion	O	O
and	O	O
intra-tubular	O	O
growth	O	O
.	O	O

Specific	O	O
interactions	O	O
of	O	O
other	O	O
oral	O	O
bacteria	O	O
with	O	O
invading	O	O
streptococci	B-bacteria	B-bacteria
may	O	O
then	O	O
facilitate	O	O
the	O	O
invasion	O	O
of	O	O
dentin	O	O
by	O	O
select	O	O
bacterial	O	O
groupings	O	O
.	O	O

An	O	O
understanding	O	O
the	O	O
mechanisms	O	O
involved	O	O
in	O	O
dentinal	O	O
tubule	O	O
invasion	O	O
by	O	O
bacteria	O	O
should	O	O
allow	O	O
for	O	O
the	O	O
development	O	O
of	O	O
new	O	O
control	O	O
strategies	O	O
,	O	O
such	O	O
as	O	O
inhibitory	O	O
compounds	O	O
incorporated	O	O
into	O	O
oral	O	O
health	O	O
care	O	O
products	O	O
or	O	O
dental	O	O
materials	O	O
,	O	O
which	O	O
would	O	O
assist	O	O
in	O	O
the	O	O
practice	O	O
of	O	O
endodontics	O	O
.	O	O

To	O	O
analyse	O	O
the	O	O
relationship	O	O
between	O	O
oral	O	O
bacteria	O	O
and	O	O
the	O	O
health	O	O
and	O	O
functional	O	O
status	O	O
of	O	O
the	O	O
elderly	O	O
.	O	O

The	O	O
bacteria	O	O
species	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
the	O	O
elderly	O	O
were	O	O
examined	O	O
.	O	O

It	O	O
was	O	O
found	O	O
that	O	O
the	O	O
bedridden	O	O
subjects	O	O
staying	O	O
at	O	O
two	O	O
hospitals	O	O
for	O	O
long-term	O	O
(	O	O
HOBR	O	O
)	O	O
showed	O	O
significantly	O	O
lower	O	O
detection	O	O
rates	O	O
of	O	O
commensal	O	O
bacteria	O	O
species	O	O
and	O	O
significantly	O	O
higher	O	O
detection	O	O
rates	O	O
of	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
,	O	O
of	O	O
methicillin-resistant	B-bacteria	B-bacteria
Staphylococcus	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
MRSA	B-bacteria	B-bacteria
)	O	O
and	O	O
of	O	O
coagulase	B-bacteria	B-bacteria
(	I-bacteria	I-bacteria
-	I-bacteria	I-bacteria
)	I-bacteria	I-bacteria
Staph	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

aureus	E-bacteria	I-bacteria
than	O	O
those	O	O
living	O	O
independently	O	O
(	O	O
the	O	O
independent	O	O
)	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
detection	O	O
rate	O	O
of	O	O
Haemophilus	B-bacteria	B-bacteria
parainfluenzae	E-bacteria	I-bacteria
in	O	O
NUBR	O	O
was	O	O
discovered	O	O
to	O	O
be	O	O
higher	O	O
than	O	O
that	O	O
found	O	O
in	O	O
the	O	O
independent	O	O
.	O	O

In	O	O
HOBR	O	O
,	O	O
the	O	O
detection	O	O
rate	O	O
of	O	O
Ps	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

aeruginosa	E-bacteria	I-bacteria
was	O	O
significantly	O	O
higher	O	O
among	O	O
in-patients	O	O
who	O	O
required	O	O
continual	O	O
care	O	O
than	O	O
those	O	O
in	O	O
need	O	O
of	O	O
partial	O	O
care	O	O
,	O	O
while	O	O
the	O	O
detection	O	O
rate	O	O
of	O	O
MRSA	B-bacteria	B-bacteria
was	O	O
significantly	O	O
higher	O	O
among	O	O
in-patients	O	O
with	O	O
low	O	O
serum	O	O
albumin	O	O
than	O	O
those	O	O
with	O	O
normal	O	O
serum	O	O
albumin	O	O
.	O	O

Oral	O	O
bacteria	O	O
examination	O	O
analysis	O	O
proved	O	O
that	O	O
the	O	O
risks	O	O
of	O	O
infection	O	O
of	O	O
some	O	O
pathogenic	O	O
bacteria	O	O
species	O	O
were	O	O
correlated	O	O
with	O	O
functional	O	O
status	O	O
,	O	O
physical	O	O
function	O	O
and	O	O
nutritional	O	O
state	O	O
.	O	O

Our	O	O
study	O	O
suggests	O	O
that	O	O
the	O	O
oral	O	O
bacteria	O	O
,	O	O
especially	O	O
pathogenic	O	O
bacteria	O	O
were	O	O
influenced	O	O
by	O	O
the	O	O
functional	O	O
status	O	O
of	O	O
the	O	O
elderly	O	O
and	O	O
the	O	O
type	O	O
and	O	O
quality	O	O
of	O	O
the	O	O
facilities	O	O
for	O	O
the	O	O
bedridden	O	O
,	O	O
physical	O	O
function	O	O
and	O	O
nutritional	O	O
state	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
assess	O	O
the	O	O
prevalence	O	O
of	O	O
different	O	O
bacteria	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
bacteria	O	O
were	O	O
present	O	O
in	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
73	O	O
(	O	O
48.7	O	O
%	O	O
)	O	O
of	O	O
150	O	O
individuals	O	O
.	O	O

Nesterenkonia	B-bacteria	B-bacteria
halobia	E-bacteria	I-bacteria
,	O	O
the	O	O
most	O	O
frequently	O	O
isolated	O	O
species	O	O
,	O	O
was	O	O
found	O	O
in	O	O
20	O	O
(	O	O
27	O	O
%	O	O
)	O	O
individuals	O	O
,	O	O
Micrococcus	B-bacteria	B-bacteria
luteus	E-bacteria	I-bacteria
in	O	O
16	O	O
(	O	O
22	O	O
%	O	O
)	O	O
,	O	O
Kocuria	B-bacteria	B-bacteria
kristinae	E-bacteria	I-bacteria
in	O	O
12	O	O
(	O	O
16	O	O
%	O	O
)	O	O
,	O	O
Kocuria	B-bacteria	B-bacteria
varians	E-bacteria	I-bacteria
in	O	O
10	O	O
(	O	O
14	O	O
%	O	O
)	O	O
,	O	O
Dermacoccus	B-bacteria	B-bacteria
sedentarius	E-bacteria	I-bacteria
in	O	O
9	O	O
(	O	O
12	O	O
%	O	O
)	O	O
,	O	O
Micrococcus	B-bacteria	B-bacteria
lylae	E-bacteria	I-bacteria
in	O	O
8	O	O
(	O	O
11	O	O
%	O	O
)	O	O
,	O	O
and	O	O
Kytococcus	B-bacteria	B-bacteria
nishinomiyaensis	E-bacteria	I-bacteria
in	O	O
3	O	O
(	O	O
4	O	O
%	O	O
)	O	O
.	O	O

Mean	O	O
counts	O	O
of	O	O
these	O	O
microorganisms	O	O
were	O	O
relatively	O	O
low	O	O
and	O	O
amounted	O	O
in	O	O
log10	O	O
CFU/ml	O	O
saliva	O	O
for	O	O
M.	B-bacteria	B-bacteria
luteus	E-bacteria	I-bacteria
1.87	O	O
+/-	O	O
0.52	O	O
,	O	O
for	O	O
M.	B-bacteria	B-bacteria
lylae	E-bacteria	I-bacteria
2.03	O	O
+/-	O	O
0.39	O	O
,	O	O
for	O	O
N.	B-bacteria	B-bacteria
halobia	E-bacteria	I-bacteria
2.14	O	O
+/-	O	O
0.56	O	O
,	O	O
for	O	O
K.	B-bacteria	B-bacteria
kristinae	E-bacteria	I-bacteria
2.20	O	O
+/-	O	O
0.69	O	O
,	O	O
for	O	O
K.	B-bacteria	B-bacteria
varians	E-bacteria	I-bacteria
2.19	O	O
+/-	O	O
0.67	O	O
,	O	O
for	O	O
K.	B-bacteria	B-bacteria
nishinomiyaensis	E-bacteria	I-bacteria
1.72	O	O
+/-	O	O
0.39	O	O
,	O	O
and	O	O
for	O	O
D.	B-bacteria	B-bacteria
sedentarius	E-bacteria	I-bacteria
2.27	O	O
+/-	O	O
0.55	O	O
.	O	O

The	O	O
factor	O	O
limiting	O	O
the	O	O
population	O	O
sizes	O	O
of	O	O
these	O	O
microorganisms	O	O
was	O	O
most	O	O
probably	O	O
the	O	O
antagonistic	O	O
activity	O	O
of	O	O
the	O	O
bacteria	O	O
living	O	O
in	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
increasing	O	O
prevalence	O	O
of	O	O
antibiotic-resistant	O	O
bacteria	O	O
emphasises	O	O
the	O	O
need	O	O
for	O	O
new	O	O
treatments	O	O
that	O	O
can	O	O
replace	O	O
traditional	O	O
antibiotics	O	O
.	O	O

Oral	O	O
immunotherapy	O	O
with	O	O
yolk	O	O
antibodies	O	O
from	O	O
hyperimmunised	O	O
hens	O	O
is	O	O
a	O	O
new	O	O
promising	O	O
treatment	O	O
strategy	O	O
,	O	O
primarily	O	O
for	O	O
infections	O	O
in	O	O
the	O	O
mouth	O	O
and	O	O
gastrointestinal	O	O
tract	O	O
.	O	O

Several	O	O
studies	O	O
show	O	O
that	O	O
bacterial	O	O
and	O	O
viral	O	O
infections	O	O
can	O	O
be	O	O
prevented	O	O
with	O	O
egg	O	O
c	O	O
c	O	O
(	O	O
IgY	O	O
)	O	O
in	O	O
a	O	O
dose-dependent	O	O
manner	O	O
.	O	O

Oral	O	O
treatment	O	O
could	O	O
potentially	O	O
be	O	O
used	O	O
against	O	O
many	O	O
frequently	O	O
encountered	O	O
diseases	O	O
(	O	O
e.g	O	O
.	O	O

common	O	O
cold	O	O
,	O	O
tonsillitis	O	O
and	O	O
caries	O	O
)	O	O
.	O	O

Healthy	O	O
volunteers	O	O
.	O	O

We	O	O
studied	O	O
the	O	O
presence	O	O
of	O	O
yolk	B-bacteria	B-bacteria
anti-Pseudomonas	I-bacteria	I-bacteria
aeruginosa	E-bacteria	I-bacteria
antibodies	O	O
in	O	O
saliva	O	O
from	O	O
healthy	O	O
volunteers	O	O
over	O	O
time	O	O
after	O	O
1	O	O
or	O	O
2	O	O
minutes	O	O
'	O	O
mouth	O	O
rinse	O	O
,	O	O
performed	O	O
in	O	O
the	O	O
evening	O	O
,	O	O
with	O	O
an	O	O
aqueous	O	O
IgY	O	O
antibody	O	O
preparation	O	O
.	O	O

The	O	O
test	O	O
persons	O	O
rinsed	O	O
the	O	O
mouth	O	O
with	O	O
8.0ml	O	O
phosphate	O	O
buffered	O	O
saline	O	O
before	O	O
gargling	O	O
with	O	O
the	O	O
antibody	O	O
preparation	O	O
8	O	O
and	O	O
24	O	O
hours	O	O
later	O	O
.	O	O

Statistical	O	O
analysis	O	O
was	O	O
performed	O	O
with	O	O
the	O	O
Mann-Whitney	O	O
U	O	O
test	O	O
.	O	O

The	O	O
antibody	O	O
titres	O	O
in	O	O
the	O	O
mouth	O	O
rinses	O	O
were	O	O
tested	O	O
for	O	O
their	O	O
specific	O	O
activity	O	O
against	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
by	O	O
ELISA	O	O
.	O	O


The	O	O
next	O	O
morning	O	O
there	O	O
were	O	O
still	O	O
active	O	O
antibodies	O	O
detected	O	O
in	O	O
the	O	O
saliva	O	O
from	O	O
18	O	O
of	O	O
19	O	O
subjects	O	O
.	O	O

After	O	O
24	O	O
hours	O	O
,	O	O
active	O	O
antibodies	O	O
could	O	O
be	O	O
detected	O	O
in	O	O
saliva	O	O
from	O	O
only	O	O
a	O	O
few	O	O
of	O	O
the	O	O
subjects	O	O
.	O	O

A	O	O
2-minute	O	O
mouth	O	O
rinse	O	O
resulted	O	O
in	O	O
higher	O	O
mean	O	O
ELISA	O	O
absorbance	O	O
values	O	O
than	O	O
a	O	O
1-minute	O	O
rinse	O	O
.	O	O

A	O	O
strain	O	O
,	O	O
No	O	O
.	O	O

90-1	O	O
,	O	O
is	O	O
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
a	O	O
patient	O	O
with	O	O
periodontophthy	O	O
.	O	O

This	O	O
strain	O	O
is	O	O
a	O	O
Gram-positive	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
non-endospore-forming	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
facultative	I-bacteria	I-bacteria
anaerobe	E-bacteria	I-bacteria
with	O	O
spherical	O	O
cells	O	O
,	O	O
0.9-1.5	O	O
microns	O	O
in	O	O
diameter	O	O
,	O	O
occuring	O	O
in	O	O
pairs	O	O
and	O	O
seldom	O	O
in	O	O
short	O	O
chains	O	O
of	O	O
four	O	O
cells	O	O
,	O	O
and	O	O
motile	O	O
by	O	O
one	O	O
flagellum	O	O
per	O	O
cell	O	O
.	O	O

The	O	O
optimum	O	O
growing	O	O
temperature	O	O
is	O	O
35-37	O	O
degrees	O	O
C	O	O
;	O	O
appreciable	O	O
growth	O	O
is	O	O
not	O	O
found	O	O
below	O	O
10	O	O
degrees	O	O
C	O	O
,	O	O
but	O	O
growth	O	O
at	O	O
53	O	O
degrees	O	O
and	O	O
tolerance	O	O
to	O	O
60	O	O
degrees	O	O
C	O	O
for	O	O
30	O	O
min	O	O
.	O	O

This	O	O
strain	O	O
is	O	O
microhalophilous	B-bacteria	B-bacteria
and	O	O
grows	O	O
best	O	O
,	O	O
well	O	O
and	O	O
poorly	O	O
in	O	O
the	O	O
medium	O	O
containing	O	O
2	O	O
%	O	O
,	O	O
10	O	O
%	O	O
-15	O	O
%	O	O
and	O	O
25	O	O
%	O	O
NaCl	O	O
respectively	O	O
.	O	O

Catalase	O	O
and	O	O
urease	O	O
are	O	O
positive	O	O
and	O	O
nitrate	O	O
is	O	O
reduced	O	O
.	O	O

Acid	O	O
is	O	O
produced	O	O
from	O	O
many	O	O
carbohydrates	O	O
,	O	O
but	O	O
no	O	O
gas	O	O
.	O	O

Gelatin	O	O
can	O	O
be	O	O
hydrolyzed	O	O
,	O	O
but	O	O
starch	O	O
,	O	O
cellulose	O	O
and	O	O
dextrin	O	O
do	O	O
not	O	O
.	O	O

G	O	O
+	O	O
C	O	O
content	O	O
in	O	O
DNA	O	O
is	O	O
41.34	O	O
mol	O	O
%	O	O
(	O	O
Tm	O	O
)	O	O
.	O	O

The	O	O
strain	O	O
(	O	O
90-1	O	O
)	O	O
is	O	O
considered	O	O
to	O	O
be	O	O
a	O	O
new	O	O
species	O	O
belonging	O	O
to	O	O
a	O	O
new	O	O
genus	O	O
because	O	O
its	O	O
some	O	O
characteristics	O	O
are	O	O
different	O	O
from	O	O
those	O	O
of	O	O
the	O	O
known	O	O
coccus	B-bacteria	B-bacteria
genuera	E-bacteria	I-bacteria
and	O	O
designated	O	O
as	O	O
Stomatostreptococcus	B-bacteria	B-bacteria
microhalophilus	I-bacteria	I-bacteria
Ping	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
Zhou	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
Sun	I-bacteria	I-bacteria
et	I-bacteria	I-bacteria
Fan	I-bacteria	I-bacteria
gen.	I-bacteria	I-bacteria
nov.	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
according	O	O
to	O	O
its	O	O
source	O	O
and	O	O
microhalophilic	O	O
trait	O	O
.	O	O

Aerobic	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
only	O	O
rarely	O	O
colonize	O	O
the	O	O
cleft	O	O
nasal	O	O
floor	O	O
in	O	O
patients	O	O
with	O	O
patent	O	O
oronasal	O	O
fistula	O	O
.	O	O

There	O	O
are	O	O
no	O	O
studies	O	O
that	O	O
have	O	O
investigated	O	O
whether	O	O
anaerobic	O	O
oral	O	O
flora	O	O
colonize	O	O
this	O	O
site	O	O
and	O	O
whether	O	O
attempting	O	O
to	O	O
culture	O	O
them	O	O
is	O	O
useful	O	O
for	O	O
assessing	O	O
the	O	O
patency	O	O
of	O	O
oronasal	O	O
fistulae	O	O
in	O	O
the	O	O
clinic	O	O
.	O	O

A	O	O
prospective	O	O
study	O	O
of	O	O
13	O	O
patients	O	O
with	O	O
cleft	O	O
with	O	O
patent	O	O
unilateral	O	O
oronasal	O	O
fistulae	O	O
.	O	O

Microbiological	O	O
culture	O	O
swabs	O	O
were	O	O
taken	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
both	O	O
nasal	O	O
floors	O	O
,	O	O
with	O	O
the	O	O
unaffected	O	O
side	O	O
being	O	O
used	O	O
as	O	O
a	O	O
control	O	O
.	O	O

Following	O	O
aerobic	O	O
and	O	O
anaerobic	O	O
culture	O	O
,	O	O
bacterial	O	O
isolates	O	O
were	O	O
identified	O	O
and	O	O
compared	O	O
.	O	O

A	O	O
significant	O	O
growth	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
from	O	O
the	O	O
cleft	O	O
nasal	O	O
floor	O	O
when	O	O
compared	O	O
with	O	O
the	O	O
unaffected	O	O
side	O	O
.	O	O

Aerobic	O	O
oral	O	O
flora	O	O
was	O	O
cultured	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
in	O	O
all	O	O
13	O	O
patients	O	O
.	O	O

A	O	O
light	O	O
growth	O	O
of	O	O
aerobic	O	O
oral	O	O
flora	O	O
was	O	O
found	O	O
in	O	O
the	O	O
cleft	O	O
nasal	O	O
floor	O	O
in	O	O
two	O	O
patients	O	O
,	O	O
and	O	O
anaerobic	O	O
oral	O	O
flora	O	O
was	O	O
cultured	O	O
from	O	O
the	O	O
cleft	O	O
nasal	O	O
floor	E-bacteria	I-bacteria
in	O	O
the	O	O
same	O	O
two	O	O
patients	O	O
.	O	O

No	O	O
statistical	O	O
correlation	O	O
was	O	O
found	O	O
between	O	O
growth	O	O
of	O	O
anaerobic	O	O
flora	O	O
and	O	O
the	O	O
cleft	O	O
nasal	O	O
floor	O	O
(	O	O
p	O	O
=.48	O	O
)	O	O
.	O	O

Like	O	O
aerobic	O	O
oral	O	O
flora	O	O
,	O	O
anaerobic	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
would	O	O
appear	O	O
to	O	O
only	O	O
rarely	O	O
colonize	O	O
the	O	O
cleft	O	O
nasal	O	O
floor	E-bacteria	I-bacteria
in	O	O
patients	O	O
with	O	O
oronasal	O	O
fistulae	O	O
.	O	O

This	O	O
additional	O	O
investigation	O	O
does	O	O
not	O	O
appear	O	O
to	O	O
be	O	O
helpful	O	O
in	O	O
the	O	O
assessment	O	O
of	O	O
oronasal	O	O
fistulae	O	O
in	O	O
the	O	O
clinic	O	O
.	O	O

Five	O	O
streptococcal	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
were	O	O
isolated	O	O
from	O	O
dental	O	O
plaque	O	O
and	O	O
saliva	O	O
of	O	O
caries-free	O	O
humans	O	O
.	O	O

The	O	O
cells	O	O
were	O	O
gram-positive	O	O
,	O	O
non-spore-forming	O	O
,	O	O
non-motile	O	O
cocci	O	O
that	O	O
were	O	O
arranged	O	O
in	O	O
short	O	O
chains	O	O
.	O	O

The	O	O
strains	O	O
were	O	O
catalase-negative	O	O
,	O	O
facultatively	O	O
anaerobic	O	O
and	O	O
produced	O	O
lactic	O	O
acid	O	O
exclusively	O	O
from	O	O
glucose	O	O
fermentation	O	O
.	O	O

Biochemical	O	O
analysis	O	O
that	O	O
used	O	O
both	O	O
conventional	O	O
methods	O	O
and	O	O
the	O	O
commercial	O	O
API	O	O
20	O	O
Strep	O	O
system	O	O
showed	O	O
that	O	O
the	O	O
five	O	O
strains	O	O
fermented	O	O
only	O	O
a	O	O
few	O	O
kinds	O	O
of	O	O
sugar	O	O
.	O	O

The	O	O
mean	O	O
DNA	O	O
G	O	O
+	O	O
C	O	O
content	O	O
of	O	O
the	O	O
five	O	O
novel	O	O
strains	O	O
was	O	O
39.5	O	O
+/-	O	O
0.8	O	O
mol	O	O
%	O	O
.	O	O

Phylogenetic	O	O
analysis	O	O
based	O	O
on	O	O
16S	O	O
rDNA	O	O
sequence	O	O
homology	O	O
indicated	O	O
that	O	O
the	O	O
new	O	O
isolates	O	O
represented	O	O
a	O	O
novel	O	O
member	O	O
of	O	O
the	O	O
mitis	O	O
group	O	O
of	O	O
the	O	O
genus	B-bacteria	B-bacteria
Streptococcus	E-bacteria	I-bacteria
,	O	O
related	O	O
most	O	O
closely	O	O
to	O	O
the	O	O
recently	O	O
described	O	O
species	B-bacteria	B-bacteria
Streptococcus	I-bacteria	I-bacteria
sinensis	E-bacteria	I-bacteria
.	O	O

DNA-DNA	O	O
relatedness	O	O
between	O	O
novel	O	O
strain	B-bacteria	B-bacteria
LMG	I-bacteria	I-bacteria
21535T	E-bacteria	I-bacteria
and	O	O
type	O	O
strains	O	O
of	O	O
phylogenetically	O	O
related	O	O
species	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
was	O	O
7.1-16.4	O	O
%	O	O
.	O	O

Therefore	O	O
a	O	O
novel	O	O
Streptococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
oligofermentans	I-bacteria	I-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria
nov.	E-bacteria	I-bacteria
,	O	O
is	O	O
proposed	O	O
.	O	O

The	O	O
type	O	O
strain	O	O
is	O	O
LMG	B-bacteria	B-bacteria
21535T=AS	I-bacteria	I-bacteria
1.3089T	E-bacteria	I-bacteria
.	O	O

Previous	O	O
work	O	O
has	O	O
shown	O	O
that	O	O
the	O	O
indigenous	O	O
gut	O	O
microflora	O	O
in	O	O
mice	O	O
plays	O	O
a	O	O
protective	O	O
role	O	O
against	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
heat-labile	O	O
enterotoxin	O	O
(	O	O
LT	O	O
)	O	O
-mediated	O	O
abrogation	O	O
of	O	O
oral	O	O
tolerance	O	O
to	O	O
an	O	O
unrelated	O	O
co-ingested	O	O
protein	O	O
.	O	O

To	O	O
assess	O	O
potential	O	O
protection	O	O
by	O	O
human	O	O
gut	O	O
microflora	O	O
,	O	O
we	O	O
studied	O	O
the	O	O
effect	O	O
of	O	O
human	O	O
gut	O	O
microflora	O	O
in	O	O
a	O	O
murine	O	O
model	O	O
.	O	O

Oral	O	O
tolerance	O	O
was	O	O
studied	O	O
in	O	O
adult	O	O
gnotobiotic	O	O
mice	O	O
(	O	O
i.e	O	O
.	O	O

ex-germ-free	O	O
mice	O	O
)	O	O
colonized	O	O
with	O	O
the	O	O
entire	O	O
human	O	O
fecal	O	O
microflora	O	O
and	O	O
orally	O	O
administered	O	O
once	O	O
with	O	O
LT	O	O
and	O	O
ovalbumin	O	O
.	O	O

Systemic	O	O
suppression	O	O
of	O	O
IgG	O	O
,	O	O
IgG1	O	O
,	O	O
IgG2a	O	O
,	O	O
and	O	O
IgE	O	O
antibody	O	O
responses	O	O
was	O	O
assessed	O	O
by	O	O
ELISA	O	O
.	O	O

Both	O	O
specific	O	O
IgG	O	O
subclasses	O	O
and	O	O
IgE	O	O
hyporesponsiveness	O	O
was	O	O
induced	O	O
in	O	O
LT	O	O
+	O	O
ovalbumin-fed	O	O
gnotobiotic	O	O
mice	O	O
,	O	O
indicating	O	O
that	O	O
the	O	O
human	O	O
gut	O	O
microflora	O	O
can	O	O
protect	O	O
against	O	O
the	O	O
LT-mediated	O	O
abrogation	O	O
of	O	O
oral	O	O
tolerance	O	O
.	O	O

However	O	O
,	O	O
as	O	O
confirmed	O	O
with	O	O
mouse	O	O
gut	O	O
microflora	O	O
,	O	O
this	O	O
protective	O	O
effect	O	O
only	O	O
occurs	O	O
when	O	O
the	O	O
gut	O	O
microflora	O	O
is	O	O
associated	O	O
from	O	O
birth	O	O
on	O	O
.	O	O

Colonization	O	O
of	O	O
germ-free	O	O
mice	O	O
with	O	O
a	O	O
single	O	O
bacterial	O	O
strain	O	O
,	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
predominant	O	O
in	O	O
the	O	O
human	O	O
and	O	O
mouse	O	O
gut	O	O
microflora	O	O
in	O	O
the	O	O
neonatal	O	O
period	O	O
,	O	O
showed	O	O
that	O	O
this	O	O
strain	O	O
alone	O	O
did	O	O
not	O	O
induce	O	O
protection	O	O
.	O	O

These	O	O
results	O	O
supported	O	O
the	O	O
hypothesis	O	O
that	O	O
the	O	O
natural	O	O
establishment	O	O
of	O	O
the	O	O
gut	O	O
microflora	O	O
in	O	O
neonates	O	O
crucially	O	O
influenced	O	O
resistance	O	O
to	O	O
LT-mediated	O	O
abrogation	O	O
of	O	O
oral	O	O
tolerance	O	O
by	O	O
reinforcing	O	O
suppression	O	O
of	O	O
both	O	O
T	O	O
helper	O	O
type	O	O
1-	O	O
and	O	O
T	O	O
helper	O	O
type	O	O
2-controlled	O	O
responses	O	O
,	O	O
and	O	O
suggested	O	O
that	O	O
sequential	O	O
bacterial	O	O
colonization	O	O
of	O	O
the	O	O
gut	O	O
rather	O	O
than	O	O
a	O	O
single	O	O
bacterial	O	O
species	O	O
may	O	O
be	O	O
involved	O	O
in	O	O
this	O	O
phenomenon	O	O
.	O	O

Our	O	O
long-term	O	O
oral	O	O
administration	O	O
of	O	O
dimethylarsinic	O	O
acid	O	O
(	O	O
DMAV	O	O
)	O	O
in	O	O
rats	O	O
revealed	O	O
that	O	O
three	O	O
unidentified	O	O
metabolites	O	O
,	O	O
M-1	O	O
,	O	O
M-2	O	O
,	O	O
and	O	O
M-3	O	O
,	O	O
were	O	O
detected	O	O
in	O	O
urine	O	O
and	O	O
feces	O	O
.	O	O

DMAV	O	O
and	O	O
trimethylarsine	O	O
oxide	O	O
(	O	O
TMAO	O	O
)	O	O
were	O	O
converted	O	O
to	O	O
M-2	O	O
and	O	O
M-3	O	O
and	O	O
M-1	O	O
by	O	O
Escherichia	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
A3-6	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
ceca	O	O
of	O	O
DMAV-administered	O	O
rats	O	O
,	O	O
respectively	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
report	O	O
on	O	O
the	O	O
mechanism	O	O
of	O	O
production	O	O
and	O	O
the	O	O
chemical	O	O
properties	O	O
of	O	O
these	O	O
unknown	O	O
metabolites	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
pattern	O	O
of	O	O
conversion	O	O
of	O	O
DMAV	O	O
or	O	O
TMAO	O	O
by	O	O
A3-6	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
cysteine	O	O
(	O	O
Cys	O	O
)	O	O
,	O	O
arsenic	O	O
metabolites	O	O
of	O	O
DMAV	O	O
or	O	O
TMAO	O	O
in	O	O
medium	O	O
after	O	O
incubation	O	O
with	O	O
A3-6	O	O
and	O	O
Cys	O	O
were	O	O
analyzed	O	O
by	O	O
liquid	O	O
chromatography	O	O
with	O	O
inductively	O	O
coupled	O	O
plasma	O	O
mass	O	O
spectrometry	O	O
(	O	O
LC-ICP-MS	O	O
)	O	O
.	O	O

DMAV	O	O
was	O	O
reduced	O	O
to	O	O
dimethylarsinous	O	O
acid	O	O
(	O	O
DMAIII	O	O
)	O	O
to	O	O
form	O	O
M-2	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
Cys	O	O
and	O	O
A3-6	O	O
,	O	O
and	O	O
M-2	O	O
was	O	O
further	O	O
converted	O	O
to	O	O
M-3	O	O
.	O	O

TMAO	O	O
was	O	O
rapidly	O	O
converted	O	O
to	O	O
M-1	O	O
by	O	O
A3-6	O	O
.	O	O

The	O	O
cytotoxicity	O	O
of	O	O
the	O	O
unidentified	O	O
metabolites	O	O
was	O	O
investigated	O	O
.	O	O

M-2	O	O
was	O	O
more	O	O
cytotoxic	O	O
than	O	O
DMAV	O	O
,	O	O
M-1	O	O
,	O	O
and	O	O
M-3	O	O
in	O	O
V79	O	O
cells	O	O
.	O	O

The	O	O
cytotoxicity	O	O
of	O	O
M-2	O	O
in	O	O
HL-60	O	O
cells	O	O
was	O	O
decreased	O	O
by	O	O
the	O	O
addition	O	O
of	O	O
superoxide	O	O
dismutase	O	O
,	O	O
suggesting	O	O
that	O	O
the	O	O
cytotoxicity	O	O
of	O	O
M-2	O	O
might	O	O
be	O	O
due	O	O
to	O	O
the	O	O
production	O	O
of	O	O
reactive	O	O
oxygen	O	O
species	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
we	O	O
examined	O	O
the	O	O
chemical	O	O
properties	O	O
of	O	O
M-2	O	O
by	O	O
LC-ICP-MS	O	O
and	O	O
LC-MS.	O	O
M-2	O	O
was	O	O
oxidized	O	O
to	O	O
DMAV	O	O
by	O	O
hydrogen	O	O
peroxide	O	O
,	O	O
suggesting	O	O
that	O	O
M-2	O	O
may	O	O
be	O	O
a	O	O
reduced	O	O
form	O	O
of	O	O
DMAV	O	O
.	O	O

M-2	O	O
was	O	O
consistent	O	O
with	O	O
the	O	O
reactant	O	O
of	O	O
DMAV	O	O
with	O	O
metabisulfite-thiosulfate	O	O
reagent	O	O
but	O	O
not	O	O
DMAIII	O	O
by	O	O
analyses	O	O
of	O	O
LC-ICP-MS	O	O
and	O	O
LC-MS	O	O
.	O	O

The	O	O
molecular	O	O
weight	O	O
of	O	O
M-2	O	O
was	O	O
154	O	O
,	O	O
and	O	O
M-2	O	O
was	O	O
a	O	O
sulfur-containing	O	O
metabolite	O	O
.	O	O

This	O	O
study	O	O
compared	O	O
removal	O	O
of	O	O
pairs	O	O
of	O	O
co-adhering	O	O
and	O	O
non-co-adhering	O	O
oral	O	O
actinomyces	B-bacteria	B-bacteria
and	O	O
streptococci	B-bacteria	B-bacteria
from	O	O
salivary	O	O
pellicles	O	O
by	O	O
manual	O	O
,	O	O
rotating/oscillating	O	O
electric	O	O
and	O	O
sonic	O	O
toothbrushes	O	O
,	O	O
applying	O	O
weights	O	O
up	O	O
to	O	O
240	O	O
g.	O	O
First	O	O
,	O	O
actinomyces	B-bacteria	B-bacteria
were	O	O
allowed	O	O
to	O	O
adhere	O	O
to	O	O
a	O	O
pellicle	O	O
in	O	O
a	O	O
parallel	O	O
plate	O	O
flow	O	O
chamber	O	O
,	O	O
after	O	O
which	O	O
streptococci	B-bacteria	B-bacteria
suspended	O	O
in	O	O
saliva	O	O
were	O	O
perfused	O	O
through	O	O
the	O	O
chamber	O	O
at	O	O
33	O	O
degrees	O	O
C.	O	O
On	O	O
average	O	O
,	O	O
34-39	O	O
%	O	O
of	O	O
the	O	O
adhering	O	O
bacteria	O	O
were	O	O
adhering	O	O
as	O	O
single	O	O
organisms	O	O
.	O	O

For	O	O
co-adhering	O	O
and	O	O
non-co-adhering	O	O
pairs	O	O
,	O	O
33	O	O
and	O	O
10	O	O
%	O	O
of	O	O
the	O	O
adhering	O	O
bacteria	O	O
were	O	O
involved	O	O
,	O	O
respectively	O	O
,	O	O
in	O	O
aggregates	O	O
comprising	O	O
more	O	O
than	O	O
10	O	O
organisms	O	O
.	O	O

Brushing	O	O
by	O	O
hand	O	O
removed	O	O
82	O	O
%	O	O
at	O	O
low	O	O
weight	O	O
(	O	O
40	O	O
g	O	O
)	O	O
,	O	O
which	O	O
was	O	O
less	O	O
than	O	O
by	O	O
electric	O	O
(	O	O
93	O	O
%	O	O
)	O	O
or	O	O
sonic	O	O
(	O	O
92	O	O
%	O	O
)	O	O
brushing	O	O
,	O	O
while	O	O
for	O	O
all	O	O
modes	O	O
of	O	O
brushing	O	O
bacterial	O	O
removal	O	O
increased	O	O
with	O	O
increasing	O	O
weight	O	O
to	O	O
95-99	O	O
%	O	O
.	O	O

For	O	O
a	O	O
non-co-adhering	O	O
pair	O	O
,	O	O
subsequent	O	O
exposure	O	O
of	O	O
brushed	O	O
pellicles	O	O
to	O	O
a	O	O
streptococcal	B-bacteria	B-bacteria
suspension	O	O
yielded	O	O
only	O	O
2-16	O	O
%	O	O
of	O	O
bacteria	O	O
involved	O	O
in	O	O
large	O	O
aggregates	O	O
,	O	O
regardless	O	O
of	O	O
the	O	O
mode	O	O
of	O	O
brushing	O	O
.	O	O

For	O	O
the	O	O
co-adhering	O	O
pair	O	O
,	O	O
however	O	O
,	O	O
de	B-bacteria	B-bacteria
novo	I-bacteria	I-bacteria
streptococcal	E-bacteria	I-bacteria
adhesion	O	O
to	O	O
hand-brushed	O	O
pellicles	O	O
yielded	O	O
34-57	O	O
%	O	O
of	O	O
bacteria	O	O
involved	O	O
in	O	O
large	O	O
aggregates	O	O
,	O	O
while	O	O
electric	O	O
and	O	O
sonic	O	O
brushing	O	O
left	O	O
22-35	O	O
%	O	O
of	O	O
the	O	O
bacteria	O	O
involved	O	O
in	O	O
large	O	O
aggregates	O	O
.	O	O

De	B-bacteria	B-bacteria
novo	I-bacteria	I-bacteria
streptococcal	E-bacteria	I-bacteria
adhesion	O	O
for	O	O
the	O	O
co-adhering	O	O
pair	O	O
increased	O	O
with	O	O
increasing	O	O
weight	O	O
for	O	O
the	O	O
electric	O	O
and	O	O
sonic	O	O
brush	O	O
in	O	O
contrast	O	O
to	O	O
the	O	O
manual	O	O
brush	O	O
.	O	O

Since	O	O
a	O	O
strong	O	O
influence	O	O
of	O	O
co-adhesion	O	O
is	O	O
evident	O	O
in	O	O
de	B-bacteria	B-bacteria
novo	I-bacteria	I-bacteria
streptococcal	E-bacteria	I-bacteria
adhesion	O	O
,	O	O
despite	O	O
nearly	O	O
complete	O	O
removal	O	O
of	O	O
all	O	O
actinomyces	B-bacteria	B-bacteria
,	O	O
these	O	O
observations	O	O
suggest	O	O
that	O	O
the	O	O
three	O	O
modes	O	O
of	O	O
brushing	O	O
leave	O	O
footprints	O	O
to	O	O
which	O	O
streptococci	B-bacteria	B-bacteria
preferentially	O	O
adhere	O	O
.	O	O

To	O	O
examine	O	O
the	O	O
occurrence	O	O
of	O	O
specific	O	O
periodontal	O	O
bacteria	O	O
in	O	O
children	O	O
and	O	O
adolescents	O	O
.	O	O

Ten	O	O
putative	O	O
periodontal	O	O
bacteria	O	O
were	O	O
longitudinally	O	O
examined	O	O
in	O	O
plaque	O	O
and	O	O
saliva	O	O
samples	O	O
from	O	O
119	O	O
periodontally	O	O
healthy	O	O
children	O	O
(	O	O
2-15	O	O
years	O	O
old	O	O
)	O	O
using	O	O
a	O	O
polymerase	O	O
chain	O	O
reaction	O	O
method	O	O
.	O	O

Capnocytophaga	B-bacteria	B-bacteria
ochracea	E-bacteria	I-bacteria
,	O	O
C.	B-bacteria	B-bacteria
sputigena	E-bacteria	I-bacteria
,	O	O
and	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
were	O	O
frequently	O	O
found	O	O
in	O	O
saliva	O	O
,	O	O
and	O	O
tended	O	O
to	O	O
persist	O	O
in	O	O
saliva	O	O
for	O	O
the	O	O
remainder	O	O
of	O	O
the	O	O
study	O	O
,	O	O
whereas	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
were	O	O
rarely	O	O
detected	O	O
.	O	O

P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
was	O	O
more	O	O
frequently	O	O
detected	O	O
in	O	O
plaque	O	O
and	O	O
its	O	O
prevalence	O	O
increased	O	O
with	O	O
age	O	O
.	O	O

Eikenella	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
and	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
were	O	O
sometimes	O	O
detected	O	O
in	O	O
both	O	O
plaque	O	O
and	O	O
saliva	O	O
,	O	O
while	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
was	O	O
occasionally	O	O
detected	O	O
in	O	O
saliva	O	O
.	O	O

A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
C.	B-bacteria	B-bacteria
ochracea	E-bacteria	I-bacteria
,	O	O
C.	B-bacteria	B-bacteria
sputigena	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
,	O	O
and	O	O
E.	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
are	O	O
common	O	O
members	O	O
of	O	O
the	O	O
oral	O	O
microbial	O	O
flora	O	O
of	O	O
healthy	O	O
children	O	O
,	O	O
whereas	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
and	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
appear	O	O
to	O	O
be	O	O
transient	O	O
organisms	O	O
.	O	O

A	O	O
selectivity	O	O
factor	O	O
was	O	O
specified	O	O
to	O	O
the	O	O
previously	O	O
developed	O	O
nutrient	O	O
medium	O	O
meant	O	O
for	O	O
the	O	O
cultivation	O	O
of	O	O
Haemophilus	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
--	O	O
CAE	O	O
,	O	O
which	O	O
is	O	O
based	O	O
on	O	O
the	O	O
acid	O	O
hydrolysate	O	O
of	O	O
casein	O	O
,	O	O
enzyme	O	O
hydrolysate	O	O
of	O	O
animal	O	O
blood	O	O
(	O	O
aminopeptide	O	O
)	O	O
and	O	O
an	O	O
extract	O	O
of	O	O
nutrient	O	O
yeast	O	O
.	O	O

The	O	O
above	O	O
nutrient	O	O
medium	O	O
containing	O	O
additionally	O	O
growth	O	O
factors	O	O
V	O	O
and	O	O
X	O	O
,	O	O
glucose	O	O
and	O	O
bacitracin	O	O
was	O	O
shown	O	O
to	O	O
fit	O	O
well	O	O
for	O	O
the	O	O
primary	O	O
sowing	O	O
of	O	O
Haemophilus	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
it	O	O
can	O	O
be	O	O
used	O	O
in	O	O
diagnostic	O	O
examinations	O	O
.	O	O

Active	O	O
immunization	O	O
with	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
whole-cell	O	O
preparations	O	O
has	O	O
been	O	O
shown	O	O
to	O	O
prevent	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
infection	O	O
and	O	O
oral	O	O
bone	O	O
loss	O	O
.	O	O

Employing	O	O
passive	O	O
antibody	O	O
transfer	O	O
and	O	O
opsonization	O	O
,	O	O
we	O	O
demonstrate	O	O
with	O	O
this	O	O
study	O	O
that	O	O
immunization-elicited	O	O
P.	O	O
gingivalis-specific	O	O
immunoglobulin	O	O
G	O	O
facilitates	O	O
clearance	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
in	O	O
a	O	O
subcutaneous	O	O
chamber	O	O
model	O	O
and	O	O
prevents	O	O
P.	O	O
gingivalis-elicited	O	O
oral	O	O
bone	O	O
loss	O	O
.	O	O

Oral	O	O
malodor	O	O
is	O	O
considered	O	O
to	O	O
originate	O	O
primarily	O	O
from	O	O
tongue	O	O
microbiota	O	O
populations	O	O
.	O	O

However	O	O
,	O	O
the	O	O
relationship	O	O
between	O	O
oral	O	O
malodor	O	O
and	O	O
tongue	O	O
microbiota	O	O
remains	O	O
unclear	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
tongue	O	O
periodontal	O	O
pathogens	O	O
were	O	O
analyzed	O	O
via	O	O
real-time	O	O
PCR	O	O
,	O	O
and	O	O
the	O	O
association	O	O
between	O	O
oral	O	O
malodor	O	O
and	O	O
tongue	O	O
periodontal	O	O
pathogens	O	O
,	O	O
including	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
was	O	O
examined	O	O
.	O	O

The	O	O
subject	O	O
population	O	O
consisted	O	O
of	O	O
29	O	O
individuals	O	O
with	O	O
and	O	O
10	O	O
healthy	O	O
persons	O	O
without	O	O
oral	O	O
malodor	O	O
.	O	O

Oral	O	O
malodor	O	O
was	O	O
assessed	O	O
by	O	O
organoleptic	O	O
test	O	O
and	O	O
volatile	O	O
sulfur	O	O
compound	O	O
(	O	O
VSC	O	O
)	O	O
levels	O	O
as	O	O
measured	O	O
by	O	O
gas	O	O
chromatography	O	O
.	O	O

Real-time	O	O
PCR	O	O
was	O	O
conducted	O	O
for	O	O
anaerobes	B-bacteria	B-bacteria
in	O	O
tongue	O	O
biofilm	O	O
samples	O	O
employing	O	O
a	O	O
LightCycler	O	O
system	O	O
;	O	O
furthermore	O	O
,	O	O
bacterial	O	O
proportion	O	O
served	O	O
as	O	O
a	O	O
quantitative	O	O
parameter	O	O
.	O	O

Among	O	O
the	O	O
five	O	O
anaerobes	B-bacteria	B-bacteria
,	O	O
only	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
displayed	O	O
higher	O	O
proportions	O	O
in	O	O
malodor	O	O
subjects	O	O
than	O	O
corresponding	O	O
values	O	O
in	O	O
healthy	O	O
controls	O	O
.	O	O

Proportions	O	O
of	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
correlated	O	O
strongly	O	O
with	O	O
hydrogen	O	O
sulfide	O	O
concentration	O	O
.	O	O

Proportions	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
also	O	O
exhibited	O	O
strong	O	O
correlation	O	O
with	O	O
methyl	O	O
mercaptan	O	O
concentration	O	O
.	O	O

The	O	O
correlation	O	O
coefficient	O	O
between	O	O
the	O	O
proportion	O	O
of	O	O
the	O	O
total	O	O
of	O	O
the	O	O
five	O	O
anaerobes	B-bacteria	B-bacteria
and	O	O
total	O	O
VSC	O	O
level	O	O
(	O	O
r	O	O
=	O	O
0.88	O	O
)	O	O
was	O	O
greater	O	O
than	O	O
that	O	O
between	O	O
bacterial	O	O
proportion	O	O
and	O	O
organoleptic	O	O
score	O	O
(	O	O
r	O	O
=	O	O
0.29	O	O
)	O	O
.	O	O

When	O	O
a	O	O
linear	O	O
regression	O	O
analysis	O	O
was	O	O
performed	O	O
utilizing	O	O
the	O	O
proportion	O	O
of	O	O
each	O	O
of	O	O
the	O	O
five	O	O
periodontal	O	O
pathogens	O	O
as	O	O
an	O	O
independent	O	O
variable	O	O
,	O	O
the	O	O
explanatory	O	O
power	O	O
of	O	O
these	O	O
independent	O	O
variables	O	O
revealed	O	O
81	O	O
%	O	O
for	O	O
total	O	O
VSC	O	O
level	O	O
and	O	O
16	O	O
%	O	O
for	O	O
organoleptic	O	O
score	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
these	O	O
five	O	O
periodontal	O	O
pathogens	O	O
on	O	O
tongue	O	O
dorsa	O	O
may	O	O
contribute	O	O
greatly	O	O
to	O	O
VSC	O	O
production	O	O
.	O	O

Fifty-three	O	O
beta-lactamase-producing	O	O
strains	O	O
of	O	O
oral	O	O
bacteria	O	O
isolated	O	O
from	O	O
patients	O	O
with	O	O
refractory	O	O
periodontitis	O	O
in	O	O
Norway	O	O
and	O	O
USA	O	O
were	O	O
screened	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
bla	O	O
(	O	O
TEM	O	O
)	O	O
,	O	O
bla	O	O
(	O	O
SHV	O	O
)	O	O
,	O	O
bla	O	O
(	O	O
OXA	O	O
)	O	O
,	O	O
bla	O	O
(	O	O
ampC	O	O
)	O	O
,	O	O
bla	O	O
(	O	O
cfxA	O	O
)	O	O
,	O	O
and	O	O
bla	O	O
(	O	O
cepA/cblA	O	O
)	O	O
genes	O	O
by	O	O
the	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
.	O	O

The	O	O
PCR	O	O
products	O	O
were	O	O
characterized	O	O
by	O	O
direct	O	O
sequencing	O	O
of	O	O
the	O	O
amplified	O	O
DNA	O	O
.	O	O

Thirty-four	O	O
of	O	O
the	O	O
53	O	O
enzyme-producing	O	O
strains	O	O
(	O	O
64	O	O
%	O	O
)	O	O
were	O	O
positive	O	O
in	O	O
one	O	O
of	O	O
the	O	O
PCR	O	O
assays	O	O
.	O	O

All	O	O
beta-lactamase-producing	B-bacteria	B-bacteria
Prevotella	E-bacteria	I-bacteria
and	O	O
Capnocytophaga	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

were	O	O
CfxA	O	O
positive	O	O
.	O	O

TEM-type	O	O
beta-lactamases	O	O
were	O	O
identified	O	O
in	O	O
one	O	O
strain	O	O
each	O	O
of	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
and	O	O
Neisseria	B-bacteria	B-bacteria
sp.	E-bacteria	I-bacteria
,	O	O
and	O	O
one	O	O
strain	O	O
of	O	O
Citrobacter	B-bacteria	B-bacteria
freundii	E-bacteria	I-bacteria
possessed	O	O
an	O	O
AmpC-type	O	O
beta-lactamase	O	O
.	O	O

Screening	O	O
for	O	O
gene	O	O
cassettes	O	O
and	O	O
genes	O	O
known	O	O
to	O	O
be	O	O
associated	O	O
with	O	O
integrons	O	O
did	O	O
not	O	O
reveal	O	O
the	O	O
presence	O	O
of	O	O
integrons	O	O
in	O	O
these	O	O
oral	O	O
bacteria	O	O
.	O	O

Sequence	O	O
analyses	O	O
showed	O	O
that	O	O
most	O	O
CfxA	B-bacteria	B-bacteria
positive	I-bacteria	I-bacteria
Prevotella	E-bacteria	I-bacteria
and	O	O
Capnocytophaga	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
from	O	O
patients	O	O
with	O	O
refractory	O	O
periodontitis	O	O
harboured	O	O
variants	O	O
of	O	O
the	O	O
CfxA2	O	O
and	O	O
CfxA3	O	O
enzyme	O	O
.	O	O

The	O	O
present	O	O
study	O	O
also	O	O
showed	O	O
that	O	O
many	O	O
different	O	O
genetic	O	O
determinants	O	O
of	O	O
beta-lactamase	O	O
production	O	O
are	O	O
found	O	O
in	O	O
bacteria	O	O
isolated	O	O
from	O	O
refractory	O	O
periodontitis	O	O
,	O	O
many	O	O
of	O	O
which	O	O
remain	O	O
to	O	O
be	O	O
characterized	O	O
.	O	O

The	O	O
oral	O	O
mucosa	O	O
is	O	O
exposed	O	O
to	O	O
a	O	O
high	O	O
density	O	O
and	O	O
diversity	O	O
of	O	O
gram-positive	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
gram-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
but	O	O
very	O	O
little	O	O
is	O	O
known	O	O
about	O	O
how	O	O
immune	O	O
homeostasis	O	O
is	O	O
maintained	O	O
in	O	O
this	O	O
environment	O	O
,	O	O
particularly	O	O
in	O	O
the	O	O
inflammatory	O	O
disease	O	O
chronic	O	O
periodontitis	O	O
(	O	O
CP	O	O
)	O	O
.	O	O

The	O	O
cells	O	O
of	O	O
the	O	O
innate	O	O
immune	O	O
response	O	O
recognize	O	O
bacterial	O	O
structures	O	O
via	O	O
the	O	O
Toll-like	O	O
receptors	O	O
(	O	O
TLR	O	O
)	O	O
.	O	O

This	O	O
activates	O	O
intracellular	O	O
signaling	O	O
and	O	O
transcription	O	O
of	O	O
proteins	O	O
essential	O	O
for	O	O
the	O	O
induction	O	O
of	O	O
an	O	O
adaptive	O	O
immune	O	O
response	O	O
;	O	O
however	O	O
,	O	O
if	O	O
unregulated	O	O
,	O	O
it	O	O
can	O	O
lead	O	O
to	O	O
destructive	O	O
inflammatory	O	O
responses	O	O
.	O	O

Using	O	O
single-immunoenzyme	O	O
labeling	O	O
,	O	O
we	O	O
show	O	O
that	O	O
the	O	O
human	O	O
oral	O	O
mucosa	O	O
(	O	O
gingiva	O	O
)	O	O
is	O	O
infiltrated	O	O
by	O	O
large	O	O
numbers	O	O
of	O	O
TLR2	O	O
(	O	O
+	O	O
)	O	O
and	O	O
TLR4	O	O
(	O	O
+	O	O
)	O	O
cells	O	O
and	O	O
that	O	O
their	O	O
numbers	O	O
increase	O	O
significantly	O	O
in	O	O
CP	O	O
,	O	O
relative	O	O
to	O	O
health	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
,	O	O
Student	O	O
's	O	O
t	O	O
test	O	O
)	O	O
.	O	O

We	O	O
also	O	O
show	O	O
that	O	O
the	O	O
numbers	O	O
of	O	O
TLR2	O	O
(	O	O
+	O	O
)	O	O
but	O	O
not	O	O
TLR4	O	O
(	O	O
+	O	O
)	O	O
cells	O	O
increase	O	O
linearly	O	O
with	O	O
inflammation	O	O
(	O	O
r	O	O
(	O	O
2	O	O
)	O	O
=	O	O
0.33	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Double-immunofluorescence	O	O
analysis	O	O
confirms	O	O
that	O	O
TLR2	O	O
is	O	O
coexpressed	O	O
by	O	O
monocytes	O	O
(	O	O
MC	O	O
)	O	O
/macrophages	O	O
(	O	O
mphi	O	O
)	O	O
in	O	O
situ	O	O
.	O	O

Further	O	O
analysis	O	O
of	O	O
gingival	O	O
tissues	O	O
by	O	O
quantitative	O	O
real-time	O	O
PCR	O	O
,	O	O
however	O	O
,	O	O
indicates	O	O
that	O	O
despite	O	O
a	O	O
threefold	O	O
increase	O	O
in	O	O
the	O	O
expression	O	O
of	O	O
interleukin-1beta	O	O
(	O	O
IL-1beta	O	O
)	O	O
mRNA	O	O
during	O	O
CP	O	O
,	O	O
there	O	O
is	O	O
significant	O	O
(	O	O
30-fold	O	O
)	O	O
downregulation	O	O
of	O	O
TLR2	O	O
mRNA	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
,	O	O
Student	O	O
's	O	O
t	O	O
test	O	O
)	O	O
.	O	O

Also	O	O
showing	O	O
similar	O	O
trends	O	O
are	O	O
the	O	O
levels	O	O
of	O	O
TLR4	O	O
(	O	O
ninefold	O	O
reduction	O	O
)	O	O
,	O	O
TLR5	O	O
(	O	O
twofold	O	O
reduction	O	O
)	O	O
,	O	O
and	O	O
MD-2	O	O
(	O	O
sevenfold	O	O
reduction	O	O
)	O	O
mRNA	O	O
in	O	O
CP	O	O
patients	O	O
compared	O	O
to	O	O
healthy	O	O
persons	O	O
,	O	O
while	O	O
the	O	O
level	O	O
of	O	O
CD14	O	O
was	O	O
unchanged	O	O
.	O	O

In	O	O
vitro	O	O
studies	O	O
with	O	O
human	O	O
MC	O	O
indicate	O	O
that	O	O
MC	O	O
respond	O	O
to	O	O
an	O	O
initial	O	O
stimulus	O	O
of	O	O
lipopolysaccharide	O	O
(	O	O
LPS	O	O
)	O	O
from	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
PgLPS	O	O
)	O	O
or	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
(	O	O
EcLPS	O	O
)	O	O
by	O	O
upregulation	O	O
of	O	O
TLR2	O	O
and	O	O
TLR4	O	O
mRNA	O	O
and	O	O
protein	O	O
;	O	O
moreover	O	O
,	O	O
IL-1beta	O	O
mRNA	O	O
is	O	O
induced	O	O
and	O	O
tumor	O	O
necrosis	O	O
factor	O	O
alpha	O	O
(	O	O
TNF-alpha	O	O
)	O	O
,	O	O
IL-10	O	O
,	O	O
IL-6	O	O
,	O	O
and	O	O
IL-8	O	O
proteins	O	O
are	O	O
secreted	O	O
.	O	O

However	O	O
,	O	O
restimulation	O	O
of	O	O
MC	O	O
with	O	O
either	O	O
PgLPS	O	O
or	O	O
EcLPS	O	O
downregulates	O	O
TLR2	O	O
and	O	O
TLR4	O	O
mRNA	O	O
and	O	O
protein	O	O
and	O	O
IL-1beta	O	O
mRNA	O	O
and	O	O
induces	O	O
a	O	O
ca	O	O
.	O	O

10-fold	O	O
reduction	O	O
in	O	O
TNF-alpha	O	O
secretion	O	O
,	O	O
suggesting	O	O
the	O	O
induction	O	O
of	O	O
endotoxin	O	O
tolerance	O	O
by	O	O
either	O	O
LPS	O	O
.	O	O

Less	O	O
susceptible	O	O
to	O	O
tolerance	O	O
than	O	O
TNF-alpha	O	O
were	O	O
IL-6	O	O
,	O	O
IL-10	O	O
,	O	O
and	O	O
IL-8	O	O
.	O	O

These	O	O
studies	O	O
suggest	O	O
that	O	O
certain	O	O
components	O	O
of	O	O
the	O	O
innate	O	O
oral	O	O
mucosal	O	O
immune	O	O
response	O	O
,	O	O
most	O	O
notably	O	O
TLRs	O	O
and	O	O
inflammatory	O	O
cytokines	O	O
,	O	O
may	O	O
become	O	O
tolerized	O	O
during	O	O
sustained	O	O
exposure	O	O
to	O	O
bacterial	O	O
structures	O	O
such	O	O
as	O	O
LPS	O	O
and	O	O
that	O	O
this	O	O
may	O	O
be	O	O
one	O	O
mechanism	O	O
used	O	O
in	O	O
the	O	O
oral	O	O
mucosa	O	O
to	O	O
attempt	O	O
to	O	O
regulate	O	O
local	O	O
immune	O	O
responses	O	O
.	O	O

Clinical	O	O
research	O	O
assessing	O	O
different	O	O
therapeutic	O	O
protocols	O	O
aimed	O	O
at	O	O
treating	O	O
oral	O	O
halitosis	O	O
is	O	O
scarce	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
effects	O	O
of	O	O
a	O	O
combined	O	O
mechanical	O	O
and	O	O
pharmacological	O	O
approach	O	O
to	O	O
treat	O	O
oral	O	O
halitosis	O	O
on	O	O
clinical	O	O
and	O	O
microbiological	O	O
outcomes	O	O
on	O	O
patients	O	O
followed	O	O
for	O	O
3	O	O
months	O	O
.	O	O

Nineteen	O	O
subjects	O	O
with	O	O
oral	O	O
malodor	O	O
participated	O	O
.	O	O

At	O	O
baseline	O	O
,	O	O
all	O	O
subjects	O	O
completed	O	O
a	O	O
questionnaire	O	O
and	O	O
carried	O	O
out	O	O
an	O	O
examination	O	O
including	O	O
full-mouth	O	O
organoleptic	O	O
and	O	O
volatile	O	O
sulfur	O	O
compound	O	O
(	O	O
VSC	O	O
)	O	O
levels	O	O
and	O	O
the	O	O
Winkel	O	O
tongue	O	O
coating	O	O
index	O	O
.	O	O

Standard	O	O
periodontal	O	O
outcome	O	O
variables	O	O
were	O	O
assessed	O	O
at	O	O
six	O	O
teeth	O	O
.	O	O

Standardized	O	O
microbiological	O	O
samples	O	O
of	O	O
subgingival	O	O
plaque	O	O
,	O	O
unstimulated	O	O
saliva	O	O
,	O	O
and	O	O
tongue	O	O
coating	O	O
were	O	O
obtained	O	O
for	O	O
culture	O	O
analysis	O	O
.	O	O

The	O	O
treatment	O	O
protocol	O	O
included	O	O
supragingival	O	O
prophylaxis	O	O
;	O	O
instructions	O	O
in	O	O
oral	O	O
hygiene	O	O
(	O	O
toothbrushing	O	O
,	O	O
interproximal	O	O
cleaning	O	O
,	O	O
and	O	O
tongue	O	O
scraping	O	O
)	O	O
;	O	O
and	O	O
gargling	O	O
with	O	O
a	O	O
mouthrinse	O	O
containing	O	O
chlorhexidine	O	O
,	O	O
cetylpiridinium	O	O
chloride	O	O
,	O	O
and	O	O
zinc	O	O
lactate	O	O
.	O	O

The	O	O
same	O	O
outcome	O	O
variables	O	O
were	O	O
registered	O	O
1	O	O
and	O	O
3	O	O
months	O	O
after	O	O
baseline	O	O
.	O	O

Statistically	O	O
significant	O	O
reductions	O	O
in	O	O
organoleptic	O	O
scores	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
,	O	O
VSC	O	O
levels	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
and	O	O
tongue	O	O
coating	O	O
index	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
were	O	O
observed	O	O
after	O	O
1	O	O
and	O	O
3	O	O
months	O	O
.	O	O

Mean	O	O
probing	O	O
depth	O	O
and	O	O
plaque	O	O
levels	O	O
also	O	O
demonstrated	O	O
significant	O	O
reductions	O	O
after	O	O
3	O	O
months	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Total	O	O
anaerobic	O	O
counts	O	O
were	O	O
significantly	O	O
reduced	O	O
at	O	O
all	O	O
three	O	O
locations	O	O
after	O	O
1	O	O
month	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
and	O	O
in	O	O
samples	O	O
from	O	O
tongue	O	O
coating	O	O
and	O	O
subgingival	O	O
plaque	O	O
at	O	O
3	O	O
months	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Aerobic	O	O
counts	O	O
were	O	O
significantly	O	O
reduced	O	O
in	O	O
saliva	O	O
at	O	O
1	O	O
month	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
and	O	O
the	O	O
anaerobic/aerobic	O	O
ratio	O	O
significantly	O	O
increased	O	O
in	O	O
the	O	O
tongue	O	O
samples	O	O
.	O	O

Among	O	O
the	O	O
selected	O	O
pathogens	O	O
evaluated	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
affected	O	O
of	O	O
the	O	O
three	O	O
microflora	O	O
evaluated	O	O
.	O	O

The	O	O
evaluated	O	O
therapeutic	O	O
approach	O	O
demonstrated	O	O
its	O	O
efficacy	O	O
in	O	O
the	O	O
management	O	O
of	O	O
oral	O	O
halitosis	O	O
,	O	O
demonstrating	O	O
statistically	O	O
significant	O	O
improvements	O	O
in	O	O
both	O	O
organoleptic	O	O
and	O	O
VSC	O	O
values	O	O
at	O	O
1	O	O
and	O	O
3	O	O
months	O	O
.	O	O

The	O	O
proposed	O	O
clinical	O	O
protocol	O	O
significantly	O	O
affected	O	O
the	O	O
microbial	O	O
composition	O	O
in	O	O
tongue	O	O
coating	O	O
,	O	O
saliva	O	O
,	O	O
and	O	O
subgingival	O	O
microflora	O	O
.	O	O

This	O	O
study	O	O
evaluated	O	O
the	O	O
in	O	O
vivo	O	O
effects	O	O
of	O	O
bleaching	O	O
agents	O	O
containing	O	O
10	O	O
%	O	O
carbamide	O	O
peroxide	O	O
(	O	O
Platinum/Colgate	O	O
)	O	O
or	O	O
7.5	O	O
%	O	O
hydrogen	O	O
peroxide	O	O
(	O	O
Day	O	O
White	O	O
2Z/Discus	O	O
Dental	O	O
)	O	O
on	O	O
mutans	B-bacteria	B-bacteria
Streptococcus	E-bacteria	I-bacteria
during	O	O
dental	O	O
bleaching	O	O
.	O	O

The	O	O
products	O	O
were	O	O
applied	O	O
on	O	O
30	O	O
volunteers	O	O
who	O	O
needed	O	O
dental	O	O
bleaching	O	O
.	O	O

In	O	O
each	O	O
volunteer	O	O
,	O	O
one	O	O
of	O	O
the	O	O
two	O	O
bleaching	O	O
agents	O	O
was	O	O
used	O	O
on	O	O
both	O	O
dental	O	O
arches	O	O
one	O	O
hour	O	O
a	O	O
day	O	O
for	O	O
three	O	O
weeks	O	O
.	O	O

Analysis	O	O
of	O	O
the	O	O
bacterial	O	O
counts	O	O
was	O	O
made	O	O
by	O	O
collecting	O	O
saliva	O	O
before	O	O
(	O	O
baseline	O	O
values	O	O
)	O	O
,	O	O
during	O	O
(	O	O
7	O	O
and	O	O
21	O	O
days	O	O
)	O	O
bleaching	O	O
treatments	O	O
and	O	O
14	O	O
days	O	O
posttreatment	O	O
.	O	O

The	O	O
Friedman	O	O
non-parametric	O	O
analysis	O	O
(	O	O
alpha=0.05	O	O
)	O	O
found	O	O
no	O	O
differences	O	O
in	O	O
microorganism	O	O
counts	O	O
at	O	O
different	O	O
times	O	O
for	O	O
each	O	O
group	O	O
for	O	O
both	O	O
agents	O	O
(	O	O
p	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
Mann	O	O
Whitney	O	O
nonparametric	O	O
test	O	O
(	O	O
alpha=0.05	O	O
)	O	O
showed	O	O
no	O	O
differences	O	O
in	O	O
micro-organism	O	O
counts	O	O
for	O	O
both	O	O
agents	O	O
(	O	O
p	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

Different	O	O
bleaching	O	O
agents	O	O
did	O	O
not	O	O
change	O	O
the	O	O
oral	O	O
cavity	O	O
mutans	O	O
Streptococcus	B-bacteria	B-bacteria
counts	O	O
.	O	O

Listeria	B-bacteria	B-bacteria
monocytogenes	E-bacteria	I-bacteria
is	O	O
a	O	O
food-borne	O	O
pathogen	O	O
that	O	O
causes	O	O
serious	O	O
listeriosis	O	O
in	O	O
humans	O	O
.	O	O

Antimicrobial	O	O
effects	O	O
of	O	O
human	O	O
lactoferrin	O	O
(	O	O
hLF	O	O
)	O	O
against	O	O
L.	B-bacteria	B-bacteria
monocytogenes	E-bacteria	I-bacteria
have	O	O
been	O	O
clearly	O	O
demonstrated	O	O
in	O	O
in	O	O
vitro	O	O
studies	O	O
.	O	O

However	O	O
,	O	O
in	O	O
vivo	O	O
studies	O	O
have	O	O
not	O	O
been	O	O
reported	O	O
yet	O	O
.	O	O

This	O	O
study	O	O
investigated	O	O
whether	O	O
the	O	O
oral	O	O
administration	O	O
of	O	O
hLF	O	O
could	O	O
inhibit	O	O
oral	O	O
infection	O	O
of	O	O
listeria	B-bacteria	B-bacteria
in	O	O
BALB/c	O	O
mice	O	O
.	O	O

The	O	O
MICs	O	O
for	O	O
several	O	O
strains	O	O
of	O	O
L.	B-bacteria	B-bacteria
monocytogenes	E-bacteria	I-bacteria
were	O	O
determined	O	O
,	O	O
and	O	O
the	O	O
most	O	O
sensitive	O	O
strain	O	O
was	O	O
used	O	O
for	O	O
the	O	O
animal	O	O
work	O	O
.	O	O

hLF	O	O
was	O	O
administered	O	O
to	O	O
BALB/c	O	O
mice	O	O
for	O	O
7	O	O
days	O	O
,	O	O
commencing	O	O
4	O	O
days	O	O
before	O	O
oral	O	O
infection	O	O
.	O	O

The	O	O
effect	O	O
of	O	O
hLF	O	O
was	O	O
determined	O	O
by	O	O
bacterial	O	O
enumeration	O	O
and	O	O
histopathological	O	O
analysis	O	O
of	O	O
the	O	O
liver	O	O
and	O	O
spleen	O	O
,	O	O
which	O	O
are	O	O
well-known	O	O
as	O	O
the	O	O
major	O	O
targets	O	O
of	O	O
oral	O	O
listeria	B-bacteria	B-bacteria
infection	O	O
in	O	O
mice	O	O
.	O	O

In	O	O
bacterial	O	O
enumeration	O	O
,	O	O
hLF	O	O
decreased	O	O
the	O	O
number	O	O
of	O	O
L.	B-bacteria	B-bacteria
monocytogenes	E-bacteria	I-bacteria
cells	O	O
in	O	O
the	O	O
liver	O	O
.	O	O

Histopathologically	O	O
,	O	O
the	O	O
size	O	O
and	O	O
frequency	O	O
of	O	O
necrotic	O	O
foci	O	O
in	O	O
the	O	O
liver	O	O
samples	O	O
decreased	O	O
with	O	O
hLF	O	O
administration	O	O
.	O	O

However	O	O
,	O	O
these	O	O
changes	O	O
were	O	O
not	O	O
observed	O	O
in	O	O
the	O	O
spleen	O	O
samples	O	O
.	O	O

The	O	O
mRNA	O	O
levels	O	O
of	O	O
inflammatory	O	O
cytokines	O	O
,	O	O
such	O	O
as	O	O
interleukin	O	O
(	O	O
IL	O	O
)	O	O
-1beta	O	O
,	O	O
tumour	O	O
necrosis	O	O
factor	O	O
(	O	O
TNF	O	O
)	O	O
-alpha	O	O
and	O	O
interferon	O	O
(	O	O
IFN	O	O
)	O	O
-gamma	O	O
,	O	O
decreased	O	O
in	O	O
the	O	O
liver	O	O
of	O	O
mice	O	O
receiving	O	O
hLF	O	O
.	O	O

This	O	O
study	O	O
has	O	O
shown	O	O
that	O	O
hLF	O	O
decreases	O	O
the	O	O
hepatic	O	O
colonization	O	O
of	O	O
L.	B-bacteria	B-bacteria
monocytogenes	E-bacteria	I-bacteria
,	O	O
hepatic	O	O
necrosis	O	O
and	O	O
expression	O	O
of	O	O
inflammatory	O	O
cytokines	O	O
.	O	O

It	O	O
revealed	O	O
that	O	O
perorally	O	O
given	O	O
hLF	O	O
could	O	O
mediate	O	O
antimicrobial	O	O
and	O	O
anti-inflammatory	O	O
activities	O	O
remote	O	O
from	O	O
the	O	O
gut	O	O
(	O	O
i.e	O	O
.	O	O

in	O	O
the	O	O
liver	O	O
)	O	O
of	O	O
mice	O	O
challenged	O	O
with	O	O
L.	B-bacteria	B-bacteria
monocytogenes	E-bacteria	I-bacteria
.	O	O

Oral	O	O
administration	O	O
of	O	O
microcapsules	O	O
containing	O	O
live	O	O
bacterial	O	O
cells	O	O
has	O	O
potential	O	O
as	O	O
an	O	O
alternative	O	O
therapy	O	O
for	O	O
several	O	O
diseases	O	O
.	O	O

This	O	O
article	O	O
evaluates	O	O
the	O	O
suitability	O	O
of	O	O
the	O	O
alginate-poly-L-lysine-alginate	O	O
(	O	O
APA	O	O
)	O	O
microcapsules	O	O
for	O	O
oral	O	O
delivery	O	O
of	O	O
live	O	O
bacterial	O	O
cells	O	O
,	O	O
in-vitro	O	O
,	O	O
using	O	O
a	O	O
dynamic	O	O
simulated	O	O
human	O	O
gastro-intestinal	O	O
(	O	O
GI	O	O
)	O	O
model	O	O
.	O	O

Results	O	O
showed	O	O
that	O	O
the	O	O
APA	O	O
microcapsules	O	O
were	O	O
morphologically	O	O
stable	O	O
in	O	O
the	O	O
simulated	O	O
stomach	O	O
conditions	O	O
,	O	O
but	O	O
did	O	O
not	O	O
retain	O	O
their	O	O
structural	O	O
integrity	O	O
after	O	O
a	O	O
3-day	O	O
exposure	O	O
in	O	O
simulated	O	O
human	O	O
GI	O	O
media	O	O
.	O	O

The	O	O
microbial	O	O
populations	O	O
of	O	O
the	O	O
tested	O	O
bacterial	O	O
cells	O	O
and	O	O
the	O	O
activities	O	O
of	O	O
the	O	O
tested	O	O
enzymes	O	O
in	O	O
the	O	O
simulated	O	O
human	O	O
GI	O	O
suspension	O	O
were	O	O
not	O	O
substantially	O	O
altered	O	O
by	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
APA	O	O
microcapsules	O	O
,	O	O
suggesting	O	O
that	O	O
there	O	O
were	O	O
no	O	O
significant	O	O
adverse	O	O
effects	O	O
of	O	O
oral	O	O
administration	O	O
of	O	O
the	O	O
APA	O	O
microcapsules	O	O
on	O	O
the	O	O
flora	O	O
of	O	O
the	O	O
human	O	O
gastrointestinal	O	O
tract	O	O
.	O	O

When	O	O
the	O	O
APA	O	O
microcapsules	O	O
containing	O	O
Lactobacillus	B-bacteria	B-bacteria
plantarum	I-bacteria	I-bacteria
80	E-bacteria	I-bacteria
(	O	O
LP80	B-bacteria	B-bacteria
)	O	O
were	O	O
challenged	O	O
in	O	O
the	O	O
simulated	O	O
gastric	O	O
medium	O	O
(	O	O
pH	O	O
=	O	O
2.0	O	O
)	O	O
,	O	O
80.0	O	O
%	O	O
of	O	O
the	O	O
encapsulated	O	O
cells	O	O
remained	O	O
viable	O	O
after	O	O
a	O	O
5-min	O	O
incubation	O	O
;	O	O
however	O	O
,	O	O
the	O	O
viability	O	O
decreased	O	O
considerably	O	O
(	O	O
8.3	O	O
%	O	O
)	O	O
after	O	O
15	O	O
min	O	O
and	O	O
dropped	O	O
to	O	O
2.6	O	O
%	O	O
after	O	O
30	O	O
min	O	O
and	O	O
lower	O	O
than	O	O
0.2	O	O
%	O	O
after	O	O
60	O	O
min	O	O
,	O	O
indicating	O	O
the	O	O
limitations	O	O
of	O	O
the	O	O
currently	O	O
obtainable	O	O
APA	O	O
membrane	O	O
for	O	O
oral	O	O
delivery	O	O
of	O	O
live	O	O
bacteria	O	O
.	O	O

Further	O	O
in-vivo	O	O
studies	O	O
are	O	O
required	O	O
before	O	O
conclusions	O	O
can	O	O
be	O	O
made	O	O
concerning	O	O
the	O	O
inadequacy	O	O
of	O	O
APA	O	O
microcapsules	O	O
for	O	O
oral	O	O
delivery	O	O
of	O	O
live	O	O
bacterial	O	O
cells	O	O
.	O	O

The	O	O
microbiota	O	O
of	O	O
the	O	O
human	O	O
stomach	O	O
and	O	O
the	O	O
influence	O	O
of	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
colonization	O	O
on	O	O
its	O	O
composition	O	O
remain	O	O
largely	O	O
unknown	O	O
.	O	O

We	O	O
characterized	O	O
bacterial	O	O
diversity	O	O
within	O	O
the	O	O
human	O	O
gastric	O	O
mucosa	O	O
by	O	O
using	O	O
a	O	O
small	O	O
subunit	O	O
16S	O	O
rDNA	O	O
clone	O	O
library	O	O
approach	O	O
and	O	O
analyzed	O	O
1,833	O	O
sequences	O	O
generated	O	O
by	O	O
broad-range	O	O
bacterial	O	O
PCR	O	O
from	O	O
23	O	O
gastric	O	O
endoscopic	O	O
biopsy	O	O
samples	O	O
.	O	O

A	O	O
diverse	O	O
community	O	O
of	O	O
128	O	O
phylotypes	O	O
was	O	O
identified	O	O
,	O	O
featuring	O	O
diversity	O	O
at	O	O
this	O	O
site	O	O
greater	O	O
than	O	O
previously	O	O
described	O	O
.	O	O

The	O	O
majority	O	O
of	O	O
sequences	O	O
were	O	O
assigned	O	O
to	O	O
the	O	O
Proteobacteria	B-bacteria	B-bacteria
,	O	O
Firmicutes	B-bacteria	B-bacteria
,	O	O
Actinobacteria	B-bacteria	B-bacteria
,	O	O
Bacteroidetes	O	O
,	O	O
and	O	O
Fusobacteria	B-bacteria	B-bacteria
phyla	E-bacteria	I-bacteria
.	O	O

Ten	O	O
percent	O	O
of	O	O
the	O	O
phylotypes	O	O
were	O	O
previously	O	O
uncharacterized	O	O
,	O	O
including	O	O
a	O	O
Deinococcus-related	O	O
organism	O	O
,	O	O
relatives	O	O
of	O	O
which	O	O
have	O	O
been	O	O
found	O	O
in	O	O
extreme	O	O
environments	O	O
but	O	O
not	O	O
reported	O	O
before	O	O
in	O	O
humans	O	O
.	O	O

The	O	O
gastric	O	O
clone	O	O
libraries	O	O
from	O	O
19	O	O
subjects	O	O
contained	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
rDNA	O	O
;	O	O
however	O	O
,	O	O
only	O	O
12	O	O
of	O	O
these	O	O
subjects	O	O
tested	O	O
positive	O	O
for	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
by	O	O
conventional	O	O
laboratory	O	O
methods	O	O
.	O	O

Statistical	O	O
analysis	O	O
revealed	O	O
a	O	O
large	O	O
degree	O	O
of	O	O
intersubject	O	O
variability	O	O
of	O	O
the	O	O
gastric	O	O
ecosystem	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
did	O	O
not	O	O
affect	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
gastric	O	O
community	O	O
.	O	O

This	O	O
gastric	O	O
bacterial	O	O
rDNA	O	O
data	O	O
set	O	O
was	O	O
significantly	O	O
different	O	O
from	O	O
sequence	O	O
collections	O	O
of	O	O
the	O	O
human	O	O
mouth	O	O
and	O	O
esophagus	O	O
described	O	O
in	O	O
other	O	O
studies	O	O
,	O	O
indicating	O	O
that	O	O
the	O	O
human	O	O
stomach	O	O
may	O	O
be	O	O
home	O	O
to	O	O
a	O	O
distinct	O	O
microbial	O	O
eco-system	O	O
.	O	O

The	O	O
gastric	O	O
microbiota	O	O
may	O	O
play	O	O
important	O	O
,	O	O
as-yet-undiscovered	O	O
roles	O	O
in	O	O
human	O	O
health	O	O
and	O	O
disease	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
work	O	O
was	O	O
to	O	O
study	O	O
clinical	O	O
changes	O	O
and	O	O
microorganisms	O	O
in	O	O
mouths	O	O
of	O	O
three	O	O
patient	O	O
groups	O	O
:	O	O
with	O	O
congenital	O	O
disorders	O	O
(	O	O
Cd	O	O
)	O	O
,	O	O
dialyzed	O	O
(	O	O
D	O	O
)	O	O
and	O	O
control	O	O
(	O	O
C	O	O
)	O	O
.	O	O

Fifty	O	O
five	O	O
patients	O	O
,	O	O
20	O	O
to	O	O
62	O	O
years	O	O
old	O	O
were	O	O
assessed	O	O
.	O	O

Swabs	O	O
and	O	O
samples	O	O
of	O	O
periodontal	O	O
tissue	O	O
were	O	O
used	O	O
for	O	O
microscopical	O	O
study	O	O
to	O	O
detect	O	O
of	O	O
protozoans	O	O
and	O	O
for	O	O
bacterial	O	O
and	O	O
fungal	O	O
cultures	O	O
.	O	O

E.	O	O
gingivalis	O	O
and	O	O
T.	O	O
tenax	O	O
were	O	O
found	O	O
in	O	O
all	O	O
groups	O	O
.	O	O

Three	O	O
out	O	O
of	O	O
Cd	O	O
patients	O	O
were	O	O
infected	O	O
with	O	O
Acanthamoeba	B-bacteria	B-bacteria
sp..	I-bacteria	I-bacteria
Fecal	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
more	O	O
often	O	O
found	O	O
in	O	O
D	O	O
than	O	O
Cd	O	O
.	O	O

In	O	O
all	O	O
30-40	O	O
years	O	O
old	O	O
D	O	O
patients	O	O
,	O	O
fecal	O	O
bacteria	O	O
and	O	O
various	O	O
strains	O	O
of	O	O
C.	O	O
albicans	O	O
occurred	O	O
.	O	O

We	O	O
found	O	O
that	O	O
systemic	O	O
diseases	O	O
favour	O	O
instabilities	O	O
in	O	O
mouths	O	O
changing	O	O
interrelations	O	O
between	O	O
protozoa	O	O
,	O	O
bacteria	O	O
and	O	O
fungi	O	O
.	O	O

It	O	O
may	O	O
increase	O	O
risk	O	O
of	O	O
clinical	O	O
complications	O	O
.	O	O

Artemisia	O	O
princeps	O	O
Pampanini	O	O
,	O	O
which	O	O
is	O	O
called	O	O
Ssajuarissuk	O	O
in	O	O
Korean	O	O
(	O	O
SS-1	O	O
)	O	O
,	O	O
was	O	O
fermented	O	O
with	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
LAB	B-bacteria	B-bacteria
)	O	O
and	O	O
their	O	O
passive	O	O
cutaneous	O	O
anaphylaxis	O	O
reaction-inhibitory	O	O
activity	O	O
was	O	O
investigated	O	O
.	O	O

Of	O	O
these	O	O
fermented	O	O
agents	O	O
,	O	O
SS-1	O	O
extract	O	O
fermented	O	O
with	O	O
Bifidobacterium	B-bacteria	B-bacteria
infantis	O	O
K-525	O	O
(	O	O
F-SS-1	O	O
)	O	O
most	O	O
effectively	O	O
inhibited	O	O
the	O	O
release	O	O
of	O	O
P-hexosamindase	O	O
from	O	O
RBL-2H3	O	O
cells	O	O
induced	O	O
IgE	O	O
.	O	O

In	O	O
IgE-induced	O	O
RBL-2H3	O	O
cells	O	O
,	O	O
F-SS-1	O	O
inhibited	O	O
proinflammatory	O	O
cytokines	O	O
IL-6	O	O
and	O	O
TNF-alpha	O	O
mRNA	O	O
expression	O	O
.	O	O

Oral	O	O
administration	O	O
of	O	O
SS-1	O	O
and	O	O
F-SS-1	O	O
to	O	O
mice	O	O
inhibited	O	O
passive	O	O
cutaneous	O	O
anaphylaxis	O	O
(	O	O
PCA	O	O
)	O	O
reaction	O	O
induced	O	O
by	O	O
IgE	O	O
and	O	O
scratching	O	O
behaviors	O	O
induced	O	O
by	O	O
compound	O	O
48/80	O	O
.	O	O

The	O	O
inhibitory	O	O
activity	O	O
of	O	O
F-SS-1	O	O
against	O	O
scratching	O	O
behaviors	O	O
was	O	O
more	O	O
effective	O	O
than	O	O
that	O	O
of	O	O
SS-1	O	O
.	O	O

These	O	O
findings	O	O
suggest	O	O
that	O	O
the	O	O
fermentation	O	O
of	O	O
SS-1	O	O
with	O	O
LAB	B-bacteria	B-bacteria
can	O	O
increase	O	O
its	O	O
antiallergic	O	O
activity	O	O
.	O	O

Squamous	O	O
cell	O	O
carcinomas	O	O
of	O	O
the	O	O
upper	O	O
aerodigestive	O	O
tract	O	O
are	O	O
a	O	O
global	O	O
health-political	O	O
challenge	O	O
.	O	O

Accordingly	O	O
,	O	O
current	O	O
research	O	O
efforts	O	O
are	O	O
aimed	O	O
towards	O	O
the	O	O
opportunities	O	O
for	O	O
early	O	O
recognition	O	O
of	O	O
risk	O	O
patients	O	O
,	O	O
and	O	O
at	O	O
the	O	O
recognition	O	O
of	O	O
risk	O	O
factors	O	O
related	O	O
to	O	O
carcinogenesis	O	O
.	O	O

We	O	O
determined	O	O
the	O	O
revertant	O	O
number	O	O
of	O	O
the	O	O
variety	O	O
Salmonella	B-bacteria	B-bacteria
typhimurium	I-bacteria	I-bacteria
TA	I-bacteria	I-bacteria
98	E-bacteria	I-bacteria
and	O	O
TA	B-bacteria	B-bacteria
100	E-bacteria	I-bacteria
after	O	O
incubation	O	O
,	O	O
with	O	O
saliva	O	O
samples	O	O
from	O	O
100	O	O
probands	O	O
as	O	O
a	O	O
measure	O	O
of	O	O
a	O	O
genotoxic	O	O
environment	O	O
within	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
depending	O	O
on	O	O
the	O	O
dental	O	O
status	O	O
as	O	O
measure	O	O
of	O	O
oral	O	O
health	O	O
.	O	O

Beside	O	O
chronic	O	O
alcohol	O	O
(	O	O
p=0.032	O	O
)	O	O
and	O	O
tobacco	O	O
consumption	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
,	O	O
the	O	O
dental	O	O
status	O	O
displayed	O	O
in	O	O
partial	O	O
aspects	O	O
(	O	O
high	O	O
plaque	O	O
index	O	O
,	O	O
high	O	O
number	O	O
of	O	O
decayed	O	O
teeth	O	O
,	O	O
prosthetically	O	O
not	O	O
rehabilitated	O	O
status	O	O
,	O	O
p	O	O
<	O	O
or=	O	O
0.050	O	O
)	O	O
a	O	O
significant	O	O
connection	O	O
with	O	O
the	O	O
genotoxic	O	O
salivary	O	O
activity	O	O
.	O	O

The	O	O
periodontal	O	O
status	O	O
and	O	O
the	O	O
type	O	O
of	O	O
restorative	O	O
filling	O	O
material	O	O
,	O	O
as	O	O
well	O	O
as	O	O
dental	O	O
prostheses	O	O
,	O	O
however	O	O
,	O	O
had	O	O
no	O	O
important	O	O
influence	O	O
on	O	O
the	O	O
revertant	O	O
number	O	O
(	O	O
p	O	O
>	O	O
or=	O	O
0.104	O	O
)	O	O
.	O	O

Therefore	O	O
,	O	O
it	O	O
can	O	O
be	O	O
concluded	O	O
that	O	O
the	O	O
polymicrobial	O	O
supragingival	O	O
plaque	O	O
,	O	O
as	O	O
a	O	O
possible	O	O
independent	O	O
factor	O	O
,	O	O
possesses	O	O
a	O	O
relevant	O	O
mutagenic	O	O
interaction	O	O
with	O	O
saliva	O	O
,	O	O
and	O	O
that	O	O
individual	O	O
oral	O	O
health	O	O
is	O	O
a	O	O
co-factor	O	O
in	O	O
the	O	O
development	O	O
of	O	O
carcinomas	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
microbiota	O	O
of	O	O
noncaries	O	O
associated	O	O
supra-gingival	O	O
plaque	O	O
(	O	O
SGP	O	O
)	O	O
microbiology	O	O
in	O	O
Sjogren	O	O
's	O	O
syndrome	O	O
(	O	O
SS	O	O
)	O	O
.	O	O

Stimulated	O	O
whole	O	O
saliva	O	O
(	O	O
SWS	O	O
)	O	O
and	O	O
full-mouth	O	O
SGP	O	O
on	O	O
intact	O	O
tooth	O	O
surfaces	O	O
were	O	O
collected	O	O
from	O	O
26	O	O
primary	O	O
(	O	O
p	O	O
)	O	O
SS	O	O
,	O	O
27	O	O
secondary	O	O
(	O	O
s	O	O
)	O	O
SS	O	O
,	O	O
and	O	O
29	O	O
control	O	O
subjects	O	O
for	O	O
selective	O	O
culture	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
,	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
and	O	O
aerobic	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
facultatively	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
gram-negative	I-bacteria	I-bacteria
rods	E-bacteria	I-bacteria
(	O	O
AGNR	B-bacteria	B-bacteria
)	O	O
.	O	O

Predominant	O	O
cultivable	B-bacteria	B-bacteria
anaerobes	E-bacteria	I-bacteria
from	O	O
SGP	O	O
of	O	O
11	O	O
randomly	O	O
selected	O	O
subjects	O	O
from	O	O
each	O	O
group	O	O
were	O	O
investigated	O	O
.	O	O

Clinical	O	O
and	O	O
sialometric	O	O
data	O	O
were	O	O
also	O	O
collected	O	O
.	O	O

SS	O	O
sufferers	O	O
had	O	O
significantly	O	O
lower	O	O
SWS	O	O
flow	O	O
rate	O	O
and	O	O
higher	O	O
mean	O	O
DMFT	O	O
(	O	O
decayed	O	O
,	O	O
missing	O	O
,	O	O
filled	O	O
teeth	O	O
)	O	O
,	O	O
while	O	O
pSS	O	O
subjects	O	O
also	O	O
had	O	O
lower	O	O
SWS	O	O
pH	O	O
and	O	O
fewer	O	O
standing	O	O
teeth	O	O
.	O	O

Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
levels	O	O
in	O	O
SWS	O	O
(	O	O
P	O	O
=	O	O
0.012	O	O
)	O	O
and	O	O
SGP	O	O
(	O	O
P	O	O
<	O	O
0.0001	O	O
)	O	O
were	O	O
significantly	O	O
elevated	O	O
in	O	O
pSS	O	O
sufferers	O	O
compared	O	O
with	O	O
sSS	O	O
individuals	O	O
and	O	O
controls	O	O
.	O	O

AGNR	B-bacteria	B-bacteria
isolation	O	O
was	O	O
uncommon	O	O
.	O	O

SS	O	O
sufferers	O	O
had	O	O
significantly	O	O
lower	O	O
proportion	O	O
of	O	O
gram-negative	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
(	O	O
P	O	O
=	O	O
0.047	O	O
)	O	O
.	O	O

Non-oral	O	O
species	O	O
were	O	O
isolated	O	O
in	O	O
greater	O	O
proportions	O	O
from	O	O
pSS	O	O
SGP	O	O
(	O	O
P	O	O
=	O	O
0.007	O	O
)	O	O
.	O	O

Subjects	O	O
with	O	O
pSS	O	O
harbored	O	O
increased	O	O
levels	O	O
of	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
and	O	O
non-oral	O	O
species	O	O
,	O	O
while	O	O
SS	O	O
sufferers	O	O
generally	O	O
had	O	O
lower	O	O
proportions	O	O
of	O	O
gram-negative	O	O
species	O	O
.	O	O

The	O	O
microbial	O	O
composition	O	O
of	O	O
noncaries	O	O
associated	O	O
SGP	O	O
indicates	O	O
a	O	O
potential	O	O
source	O	O
of	O	O
increased	O	O
caries	O	O
risk	O	O
in	O	O
SS	O	O
.	O	O

New	O	O
molecules	O	O
were	O	O
designed	O	O
for	O	O
efficient	O	O
intra-oral	O	O
delivery	O	O
of	O	O
antimicrobials	O	O
to	O	O
prevent	O	O
and	O	O
treat	O	O
oral	O	O
infection	O	O
.	O	O

The	O	O
salivary	O	O
statherin	O	O
fragment	O	O
,	O	O
which	O	O
has	O	O
high	O	O
affinity	O	O
for	O	O
the	O	O
tooth	O	O
enamel	O	O
,	O	O
was	O	O
used	O	O
as	O	O
a	O	O
carrier	O	O
peptide	O	O
.	O	O

This	O	O
was	O	O
linked	O	O
through	O	O
the	O	O
side	O	O
chain	O	O
of	O	O
the	O	O
N-terminal	O	O
residue	O	O
to	O	O
the	O	O
C-terminus	O	O
of	O	O
a	O	O
defensin-like	O	O
12-residue	O	O
peptide	O	O
to	O	O
generate	O	O
two	O	O
bifunctional	O	O
hybrid	O	O
molecules	O	O
,	O	O
one	O	O
with	O	O
an	O	O
ester	O	O
linkage	O	O
and	O	O
the	O	O
other	O	O
with	O	O
an	O	O
anhydride	O	O
bond	O	O
between	O	O
the	O	O
carrier	O	O
and	O	O
the	O	O
antimicrobial	O	O
components	O	O
.	O	O

They	O	O
were	O	O
examined	O	O
for	O	O
their	O	O
affinity	O	O
to	O	O
a	O	O
HAP	O	O
(	O	O
hydroxyapatite	O	O
)	O	O
surface	O	O
.	O	O

The	O	O
extent	O	O
of	O	O
the	O	O
antimicrobial	O	O
release	O	O
in	O	O
human	O	O
whole	O	O
saliva	O	O
was	O	O
determined	O	O
using	O	O
13C-NMR	O	O
spectroscopy	O	O
.	O	O

The	O	O
candidacidal	O	O
activity	O	O
of	O	O
the	O	O
molecules	O	O
was	O	O
determined	O	O
as	O	O
a	O	O
function	O	O
of	O	O
the	O	O
antimicrobial	O	O
release	O	O
from	O	O
the	O	O
carrier	O	O
peptide	O	O
in	O	O
human	O	O
saliva	O	O
.	O	O

The	O	O
hybrid-adsorbed	O	O
HAP	O	O
surface	O	O
was	O	O
examined	O	O
against	O	O
Candida	O	O
albicans	O	O
and	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
using	O	O
the	O	O
fluorescence	O	O
technique	O	O
.	O	O

The	O	O
bifunctional	O	O
molecules	O	O
were	O	O
tested	O	O
on	O	O
human	O	O
erythrocytes	O	O
,	O	O
GECs	O	O
(	O	O
gingival	O	O
epithelial	O	O
cells	O	O
)	O	O
and	O	O
GFCs	O	O
(	O	O
gingival	O	O
fibroblast	O	O
cells	O	O
)	O	O
for	O	O
cytotoxicity	O	O
.	O	O

They	O	O
were	O	O
found	O	O
to	O	O
possess	O	O
high	O	O
affinity	O	O
for	O	O
the	O	O
HAP	O	O
mineral	O	O
.	O	O

In	O	O
human	O	O
whole	O	O
saliva	O	O
,	O	O
a	O	O
sustained	O	O
antimicrobial	O	O
release	O	O
over	O	O
a	O	O
period	O	O
of	O	O
more	O	O
than	O	O
40-60	O	O
h	O	O
,	O	O
and	O	O
candidacidal	O	O
activity	O	O
consistent	O	O
with	O	O
the	O	O
extent	O	O
of	O	O
hybrid	O	O
dissociation	O	O
were	O	O
observed	O	O
.	O	O

Moreover	O	O
,	O	O
the	O	O
bifunctional	O	O
peptide-bound	O	O
HAP	O	O
surface	O	O
was	O	O
found	O	O
to	O	O
exhibit	O	O
antimicrobial	O	O
activity	O	O
when	O	O
suspended	O	O
in	O	O
clarified	O	O
human	O	O
saliva	O	O
.	O	O

The	O	O
hybrid	O	O
peptides	O	O
did	O	O
not	O	O
show	O	O
any	O	O
toxic	O	O
influence	O	O
on	O	O
human	O	O
erythrocytes	O	O
,	O	O
GECs	O	O
and	O	O
GFCs	O	O
.	O	O

These	O	O
novel	O	O
hybrids	O	O
could	O	O
be	O	O
safely	O	O
used	O	O
to	O	O
deliver	O	O
therapeutic	O	O
agents	O	O
intra-orally	O	O
for	O	O
the	O	O
treatment	O	O
and	O	O
prevention	O	O
of	O	O
oral	O	O
infectious	O	O
diseases	O	O
.	O	O

Human	O	O
papillomavirus	O	O
type	O	O
16	O	O
L1	O	O
(	O	O
HPV16	O	O
L1	O	O
)	O	O
has	O	O
shown	O	O
considerable	O	O
promise	O	O
as	O	O
a	O	O
parenteral	O	O
vaccine	O	O
for	O	O
prevention	O	O
of	O	O
cervical	O	O
cancers	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
report	O	O
the	O	O
possibility	O	O
of	O	O
oral	O	O
vaccination	O	O
for	O	O
HPV16	O	O
L1	O	O
using	O	O
Lactococcus	B-bacteria	B-bacteria
lactis	E-bacteria	I-bacteria
(	O	O
L.	B-bacteria	B-bacteria
lactis	E-bacteria	I-bacteria
)	O	O
as	O	O
a	O	O
live	O	O
vector	O	O
.	O	O

L.	B-bacteria	B-bacteria
lactis	I-bacteria	I-bacteria
MG1363	E-bacteria	I-bacteria
was	O	O
transformed	O	O
with	O	O
two	O	O
types	O	O
of	O	O
HPV16	O	O
L1-encoding	O	O
plasmids	O	O
for	O	O
intracellular	O	O
expression	O	O
or	O	O
secretion	O	O
.	O	O

L.	B-bacteria	B-bacteria
lactis	E-bacteria	I-bacteria
transformed	O	O
with	O	O
HPV16	O	O
L1-encoding	O	O
plasmids	O	O
retained	O	O
biochemical	O	O
lactic	O	O
acid	O	O
production	O	O
capability	O	O
.	O	O

The	O	O
mucosal	O	O
and	O	O
systemic	O	O
immune	O	O
responses	O	O
were	O	O
affected	O	O
by	O	O
the	O	O
cellular	O	O
location	O	O
of	O	O
expressed	O	O
HPV16	O	O
L1	O	O
proteins	O	O
in	O	O
L.	B-bacteria	B-bacteria
lactis	E-bacteria	I-bacteria
.	O	O

Serum	O	O
IgG	O	O
responses	O	O
were	O	O
induced	O	O
after	O	O
oral	O	O
immunizations	O	O
of	O	O
L.	B-bacteria	B-bacteria
lactis	E-bacteria	I-bacteria
secreting	O	O
HPV16	O	O
L1	O	O
.	O	O

Vaginal	O	O
IgA	O	O
immune	O	O
responses	O	O
were	O	O
observed	O	O
following	O	O
oral	O	O
immunization	O	O
with	O	O
L.	B-bacteria	B-bacteria
lactis	E-bacteria	I-bacteria
expressing	O	O
HPV16	O	O
L1	O	O
in	O	O
an	O	O
intracellular	O	O
form	O	O
,	O	O
but	O	O
not	O	O
with	O	O
L.	B-bacteria	B-bacteria
lactis	E-bacteria	I-bacteria
secreting	O	O
HPV16	O	O
L1	O	O
.	O	O

Furthermore	O	O
,	O	O
induction	O	O
of	O	O
HPV16	O	O
L1-specific	O	O
mucosal	O	O
immune	O	O
responses	O	O
was	O	O
affected	O	O
by	O	O
immunization	O	O
frequency	O	O
.	O	O

Six	O	O
immunizations	O	O
over	O	O
5	O	O
weeks	O	O
were	O	O
required	O	O
to	O	O
induce	O	O
vaginal	O	O
immune	O	O
responses	O	O
.	O	O

The	O	O
levels	O	O
of	O	O
HPV16	O	O
L1-specific	O	O
vaginal	O	O
IgA	O	O
were	O	O
maintained	O	O
until	O	O
12	O	O
weeks	O	O
after	O	O
the	O	O
first	O	O
vaccination	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
the	O	O
feasibility	O	O
of	O	O
L.	B-bacteria	B-bacteria
lactis	E-bacteria	I-bacteria
as	O	O
an	O	O
oral	O	O
vaccine	O	O
vehicle	O	O
of	O	O
HPV16	O	O
L1	O	O
and	O	O
demonstrate	O	O
the	O	O
importance	O	O
of	O	O
cellular	O	O
loci	O	O
of	O	O
expressed	O	O
antigen	O	O
for	O	O
induction	O	O
of	O	O
vaginal	O	O
and	O	O
systemic	O	O
immune	O	O
responses	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
examine	O	O
the	O	O
presence	O	O
of	O	O
bacteria	O	O
in	O	O
synovial	O	O
fluids	O	O
from	O	O
patients	O	O
with	O	O
temporomandibular	O	O
joint	O	O
disorder	O	O
(	O	O
TMD	O	O
)	O	O
by	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
targeting	O	O
the	O	O
16S	O	O
ribosomal	O	O
RNA	O	O
(	O	O
rRNA	O	O
)	O	O
gene	O	O
,	O	O
followed	O	O
by	O	O
cloning	O	O
and	O	O
sequencing	O	O
.	O	O

Universal	O	O
bacterial	O	O
primers	O	O
were	O	O
used	O	O
to	O	O
amplify	O	O
16S	O	O
rRNA	O	O
genes	O	O
in	O	O
28	O	O
synovial	O	O
fluid	O	O
samples	O	O
from	O	O
27	O	O
patients	O	O
with	O	O
TMD	O	O
(	O	O
TMD	O	O
group	O	O
)	O	O
as	O	O
well	O	O
as	O	O
control	O	O
subjects	O	O
:	O	O
5	O	O
patients	O	O
with	O	O
dislocation	O	O
of	O	O
TMJ	O	O
(	O	O
non-TMD	O	O
group	O	O
)	O	O
.	O	O

Subsequently	O	O
,	O	O
PCR	O	O
amplicons	O	O
were	O	O
purified	O	O
and	O	O
cloned	O	O
.	O	O

Partial	O	O
16S	O	O
rRNA	O	O
sequences	O	O
of	O	O
the	O	O
cloned	O	O
insert	O	O
were	O	O
used	O	O
to	O	O
determine	O	O
the	O	O
species	O	O
identities	O	O
or	O	O
closest	O	O
relative	O	O
by	O	O
comparison	O	O
with	O	O
known	O	O
sequences	O	O
using	O	O
GeneBank	O	O
.	O	O

Nineteen	O	O
(	O	O
67.86	O	O
%	O	O
)	O	O
of	O	O
28	O	O
samples	O	O
from	O	O
patients	O	O
in	O	O
the	O	O
TMD	O	O
group	O	O
were	O	O
identified	O	O
with	O	O
the	O	O
presence	O	O
of	O	O
bacterial	O	O
DNA	O	O
by	O	O
PCR	O	O
.	O	O

The	O	O
5	O	O
control	O	O
samples	O	O
from	O	O
the	O	O
nonTMD	O	O
group	O	O
were	O	O
all	O	O
negative	O	O
in	O	O
this	O	O
study	O	O
.	O	O

After	O	O
cloning	O	O
and	O	O
sequencing	O	O
,	O	O
a	O	O
total	O	O
of	O	O
11	O	O
bacterial	O	O
species	O	O
was	O	O
detected	O	O
,	O	O
including	O	O
Granulicatella	B-bacteria	B-bacteria
adiacen	E-bacteria	I-bacteria
(	O	O
6	O	O
samples	O	O
)	O	O
,	O	O
Pseudomonas	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
6	O	O
samples	O	O
)	O	O
,	O	O
Methylobacterium	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
5	O	O
samples	O	O
)	O	O
,	O	O
and	O	O
Beta	B-bacteria	B-bacteria
proteobacterium	E-bacteria	I-bacteria
(	O	O
4	O	O
samples	O	O
)	O	O
.	O	O

Other	O	O
species	O	O
,	O	O
such	O	O
as	O	O
Acidovorax	B-bacteria	B-bacteria
sp.	E-bacteria	I-bacteria
,	O	O
Bradyrhizobium	B-bacteria	B-bacteria
sp.	E-bacteria	I-bacteria
,	O	O
Sphingomonas	B-bacteria	B-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Leptothrix	B-bacteria	B-bacteria
sp	E-bacteria	I-bacteria
.	O	O

oral	O	O
clone	O	O
,	O	O
Thiobacillus	B-bacteria	B-bacteria
denitrificans	E-bacteria	I-bacteria
,	O	O
and	O	O
Comamonadaceae	B-bacteria	B-bacteria
bacterium	E-bacteria	I-bacteria
,	O	O
were	O	O
also	O	O
identified	O	O
.	O	O

Eight	O	O
patients	O	O
were	O	O
found	O	O
with	O	O
mixed	O	O
bacteria	O	O
,	O	O
with	O	O
2-4	O	O
bacteria	O	O
per	O	O
sample	O	O
.	O	O

The	O	O
patients	O	O
with	O	O
fastidious	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
such	O	O
as	O	O
Granulicatella	B-bacteria	B-bacteria
adiacen	E-bacteria	I-bacteria
and	O	O
mixed	O	O
bacteria	O	O
were	O	O
more	O	O
likely	O	O
to	O	O
be	O	O
older	O	O
than	O	O
45	O	O
years	O	O
(	O	O
P	O	O
<	O	O
.05	O	O
)	O	O
.	O	O

A	O	O
wide	O	O
variety	O	O
of	O	O
bacteria	O	O
,	O	O
including	O	O
some	O	O
not	O	O
previously	O	O
reported	O	O
associated	O	O
with	O	O
TMD	O	O
,	O	O
were	O	O
identified	O	O
in	O	O
the	O	O
synovial	O	O
fluids	O	O
from	O	O
patients	O	O
with	O	O
TMD	O	O
.	O	O

Actinomyces	B-bacteria	B-bacteria
are	O	O
members	O	O
of	O	O
the	O	O
indigenous	O	O
oral	O	O
microbiota	O	O
which	O	O
have	O	O
been	O	O
implicated	O	O
in	O	O
root	O	O
caries	O	O
,	O	O
but	O	O
their	O	O
role	O	O
in	O	O
childhood	O	O
caries	O	O
initiation	O	O
and	O	O
progression	O	O
is	O	O
not	O	O
well-understood	O	O
.	O	O

The	O	O
distribution	O	O
of	O	O
Actinomyces	B-bacteria	B-bacteria
in	O	O
supragingival	O	O
plaque	O	O
on	O	O
the	O	O
primary	O	O
teeth	O	O
and	O	O
the	O	O
relationship	O	O
between	O	O
oral	O	O
Actinomyces	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
childhood	O	O
caries	O	O
primarily	O	O
were	O	O
investigated	O	O
.	O	O

Forty	O	O
children	O	O
aged	O	O
from	O	O
three	O	O
to	O	O
five	O	O
years	O	O
old	O	O
were	O	O
divided	O	O
into	O	O
two	O	O
groups	O	O
.	O	O

Twenty	O	O
children	O	O
were	O	O
caries-free	O	O
and	O	O
twenty	O	O
were	O	O
caries-susceptible	O	O
.	O	O

Dental	O	O
plaque	O	O
samples	O	O
from	O	O
different	O	O
places	O	O
of	O	O
the	O	O
teeth	O	O
were	O	O
collected	O	O
with	O	O
sterile	O	O
toothpick	O	O
and	O	O
polymerase	O	O
chain	O	O
reaction	O	O
was	O	O
performed	O	O
with	O	O
specific	O	O
primers	O	O
which	O	O
were	O	O
designed	O	O
for	O	O
this	O	O
research	O	O
.	O	O

Actinomyces	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

were	O	O
detected	O	O
100	O	O
%	O	O
in	O	O
the	O	O
caries-free	O	O
group	O	O
,	O	O
while	O	O
95	O	O
%	O	O
in	O	O
the	O	O
caries-susceptible	O	O
group	O	O
.	O	O

There	O	O
was	O	O
no	O	O
significant	O	O
differences	O	O
between	O	O
the	O	O
two	O	O
groups	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
gerencseriae	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
all	O	O
could	O	O
be	O	O
detected	O	O
in	O	O
both	O	O
groups	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
gerencseriae	E-bacteria	I-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
were	O	O
higher	O	O
in	O	O
caries-free	O	O
group	O	O
than	O	O
those	O	O
in	O	O
caries-susceptible	O	O
group	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
while	O	O
the	O	O
prevalence	O	O
of	O	O
Actinomyces	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
had	O	O
no	O	O
significant	O	O
difference	O	O
between	O	O
the	O	O
two	O	O
groups	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

Actinomyces	B-bacteria	B-bacteria
is	O	O
the	O	O
main	O	O
colonized	O	O
bacteria	O	O
in	O	O
the	O	O
supragingival	O	O
plaque	O	O
of	O	O
children	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
the	O	O
Actinomyces	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

may	O	O
have	O	O
a	O	O
negative	O	O
relationship	O	O
with	O	O
the	O	O
childhood	O	O
caries	O	O
,	O	O
and	O	O
has	O	O
nothing	O	O
to	O	O
do	O	O
with	O	O
different	O	O
places	O	O
of	O	O
the	O	O
teeth	O	O
.	O	O

The	O	O
use	O	O
of	O	O
vaccines	O	O
against	O	O
infectious	O	O
microbes	O	O
has	O	O
been	O	O
critical	O	O
to	O	O
the	O	O
advancement	O	O
of	O	O
medicine	O	O
.	O	O

Vaccine	O	O
strategies	O	O
combined	O	O
with	O	O
,	O	O
or	O	O
without	O	O
,	O	O
adjuvants	O	O
have	O	O
been	O	O
established	O	O
to	O	O
eradicate	O	O
various	O	O
bacterial	O	O
and	O	O
viral	O	O
pathogens	O	O
.	O	O

A	O	O
new	O	O
generation	O	O
of	O	O
vaccines	O	O
is	O	O
being	O	O
developed	O	O
using	O	O
specific	O	O
strains	B-bacteria	B-bacteria
of	I-bacteria	I-bacteria
Gram-positive	E-bacteria	I-bacteria
,	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
,	O	O
notably	O	O
,	O	O
some	O	O
probiotic	B-bacteria	B-bacteria
lactobacilli	E-bacteria	I-bacteria
.	O	O

These	O	O
bacteria	O	O
have	O	O
been	O	O
safely	O	O
consumed	O	O
by	O	O
humans	O	O
for	O	O
centuries	O	O
in	O	O
fermented	O	O
foods	O	O
.	O	O

Thus	O	O
,	O	O
they	O	O
can	O	O
be	O	O
orally	O	O
administered	O	O
,	O	O
are	O	O
well	O	O
tolerated	O	O
by	O	O
recipients	O	O
and	O	O
could	O	O
be	O	O
easily	O	O
and	O	O
economically	O	O
provided	O	O
to	O	O
large	O	O
populations	O	O
.	O	O

In	O	O
this	O	O
overview	O	O
,	O	O
we	O	O
focus	O	O
on	O	O
mucosal	O	O
immunity	O	O
and	O	O
how	O	O
its	O	O
cellular	O	O
component	O	O
(	O	O
s	O	O
)	O	O
,	O	O
particularly	O	O
dendritic	O	O
cells	O	O
,	O	O
can	O	O
be	O	O
specifically	O	O
targeted	O	O
to	O	O
deliver	O	O
immunogenic	O	O
subunits	O	O
,	O	O
such	O	O
as	O	O
the	O	O
protective	O	O
antigen	O	O
from	O	O
Bacillus	B-bacteria	B-bacteria
anthracis	E-bacteria	I-bacteria
(	O	O
the	O	O
causative	O	O
agent	O	O
of	O	O
anthrax	B-bacteria	B-bacteria
)	O	O
.	O	O

An	O	O
antigen-specific	O	O
immune	O	O
response	O	O
can	O	O
be	O	O
elicited	O	O
using	O	O
specific	O	O
strains	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
expressing	O	O
the	O	O
protective	O	O
antigen	O	O
.	O	O

A	O	O
mucosal	O	O
,	O	O
dendritic	O	O
cell-targeted	O	O
approach	O	O
increases	O	O
the	O	O
bioavailability	O	O
of	O	O
an	O	O
immunogen	O	O
of	O	O
interest	O	O
when	O	O
delivered	O	O
orally	O	O
by	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
.	O	O

This	O	O
provides	O	O
an	O	O
efficiently	O	O
elegant	O	O
natural	O	O
strategy	O	O
and	O	O
serves	O	O
a	O	O
dual	O	O
function	O	O
as	O	O
an	O	O
immune-stimulating	O	O
adjuvant	O	O
in	O	O
vivo	O	O
.	O	O

To	O	O
analyze	O	O
the	O	O
localization	O	O
of	O	O
attenuated	O	O
Salmonella	B-bacteria	B-bacteria
typhimurium	E-bacteria	I-bacteria
after	O	O
oral	O	O
immunization	O	O
.	O	O

Prokaryotic	O	O
expression	O	O
plasmid	O	O
pYA33-DsRed	O	O
,	O	O
carrying	O	O
the	O	O
RFP	O	O
gene	O	O
,	O	O
was	O	O
constructed	O	O
and	O	O
electro-transformed	O	O
into	O	O
an	O	O
attenuated	O	O
strain	B-bacteria	B-bacteria
X4550	I-bacteria	I-bacteria
of	I-bacteria	I-bacteria
Salmonella	I-bacteria	I-bacteria
typhimurium	E-bacteria	I-bacteria
,	O	O
the	O	O
recombinant	O	O
bacteria	O	O
were	O	O
named	O	O
as	O	O
X4550	B-bacteria	B-bacteria
(	O	O
33-DsRed	O	O
)	O	O
.	O	O

The	O	O
macrophage	O	O
cell	O	O
line	O	O
RAW264.7	O	O
and	O	O
bone	O	O
marrow	O	O
dendritic	O	O
cell	O	O
(	O	O
BMDC	O	O
)	O	O
were	O	O
invaded	O	O
by	O	O
X4550	B-bacteria	B-bacteria
(	O	O
33-DsRed	O	O
)	O	O
in	O	O
vitro	O	O
.	O	O

Furthermore	O	O
,	O	O
BALB/c	O	O
mice	O	O
were	O	O
immunized	O	O
with	O	O
recombinant	O	O
bacteria	O	O
orally	O	O
.	O	O

RFP	O	O
positive	O	O
cells	O	O
(	O	O
RFP+	O	O
cells	O	O
)	O	O
were	O	O
detected	O	O
by	O	O
Flow	O	O
Cytometry	O	O
(	O	O
FCM	O	O
)	O	O
from	O	O
spleen	O	O
,	O	O
liver	O	O
,	O	O
Mesenteric	O	O
lymp	O	O
node	O	O
(	O	O
MLN	O	O
)	O	O
,	O	O
Peyer's	O	O
patch	O	O
(	O	O
PP	O	O
)	O	O
,	O	O
Inguinal	O	O
lymph	O	O
node	O	O
(	O	O
ILN	O	O
)	O	O
.	O	O

The	O	O
invasion	O	O
rate	O	O
increased	O	O
when	O	O
the	O	O
multiplicity	O	O
of	O	O
infection	O	O
(	O	O
MOI	O	O
)	O	O
were	O	O
improved	O	O
in	O	O
this	O	O
two	O	O
kinds	O	O
of	O	O
cells	O	O
respectively	O	O
.	O	O

After	O	O
oral	O	O
immunization	O	O
with	O	O
X4550	B-bacteria	B-bacteria
(	O	O
33-DsRed	O	O
)	O	O
,	O	O
RFP+	O	O
cells	O	O
were	O	O
detected	O	O
by	O	O
FCM	O	O
on	O	O
1d	O	O
,	O	O
2d	O	O
,	O	O
3d	O	O
,	O	O
5d	O	O
,	O	O
7d	O	O
in	O	O
spleen	O	O
,	O	O
liver	O	O
,	O	O
MLN	O	O
,	O	O
PP	O	O
,	O	O
ILN	O	O
cells	O	O
.	O	O

The	O	O
first	O	O
day	O	O
,	O	O
RFP+	O	O
cells	O	O
were	O	O
detected	O	O
in	O	O
MLN	O	O
and	O	O
PP	O	O
,	O	O
and	O	O
in	O	O
PP	O	O
at	O	O
a	O	O
higher	O	O
rate	O	O
of	O	O
1.4	O	O
%	O	O
than	O	O
that	O	O
of	O	O
MLN	O	O
.	O	O

0.4	O	O
%	O	O
RFP+	O	O
cells	O	O
were	O	O
detected	O	O
the	O	O
next	O	O
day	O	O
in	O	O
ILN	O	O
.	O	O

On	O	O
3th	O	O
day	O	O
,	O	O
the	O	O
rates	O	O
of	O	O
RFP+	O	O
cells	O	O
were	O	O
increased	O	O
in	O	O
all	O	O
of	O	O
above	O	O
tissues	O	O
or	O	O
organs	O	O
and	O	O
decreased	O	O
on	O	O
the	O	O
5th	O	O
day	O	O
.	O	O

At	O	O
the	O	O
7th	O	O
day	O	O
,	O	O
RFP+	O	O
cells	O	O
could	O	O
n't	O	O
be	O	O
detected	O	O
in	O	O
all	O	O
tissues	O	O
or	O	O
organs	O	O
tested	O	O
.	O	O

It	O	O
is	O	O
suggested	O	O
that	O	O
the	O	O
invasion	O	O
ability	O	O
and	O	O
the	O	O
transfer	O	O
through	O	O
mucosal	O	O
pathway	O	O
and	O	O
targeting	O	O
to	O	O
recognize	O	O
immune	O	O
tissue	O	O
or	O	O
organs	O	O
are	O	O
favor	O	O
of	O	O
the	O	O
research	O	O
in	O	O
mucosal	O	O
vaccine	O	O
and	O	O
the	O	O
vaccine	O	O
efficiency	O	O
.	O	O

We	O	O
evaluated	O	O
the	O	O
possibility	O	O
of	O	O
using	O	O
Yersinia	B-bacteria	B-bacteria
pseudotuberculosis	E-bacteria	I-bacteria
as	O	O
a	O	O
live	O	O
vaccine	O	O
against	O	O
plague	O	O
because	O	O
it	O	O
shares	O	O
high	O	O
genetic	O	O
identity	O	O
with	O	O
Y.	B-bacteria	B-bacteria
pestis	E-bacteria	I-bacteria
while	O	O
being	O	O
much	O	O
less	O	O
virulent	O	O
,	O	O
genetically	O	O
much	O	O
more	O	O
stable	O	O
,	O	O
and	O	O
deliverable	O	O
orally	O	O
.	O	O

A	O	O
total	O	O
of	O	O
41	O	O
Y.	B-bacteria	B-bacteria
pseudotuberculosis	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
were	O	O
screened	O	O
by	O	O
PCR	O	O
for	O	O
the	O	O
absence	O	O
of	O	O
the	O	O
high	O	O
pathogenicity	O	O
island	O	O
,	O	O
the	O	O
superantigens	O	O
YPM	O	O
,	O	O
and	O	O
the	O	O
type	O	O
IV	O	O
pilus	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
pYV	O	O
virulence	O	O
plasmid	O	O
.	O	O

One	O	O
strain	O	O
(	O	O
IP32680	B-bacteria	B-bacteria
)	O	O
fulfilled	O	O
these	O	O
criteria	O	O
.	O	O

This	O	O
strain	O	O
was	O	O
avirulent	O	O
in	O	O
mice	O	O
upon	O	O
intragastric	O	O
or	O	O
subcutaneous	O	O
inoculation	O	O
and	O	O
persisted	O	O
for	O	O
2	O	O
months	O	O
in	O	O
the	O	O
mouse	O	O
intestine	O	O
without	O	O
clinical	O	O
signs	O	O
of	O	O
disease	O	O
.	O	O

IP32680	B-bacteria	B-bacteria
reached	O	O
the	O	O
mesenteric	O	O
lymph	O	O
nodes	O	O
,	O	O
spleen	O	O
,	O	O
and	O	O
liver	O	O
without	O	O
causing	O	O
major	O	O
histological	O	O
lesions	O	O
and	O	O
was	O	O
cleared	O	O
after	O	O
13	O	O
days	O	O
.	O	O

The	O	O
antibodies	O	O
produced	O	O
in	O	O
vaccinated	O	O
animals	O	O
recognized	O	O
both	O	O
Y.	B-bacteria	B-bacteria
pseudotuberculosis	E-bacteria	I-bacteria
and	O	O
Y.	B-bacteria	B-bacteria
pestis	E-bacteria	I-bacteria
antigens	O	O
efficiently	O	O
.	O	O

After	O	O
a	O	O
subcutaneous	O	O
challenge	O	O
with	O	O
Y.	B-bacteria	B-bacteria
pestis	I-bacteria	I-bacteria
CO92	E-bacteria	I-bacteria
,	O	O
bacteria	O	O
were	O	O
found	O	O
in	O	O
low	O	O
amounts	O	O
in	O	O
the	O	O
organs	O	O
and	O	O
rarely	O	O
in	O	O
the	O	O
blood	O	O
of	O	O
vaccinated	O	O
animals	O	O
.	O	O

One	O	O
oral	O	O
IP32680	B-bacteria	B-bacteria
inoculation	O	O
protected	O	O
75	O	O
%	O	O
of	O	O
the	O	O
mice	O	O
,	O	O
and	O	O
two	O	O
inoculations	O	O
induced	O	O
much	O	O
higher	O	O
antibody	O	O
titers	O	O
and	O	O
protected	O	O
88	O	O
%	O	O
of	O	O
the	O	O
mice	O	O
.	O	O

Our	O	O
results	O	O
thus	O	O
validate	O	O
the	O	O
concept	O	O
that	O	O
an	O	O
attenuated	O	O
Y.	B-bacteria	B-bacteria
pseudotuberculosis	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
can	O	O
be	O	O
an	O	O
efficient	O	O
,	O	O
inexpensive	O	O
,	O	O
safe	O	O
,	O	O
and	O	O
easy-to-produce	O	O
live	O	O
vaccine	O	O
for	O	O
oral	O	O
immunization	O	O
against	O	O
bubonic	O	O
plague	O	O
.	O	O

In	O	O
order	O	O
to	O	O
assess	O	O
the	O	O
prevalence	O	O
of	O	O
beta-lactamase	B-bacteria	B-bacteria
producing	I-bacteria	I-bacteria
oral	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
childhood	O	O
,	O	O
the	O	O
influence	O	O
of	O	O
different	O	O
parameters	O	O
on	O	O
the	O	O
oral	O	O
carriage	O	O
of	O	O
Capnocytophaga	B-bacteria	B-bacteria
was	O	O
studied	O	O
in	O	O
a	O	O
specific	O	O
population	O	O
of	O	O
children	O	O
with	O	O
cancer	O	O
.	O	O

The	O	O
examined	O	O
parameters	O	O
included	O	O
clinical	O	O
observation	O	O
of	O	O
oropharyngeal	O	O
mucosa	O	O
,	O	O
type	O	O
of	O	O
malignant	O	O
disease	O	O
and	O	O
intake	O	O
of	O	O
chemotherapy	O	O
and	O	O
antimicrobial	O	O
treatment	O	O
.	O	O

The	O	O
gingival	O	O
and	O	O
mucosal	O	O
status	O	O
of	O	O
the	O	O
patients	O	O
was	O	O
recorded	O	O
before	O	O
each	O	O
sampling	O	O
procedure	O	O
.	O	O

Samples	O	O
were	O	O
collected	O	O
by	O	O
oropharyngeal	O	O
swabbing	O	O
in	O	O
children	O	O
with	O	O
leukaemia	O	O
or	O	O
other	O	O
oncological	O	O
diseases	O	O
for	O	O
isolation	O	O
of	O	O
Capnocytophaga	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
.	O	O

Capnocytophaga	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
were	O	O
more	O	O
often	O	O
isolated	O	O
in	O	O
samples	O	O
from	O	O
children	O	O
with	O	O
oncological	O	O
diseases	O	O
(	O	O
71	O	O
%	O	O
)	O	O
other	O	O
than	O	O
leukaemia	O	O
(	O	O
57	O	O
%	O	O
)	O	O
.	O	O

Concomitant	O	O
chemotherapy	O	O
had	O	O
no	O	O
influence	O	O
on	O	O
oral	O	O
Capnocytophaga	B-bacteria	B-bacteria
carriage	O	O
.	O	O

A	O	O
significant	O	O
decrease	O	O
of	O	O
the	O	O
prevalence	O	O
of	O	O
Capnocytophaga	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
isolated	O	O
was	O	O
observed	O	O
in	O	O
children	O	O
who	O	O
received	O	O
antimicrobial	O	O
treatment	O	O
within	O	O
8	O	O
days	O	O
before	O	O
the	O	O
sampling	O	O
procedure	O	O
(	O	O
15.5	O	O
%	O	O
vs.	O	O
28	O	O
%	O	O
)	O	O
.	O	O

But	O	O
,	O	O
the	O	O
incidence	O	O
of	O	O
beta-lactamase-producing	O	O
strains	O	O
was	O	O
not	O	O
linked	O	O
to	O	O
previous	O	O
antimicrobial	O	O
treatments	O	O
.	O	O

Oral	O	O
carriage	O	O
of	O	O
Capnocytophaga	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
can	O	O
be	O	O
linked	O	O
to	O	O
haematological	O	O
disease	O	O
and	O	O
previous	O	O
antibiotherapy	O	O
,	O	O
but	O	O
results	O	O
did	O	O
not	O	O
confirm	O	O
that	O	O
beta-lactamase	O	O
treatments	O	O
exert	O	O
a	O	O
selective	O	O
pressure	O	O
.	O	O

Other	O	O
factors	O	O
might	O	O
be	O	O
involved	O	O
in	O	O
emerging	O	O
for	O	O
oral	O	O
beta-lactamase-producing	B-bacteria	B-bacteria
Capnocytophaga	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
.	O	O

During	O	O
periodontitis	O	O
,	O	O
an	O	O
innate	O	O
immune	O	O
response	O	O
to	O	O
bacterial	O	O
challenge	O	O
is	O	O
primarily	O	O
mediated	O	O
by	O	O
neutrophils	O	O
.	O	O

We	O	O
compared	O	O
neutrophilic	O	O
content	O	O
and	O	O
the	O	O
level	O	O
of	O	O
neutrophil-derived	O	O
antimicrobial	O	O
peptides	O	O
in	O	O
gingival	O	O
crevicular	O	O
fluid	O	O
(	O	O
GCF	O	O
)	O	O
in	O	O
two	O	O
clinical	O	O
forms	O	O
of	O	O
severe	O	O
periodontitis	O	O
.	O	O

GCF	O	O
was	O	O
collected	O	O
from	O	O
14	O	O
patients	O	O
with	O	O
aggressive	O	O
periodontitis	O	O
,	O	O
17	O	O
patients	O	O
with	O	O
chronic	O	O
periodontitis	O	O
,	O	O
and	O	O
nine	O	O
healthy	O	O
subjects	O	O
.	O	O

Samples	O	O
were	O	O
analyzed	O	O
for	O	O
periodontopathogen	O	O
load	O	O
using	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reactions	O	O
.	O	O

The	O	O
amounts	O	O
of	O	O
myeloperoxidase	O	O
and	O	O
alpha-defensins	O	O
(	O	O
HNP1-3	O	O
)	O	O
were	O	O
determined	O	O
by	O	O
enzyme-linked	O	O
immunosorbent	O	O
assay	O	O
,	O	O
and	O	O
the	O	O
level	O	O
of	O	O
cathelicidin	O	O
(	O	O
hCAP18/LL-37	O	O
)	O	O
was	O	O
assayed	O	O
by	O	O
Western	O	O
blot	O	O
.	O	O

Myeloperoxidase	O	O
concentration	O	O
was	O	O
not	O	O
correlated	O	O
with	O	O
levels	O	O
of	O	O
LL-37	O	O
and	O	O
HNP1-3	O	O
in	O	O
samples	O	O
from	O	O
patients	O	O
,	O	O
compared	O	O
to	O	O
controls	O	O
.	O	O

The	O	O
amount	O	O
of	O	O
HNP1-3	O	O
was	O	O
twofold	O	O
and	O	O
fourfold	O	O
higher	O	O
in	O	O
patients	O	O
with	O	O
aggressive	O	O
and	O	O
chronic	O	O
periodontitis	O	O
,	O	O
respectively	O	O
.	O	O

Those	O	O
with	O	O
chronic	O	O
disease	O	O
had	O	O
significantly	O	O
elevated	O	O
amounts	O	O
of	O	O
mature	O	O
LL-37	O	O
.	O	O

The	O	O
increased	O	O
concentration	O	O
of	O	O
both	O	O
peptides	O	O
in	O	O
chronic	O	O
periodontitis	O	O
correlated	O	O
with	O	O
the	O	O
load	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
.	O	O

The	O	O
lack	O	O
of	O	O
a	O	O
correlation	O	O
between	O	O
LL-37	O	O
,	O	O
HNP1-3	O	O
,	O	O
and	O	O
myeloperoxidase	O	O
content	O	O
suggests	O	O
that	O	O
neutrophils	O	O
are	O	O
not	O	O
the	O	O
sole	O	O
source	O	O
of	O	O
these	O	O
bactericidal	O	O
peptides	O	O
in	O	O
the	O	O
GCF	O	O
of	O	O
patients	O	O
with	O	O
periodontitis	O	O
;	O	O
and	O	O
that	O	O
other	O	O
cells	O	O
contribute	O	O
to	O	O
their	O	O
local	O	O
production	O	O
.	O	O

The	O	O
bacterial	O	O
proteases	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
and	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
might	O	O
degrade	O	O
hCAP18/LL-37	O	O
,	O	O
because	O	O
the	O	O
11-kDa	O	O
cathelicidin-derived	O	O
fragment	O	O
was	O	O
present	O	O
in	O	O
GCF	O	O
collected	O	O
from	O	O
pockets	O	O
infected	O	O
with	O	O
these	O	O
bacteria	O	O
.	O	O

Collectively	O	O
,	O	O
it	O	O
appears	O	O
that	O	O
a	O	O
local	O	O
deficiency	O	O
in	O	O
LL-37	O	O
can	O	O
be	O	O
considered	O	O
as	O	O
a	O	O
supporting	O	O
factor	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
severe	O	O
cases	O	O
of	O	O
periodontitis	O	O
.	O	O

Lipoteichoic	O	O
acid	O	O
(	O	O
LTA	O	O
)	O	O
is	O	O
a	O	O
major	O	O
immunostimulating	O	O
component	O	O
in	O	O
the	O	O
cell	O	O
wall	O	O
of	O	O
Gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
as	O	O
lipopolysaccharide	O	O
of	O	O
Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

However	O	O
,	O	O
LTA	O	O
is	O	O
expressed	O	O
on	O	O
not	O	O
only	O	O
pathogenic	O	O
but	O	O
also	O	O
nonpathogenic	O	O
Gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

In	O	O
order	O	O
to	O	O
examine	O	O
whether	O	O
the	O	O
immunostimulating	O	O
potentials	O	O
of	O	O
Gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
are	O	O
correlated	O	O
with	O	O
their	O	O
LTAs	O	O
,	O	O
we	O	O
prepared	O	O
highly	O	O
pure	O	O
LTAs	O	O
from	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	O	O
(	O	O
pathogenic	O	O
)	O	O
,	O	O
Bacillus	B-bacteria	B-bacteria
subtilis	E-bacteria	I-bacteria
(	O	O
non-pathogenic	O	O
)	O	O
,	O	O
or	O	O
Lactobacillus	B-bacteria	B-bacteria
plantarum	E-bacteria	I-bacteria
(	O	O
beneficial	O	O
)	O	O
.	O	O

When	O	O
a	O	O
murine	O	O
macrophage	O	O
cell-line	O	O
,	O	O
RAW	O	O
264.7	O	O
,	O	O
was	O	O
stimulated	O	O
with	O	O
heat-killed	O	O
bacteria	O	O
,	O	O
both	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
and	O	O
B.	B-bacteria	B-bacteria
subtilis	E-bacteria	I-bacteria
induced	O	O
nitric	O	O
oxide	O	O
(	O	O
NO	O	O
)	O	O
production	O	O
in	O	O
a	O	O
dose-dependent	O	O
manner	O	O
while	O	O
L.	B-bacteria	B-bacteria
plantarum	E-bacteria	I-bacteria
showed	O	O
a	O	O
minimal	O	O
induction	O	O
.	O	O

Interestingly	O	O
,	O	O
purified	O	O
LTAs	O	O
from	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
and	O	O
B.	B-bacteria	B-bacteria
subtilis	E-bacteria	I-bacteria
,	O	O
but	O	O
not	O	O
from	O	O
L.	B-bacteria	B-bacteria
plantarum	E-bacteria	I-bacteria
,	O	O
were	O	O
able	O	O
to	O	O
induce	O	O
the	O	O
production	O	O
of	O	O
NO	O	O
.	O	O

The	O	O
differential	O	O
inflammatory	O	O
potentials	O	O
of	O	O
LTAs	O	O
coincided	O	O
with	O	O
their	O	O
abilities	O	O
to	O	O
activate	O	O
Toll-like	O	O
receptor	O	O
2	O	O
(	O	O
TLR2	O	O
)	O	O
,	O	O
which	O	O
is	O	O
known	O	O
to	O	O
recognize	O	O
Gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
LTA	O	O
,	O	O
and	O	O
transcription	O	O
factors	O	O
NF-kappaB	O	O
and	O	O
AP-1	O	O
.	O	O

Similar	O	O
results	O	O
were	O	O
obtained	O	O
with	O	O
the	O	O
expression	O	O
of	O	O
cytokines	O	O
related	O	O
to	O	O
inflammation	O	O
by	O	O
RAW	O	O
264.7	O	O
and	O	O
human	O	O
peripheral	O	O
blood	O	O
mononuclear	O	O
cells	O	O
as	O	O
well	O	O
.	O	O

The	O	O
ability	O	O
of	O	O
LTA	O	O
to	O	O
induce	O	O
TNF-alpha	O	O
and	O	O
NO	O	O
production	O	O
was	O	O
abolished	O	O
when	O	O
the	O	O
LTAs	O	O
were	O	O
treated	O	O
with	O	O
0.2	O	O
N	O	O
NaOH	O	O
.	O	O

Collectively	O	O
,	O	O
we	O	O
suggest	O	O
that	O	O
the	O	O
immunostimulating	O	O
potentials	O	O
of	O	O
Gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
differ	O	O
due	O	O
to	O	O
their	O	O
LTAs	O	O
with	O	O
differential	O	O
potencies	O	O
in	O	O
the	O	O
stimulation	O	O
of	O	O
TLR2	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
test	O	O
the	O	O
hypothesis	O	O
that	O	O
periodontal	O	O
pathogens	O	O
associated	O	O
with	O	O
aggressive	O	O
periodontitis	O	O
persist	O	O
in	O	O
extracrevicular	O	O
locations	O	O
following	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
,	O	O
systemic	O	O
antibiotics	O	O
,	O	O
and	O	O
antimicrobial	O	O
rinses	O	O
.	O	O

Eighteen	O	O
patients	O	O
with	O	O
aggressive	O	O
periodontitis	O	O
received	O	O
a	O	O
clinical	O	O
examination	O	O
during	O	O
which	O	O
samples	O	O
of	O	O
subgingival	O	O
plaque	O	O
and	O	O
buccal	O	O
epithelial	O	O
cells	O	O
were	O	O
obtained	O	O
.	O	O

Treatment	O	O
consisted	O	O
of	O	O
full-mouth	O	O
root	O	O
planing	O	O
,	O	O
systemic	O	O
antibiotics	O	O
,	O	O
and	O	O
chlorhexidine	O	O
rinses	O	O
.	O	O

Clinical	O	O
measurements	O	O
and	O	O
sampling	O	O
were	O	O
repeated	O	O
at	O	O
3	O	O
and	O	O
6	O	O
months	O	O
.	O	O

Quantitative	O	O
polymerase	O	O
chain	O	O
reaction	O	O
determined	O	O
the	O	O
number	O	O
of	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
previously	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
)	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
(	O	O
previously	O	O
T.	B-bacteria	B-bacteria
forsythensis	B-bacteria	B-bacteria
)	O	O
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
in	O	O
the	O	O
plaque	O	O
.	O	O

Fluorescence	O	O
in	O	O
situ	O	O
hybridization	O	O
and	O	O
confocal	O	O
microscopy	O	O
determined	O	O
the	O	O
extent	O	O
of	O	O
intracellular	O	O
invasion	O	O
in	O	O
epithelial	O	O
cells	O	O
.	O	O

Clinical	O	O
measurements	O	O
improved	O	O
significantly	O	O
following	O	O
treatment	O	O
.	O	O

All	O	O
bacterial	O	O
species	O	O
except	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
were	O	O
significantly	O	O
reduced	O	O
in	O	O
plaque	O	O
between	O	O
baseline	O	O
and	O	O
3	O	O
months	O	O
.	O	O

However	O	O
,	O	O
all	O	O
species	O	O
showed	O	O
a	O	O
trend	O	O
to	O	O
repopulate	O	O
between	O	O
3	O	O
and	O	O
6	O	O
months	O	O
.	O	O

This	O	O
increase	O	O
was	O	O
statistically	O	O
significant	O	O
for	O	O
log	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
counts	O	O
.	O	O

All	O	O
species	O	O
were	O	O
detected	O	O
intracellularly	O	O
.	O	O

The	O	O
percentage	O	O
of	O	O
cells	O	O
infected	O	O
intracellularly	O	O
was	O	O
not	O	O
affected	O	O
by	O	O
therapy	O	O
.	O	O

The	O	O
6-month	O	O
increasing	O	O
trend	O	O
in	O	O
the	O	O
levels	O	O
of	O	O
plaque	O	O
bacteria	O	O
suggests	O	O
that	O	O
subgingival	O	O
recolonization	O	O
was	O	O
occurring	O	O
.	O	O

Because	O	O
the	O	O
presence	O	O
of	O	O
these	O	O
species	O	O
within	O	O
epithelial	O	O
cells	O	O
was	O	O
not	O	O
altered	O	O
after	O	O
treatment	O	O
,	O	O
it	O	O
is	O	O
plausible	O	O
that	O	O
recolonization	O	O
may	O	O
occur	O	O
from	O	O
the	O	O
oral	O	O
mucosa	O	O
.	O	O

Systemic	O	O
antibiotics	O	O
and	O	O
topical	O	O
chlorhexidine	O	O
did	O	O
not	O	O
reduce	O	O
the	O	O
percentage	O	O
of	O	O
invaded	O	O
epithelial	O	O
cells	O	O
.	O	O

These	O	O
data	O	O
support	O	O
the	O	O
hypothesis	O	O
that	O	O
extracrevicular	O	O
reservoirs	O	O
of	O	O
bacteria	O	O
exist	O	O
,	O	O
which	O	O
might	O	O
contribute	O	O
to	O	O
recurrent	O	O
or	O	O
refractory	O	O
disease	O	O
in	O	O
some	O	O
patients	O	O
.	O	O

The	O	O
oral	O	O
pathogen	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
has	O	O
been	O	O
shown	O	O
to	O	O
modulate	O	O
apoptosis	O	O
in	O	O
different	O	O
cell	O	O
types	O	O
,	O	O
but	O	O
its	O	O
effect	O	O
on	O	O
epithelial	O	O
cells	O	O
remains	O	O
unclear	O	O
.	O	O

We	O	O
demonstrate	O	O
that	O	O
primary	O	O
human	O	O
gingival	O	O
epithelial	O	O
cells	O	O
(	O	O
HGECs	O	O
)	O	O
challenged	O	O
with	O	O
live	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
for	O	O
24	O	O
hours	O	O
exhibit	O	O
apoptosis	O	O
,	O	O
and	O	O
we	O	O
characterize	O	O
this	O	O
by	O	O
M30	O	O
epitope	O	O
detection	O	O
,	O	O
caspase-3	O	O
activity	O	O
,	O	O
DNA	O	O
fragmentation	O	O
and	O	O
Annexin-V	O	O
staining	O	O
.	O	O

Live	O	O
bacteria	O	O
strongly	O	O
upregulated	O	O
intrinsic	O	O
and	O	O
extrinsic	O	O
apoptotic	O	O
pathways	O	O
.	O	O

Pro-apoptotic	O	O
molecules	O	O
such	O	O
as	O	O
caspase-3	O	O
,	O	O
-8	O	O
,	O	O
-9	O	O
,	O	O
Bid	O	O
and	O	O
Bax	O	O
were	O	O
upregulated	O	O
after	O	O
24	O	O
hours	O	O
.	O	O

The	O	O
anti-apoptotic	O	O
Bcl-2	O	O
was	O	O
also	O	O
upregulated	O	O
,	O	O
but	O	O
this	O	O
was	O	O
not	O	O
sufficient	O	O
to	O	O
ensure	O	O
cell	O	O
survival	O	O
.	O	O

The	O	O
main	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
proteases	O	O
arginine	O	O
and	O	O
lysine	O	O
gingipains	O	O
are	O	O
necessary	O	O
and	O	O
sufficient	O	O
to	O	O
induce	O	O
host	O	O
cell	O	O
apoptosis	O	O
.	O	O

Thus	O	O
,	O	O
live	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
can	O	O
invoke	O	O
gingival	O	O
epithelial	O	O
cell	O	O
apoptosis	O	O
in	O	O
a	O	O
time	O	O
and	O	O
dose	O	O
dependent	O	O
manner	O	O
with	O	O
significant	O	O
apoptosis	O	O
occurring	O	O
between	O	O
12	O	O
and	O	O
24	O	O
hours	O	O
of	O	O
challenge	O	O
via	O	O
a	O	O
gingipain-dependent	O	O
mechanism	O	O
.	O	O

The	O	O
present	O	O
study	O	O
provides	O	O
evidence	O	O
that	O	O
live	O	O
,	O	O
but	O	O
not	O	O
heat-killed	O	O
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	B-bacteria	B-bacteria
can	O	O
induce	O	O
apoptosis	O	O
after	O	O
24	O	O
hours	O	O
of	O	O
challenge	O	O
in	O	O
primary	O	O
human	O	O
gingival	O	O
epithelial	O	O
cells	O	O
.	O	O

Either	O	O
arginine	O	O
or	O	O
lysine	O	O
gingipains	O	O
are	O	O
necessary	O	O
and	O	O
sufficient	O	O
factors	O	O
in	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
elicited	O	O
apoptosis	O	O
.	O	O

This	O	O
study	O	O
covers	O	O
phase	O	O
IV	O	O
of	O	O
a	O	O
prospective	O	O
clinical	O	O
long-term	O	O
study	O	O
.	O	O

Objective	O	O
of	O	O
this	O	O
clinical	O	O
investigation	O	O
was	O	O
to	O	O
analyze	O	O
the	O	O
effects	O	O
of	O	O
a	O	O
long-term	O	O
prevention	O	O
program	O	O
on	O	O
dental	O	O
and	O	O
oral	O	O
health	O	O
of	O	O
teenagers	O	O
at	O	O
the	O	O
age	O	O
of	O	O
13	O	O
to	O	O
14	O	O
years	O	O
.	O	O

The	O	O
entire	O	O
study	O	O
was	O	O
subdivided	O	O
into	O	O
four	O	O
phases	O	O
.	O	O

Phase	O	O
I	O	O
comprised	O	O
an	O	O
individual	O	O
preventive	O	O
care	O	O
during	O	O
pregnancy	O	O
(	O	O
``	O	O
primary-primary	O	O
prevention	O	O
''	O	O
)	O	O
;	O	O
phase	O	O
II	O	O
assessed	O	O
mothers	O	O
and	O	O
their	O	O
young	O	O
children	O	O
until	O	O
the	O	O
age	O	O
of	O	O
3	O	O
years	O	O
(	O	O
``	O	O
primary	O	O
prevention	O	O
''	O	O
)	O	O
;	O	O
and	O	O
in	O	O
phase	O	O
III	O	O
,	O	O
mothers	O	O
and	O	O
children	O	O
at	O	O
the	O	O
age	O	O
of	O	O
6	O	O
years	O	O
were	O	O
investigated	O	O
.	O	O

In	O	O
phase	O	O
IV	O	O
of	O	O
the	O	O
study	O	O
,	O	O
the	O	O
oral	O	O
health	O	O
of	O	O
13-	O	O
to	O	O
14-year-old	O	O
teenagers	O	O
was	O	O
examined	O	O
(	O	O
13.4	O	O
+/-	O	O
0.5	O	O
years	O	O
;	O	O
n	O	O
=	O	O
29	O	O
)	O	O
.	O	O

All	O	O
phases	O	O
consisted	O	O
of	O	O
an	O	O
examination	O	O
,	O	O
education	O	O
about	O	O
oral	O	O
health	O	O
care	O	O
,	O	O
and	O	O
treatment	O	O
based	O	O
on	O	O
the	O	O
concept	O	O
of	O	O
an	O	O
early	O	O
oral	O	O
health	O	O
care	O	O
promotion	O	O
.	O	O

The	O	O
control	O	O
group	O	O
consisted	O	O
of	O	O
randomly	O	O
selected	O	O
adolescents	O	O
at	O	O
the	O	O
same	O	O
age	O	O
(	O	O
n	O	O
=	O	O
30	O	O
)	O	O
.	O	O

The	O	O
following	O	O
clinical	O	O
parameters	O	O
were	O	O
assessed	O	O
:	O	O
decayed/missing/filled	O	O
teeth	O	O
(	O	O
DMF-T	O	O
)	O	O
/decayed	O	O
,	O	O
missing	O	O
,	O	O
and	O	O
filled	O	O
surface	O	O
teeth	O	O
index	O	O
,	O	O
hygiene	O	O
index	O	O
,	O	O
papilla	O	O
bleeding	O	O
index	O	O
,	O	O
Periodontal	O	O
Screening	O	O
Index	O	O
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans/Lactobacillus	E-bacteria	I-bacteria
concentration	O	O
in	O	O
saliva	O	O
.	O	O

The	O	O
teenagers	O	O
of	O	O
the	O	O
``	O	O
prevention	O	O
''	O	O
group	O	O
of	O	O
phase	O	O
IV	O	O
of	O	O
our	O	O
prospective	O	O
study	O	O
revealed	O	O
a	O	O
share	O	O
of	O	O
89.7	O	O
%	O	O
caries-free	O	O
dentitions	O	O
(	O	O
65.5	O	O
%	O	O
sound	O	O
;	O	O
24.2	O	O
%	O	O
caries-free	O	O
with	O	O
fillings	O	O
)	O	O
.	O	O

Mean	O	O
DMF-T	O	O
was	O	O
0.55	O	O
+/-	O	O
1.0	O	O
.	O	O

The	O	O
control	O	O
group	O	O
showed	O	O
a	O	O
significantly	O	O
higher	O	O
mean	O	O
DMF-T	O	O
of	O	O
1.5	O	O
+/-	O	O
1.5	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
and	O	O
revealed	O	O
56.7	O	O
%	O	O
of	O	O
caries-free	O	O
dentitions	O	O
(	O	O
30	O	O
%	O	O
sound	O	O
,	O	O
26.7	O	O
%	O	O
caries-free	O	O
with	O	O
restorations	O	O
)	O	O
.	O	O

Our	O	O
data	O	O
clearly	O	O
document	O	O
that	O	O
an	O	O
early	O	O
oral	O	O
health	O	O
care	O	O
promotion	O	O
starting	O	O
during	O	O
pregnancy	O	O
may	O	O
cause	O	O
a	O	O
sustained	O	O
and	O	O
long-term	O	O
improvement	O	O
of	O	O
the	O	O
oral	O	O
health	O	O
of	O	O
children	O	O
.	O	O

The	O	O
arginine	O	O
deiminase	O	O
system	O	O
(	O	O
ADS	O	O
)	O	O
of	O	O
oral	O	O
bacteria	O	O
is	O	O
a	O	O
major	O	O
generator	O	O
of	O	O
alkali	O	O
(	O	O
ammonia	O	O
)	O	O
in	O	O
dental	O	O
plaque	O	O
and	O	O
is	O	O
considered	O	O
to	O	O
have	O	O
anticaries	O	O
effects	O	O
.	O	O

However	O	O
,	O	O
many	O	O
of	O	O
the	O	O
antimicrobial	O	O
agents	O	O
used	O	O
in	O	O
oral	O	O
care	O	O
products	O	O
may	O	O
reduce	O	O
alkali	O	O
production	O	O
by	O	O
the	O	O
ADS	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
our	O	O
work	O	O
was	O	O
to	O	O
assess	O	O
the	O	O
sensitivity	O	O
of	O	O
the	O	O
ADS	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
to	O	O
commonly	O	O
used	O	O
antimicrobials	O	O
,	O	O
fluoride	O	O
,	O	O
triclosan	O	O
and	O	O
organic	O	O
weak	O	O
acids	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
sanguinis	I-bacteria	I-bacteria
NCTC	I-bacteria	I-bacteria
10904	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
ratti	I-bacteria	I-bacteria
FA-1	E-bacteria	I-bacteria
were	O	O
grown	O	O
in	O	O
suspension	O	O
cultures	O	O
and	O	O
mono-organism	O	O
biofilms	O	O
.	O	O

ADS	O	O
activity	O	O
at	O	O
pH	O	O
values	O	O
of	O	O
4	O	O
,	O	O
5	O	O
and	O	O
6	O	O
was	O	O
assessed	O	O
,	O	O
and	O	O
the	O	O
actions	O	O
of	O	O
the	O	O
agents	O	O
was	O	O
determined	O	O
in	O	O
terms	O	O
of	O	O
reduced	O	O
production	O	O
of	O	O
alkali	O	O
from	O	O
arginine	O	O
,	O	O
inhibition	O	O
of	O	O
ADS	O	O
enzymes	O	O
and	O	O
changes	O	O
in	O	O
uptake	O	O
of	O	O
arginine	O	O
.	O	O

ADS	O	O
activity	O	O
was	O	O
not	O	O
greatly	O	O
affected	O	O
by	O	O
pH	O	O
changes	O	O
between	O	O
4	O	O
and	O	O
6	O	O
and	O	O
was	O	O
greater	O	O
per	O	O
unit	O	O
of	O	O
biomass	O	O
for	O	O
cell	O	O
suspensions	O	O
than	O	O
for	O	O
biofilms	O	O
.	O	O

NaF	O	O
was	O	O
a	O	O
poor	O	O
inhibitor	O	O
,	O	O
while	O	O
triclosan	O	O
was	O	O
highly	O	O
effective	O	O
with	O	O
a	O	O
50	O	O
%	O	O
inhibitory	O	O
dose	O	O
for	O	O
the	O	O
two	O	O
organisms	O	O
between	O	O
0.03	O	O
and	O	O
0.05	O	O
and	O	O
between	O	O
0.10	O	O
and	O	O
0.15	O	O
mm-h	O	O
for	O	O
suspension	O	O
cells	O	O
and	O	O
biofilms	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
weak	O	O
acid	O	O
indomethacin	O	O
was	O	O
nearly	O	O
as	O	O
potent	O	O
at	O	O
pH	O	O
4.0	O	O
as	O	O
triclosan	O	O
,	O	O
while	O	O
capric	O	O
and	O	O
lauric	O	O
acids	O	O
were	O	O
less	O	O
potent	O	O
,	O	O
especially	O	O
for	O	O
biofilms	O	O
.	O	O

The	O	O
methyl	O	O
ester	O	O
of	O	O
lauric	O	O
acid	O	O
was	O	O
slightly	O	O
stimulatory	O	O
.	O	O

The	O	O
major	O	O
targets	O	O
for	O	O
the	O	O
inhibitors	O	O
appeared	O	O
to	O	O
be	O	O
transport	O	O
systems	O	O
for	O	O
arginine	O	O
uptake	O	O
,	O	O
although	O	O
carbamate	O	O
kinase	O	O
was	O	O
a	O	O
secondary	O	O
target	O	O
.	O	O

Triclosan	O	O
,	O	O
indomethacin	O	O
,	O	O
caprate	O	O
and	O	O
laurate	O	O
can	O	O
reduce	O	O
ADS	O	O
activity	O	O
in	O	O
dental	O	O
plaque	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
the	O	O
prevalence	O	O
of	O	O
select	O	O
microorganisms	O	O
in	O	O
oral	O	O
biofilms	O	O
and	O	O
to	O	O
investigate	O	O
relationships	O	O
between	O	O
oral	O	O
and	O	O
respiratory	O	O
status	O	O
in	O	O
persons	O	O
with	O	O
mental	O	O
retardation/intellectual	O	O
and	O	O
developmental	O	O
disabilities	O	O
(	O	O
IDD	O	O
)	O	O
.	O	O

We	O	O
conducted	O	O
a	O	O
6-month-long	O	O
observational	O	O
cohort	O	O
study	O	O
with	O	O
63	O	O
persons	O	O
with	O	O
IDD	O	O
.	O	O

Oral	O	O
examinations	O	O
,	O	O
oral	O	O
sampling	O	O
,	O	O
and	O	O
medical	O	O
record	O	O
reviews	O	O
were	O	O
performed	O	O
at	O	O
baseline	O	O
and	O	O
then	O	O
monthly	O	O
.	O	O

Polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
was	O	O
used	O	O
to	O	O
analyze	O	O
all	O	O
baseline	O	O
oral	O	O
samples	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
,	O	O
Methicillin-resistant	B-bacteria	B-bacteria
Staphylococcus	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
MRSA	B-bacteria	B-bacteria
)	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
,	O	O
and	O	O
Candida	O	O
albicans	O	O
.	O	O

PCR	O	O
analyses	O	O
were	O	O
also	O	O
performed	O	O
on	O	O
participants	O	O
'	O	O
samples	O	O
collected	O	O
in	O	O
the	O	O
month	O	O
before	O	O
being	O	O
diagnosed	O	O
with	O	O
a	O	O
respiratory	O	O
infection	O	O
.	O	O

All	O	O
subjects	O	O
had	O	O
P.	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
detected	O	O
by	O	O
PCR	O	O
in	O	O
their	O	O
oral	O	O
samples	O	O
.	O	O

Fifty-five	O	O
percent	O	O
(	O	O
35	O	O
of	O	O
63	O	O
)	O	O
of	O	O
participants	O	O
had	O	O
S.	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
,	O	O
MRSA	B-bacteria	B-bacteria
,	O	O
and	O	O
C.	O	O
albicans	O	O
in	O	O
their	O	O
oral	O	O
samples	O	O
at	O	O
baseline	O	O
.	O	O

No	O	O
dental	O	O
decay	O	O
was	O	O
detected	O	O
clinically	O	O
,	O	O
oral	O	O
hygiene	O	O
was	O	O
fair	O	O
,	O	O
and	O	O
dysphagia	O	O
was	O	O
common	O	O
.	O	O

During	O	O
the	O	O
6	O	O
months	O	O
of	O	O
the	O	O
study	O	O
,	O	O
there	O	O
were	O	O
22	O	O
respiratory	O	O
infections	O	O
(	O	O
35	O	O
%	O	O
of	O	O
participants	O	O
)	O	O
-12	O	O
pneumonias	O	O
,	O	O
7	O	O
sinusitis	O	O
,	O	O
1	O	O
bronchitis	O	O
,	O	O
and	O	O
1	O	O
upper	O	O
respiratory	O	O
tract	O	O
infection	O	O
.	O	O

Participants	O	O
with	O	O
microorganisms	O	O
in	O	O
their	O	O
baseline	O	O
samples	O	O
were	O	O
significantly	O	O
more	O	O
likely	O	O
to	O	O
develop	O	O
any	O	O
respiratory	O	O
infection	O	O
and	O	O
those	O	O
who	O	O
had	O	O
poor	O	O
oral	O	O
status	O	O
were	O	O
significantly	O	O
more	O	O
likely	O	O
to	O	O
develop	O	O
pneumonia	O	O
.	O	O

Almost	O	O
60	O	O
%	O	O
of	O	O
participants	O	O
who	O	O
developed	O	O
respiratory	O	O
infections	O	O
had	O	O
the	O	O
same	O	O
microorganism	O	O
detected	O	O
in	O	O
the	O	O
sample	O	O
collected	O	O
in	O	O
the	O	O
month	O	O
before	O	O
infection	O	O
as	O	O
had	O	O
been	O	O
detected	O	O
in	O	O
their	O	O
baseline	O	O
sample	O	O
.	O	O

Potentially	O	O
pathogenic	O	O
microorganisms	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
poor	O	O
oral	O	O
status	O	O
significantly	O	O
increased	O	O
the	O	O
risk	O	O
of	O	O
developing	O	O
respiratory	O	O
infections	O	O
,	O	O
including	O	O
pneumonia	O	O
,	O	O
in	O	O
persons	O	O
with	O	O
IDD	O	O
.	O	O

The	O	O
results	O	O
suggest	O	O
that	O	O
colonization	O	O
with	O	O
these	O	O
microorganisms	O	O
may	O	O
persist	O	O
despite	O	O
routine	O	O
tooth	O	O
brushing	O	O
.	O	O

Meticulous	O	O
comprehensive	O	O
oral	O	O
hygiene	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
may	O	O
be	O	O
needed	O	O
to	O	O
reduce	O	O
oropharyngeal	O	O
microbial	O	O
load	O	O
.	O	O

The	O	O
aim	O	O
was	O	O
to	O	O
study	O	O
the	O	O
oral	O	O
carriage	O	O
of	O	O
Enterococcus	B-bacteria	B-bacteria
and	O	O
Escherichia	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
and	O	O
their	O	O
content	O	O
in	O	O
antimicrobial-resistance	O	O
and	O	O
virulence	O	O
genes	O	O
in	O	O
patients	O	O
with	O	O
fixed	O	O
appliances	O	O
and	O	O
in	O	O
healthy	O	O
volunteers	O	O
.	O	O

STUDY	O	O
Samples	O	O
from	O	O
supragingival	O	O
plaques/tooth	O	O
surfaces/fixed	O	O
orthodontic	O	O
appliances	O	O
were	O	O
taken	O	O
in	O	O
patients	O	O
with	O	O
fixed	O	O
appliances	O	O
(	O	O
n	O	O
=	O	O
46	O	O
)	O	O
and	O	O
in	O	O
healthy	O	O
volunteers	O	O
(	O	O
n	O	O
=	O	O
55	O	O
)	O	O
.	O	O

Samples	O	O
were	O	O
seeded	O	O
on	O	O
specific	O	O
media	O	O
for	O	O
enterococcal	O	O
and	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
recovery	O	O
,	O	O
and	O	O
1	O	O
isolate	O	O
of	O	O
each	O	O
type	O	O
per	O	O
sample	O	O
was	O	O
selected	O	O
.	O	O

Antimicrobial	O	O
susceptibility	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
genes	O	O
encoding	O	O
antimicrobial	O	O
resistance	O	O
,	O	O
bacteriocins	O	O
,	O	O
and	O	O
virulence	O	O
factors	O	O
were	O	O
checked	O	O
by	O	O
polymerase	O	O
chain	O	O
reaction	O	O
.	O	O

Enterococci	B-bacteria	B-bacteria
or	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
were	O	O
not	O	O
recovered	O	O
from	O	O
healthy	O	O
volunteers	O	O
.	O	O

Nevertheless	O	O
,	O	O
10	O	O
isolates	O	O
(	O	O
5	O	O
E.	B-bacteria	B-bacteria
faecium	E-bacteria	I-bacteria
,	O	O
3	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
and	O	O
2	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
)	O	O
were	O	O
obtained	O	O
from	O	O
19.5	O	O
%	O	O
of	O	O
patients	O	O
with	O	O
fixed	O	O
appliances	O	O
,	O	O
and	O	O
poor	O	O
oral	O	O
hygiene	O	O
was	O	O
evidenced	O	O
in	O	O
all	O	O
of	O	O
the	O	O
these	O	O
patients	O	O
.	O	O

Percentages	O	O
of	O	O
antimicrobial	O	O
resistance	O	O
and	O	O
the	O	O
resistance	O	O
genes	O	O
detected	O	O
among	O	O
the	O	O
enterococci	B-bacteria	B-bacteria
were	O	O
:	O	O
erythromycin	O	O
:	O	O
100	O	O
%	O	O
,	O	O
erm	O	O
(	O	O
B	O	O
)	O	O
;	O	O
kanamycin	O	O
:	O	O
75	O	O
%	O	O
,	O	O
aph	O	O
(	O	O
3	O	O
'	O	O
)	O	O
-IIIa	O	O
;	O	O
tetracycline	O	O
:	O	O
50	O	O
%	O	O
,	O	O
tet	O	O
(	O	O
L	O	O
)	O	O
with/without	O	O
tet	O	O
(	O	O
M	O	O
)	O	O
;	O	O
streptomycin	O	O
:	O	O
37	O	O
%	O	O
,	O	O
ant	O	O
(	O	O
6	O	O
)	O	O
-Ia	O	O
;	O	O
chloramphenicol	O	O
:	O	O
12	O	O
%	O	O
,	O	O
catA	O	O
.	O	O

One	O	O
E.	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
isolate	E-bacteria	I-bacteria
showed	O	O
a	O	O
phenotype	O	O
of	O	O
multiresistance	O	O
containing	O	O
5	O	O
resistance	O	O
genes	O	O
and	O	O
class	O	O
1	O	O
and	O	O
2	O	O
integrons	O	O
.	O	O

All	O	O
enterococci	B-bacteria	B-bacteria
produced	O	O
gelatinase	O	O
,	O	O
and	O	O
4	O	O
isolates	O	O
contained	O	O
genes	O	O
encoding	O	O
enterocins	O	O
L50A/B	O	O
and	O	O
P.	O	O
The	O	O
esp	O	O
virulence	O	O
gene	O	O
was	O	O
found	O	O
in	O	O
1	O	O
multiresistant	O	O
E.	B-bacteria	B-bacteria
faecalis	I-bacteria	I-bacteria
isolate	E-bacteria	I-bacteria
.	O	O

Poor	O	O
or	O	O
improper	O	O
oral	O	O
hygiene	O	O
in	O	O
individuals	O	O
with	O	O
fixed	O	O
appliances	O	O
favors	O	O
the	O	O
oral	O	O
carriage	O	O
of	O	O
antimicrobial-resistant	B-bacteria	B-bacteria
E.	I-bacteria	I-bacteria
coli	E-bacteria	I-bacteria
and	O	O
enterococci	B-bacteria	B-bacteria
.	O	O

Additional	O	O
investigations	O	O
are	O	O
needed	O	O
to	O	O
assess	O	O
its	O	O
implication	O	O
in	O	O
human	O	O
health	O	O
.	O	O

Vaccination	O	O
against	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
is	O	O
a	O	O
desirable	O	O
,	O	O
yet	O	O
challenging	O	O
strategy	O	O
for	O	O
prevention	O	O
of	O	O
airway	O	O
infection	O	O
in	O	O
patients	O	O
with	O	O
cystic	O	O
fibrosis	O	O
.	O	O

We	O	O
compared	O	O
the	O	O
formation	O	O
of	O	O
antibodies	O	O
in	O	O
lower	O	O
airways	O	O
induced	O	O
by	O	O
systemic	O	O
and	O	O
mucosal	O	O
vaccination	O	O
strategies	O	O
.	O	O

We	O	O
immunised	O	O
48	O	O
volunteers	O	O
in	O	O
six	O	O
vaccination	O	O
groups	O	O
with	O	O
either	O	O
a	O	O
systemic	O	O
,	O	O
a	O	O
nasal	O	O
,	O	O
or	O	O
four	O	O
newly	O	O
constructed	O	O
oral	O	O
live	O	O
vaccines	O	O
based	O	O
on	O	O
attenuated	O	O
live	O	O
Salmonella	B-bacteria	B-bacteria
(	O	O
strains	B-bacteria	B-bacteria
CVD908	E-bacteria	I-bacteria
and	O	O
Ty21a	B-bacteria	B-bacteria
)	O	O
,	O	O
followed	O	O
by	O	O
a	O	O
systemic	O	O
booster	O	O
vaccination	O	O
.	O	O

All	O	O
vaccines	O	O
were	O	O
based	O	O
on	O	O
a	O	O
recombinant	O	O
fusion	O	O
protein	O	O
of	O	O
the	O	O
highly	O	O
conserved	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
outer	O	O
membrane	O	O
proteins	O	O
OprF	O	O
and	O	O
OprI	O	O
as	O	O
antigen	O	O
.	O	O

While	O	O
systemic	O	O
and	O	O
mucosal	O	O
vaccines	O	O
induced	O	O
a	O	O
comparable	O	O
rise	O	O
of	O	O
serum	O	O
antibody	O	O
titers	O	O
,	O	O
a	O	O
significant	O	O
rise	O	O
of	O	O
IgA	O	O
and	O	O
IgG	O	O
antibodies	O	O
in	O	O
the	O	O
lower	O	O
airways	O	O
was	O	O
noted	O	O
only	O	O
after	O	O
nasal	O	O
and	O	O
oral	O	O
vaccinations	O	O
.	O	O

We	O	O
conclude	O	O
that	O	O
nasal	O	O
and	O	O
oral	O	O
OprF-OprI	O	O
vaccines	O	O
are	O	O
promising	O	O
candidates	O	O
for	O	O
development	O	O
of	O	O
antipseudomonal	O	O
immunisation	O	O
through	O	O
inducing	O	O
a	O	O
specific	O	O
antibody	O	O
response	O	O
in	O	O
the	O	O
lung	O	O
.	O	O

Periodontal	O	O
diseases	O	O
(	O	O
PDs	O	O
)	O	O
are	O	O
infectious	O	O
diseases	O	O
in	O	O
which	O	O
periodontopathogens	O	O
trigger	O	O
chronic	O	O
inflammatory	O	O
and	O	O
immune	O	O
responses	O	O
that	O	O
lead	O	O
to	O	O
tissue	O	O
destruction	O	O
.	O	O

Recently	O	O
,	O	O
viruses	O	O
have	O	O
been	O	O
implicated	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
PDs	O	O
.	O	O

Individuals	O	O
infected	O	O
with	O	O
human	O	O
T	O	O
lymphotropic	O	O
virus	O	O
1	O	O
(	O	O
HTLV-1	O	O
)	O	O
present	O	O
with	O	O
abnormal	O	O
oral	O	O
health	O	O
and	O	O
a	O	O
marked	O	O
increased	O	O
prevalence	O	O
of	O	O
periodontal	O	O
disease	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
investigated	O	O
the	O	O
patterns	O	O
of	O	O
periodontopathogen	O	O
infection	O	O
and	O	O
local	O	O
inflammatory	O	O
immune	O	O
markers	O	O
in	O	O
HTLV-1-seropositive	O	O
individuals	O	O
with	O	O
chronic	O	O
periodontitis	O	O
(	O	O
CP/HTLV-1	O	O
group	O	O
)	O	O
compared	O	O
with	O	O
HTLV-1-seronegative	O	O
individuals	O	O
with	O	O
chronic	O	O
periodontitis	O	O
(	O	O
CP	O	O
group	O	O
)	O	O
and	O	O
periodontally	O	O
healthy	O	O
,	O	O
HTLV-1-seronegative	O	O
individuals	O	O
(	O	O
control	O	O
group	O	O
)	O	O
.	O	O

Patients	O	O
in	O	O
the	O	O
CP/HTLV-1	O	O
group	O	O
had	O	O
significantly	O	O
higher	O	O
values	O	O
of	O	O
bleeding	O	O
on	O	O
probing	O	O
,	O	O
mean	O	O
probing	O	O
depth	O	O
,	O	O
and	O	O
attachment	O	O
loss	O	O
than	O	O
patients	O	O
in	O	O
the	O	O
CP	O	O
group	O	O
.	O	O

The	O	O
expression	O	O
of	O	O
tumor	O	O
necrosis	O	O
factor	O	O
alpha	O	O
and	O	O
interleukin	O	O
(	O	O
IL	O	O
)	O	O
4	O	O
was	O	O
found	O	O
to	O	O
be	O	O
similar	O	O
in	O	O
the	O	O
CP	O	O
and	O	O
CP/HTLV-1	O	O
groups	O	O
,	O	O
whereas	O	O
IL-12	O	O
and	O	O
IL-17	O	O
levels	O	O
trended	O	O
toward	O	O
a	O	O
higher	O	O
expression	O	O
in	O	O
the	O	O
CP/HTLV-1	O	O
group	O	O
.	O	O

A	O	O
significant	O	O
increase	O	O
was	O	O
seen	O	O
in	O	O
the	O	O
levels	O	O
of	O	O
IL-1beta	O	O
and	O	O
interferon	O	O
gamma	O	O
in	O	O
the	O	O
CP/HTLV-1	O	O
group	O	O
compared	O	O
with	O	O
the	O	O
CP	O	O
group	O	O
,	O	O
whereas	O	O
expression	O	O
of	O	O
the	O	O
regulatory	O	O
T	O	O
cell	O	O
marker	O	O
FOXp3	O	O
and	O	O
IL-10	O	O
was	O	O
significantly	O	O
decreased	O	O
in	O	O
the	O	O
lesions	O	O
from	O	O
the	O	O
CP/HTLV-1	O	O
group	O	O
.	O	O

Interestingly	O	O
,	O	O
similar	O	O
frequency	O	O
and/or	O	O
load	O	O
of	O	O
periodontopathogens	O	O
(	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
and	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
)	O	O
and	O	O
frequency	O	O
of	O	O
viruses	O	O
(	O	O
herpes	O	O
simplex	O	O
virus	O	O
1	O	O
,	O	O
human	O	O
cytomegalovirus	O	O
,	O	O
and	O	O
Epstein-Barr	O	O
virus	O	O
)	O	O
characteristically	O	O
associated	O	O
with	O	O
PDs	O	O
were	O	O
found	O	O
in	O	O
the	O	O
CP/HTLV	O	O
and	O	O
CP	O	O
groups	O	O
.	O	O

HTLV-1	O	O
may	O	O
play	O	O
a	O	O
critical	O	O
role	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
periodontal	O	O
disease	O	O
through	O	O
the	O	O
deregulation	O	O
of	O	O
the	O	O
local	O	O
cytokine	O	O
network	O	O
,	O	O
resulting	O	O
in	O	O
an	O	O
exacerbated	O	O
response	O	O
against	O	O
a	O	O
standard	O	O
periodontopathogen	O	O
infection	O	O
.	O	O

It	O	O
is	O	O
well	O	O
established	O	O
that	O	O
severe	O	O
periodontitis	O	O
clusters	O	O
in	O	O
families	O	O
,	O	O
but	O	O
there	O	O
are	O	O
no	O	O
data	O	O
about	O	O
the	O	O
relationship	O	O
between	O	O
mothers	O	O
with	O	O
chronic	O	O
periodontitis	O	O
and	O	O
their	O	O
children	O	O
's	O	O
periodontal	O	O
status	O	O
.	O	O

To	O	O
evaluate	O	O
a	O	O
risk	O	O
for	O	O
periodontal	O	O
diseases	O	O
in	O	O
children	O	O
of	O	O
periodontally	O	O
diseased	O	O
and	O	O
healthy	O	O
mothers	O	O
.	O	O

Four	O	O
study	O	O
groups	O	O
were	O	O
included	O	O
:	O	O
(	O	O
I	O	O
)	O	O
20	O	O
female	O	O
patients	O	O
with	O	O
untreated	O	O
generalized	O	O
severe	O	O
chronic	O	O
periodontitis	O	O
,	O	O
(	O	O
II	O	O
)	O	O
their	O	O
children	O	O
(	O	O
34	O	O
)	O	O
,	O	O
(	O	O
III	O	O
)	O	O
13	O	O
periodontally	O	O
healthy	O	O
mothers	O	O
and	O	O
(	O	O
IV	O	O
)	O	O
their	O	O
children	O	O
(	O	O
13	O	O
)	O	O
.	O	O

Material	O	O
was	O	O
collected	O	O
from	O	O
years	O	O
2004-2006	O	O
.	O	O

The	O	O
clinical	O	O
examination	O	O
included	O	O
registration	O	O
of	O	O
visible	O	O
plaque	O	O
index	O	O
,	O	O
modified	O	O
gingival	O	O
index	O	O
and	O	O
,	O	O
bleeding	O	O
sites	O	O
on	O	O
probing	O	O
.	O	O

Periodontal	O	O
microbiological	O	O
samples	O	O
were	O	O
obtained	O	O
from	O	O
all	O	O
study	O	O
subjects	O	O
and	O	O
the	O	O
isolates	O	O
were	O	O
identified	O	O
according	O	O
to	O	O
morphology	O	O
and	O	O
biochemical	O	O
profiles	O	O
;	O	O
similar	O	O
interfamilial	O	O
pathogens	O	O
were	O	O
compared	O	O
by	O	O
PCR-technique	O	O
.	O	O

The	O	O
children	O	O
of	O	O
diseased	O	O
mothers	O	O
more	O	O
frequently	O	O
had	O	O
periodontal	O	O
diseases	O	O
,	O	O
especially	O	O
gingivitis	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
clinical	O	O
parameters	O	O
of	O	O
gingival	O	O
inflammation	O	O
were	O	O
more	O	O
expressed	O	O
and	O	O
oral	O	O
hygiene	O	O
was	O	O
worse	O	O
in	O	O
this	O	O
group	O	O
of	O	O
children	O	O
.	O	O

VPI	O	O
and	O	O
VPI	O	O
%	O	O
of	O	O
the	O	O
diseased	O	O
and	O	O
healthy	O	O
mothers	O	O
differed	O	O
significantly	O	O
.	O	O

The	O	O
most	O	O
common	O	O
oral	O	O
pathogens	O	O
were	O	O
P.	B-bacteria	B-bacteria
intermedia/nigrescens	E-bacteria	I-bacteria
and	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
.	O	O

The	O	O
children	O	O
of	O	O
healthy	O	O
mothers	O	O
harboured	O	O
pathogens	O	O
less	O	O
frequently	O	O
than	O	O
the	O	O
children	O	O
of	O	O
diseased	O	O
mothers	O	O
.	O	O

The	O	O
sharing	O	O
of	O	O
P.	B-bacteria	B-bacteria
intermedia/nigrescens	E-bacteria	I-bacteria
was	O	O
more	O	O
frequent	O	O
(	O	O
5	O	O
families	O	O
)	O	O
than	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
2	O	O
families	O	O
)	O	O
.	O	O

Maternal	O	O
indicators	O	O
,	O	O
such	O	O
as	O	O
periodontitis	O	O
,	O	O
hygiene	O	O
habits	O	O
,	O	O
and	O	O
periodontal	O	O
microflora	O	O
are	O	O
risk	O	O
factors	O	O
for	O	O
childhood	O	O
periodontal	O	O
diseases	O	O
,	O	O
and	O	O
might	O	O
be	O	O
predictive	O	O
of	O	O
future	O	O
childhood	O	O
and	O	O
adolescent	O	O
periodontitis	O	O
.	O	O

A-type	O	O
cranberry	O	O
proanthocyanidins	O	O
(	O	O
AC-PACs	O	O
)	O	O
have	O	O
recently	O	O
been	O	O
reported	O	O
to	O	O
be	O	O
beneficial	O	O
for	O	O
human	O	O
health	O	O
,	O	O
especially	O	O
urinary	O	O
tract	O	O
health	O	O
.	O	O

The	O	O
effect	O	O
of	O	O
these	O	O
proanthocyanidins	O	O
on	O	O
periodontitis	O	O
,	O	O
a	O	O
destructive	O	O
disease	O	O
of	O	O
tooth-supporting	O	O
tissues	O	O
,	O	O
needs	O	O
to	O	O
be	O	O
investigated	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
effects	O	O
of	O	O
AC-PACs	O	O
on	O	O
various	O	O
virulence	O	O
determinants	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
as	O	O
well	O	O
as	O	O
on	O	O
the	O	O
inflammatory	O	O
response	O	O
of	O	O
oral	O	O
epithelial	O	O
cells	O	O
stimulated	O	O
by	O	O
this	O	O
periodontopathogen	O	O
.	O	O

We	O	O
examined	O	O
the	O	O
effects	O	O
of	O	O
AC-PACs	O	O
on	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
growth	O	O
and	O	O
biofilm	O	O
formation	O	O
,	O	O
adherence	O	O
to	O	O
human	O	O
oral	O	O
epithelial	O	O
cells	O	O
and	O	O
protein-coated	O	O
surfaces	O	O
,	O	O
collagenase	O	O
activity	O	O
,	O	O
and	O	O
invasiveness	O	O
.	O	O

We	O	O
also	O	O
tested	O	O
the	O	O
ability	O	O
of	O	O
AC-PACs	O	O
to	O	O
modulate	O	O
the	O	O
P.	O	O
gingivalis-induced	O	O
inflammatory	O	O
response	O	O
by	O	O
human	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

Our	O	O
results	O	O
showed	O	O
that	O	O
while	O	O
AC-PACs	O	O
neutralized	O	O
all	O	O
the	O	O
virulence	O	O
properties	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
in	O	O
a	O	O
dose-dependent	O	O
fashion	O	O
,	O	O
they	O	O
did	O	O
not	O	O
interfere	O	O
with	O	O
growth	O	O
.	O	O

They	O	O
also	O	O
inhibited	O	O
the	O	O
secretion	O	O
of	O	O
interleukin-8	O	O
(	O	O
IL-8	O	O
)	O	O
and	O	O
chemokine	O	O
(	O	O
C-C	O	O
motif	O	O
)	O	O
ligand	O	O
5	O	O
(	O	O
CCL5	O	O
)	O	O
but	O	O
did	O	O
not	O	O
affect	O	O
the	O	O
secretion	O	O
of	O	O
IL-6	O	O
by	O	O
epithelial	O	O
cells	O	O
stimulated	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

This	O	O
anti-inflammatory	O	O
effect	O	O
was	O	O
associated	O	O
with	O	O
reduced	O	O
activation	O	O
of	O	O
the	O	O
nuclear	O	O
factor-kappaB	O	O
(	O	O
NF-kappaB	O	O
)	O	O
p65	O	O
pathway	O	O
.	O	O

AC-PACs	O	O
may	O	O
be	O	O
potentially	O	O
valuable	O	O
bioactive	O	O
molecules	O	O
for	O	O
the	O	O
development	O	O
of	O	O
new	O	O
strategies	O	O
to	O	O
treat	O	O
and	O	O
prevent	O	O
P.	O	O
gingivalis-associated	O	O
periodontal	O	O
diseases	O	O
.	O	O

The	O	O
subgingival	O	O
microbiome	O	O
is	O	O
largely	O	O
uncultivated	O	O
,	O	O
and	O	O
therefore	O	O
,	O	O
cultivation-based	O	O
and	O	O
targeted	O	O
molecular	O	O
approaches	O	O
have	O	O
limited	O	O
value	O	O
in	O	O
examining	O	O
the	O	O
effect	O	O
of	O	O
smoking	O	O
on	O	O
this	O	O
community	O	O
.	O	O

We	O	O
tested	O	O
the	O	O
hypothesis	O	O
that	O	O
the	O	O
subgingival	O	O
biofilm	O	O
is	O	O
compositionally	O	O
different	O	O
in	O	O
current	O	O
and	O	O
never-smokers	O	O
by	O	O
using	O	O
an	O	O
open-ended	O	O
molecular	O	O
approach	O	O
for	O	O
bacterial	O	O
identification	O	O
.	O	O

Subgingival	O	O
plaque	O	O
from	O	O
deep	O	O
sites	O	O
of	O	O
current	O	O
and	O	O
never-smokers	O	O
matched	O	O
for	O	O
disease	O	O
was	O	O
analyzed	O	O
by	O	O
16S	O	O
sequencing	O	O
.	O	O

Smokers	O	O
demonstrated	O	O
greater	O	O
abundance	O	O
of	O	O
Parvimonas	B-bacteria	B-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
,	O	O
Campylobacter	B-bacteria	B-bacteria
,	O	O
Bacteroides	B-bacteria	B-bacteria
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
and	O	O
lower	O	O
levels	O	O
of	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
Neisseria	B-bacteria	B-bacteria
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
.	O	O

Several	O	O
uncultivated	O	O
Peptostreptococci	B-bacteria	B-bacteria
,	O	O
Parvimonas	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
,	O	O
Campylobacter	B-bacteria	B-bacteria
gracilis	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
socranskii	E-bacteria	I-bacteria
,	O	O
Dialister	B-bacteria	B-bacteria
pneumosintes	E-bacteria	I-bacteria
,	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
were	O	O
elevated	O	O
in	O	O
this	O	O
group	O	O
,	O	O
while	O	O
Veillonella	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

oral	I-bacteria	I-bacteria
clone	I-bacteria	I-bacteria
B2	E-bacteria	I-bacteria
,	O	O
Neisseria	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

oral	I-bacteria	I-bacteria
clone	I-bacteria	I-bacteria
2.24	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
and	O	O
Capnocytophaga	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

clone	I-bacteria	I-bacteria
AH015	E-bacteria	I-bacteria
were	O	O
at	O	O
lower	O	O
levels	O	O
.	O	O

The	O	O
microbial	O	O
profile	O	O
of	O	O
smoking-associated	O	O
periodontitis	O	O
is	O	O
distinct	O	O
from	O	O
that	O	O
of	O	O
non-smokers	O	O
,	O	O
with	O	O
significant	O	O
differences	O	O
in	O	O
the	O	O
prevalence	O	O
and	O	O
abundance	O	O
of	O	O
disease-associated	O	O
and	O	O
health-compatible	O	O
organisms	O	O
.	O	O

Feline	O	O
chronic	O	O
gingivostomatitis	O	O
(	O	O
FCGS	O	O
)	O	O
is	O	O
a	O	O
chronic	O	O
inflammatory	O	O
disease	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
that	O	O
causes	O	O
severe	O	O
pain	O	O
and	O	O
distress	O	O
.	O	O

There	O	O
are	O	O
currently	O	O
no	O	O
specific	O	O
treatment	O	O
methods	O	O
available	O	O
and	O	O
little	O	O
is	O	O
known	O	O
regarding	O	O
its	O	O
aetiology	O	O
,	O	O
although	O	O
bacteria	O	O
are	O	O
thought	O	O
to	O	O
play	O	O
a	O	O
major	O	O
role	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
identify	O	O
the	O	O
oral	O	O
bacterial	O	O
flora	O	O
in	O	O
normal	O	O
and	O	O
diseased	O	O
cats	O	O
.	O	O

Oral	O	O
swabs	O	O
were	O	O
obtained	O	O
from	O	O
the	O	O
palatoglossal	O	O
folds	O	O
of	O	O
eight	O	O
cats	O	O
(	O	O
three	O	O
normal	O	O
and	O	O
five	O	O
FCGS	O	O
)	O	O
and	O	O
were	O	O
subjected	O	O
to	O	O
microbiological	O	O
culture	O	O
.	O	O

Pasteurella	B-bacteria	B-bacteria
pneumotropica	E-bacteria	I-bacteria
and	O	O
Pasteurella	B-bacteria	B-bacteria
multocida	I-bacteria	I-bacteria
subsp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria
multocida	E-bacteria	I-bacteria
were	O	O
the	O	O
most	O	O
prevalent	O	O
species	O	O
identified	O	O
by	O	O
culture	O	O
methods	O	O
in	O	O
the	O	O
normal	O	O
and	O	O
FCGS	O	O
samples	O	O
,	O	O
respectively	O	O
.	O	O

Bacteria	O	O
were	O	O
also	O	O
identified	O	O
using	O	O
culture-independent	O	O
methods	O	O
(	O	O
bacterial	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
)	O	O
.	O	O

For	O	O
the	O	O
normal	O	O
samples	O	O
,	O	O
158	O	O
clones	O	O
were	O	O
analysed	O	O
and	O	O
85	O	O
clones	O	O
were	O	O
sequenced	O	O
.	O	O

Capnocytophaga	B-bacteria	B-bacteria
canimorsus	E-bacteria	I-bacteria
(	O	O
10.8	O	O
%	O	O
of	O	O
clones	O	O
analysed	O	O
)	O	O
was	O	O
the	O	O
predominant	O	O
species	O	O
.	O	O

Uncultured	O	O
species	O	O
accounted	O	O
for	O	O
8.2	O	O
%	O	O
of	O	O
clones	O	O
analysed	O	O
,	O	O
and	O	O
43.7	O	O
%	O	O
of	O	O
clones	O	O
analysed	O	O
represented	O	O
potentially	O	O
novel	O	O
species	O	O
.	O	O

For	O	O
the	O	O
FCGS	O	O
samples	O	O
,	O	O
253	O	O
clones	O	O
were	O	O
analysed	O	O
and	O	O
91	O	O
clones	O	O
were	O	O
sequenced	O	O
.	O	O

The	O	O
predominant	O	O
species	O	O
was	O	O
P.	B-bacteria	B-bacteria
multocida	I-bacteria	I-bacteria
subsp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria
multocida	E-bacteria	I-bacteria
(	O	O
51.8	O	O
%	O	O
of	O	O
clones	O	O
analysed	O	O
)	O	O
.	O	O

Uncultured	O	O
species	O	O
accounted	O	O
for	O	O
8.7	O	O
%	O	O
of	O	O
clones	O	O
analysed	O	O
,	O	O
and	O	O
4.7	O	O
%	O	O
of	O	O
clones	O	O
analysed	O	O
represented	O	O
potentially	O	O
novel	O	O
species	O	O
.	O	O

It	O	O
is	O	O
concluded	O	O
that	O	O
the	O	O
oral	O	O
flora	O	O
in	O	O
cats	O	O
with	O	O
FCGS	O	O
appears	O	O
to	O	O
be	O	O
less	O	O
diverse	O	O
than	O	O
that	O	O
found	O	O
in	O	O
normal	O	O
cats	O	O
.	O	O

However	O	O
,	O	O
P.	B-bacteria	B-bacteria
multocida	I-bacteria	I-bacteria
subsp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria
multocida	E-bacteria	I-bacteria
is	O	O
found	O	O
to	O	O
be	O	O
significantly	O	O
more	O	O
prevalent	O	O
in	O	O
FCGS	O	O
than	O	O
in	O	O
normal	O	O
cats	O	O
and	O	O
consequently	O	O
may	O	O
be	O	O
of	O	O
aetiological	O	O
significance	O	O
in	O	O
this	O	O
disease	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
compare	O	O
dental	O	O
caries	O	O
and	O	O
periodontal	O	O
disease	O	O
status	O	O
associated	O	O
with	O	O
oral	O	O
microflora	O	O
among	O	O
smokeless	O	O
tobacco	O	O
chewers	O	O
and	O	O
non-chewers	O	O
.	O	O

Forty-two	O	O
smokeless	O	O
tobacco	O	O
chewers	O	O
and	O	O
42	O	O
non-chewers	O	O
(	O	O
age	O	O
20	O	O
to	O	O
60	O	O
years	O	O
)	O	O
were	O	O
assessed	O	O
for	O	O
dental	O	O
caries	O	O
and	O	O
periodontal	O	O
disease	O	O
status	O	O
using	O	O
the	O	O
Decayed	O	O
Missing	O	O
Filled	O	O
Surface	O	O
(	O	O
DMFS	O	O
)	O	O
Index	O	O
,	O	O
Community	O	O
Periodontal	O	O
Index	O	O
(	O	O
CPI	O	O
)	O	O
and	O	O
Loss	O	O
of	O	O
Attachment	O	O
(	O	O
LA	O	O
)	O	O
Index	O	O
.	O	O

Stimulated	O	O
saliva	O	O
and	O	O
subgingival	O	O
plaque	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
each	O	O
subject	O	O
for	O	O
performing	O	O
a	O	O
culture-based	O	O
analysis	O	O
of	O	O
20	O	O
types	O	O
of	O	O
oral	O	O
microorganisms	O	O
.	O	O

Qualitative	O	O
and	O	O
semi-quantitative	O	O
culture-based	O	O
analysis	O	O
using	O	O
MacConkey	O	O
agar	O	O
,	O	O
and	O	O
aerobic	O	O
and	O	O
anaerobic	O	O
blood	O	O
agar	O	O
was	O	O
carried	O	O
out	O	O
to	O	O
determine	O	O
the	O	O
total	O	O
cultivable	O	O
microflora	O	O
.	O	O

Mutans-Sanguis	O	O
agar	O	O
,	O	O
Pfizer	O	O
selective	O	O
Enterococcus	B-bacteria	B-bacteria
agar	O	O
and	O	O
Rogosa	O	O
SL	O	O
agar	O	O
were	O	O
used	O	O
for	O	O
the	O	O
culture	O	O
of	O	O
microorganisms	O	O
associated	O	O
with	O	O
dental	O	O
caries	O	O
.	O	O

Mann-Whitney	O	O
U	O	O
test	O	O
and	O	O
Student	O	O
t	O	O
test	O	O
were	O	O
employed	O	O
to	O	O
compare	O	O
colony-forming	O	O
units	O	O
(	O	O
CFUs	O	O
)	O	O
and	O	O
caries	O	O
experience	O	O
between	O	O
smokeless	O	O
tobacco	O	O
chewers	O	O
and	O	O
nonchewers	O	O
.	O	O

Z	O	O
proportionality	O	O
test	O	O
was	O	O
used	O	O
to	O	O
compare	O	O
the	O	O
periodontal	O	O
disease	O	O
status	O	O
.	O	O

Caries	O	O
experience	O	O
among	O	O
chewers	O	O
(	O	O
26	O	O
of	O	O
42	O	O
)	O	O
,	O	O
that	O	O
is	O	O
those	O	O
subjects	O	O
who	O	O
were	O	O
affected	O	O
by	O	O
caries	O	O
,	O	O
was	O	O
significantly	O	O
less	O	O
at	O	O
61.9	O	O
%	O	O
(	O	O
mean	O	O
DMFS	O	O
=	O	O
3.5	O	O
)	O	O
compared	O	O
to	O	O
non-chewers	O	O
(	O	O
38	O	O
of	O	O
42	O	O
,	O	O
90.5	O	O
%	O	O
)	O	O
(	O	O
mean	O	O
DMFS	O	O
=	O	O
5.5	O	O
)	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Deep	O	O
pockets	O	O
measuring	O	O
>	O	O
5.5	O	O
mm	O	O
on	O	O
a	O	O
CPI	O	O
probe	O	O
were	O	O
found	O	O
among	O	O
26.2	O	O
%	O	O
of	O	O
chewers	O	O
and	O	O
19.1	O	O
%	O	O
of	O	O
nonchewers	O	O
,	O	O
with	O	O
no	O	O
statistically	O	O
significant	O	O
differences	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

Counts	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
were	O	O
significantly	O	O
lower	O	O
among	O	O
chewers	O	O
(	O	O
median	O	O
CFU	O	O
=	O	O
0.788	O	O
x	O	O
10	O	O
(	O	O
5	O	O
)	O	O
)	O	O
than	O	O
among	O	O
non-chewers	O	O
(	O	O
median	O	O
CFU	O	O
=	O	O
1.52	O	O
x	O	O
10	O	O
(	O	O
5	O	O
)	O	O
)	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Prevotella	B-bacteria	B-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
had	O	O
a	O	O
median	O	O
CFU	O	O
of	O	O
0.04	O	O
x	O	O
105	O	O
in	O	O
chewers	O	O
and	O	O
0.15	O	O
x	O	O
10	O	O
(	O	O
5	O	O
)	O	O
in	O	O
non-chewers	O	O
,	O	O
whereas	O	O
Fusobacterium	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
had	O	O
a	O	O
median	O	O
CFU	O	O
of	O	O
0.02	O	O
x	O	O
10	O	O
(	O	O
5	O	O
)	O	O
in	O	O
chewers	O	O
and	O	O
0.1	O	O
x	O	O
10	O	O
(	O	O
5	O	O
)	O	O
in	O	O
non-chewers	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

A	O	O
higher	O	O
percentage	O	O
of	O	O
caries	O	O
among	O	O
non-chewers	O	O
can	O	O
be	O	O
explained	O	O
by	O	O
greater	O	O
numbers	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
in	O	O
this	O	O
population	O	O
.	O	O

Chewers	O	O
experienced	O	O
a	O	O
slightly	O	O
higher	O	O
incidence	O	O
of	O	O
periodontal	O	O
disease	O	O
than	O	O
non-chewers	O	O
,	O	O
but	O	O
the	O	O
difference	O	O
was	O	O
not	O	O
significant	O	O
.	O	O

These	O	O
clinical	O	O
observations	O	O
suggest	O	O
a	O	O
lower	O	O
ability	O	O
of	O	O
Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
to	O	O
mediate	O	O
more	O	O
periodontal	O	O
disease	O	O
in	O	O
this	O	O
population	O	O
.	O	O

The	O	O
escalating	O	O
global	O	O
incidence	O	O
of	O	O
bacterial	O	O
infection	O	O
,	O	O
particularly	O	O
in	O	O
chronic	O	O
wounds	O	O
,	O	O
is	O	O
a	O	O
problem	O	O
that	O	O
requires	O	O
significant	O	O
improvements	O	O
to	O	O
existing	O	O
therapies	O	O
.	O	O

We	O	O
have	O	O
developed	O	O
hyperbranched	O	O
poly	O	O
(	O	O
NIPAM	O	O
)	O	O
polymers	O	O
functionalized	O	O
with	O	O
the	O	O
antibiotics	O	O
Vancomycin	O	O
and	O	O
Polymyxin-B	O	O
that	O	O
are	O	O
sensitive	O	O
to	O	O
the	O	O
presence	O	O
of	O	O
bacteria	O	O
in	O	O
solution	O	O
.	O	O

Binding	O	O
of	O	O
bacteria	O	O
to	O	O
the	O	O
polymers	O	O
causes	O	O
a	O	O
conformational	O	O
change	O	O
,	O	O
resulting	O	O
in	O	O
collapse	O	O
of	O	O
the	O	O
polymers	O	O
and	O	O
the	O	O
formation	O	O
of	O	O
insoluble	O	O
polymer/bacteria	O	O
complexes	O	O
.	O	O

We	O	O
have	O	O
applied	O	O
these	O	O
novel	O	O
polymers	O	O
to	O	O
our	O	O
tissue	O	O
engineered	O	O
human	O	O
skin	O	O
model	O	O
of	O	O
a	O	O
burn	O	O
wound	O	O
infected	O	O
with	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
and	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
.	O	O

When	O	O
the	O	O
polymers	O	O
were	O	O
removed	O	O
from	O	O
the	O	O
infected	O	O
skin	O	O
,	O	O
either	O	O
in	O	O
a	O	O
polymer	O	O
gel	O	O
solution	O	O
or	O	O
in	O	O
the	O	O
form	O	O
of	O	O
hydrogel	O	O
membranes	O	O
,	O	O
they	O	O
removed	O	O
bound	O	O
bacteria	O	O
,	O	O
thus	O	O
reducing	O	O
the	O	O
bacterial	O	O
load	O	O
in	O	O
the	O	O
infected	O	O
skin	O	O
model	O	O
.	O	O

These	O	O
bacteria-binding	O	O
polymers	O	O
have	O	O
many	O	O
potential	O	O
uses	O	O
,	O	O
including	O	O
coatings	O	O
for	O	O
wound	O	O
dressings	O	O
.	O	O

Following	O	O
an	O	O
outbreak	O	O
of	O	O
carbapenem	B-bacteria	B-bacteria
resistant	I-bacteria	I-bacteria
Klebsiella	I-bacteria	I-bacteria
pneumoniae	E-bacteria	I-bacteria
(	O	O
CRKP	B-bacteria	B-bacteria
)	O	O
bacteremia	O	O
among	O	O
inpatients	O	O
in	O	O
the	O	O
Hemato-oncology	O	O
and	O	O
BMT	O	O
unit	O	O
,	O	O
we	O	O
studied	O	O
the	O	O
course	O	O
of	O	O
this	O	O
infection	O	O
in	O	O
patients	O	O
undergoing	O	O
intensive	O	O
chemotherapy	O	O
and	O	O
SCT	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
we	O	O
conducted	O	O
a	O	O
pilot	O	O
study	O	O
aimed	O	O
to	O	O
eradicate	O	O
CRKP	B-bacteria	B-bacteria
colonization	O	O
in	O	O
the	O	O
gastrointestinal	O	O
tract	O	O
,	O	O
using	O	O
oral	O	O
gentamicin	O	O
.	O	O

Adult	O	O
patients	O	O
admitted	O	O
to	O	O
the	O	O
BMT	O	O
unit	O	O
,	O	O
identified	O	O
as	O	O
CRKP	B-bacteria	B-bacteria
carriers	O	O
on	O	O
surveillance	O	O
rectal	O	O
cultures	O	O
,	O	O
were	O	O
included	O	O
in	O	O
the	O	O
study	O	O
.	O	O

Oral	O	O
gentamicin	O	O
at	O	O
a	O	O
dose	O	O
of	O	O
80	O	O
mg	O	O
q.i.d	O	O
.	O	O

was	O	O
administered	O	O
to	O	O
all	O	O
identified	O	O
carriers	O	O
until	O	O
eradication	O	O
.	O	O

Among	O	O
15	O	O
colonized	O	O
patients	O	O
included	O	O
in	O	O
the	O	O
study	O	O
,	O	O
the	O	O
eradication	O	O
rate	O	O
achieved	O	O
was	O	O
66	O	O
%	O	O
(	O	O
10/15	O	O
)	O	O
;	O	O
discontinuation	O	O
of	O	O
persistent	O	O
bacteremia	O	O
occurred	O	O
in	O	O
62.5	O	O
%	O	O
(	O	O
5/8	O	O
)	O	O
and	O	O
nosocomial	O	O
spread	O	O
of	O	O
CRKP	B-bacteria	B-bacteria
carrier	O	O
state	O	O
ceased	O	O
.	O	O

Administration	O	O
of	O	O
intensive	O	O
chemotherapy	O	O
and	O	O
SCT	O	O
is	O	O
feasible	O	O
,	O	O
although	O	O
associated	O	O
with	O	O
increased	O	O
risk	O	O
.	O	O

Hematological	O	O
patients	O	O
in	O	O
need	O	O
of	O	O
intensive	O	O
chemotherapy/SCT	O	O
should	O	O
not	O	O
be	O	O
denied	O	O
the	O	O
required	O	O
treatment	O	O
on	O	O
the	O	O
basis	O	O
of	O	O
being	O	O
CRKP	B-bacteria	B-bacteria
carriers	O	O
.	O	O

Oral	O	O
gentamicin	O	O
treatment	O	O
for	O	O
eradication	O	O
of	O	O
CRKP	B-bacteria	B-bacteria
from	O	O
the	O	O
gastrointestinal	O	O
reservoir	O	O
could	O	O
serve	O	O
as	O	O
additional	O	O
tool	O	O
in	O	O
the	O	O
combat	O	O
against	O	O
the	O	O
nosocomial	O	O
spread	O	O
and	O	O
severe	O	O
infections	O	O
caused	O	O
by	O	O
this	O	O
difficult-to-treat	O	O
organism	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
electrochemical	O	O
behavior	O	O
of	O	O
nickel	O	O
titanium	O	O
(	O	O
NiTi	O	O
)	O	O
orthodontic	O	O
wires	O	O
in	O	O
a	O	O
solution	O	O
containing	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
oral	O	O
bacteria	O	O
.	O	O

In	O	O
this	O	O
article	O	O
,	O	O
we	O	O
explain	O	O
our	O	O
choice	O	O
of	O	O
bacterial	O	O
species	O	O
before	O	O
describing	O	O
the	O	O
culture	O	O
process	O	O
in	O	O
artificial	O	O
saliva	O	O
and	O	O
the	O	O
precautions	O	O
needed	O	O
to	O	O
prevent	O	O
contamination	O	O
by	O	O
other	O	O
bacteria	O	O
.	O	O

The	O	O
electrochemical	O	O
behavior	O	O
of	O	O
the	O	O
alloy	O	O
(	O	O
NiTi	O	O
)	O	O
was	O	O
analyzed	O	O
electrochemically	O	O
in	O	O
Ringer	O	O
sterile	O	O
artificial	O	O
saliva	O	O
and	O	O
in	O	O
artificial	O	O
saliva	O	O
enriched	O	O
with	O	O
a	O	O
sterile	O	O
broth	O	O
and	O	O
modified	O	O
by	O	O
addition	O	O
of	O	O
bacteria	O	O
.	O	O

The	O	O
electrochemical	O	O
procedures	O	O
chosen	O	O
for	O	O
this	O	O
study	O	O
were	O	O
:	O	O
free	O	O
corrosion	O	O
potential	O	O
,	O	O
potentiodynamic	O	O
curves	O	O
and	O	O
impedance	O	O
spectroscopy	O	O
.	O	O

In	O	O
this	O	O
way	O	O
,	O	O
we	O	O
were	O	O
able	O	O
to	O	O
show	O	O
that	O	O
the	O	O
free	O	O
corrosion	O	O
potential	O	O
of	O	O
the	O	O
NiTi	O	O
in	O	O
the	O	O
Ringer	O	O
solution	O	O
increases	O	O
with	O	O
time	O	O
and	O	O
then	O	O
stabilizes	O	O
,	O	O
thus	O	O
passivating	O	O
the	O	O
alloy	O	O
.	O	O

We	O	O
also	O	O
demonstrated	O	O
that	O	O
colonization	O	O
of	O	O
the	O	O
metal	O	O
surface	O	O
by	O	O
bacteria	O	O
triggered	O	O
a	O	O
drop	O	O
in	O	O
the	O	O
free	O	O
corrosion	O	O
potential	O	O
.	O	O

The	O	O
electrochemical	O	O
impedance	O	O
findings	O	O
revealed	O	O
no	O	O
significant	O	O
difference	O	O
in	O	O
NiTi	O	O
behavior	O	O
between	O	O
the	O	O
two	O	O
media	O	O
.	O	O

Finally	O	O
,	O	O
we	O	O
observed	O	O
a	O	O
slight	O	O
difference	O	O
between	O	O
the	O	O
two	O	O
corrosion	O	O
currents	O	O
in	O	O
favor	O	O
of	O	O
the	O	O
bacteria-enriched	O	O
solution	O	O
,	O	O
in	O	O
which	O	O
the	O	O
NiTi	O	O
underwent	O	O
greater	O	O
corrosion	O	O
.	O	O

These	O	O
findings	O	O
demonstrate	O	O
the	O	O
impact	O	O
of	O	O
acidogenic	O	O
bacteria	O	O
on	O	O
corrosion	O	O
behavior	O	O
of	O	O
the	O	O
NiTi	O	O
wires	O	O
investigated	O	O
.	O	O

However	O	O
,	O	O
further	O	O
research	O	O
is	O	O
required	O	O
,	O	O
notably	O	O
incorporating	O	O
longer	O	O
immersion	O	O
times	O	O
in	O	O
the	O	O
two	O	O
media	O	O
.	O	O

As	O	O
in	O	O
other	O	O
fields	O	O
of	O	O
healthcare	O	O
,	O	O
probiotics	B-bacteria	B-bacteria
have	O	O
been	O	O
introduced	O	O
for	O	O
prevention	O	O
and	O	O
treatment	O	O
of	O	O
periodontal	O	O
diseases	O	O
.	O	O

This	O	O
review	O	O
was	O	O
initiated	O	O
to	O	O
explore	O	O
whether	O	O
the	O	O
use	O	O
of	O	O
probiotics	B-bacteria	B-bacteria
can	O	O
influence	O	O
the	O	O
periodontal	O	O
microbiota	O	O
and	O	O
periodontal	O	O
health	O	O
.	O	O

Literature	O	O
on	O	O
the	O	O
mode	O	O
of	O	O
action	O	O
of	O	O
oral	O	O
probiotics	B-bacteria	B-bacteria
was	O	O
reviewed	O	O
and	O	O
a	O	O
systematic	O	O
review	O	O
was	O	O
performed	O	O
on	O	O
the	O	O
microbiological	O	O
and	O	O
clinical	O	O
effects	O	O
of	O	O
oral	O	O
probiotics	O	O
on	O	O
periodontal	O	O
health	O	O
.	O	O

Three	O	O
animal	O	O
and	O	O
11	O	O
in	O	O
vivo	O	O
human	O	O
studies	O	O
were	O	O
retrieved	O	O
.	O	O

Six	O	O
studies	O	O
reported	O	O
on	O	O
microbiological	O	O
effects	O	O
whereas	O	O
eight	O	O
studies	O	O
report	O	O
on	O	O
clinical	O	O
effects	O	O
.	O	O

Seven	O	O
studies	O	O
were	O	O
performed	O	O
on	O	O
healthy	O	O
or	O	O
gingivitis	O	O
patients	O	O
and	O	O
four	O	O
studies	O	O
on	O	O
periodontitis	O	O
patients	O	O
.	O	O

Many	O	O
of	O	O
the	O	O
retrieved	O	O
studies	O	O
are	O	O
pilot	O	O
in	O	O
nature	O	O
and	O	O
with	O	O
low	O	O
quality	O	O
.	O	O

The	O	O
high	O	O
degree	O	O
of	O	O
heterogeneity	O	O
between	O	O
studies	O	O
hampered	O	O
analysis	O	O
.	O	O

Taking	O	O
into	O	O
consideration	O	O
all	O	O
limitations	O	O
,	O	O
the	O	O
currently	O	O
available	O	O
data	O	O
indicate	O	O
an	O	O
effect	O	O
of	O	O
probiotics	B-bacteria	B-bacteria
on	O	O
the	O	O
oral	O	O
microbiota	O	O
and	O	O
a	O	O
more	O	O
limited	O	O
effect	O	O
on	O	O
clinical	O	O
periodontal	O	O
outcome	O	O
measures	O	O
.	O	O

However	O	O
,	O	O
there	O	O
is	O	O
an	O	O
urgent	O	O
need	O	O
for	O	O
properly	O	O
conducted	O	O
clinical	O	O
trials	O	O
where	O	O
probiotics	B-bacteria	B-bacteria
are	O	O
used	O	O
as	O	O
adjuncts	O	O
to	O	O
standard	O	O
periodontal	O	O
care	O	O
,	O	O
similar	O	O
to	O	O
antibiotics	O	O
,	O	O
using	O	O
probiotic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
with	O	O
,	O	O
at	O	O
least	O	O
at	O	O
an	O	O
in	O	O
vitro	O	O
level	O	O
,	O	O
proven	O	O
periodontal	O	O
probiotic	B-bacteria	B-bacteria
effects	O	O
.	O	O

Atopic	O	O
dermatitis	O	O
(	O	O
AD	O	O
)	O	O
is	O	O
marked	O	O
by	O	O
elevated	O	O
levels	O	O
of	O	O
immunoglobulin	O	O
E	O	O
and	O	O
skin	O	O
lesions	O	O
such	O	O
as	O	O
oedema	O	O
and	O	O
haemorrhage	O	O
.	O	O

Kimchi	O	O
is	O	O
a	O	O
Korean	O	O
fermented	O	O
food	O	O
that	O	O
contains	O	O
beneficial	O	O
bacteria	O	O
for	O	O
human	O	O
health	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
plantarum	I-bacteria	I-bacteria
CJLP55	E-bacteria	I-bacteria
,	O	O
CJLP56	B-bacteria	B-bacteria
,	O	O
CJLP133	B-bacteria	B-bacteria
and	O	O
CJLP136	B-bacteria	B-bacteria
isolated	O	O
from	O	O
Kimchi	O	O
were	O	O
investigated	O	O
for	O	O
their	O	O
capacity	O	O
to	O	O
inhibit	O	O
AD	O	O
.	O	O

The	O	O
three	O	O
strains	O	O
,	O	O
CJLP55	B-bacteria	B-bacteria
,	O	O
CJLP133	B-bacteria	B-bacteria
and	O	O
CJLP136	B-bacteria	B-bacteria
,	O	O
suppressed	O	O
AD-like	O	O
skin	O	O
lesions	O	O
,	O	O
high	O	O
serum	O	O
IgE	O	O
levels	O	O
and	O	O
epidermal	O	O
thickening	O	O
.	O	O

The	O	O
three	O	O
strains	O	O
diminished	O	O
the	O	O
accumulation	O	O
of	O	O
eosinophils	O	O
and	O	O
mast	O	O
cells	O	O
into	O	O
topical	O	O
inflammatory	O	O
sites	O	O
and	O	O
the	O	O
enlargement	O	O
of	O	O
axillary	O	O
lymph	O	O
nodes	O	O
,	O	O
which	O	O
are	O	O
responsible	O	O
for	O	O
the	O	O
dorsal	O	O
dermatitis	O	O
.	O	O

CJLP55	B-bacteria	B-bacteria
,	O	O
CJLP133	B-bacteria	B-bacteria
and	O	O
CJLP136	B-bacteria	B-bacteria
decreased	O	O
production	O	O
of	O	O
type	O	O
2	O	O
cytokines	O	O
such	O	O
as	O	O
IL-4	O	O
and	O	O
IL-5	O	O
in	O	O
lymph	O	O
node	O	O
cell	O	O
culture	O	O
.	O	O

CJLP133	B-bacteria	B-bacteria
and	O	O
CJLP136	B-bacteria	B-bacteria
increased	O	O
IFN-gamma	O	O
secretion	O	O
,	O	O
while	O	O
CJLP55	B-bacteria	B-bacteria
enhanced	O	O
IL-10	O	O
production	O	O
.	O	O

The	O	O
three	O	O
strains	O	O
isolated	O	O
from	O	O
Kimchi	O	O
suppress	O	O
house-dust	O	O
mite-induced	O	O
dermatitis	O	O
in	O	O
NC/Nga	O	O
mouse	O	O
,	O	O
a	O	O
representative	O	O
animal	O	O
model	O	O
of	O	O
human	O	O
AD	O	O
.	O	O

These	O	O
findings	O	O
suggest	O	O
that	O	O
lactobacilli	B-bacteria	B-bacteria
isolated	O	O
from	O	O
Kimchi	O	O
inhibit	O	O
AD	O	O
,	O	O
probably	O	O
by	O	O
altering	O	O
the	O	O
balance	O	O
of	O	O
Th1/Th2	O	O
ratio	O	O
or	O	O
inducing	O	O
IL-10	O	O
production	O	O
.	O	O

The	O	O
areca	O	O
nut	O	O
is	O	O
the	O	O
most	O	O
widely	O	O
consumed	O	O
psychoactive	O	O
substance	O	O
in	O	O
Taiwan	O	O
,	O	O
India	O	O
,	O	O
and	O	O
Southeast	O	O
Asia	O	O
.	O	O

It	O	O
is	O	O
considered	O	O
to	O	O
be	O	O
an	O	O
environmental	O	O
risk	O	O
factor	O	O
for	O	O
the	O	O
development	O	O
of	O	O
oral	O	O
submucous	O	O
fibrosis	O	O
and	O	O
cancer	O	O
.	O	O

Arecoline	O	O
,	O	O
the	O	O
major	O	O
alkaloid	O	O
of	O	O
areca	O	O
nut	O	O
,	O	O
has	O	O
been	O	O
known	O	O
to	O	O
cause	O	O
cytotoxicity	O	O
and	O	O
genotoxicity	O	O
in	O	O
various	O	O
systems	O	O
.	O	O

However	O	O
,	O	O
the	O	O
active	O	O
compound	O	O
accounting	O	O
for	O	O
arecoline-induced	O	O
damage	O	O
in	O	O
normal	O	O
human	O	O
oral	O	O
cells	O	O
is	O	O
still	O	O
uncharacterized	O	O
.	O	O

The	O	O
present	O	O
study	O	O
was	O	O
undertaken	O	O
to	O	O
identify	O	O
the	O	O
active	O	O
metabolite	O	O
of	O	O
arecoline	O	O
that	O	O
might	O	O
induce	O	O
damage	O	O
in	O	O
human	O	O
oral	O	O
tissues	O	O
and	O	O
cause	O	O
mutagenicity	O	O
in	O	O
Salmonella	B-bacteria	B-bacteria
typhimurium	I-bacteria	I-bacteria
tester	I-bacteria	I-bacteria
strains	I-bacteria	I-bacteria
TA	I-bacteria	I-bacteria
100	E-bacteria	I-bacteria
and	O	O
TA	B-bacteria	B-bacteria
98	E-bacteria	I-bacteria
.	O	O

It	O	O
is	O	O
interesting	O	O
to	O	O
find	O	O
that	O	O
the	O	O
major	O	O
metabolite	O	O
of	O	O
arecoline	O	O
,	O	O
arecoline	O	O
N-oxide	O	O
,	O	O
is	O	O
moderately	O	O
mutagenic	O	O
to	O	O
these	O	O
Salmonella	B-bacteria	B-bacteria
tester	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
.	O	O

This	O	O
mutagenicity	O	O
was	O	O
potently	O	O
inhibited	O	O
by	O	O
sulfhydryl	O	O
compounds	O	O
,	O	O
namely	O	O
,	O	O
glutathione	O	O
,	O	O
N-acetylcysteine	O	O
,	O	O
and	O	O
cysteine	O	O
,	O	O
whereas	O	O
methionine	O	O
is	O	O
inactive	O	O
in	O	O
this	O	O
inhibition	O	O
.	O	O

The	O	O
mutagenicity	O	O
of	O	O
arecoline	O	O
N-oxide	O	O
was	O	O
strongly	O	O
inhibited	O	O
by	O	O
the	O	O
N-oxide	O	O
reducing	O	O
agent	O	O
titanium	O	O
trichloride	O	O
.	O	O

The	O	O
possible	O	O
role	O	O
of	O	O
arecoline	O	O
N-oxide	O	O
in	O	O
the	O	O
induction	O	O
of	O	O
oral	O	O
carcinogenesis	O	O
by	O	O
areca	O	O
nut	O	O
chewing	O	O
is	O	O
discussed	O	O
.	O	O

Periodontal	O	O
disease	O	O
is	O	O
one	O	O
of	O	O
the	O	O
most	O	O
common	O	O
diseases	O	O
of	O	O
adult	O	O
dogs	O	O
,	O	O
with	O	O
up	O	O
to	O	O
80	O	O
%	O	O
of	O	O
animals	O	O
affected	O	O
.	O	O

The	O	O
aetiology	O	O
of	O	O
the	O	O
disease	O	O
is	O	O
poorly	O	O
studied	O	O
,	O	O
although	O	O
bacteria	O	O
are	O	O
known	O	O
to	O	O
play	O	O
a	O	O
major	O	O
role	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
identify	O	O
the	O	O
bacteria	O	O
associated	O	O
with	O	O
canine	O	O
gingivitis	O	O
and	O	O
periodontitis	O	O
and	O	O
to	O	O
compare	O	O
this	O	O
with	O	O
the	O	O
normal	O	O
oral	O	O
flora	O	O
.	O	O

Swabs	O	O
were	O	O
obtained	O	O
from	O	O
the	O	O
gingival	O	O
margin	O	O
of	O	O
three	O	O
dogs	O	O
with	O	O
gingivitis	O	O
and	O	O
three	O	O
orally	O	O
healthy	O	O
controls	O	O
,	O	O
and	O	O
subgingival	O	O
plaque	O	O
was	O	O
collected	O	O
from	O	O
three	O	O
dogs	O	O
with	O	O
periodontitis	O	O
.	O	O

Samples	O	O
were	O	O
subjected	O	O
to	O	O
routine	O	O
bacterial	O	O
culture	O	O
.	O	O

The	O	O
prevalent	O	O
species	O	O
identified	O	O
in	O	O
the	O	O
normal	O	O
,	O	O
gingivitis	O	O
and	O	O
periodontitis	O	O
groups	O	O
were	O	O
uncultured	O	O
bacterium	O	O
(	O	O
12.5	O	O
%	O	O
of	O	O
isolates	O	O
)	O	O
,	O	O
Bacteroides	B-bacteria	B-bacteria
heparinolyticus/Pasteurella	I-bacteria	I-bacteria
dagmatis	E-bacteria	I-bacteria
(	O	O
10.0	O	O
%	O	O
)	O	O
and	O	O
Actinomyces	B-bacteria	B-bacteria
canis	E-bacteria	I-bacteria
(	O	O
19.4	O	O
%	O	O
)	O	O
,	O	O
respectively	O	O
.	O	O

Bacteria	O	O
were	O	O
also	O	O
identified	O	O
using	O	O
culture-independent	O	O
methods	O	O
(	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
)	O	O
and	O	O
the	O	O
predominant	O	O
species	O	O
identified	O	O
were	O	O
Pseudomonas	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
30.9	O	O
%	O	O
of	O	O
clones	O	O
analysed	O	O
)	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
cangingivalis	E-bacteria	I-bacteria
(	O	O
16.1	O	O
%	O	O
)	O	O
and	O	O
Desulfomicrobium	B-bacteria	B-bacteria
orale	E-bacteria	I-bacteria
(	O	O
12.0	O	O
%	O	O
)	O	O
in	O	O
the	O	O
normal	O	O
,	O	O
gingivitis	O	O
and	O	O
periodontitis	O	O
groups	O	O
,	O	O
respectively	O	O
.	O	O

Uncultured	O	O
species	O	O
accounted	O	O
for	O	O
13.2	O	O
%	O	O
,	O	O
2.0	O	O
%	O	O
and	O	O
10.5	O	O
%	O	O
,	O	O
and	O	O
potentially	O	O
novel	O	O
species	O	O
for	O	O
38.2	O	O
%	O	O
,	O	O
38.3	O	O
%	O	O
and	O	O
35.3	O	O
%	O	O
,	O	O
of	O	O
clones	O	O
in	O	O
the	O	O
normal	O	O
,	O	O
gingivitis	O	O
and	O	O
periodontitis	O	O
groups	O	O
,	O	O
respectively	O	O
.	O	O

This	O	O
is	O	O
the	O	O
first	O	O
study	O	O
to	O	O
use	O	O
utilise	O	O
culture-independent	O	O
methods	O	O
for	O	O
the	O	O
identification	O	O
of	O	O
bacteria	O	O
associated	O	O
with	O	O
this	O	O
disease	O	O
.	O	O

It	O	O
is	O	O
concluded	O	O
that	O	O
the	O	O
canine	O	O
oral	O	O
flora	O	O
in	O	O
health	O	O
and	O	O
disease	O	O
is	O	O
highly	O	O
diverse	O	O
and	O	O
also	O	O
contains	O	O
a	O	O
high	O	O
proportion	O	O
of	O	O
uncultured	O	O
and	O	O
,	O	O
in	O	O
particular	O	O
,	O	O
potentially	O	O
novel	O	O
species	O	O
.	O	O

Advances	O	O
in	O	O
isolation	O	O
and	O	O
culturing	O	O
techniques	O	O
have	O	O
brought	O	O
the	O	O
role	O	O
of	O	O
anaerobic	O	O
bacteria-causing	O	O
maxillofacial	O	O
infections	O	O
to	O	O
the	O	O
fore	O	O
.	O	O

Recent	O	O
literature	O	O
also	O	O
favors	O	O
the	O	O
role	O	O
of	O	O
anaerobes	B-bacteria	B-bacteria
in	O	O
maxillofacial	O	O
infections	O	O
.	O	O

A	O	O
prospective	O	O
clinical	O	O
and	O	O
microbiological	O	O
study	O	O
was	O	O
designed	O	O
to	O	O
check	O	O
the	O	O
validity	O	O
of	O	O
such	O	O
claims	O	O
.	O	O

This	O	O
study	O	O
included	O	O
88	O	O
patients	O	O
who	O	O
fulfilled	O	O
the	O	O
inclusion	O	O
criteria	O	O
.	O	O

Pus	O	O
was	O	O
obtained	O	O
by	O	O
aspirating	O	O
the	O	O
involved	O	O
spaces	O	O
and	O	O
culture	O	O
and	O	O
sensitivity	O	O
tests	O	O
were	O	O
performed	O	O
to	O	O
determine	O	O
the	O	O
microbes	O	O
involved	O	O
and	O	O
their	O	O
sensitivity	O	O
to	O	O
various	O	O
antibiotics	O	O
.	O	O

Upon	O	O
isolating	O	O
the	O	O
various	O	O
organisms	O	O
causing	O	O
infection	O	O
,	O	O
it	O	O
was	O	O
found	O	O
that	O	O
68.2	O	O
%	O	O
were	O	O
aerobes	B-bacteria	B-bacteria
,	O	O
13.6	O	O
%	O	O
were	O	O
mixed	O	O
infections	O	O
,	O	O
and	O	O
9.1	O	O
%	O	O
were	O	O
anaerobes	B-bacteria	B-bacteria
.	O	O

Streptococcus	B-bacteria	B-bacteria
and	O	O
Peptostreptococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
were	O	O
the	O	O
most	O	O
common	O	O
among	O	O
aerobes	B-bacteria	B-bacteria
and	O	O
anaerobes	B-bacteria	B-bacteria
,	O	O
respectively	O	O
.	O	O

On	O	O
determining	O	O
sensitivity	O	O
to	O	O
penicillin	O	O
,	O	O
81.3	O	O
%	O	O
were	O	O
sensitive	O	O
and	O	O
18.8	O	O
%	O	O
were	O	O
resistant	O	O
.	O	O

Coagulase-negative	B-bacteria	B-bacteria
Staphylococcus	E-bacteria	I-bacteria
and	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
were	O	O
predominantly	O	O
resistant	O	O
to	O	O
penicillin	O	O
.	O	O

Analysis	O	O
of	O	O
the	O	O
results	O	O
indicated	O	O
no	O	O
change	O	O
in	O	O
microflora-causing	O	O
infections	O	O
in	O	O
the	O	O
maxillofacial	O	O
region	O	O
and	O	O
penicillin	O	O
remains	O	O
the	O	O
drug	O	O
of	O	O
choice	O	O
in	O	O
treating	O	O
these	O	O
infections	O	O
.	O	O

To	O	O
clarify	O	O
the	O	O
regulatory	O	O
mechanism	O	O
by	O	O
bactericidal	O	O
peptides	O	O
secretion	O	O
,	O	O
the	O	O
secretion	O	O
of	O	O
bactericidal	O	O
peptides	O	O
was	O	O
immunohistochemically	O	O
and	O	O
histoplanimetrically	O	O
compared	O	O
with	O	O
the	O	O
degree	O	O
of	O	O
Gram-positive/negative	O	O
bacterial	O	O
colonization	O	O
throughout	O	O
the	O	O
rat	O	O
alimentary	O	O
tract	O	O
.	O	O

In	O	O
the	O	O
associated	O	O
exocrine	O	O
glands	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
to	O	O
the	O	O
stomach	O	O
,	O	O
no	O	O
comparable	O	O
differences	O	O
were	O	O
observed	O	O
under	O	O
the	O	O
changes	O	O
of	O	O
development	O	O
of	O	O
indigenous	O	O
bacterial	O	O
colonies	O	O
.	O	O

In	O	O
the	O	O
small	O	O
intestine	O	O
,	O	O
immunopositive	O	O
granules	O	O
for	O	O
lysozyme	O	O
and	O	O
secretory	O	O
phospholipase	O	O
A2	O	O
(	O	O
sPLA2	O	O
)	O	O
were	O	O
markedly	O	O
decreased	O	O
,	O	O
whereas	O	O
immunopositive	O	O
vacuoles	O	O
in	O	O
the	O	O
Paneth	O	O
cells	O	O
were	O	O
more	O	O
increased	O	O
at	O	O
sites	O	O
with	O	O
hyper-development	O	O
of	O	O
indigenous	O	O
bacterial	O	O
colonies	O	O
in	O	O
the	O	O
intervillous	O	O
spaces	O	O
than	O	O
at	O	O
sites	O	O
with	O	O
no	O	O
or	O	O
less	O	O
development	O	O
.	O	O

No	O	O
changes	O	O
in	O	O
exocrine	O	O
glands	O	O
were	O	O
observed	O	O
in	O	O
the	O	O
large	O	O
intestine	O	O
because	O	O
of	O	O
the	O	O
constant	O	O
existence	O	O
of	O	O
large	O	O
quantities	O	O
of	O	O
bacteria	O	O
.	O	O

Gram-positive	O	O
bacterial	O	O
colonies	O	O
on	O	O
the	O	O
mucosal	O	O
surfaces	O	O
were	O	O
dominant	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
to	O	O
the	O	O
stomach	O	O
.	O	O

Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
dominant	O	O
in	O	O
the	O	O
large	O	O
intestine	O	O
,	O	O
and	O	O
the	O	O
distributions	O	O
of	O	O
both	O	O
Gram-positive	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
intermediate	O	O
in	O	O
the	O	O
small	O	O
intestine	O	O
.	O	O

These	O	O
findings	O	O
suggest	O	O
that	O	O
lysozyme	O	O
and	O	O
sPLA2	O	O
secreted	O	O
from	O	O
the	O	O
Paneth	O	O
cells	O	O
contribute	O	O
to	O	O
the	O	O
regulation	O	O
of	O	O
the	O	O
proliferation	O	O
of	O	O
indigenous	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
the	O	O
intervillous	O	O
spaces	O	O
of	O	O
the	O	O
small	O	O
intestine	O	O
,	O	O
and	O	O
that	O	O
the	O	O
inversion	O	O
of	O	O
distributions	O	O
of	O	O
Gram-positive	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
the	O	O
alimentary	O	O
tract	O	O
might	O	O
be	O	O
caused	O	O
by	O	O
the	O	O
secretion	O	O
of	O	O
lysozyme	O	O
and	O	O
sPLA2	O	O
in	O	O
the	O	O
small	O	O
intestine	O	O
.	O	O

The	O	O
goal	O	O
of	O	O
this	O	O
project	O	O
was	O	O
to	O	O
develop	O	O
an	O	O
alternative	O	O
foot	O	O
and	O	O
mouth	O	O
disease	O	O
(	O	O
FMD	O	O
)	O	O
vaccine	O	O
candidate	O	O
based	O	O
on	O	O
a	O	O
recombinant	O	O
protein	O	O
consisting	O	O
of	O	O
efficient	O	O
viral	O	O
epitopes	O	O
.	O	O

A	O	O
recombinant	O	O
gene	O	O
was	O	O
designed	O	O
that	O	O
encodes	O	O
B-cell	O	O
epitopes	O	O
of	O	O
proteins	O	O
VP1	O	O
and	O	O
VP4	O	O
and	O	O
T-cell	O	O
epitopes	O	O
of	O	O
proteins	O	O
2C	O	O
and	O	O
3D	O	O
.	O	O

The	O	O
polyepitope	O	O
protein	O	O
(	O	O
H-PE	O	O
)	O	O
was	O	O
produced	O	O
in	O	O
E.	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
or	O	O
in	O	O
N.	O	O
benthamiana	O	O
plants	O	O
using	O	O
a	O	O
phytovirus	O	O
expression	O	O
system	O	O
.	O	O

The	O	O
methods	O	O
of	O	O
extraction	O	O
and	O	O
purification	O	O
of	O	O
H-PE	O	O
proteins	O	O
from	O	O
bacteria	O	O
and	O	O
plants	O	O
were	O	O
developed	O	O
.	O	O

Immunization	O	O
of	O	O
guinea	O	O
pigs	O	O
with	O	O
the	O	O
purified	O	O
H-PE	O	O
proteins	O	O
induced	O	O
an	O	O
efficient	O	O
immune	O	O
response	O	O
against	O	O
foot	O	O
and	O	O
mouth	O	O
disease	O	O
virus	O	O
(	O	O
FMDV	O	O
)	O	O
serotype	O	O
O/Taiwan/99	O	O
and	O	O
protection	O	O
against	O	O
the	O	O
disease	O	O
.	O	O

The	O	O
polyepitope	O	O
protein	O	O
H-PE	O	O
can	O	O
be	O	O
used	O	O
as	O	O
a	O	O
basis	O	O
for	O	O
developing	O	O
a	O	O
new	O	O
recombinant	O	O
vaccine	O	O
against	O	O
FMD	O	O
.	O	O

Although	O	O
Candida	O	O
albicans	O	O
has	O	O
been	O	O
isolated	O	O
from	O	O
periodontal	O	O
pockets	O	O
,	O	O
its	O	O
relationship	O	O
to	O	O
periodontitis	O	O
is	O	O
unclear	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
investigated	O	O
the	O	O
effect	O	O
of	O	O
C.	O	O
albicans	O	O
on	O	O
the	O	O
adhesion	O	O
and	O	O
invasion	O	O
of	O	O
Ca9-22	O	O
,	O	O
a	O	O
human	O	O
gingival	O	O
epithelial	O	O
cell	O	O
line	O	O
,	O	O
and	O	O
human	O	O
gingival	O	O
fibroblasts	O	O
by	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

Heat-killed	O	O
C.	O	O
albicans	O	O
and	O	O
water-soluble	O	O
mannoprotein-beta-glucan	O	O
complex	O	O
from	O	O
C.	O	O
albicans	O	O
(	O	O
CAWS	O	O
)	O	O
did	O	O
not	O	O
enhance	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
adhesion	O	O
or	O	O
upregulate	O	O
the	O	O
expression	O	O
of	O	O
beta1	O	O
integrin	O	O
and	O	O
ICAM-1	O	O
,	O	O
which	O	O
are	O	O
required	O	O
for	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
invasion	O	O
;	O	O
both	O	O
the	O	O
epithelial	O	O
cells	O	O
and	O	O
fibroblasts	O	O
expressed	O	O
dectin-1	O	O
,	O	O
which	O	O
recognizes	O	O
components	O	O
of	O	O
the	O	O
C.	O	O
albicans	O	O
cell	O	O
wall	O	O
.	O	O

However	O	O
,	O	O
pretreatment	O	O
of	O	O
Ca9-22	O	O
cells	O	O
and	O	O
human	O	O
gingival	O	O
fibroblasts	O	O
with	O	O
heat-killed	O	O
C.	O	O
albicans	O	O
or	O	O
CAWS	O	O
significantly	O	O
enhanced	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
invasion	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
C.	O	O
albicans	O	O
may	O	O
exacerbate	O	O
infectious	O	O
disease	O	O
by	O	O
enhancing	O	O
the	O	O
invasion	O	O
of	O	O
host	O	O
cells	O	O
by	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

Retrospective	O	O
and	O	O
prospective	O	O
studies	O	O
were	O	O
used	O	O
to	O	O
assess	O	O
the	O	O
numbers	O	O
,	O	O
types	O	O
and	O	O
persistence	O	O
of	O	O
microbes	O	O
that	O	O
contaminate	O	O
wind	O	O
instruments	O	O
.	O	O

All	O	O
previously	O	O
played	O	O
instruments	O	O
(	O	O
n	O	O
=	O	O
20	O	O
)	O	O
harbored	O	O
viable	O	O
bacteria	O	O
as	O	O
well	O	O
as	O	O
mold	O	O
and/or	O	O
yeast	O	O
.	O	O

Reedinstruments	O	O
consistently	O	O
carried	O	O
higher	O	O
microbial	O	O
loads	O	O
than	O	O
did	O	O
flutes	O	O
or	O	O
trumpets	O	O
.	O	O

Instruments	O	O
played	O	O
within	O	O
the	O	O
previous	O	O
three	O	O
days	O	O
bore	O	O
typical	O	O
mouth	O	O
flora	O	O
,	O	O
while	O	O
bacteria	O	O
recovered	O	O
after	O	O
72	O	O
h	O	O
following	O	O
play	O	O
consisted	O	O
of	O	O
normal	O	O
environmental	O	O
flora	O	O
.	O	O

Prospective	O	O
studies	O	O
tested	O	O
survival	O	O
of	O	O
potentially	O	O
pathogenic	O	O
bacteria	O	O
(	O	O
Staphylococcus	B-bacteria	B-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Moraxella	B-bacteria	B-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
and	O	O
attenuated	B-bacteria	B-bacteria
Mycobacterium	I-bacteria	I-bacteria
tuberculosis	E-bacteria	I-bacteria
)	O	O
when	O	O
applied	O	O
to	O	O
reeds	O	O
or	O	O
following	O	O
simulated	O	O
'play	O	O
'	O	O
of	O	O
a	O	O
clarinet	O	O
.	O	O

All	O	O
species	O	O
survived	O	O
for	O	O
a	O	O
maximum	O	O
of	O	O
24-48	O	O
h	O	O
on	O	O
reeds	O	O
,	O	O
except	O	O
Mycobacterium	B-bacteria	B-bacteria
,	O	O
which	O	O
persisted	O	O
through	O	O
13	O	O
days	O	O
.	O	O

In	O	O
simulated	O	O
play	O	O
experiments	O	O
,	O	O
test	O	O
bacteria	O	O
could	O	O
persist	O	O
for	O	O
up	O	O
to	O	O
five	O	O
days	O	O
.	O	O

These	O	O
findings	O	O
support	O	O
the	O	O
establishment	O	O
of	O	O
guidelines	O	O
for	O	O
decontamination	O	O
of	O	O
wind	O	O
instruments	O	O
and	O	O
for	O	O
sharing	O	O
or	O	O
transfer	O	O
of	O	O
these	O	O
instruments	O	O
among	O	O
players	O	O
.	O	O

Patients	O	O
with	O	O
xerostomia	O	O
,	O	O
or	O	O
dry	O	O
mouth	O	O
,	O	O
resulting	O	O
from	O	O
various	O	O
causes	O	O
,	O	O
are	O	O
at	O	O
higher	O	O
risk	O	O
for	O	O
developing	O	O
caries	O	O
because	O	O
of	O	O
a	O	O
loss	O	O
of	O	O
saliva	O	O
and	O	O
its	O	O
benefits	O	O
.	O	O

A	O	O
loss	O	O
of	O	O
saliva	O	O
increases	O	O
the	O	O
acidity	O	O
of	O	O
the	O	O
mouth	O	O
,	O	O
which	O	O
affects	O	O
many	O	O
factors	O	O
that	O	O
contribute	O	O
to	O	O
the	O	O
development	O	O
of	O	O
caries	O	O
,	O	O
such	O	O
as	O	O
proliferation	O	O
of	O	O
acid-producing	O	O
bacteria	O	O
,	O	O
inability	O	O
to	O	O
buffer	O	O
the	O	O
acid	O	O
produced	O	O
by	O	O
bacteria	O	O
or	O	O
from	O	O
ingested	O	O
foods	O	O
,	O	O
loss	O	O
of	O	O
minerals	O	O
from	O	O
tooth	O	O
surfaces	O	O
and	O	O
inability	O	O
to	O	O
replenish	O	O
the	O	O
lost	O	O
minerals	O	O
,	O	O
and	O	O
loss	O	O
of	O	O
lubrication	O	O
.	O	O

Currently	O	O
,	O	O
a	O	O
number	O	O
of	O	O
new	O	O
products	O	O
that	O	O
can	O	O
substitute	O	O
for	O	O
these	O	O
functions	O	O
of	O	O
saliva	O	O
or	O	O
induce	O	O
production	O	O
of	O	O
saliva	O	O
are	O	O
available	O	O
in	O	O
Canada	O	O
.	O	O

Some	O	O
of	O	O
these	O	O
products	O	O
are	O	O
reviewed	O	O
and	O	O
a	O	O
protocol	O	O
for	O	O
caries	O	O
prevention	O	O
in	O	O
this	O	O
high-risk	O	O
population	O	O
is	O	O
proposed	O	O
.	O	O

Trying	O	O
to	O	O
find	O	O
out	O	O
the	O	O
mechanism	O	O
of	O	O
microstructure	O	O
influencing	O	O
bacterial	O	O
adhesion	O	O
,	O	O
we	O	O
prepared	O	O
different	O	O
microstructures	O	O
to	O	O
compare	O	O
the	O	O
adsorptive	O	O
behavior	O	O
of	O	O
graphite	O	O
powder	O	O
and	O	O
adhesive	O	O
behavior	O	O
of	O	O
oral	O	O
microbe	O	O
.	O	O

We	O	O
used	O	O
polydimethylsiloxane	O	O
(	O	O
PDMS	O	O
)	O	O
to	O	O
copy	O	O
23	O	O
microstructures	O	O
of	O	O
hydroxyapatite	O	O
(	O	O
HA	O	O
)	O	O
chip	O	O
,	O	O
and	O	O
cultured	O	O
them	O	O
with	O	O
different	O	O
sizes	O	O
graphite	O	O
powder	O	O
and	O	O
oral	O	O
microbes	O	O
respectively	O	O
,	O	O
to	O	O
observe	O	O
and	O	O
compare	O	O
their	O	O
behavior	O	O
on	O	O
microstructures	O	O
.	O	O

The	O	O
adsorption	O	O
of	O	O
30-50	O	O
microm	O	O
powder	O	O
on	O	O
different	O	O
microstructures	O	O
was	O	O
insignificant	O	O
,	O	O
while	O	O
10-20	O	O
microm	O	O
powder	O	O
had	O	O
maximum	O	O
adsorption	O	O
on	O	O
10	O	O
microm	O	O
and	O	O
20	O	O
microm	O	O
microstructures	O	O
.	O	O

Saccharomyces	O	O
albicans	O	O
was	O	O
most	O	O
likely	O	O
to	O	O
adhere	O	O
to	O	O
5	O	O
microm	O	O
microstructures	O	O
which	O	O
was	O	O
equivalent	O	O
to	O	O
its	O	O
own	O	O
size	O	O
.	O	O

However	O	O
,	O	O
microstructures	O	O
had	O	O
little	O	O
effect	O	O
on	O	O
adhesion	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
which	O	O
grew	O	O
in	O	O
a	O	O
chain	O	O
.	O	O

The	O	O
size	O	O
of	O	O
microstructure	O	O
was	O	O
the	O	O
most	O	O
effective	O	O
factor	O	O
that	O	O
affects	O	O
the	O	O
adsorption	O	O
of	O	O
non-living	O	O
powder	O	O
,	O	O
and	O	O
it	O	O
also	O	O
had	O	O
the	O	O
same	O	O
effect	O	O
on	O	O
the	O	O
microbial	O	O
adhesion	O	O
;	O	O
but	O	O
some	O	O
special	O	O
bacteria	O	O
,	O	O
such	O	O
as	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
which	O	O
grew	O	O
in	O	O
a	O	O
chain	O	O
,	O	O
was	O	O
not	O	O
affected	O	O
by	O	O
the	O	O
sizes	O	O
or	O	O
shapes	O	O
of	O	O
microstructures	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
,	O	O
the	O	O
causative	O	O
agent	O	O
of	O	O
gastritis	O	O
and	O	O
gastric	O	O
ulcer	O	O
,	O	O
plays	O	O
a	O	O
crucial	O	O
role	O	O
in	O	O
development	O	O
of	O	O
gastric	O	O
carcinomas	O	O
.	O	O

Antibiotic	O	O
therapy	O	O
fails	O	O
in	O	O
almost	O	O
20	O	O
%	O	O
of	O	O
cases	O	O
due	O	O
to	O	O
development	O	O
of	O	O
antibiotic	O	O
resistance	O	O
.	O	O

Development	O	O
of	O	O
antibodies	O	O
against	O	O
specific	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
targets	O	O
could	O	O
have	O	O
significant	O	O
therapeutic	O	O
effect	O	O
.	O	O

In	O	O
the	O	O
present	O	O
research	O	O
attempts	O	O
have	O	O
been	O	O
made	O	O
to	O	O
study	O	O
the	O	O
effect	O	O
of	O	O
IgY	O	O
purified	O	O
from	O	O
egg	O	O
yolk	O	O
of	O	O
hens	O	O
immunized	O	O
with	O	O
recombinant	O	O
UreC	O	O
in	O	O
treatment	O	O
of	O	O
mice	O	O
infected	O	O
with	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

Purified	O	O
IgY-HpUc	O	O
was	O	O
used	O	O
in	O	O
two	O	O
forms	O	O
:	O	O
powdered	O	O
and	O	O
PBS	O	O
dissolved	O	O
.	O	O

10	O	O
(	O	O
9	O	O
)	O	O
bacteria	O	O
in	O	O
BHI	O	O
were	O	O
orally	O	O
administered	O	O
to	O	O
C57BL6/j	O	O
mice	O	O
three	O	O
times	O	O
on	O	O
alternate	O	O
day	O	O
intervals	O	O
.	O	O

Eight	O	O
weeks	O	O
after	O	O
the	O	O
last	O	O
inoculation	O	O
,	O	O
the	O	O
serum	O	O
was	O	O
assayed	O	O
for	O	O
infection	O	O
rate	O	O
by	O	O
ELISA	O	O
.	O	O

The	O	O
severity	O	O
of	O	O
gastritis	O	O
was	O	O
analyzed	O	O
histopathologically	O	O
.	O	O

Infected	O	O
mice	O	O
were	O	O
randomly	O	O
divided	O	O
into	O	O
three	O	O
groups	O	O
.	O	O

Groups	O	O
one	O	O
and	O	O
two	O	O
were	O	O
treated	O	O
with	O	O
dietary	O	O
IgY-HpUc	O	O
and	O	O
IgY-HpUc	O	O
dissolved	O	O
in	O	O
PBS	O	O
respectively	O	O
for	O	O
28	O	O
days	O	O
.	O	O

The	O	O
untreated	O	O
group	O	O
served	O	O
as	O	O
control	O	O
.	O	O

Serology	O	O
and	O	O
histopathology	O	O
confirmed	O	O
the	O	O
establishment	O	O
of	O	O
the	O	O
infection	O	O
.	O	O

Indirect	O	O
ELISA	O	O
results	O	O
in	O	O
the	O	O
treated	O	O
animals	O	O
showed	O	O
considerable	O	O
reduction	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
specific	O	O
antibodies	O	O
in	O	O
their	O	O
sera	O	O
.	O	O

Pathological	O	O
examination	O	O
of	O	O
gastric	O	O
mucosa	O	O
of	O	O
infected	O	O
mice	O	O
treated	O	O
with	O	O
IgY-HpUc	O	O
showed	O	O
considerable	O	O
reduction	O	O
of	O	O
inflammation	O	O
in	O	O
the	O	O
stomach	O	O
tissues	O	O
.	O	O

The	O	O
bacterial	O	O
presence	O	O
on	O	O
mucosal	O	O
layer	O	O
of	O	O
the	O	O
stomach	O	O
was	O	O
considerably	O	O
reduced	O	O
.	O	O

UreC-induced	O	O
IgY	O	O
is	O	O
specifically	O	O
successful	O	O
in	O	O
inhibition	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
and	O	O
could	O	O
be	O	O
an	O	O
alternative	O	O
to	O	O
antibiotic	O	O
treatment	O	O
.	O	O

The	O	O
vaginal	O	O
microbiome	O	O
,	O	O
which	O	O
harbors	O	O
beneficial	B-bacteria	B-bacteria
Lactobacillus	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
,	O	O
is	O	O
believed	O	O
to	O	O
be	O	O
a	O	O
major	O	O
host	O	O
defense	O	O
mechanism	O	O
for	O	O
preventing	O	O
infections	O	O
of	O	O
the	O	O
urogenital	O	O
tract	O	O
.	O	O

It	O	O
has	O	O
been	O	O
suggested	O	O
that	O	O
the	O	O
gastrointestinal	O	O
tract	O	O
serves	O	O
as	O	O
a	O	O
reservoir	O	O
for	O	O
lactobacilli	B-bacteria	B-bacteria
that	O	O
colonize	O	O
the	O	O
vagina	O	O
.	O	O

Using	O	O
rhesus	O	O
macaques	O	O
,	O	O
we	O	O
examined	O	O
whether	O	O
oral	O	O
delivery	O	O
of	O	O
human	O	O
vaginal	B-bacteria	B-bacteria
Lactobacillus	I-bacteria	I-bacteria
jensenii	I-bacteria	I-bacteria
1153-1646	E-bacteria	I-bacteria
,	O	O
a	O	O
GusA-producing	O	O
strain	O	O
,	O	O
would	O	O
result	O	O
in	O	O
colonization	O	O
of	O	O
the	O	O
rectum	O	O
and	O	O
the	O	O
vagina	O	O
.	O	O

Lactobacilli	B-bacteria	B-bacteria
were	O	O
identified	O	O
from	O	O
the	O	O
vagina	O	O
tracts	O	O
of	O	O
three	O	O
macaques	O	O
on	O	O
the	O	O
basis	O	O
of	O	O
beta-glucuronidase	O	O
enzyme	O	O
production	O	O
,	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
and	O	O
DNA	O	O
homology	O	O
using	O	O
a	O	O
repetitive	O	O
sequence-based	O	O
polymerase	O	O
chain	O	O
reaction	O	O
.	O	O

No	O	O
consensus	O	O
has	O	O
yet	O	O
been	O	O
reached	O	O
to	O	O
associate	O	O
oral	O	O
bacteria	O	O
conclusively	O	O
with	O	O
the	O	O
etio-pathogenesis	O	O
of	O	O
bisphosphonate-induced	O	O
osteonecrosis	O	O
of	O	O
the	O	O
jaw	O	O
(	O	O
BONJ	O	O
)	O	O
.	O	O

Therefore	O	O
,	O	O
the	O	O
present	O	O
study	O	O
examined	O	O
the	O	O
effects	O	O
of	O	O
oral	O	O
bacteria	O	O
on	O	O
the	O	O
development	O	O
of	O	O
BONJ-like	O	O
lesions	O	O
in	O	O
a	O	O
mouse	O	O
model	O	O
.	O	O

In	O	O
the	O	O
pamidronate	O	O
(	O	O
Pam	O	O
)	O	O
-treated	O	O
mice	O	O
,	O	O
but	O	O
not	O	O
control	O	O
non-drug-treated	O	O
mice	O	O
,	O	O
tooth	O	O
extraction	O	O
followed	O	O
by	O	O
oral	O	O
infection	O	O
with	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
caused	O	O
BONJ-like	O	O
lesions	O	O
and	O	O
delayed	O	O
epithelial	O	O
healing	O	O
,	O	O
both	O	O
of	O	O
which	O	O
were	O	O
completely	O	O
suppressed	O	O
by	O	O
a	O	O
broad-spectrum	O	O
antibiotic	O	O
cocktail	O	O
.	O	O

Furthermore	O	O
,	O	O
in	O	O
both	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo	O	O
experiments	O	O
,	O	O
the	O	O
combination	O	O
of	O	O
Pam	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
caused	O	O
the	O	O
death	O	O
of	O	O
gingival	O	O
fibroblasts	O	O
(	O	O
GFs	O	O
)	O	O
and	O	O
down-regulated	O	O
their	O	O
production	O	O
of	O	O
keratinocyte	O	O
growth	O	O
factor	O	O
(	O	O
KGF	O	O
)	O	O
,	O	O
which	O	O
induces	O	O
epithelial	O	O
cell	O	O
growth	O	O
and	O	O
migration	O	O
.	O	O

Therefore	O	O
,	O	O
in	O	O
periodontal	O	O
tissues	O	O
pre-exposed	O	O
to	O	O
bisphosphonate	O	O
,	O	O
bacterial	O	O
infection	O	O
at	O	O
tooth	O	O
extraction	O	O
sites	O	O
caused	O	O
diminished	O	O
KGF	O	O
expression	O	O
in	O	O
GFs	O	O
,	O	O
leading	O	O
to	O	O
a	O	O
delay	O	O
in	O	O
the	O	O
epithelial	O	O
wound-healing	O	O
process	O	O
that	O	O
was	O	O
mitigated	O	O
by	O	O
antibiotics	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
prevalence	O	O
of	O	O
dental	O	O
enamel	O	O
defects	O	O
,	O	O
recurrent	O	O
aphthous	O	O
stomatitis	O	O
(	O	O
RAS	O	O
)	O	O
and	O	O
caries	O	O
experience	O	O
and	O	O
to	O	O
measure	O	O
salivary	O	O
flow	O	O
rate	O	O
,	O	O
buffer	O	O
capacity	O	O
,	O	O
saliva	O	O
and	O	O
plaque	O	O
pH	O	O
and	O	O
salivary	O	O
cariogenic	O	O
microflora	O	O
in	O	O
patients	O	O
with	O	O
celiac	O	O
disease	O	O
(	O	O
CD	O	O
)	O	O
compared	O	O
to	O	O
healthy	O	O
subjects	O	O
.	O	O
Thirty-five	O	O
patients	O	O
,	O	O
aged	O	O
6-19	O	O
years	O	O
,	O	O
with	O	O
a	O	O
diagnosis	O	O
of	O	O
CD	O	O
and	O	O
35	O	O
healthy	O	O
children	O	O
of	O	O
the	O	O
same	O	O
age	O	O
participated	O	O
in	O	O
the	O	O
study	O	O
.	O	O

Enamel	O	O
defects	O	O
were	O	O
diagnosed	O	O
and	O	O
classified	O	O
using	O	O
Aine	O	O
's	O	O
classification	O	O
.	O	O

The	O	O
patients	O	O
with	O	O
RAS	O	O
and	O	O
dental	O	O
caries	O	O
were	O	O
recorded	O	O
using	O	O
WHO	O	O
criteria	O	O
.	O	O

The	O	O
parents	O	O
were	O	O
interviewed	O	O
about	O	O
various	O	O
oral	O	O
health-related	O	O
factors	O	O
.	O	O

Saliva	O	O
samples	O	O
were	O	O
collected	O	O
to	O	O
measure	O	O
the	O	O
stimulated	O	O
salivary	O	O
flow	O	O
rate	O	O
,	O	O
buffer	O	O
capacity	O	O
and	O	O
pH	O	O
values	O	O
of	O	O
saliva	O	O
and	O	O
plaque	O	O
.	O	O

Salivary	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
were	O	O
counted	O	O
.	O	O

The	O	O
enamel	O	O
defects	O	O
and	O	O
RAS	O	O
prevalence	O	O
were	O	O
statistically	O	O
higher	O	O
(	O	O
40	O	O
and	O	O
37.1	O	O
%	O	O
,	O	O
respectively	O	O
)	O	O
in	O	O
the	O	O
CD	O	O
group	O	O
,	O	O
and	O	O
the	O	O
prevalence	O	O
of	O	O
salivary	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
48	O	O
and	O	O
14	O	O
%	O	O
)	O	O
and	O	O
lactobacilli	B-bacteria	B-bacteria
(	O	O
51	O	O
and	O	O
34	O	O
%	O	O
)	O	O
colonization	O	O
was	O	O
statistically	O	O
lower	O	O
(	O	O
p	O	O
=	O	O
0.012	O	O
,	O	O
p	O	O
=	O	O
0.010	O	O
)	O	O
in	O	O
the	O	O
CD	O	O
group	O	O
;	O	O
the	O	O
DMFS	O	O
and	O	O
dfs	O	O
values	O	O
were	O	O
similar	O	O
in	O	O
both	O	O
groups	O	O
.	O	O

CD	O	O
appeared	O	O
to	O	O
be	O	O
associated	O	O
with	O	O
a	O	O
significantly	O	O
higher	O	O
prevalence	O	O
of	O	O
developing	O	O
enamel	O	O
defects	O	O
and	O	O
RAS	O	O
,	O	O
but	O	O
a	O	O
lower	O	O
prevalence	O	O
of	O	O
salivary	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
colonization	O	O
,	O	O
and	O	O
the	O	O
diagnosis	O	O
of	O	O
these	O	O
oral	O	O
manifestations	O	O
might	O	O
be	O	O
helpful	O	O
for	O	O
an	O	O
early	O	O
diagnosis	O	O
of	O	O
CD	O	O
.	O	O

Previously	O	O
,	O	O
we	O	O
reported	O	O
that	O	O
epithelial	O	O
cells	O	O
respond	O	O
to	O	O
exogenous	O	O
interleukin	O	O
(	O	O
IL	O	O
)	O	O
-1alpha	O	O
by	O	O
increasing	O	O
expression	O	O
of	O	O
several	O	O
genes	O	O
involved	O	O
in	O	O
the	O	O
host	O	O
response	O	O
to	O	O
microbes	O	O
,	O	O
including	O	O
the	O	O
antimicrobial	O	O
protein	O	O
complex	O	O
calprotectin	O	O
(	O	O
S100A8/A9	O	O
)	O	O
.	O	O

Given	O	O
that	O	O
S100A8/A9	O	O
protects	O	O
epithelial	O	O
cells	O	O
against	O	O
invading	O	O
bacteria	O	O
,	O	O
we	O	O
studied	O	O
whether	O	O
IL-1alpha	O	O
augments	O	O
S100A8/A9-dependent	O	O
resistance	O	O
to	O	O
bacterial	O	O
invasion	O	O
of	O	O
oral	O	O
keratinocytes	O	O
.	O	O

When	O	O
inoculated	O	O
with	O	O
Listeria	B-bacteria	B-bacteria
monocytogenes	E-bacteria	I-bacteria
,	O	O
human	O	O
buccal	O	O
epithelial	O	O
(	O	O
TR146	O	O
)	O	O
cells	O	O
expressed	O	O
and	O	O
released	O	O
IL-1alpha	O	O
.	O	O

Subsequently	O	O
,	O	O
IL-1alpha-containing	O	O
media	O	O
from	O	O
Listeria-infected	O	O
cells	O	O
increased	O	O
S100A8/A9	O	O
gene	O	O
expression	O	O
in	O	O
naive	O	O
TR146	O	O
cells	O	O
an	O	O
IL-1	O	O
receptor	O	O
(	O	O
IL-1R	O	O
)	O	O
-dependent	O	O
manner	O	O
.	O	O

Incubation	O	O
with	O	O
exogenous	O	O
IL-1alpha	O	O
decreased	O	O
Listeria	O	O
invasion	O	O
into	O	O
TR146	O	O
cells	O	O
,	O	O
whereas	O	O
invasion	O	O
increased	O	O
with	O	O
IL-1R	O	O
antagonist	O	O
.	O	O

Conversely	O	O
,	O	O
when	O	O
S100A8/A9	O	O
genes	O	O
were	O	O
knocked	O	O
down	O	O
using	O	O
short	O	O
hairpin	O	O
RNA	O	O
(	O	O
shRNA	O	O
)	O	O
,	O	O
TR146	O	O
cells	O	O
responded	O	O
to	O	O
exogenous	O	O
IL-1alpha	O	O
with	O	O
increased	O	O
intracellular	O	O
bacteria	O	O
.	O	O

These	O	O
data	O	O
strongly	O	O
suggest	O	O
that	O	O
infected	O	O
epithelial	O	O
cells	O	O
release	O	O
IL-1alpha	O	O
to	O	O
signal	O	O
neighboring	O	O
keratinocytes	O	O
in	O	O
a	O	O
paracrine	O	O
manner	O	O
,	O	O
promoting	O	O
S100A8/A9-dependent	O	O
resistance	O	O
to	O	O
invasive	O	O
L.	B-bacteria	B-bacteria
monocytogenes	E-bacteria	I-bacteria
.	O	O

Modifications	O	O
of	O	O
titanium	O	O
(	O	O
Ti	O	O
)	O	O
implant	O	O
surfaces	O	O
have	O	O
a	O	O
significant	O	O
effect	O	O
on	O	O
early	O	O
biofilm	O	O
formation	O	O
and	O	O
the	O	O
outcome	O	O
of	O	O
implant	O	O
procedures	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
examine	O	O
the	O	O
role	O	O
of	O	O
plasma	O	O
proteins	O	O
and	O	O
electrostatic	O	O
forces	O	O
in	O	O
the	O	O
adhesion	O	O
mechanism	O	O
of	O	O
oral	O	O
bacteria	O	O
to	O	O
modified	O	O
Ti	O	O
surfaces	O	O
.	O	O

Ti	O	O
discs	O	O
with	O	O
three	O	O
different	O	O
types	O	O
of	O	O
surface	O	O
modifications	O	O
,	O	O
machined	O	O
,	O	O
acid-etched	O	O
,	O	O
and	O	O
acid-etched	O	O
and	O	O
blasted	O	O
,	O	O
were	O	O
examined	O	O
for	O	O
adhesion	O	O
of	O	O
oral	O	O
bacteria	O	O
:	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

Following	O	O
pretreatment	O	O
of	O	O
the	O	O
Ti	O	O
with	O	O
ion	O	O
rich	O	O
solutions	O	O
or	O	O
coating	O	O
by	O	O
human	O	O
serum	O	O
albumin	O	O
or	O	O
fibronectin	O	O
,	O	O
bacterial	O	O
adhesion	O	O
was	O	O
examined	O	O
by	O	O
scanning	O	O
electron	O	O
microscopy	O	O
and	O	O
assessed	O	O
quantitatively	O	O
by	O	O
DNA	O	O
analysis	O	O
.	O	O

Ti	O	O
coating	O	O
by	O	O
proteins	O	O
as	O	O
well	O	O
as	O	O
bacterial	O	O
adhesion	O	O
and	O	O
their	O	O
interrelationships	O	O
were	O	O
further	O	O
investigated	O	O
through	O	O
confocal	O	O
scanning	O	O
laser	O	O
microscopy	O	O
.	O	O

Acid-etched	O	O
and	O	O
blasted	O	O
Ti	O	O
surfaces	O	O
exhibited	O	O
significantly	O	O
higher	O	O
amounts	O	O
of	O	O
bacteria	O	O
adhesion	O	O
than	O	O
the	O	O
other	O	O
two	O	O
surfaces	O	O
.	O	O

Calcium	O	O
was	O	O
found	O	O
to	O	O
serve	O	O
as	O	O
a	O	O
bridging	O	O
agent	O	O
in	O	O
the	O	O
adhesion	O	O
process	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
to	O	O
Ti	O	O
surfaces	O	O
.	O	O

Although	O	O
albumin	O	O
coating	O	O
of	O	O
the	O	O
Ti	O	O
reduced	O	O
the	O	O
adhesion	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
to	O	O
all	O	O
surfaces	O	O
,	O	O
it	O	O
had	O	O
no	O	O
influence	O	O
on	O	O
the	O	O
adhesion	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
or	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

Coating	O	O
the	O	O
Ti	O	O
with	O	O
fibronectin	O	O
enhanced	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
adhesion	O	O
.	O	O

Bacterial	O	O
adhesion	O	O
to	O	O
Ti	O	O
surfaces	O	O
is	O	O
roughness-dependent	O	O
,	O	O
and	O	O
the	O	O
adhesion	O	O
mechanism	O	O
is	O	O
influenced	O	O
by	O	O
ions	O	O
and	O	O
proteins	O	O
of	O	O
the	O	O
initial	O	O
coating	O	O
derived	O	O
from	O	O
the	O	O
blood	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
the	O	O
profiles	O	O
of	O	O
periodontopathogenic	O	O
bacteria	O	O
in	O	O
a	O	O
Chinese	O	O
population	O	O
using	O	O
quantitative	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
qRT-PCR	O	O
)	O	O
.	O	O

Twenty-four	O	O
periodontally	O	O
healthy	O	O
Chinese	O	O
subjects	O	O
and	O	O
60	O	O
patients	O	O
with	O	O
chronic	O	O
periodontitis	O	O
(	O	O
CP	O	O
)	O	O
were	O	O
enrolled	O	O
in	O	O
this	O	O
cross-sectional	O	O
study	O	O
.	O	O

qRT-PCR	O	O
was	O	O
used	O	O
to	O	O
quantify	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
as	O	O
well	O	O
as	O	O
total	O	O
bacterial	O	O
counts	O	O
from	O	O
252	O	O
samples	O	O
collected	O	O
from	O	O
the	O	O
saliva	O	O
,	O	O
supragingival	O	O
plaque	O	O
,	O	O
and	O	O
subgingival	O	O
plaque	O	O
of	O	O
all	O	O
84	O	O
subjects	O	O
.	O	O

The	O	O
detection	O	O
frequency	O	O
of	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
was	O	O
less	O	O
than	O	O
50	O	O
%	O	O
.	O	O

F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
all	O	O
subjects	O	O
and	O	O
CP	O	O
patients	O	O
had	O	O
higher	O	O
bacterial	O	O
loads	O	O
than	O	O
healthy	O	O
subjects	O	O
.	O	O

The	O	O
median	O	O
proportion	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
was	O	O
significantly	O	O
higher	O	O
in	O	O
subgingival	O	O
plaque	O	O
than	O	O
in	O	O
supragingival	O	O
plaque	O	O
and	O	O
saliva	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
had	O	O
higher	O	O
detection	O	O
frequencies	O	O
and	O	O
bacterial	O	O
loads	O	O
in	O	O
CP	O	O
patients	O	O
than	O	O
in	O	O
healthy	O	O
subjects	O	O
.	O	O

The	O	O
median	O	O
proportion	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
significantly	O	O
different	O	O
among	O	O
the	O	O
three	O	O
intraoral	O	O
locations	O	O
in	O	O
the	O	O
CP	O	O
group	O	O
and	O	O
its	O	O
proportion	O	O
in	O	O
subgingival	O	O
plaque	O	O
was	O	O
9.01	O	O
%	O	O
.	O	O

Moreover	O	O
,	O	O
strong	O	O
positive	O	O
Spearman	O	O
's	O	O
correlations	O	O
were	O	O
found	O	O
in	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
counts	O	O
across	O	O
the	O	O
three	O	O
intraoral	O	O
locations	O	O
.	O	O

The	O	O
presence	O	O
and	O	O
bacteria	O	O
loads	O	O
of	O	O
these	O	O
four	O	O
bacteria	O	O
in	O	O
this	O	O
Chinese	O	O
population	O	O
are	O	O
similar	O	O
to	O	O
those	O	O
from	O	O
other	O	O
populations	O	O
.	O	O

Examination	O	O
of	O	O
bacterial	O	O
detection	O	O
frequency	O	O
and	O	O
loads	O	O
in	O	O
Chinese	O	O
adults	O	O
may	O	O
assist	O	O
microbial	O	O
studies	O	O
of	O	O
periodontal	O	O
disease	O	O
and	O	O
will	O	O
shed	O	O
light	O	O
on	O	O
periodontal	O	O
disease	O	O
diagnosis	O	O
and	O	O
treatment	O	O
using	O	O
antibiotics	O	O
in	O	O
the	O	O
Chinese	O	O
population	O	O
.	O	O

Recently	O	O
,	O	O
plasma	O	O
sterilization	O	O
has	O	O
attracted	O	O
increasing	O	O
attention	O	O
in	O	O
dental	O	O
community	O	O
for	O	O
the	O	O
atmospheric	O	O
pressure	O	O
non-equilibrium	O	O
plasma	O	O
jet	O	O
(	O	O
APNPs	O	O
)	O	O
,	O	O
which	O	O
is	O	O
driven	O	O
by	O	O
a	O	O
kilohertz	O	O
pulsed	O	O
DC	O	O
power	O	O
,	O	O
may	O	O
be	O	O
applied	O	O
to	O	O
the	O	O
dental	O	O
and	O	O
oral	O	O
diseases	O	O
.	O	O

However	O	O
,	O	O
it	O	O
is	O	O
still	O	O
in	O	O
doubt	O	O
whether	O	O
APNPs	O	O
can	O	O
effectively	O	O
kill	O	O
pathogenic	O	O
bacteria	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
produce	O	O
no	O	O
harmful	O	O
effects	O	O
on	O	O
normal	O	O
oral	O	O
tissues	O	O
,	O	O
especially	O	O
on	O	O
normal	O	O
mucosa	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
bacterial-killing	O	O
effect	O	O
of	O	O
APNPs	O	O
in	O	O
the	O	O
biofilms	O	O
containing	O	O
a	O	O
single	O	O
breed	O	O
of	O	O
bacteria	O	O
(	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
P.g	B-bacteria	B-bacteria
.	E-bacteria	I-bacteria

)	O	O
,	O	O
and	O	O
the	O	O
pathological	O	O
changes	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
after	O	O
treatment	O	O
by	O	O
APNPs	O	O
.	O	O

P.g	B-bacteria	B-bacteria
.	E-bacteria	I-bacteria

was	O	O
incubated	O	O
to	O	O
form	O	O
the	O	O
biofilms	O	O
in	O	O
vitro	O	O
,	O	O
and	O	O
the	O	O
samples	O	O
were	O	O
divided	O	O
into	O	O
three	O	O
groups	O	O
randomly	O	O
:	O	O
group	O	O
A	O	O
(	O	O
blank	O	O
control	O	O
)	O	O
;	O	O
group	O	O
B	O	O
in	O	O
which	O	O
the	O	O
biofilms	O	O
were	O	O
treated	O	O
by	O	O
APNPs	O	O
(	O	O
the	O	O
setting	O	O
of	O	O
the	O	O
equipment	O	O
:	O	O
10	O	O
kHz	O	O
,	O	O
1600	O	O
ns	O	O
and	O	O
8	O	O
kV	O	O
)	O	O
;	O	O
group	O	O
C	O	O
in	O	O
which	O	O
the	O	O
biofilms	O	O
were	O	O
exposed	O	O
only	O	O
to	O	O
a	O	O
gas	O	O
jet	O	O
without	O	O
ignition	O	O
of	O	O
the	O	O
plasma	O	O
.	O	O

Each	O	O
group	O	O
had	O	O
three	O	O
samples	O	O
and	O	O
each	O	O
sample	O	O
was	O	O
processed	O	O
for	O	O
up	O	O
to	O	O
5	O	O
min	O	O
.	O	O

The	O	O
biofilms	O	O
were	O	O
then	O	O
fluorescently	O	O
stained	O	O
,	O	O
observed	O	O
and	O	O
photographed	O	O
under	O	O
a	O	O
laser	O	O
scanning	O	O
confocal	O	O
microscope	O	O
.	O	O

In	O	O
the	O	O
animal	O	O
experiment	O	O
,	O	O
six	O	O
male	O	O
Japanese	O	O
white	O	O
rabbits	O	O
were	O	O
divided	O	O
into	O	O
two	O	O
groups	O	O
randomly	O	O
(	O	O
n=3	O	O
in	O	O
each	O	O
group	O	O
)	O	O
in	O	O
terms	O	O
of	O	O
the	O	O
different	O	O
post-treatment	O	O
time	O	O
(	O	O
1-day	O	O
group	O	O
and	O	O
5-day	O	O
group	O	O
)	O	O
.	O	O

The	O	O
buccal	O	O
mucosa	O	O
of	O	O
the	O	O
left	O	O
side	O	O
and	O	O
the	O	O
mucosa	O	O
of	O	O
the	O	O
ventral	O	O
surface	O	O
of	O	O
the	O	O
tongue	O	O
were	O	O
treated	O	O
by	O	O
APNPs	O	O
for	O	O
10	O	O
min	O	O
in	O	O
the	O	O
same	O	O
way	O	O
as	O	O
the	O	O
bacterial	O	O
biofilm	O	O
experiment	O	O
in	O	O
each	O	O
rabbit	O	O
,	O	O
and	O	O
the	O	O
corresponding	O	O
mucosa	O	O
of	O	O
the	O	O
other	O	O
sides	O	O
served	O	O
as	O	O
normal	O	O
control	O	O
.	O	O

The	O	O
clinical	O	O
manifestations	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
were	O	O
observed	O	O
and	O	O
recorded	O	O
every	O	O
day	O	O
.	O	O

The	O	O
rabbits	O	O
were	O	O
sacrificed	O	O
one	O	O
or	O	O
five	O	O
day	O	O
(	O	O
s	O	O
)	O	O
after	O	O
APNPs	O	O
treatment	O	O
.	O	O

The	O	O
oral	O	O
mucosa	O	O
were	O	O
harvested	O	O
and	O	O
prepared	O	O
to	O	O
haematoxylin	O	O
and	O	O
eosin-stained	O	O
sections	O	O
.	O	O

Clinical	O	O
observation	O	O
and	O	O
histopathological	O	O
scores	O	O
were	O	O
used	O	O
to	O	O
assess	O	O
mucosal	O	O
changes	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
the	O	O
obvious	O	O
P.g	B-bacteria	B-bacteria
.	E-bacteria	I-bacteria

biofilms	O	O
were	O	O
formed	O	O
at	O	O
10	O	O
days	O	O
,	O	O
and	O	O
most	O	O
of	O	O
the	O	O
bacteria	O	O
in	O	O
groups	O	O
A	O	O
and	O	O
C	O	O
were	O	O
alive	O	O
under	O	O
a	O	O
laser	O	O
scanning	O	O
confocal	O	O
microscope	O	O
,	O	O
but	O	O
the	O	O
bacteria	O	O
in	O	O
the	O	O
group	O	O
B	O	O
were	O	O
almost	O	O
all	O	O
dead	O	O
.	O	O

In	O	O
animal	O	O
experiment	O	O
,	O	O
no	O	O
ulcers	O	O
,	O	O
anabrosis	O	O
and	O	O
oral	O	O
mucositis	O	O
were	O	O
found	O	O
in	O	O
both	O	O
the	O	O
1-day	O	O
and	O	O
5-day	O	O
groups	O	O
.	O	O

The	O	O
average	O	O
mucous	O	O
membrane	O	O
irritation	O	O
index	O	O
was	O	O
-0.83	O	O
and	O	O
-0.67	O	O
in	O	O
the	O	O
1-day	O	O
and	O	O
5-day	O	O
groups	O	O
,	O	O
respectively	O	O
,	O	O
suggesting	O	O
that	O	O
no	O	O
intense	O	O
mucosal	O	O
membrane	O	O
irritation	O	O
responses	O	O
occurred	O	O
.	O	O

It	O	O
was	O	O
concluded	O	O
that	O	O
APNPs	O	O
could	O	O
effectively	O	O
kill	O	O
P.g	B-bacteria	B-bacteria
.	E-bacteria	I-bacteria

in	O	O
the	O	O
biofilms	O	O
and	O	O
did	O	O
not	O	O
cause	O	O
any	O	O
pathological	O	O
changes	O	O
in	O	O
the	O	O
normal	O	O
mucosa	O	O
,	O	O
suggesting	O	O
that	O	O
the	O	O
plasma	O	O
jet	O	O
(	O	O
APNPs	O	O
)	O	O
may	O	O
be	O	O
applied	O	O
to	O	O
oral	O	O
diseases	O	O
as	O	O
a	O	O
novel	O	O
sterilization	O	O
device	O	O
in	O	O
the	O	O
future	O	O
.	O	O

This	O	O
study	O	O
sought	O	O
to	O	O
determine	O	O
whether	O	O
the	O	O
mechanical	O	O
properties	O	O
of	O	O
titanium	O	O
dental	O	O
implants	O	O
changed	O	O
after	O	O
exposure	O	O
to	O	O
bacteria	O	O
.	O	O

Two	O	O
strains	O	O
of	O	O
bacteria	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
)	O	O
were	O	O
used	O	O
in	O	O
the	O	O
study	O	O
.	O	O

The	O	O
adhesive	O	O
properties	O	O
of	O	O
the	O	O
two	O	O
strains	O	O
were	O	O
investigated	O	O
as	O	O
follows	O	O
.	O	O

Titanium	O	O
implants	O	O
were	O	O
placed	O	O
in	O	O
bacteria	O	O
broth	O	O
,	O	O
seeded	O	O
with	O	O
the	O	O
two	O	O
bacteria	O	O
strains	O	O
,	O	O
and	O	O
left	O	O
in	O	O
the	O	O
broth	O	O
for	O	O
1	O	O
or	O	O
3	O	O
months	O	O
.	O	O

Another	O	O
group	O	O
of	O	O
titanium	O	O
implants	O	O
was	O	O
immersed	O	O
in	O	O
artificial	O	O
saliva	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
for	O	O
3	O	O
months	O	O
.	O	O

Ten	O	O
implants	O	O
in	O	O
each	O	O
group	O	O
were	O	O
tested	O	O
in	O	O
37	O	O
degrees	O	O
C	O	O
artificial	O	O
saliva	O	O
to	O	O
evaluate	O	O
their	O	O
mechanical	O	O
flexural	O	O
strength	O	O
and	O	O
fatigue	O	O
life	O	O
.	O	O

The	O	O
bacterial	O	O
cultures	O	O
grew	O	O
quickly	O	O
on	O	O
titanium	O	O
surfaces	O	O
.	O	O

After	O	O
1	O	O
month	O	O
of	O	O
bacteria	O	O
culture	O	O
in	O	O
vitro	O	O
,	O	O
the	O	O
bacteria	O	O
had	O	O
produced	O	O
corrosion	O	O
pits	O	O
on	O	O
the	O	O
titanium	O	O
surfaces	O	O
.	O	O

After	O	O
3	O	O
months	O	O
of	O	O
bacterial	O	O
culture	O	O
,	O	O
a	O	O
7	O	O
%	O	O
decrease	O	O
in	O	O
the	O	O
flexural	O	O
strength	O	O
of	O	O
the	O	O
implant	O	O
samples	O	O
and	O	O
a	O	O
decrease	O	O
of	O	O
15	O	O
%	O	O
in	O	O
the	O	O
number	O	O
of	O	O
cycles	O	O
to	O	O
failure	O	O
by	O	O
fatigue	O	O
were	O	O
seen	O	O
versus	O	O
implants	O	O
not	O	O
exposed	O	O
to	O	O
bacteria	O	O
.	O	O

These	O	O
results	O	O
demonstrate	O	O
that	O	O
,	O	O
in	O	O
physiologic	O	O
conditions	O	O
in	O	O
vitro	O	O
,	O	O
bacteria	O	O
have	O	O
the	O	O
capacity	O	O
to	O	O
produce	O	O
a	O	O
pitting	O	O
corrosion	O	O
phenomenon	O	O
on	O	O
exposed	O	O
titanium	O	O
surfaces	O	O
,	O	O
leading	O	O
to	O	O
a	O	O
significant	O	O
deterioration	O	O
in	O	O
the	O	O
mechanical	O	O
properties	O	O
of	O	O
the	O	O
implant	O	O
.	O	O

It	O	O
is	O	O
therefore	O	O
logical	O	O
to	O	O
conclude	O	O
that	O	O
bacteria	O	O
may	O	O
produce	O	O
corrosion	O	O
that	O	O
reduces	O	O
the	O	O
useful	O	O
life	O	O
of	O	O
dental	O	O
implants	O	O
.	O	O

Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
is	O	O
found	O	O
ubiquitously	O	O
in	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
and	O	O
is	O	O
mainly	O	O
associated	O	O
with	O	O
bacterial	O	O
communities	O	O
implicated	O	O
in	O	O
the	O	O
establishment	O	O
and	O	O
development	O	O
of	O	O
periodontal	O	O
disease	O	O
.	O	O

The	O	O
ability	O	O
to	O	O
become	O	O
integrated	O	O
within	O	O
biofilm	O	O
communities	O	O
is	O	O
crucial	O	O
to	O	O
the	O	O
growth	O	O
and	O	O
survival	O	O
of	O	O
oral	O	O
bacteria	O	O
,	O	O
and	O	O
involves	O	O
inter-bacterial	O	O
coaggregation	O	O
,	O	O
metabolic	O	O
cooperation	O	O
,	O	O
and	O	O
synergy	O	O
against	O	O
host	O	O
defences	O	O
.	O	O

In	O	O
this	O	O
article	O	O
we	O	O
show	O	O
that	O	O
the	O	O
chymotrypsin-like	O	O
proteinase	O	O
(	O	O
CTLP	O	O
)	O	O
,	O	O
found	O	O
within	O	O
a	O	O
high-molecular-mass	O	O
complex	O	O
on	O	O
the	O	O
cell	O	O
surface	O	O
,	O	O
mediates	O	O
adherence	O	O
of	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
to	O	O
other	O	O
potential	O	O
periodontal	O	O
pathogens	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
Parvimonas	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
.	O	O

Proteolytic	O	O
activity	O	O
per	O	O
se	O	O
did	O	O
not	O	O
appear	O	O
to	O	O
be	O	O
required	O	O
for	O	O
the	O	O
interactions	O	O
,	O	O
and	O	O
expression	O	O
of	O	O
the	O	O
major	O	O
outer-sheath	O	O
protein	O	O
(	O	O
Msp	O	O
)	O	O
was	O	O
not	O	O
necessary	O	O
,	O	O
except	O	O
for	O	O
binding	O	O
Parv	O	O
.	O	O

micra	O	O
.	O	O

Biofilms	O	O
of	O	O
densely	O	O
packed	O	O
cells	O	O
and	O	O
matrix	O	O
,	O	O
up	O	O
to	O	O
40	O	O
microm	O	O
in	O	O
depth	O	O
,	O	O
were	O	O
formed	O	O
between	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
on	O	O
salivary	O	O
pellicle	O	O
,	O	O
with	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
cells	O	O
enriched	O	O
in	O	O
the	O	O
upper	O	O
layers	O	O
.	O	O

Expression	O	O
of	O	O
CTLP	O	O
,	O	O
but	O	O
not	O	O
Msp	O	O
,	O	O
was	O	O
critical	O	O
for	O	O
dual-species	O	O
biofilm	O	O
formation	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
did	O	O
not	O	O
form	O	O
dual-species	O	O
biofilms	O	O
with	O	O
any	O	O
of	O	O
the	O	O
other	O	O
three	O	O
periodontal	O	O
bacterial	O	O
species	O	O
under	O	O
various	O	O
conditions	O	O
.	O	O

Synergy	O	O
between	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
also	O	O
shown	O	O
by	O	O
increased	O	O
inhibition	O	O
of	O	O
blood	O	O
clotting	O	O
,	O	O
which	O	O
was	O	O
CTLP-dependent	O	O
.	O	O

The	O	O
results	O	O
demonstrate	O	O
the	O	O
critical	O	O
role	O	O
of	O	O
CTLP	O	O
in	O	O
interactions	O	O
of	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
with	O	O
other	O	O
oral	O	O
micro-organisms	O	O
,	O	O
leading	O	O
to	O	O
synergy	O	O
in	O	O
microbial	O	O
community	O	O
development	O	O
and	O	O
host	O	O
tissue	O	O
pathogenesis	O	O
.	O	O

Periodontitis	O	O
is	O	O
an	O	O
inflammatory	O	O
disease	O	O
caused	O	O
by	O	O
pathogenic	O	O
microorganisms	O	O
,	O	O
such	O	O
as	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
characterized	O	O
by	O	O
the	O	O
destruction	O	O
of	O	O
the	O	O
periodontium	O	O
.	O	O

Obese	O	O
individuals	O	O
have	O	O
an	O	O
increased	O	O
risk	O	O
for	O	O
periodontitis	O	O
and	O	O
show	O	O
decreased	O	O
serum	O	O
levels	O	O
of	O	O
adiponectin	O	O
.	O	O

This	O	O
in-vitro	O	O
study	O	O
was	O	O
established	O	O
to	O	O
examine	O	O
whether	O	O
adiponectin	O	O
modulates	O	O
critical	O	O
effects	O	O
of	O	O
lipopolysaccharide	O	O
(	O	O
LPS	O	O
)	O	O
from	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
on	O	O
oral	O	O
epithelial	O	O
cells	O	O
(	O	O
OECs	O	O
)	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
adiponectin	O	O
and	O	O
its	O	O
receptors	O	O
in	O	O
human	O	O
gingival	O	O
tissue	O	O
samples	O	O
and	O	O
OECs	O	O
was	O	O
analyzed	O	O
by	O	O
immunohistochemistry	O	O
and	O	O
PCR	O	O
.	O	O

Furthermore	O	O
,	O	O
OECs	O	O
were	O	O
treated	O	O
with	O	O
LPS	O	O
and/or	O	O
adiponectin	O	O
for	O	O
up	O	O
to	O	O
72	O	O
h	O	O
,	O	O
and	O	O
the	O	O
gene	O	O
expression	O	O
and	O	O
protein	O	O
synthesis	O	O
of	O	O
pro-	O	O
and	O	O
anti-inflammatory	O	O
mediators	O	O
,	O	O
matrix	O	O
metalloproteinases	O	O
(	O	O
MMPs	O	O
)	O	O
and	O	O
growth	O	O
factors	O	O
were	O	O
analyzed	O	O
by	O	O
real-time	O	O
PCR	O	O
and	O	O
ELISA	O	O
.	O	O

Additionally	O	O
,	O	O
cell	O	O
proliferation	O	O
,	O	O
differentiation	O	O
and	O	O
in-vitro	O	O
wound	O	O
healing	O	O
were	O	O
studied	O	O
.	O	O

The	O	O
nuclear	O	O
translocation	O	O
of	O	O
NFkappaB	O	O
was	O	O
investigated	O	O
by	O	O
immunofluorescence	O	O
.	O	O

Gingival	O	O
tissue	O	O
sections	O	O
showed	O	O
a	O	O
strong	O	O
synthesis	O	O
of	O	O
adiponectin	O	O
and	O	O
its	O	O
receptors	O	O
in	O	O
the	O	O
epithelial	O	O
layer	O	O
.	O	O

In	O	O
cell	O	O
cultures	O	O
,	O	O
LPS	O	O
induced	O	O
a	O	O
significant	O	O
up-regulation	O	O
of	O	O
interleukin	O	O
(	O	O
IL	O	O
)	O	O
1beta	O	O
,	O	O
IL6	O	O
,	O	O
IL8	O	O
,	O	O
MMP1	O	O
and	O	O
MMP3	O	O
.	O	O

Adiponectin	O	O
abrogated	O	O
significantly	O	O
the	O	O
stimulatory	O	O
effects	O	O
of	O	O
LPS	O	O
on	O	O
these	O	O
molecules	O	O
.	O	O

Similarly	O	O
,	O	O
adiponectin	O	O
inhibited	O	O
significantly	O	O
the	O	O
LPS-induced	O	O
decrease	O	O
in	O	O
cell	O	O
viability	O	O
and	O	O
increase	O	O
in	O	O
cell	O	O
proliferation	O	O
and	O	O
differentiation	O	O
.	O	O

Adiponectin	O	O
led	O	O
to	O	O
a	O	O
time-dependent	O	O
induction	O	O
of	O	O
the	O	O
anti-inflammatory	O	O
mediators	O	O
IL10	O	O
and	O	O
heme	O	O
oxygenase	O	O
1	O	O
,	O	O
and	O	O
blocked	O	O
the	O	O
LPS-stimulated	O	O
NFkappaB	O	O
nuclear	O	O
translocation	O	O
.	O	O

Adiponectin	O	O
may	O	O
counteract	O	O
critical	O	O
actions	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
on	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

Low	O	O
levels	O	O
of	O	O
adiponectin	O	O
,	O	O
as	O	O
observed	O	O
in	O	O
obese	O	O
individuals	O	O
,	O	O
may	O	O
increase	O	O
the	O	O
risk	O	O
for	O	O
periodontal	O	O
inflammation	O	O
and	O	O
destruction	O	O

.	O	O

Latently	O	O
infected	O	O
cells	O	O
harbor	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
type	O	O
1	O	O
(	O	O
HIV-1	O	O
)	O	O
proviral	O	O
DNA	O	O
copies	O	O
integrated	O	O
in	O	O
heterochromatin	O	O
,	O	O
allowing	O	O
persistence	O	O
of	O	O
transcriptionally	O	O
silent	O	O
proviruses	O	O
.	O	O

It	O	O
is	O	O
widely	O	O
accepted	O	O
that	O	O
hypoacetylation	O	O
of	O	O
histone	O	O
proteins	O	O
by	O	O
histone	O	O
deacetylases	O	O
(	O	O
HDACs	O	O
)	O	O
is	O	O
involved	O	O
in	O	O
maintaining	O	O
the	O	O
HIV-1	O	O
latency	O	O
by	O	O
repressing	O	O
viral	O	O
transcription	O	O
.	O	O

HIV-1	O	O
replication	O	O
can	O	O
be	O	O
induced	O	O
from	O	O
latently	O	O
infected	O	O
cells	O	O
by	O	O
environmental	O	O
factors	O	O
,	O	O
such	O	O
as	O	O
inflammation	O	O
and	O	O
co-infection	O	O
with	O	O
other	O	O
microbes	O	O
.	O	O

It	O	O
is	O	O
known	O	O
that	O	O
a	O	O
bacterial	O	O
metabolite	O	O
butyric	O	O
acid	O	O
inhibits	O	O
catalytic	O	O
action	O	O
of	O	O
HDAC	O	O
and	O	O
induces	O	O
transcription	O	O
of	O	O
silenced	O	O
genes	O	O
including	O	O
HIV-1	O	O
provirus	O	O
.	O	O

There	O	O
are	O	O
a	O	O
number	O	O
of	O	O
such	O	O
bacteria	O	O
in	O	O
gut	O	O
,	O	O
vaginal	O	O
,	O	O
and	O	O
oral	O	O
cavities	O	O
that	O	O
produce	O	O
butyric	O	O
acid	O	O
during	O	O
their	O	O
anaerobic	O	O
glycolysis	O	O
.	O	O

Since	O	O
these	O	O
organs	O	O
are	O	O
known	O	O
to	O	O
be	O	O
the	O	O
major	O	O
site	O	O
of	O	O
HIV-1	O	O
transmission	O	O
and	O	O
its	O	O
replication	O	O
,	O	O
we	O	O
explored	O	O
a	O	O
possibility	O	O
that	O	O
explosive	O	O
viral	O	O
replication	O	O
in	O	O
these	O	O
organs	O	O
could	O	O
be	O	O
ascribable	O	O
to	O	O
butyric	O	O
acid	O	O
produced	O	O
from	O	O
anaerobic	O	O
resident	O	O
bacteria	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
demonstrate	O	O
that	O	O
the	O	O
culture	O	O
supernatant	O	O
of	O	O
various	O	O
bacteria	O	O
producing	O	O
butyric	O	O
acid	O	O
could	O	O
greatly	O	O
reactivate	O	O
the	O	O
latently-infected	O	O
HIV-1	O	O
.	O	O

These	O	O
bacteria	O	O
include	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
commonly	O	O
present	O	O
in	O	O
oral	O	O
cavity	O	O
,	O	O
and	O	O
gut	O	O
)	O	O
,	O	O
Clostridium	B-bacteria	B-bacteria
cochlearium	E-bacteria	I-bacteria
,	O	O
Eubacterium	B-bacteria	B-bacteria
multiforme	E-bacteria	I-bacteria
(	O	O
gut	O	O
)	O	O
,	O	O
and	O	O
Anaerococcus	B-bacteria	B-bacteria
tetradius	E-bacteria	I-bacteria
(	O	O
vagina	O	O
)	O	O
.	O	O

We	O	O
also	O	O
clarified	O	O
that	O	O
butyric	O	O
acid	O	O
in	O	O
these	O	O
culture	O	O
supernatants	O	O
could	O	O
induce	O	O
histone	O	O
acetylation	O	O
and	O	O
HIV-1	O	O
replication	O	O
by	O	O
inhibiting	O	O
HDAC	O	O
.	O	O

Our	O	O
observations	O	O
indicate	O	O
that	O	O
butyric	O	O
acid-producing	O	O
bacteria	O	O
could	O	O
be	O	O
involved	O	O
in	O	O
AIDS	O	O
progression	O	O
by	O	O
reactivating	O	O
the	O	O
latent	O	O
HIV	O	O
provirus	O	O
and	O	O
,	O	O
subsequently	O	O
,	O	O
by	O	O
eliminating	O	O
such	O	O
bacterial	O	O
infection	O	O
may	O	O
contribute	O	O
to	O	O
the	O	O
prevention	O	O
of	O	O
the	O	O
AIDS	O	O
development	O	O
and	O	O
transmission	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
examine	O	O
the	O	O
relationship	O	O
between	O	O
turbidity	O	O
of	O	O
mouth	O	O
rinsed	O	O
water	O	O
and	O	O
oral	O	O
health	O	O
status	O	O
such	O	O
as	O	O
dental	O	O
and	O	O
periodontal	O	O
conditions	O	O
,	O	O
oral	O	O
hygiene	O	O
status	O	O
,	O	O
flow	O	O
rate	O	O
of	O	O
saliva	O	O
and	O	O
oral	O	O
bacteria	O	O
.	O	O

Subjects	O	O
were	O	O
165	O	O
patients	O	O
who	O	O
visited	O	O
the	O	O
Dental	O	O
Hospital	O	O
,	O	O
Tokyo	O	O
Medical	O	O
and	O	O
Dental	O	O
University	O	O
.	O	O

Oral	O	O
health	O	O
status	O	O
,	O	O
including	O	O
dental	O	O
and	O	O
periodontal	O	O
conditions	O	O
,	O	O
oral	O	O
hygiene	O	O
status	O	O
and	O	O
flow	O	O
rate	O	O
of	O	O
saliva	O	O
,	O	O
was	O	O
clinically	O	O
examined	O	O
.	O	O

The	O	O
turbidity	O	O
was	O	O
measured	O	O
with	O	O
a	O	O
turbidimeter	O	O
.	O	O

Quantification	O	O
of	O	O
Fusobacterium	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
and	O	O
total	O	O
bacteria	O	O
levels	O	O
was	O	O
performed	O	O
using	O	O
real-time	O	O
PCR	O	O
.	O	O

The	O	O
Pearson	O	O
correlation	O	O
and	O	O
multiple	O	O
regression	O	O
analysis	O	O
were	O	O
used	O	O
to	O	O
explore	O	O
the	O	O
associations	O	O
between	O	O
the	O	O
turbidity	O	O
and	O	O
oral	O	O
health	O	O
parameters	O	O
.	O	O

The	O	O
turbidity	O	O
showed	O	O
significant	O	O
correlations	O	O
with	O	O
the	O	O
number	O	O
of	O	O
decayed	O	O
teeth	O	O
and	O	O
deep	O	O
pockets	O	O
,	O	O
the	O	O
plaque	O	O
index	O	O
,	O	O
extent	O	O
of	O	O
tongue	O	O
coating	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
and	O	O
total	O	O
bacteria	O	O
levels	O	O
.	O	O

In	O	O
a	O	O
multiple	O	O
regression	O	O
model	O	O
,	O	O
the	O	O
turbidity	O	O
was	O	O
negatively	O	O
associated	O	O
with	O	O
the	O	O
flow	O	O
rate	O	O
of	O	O
saliva	O	O
and	O	O
positively	O	O
associated	O	O
with	O	O
the	O	O
total	O	O
number	O	O
of	O	O
bacteria	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

Current	O	O
findings	O	O
suggested	O	O
that	O	O
turbidity	O	O
of	O	O
mouth	O	O
rinsed	O	O
water	O	O
could	O	O
be	O	O
used	O	O
as	O	O
an	O	O
indicator	O	O
to	O	O
evaluate	O	O
oral	O	O
health	O	O
condition	O	O
and	O	O
the	O	O
amount	O	O
of	O	O
bacteria	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
turbiditimeter	O	O
appeared	O	O
as	O	O
a	O	O
simple	O	O
and	O	O
objective	O	O
device	O	O
for	O	O
screening	O	O
abnormality	O	O
of	O	O
oral	O	O
health	O	O
condition	O	O
at	O	O
chair	O	O
side	O	O
as	O	O
well	O	O
as	O	O
community-based	O	O
research	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
paper	O	O
is	O	O
to	O	O
evaluate	O	O
the	O	O
effects	O	O
of	O	O
oil	O	O
drops	O	O
containing	O	O
Lactobacillus	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
WB21	E-bacteria	I-bacteria
on	O	O
periodontal	O	O
health	O	O
and	O	O
oral	O	O
microbiota	O	O
producing	O	O
volatile	O	O
sulfur	O	O
compounds	O	O
(	O	O
VSCs	O	O
)	O	O
.	O	O

For	O	O
this	O	O
study	O	O
,	O	O
42	O	O
subjects	O	O
were	O	O
randomly	O	O
assigned	O	O
to	O	O
receive	O	O
oil	O	O
samples	O	O
containing	O	O
L.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
WB21	E-bacteria	I-bacteria
or	O	O
a	O	O
placebo	O	O
for	O	O
two	O	O
weeks	O	O
.	O	O

Oral	O	O
assessment	O	O
and	O	O
saliva	O	O
collection	O	O
were	O	O
performed	O	O
on	O	O
days	O	O
1	O	O
and	O	O
15	O	O
.	O	O

Bacterial	O	O
analysis	O	O
was	O	O
performed	O	O
using	O	O
the	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
and	O	O
terminal	O	O
restriction	O	O
fragment	O	O
length	O	O
polymorphism	O	O
(	O	O
T-RFLP	O	O
)	O	O
.	O	O

In	O	O
both	O	O
the	O	O
experimental	O	O
and	O	O
placebo	O	O
groups	O	O
,	O	O
the	O	O
average	O	O
probing	O	O
depth	O	O
,	O	O
number	O	O
of	O	O
periodontal	O	O
pockets	O	O
,	O	O
and	O	O
the	O	O
percentage	O	O
of	O	O
bleeding	O	O
on	O	O
probing	O	O
(	O	O
BOP	O	O
)	O	O
decreased	O	O
while	O	O
stimulated	O	O
salivary	O	O
flow	O	O
increased	O	O
on	O	O
day	O	O
15	O	O
.	O	O

BOP	O	O
was	O	O
reduced	O	O
in	O	O
the	O	O
experimental	O	O
group	O	O
compared	O	O
with	O	O
the	O	O
placebo	O	O
group	O	O
(	O	O
P	O	O
=	O	O
0.010	O	O
)	O	O
.	O	O

In	O	O
the	O	O
experimental	O	O
group	O	O
,	O	O
total	O	O
bacterial	O	O
numbers	O	O
decreased	O	O
,	O	O
and	O	O
the	O	O
number	O	O
of	O	O
L.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
increased	O	O
.	O	O

The	O	O
number	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
which	O	O
is	O	O
correlated	O	O
with	O	O
hydrogen	O	O
sulfide	O	O
concentration	O	O
in	O	O
mouth	O	O
air	O	O
,	O	O
increased	O	O
in	O	O
the	O	O
placebo	O	O
group	O	O
and	O	O
did	O	O
not	O	O
change	O	O
in	O	O
the	O	O
experimental	O	O
group	O	O
.	O	O

T-RFLP	O	O
analysis	O	O
found	O	O
that	O	O
the	O	O
peak	O	O
area	O	O
proportions	O	O
representing	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
decreased	O	O
in	O	O
the	O	O
experimental	O	O
group	O	O
,	O	O
although	O	O
there	O	O
was	O	O
no	O	O
significant	O	O
change	O	O
in	O	O
the	O	O
bacterial	O	O
composition	O	O
.	O	O

Thus	O	O
we	O	O
observed	O	O
oil	O	O
drops	O	O
containing	O	O
L.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
WB21	E-bacteria	I-bacteria
improved	O	O
BOP	O	O
and	O	O
inhibited	O	O
the	O	O
reproduction	O	O
of	O	O
total	O	O
and	O	O
VSC-producing	O	O
periodontopathic	O	O
bacteria	O	O
compared	O	O
with	O	O
the	O	O
placebo	O	O
group	O	O
,	O	O
but	O	O
also	O	O
showed	O	O
the	O	O
limit	O	O
of	O	O
its	O	O
efficacy	O	O
in	O	O
controlling	O	O
VSCs	O	O
producing	O	O
and	O	O
periodontal	O	O
pathogens	O	O
.	O	O

This	O	O
reference	O	O
study	O	O
aims	O	O
to	O	O
survey	O	O
the	O	O
bacterial	O	O
flora	O	O
of	O	O
the	O	O
healthy	O	O
lower	O	O
human	O	O
esophagus	O	O
and	O	O
to	O	O
compare	O	O
it	O	O
with	O	O
that	O	O
of	O	O
the	O	O
upper	O	O
esophagus	O	O
and	O	O
oral	O	O
mucosa	O	O
.	O	O

The	O	O
use	O	O
of	O	O
biopsies	O	O
,	O	O
in	O	O
addition	O	O
to	O	O
brush	O	O
samples	O	O
,	O	O
allows	O	O
inclusion	O	O
of	O	O
not	O	O
only	O	O
transient	O	O
bacteria	O	O
present	O	O
on	O	O
the	O	O
surface	O	O
but	O	O
also	O	O
bacteria	O	O
residing	O	O
in	O	O
the	O	O
epithelia	O	O
,	O	O
and	O	O
the	O	O
yield	O	O
of	O	O
the	O	O
two	O	O
methods	O	O
can	O	O
be	O	O
compared	O	O
.	O	O

Forty	O	O
patients	O	O
scheduled	O	O
for	O	O
surgery	O	O
for	O	O
reasons	O	O
with	O	O
no	O	O
known	O	O
influence	O	O
on	O	O
esophageal	O	O
flora	O	O
and	O	O
with	O	O
no	O	O
symptoms	O	O
or	O	O
endoscopic	O	O
signs	O	O
of	O	O
esophageal	O	O
disease	O	O
were	O	O
included	O	O
.	O	O

Samples	O	O
were	O	O
collected	O	O
from	O	O
the	O	O
oral	O	O
,	O	O
upper	O	O
esophageal	O	O
,	O	O
and	O	O
lower	O	O
esophageal	O	O
mucosa	O	O
using	O	O
sealed	O	O
brushes	O	O
and	O	O
biopsy	O	O
forceps	O	O
.	O	O

Colonies	O	O
cultivated	O	O
on	O	O
agar	O	O
plates	O	O
were	O	O
classified	O	O
and	O	O
semiquantified	O	O
.	O	O

Twenty-three	O	O
different	O	O
bacterial	O	O
species	O	O
were	O	O
identified	O	O
,	O	O
with	O	O
similar	O	O
strains	O	O
present	O	O
at	O	O
the	O	O
three	O	O
sites	O	O
.	O	O

The	O	O
most	O	O
common	O	O
group	O	O
of	O	O
bacteria	O	O
was	O	O
viridans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
with	O	O
an	O	O
occurrence	O	O
rate	O	O
in	O	O
brush	O	O
samples	O	O
and	O	O
biopsies	O	O
of	O	O
98	O	O
%	O	O
and	O	O
95	O	O
%	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
median	O	O
number	O	O
of	O	O
species	O	O
occurring	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
upper	O	O
esophagus	O	O
,	O	O
and	O	O
lower	O	O
esophagus	O	O
was	O	O
between	O	O
3	O	O
and	O	O
4	O	O
(	O	O
range	O	O
0-7	O	O
)	O	O
.	O	O

The	O	O
total	O	O
number	O	O
of	O	O
species	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
was	O	O
significantly	O	O
higher	O	O
when	O	O
compared	O	O
with	O	O
either	O	O
level	O	O
in	O	O
the	O	O
esophagus	O	O
,	O	O
while	O	O
the	O	O
yields	O	O
obtained	O	O
by	O	O
brush	O	O
and	O	O
biopsy	O	O
sampling	O	O
were	O	O
highly	O	O
correlated	O	O
.	O	O

Hence	O	O
,	O	O
the	O	O
normal	O	O
human	O	O
esophagus	O	O
is	O	O
colonized	O	O
with	O	O
a	O	O
resident	O	O
bacterial	O	O
flora	O	O
of	O	O
its	O	O
own	O	O
,	O	O
which	O	O
has	O	O
similarities	O	O
to	O	O
that	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
.	O	O

There	O	O
are	O	O
diverse	O	O
species	O	O
that	O	O
make	O	O
up	O	O
this	O	O
flora	O	O
,	O	O
although	O	O
in	O	O
relatively	O	O
low	O	O
amounts	O	O
.	O	O

The	O	O
most	O	O
frequent	O	O
inhabitants	O	O
of	O	O
the	O	O
esophagus	O	O
are	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
with	O	O
an	O	O
occurrence	O	O
rate	O	O
in	O	O
brush	O	O
samples	O	O
and	O	O
biopsies	O	O
of	O	O
95-98	O	O
%	O	O
.	O	O

Comparative	O	O
studies	O	O
of	O	O
patients	O	O
with	O	O
eosinophilic	O	O
esophagitis	O	O
and	O	O
gastroesophageal	O	O
reflux	O	O
disease	O	O
are	O	O
warranted	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
antimicrobial	O	O
activity	O	O
of	O	O
the	O	O
bacteriocin-producing	B-bacteria	B-bacteria
strain	I-bacteria	I-bacteria
Streptococcus	I-bacteria	I-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
against	O	O
several	O	O
bacteria	O	O
involved	O	O
in	O	O
halitosis	O	O
.	O	O

The	O	O
inhibitory	O	O
activity	O	O
of	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
against	O	O
Solobacterium	B-bacteria	B-bacteria
moorei	I-bacteria	I-bacteria
CCUG39336	E-bacteria	I-bacteria
,	O	O
four	O	O
clinical	O	O
S.	B-bacteria	B-bacteria
moorei	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
,	O	O
Atopobium	B-bacteria	B-bacteria
parvulum	I-bacteria	I-bacteria
ATCC33793	E-bacteria	I-bacteria
and	O	O
Eubacterium	B-bacteria	B-bacteria
sulci	I-bacteria	I-bacteria
ATCC35585	E-bacteria	I-bacteria
was	O	O
examined	O	O
by	O	O
a	O	O
deferred	O	O
antagonism	O	O
test	O	O
.	O	O

Eubacterium	B-bacteria	B-bacteria
saburreum	I-bacteria	I-bacteria
ATCC33271	E-bacteria	I-bacteria
and	O	O
Parvimonas	B-bacteria	B-bacteria
micra	I-bacteria	I-bacteria
ATCC33270	E-bacteria	I-bacteria
,	O	O
which	O	O
have	O	O
been	O	O
tested	O	O
in	O	O
previous	O	O
studies	O	O
,	O	O
served	O	O
as	O	O
positive	O	O
controls	O	O
,	O	O
and	O	O
the	O	O
Gram-negative	B-bacteria	B-bacteria
strain	I-bacteria	I-bacteria
Bacteroides	I-bacteria	I-bacteria
fragilis	I-bacteria	I-bacteria
ZIB2800	E-bacteria	I-bacteria
served	O	O
as	O	O
a	O	O
negative	O	O
control	O	O
.	O	O

Additionally	O	O
,	O	O
the	O	O
occurrence	O	O
of	O	O
resistance	O	O
in	O	O
S.	B-bacteria	B-bacteria
moorei	I-bacteria	I-bacteria
CCUG39336	E-bacteria	I-bacteria
to	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
was	O	O
analysed	O	O
by	O	O
either	O	O
direct	O	O
plating	O	O
or	O	O
by	O	O
passage	O	O
of	O	O
S.	B-bacteria	B-bacteria
moorei	I-bacteria	I-bacteria
CCUG39336	E-bacteria	I-bacteria
on	O	O
chloroform-inactived	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
K12-containing	O	O
agar	O	O
plates	O	O
.	O	O

S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
suppressed	O	O
the	O	O
growth	O	O
of	O	O
all	O	O
Gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
tested	O	O
,	O	O
but	O	O
the	O	O
extent	O	O
to	O	O
which	O	O
the	O	O
bacteria	O	O
were	O	O
inhibited	O	O
varied	O	O
.	O	O

E.	B-bacteria	B-bacteria
sulci	I-bacteria	I-bacteria
ATCC35585	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
sensitive	O	O
strain	O	O
,	O	O
while	O	O
all	O	O
five	O	O
S.	B-bacteria	B-bacteria
moorei	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
were	O	O
inhibited	O	O
to	O	O
a	O	O
lesser	O	O
extent	O	O
.	O	O

Natural	O	O
resistance	O	O
seems	O	O
to	O	O
be	O	O
very	O	O
low	O	O
in	O	O
S.	B-bacteria	B-bacteria
moorei	I-bacteria	I-bacteria
CCUG39336	E-bacteria	I-bacteria
,	O	O
and	O	O
there	O	O
was	O	O
only	O	O
a	O	O
slight	O	O
decrease	O	O
in	O	O
sensitivity	O	O
after	O	O
exposure	O	O
to	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
over	O	O
10	O	O
passages	O	O
.	O	O

Our	O	O
studies	O	O
demonstrate	O	O
that	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
has	O	O
antimicrobial	O	O
activity	O	O
against	O	O
bacteria	O	O
involved	O	O
in	O	O
halitosis	O	O
.	O	O

This	O	O
strain	O	O
might	O	O
be	O	O
an	O	O
interesting	O	O
and	O	O
valuable	O	O
candidate	O	O
for	O	O
the	O	O
development	O	O
of	O	O
an	O	O
antimicrobial	O	O
therapy	O	O
for	O	O
halitosis	O	O
.	O	O

Bacterial	O	O
cultures	O	O
and	O	O
chemical	O	O
analyses	O	O
were	O	O
performed	O	O
from	O	O
cloacal	O	O
and	O	O
oral	O	O
swabs	O	O
taken	O	O
from	O	O
43	O	O
American	O	O
crocodiles	O	O
Crocodylus	O	O
acutus	O	O
and	O	O
28	O	O
Morelet's	O	O
crocodiles	O	O
C.	O	O
moreletii	O	O
captured	O	O
in	O	O
Quintana	O	O
Roo	O	O
State	O	O
,	O	O
Mexico	O	O
.	O	O

We	O	O
recovered	O	O
47	O	O
bacterial	O	O
species	O	O
(	O	O
28	O	O
genera	O	O
and	O	O
14	O	O
families	O	O
)	O	O
from	O	O
all	O	O
samples	O	O
with	O	O
51.1	O	O
%	O	O
of	O	O
these	O	O
belonging	O	O
to	O	O
the	O	O
family	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
.	O	O

Fourteen	O	O
species	O	O
(	O	O
29.8	O	O
%	O	O
)	O	O
were	O	O
detected	O	O
in	O	O
both	O	O
crocodile	O	O
species	O	O
and	O	O
18	O	O
(	O	O
38.3	O	O
%	O	O
)	O	O
and	O	O
15	O	O
(	O	O
31.9	O	O
%	O	O
)	O	O
species	O	O
were	O	O
only	O	O
detected	O	O
in	O	O
American	O	O
and	O	O
Morelet	O	O
's	O	O
crocodiles	O	O
,	O	O
respectively	O	O
.	O	O

We	O	O
recovered	O	O
35	O	O
bacterial	O	O
species	O	O
from	O	O
all	O	O
oral	O	O
samples	O	O
,	O	O
of	O	O
which	O	O
9	O	O
(	O	O
25.8	O	O
%	O	O
)	O	O
were	O	O
detected	O	O
in	O	O
both	O	O
crocodile	O	O
species	O	O
.	O	O

From	O	O
all	O	O
cloacal	O	O
samples	O	O
,	O	O
we	O	O
recovered	O	O
21	O	O
bacterial	O	O
species	O	O
,	O	O
of	O	O
which	O	O
8	O	O
(	O	O
38.1	O	O
%	O	O
)	O	O
were	O	O
detected	O	O
in	O	O
both	O	O
crocodile	O	O
species	O	O
.	O	O

The	O	O
most	O	O
commonly	O	O
isolated	O	O
bacteria	O	O
in	O	O
cloacal	O	O
samples	O	O
were	O	O
Aeromonas	B-bacteria	B-bacteria
hydrophila	E-bacteria	I-bacteria
and	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
whereas	O	O
in	O	O
oral	O	O
samples	O	O
the	O	O
most	O	O
common	O	O
bacteria	O	O
were	O	O
A.	B-bacteria	B-bacteria
hydrophila	E-bacteria	I-bacteria
and	O	O
Arcanobacterium	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
.	O	O

The	O	O
bacteria	O	O
isolated	O	O
represent	O	O
a	O	O
potential	O	O
threat	O	O
to	O	O
crocodile	O	O
health	O	O
during	O	O
conditions	O	O
of	O	O
stress	O	O
and	O	O
a	O	O
threat	O	O
to	O	O
human	O	O
health	O	O
through	O	O
crocodile	O	O
bites	O	O
,	O	O
crocodile	O	O
meat	O	O
consumption	O	O
or	O	O
carrying	O	O
out	O	O
activities	O	O
in	O	O
crocodile	O	O
habitat	O	O
.	O	O

We	O	O
especially	O	O
warn	O	O
about	O	O
the	O	O
presence	O	O
of	O	O
Salmonella	B-bacteria	B-bacteria
arizonae	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
typhi	E-bacteria	I-bacteria
,	O	O
which	O	O
cause	O	O
enteritis	O	O
and	O	O
septicemia	O	O
in	O	O
crocodiles	O	O
and	O	O
salmonellosis	O	O
and	O	O
typhoid	O	O
fever	O	O
in	O	O
humans	O	O
.	O	O

The	O	O
risk	O	O
of	O	O
bacterial	O	O
contamination	O	O
from	O	O
crocodiles	O	O
to	O	O
humans	O	O
could	O	O
increase	O	O
in	O	O
the	O	O
future	O	O
because	O	O
of	O	O
the	O	O
accelerated	O	O
destruction	O	O
of	O	O
crocodile	O	O
habitat	O	O
,	O	O
which	O	O
could	O	O
lead	O	O
to	O	O
an	O	O
augmentation	O	O
of	O	O
human-crocodile	O	O
interactions	O	O
.	O	O

Information	O	O
on	O	O
bacterial	O	O
diversity	O	O
reported	O	O
here	O	O
could	O	O
help	O	O
in	O	O
the	O	O
choice	O	O
of	O	O
antibacterial	O	O
products	O	O
in	O	O
case	O	O
of	O	O
infections	O	O
that	O	O
are	O	O
of	O	O
crocodile	O	O
origin	O	O
.	O	O

Infection	O	O
has	O	O
been	O	O
hypothesized	O	O
as	O	O
a	O	O
contributing	O	O
factor	O	O
to	O	O
bisphosphonate	O	O
(	O	O
BP	O	O
)	O	O
-related	O	O
osteonecrosis	O	O
of	O	O
the	O	O
jaw	O	O
(	O	O
BRONJ	O	O
)	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
the	O	O
bacterial	O	O
colonization	O	O
of	O	O
jawbone	O	O
and	O	O
identify	O	O
the	O	O
bacterial	O	O
phylotypes	O	O
associated	O	O
with	O	O
BRONJ	O	O
.	O	O
Culture-independent	O	O
16S	O	O
rRNA	O	O
gene-based	O	O
molecular	O	O
techniques	O	O
were	O	O
used	O	O
to	O	O
determine	O	O
and	O	O
compare	O	O
the	O	O
total	O	O
bacterial	O	O
diversity	O	O
in	O	O
bone	O	O
samples	O	O
collected	O	O
from	O	O
12	O	O
patients	O	O
with	O	O
cancer	O	O
(	O	O
six	O	O
,	O	O
BRONJ	O	O
with	O	O
history	O	O
of	O	O
BP	O	O
;	O	O
six	O	O
,	O	O
controls	O	O
without	O	O
BRONJ	O	O
,	O	O
no	O	O
history	O	O
of	O	O
BP	O	O
but	O	O
have	O	O
infection	O	O
)	O	O
.	O	O

Denaturing	O	O
gradient	O	O
gel	O	O
electrophoresis	O	O
profile	O	O
and	O	O
Dice	O	O
coefficient	O	O
displayed	O	O
a	O	O
statistically	O	O
significant	O	O
clustering	O	O
of	O	O
profiles	O	O
,	O	O
indicating	O	O
different	O	O
bacterial	O	O
population	O	O
in	O	O
BRONJ	O	O
subjects	O	O
and	O	O
control	O	O
.	O	O

The	O	O
top	O	O
three	O	O
genera	O	O
ranked	O	O
among	O	O
the	O	O
BRONJ	O	O
group	O	O
were	O	O
Streptococcus	B-bacteria	B-bacteria
(	O	O
29	O	O
%	O	O
)	O	O
,	O	O
Eubacterium	B-bacteria	B-bacteria
(	O	O
9	O	O
%	O	O
)	O	O
,	O	O
and	O	O
Pseudoramibacter	B-bacteria	B-bacteria
(	O	O
8	O	O
%	O	O
)	O	O
,	O	O
while	O	O
in	O	O
the	O	O
control	O	O
group	O	O
were	O	O
Parvimonas	B-bacteria	B-bacteria
(	O	O
17	O	O
%	O	O
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
(	O	O
15	O	O
%	O	O
)	O	O
,	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
(	O	O
15	O	O
%	O	O
)	O	O
.	O	O

H	O	O
&	O	O
E	O	O
sections	O	O
of	O	O
BRONJ	O	O
bone	O	O
revealed	O	O
layers	O	O
of	O	O
bacteria	O	O
along	O	O
the	O	O
surfaces	O	O
and	O	O
often	O	O
are	O	O
packed	O	O
into	O	O
the	O	O
scalloped	O	O
edges	O	O
of	O	O
the	O	O
bone	O	O
.	O	O

This	O	O
study	O	O
using	O	O
limited	O	O
sample	O	O
size	O	O
indicated	O	O
that	O	O
the	O	O
jawbone	O	O
associated	O	O
with	O	O
BRONJ	O	O
was	O	O
heavily	O	O
colonized	O	O
by	O	O
specific	O	O
oral	O	O
bacteria	O	O
and	O	O
there	O	O
were	O	O
apparent	O	O
differences	O	O
between	O	O
the	O	O
microbiota	O	O
of	O	O
BRONJ	O	O
and	O	O
controls	O	O
.	O	O

Bacterial	O	O
vaginosis	O	O
(	O	O
BV	O	O
)	O	O
represents	O	O
shifts	O	O
in	O	O
microbiota	O	O
from	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

to	O	O
diverse	O	O
anaerobes	B-bacteria	B-bacteria
.	O	O

Although	O	O
antibiotics	O	O
relieve	O	O
symptoms	O	O
and	O	O
temporarily	O	O
eradicate	O	O
BV-associated	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
BVAB	B-bacteria	B-bacteria
)	O	O
,	O	O
BV	O	O
usually	O	O
recurs	O	O
.	O	O

We	O	O
investigated	O	O
the	O	O
role	O	O
of	O	O
extravaginal	O	O
BVAB	B-bacteria	B-bacteria
reservoirs	O	O
in	O	O
recurrence	O	O
.	O	O

Risks	O	O
for	O	O
BV	O	O
acquisition	O	O
over	O	O
the	O	O
course	O	O
of	O	O
1	O	O
year	O	O
were	O	O
defined	O	O
.	O	O

DNA	O	O
in	O	O
vaginal	O	O
,	O	O
anal	O	O
,	O	O
and	O	O
oral	O	O
swab	O	O
samples	O	O
from	O	O
enrollment	O	O
was	O	O
subjected	O	O
to	O	O
quantitative	O	O
polymerase	O	O
chain	O	O
reaction	O	O
assays	O	O
targeting	O	O
16S	O	O
ribosomal	O	O
RNA	O	O
genes	O	O
of	O	O
Gardnerella	B-bacteria	B-bacteria
vaginalis	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
crispatus	E-bacteria	I-bacteria
,	O	O
BVAB1	B-bacteria	B-bacteria
,	O	O
BVAB2	B-bacteria	B-bacteria
,	O	O
BVAB3	B-bacteria	B-bacteria
,	O	O
Megasphaera	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
jensenii	E-bacteria	I-bacteria
,	O	O
and	O	O
Leptotrichia/Sneathia	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	O	O

A	O	O
case-control	O	O
approach	O	O
analyzed	O	O
BVAB	B-bacteria	B-bacteria
detection	O	O
at	O	O
enrollment	O	O
for	O	O
case	O	O
patients	O	O
(	O	O
BV	O	O
acquisition	O	O
)	O	O
versus	O	O
controls	O	O
(	O	O
none	O	O
)	O	O
.	O	O

Of	O	O
239	O	O
women	O	O
enrolled	O	O
without	O	O
BV	O	O
,	O	O
199	O	O
were	O	O
seen	O	O
in	O	O
follow-up	O	O
,	O	O
and	O	O
40	O	O
experienced	O	O
BV	O	O
;	O	O
15	O	O
had	O	O
all	O	O
samples	O	O
for	O	O
analysis	O	O
.	O	O

Detection	O	O
of	O	O
G.	B-bacteria	B-bacteria
vaginalis	E-bacteria	I-bacteria
in	O	O
oral	O	O
cavity	O	O
or	O	O
anal	O	O
samples	O	O
and	O	O
Leptotrichia/Sneathia	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

in	O	O
anal	O	O
samples	O	O
was	O	O
more	O	O
common	O	O
at	O	O
enrollment	O	O
among	O	O
case	O	O
patients	O	O
,	O	O
who	O	O
also	O	O
had	O	O
higher	O	O
concentrations	O	O
of	O	O
these	O	O
bacteria	O	O
and	O	O
Megasphaera	B-bacteria	B-bacteria
relative	O	O
to	O	O
30	O	O
controls	O	O
at	O	O
each	O	O
site	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
L.	B-bacteria	B-bacteria
crispatus	E-bacteria	I-bacteria
was	O	O
detected	O	O
more	O	O
frequently	O	O
in	O	O
anal	O	O
samples	O	O
among	O	O
controls	O	O
.	O	O

Women	O	O
who	O	O
acquire	O	O
BV	O	O
are	O	O
more	O	O
likely	O	O
have	O	O
previous	O	O
colonization	O	O
of	O	O
extravaginal	O	O
reservoirs	O	O
with	O	O
some	O	O
BVAB	B-bacteria	B-bacteria
,	O	O
and	O	O
less	O	O
likely	O	O
to	O	O
have	O	O
L.	B-bacteria	B-bacteria
crispatus	E-bacteria	I-bacteria
,	O	O
suggesting	O	O
that	O	O
BVAB	B-bacteria	B-bacteria
may	O	O
be	O	O
acquired	O	O
vaginally	O	O
from	O	O
extravaginal	O	O
reservoirs	O	O
.	O	O

Treating	O	O
patients	O	O
with	O	O
systemic	O	O
lupus	O	O
erythematosus	O	O
(	O	O
SLE	O	O
)	O	O
with	O	O
steroids	O	O
and	O	O
immunosuppressive	O	O
drugs	O	O
may	O	O
interfere	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
potentially	O	O
opportunistic	O	O
microorganisms	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
presence	O	O
of	O	O
Candida	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Enterobacteria	B-bacteria	B-bacteria
and	O	O
Pseudomonas	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	O	O

in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
SLE	O	O
patients	O	O
,	O	O
compared	O	O
with	O	O
healthy	O	O
controls	O	O
.	O	O

A	O	O
group	O	O
of	O	O
40	O	O
patients	O	O
who	O	O
had	O	O
received	O	O
therapy	O	O
for	O	O
at	O	O
least	O	O
60	O	O
days	O	O
was	O	O
selected	O	O
(	O	O
19-53	O	O
years	O	O
)	O	O
.	O	O

For	O	O
the	O	O
control	O	O
group	O	O
,	O	O
40	O	O
healthy	O	O
individuals	O	O
matched	O	O
for	O	O
age	O	O
,	O	O
gender	O	O
and	O	O
use	O	O
of	O	O
partial	O	O
prosthesis	O	O
were	O	O
selected	O	O
.	O	O

Oral	O	O
rinse	O	O
samples	O	O
were	O	O
collected	O	O
and	O	O
plated	O	O
on	O	O
specific	O	O
culture	O	O
media	O	O
.	O	O

After	O	O
incubation	O	O
,	O	O
the	O	O
number	O	O
of	O	O
colony	O	O
forming	O	O
units	O	O
(	O	O
CFU	O	O
)	O	O
was	O	O
obtained	O	O
and	O	O
the	O	O
isolates	O	O
were	O	O
identified	O	O
at	O	O
species	O	O
level	O	O
.	O	O

Microbial	O	O
counts	O	O
were	O	O
compared	O	O
between	O	O
SLE	O	O
and	O	O
control	O	O
by	O	O
analysis	O	O
of	O	O
variance	O	O
(	O	O
ANOVA	O	O
)	O	O
and	O	O
Mann-Whitney	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
significant	O	O
)	O	O
.	O	O

Microorganism	O	O
counts	O	O
in	O	O
patients	O	O
with	O	O
and	O	O
without	O	O
immunosuppressive	O	O
drugs	O	O
,	O	O
as	O	O
well	O	O
with	O	O
active	O	O
and	O	O
inactive	O	O
disease	O	O
(	O	O
according	O	O
to	O	O
SLEDAI	O	O
score	O	O
)	O	O
were	O	O
also	O	O
compared	O	O
.	O	O

No	O	O
significant	O	O
differences	O	O
in	O	O
CFU/mL	O	O
between	O	O
SLE	O	O
and	O	O
control	O	O
patients	O	O
were	O	O
observed	O	O
(	O	O
yeasts	O	O
,	O	O
p	O	O
=	O	O
0.55	O	O
;	O	O
Staphylococci	B-bacteria	B-bacteria
,	O	O
p	O	O
=	O	O
0.24	O	O
;	O	O
Enterobacteria/Pseudomonas	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
p	O	O
=	O	O
0.26	O	O
)	O	O
.	O	O

No	O	O
differences	O	O
in	O	O
microbial	O	O
counts	O	O
were	O	O
observed	O	O
regarding	O	O
clinical	O	O
parameters	O	O
tested	O	O
.	O	O

The	O	O
most	O	O
frequent	O	O
species	O	O
isolated	O	O
in	O	O
the	O	O
SLE	O	O
group	O	O
were	O	O
Candida	O	O
albicans	O	O
,	O	O
Staphylococcus	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
and	O	O
Klebsiella	B-bacteria	B-bacteria
oxytoca	E-bacteria	I-bacteria
.	O	O

In	O	O
conclusion	O	O
,	O	O
no	O	O
differences	O	O
in	O	O
frequency	O	O
and	O	O
microorganism	O	O
levels	O	O
were	O	O
found	O	O
between	O	O
SLE	O	O
patients	O	O
and	O	O
healthy	O	O
individuals	O	O
.	O	O

SGP1	B-bacteria	B-bacteria
(	O	O
T	O	O
)	O	O
,	O	O
a	O	O
strain	O	O
belonging	O	O
to	O	O
a	O	O
lineage	O	O
of	O	O
the	O	O
phylum	B-bacteria	B-bacteria
Synergistetes	E-bacteria	I-bacteria
with	O	O
no	O	O
previously	O	O
cultivated	O	O
representatives	O	O
was	O	O
subjected	O	O
to	O	O
a	O	O
comprehensive	O	O
range	O	O
of	O	O
phenotypic	O	O
and	O	O
genotypic	O	O
tests	O	O
.	O	O

For	O	O
good	O	O
growth	O	O
the	O	O
strain	O	O
was	O	O
dependent	O	O
on	O	O
co-culture	O	O
with	O	O
,	O	O
or	O	O
extracts	O	O
from	O	O
,	O	O
selected	O	O
other	O	O
oral	O	O
bacteria	O	O
.	O	O

Cells	O	O
of	O	O
strain	O	O
SGP1	B-bacteria	B-bacteria
(	O	O
T	O	O
)	O	O
were	O	O
asaccharolytic	O	O
and	O	O
major	O	O
amounts	O	O
of	O	O
acetic	O	O
acid	O	O
and	O	O
moderate	O	O
amounts	O	O
of	O	O
propionic	O	O
acid	O	O
were	O	O
produced	O	O
as	O	O
end	O	O
products	O	O
of	O	O
metabolism	O	O
in	O	O
peptone-yeast	O	O
extract-glucose	O	O
broth	O	O
supplemented	O	O
with	O	O
a	O	O
filtered	O	O
cell	O	O
sonicate	O	O
of	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
subsp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

nucleatum	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25586	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
(	O	O
25	O	O
%	O	O
,	O	O
v/v	O	O
)	O	O
.	O	O

Hydrogen	O	O
sulphide	O	O
was	O	O
produced	O	O
and	O	O
gelatin	O	O
was	O	O
weakly	O	O
hydrolysed	O	O
.	O	O

The	O	O
major	O	O
cellular	O	O
fatty	O	O
acids	O	O
were	O	O
C	O	O
(	O	O
14	O	O
:	O	O
0	O	O
)	O	O
,	O	O
C	O	O
(	O	O
18	O	O
:	O	O
0	O	O
)	O	O
and	O	O
C	O	O
(	O	O
16	O	O
:	O	O
0	O	O
)	O	O
.	O	O

The	O	O
DNA	O	O
G+C	O	O
content	O	O
of	O	O
strain	B-bacteria	B-bacteria
SGP1	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
was	O	O
63	O	O
mol	O	O
%	O	O
.	O	O

Phylogenetic	O	O
analysis	O	O
of	O	O
the	O	O
full-length	O	O
16S	O	O
rRNA	O	O
gene	O	O
showed	O	O
that	O	O
strain	B-bacteria	B-bacteria
SGP1	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
represented	O	O
a	O	O
novel	O	O
group	O	O
within	O	O
the	O	O
phylum	B-bacteria	B-bacteria
Synergistetes	E-bacteria	I-bacteria
.	O	O

A	O	O
novel	O	O
species	O	O
in	O	O
a	O	O
new	O	O
genus	O	O
,	O	O
Fretibacterium	B-bacteria	B-bacteria
fastidiosum	I-bacteria	I-bacteria
gen.	I-bacteria	I-bacteria
nov.	E-bacteria	I-bacteria
,	O	O
sp	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
,	O	O
is	O	O
proposed	O	O
.	O	O

The	O	O
type	O	O
strain	O	O
of	O	O
Fretibacterium	B-bacteria	B-bacteria
fastidiosum	I-bacteria	I-bacteria
is	O	O
SGP1	B-bacteria	B-bacteria
(	O	O
T	O	O
)	O	O
(	O	O
=	O	O
DSM	B-bacteria	B-bacteria
25557	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=	O	O
JCM	B-bacteria	B-bacteria
16858	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
)	O	O
.	O	O

Critical	O	O
care	O	O
nursing	O	O
interventions	O	O
to	O	O
oral	O	O
care	O	O
can	O	O
reduce	O	O
microorganisms	O	O
in	O	O
the	O	O
oropharynx	O	O
available	O	O
for	O	O
translocation	O	O
.	O	O

To	O	O
analyse	O	O
the	O	O
effect	O	O
of	O	O
0.12	O	O
%	O	O
chlorhexidine	O	O
digluconate	O	O
on	O	O
the	O	O
colonization	O	O
of	O	O
oropharyngeal	O	O
and	O	O
tracheal	O	O
secretions	O	O
by	O	O
Gram-negative	B-bacteria	B-bacteria
pathogens	E-bacteria	I-bacteria
in	O	O
mechanically	O	O
ventilated	O	O
children	O	O
.	O	O

A	O	O
randomized	O	O
,	O	O
controlled	O	O
and	O	O
double-blinded	O	O
study	O	O
was	O	O
performed	O	O
in	O	O
the	O	O
paediatric	O	O
intensive	O	O
care	O	O
unit	O	O
(	O	O
PICU	O	O
)	O	O
of	O	O
a	O	O
Brazilian	O	O
university	O	O
hospital	O	O
.	O	O

Exclusion	O	O
criteria	O	O
included	O	O
child	O	O
age	O	O
under	O	O
28	O	O
days	O	O
,	O	O
pneumonia	O	O
diagnosis	O	O
at	O	O
admission	O	O
,	O	O
use	O	O
of	O	O
tracheostomy	O	O
,	O	O
PICU	O	O
length	O	O
of	O	O
stay	O	O
(	O	O
LOS	O	O
)	O	O
less	O	O
than	O	O
48	O	O
h	O	O
and	O	O
refusal	O	O
to	O	O
participate	O	O
.	O	O

Children	O	O
were	O	O
randomly	O	O
allocated	O	O
to	O	O
the	O	O
interventional	O	O
group	O	O
(	O	O
IG	O	O
)	O	O
,	O	O
in	O	O
which	O	O
oral	O	O
care	O	O
with	O	O
chlorhexidine	O	O
was	O	O
administered	O	O
,	O	O
or	O	O
to	O	O
the	O	O
placebo	O	O
group	O	O
(	O	O
PG	O	O
)	O	O
,	O	O
which	O	O
received	O	O
oral	O	O
care	O	O
without	O	O
antiseptic	O	O
use	O	O
.	O	O

The	O	O
data	O	O
were	O	O
analysed	O	O
through	O	O
Pearson	O	O
's	O	O
chi	O	O
(	O	O
2	O	O
)	O	O
test	O	O
,	O	O
Fisher's	O	O
exact	O	O
and	O	O
ANOVA	O	O
tests	O	O
with	O	O
significance	O	O
levels	O	O
set	O	O
at	O	O
0.05	O	O
.	O	O

The	O	O
demographic	O	O
characteristics	O	O
of	O	O
the	O	O
74	O	O
children	O	O
were	O	O
not	O	O
statistically	O	O
different	O	O
between	O	O
groups	O	O
.	O	O

No	O	O
between-group	O	O
differences	O	O
in	O	O
oropharyx	O	O
colonization	O	O
by	O	O
Gram-negative	B-bacteria	B-bacteria
pathogens	E-bacteria	I-bacteria
were	O	O
identified	O	O
(	O	O
p	O	O
=	O	O
0.316	O	O
)	O	O
.	O	O

Pathogens	O	O
were	O	O
isolated	O	O
in	O	O
the	O	O
tracheal	O	O
secretions	O	O
of	O	O
two	O	O
(	O	O
10.0	O	O
%	O	O
)	O	O
children	O	O
in	O	O
the	O	O
PG	O	O
and	O	O
four	O	O
(	O	O
19.0	O	O
%	O	O
)	O	O
children	O	O
in	O	O
the	O	O
IG	O	O
(	O	O
p	O	O
=	O	O
0.355	O	O
)	O	O
.	O	O

The	O	O
use	O	O
of	O	O
chlorhexidine	O	O
did	O	O
not	O	O
significantly	O	O
influence	O	O
the	O	O
colonization	O	O
of	O	O
oropharyngeal	O	O
and	O	O
tracheal	O	O
secretions	O	O
by	O	O
Gram-negative	B-bacteria	B-bacteria
pathogens	E-bacteria	I-bacteria
of	O	O
the	O	O
studied	O	O
sample	O	O
.	O	O

This	O	O
study	O	O
demonstrated	O	O
no	O	O
influence	O	O
of	O	O
a	O	O
specific	O	O
antiseptic	O	O
agent	O	O
on	O	O
colonization	O	O
profile	O	O
of	O	O
mechanically	O	O
ventilated	O	O
children	O	O
in	O	O
PICU	O	O
.	O	O

Further	O	O
research	O	O
in	O	O
this	O	O
field	O	O
is	O	O
necessary	O	O
to	O	O
promote	O	O
evidence-based	O	O
nursing	O	O
practice	O	O
on	O	O
oral	O	O
care	O	O
of	O	O
critically	O	O
ill	O	O
children	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
colonizes	O	O
the	O	O
stomachs	O	O
of	O	O
at	O	O
least	O	O
half	O	O
of	O	O
the	O	O
world	O	O
's	O	O
human	O	O
population	O	O
.	O	O

The	O	O
role	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
in	O	O
this	O	O
colonization	O	O
is	O	O
not	O	O
clear	O	O
and	O	O
there	O	O
are	O	O
,	O	O
to	O	O
date	O	O
,	O	O
no	O	O
comprehensive	O	O
data	O	O
that	O	O
clearly	O	O
demonstrate	O	O
the	O	O
isolation	O	O
of	O	O
this	O	O
bacterium	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
prevalence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
15	O	O
patients	O	O
who	O	O
tested	O	O
positive	O	O
for	O	O
H.	O	O
pylori	O	O
.	O	O

A	O	O
comprehensive	O	O
dental	O	O
examination	O	O
of	O	O
all	O	O
patients	O	O
was	O	O
conducted	O	O
.	O	O

Samples	O	O
were	O	O
taken	O	O
from	O	O
supragingival	O	O
and	O	O
subgingival	O	O
plaque	O	O
,	O	O
saliva	O	O
,	O	O
periapical	O	O
exudates	O	O
and	O	O
tongue	O	O
swabs	O	O
.	O	O

All	O	O
samples	O	O
were	O	O
taken	O	O
before	O	O
the	O	O
application	O	O
of	O	O
antibiotics	O	O
.	O	O

A	O	O
total	O	O
of	O	O
163	O	O
oral	O	O
samples	O	O
were	O	O
investigated	O	O
by	O	O
PCR	O	O
using	O	O
two	O	O
different	O	O
H.	B-bacteria	B-bacteria
pylori-specific	E-bacteria	I-bacteria
primer	O	O
pairs	O	O
.	O	O

A	O	O
PCR	O	O
inhibition	O	O
control	O	O
using	O	O
a	O	O
modified	O	O
plasmid	O	O
was	O	O
always	O	O
included	O	O
for	O	O
the	O	O
most	O	O
specific	O	O
primer	O	O
pair	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
a	O	O
culture	O	O
technique	O	O
was	O	O
used	O	O
to	O	O
confirm	O	O
PCR	O	O
results	O	O
.	O	O

Despite	O	O
a	O	O
PCR	O	O
detection	O	O
limit	O	O
of	O	O
10	O	O
(	O	O
2	O	O
)	O	O
bacteria	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
,	O	O
out	O	O
of	O	O
14	O	O
patients	O	O
,	O	O
H.	O	O
pylori	O	O
could	O	O
not	O	O
be	O	O
detected	O	O
in	O	O
any	O	O
of	O	O
the	O	O
samples	O	O
taken	O	O
.	O	O

In	O	O
one	O	O
patient	O	O
,	O	O
H.	B-bacteria	B-bacteria
pylori-positive	E-bacteria	I-bacteria
PCR	O	O
signals	O	O
were	O	O
obtained	O	O
in	O	O
two	O	O
samples	O	O
using	O	O
only	O	O
one	O	O
primer	O	O
pair	O	O
.	O	O

H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
could	O	O
not	O	O
be	O	O
cultivated	O	O
from	O	O
these	O	O
two	O	O
PCR-positive	O	O
samples	O	O
;	O	O
therefore	O	O
,	O	O
no	O	O
correlation	O	O
to	O	O
oral	O	O
colonization	O	O
status	O	O
could	O	O
be	O	O
established	O	O
.	O	O

This	O	O
study	O	O
challenges	O	O
the	O	O
misleading	O	O
preconception	O	O
that	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
resides	O	O
in	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
and	O	O
suggests	O	O
that	O	O
this	O	O
bacterium	O	O
should	O	O
be	O	O
considered	O	O
transient	O	O
and	O	O
independent	O	O
of	O	O
the	O	O
oral	O	O
status	O	O
.	O	O

To	O	O
date	O	O
,	O	O
positive	O	O
PCR	O	O
results	O	O
for	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
have	O	O
been	O	O
overestimated	O	O
and	O	O
not	O	O
critically	O	O
interpreted	O	O
in	O	O
literature	O	O
.	O	O

Microbial	O	O
flora	O	O
can	O	O
provide	O	O
insight	O	O
into	O	O
the	O	O
ecology	O	O
and	O	O
natural	O	O
history	O	O
of	O	O
wildlife	O	O
in	O	O
addition	O	O
to	O	O
improving	O	O
understanding	O	O
of	O	O
health	O	O
risks	O	O
.	O	O

This	O	O
study	O	O
examines	O	O
the	O	O
anaerobic	O	O
oral	O	O
flora	O	O
of	O	O
hunter	O	O
killed	O	O
black	O	O
bears	O	O
(	O	O
Ursus	O	O
americanus	O	O
)	O	O
in	O	O
eastern	O	O
North	O	O
Carolina	O	O
.	O	O

Oral	O	O
swabs	O	O
from	O	O
the	O	O
buccal	O	O
and	O	O
lingual	O	O
supragingival	O	O
tooth	O	O
surfaces	O	O
of	O	O
the	O	O
first	O	O
and	O	O
second	O	O
mandibular	O	O
and	O	O
maxillary	O	O
molars	O	O
of	O	O
22	O	O
black	O	O
bears	O	O
were	O	O
inoculated	O	O
onto	O	O
Brucella	O	O
Blood	O	O
Agar	O	O
plates	O	O
supplemented	O	O
with	O	O
hemin	O	O
and	O	O
vitamin	O	O
K	O	O
after	O	O
transport	O	O
from	O	O
the	O	O
field	O	O
using	O	O
reduced	O	O
oxoid	O	O
nutrient	O	O
broth	O	O
.	O	O

Sixteen	O	O
anaerobic	B-bacteria	B-bacteria
bacterial	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
,	O	O
representing	O	O
nine	O	O
genera	O	O
were	O	O
identified	O	O
using	O	O
the	O	O
RapID	O	O
ANA	O	O
II	O	O
Micromethod	O	O
Kit	O	O
system	O	O
and	O	O
a	O	O
number	O	O
of	O	O
organisms	O	O
grown	O	O
that	O	O
could	O	O
not	O	O
be	O	O
identified	O	O
with	O	O
the	O	O
system	O	O
.	O	O

The	O	O
most	O	O
frequently	O	O
identified	O	O
anaerobes	B-bacteria	B-bacteria
were	O	O
Peptostreptococcus	B-bacteria	B-bacteria
prevotii	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
constellatus	E-bacteria	I-bacteria
,	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

The	O	O
diversity	O	O
in	O	O
the	O	O
anaerobic	O	O
oral	O	O
flora	O	O
of	O	O
black	O	O
bear	O	O
in	O	O
eastern	O	O
North	O	O
Carolina	O	O
suggests	O	O
the	O	O
importance	O	O
of	O	O
including	O	O
these	O	O
organisms	O	O
in	O	O
basic	O	O
health	O	O
risk	O	O
assessment	O	O
protocols	O	O
and	O	O
suggests	O	O
a	O	O
potential	O	O
tool	O	O
for	O	O
assessment	O	O
of	O	O
bear/habitat	O	O
interactions	O	O
.	O	O

Tobacco	O	O
chewing	O	O
habit	O	O
,	O	O
presence	O	O
of	O	O
squamous	O	O
cell	O	O
carcinoma	O	O
in	O	O
oral	O	O
cavity	O	O
and	O	O
radiotherapy	O	O
causes	O	O
alterations	O	O
in	O	O
healthy	O	O
oral	O	O
microflora	O	O
.	O	O

Abnormal	O	O
flora	O	O
developed	O	O
due	O	O
to	O	O
radiotherapy	O	O
in	O	O
oral	O	O
squamous	O	O
cell	O	O
carcinoma	O	O
(	O	O
OSCC	O	O
)	O	O
patients	O	O
can	O	O
exacerbate	O	O
mucositis	O	O
and	O	O
can	O	O
cause	O	O
systemic	O	O
infections	O	O
.	O	O

The	O	O
role	O	O
of	O	O
oral	O	O
microorganisms	O	O
in	O	O
carcinogenesis	O	O
is	O	O
gaining	O	O
interest	O	O
recently	O	O
.	O	O

Abnormal	O	O
flora	O	O
in	O	O
development	O	O
of	O	O
second	O	O
tumor	O	O
in	O	O
the	O	O
field	O	O
of	O	O
first	O	O
tumor	O	O
is	O	O
to	O	O
be	O	O
established	O	O
.	O	O

The	O	O
study	O	O
fundamentally	O	O
tries	O	O
to	O	O
evaluate	O	O
the	O	O
shift	O	O
that	O	O
occurs	O	O
during	O	O
the	O	O
radiotherapy	O	O
in	O	O
OSCC	O	O
patients	O	O
.	O	O

Microbial	O	O
analysis	O	O
of	O	O
saliva	O	O
samples	O	O
from	O	O
OSCC	O	O
patients	O	O
undergoing	O	O
radiotherapy	O	O
,	O	O
tobacco	O	O
chewers	O	O
and	O	O
controls	O	O
was	O	O
undertaken	O	O
.	O	O

The	O	O
microorganisms	O	O
were	O	O
grouped	O	O
into	O	O
categories	O	O
as	O	O
total	O	O
aerobes	B-bacteria	B-bacteria
,	O	O
total	O	O
anaerobes	B-bacteria	B-bacteria
,	O	O
candida	O	O
,	O	O
coliforms	B-bacteria	B-bacteria
and	O	O
gram	B-bacteria	B-bacteria
negative	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

The	O	O
frequency	O	O
of	O	O
isolation	O	O
of	O	O
total	O	O
aerobes	B-bacteria	B-bacteria
,	O	O
total	O	O
anaerobes	B-bacteria	B-bacteria
,	O	O
coliforms	B-bacteria	B-bacteria
and	O	O
gram	B-bacteria	B-bacteria
negative	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
was	O	O
significantly	O	O
high	O	O
in	O	O
OSCC	O	O
patients	O	O
compared	O	O
to	O	O
healthy	O	O
controls	O	O
whereas	O	O
candida	O	O
was	O	O
isolated	O	O
most	O	O
frequently	O	O
during	O	O
radiation	O	O
period	O	O
.	O	O

The	O	O
tobacco	O	O
chewers	O	O
showed	O	O
significant	O	O
increase	O	O
in	O	O
colony	O	O
forming	O	O
units	O	O
of	O	O
total	O	O
aerobes	B-bacteria	B-bacteria
and	O	O
coliforms	B-bacteria	B-bacteria
.	O	O

All	O	O
the	O	O
microbial	O	O
groups	O	O
were	O	O
high	O	O
in	O	O
OSCC	O	O
and	O	O
radiotherapy	O	O
patients	O	O
.	O	O

While	O	O
OSCC	O	O
patients	O	O
showed	O	O
significant	O	O
increase	O	O
in	O	O
total	O	O
anaerobes	B-bacteria	B-bacteria
and	O	O
gram	B-bacteria	B-bacteria
negative	I-bacteria	I-bacteria
anaerobes	E-bacteria	I-bacteria
,	O	O
candida	O	O
was	O	O
increased	O	O
in	O	O
radiotherapy	O	O
patients	O	O
only	O	O
.	O	O

Habits	O	O
promote	O	O
coliforms	B-bacteria	B-bacteria
.	O	O

Tumor	O	O
supports	O	O
efficiently	O	O
anaerobes	B-bacteria	B-bacteria
and	O	O
candida	O	O
.	O	O

The	O	O
latter	O	O
is	O	O
supported	O	O
more	O	O
by	O	O
radiation	O	O
.	O	O

The	O	O
study	O	O
stresses	O	O
the	O	O
importance	O	O
on	O	O
administration	O	O
of	O	O
appropriate	O	O
antimicrobial	O	O
therapy	O	O
right	O	O
at	O	O
the	O	O
time	O	O
of	O	O
diagnosis	O	O
of	O	O
the	O	O
lesion	O	O
.	O	O

High	O	O
throughput	O	O
sequencing	O	O
of	O	O
16S	O	O
ribosomal	O	O
RNA	O	O
gene	O	O
amplicons	O	O
is	O	O
a	O	O
cost-effective	O	O
method	O	O
for	O	O
characterization	O	O
of	O	O
oral	O	O
bacterial	O	O
communities	O	O
.	O	O

However	O	O
,	O	O
before	O	O
undertaking	O	O
large-scale	O	O
studies	O	O
,	O	O
it	O	O
is	O	O
necessary	O	O
to	O	O
understand	O	O
the	O	O
technique-associated	O	O
limitations	O	O
and	O	O
intrinsic	O	O
variability	O	O
of	O	O
the	O	O
oral	O	O
ecosystem	O	O
.	O	O

In	O	O
this	O	O
work	O	O
we	O	O
evaluated	O	O
bias	O	O
in	O	O
species	O	O
representation	O	O
using	O	O
an	O	O
in	O	O
vitro-assembled	O	O
mock	O	O
community	O	O
of	O	O
oral	O	O
bacteria	O	O
.	O	O

We	O	O
then	O	O
characterized	O	O
the	O	O
bacterial	O	O
communities	O	O
in	O	O
saliva	O	O
and	O	O
buccal	O	O
mucosa	O	O
of	O	O
five	O	O
healthy	O	O
subjects	O	O
to	O	O
investigate	O	O
the	O	O
power	O	O
of	O	O
high	O	O
throughput	O	O
sequencing	O	O
in	O	O
revealing	O	O
their	O	O
diversity	O	O
and	O	O
biogeography	O	O
patterns	O	O
.	O	O

Mock	O	O
community	O	O
analysis	O	O
showed	O	O
primer	O	O
and	O	O
DNA	O	O
isolation	O	O
biases	O	O
and	O	O
an	O	O
overestimation	O	O
of	O	O
diversity	O	O
that	O	O
was	O	O
reduced	O	O
after	O	O
eliminating	O	O
singleton	O	O
operational	O	O
taxonomic	O	O
units	O	O
(	O	O
OTUs	O	O
)	O	O
.	O	O

Sequencing	O	O
of	O	O
salivary	O	O
and	O	O
mucosal	O	O
communities	O	O
found	O	O
a	O	O
total	O	O
of	O	O
455	O	O
OTUs	O	O
(	O	O
0.3	O	O
%	O	O
dissimilarity	O	O
)	O	O
with	O	O
only	O	O
78	O	O
of	O	O
these	O	O
present	O	O
in	O	O
all	O	O
subjects	O	O
.	O	O

We	O	O
demonstrate	O	O
that	O	O
this	O	O
variability	O	O
was	O	O
partly	O	O
the	O	O
result	O	O
of	O	O
incomplete	O	O
richness	O	O
coverage	O	O
even	O	O
at	O	O
great	O	O
sequencing	O	O
depths	O	O
,	O	O
and	O	O
so	O	O
comparing	O	O
communities	O	O
by	O	O
their	O	O
structure	O	O
was	O	O
more	O	O
effective	O	O
than	O	O
comparisons	O	O
based	O	O
solely	O	O
on	O	O
membership	O	O
.	O	O

With	O	O
respect	O	O
to	O	O
oral	O	O
biogeography	O	O
,	O	O
we	O	O
found	O	O
inter-subject	O	O
variability	O	O
in	O	O
community	O	O
structure	O	O
was	O	O
lower	O	O
than	O	O
site	O	O
differences	O	O
between	O	O
salivary	O	O
and	O	O
mucosal	O	O
communities	O	O
within	O	O
subjects	O	O
.	O	O

These	O	O
differences	O	O
were	O	O
evident	O	O
at	O	O
very	O	O
low	O	O
sequencing	O	O
depths	O	O
and	O	O
were	O	O
mostly	O	O
caused	O	O
by	O	O
the	O	O
abundance	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
and	O	O
Gemella	B-bacteria	B-bacteria
haemolysans	E-bacteria	I-bacteria
in	O	O
mucosa	O	O
.	O	O

In	O	O
summary	O	O
,	O	O
we	O	O
present	O	O
an	O	O
experimental	O	O
and	O	O
data	O	O
analysis	O	O
framework	O	O
that	O	O
will	O	O
facilitate	O	O
design	O	O
and	O	O
interpretation	O	O
of	O	O
pyrosequencing-based	O	O
studies	O	O
.	O	O

Despite	O	O
challenges	O	O
associated	O	O
with	O	O
this	O	O
technique	O	O
,	O	O
we	O	O
demonstrate	O	O
its	O	O
power	O	O
for	O	O
evaluation	O	O
of	O	O
oral	O	O
diversity	O	O
and	O	O
biogeography	O	O
patterns	O	O
.	O	O

to	O	O
test	O	O
the	O	O
association	O	O
between	O	O
Candida	O	O
and	O	O
mutans	B-bacteria	B-bacteria
streptococci	I-bacteria	I-bacteria
(	O	O
ms	B-bacteria	B-bacteria
)	O	O
,	O	O
oral	O	O
hygiene	O	O
and	O	O
caries	O	O
levels	O	O
and	O	O
in	O	O
children	O	O
.	O	O

22	O	O
boys	O	O
and	O	O
12	O	O
girls	O	O
(	O	O
age	O	O
6	O	O
to	O	O
14.5	O	O
years	O	O
)	O	O
participated	O	O
in	O	O
the	O	O
study	O	O
.	O	O

Each	O	O
participant	O	O
received	O	O
a	O	O
toothbrush	O	O
,	O	O
and	O	O
was	O	O
asked	O	O
to	O	O
brush	O	O
his/her	O	O
teeth	O	O
after	O	O
proper	O	O
instructions	O	O
.	O	O

Dental	O	O
caries	O	O
and	O	O
oral	O	O
hygiene	O	O
were	O	O
recorded	O	O
.	O	O

Candida	O	O
and	O	O
ms	B-bacteria	B-bacteria
levels	O	O
were	O	O
determined	O	O
in	O	O
saliva	O	O
samples	O	O
.	O	O

Candida	O	O
colonies	O	O
were	O	O
observed	O	O
in	O	O
70.5	O	O
%	O	O
of	O	O
the	O	O
children	O	O
.	O	O

No	O	O
association	O	O
was	O	O
found	O	O
between	O	O
Candida	O	O
and	O	O
caries	O	O
or	O	O
plaque	O	O
and	O	O
gingival	O	O
indices	O	O
.	O	O

C.	O	O
albicans-positive	O	O
children	O	O
demonstrated	O	O
significantly	O	O
higher	O	O
brushing	O	O
scores	O	O
.	O	O

Our	O	O
findings	O	O
may	O	O
suggest	O	O
that	O	O
there	O	O
is	O	O
no	O	O
clear	O	O
association	O	O
between	O	O
Candida	O	O
in	O	O
saliva	O	O
,	O	O
and	O	O
levels	O	O
of	O	O
cariogenic	O	O
bacteria	O	O
and	O	O
caries	O	O
risk	O	O
in	O	O
children	O	O
.	O	O

Oral	O	O
mucositis	O	O
is	O	O
a	O	O
serious	O	O
and	O	O
debilitating	O	O
side	O	O
effect	O	O
of	O	O
conditioning	O	O
regimens	O	O
for	O	O
hematopoietic	O	O
stem	O	O
cell	O	O
transplant	O	O
(	O	O
HSCT	O	O
)	O	O
.	O	O

Through	O	O
HSCT	O	O
,	O	O
the	O	O
homeostasis	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
disrupted	O	O
.	O	O

The	O	O
contribution	O	O
of	O	O
the	O	O
oral	O	O
microflora	O	O
to	O	O
mucositis	O	O
remains	O	O
to	O	O
be	O	O
clarified	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
our	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
relationship	O	O
between	O	O
yeasts	O	O
,	O	O
bacteria	O	O
associated	O	O
with	O	O
periodontitis	O	O
,	O	O
and	O	O
oral	O	O
ulcerations	O	O
in	O	O
HSCT	O	O
recipients	O	O
.	O	O

This	O	O
prospective	O	O
observational	O	O
study	O	O
included	O	O
49	O	O
adult	O	O
HSCT	O	O
recipients	O	O
.	O	O

Twice	O	O
weekly	O	O
,	O	O
oral	O	O
ulcerations	O	O
were	O	O
scored	O	O
,	O	O
and	O	O
oral	O	O
rinsing	O	O
samples	O	O
were	O	O
obtained	O	O
.	O	O

Samples	O	O
were	O	O
evaluated	O	O
for	O	O
the	O	O
total	O	O
bacterial	O	O
load	O	O
;	O	O
the	O	O
Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
:	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Parvimonas	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
;	O	O
and	O	O
the	O	O
yeasts	O	O
:	O	O
Candida	O	O
albicans	O	O
,	O	O
Candida	O	O
glabrata	O	O
,	O	O
Candida	O	O
kefyr	O	O
,	O	O
Candida	O	O
krusei	O	O
,	O	O
Candida	O	O
parapsilosis	O	O
,	O	O
and	O	O
Candida	O	O
tropicalis	O	O
using	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
with	O	O
specific	O	O
primers	O	O
and	O	O
probes	O	O
.	O	O

Explanatory	O	O
variables	O	O
for	O	O
oral	O	O
ulcerations	O	O
were	O	O
calculated	O	O
using	O	O
the	O	O
multilevel	O	O
generalized	O	O
estimated	O	O
equations	O	O
(	O	O
GEE	O	O
)	O	O
technique	O	O
.	O	O

None	O	O
of	O	O
the	O	O
samples	O	O
was	O	O
positive	O	O
for	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
while	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
was	O	O
found	O	O
most	O	O
often	O	O
(	O	O
66	O	O
%	O	O
of	O	O
samples	O	O
)	O	O
.	O	O

C.	O	O
albicans	O	O
was	O	O
the	O	O
most	O	O
isolated	O	O
yeast	O	O
(	O	O
88	O	O
%	O	O
of	O	O
samples	O	O
)	O	O
,	O	O
whereas	O	O
C.	O	O
parapsilosis	O	O
was	O	O
found	O	O
in	O	O
only	O	O
8	O	O
%	O	O
of	O	O
the	O	O
samples	O	O
.	O	O

Multivariate	O	O
GEE	O	O
analyses	O	O
identified	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
,	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
C.	O	O
glabrata	O	O
,	O	O
and	O	O
C.	O	O
kefyr	O	O
as	O	O
significant	O	O
explanatory	O	O
variables	O	O
of	O	O
oral	O	O
ulcerations	O	O
.	O	O

Our	O	O
data	O	O
indicate	O	O
that	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
in	O	O
particular	O	O
,	O	O
but	O	O
also	O	O
P.	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
,	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
C.	O	O
glabrata	O	O
,	O	O
and	O	O
C.	O	O
kefyr	O	O
may	O	O
play	O	O
a	O	O
role	O	O
in	O	O
ulcerative	O	O
oral	O	O
mucositis	O	O
in	O	O
patients	O	O
undergoing	O	O
HSCT	O	O
.	O	O

This	O	O
study	O	O
aims	O	O
to	O	O
assess	O	O
the	O	O
effects	O	O
of	O	O
rinsing	O	O
with	O	O
zinc-	O	O
and	O	O
chlorhexidine-containing	O	O
mouth	O	O
rinse	O	O
with	O	O
or	O	O
without	O	O
adjunct	O	O
tongue	O	O
scraping	O	O
on	O	O
volatile	O	O
sulfur	O	O
compounds	O	O
(	O	O
VSCs	O	O
)	O	O
in	O	O
breath	O	O
air	O	O
,	O	O
and	O	O
the	O	O
microbiota	O	O
at	O	O
the	O	O
dorsum	O	O
of	O	O
the	O	O
tongue	O	O
.	O	O

A	O	O
randomized	O	O
single-masked	O	O
controlled	O	O
clinical	O	O
trial	O	O
with	O	O
a	O	O
cross-over	O	O
study	O	O
design	O	O
over	O	O
14	O	O
days	O	O
including	O	O
21	O	O
subjects	O	O
was	O	O
performed	O	O
.	O	O

Bacterial	O	O
samples	O	O
from	O	O
the	O	O
dorsum	O	O
of	O	O
the	O	O
tongue	O	O
were	O	O
assayed	O	O
by	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
.	O	O

No	O	O
halitosis	O	O
(	O	O
identified	O	O
by	O	O
VSC	O	O
assessments	O	O
)	O	O
at	O	O
day	O	O
14	O	O
was	O	O
identified	O	O
in	O	O
12/21	O	O
subjects	O	O
with	O	O
active	O	O
rinse	O	O
alone	O	O
,	O	O
in	O	O
10/21	O	O
with	O	O
adjunct	O	O
use	O	O
of	O	O
tongue	O	O
scraper	O	O
,	O	O
in	O	O
1/21	O	O
for	O	O
negative	O	O
control	O	O
rinse	O	O
alone	O	O
,	O	O
and	O	O
in	O	O
3/21	O	O
in	O	O
the	O	O
control	O	O
and	O	O
tongue	O	O
scraping	O	O
sequence	O	O
.	O	O

At	O	O
day	O	O
14	O	O
,	O	O
significantly	O	O
lower	O	O
counts	O	O
were	O	O
identified	O	O
only	O	O
in	O	O
the	O	O
active	O	O
rinse	O	O
sequence	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
for	O	O
15/78	O	O
species	O	O
including	O	O
,	O	O
Fusobacterium	B-bacteria	B-bacteria
sp.	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
.	O	O

A	O	O
decrease	O	O
in	O	O
bacteria	O	O
from	O	O
baseline	O	O
to	O	O
day	O	O
14	O	O
was	O	O
found	O	O
in	O	O
successfully	O	O
treated	O	O
subjects	O	O
for	O	O
9/74	O	O
species	O	O
including	O	O
:	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
.	O	O

Baseline	O	O
VSC	O	O
scores	O	O
were	O	O
correlated	O	O
with	O	O
several	O	O
bacterial	O	O
species	O	O
.	O	O

The	O	O
use	O	O
of	O	O
a	O	O
tongue	O	O
scraper	O	O
combined	O	O
with	O	O
active	O	O
rinse	O	O
did	O	O
not	O	O
change	O	O
the	O	O
levels	O	O
of	O	O
VSC	O	O
compared	O	O
to	O	O
rinsing	O	O
alone	O	O
.	O	O

VSC	O	O
scores	O	O
were	O	O
not	O	O
associated	O	O
with	O	O
bacterial	O	O
counts	O	O
in	O	O
samples	O	O
taken	O	O
from	O	O
the	O	O
dorsum	O	O
of	O	O
the	O	O
tongue	O	O
.	O	O

The	O	O
active	O	O
rinse	O	O
alone	O	O
containing	O	O
zinc	O	O
and	O	O
chlorhexidine	O	O
had	O	O
effects	O	O
on	O	O
intra-oral	O	O
halitosis	O	O
and	O	O
reduced	O	O
bacterial	O	O
counts	O	O
of	O	O
species	O	O
associated	O	O
with	O	O
malodor	O	O
.	O	O

Tongue	O	O
scraping	O	O
provided	O	O
no	O	O
beneficial	O	O
effects	O	O
on	O	O
the	O	O
microbiota	O	O
studied	O	O
.	O	O

Periodontally	O	O
healthy	O	O
subjects	O	O
with	O	O
intra-oral	O	O
halitosis	O	O
benefit	O	O
from	O	O
daily	O	O
rinsing	O	O
with	O	O
zinc-	O	O
and	O	O
chlorhexidine-containing	O	O
mouth	O	O
rinse	O	O
.	O	O

To	O	O
profile	O	O
the	O	O
abundance	O	O
and	O	O
diversity	O	O
of	O	O
subgingival	O	O
oral	O	O
microbiota	O	O
in	O	O
patients	O	O
with	O	O
never-treated	O	O
,	O	O
new-onset	O	O
rheumatoid	O	O
arthritis	O	O
(	O	O
RA	O	O
)	O	O
.	O	O

Periodontal	O	O
disease	O	O
(	O	O
PD	O	O
)	O	O
status	O	O
,	O	O
clinical	O	O
activity	O	O
,	O	O
and	O	O
sociodemographic	O	O
factors	O	O
were	O	O
determined	O	O
in	O	O
patients	O	O
with	O	O
new-onset	O	O
RA	O	O
,	O	O
patients	O	O
with	O	O
chronic	O	O
RA	O	O
,	O	O
and	O	O
healthy	O	O
subjects	O	O
.	O	O

Multiplexed-454	O	O
pyrosequencing	O	O
was	O	O
used	O	O
to	O	O
compare	O	O
the	O	O
composition	O	O
of	O	O
subgingival	O	O
microbiota	O	O
and	O	O
establish	O	O
correlations	O	O
between	O	O
the	O	O
presence/abundance	O	O
of	O	O
bacteria	O	O
and	O	O
disease	O	O
phenotypes	O	O
.	O	O

Anti-Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
antibody	O	O
testing	O	O
was	O	O
performed	O	O
to	O	O
assess	O	O
prior	O	O
exposure	O	O
to	O	O
the	O	O
bacterial	O	O
pathogen	O	O
P	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

The	O	O
more	O	O
advanced	O	O
forms	O	O
of	O	O
periodontitis	O	O
were	O	O
already	O	O
present	O	O
at	O	O
disease	O	O
onset	O	O
in	O	O
patients	O	O
with	O	O
new-onset	O	O
RA	O	O
.	O	O

The	O	O
subgingival	O	O
microbiota	O	O
observed	O	O
in	O	O
patients	O	O
with	O	O
new-onset	O	O
RA	O	O
was	O	O
distinct	O	O
from	O	O
that	O	O
found	O	O
in	O	O
healthy	O	O
controls	O	O
.	O	O

In	O	O
most	O	O
cases	O	O
,	O	O
however	O	O
,	O	O
these	O	O
microbial	O	O
differences	O	O
could	O	O
be	O	O
attributed	O	O
to	O	O
the	O	O
severity	O	O
of	O	O
PD	O	O
and	O	O
were	O	O
not	O	O
inherent	O	O
to	O	O
RA	O	O
.	O	O

The	O	O
presence	O	O
and	O	O
abundance	O	O
of	O	O
P	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
were	O	O
also	O	O
directly	O	O
associated	O	O
with	O	O
the	O	O
severity	O	O
of	O	O
PD	O	O
and	O	O
were	O	O
not	O	O
unique	O	O
to	O	O
RA	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
P	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
not	O	O
correlated	O	O
with	O	O
anti-citrullinated	O	O
protein	O	O
antibody	O	O
(	O	O
ACPA	O	O
)	O	O
titers	O	O
.	O	O

Overall	O	O
exposure	O	O
to	O	O
P	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
similar	O	O
between	O	O
patients	O	O
with	O	O
new-onset	O	O
RA	O	O
and	O	O
controls	O	O
,	O	O
observed	O	O
in	O	O
78	O	O
%	O	O
of	O	O
patients	O	O
and	O	O
83	O	O
%	O	O
of	O	O
controls	O	O
.	O	O

The	O	O
presence	O	O
and	O	O
abundance	O	O
of	O	O
Anaeroglobus	B-bacteria	B-bacteria
geminatus	E-bacteria	I-bacteria
correlated	O	O
with	O	O
the	O	O
presence	O	O
of	O	O
ACPAs/rheumatoid	O	O
factor	O	O
.	O	O

Prevotella	B-bacteria	B-bacteria
and	O	O
Leptotrichia	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
were	O	O
the	O	O
only	O	O
characteristic	O	O
taxa	O	O
observed	O	O
in	O	O
patients	O	O
with	O	O
new-onset	O	O
RA	O	O
irrespective	O	O
of	O	O
PD	O	O
status	O	O
.	O	O

Patients	O	O
with	O	O
new-onset	O	O
RA	O	O
exhibited	O	O
a	O	O
high	O	O
prevalence	O	O
of	O	O
PD	O	O
at	O	O
disease	O	O
onset	O	O
,	O	O
despite	O	O
their	O	O
young	O	O
age	O	O
and	O	O
paucity	O	O
of	O	O
smoking	O	O
history	O	O
.	O	O

The	O	O
subgingival	B-bacteria	B-bacteria
microbiota	E-bacteria	I-bacteria
profile	O	O
in	O	O
patients	O	O
with	O	O
new-onset	O	O
RA	O	O
was	O	O
similar	O	O
to	O	O
that	O	O
in	O	O
patients	O	O
with	O	O
chronic	O	O
RA	O	O
and	O	O
healthy	O	O
subjects	O	O
whose	O	O
PD	O	O
was	O	O
of	O	O
comparable	O	O
severity	O	O
.	O	O

Although	O	O
colonization	O	O
with	O	O
P	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
correlated	O	O
with	O	O
the	O	O
severity	O	O
of	O	O
PD	O	O
,	O	O
overall	O	O
exposure	O	O
to	O	O
P	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
similar	O	O
among	O	O
the	O	O
groups	O	O
.	O	O

The	O	O
role	O	O
of	O	O
A	B-bacteria	B-bacteria
geminatus	E-bacteria	I-bacteria
and	O	O
Prevotella/Leptotrichia	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
in	O	O
this	O	O
process	O	O
merits	O	O
further	O	O
study	O	O
.	O	O

Antimicrobial	O	O
peptides	O	O
,	O	O
molecules	O	O
produced	O	O
in	O	O
many	O	O
different	O	O
organisms	O	O
,	O	O
have	O	O
high	O	O
biocidal	O	O
activity	O	O
against	O	O
several	O	O
microorganisms	O	O
.	O	O

However	O	O
,	O	O
several	O	O
questions	O	O
about	O	O
these	O	O
molecules	O	O
remain	O	O
unclear	O	O
.	O	O

Therefore	O	O
,	O	O
this	O	O
report	O	O
details	O	O
a	O	O
systematic	O	O
survey	O	O
of	O	O
the	O	O
literature	O	O
on	O	O
the	O	O
use	O	O
of	O	O
antimicrobial	O	O
peptides	O	O
against	O	O
oral	O	O
pathogens	O	O
and	O	O
indicates	O	O
which	O	O
peptides	O	O
and	O	O
microorganisms	O	O
are	O	O
most	O	O
extensively	O	O
studied	O	O
.	O	O

Articles	O	O
were	O	O
located	O	O
using	O	O
the	O	O
PubMed	O	O
and	O	O
Science	O	O
Direct	O	O
databases	O	O
with	O	O
the	O	O
following	O	O
inclusion	O	O
criteria	O	O
:	O	O
publication	O	O
date	O	O
between	O	O
2002	O	O
and	O	O
2011	O	O
;	O	O
keywords	O	O
``	O	O
biofilm	O	O
OR	O	O
biological	O	O
film	O	O
OR	O	O
biological	O	O
layer	O	O
OR	O	O
bacterial	O	O
growth	O	O
''	O	O
AND	O	O
``	O	O
peptide	O	O
''	O	O
AND	O	O
``	O	O
oral	O	O
cavity	O	O
OR	O	O
mouth	O	O
OR	O	O
buccal	O	O
mucosa	O	O
OR	O	O
oral	O	O
mucosa	O	O
OR	O	O
mouth	O	O
mucosa	O	O
''	O	O
;	O	O
and	O	O
abstract	O	O
in	O	O
English	O	O
.	O	O

A	O	O
total	O	O
of	O	O
73	O	O
articles	O	O
were	O	O
selected	O	O
after	O	O
refinement	O	O
of	O	O
the	O	O
data	O	O
.	O	O

An	O	O
increase	O	O
in	O	O
publications	O	O
focusing	O	O
on	O	O
the	O	O
use	O	O
of	O	O
antimicrobial	O	O
peptides	O	O
against	O	O
oral	O	O
microorganisms	O	O
was	O	O
observed	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
peptides	O	O
produced	O	O
by	O	O
cells	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
(	O	O
defensins	O	O
,	O	O
LL-37	O	O
and	O	O
histatins	O	O
)	O	O
as	O	O
well	O	O
as	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
among	O	O
cariogenic	O	O
bacteria	O	O
)	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
among	O	O
periodontal	O	O
bacteria	O	O
)	O	O
were	O	O
the	O	O
most	O	O
studied	O	O
subjects	O	O
.	O	O

It	O	O
was	O	O
concluded	O	O
that	O	O
the	O	O
use	O	O
of	O	O
antimicrobial	O	O
peptides	O	O
as	O	O
a	O	O
tool	O	O
for	O	O
microbial	O	O
control	O	O
is	O	O
of	O	O
increasing	O	O
importance	O	O
,	O	O
likely	O	O
due	O	O
to	O	O
its	O	O
widespread	O	O
use	O	O
,	O	O
mechanism	O	O
of	O	O
action	O	O
,	O	O
and	O	O
low	O	O
rates	O	O
of	O	O
bacterial	O	O
resistance	O	O
.	O	O

Oral	O	O
health	O	O
is	O	O
affected	O	O
by	O	O
its	O	O
resident	O	O
microorganisms	O	O
.	O	O

Three	O	O
prominent	O	O
oral	O	O
disorders	O	O
are	O	O
dental	O	O
caries	O	O
,	O	O
gingivitis	O	O
and	O	O
periodontitis	O	O
,	O	O
with	O	O
the	O	O
oral	O	O
microbiota	O	O
playing	O	O
a	O	O
key	O	O
role	O	O
in	O	O
the	O	O
initiation/progression	O	O
of	O	O
all	O	O
three	O	O
.	O	O

Understanding	O	O
the	O	O
microbiota	O	O
and	O	O
the	O	O
diseases	O	O
they	O	O
may	O	O
cause	O	O
is	O	O
critical	O	O
to	O	O
the	O	O
development	O	O
of	O	O
new	O	O
therapeutics	O	O
.	O	O

This	O	O
review	O	O
is	O	O
focused	O	O
on	O	O
probiotics	B-bacteria	B-bacteria
for	O	O
the	O	O
prevention	O	O
and/or	O	O
treatment	O	O
of	O	O
oral	O	O
diseases	O	O
.	O	O

This	O	O
review	O	O
describes	O	O
the	O	O
oral	O	O
ecosystem	O	O
and	O	O
its	O	O
correlation	O	O
with	O	O
oral	O	O
health/disease	O	O
.	O	O

The	O	O
pathogenesis	O	O
and	O	O
current	O	O
prevention/treatment	O	O
strategies	O	O
of	O	O
periodontal	O	O
diseases	O	O
(	O	O
PD	O	O
)	O	O
and	O	O
dental	O	O
caries	O	O
(	O	O
DC	O	O
)	O	O
are	O	O
depicted	O	O
.	O	O

An	O	O
introduction	O	O
of	O	O
probiotics	B-bacteria	B-bacteria
is	O	O
followed	O	O
by	O	O
an	O	O
analysis	O	O
of	O	O
their	O	O
role	O	O
in	O	O
PD	O	O
and	O	O
DC	O	O
,	O	O
and	O	O
their	O	O
potential	O	O
role	O	O
(	O	O
s	O	O
)	O	O
in	O	O
oral	O	O
health	O	O
.	O	O

Finally	O	O
,	O	O
a	O	O
discussion	O	O
ensues	O	O
on	O	O
the	O	O
future	O	O
research	O	O
directions	O	O
and	O	O
limitations	O	O
of	O	O
probiotics	B-bacteria	B-bacteria
for	O	O
oral	O	O
health	O	O
.	O	O

An	O	O
effective	O	O
oral	O	O
probiotic	O	O
formulation	O	O
should	O	O
contribute	O	O
to	O	O
the	O	O
prevention/treatment	O	O
of	O	O
microbial	O	O
diseases	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Understanding	O	O
the	O	O
oral	O	O
microbiota	O	O
's	O	O
role	O	O
in	O	O
oral	O	O
disease	O	O
is	O	O
important	O	O
for	O	O
the	O	O
development	O	O
of	O	O
a	O	O
therapeutic	O	O
to	O	O
prevent/treat	O	O
dental	O	O
diseases	O	O
.	O	O

However	O	O
,	O	O
investigations	O	O
into	O	O
clinical	O	O
efficacy	O	O
,	O	O
delivery/dose	O	O
optimization	O	O
,	O	O
mechanism	O	O
(	O	O
s	O	O
)	O	O
of	O	O
action	O	O
and	O	O
other	O	O
related	O	O
parameters	O	O
are	O	O
yet	O	O
to	O	O
be	O	O
fully	O	O
explored	O	O
.	O	O

Keeping	O	O
this	O	O
in	O	O
mind	O	O
,	O	O
investigations	O	O
into	O	O
oral	O	O
probiotic	B-bacteria	B-bacteria
therapies	O	O
are	O	O
proving	O	O
promising	O	O
.	O	O

To	O	O
understand	O	O
the	O	O
relationship	O	O
between	O	O
our	O	O
bacterial	O	O
microbiome	O	O
and	O	O
health	O	O
,	O	O
it	O	O
is	O	O
essential	O	O
to	O	O
define	O	O
the	O	O
microbiome	O	O
in	O	O
the	O	O
absence	O	O
of	O	O
disease	O	O
.	O	O

The	O	O
digestive	O	O
tract	O	O
includes	O	O
diverse	O	O
habitats	O	O
and	O	O
hosts	O	O
the	O	O
human	O	O
body	O	O
's	O	O
greatest	O	O
bacterial	O	O
density	O	O
.	O	O

We	O	O
describe	O	O
the	O	O
bacterial	O	O
community	O	O
composition	O	O
of	O	O
ten	O	O
digestive	O	O
tract	O	O
sites	O	O
from	O	O
more	O	O
than	O	O
200	O	O
normal	O	O
adults	O	O
enrolled	O	O
in	O	O
the	O	O
Human	O	O
Microbiome	O	O
Project	O	O
,	O	O
and	O	O
metagenomically	O	O
determined	O	O
metabolic	O	O
potentials	O	O
of	O	O
four	O	O
representative	O	O
sites	O	O
.	O	O

The	O	O
microbiota	O	O
of	O	O
these	O	O
diverse	O	O
habitats	O	O
formed	O	O
four	O	O
groups	O	O
based	O	O
on	O	O
similar	O	O
community	O	O
compositions	O	O
:	O	O
buccal	O	O
mucosa	O	O
,	O	O
keratinized	O	O
gingiva	O	O
,	O	O
hard	O	O
palate	O	O
;	O	O
saliva	O	O
,	O	O
tongue	O	O
,	O	O
tonsils	O	O
,	O	O
throat	O	O
;	O	O
sub-	O	O
and	O	O
supra-gingival	O	O
plaques	O	O
;	O	O
and	O	O
stool	O	O
.	O	O

Phyla	O	O
initially	O	O
identified	O	O
from	O	O
environmental	O	O
samples	O	O
were	O	O
detected	O	O
throughout	O	O
this	O	O
population	O	O
,	O	O
primarily	O	O
TM7	O	O
,	O	O
SR1	O	O
,	O	O
and	O	O
Synergistetes	B-bacteria	B-bacteria
.	O	O

Genera	O	O
with	O	O
pathogenic	O	O
members	O	O
were	O	O
well-represented	O	O
among	O	O
this	O	O
disease-free	O	O
cohort	O	O
.	O	O

Tooth-associated	O	O
communities	O	O
were	O	O
distinct	O	O
,	O	O
but	O	O
not	O	O
entirely	O	O
dissimilar	O	O
,	O	O
from	O	O
other	O	O
oral	O	O
surfaces	O	O
.	O	O

The	O	O
Porphyromonadaceae	B-bacteria	B-bacteria
,	O	O
Veillonellaceae	B-bacteria	B-bacteria
and	O	O
Lachnospiraceae	B-bacteria	B-bacteria
families	O	O
were	O	O
common	O	O
to	O	O
all	O	O
sites	O	O
,	O	O
but	O	O
the	O	O
distributions	O	O
of	O	O
their	O	O
genera	O	O
varied	O	O
significantly	O	O
.	O	O

Most	O	O
metabolic	O	O
processes	O	O
were	O	O
distributed	O	O
widely	O	O
throughout	O	O
the	O	O
digestive	O	O
tract	O	O
microbiota	O	O
,	O	O
with	O	O
variations	O	O
in	O	O
metagenomic	O	O
abundance	O	O
between	O	O
body	O	O
habitats	O	O
.	O	O

These	O	O
included	O	O
shifts	O	O
in	O	O
sugar	O	O
transporter	O	O
types	O	O
between	O	O
the	O	O
supragingival	O	O
plaque	O	O
,	O	O
other	O	O
oral	O	O
surfaces	O	O
,	O	O
and	O	O
stool	O	O
;	O	O
hydrogen	O	O
and	O	O
hydrogen	O	O
sulfide	O	O
production	O	O
were	O	O
also	O	O
differentially	O	O
distributed	O	O
.	O	O

The	O	O
microbiomes	O	O
of	O	O
ten	O	O
digestive	O	O
tract	O	O
sites	O	O
separated	O	O
into	O	O
four	O	O
types	O	O
based	O	O
on	O	O
composition	O	O
.	O	O

A	O	O
core	O	O
set	O	O
of	O	O
metabolic	O	O
pathways	O	O
was	O	O
present	O	O
across	O	O
these	O	O
diverse	O	O
digestive	O	O
tract	O	O
habitats	O	O
.	O	O

These	O	O
data	O	O
provide	O	O
a	O	O
critical	O	O
baseline	O	O
for	O	O
future	O	O
studies	O	O
investigating	O	O
local	O	O
and	O	O
systemic	O	O
diseases	O	O
affecting	O	O
human	O	O
health	O	O
.	O	O

The	O	O
compounds	O	O
2',6'-dihydroxy-4'-geranyloxyacetophenone	O	O
(	O	O
1	O	O
)	O	O
and	O	O
2',6'-dihydroxy-4'-farnesyloxy-acetophenone	O	O
(	O	O
2	O	O
)	O	O
are	O	O
oxyprenylated	O	O
secondary	O	O
metabolites	O	O
extracted	O	O
from	O	O
plants	O	O
belonging	O	O
to	O	O
the	O	O
Rutaceae	O	O
family	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
1	O	O
and	O	O
2	O	O
were	O	O
synthesized	O	O
and	O	O
tested	O	O
for	O	O
their	O	O
antimicrobial	O	O
activity	O	O
toward	O	O
major	O	O
oral	O	O
pathogens	O	O
.	O	O

Compounds	O	O
1	O	O
and	O	O
2	O	O
were	O	O
synthesized	O	O
by	O	O
selective	O	O
prenylation	O	O
of	O	O
2,4,6-trihydroxyacetophenone	O	O
at	O	O
the	O	O
4	O	O
'	O	O
position	O	O
with	O	O
geranyl	O	O
and	O	O
farnesyl	O	O
bromide	O	O
,	O	O
respectively	O	O
.	O	O

Compound	O	O
1	O	O
showed	O	O
stronger	O	O
antimicrobial	O	O
activity	O	O
than	O	O
2	O	O
against	O	O
major	O	O
oral	O	O
pathogens	O	O
,	O	O
including	O	O
Gram	B-bacteria	B-bacteria
positive	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
)	O	O
,	O	O
Gram	B-bacteria	B-bacteria
negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
)	O	O
and	O	O
Candida	O	O
albicans	O	O
.	O	O

Evidences	O	O
were	O	O
obtained	O	O
that	O	O
the	O	O
mode	O	O
of	O	O
action	O	O
of	O	O
1	O	O
and	O	O
2	O	O
may	O	O
be	O	O
related	O	O
to	O	O
their	O	O
iron-chelating	O	O
property	O	O
.	O	O

This	O	O
study	O	O
suggests	O	O
that	O	O
1	O	O
and	O	O
2	O	O
may	O	O
represent	O	O
potential	O	O
natural	O	O
molecules	O	O
for	O	O
the	O	O
prevention/treatment	O	O
of	O	O
common	O	O
oral	O	O
infections	O	O
,	O	O
including	O	O
dental	O	O
caries	O	O
,	O	O
periodontal	O	O
disease	O	O
,	O	O
and	O	O
candidiasis	O	O
.	O	O

Attenuated	B-bacteria	B-bacteria
Salmonella	O	O
has	O	O
been	O	O
used	O	O
as	O	O
a	O	O
carrier	O	O
for	O	O
DNA	O	O
vaccine	O	O
.	O	O

However	O	O
,	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo	O	O
studies	O	O
on	O	O
the	O	O
bacteria	O	O
following	O	O
transfection	O	O
of	O	O
plasmid	O	O
DNA	O	O
were	O	O
poorly	O	O
studied	O	O
.	O	O

In	O	O
this	O	O
paper	O	O
,	O	O
eukaryotic	O	O
expression	O	O
plasmids	O	O
encoding	O	O
avian	O	O
influenza	O	O
virus	O	O
(	O	O
AIV	O	O
)	O	O
subtype	O	O
H5N1	O	O
genes	O	O
,	O	O
pcDNA3.1/HA	O	O
,	O	O
NA	O	O
,	O	O
and	O	O
NP	O	O
,	O	O
were	O	O
transfected	O	O
into	O	O
an	O	O
attenuated	B-bacteria	B-bacteria
Salmonella	I-bacteria	I-bacteria
enteric	I-bacteria	I-bacteria
typhimurium	I-bacteria	I-bacteria
SV4089	E-bacteria	I-bacteria
.	O	O

In	O	O
vitro	O	O
stability	O	O
of	O	O
the	O	O
transfected	O	O
plasmids	O	O
into	O	O
Salmonella	B-bacteria	B-bacteria
were	O	O
over	O	O
90	O	O
%	O	O
after	O	O
100	O	O
generations	O	O
.	O	O

The	O	O
attenuated	B-bacteria	B-bacteria
Salmonella	E-bacteria	I-bacteria
were	O	O
able	O	O
to	O	O
invade	O	O
MCF-7	O	O
(	O	O
1.2	O	O
%	O	O
)	O	O
and	O	O
MCF-10A	O	O
(	O	O
0.5	O	O
%	O	O
)	O	O
human	O	O
breast	O	O
cancer	O	O
cells	O	O
.	O	O

Newly	O	O
hatched	O	O
specific-pathogen-free	O	O
(	O	O
SPF	O	O
)	O	O
chicks	O	O
were	O	O
inoculated	O	O
once	O	O
by	O	O
oral	O	O
gavage	O	O
with	O	O
10	O	O
(	O	O
9	O	O
)	O	O
colony-forming	O	O
unit	O	O
(	O	O
CFU	O	O
)	O	O
of	O	O
the	O	O
attenuated	B-bacteria	B-bacteria
Salmonella	E-bacteria	I-bacteria
.	O	O

No	O	O
abnormal	O	O
clinical	O	O
signs	O	O
or	O	O
deaths	O	O
were	O	O
recorded	O	O
after	O	O
inoculation	O	O
.	O	O

Viable	O	O
bacteria	O	O
were	O	O
detected	O	O
3	O	O
days	O	O
after	O	O
inoculation	O	O
by	O	O
plating	O	O
from	O	O
spleen	O	O
,	O	O
liver	O	O
,	O	O
and	O	O
cecum	O	O
.	O	O

Fluorescent	O	O
in	O	O
situ	O	O
hybridization	O	O
(	O	O
FISH	O	O
)	O	O
and	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
were	O	O
carried	O	O
out	O	O
for	O	O
confirmation	O	O
.	O	O

Salmonella	B-bacteria	B-bacteria
was	O	O
not	O	O
detected	O	O
in	O	O
blood	O	O
cultures	O	O
although	O	O
serum	O	O
antibody	O	O
immune	O	O
responses	O	O
to	O	O
Salmonella	B-bacteria	B-bacteria
O	O	O
antiserum	O	O
group	O	O
D1	O	O
factor	O	O
1	O	O
,	O	O
9	O	O
,	O	O
and	O	O
12	O	O
antigens	O	O
were	O	O
observed	O	O
in	O	O
all	O	O
the	O	O
inoculated	O	O
chickens	O	O
after	O	O
7	O	O
days	O	O
up	O	O
to	O	O
35	O	O
days	O	O
.	O	O

Our	O	O
results	O	O
showed	O	O
that	O	O
live	O	O
attenuated	O	O
S.	B-bacteria	B-bacteria
typhimurium	I-bacteria	I-bacteria
SV4089	E-bacteria	I-bacteria
harboring	O	O
pcDNA3.1/HA	O	O
,	O	O
NA	O	O
,	O	O
and	O	O
NP	O	O
may	O	O
provide	O	O
a	O	O
unique	O	O
alternative	O	O
as	O	O
a	O	O
carrier	O	O
for	O	O
DNA	O	O
oral	O	O
vaccine	O	O
in	O	O
chickens	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
microorganisms	O	O
in	O	O
pharmaceuticals	O	O
is	O	O
undesirable	O	O
because	O	O
they	O	O
may	O	O
cause	O	O
spoilage	O	O
of	O	O
the	O	O
product	O	O
and	O	O
may	O	O
present	O	O
an	O	O
infection	O	O
hazard	O	O
to	O	O
the	O	O
consumers	O	O
or	O	O
patients	O	O
.	O	O

A	O	O
total	O	O
of	O	O
102	O	O
samples	O	O
of	O	O
oral	O	O
and	O	O
topical	O	O
non-sterile	O	O
pharmaceutical	O	O
products	O	O
were	O	O
collected	O	O
at	O	O
random	O	O
from	O	O
different	O	O
drug	O	O
houses	O	O
and	O	O
pharmacies	O	O
in	O	O
Iraq	O	O
,	O	O
to	O	O
investigate	O	O
the	O	O
microbial	O	O
contamination	O	O
of	O	O
these	O	O
products	O	O
.	O	O

Bacterial	O	O
isolates	O	O
recovered	O	O
from	O	O
these	O	O
medicaments	O	O
were	O	O
subjected	O	O
to	O	O
susceptibility	O	O
testing	O	O
against	O	O
various	O	O
antibiotics	O	O
by	O	O
disk	O	O
diffusion	O	O
method	O	O
according	O	O
to	O	O
Clinical	O	O
and	O	O
Laboratory	O	O
Standards	O	O
(	O	O
CLSI	O	O
)	O	O
guidelines	O	O
.	O	O

The	O	O
results	O	O
revealed	O	O
that	O	O
the	O	O
occurrence	O	O
of	O	O
gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
was	O	O
in	O	O
oral	O	O
and	O	O
topical	O	O
medicaments	O	O
while	O	O
gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
only	O	O
detected	O	O
in	O	O
topical	O	O
medicaments	O	O
.	O	O

More	O	O
than	O	O
58	O	O
%	O	O
of	O	O
Bacillus	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
were	O	O
resistant	O	O
to	O	O
lincomycin	B-bacteria	B-bacteria
and	O	O
Bacillus	B-bacteria	B-bacteria
mycoides	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
were	O	O
resistant	O	O
to	O	O
beta-lactam	O	O
antibiotics	O	O
and	O	O
trimethoprim-sulfamethoxazole	O	O
.	O	O

Staphylococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
showed	O	O
a	O	O
relatively	O	O
high	O	O
resistance	O	O
to	O	O
ampicillin	O	O
,	O	O
amoxicillin	O	O
,	O	O
penicillin	O	O
,	O	O
tetracycline	O	O
,	O	O
and	O	O
trimethoprim-sulfamethoxazole	O	O
.	O	O

S.	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
had	O	O
the	O	O
highest	O	O
number	O	O
of	O	O
multi-resistant	O	O
isolates	O	O
.	O	O

Furthermore	O	O
,	O	O
87.5	O	O
%	O	O
of	O	O
isolated	O	O
gram-negative	B-bacteria	B-bacteria
rods	E-bacteria	I-bacteria
showed	O	O
high	O	O
resistance	O	O
to	O	O
beta-lactam	O	O
antibiotics	O	O
and	O	O
75	O	O
%	O	O
of	O	O
them	O	O
were	O	O
highly	O	O
resistant	O	O
to	O	O
erythromycin	O	O
.	O	O

One	O	O
isolate	O	O
of	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
resistant	O	O
among	O	O
all	O	O
gram-negative	B-bacteria	B-bacteria
rod	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
.	O	O

The	O	O
high	O	O
rate	O	O
of	O	O
resistance	O	O
to	O	O
antimicrobial	O	O
agents	O	O
of	O	O
bacterial	O	O
isolates	O	O
recovered	O	O
from	O	O
oral	O	O
and	O	O
topical	O	O
medicaments	O	O
in	O	O
this	O	O
study	O	O
may	O	O
indicate	O	O
a	O	O
widespread	O	O
antibiotic	O	O
resistance	O	O
among	O	O
bacteria	O	O
isolated	O	O
from	O	O
different	O	O
sources	O	O
,	O	O
including	O	O
those	O	O
of	O	O
anthropological	O	O
and	O	O
environmental	O	O
origin	O	O
.	O	O

The	O	O
inherent	O	O
instabilities	O	O
associated	O	O
with	O	O
the	O	O
development	O	O
of	O	O
multispecies	O	O
biofilm	O	O
communities	O	O
within	O	O
the	O	O
constant-depth	O	O
film	O	O
fermenter	O	O
(	O	O
CDFF	O	O
)	O	O
and	O	O
other	O	O
microcosm	O	O
systems	O	O
can	O	O
yield	O	O
unacceptable	O	O
variability	O	O
between	O	O
experiments	O	O
,	O	O
which	O	O
could	O	O
limit	O	O
their	O	O
potential	O	O
applications	O	O
in	O	O
oral	O	O
microbiology	O	O
.	O	O

The	O	O
extent	O	O
of	O	O
this	O	O
variability	O	O
needs	O	O
to	O	O
be	O	O
determined	O	O
and	O	O
a	O	O
protocol	O	O
developed	O	O
which	O	O
minimizes	O	O
it	O	O
.	O	O

Two	O	O
custom-made	O	O
CDFFs	O	O
were	O	O
supplied	O	O
concurrently	O	O
with	O	O
the	O	O
same	O	O
inoculation	O	O
culture	O	O
,	O	O
begat	O	O
from	O	O
an	O	O
aliquot	O	O
of	O	O
a	O	O
saliva	O	O
pool	O	O
and	O	O
artificial	O	O
saliva	O	O
growth	O	O
medium	O	O
via	O	O
a	O	O
dual-channel	O	O
pump	O	O
.	O	O

Transformed	O	O
log	O	O
(	O	O
10	O	O
)	O	O
data	O	O
of	O	O
the	O	O
viable	O	O
counts	O	O
at	O	O
fixed	O	O
time	O	O
points	O	O
were	O	O
analysed	O	O
using	O	O
the	O	O
Bland-Altman	O	O
approach	O	O
to	O	O
test	O	O
for	O	O
the	O	O
levels	O	O
of	O	O
agreement	O	O
between	O	O
two	O	O
CDFFs	O	O
running	O	O
concurrently	O	O
and	O	O
those	O	O
CDFFs	O	O
run	O	O
in	O	O
series	O	O
.	O	O

The	O	O
coefficients	O	O
(	O	O
95	O	O
%	O	O
)	O	O
of	O	O
agreement	O	O
were	O	O
lower	O	O
(	O	O
i.e	O	O
.	O	O

less	O	O
variable	O	O
)	O	O
in	O	O
the	O	O
concurrent	O	O
model	O	O
than	O	O
when	O	O
run	O	O
in	O	O
series	O	O
for	O	O
total	O	O
counts	O	O
of	O	O
bacteria	O	O
(	O	O
1.238	O	O
vs	O	O
2.124	O	O
)	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
0.517	O	O
vs	O	O
1.431	O	O
)	O	O
and	O	O
Mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
2.817	O	O
vs	O	O
3.864	O	O
)	O	O
.	O	O

Other	O	O
measures	O	O
of	O	O
variability	O	O
showed	O	O
a	O	O
similar	O	O
trend	O	O
.	O	O

Operating	O	O
CDFFs	O	O
concurrently	O	O
minimizes	O	O
the	O	O
degree	O	O
of	O	O
difference	O	O
and	O	O
variability	O	O
between	O	O
them	O	O
.	O	O

Operating	O	O
CDFFs	O	O
concurrently	O	O
will	O	O
improve	O	O
the	O	O
sensitivity	O	O
for	O	O
experiments	O	O
that	O	O
seek	O	O
to	O	O
determine	O	O
the	O	O
effects	O	O
of	O	O
a	O	O
variable	O	O
,	O	O
such	O	O
as	O	O
a	O	O
nutritional	O	O
supplement	O	O
or	O	O
antimicrobial	O	O
agent	O	O
,	O	O
and	O	O
a	O	O
control	O	O
.	O	O

Five	O	O
strains	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
gram-negative	I-bacteria	I-bacteria
bacilli	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
were	O	O
subjected	O	O
to	O	O
a	O	O
comprehensive	O	O
range	O	O
of	O	O
phenotypic	O	O
and	O	O
genotypic	O	O
tests	O	O
and	O	O
were	O	O
found	O	O
to	O	O
comprise	O	O
a	O	O
homogeneous	O	O
group	O	O
.	O	O

Phylogenetic	O	O
analysis	O	O
of	O	O
full-length	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
showed	O	O
that	O	O
these	O	O
strains	O	O
represented	O	O
a	O	O
novel	O	O
group	O	O
within	O	O
the	O	O
family	O	O
Prevotellaceae	B-bacteria	B-bacteria
,	O	O
and	O	O
the	O	O
most	O	O
closely	O	O
related	O	O
species	O	O
was	O	O
Prevotella	B-bacteria	B-bacteria
tannerae	E-bacteria	I-bacteria
.	O	O

P.	B-bacteria	B-bacteria
tannerae	E-bacteria	I-bacteria
and	O	O
the	O	O
novel	O	O
taxon	O	O
are	O	O
deeply	O	O
branched	O	O
from	O	O
the	O	O
genus	B-bacteria	B-bacteria
Prevotella	E-bacteria	I-bacteria
,	O	O
with	O	O
sequence	O	O
identities	O	O
to	O	O
the	O	O
type	O	O
strain	O	O
of	O	O
the	O	O
type	O	O
species	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
,	O	O
of	O	O
82.2	O	O
and	O	O
85.6	O	O
%	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
novel	O	O
genus	B-bacteria	B-bacteria
Alloprevotella	I-bacteria	I-bacteria
gen.	I-bacteria	I-bacteria
nov.	E-bacteria	I-bacteria
is	O	O
proposed	O	O
to	O	O
accommodate	O	O
the	O	O
novel	O	O
species	O	O
Alloprevotella	B-bacteria	B-bacteria
rava	I-bacteria	I-bacteria
gen.	I-bacteria	I-bacteria
nov.	E-bacteria	I-bacteria
,	O	O
sp	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
and	O	O
the	O	O
previously	O	O
named	O	O
Prevotella	B-bacteria	B-bacteria
tannerae	E-bacteria	I-bacteria
Moore	I-bacteria	I-bacteria
et	I-bacteria	I-bacteria
al	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

1994	I-bacteria	I-bacteria
as	O	O
Alloprevotella	B-bacteria	B-bacteria
tannerae	I-bacteria	I-bacteria
gen.	I-bacteria	I-bacteria
nov.	E-bacteria	I-bacteria
,	O	O
comb	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

nov	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

The	O	O
type	O	O
species	O	O
is	O	O
Alloprevotella	B-bacteria	B-bacteria
tannerae	E-bacteria	I-bacteria
.	O	O

The	O	O
type	O	O
strain	O	O
of	O	O
Alloprevotella	B-bacteria	B-bacteria
rava	E-bacteria	I-bacteria
is	O	O
81/4-12	O	O
(	O	O
T	O	O
)	O	O
(	O	O
=	O	O
DSM	B-bacteria	B-bacteria
22548	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=	O	O
CCUG	B-bacteria	B-bacteria
58091	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
)	O	O
and	O	O
the	O	O
type	O	O
strain	O	O
of	O	O
Alloprevotella	B-bacteria	B-bacteria
tannerae	E-bacteria	I-bacteria
is	O	O
ATCC	B-bacteria	B-bacteria
51259	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=	O	O
CCUG	B-bacteria	B-bacteria
34292	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=	O	O
CIP	B-bacteria	B-bacteria
104476	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
=	O	O
NCTC	B-bacteria	B-bacteria
13073	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
.	O	O

Alloprevotella	B-bacteria	B-bacteria
rava	E-bacteria	I-bacteria
is	O	O
weakly	O	O
to	O	O
moderately	O	O
saccharolytic	O	O
and	O	O
produces	O	O
moderate	O	O
amounts	O	O
of	O	O
acetic	O	O
acid	O	O
and	O	O
major	O	O
amounts	O	O
of	O	O
succinic	O	O
acid	O	O
as	O	O
end	O	O
products	O	O
of	O	O
fermentation	O	O
.	O	O

Strains	O	O
are	O	O
sensitive	O	O
to	O	O
20	O	O
%	O	O
bile	O	O
and	O	O
hydrolyse	O	O
gelatin	O	O
.	O	O

The	O	O
principal	O	O
cellular	O	O
long-chain	O	O
fatty	O	O
acids	O	O
are	O	O
anteiso-C15	O	O
:	O	O
0	O	O
,	O	O
iso-C15	O	O
:	O	O
0	O	O
,	O	O
C16	O	O
:	O	O
0	O	O
,	O	O
iso-C17	O	O
:	O	O
0	O	O
and	O	O
iso-C17	O	O
:	O	O
0	O	O
3-OH	O	O
.	O	O

The	O	O
G+C	O	O
content	O	O
of	O	O
the	O	O
DNA	O	O
of	O	O
the	O	O
type	O	O
strain	O	O
is	O	O
47	O	O
mol	O	O
%	O	O
.	O	O

Despite	O	O
the	O	O
increased	O	O
frequency	O	O
of	O	O
recurrent	O	O
pneumonia	O	O
in	O	O
HIV-infected	O	O
patients	O	O
and	O	O
recent	O	O
studies	O	O
linking	O	O
the	O	O
airway	O	O
bacterial	O	O
community	O	O
(	O	O
microbiota	O	O
)	O	O
to	O	O
acute	O	O
and	O	O
chronic	O	O
respiratory	O	O
infection	O	O
,	O	O
little	O	O
is	O	O
known	O	O
of	O	O
the	O	O
oral	O	O
and	O	O
airway	O	O
microbiota	O	O
that	O	O
exist	O	O
in	O	O
these	O	O
individuals	O	O
and	O	O
their	O	O
propensity	O	O
to	O	O
harbor	O	O
pathogens	O	O
despite	O	O
antimicrobial	O	O
treatment	O	O
for	O	O
acute	O	O
pneumonia	O	O
.	O	O

This	O	O
pilot	O	O
study	O	O
compared	O	O
paired	O	O
samples	O	O
of	O	O
the	O	O
oral	O	O
and	O	O
airway	O	O
microbiota	O	O
from	O	O
15	O	O
hospitalized	O	O
HIV-infected	O	O
patients	O	O
receiving	O	O
antimicrobial	O	O
treatment	O	O
for	O	O
acute	O	O
pneumonia	O	O
.	O	O

Total	O	O
DNA	O	O
was	O	O
extracted	O	O
,	O	O
bacterial	O	O
burden	O	O
was	O	O
assessed	O	O
by	O	O
quantitative	O	O
PCR	O	O
,	O	O
and	O	O
amplified	O	O
16S	O	O
rRNA	O	O
was	O	O
profiled	O	O
for	O	O
microbiome	O	O
composition	O	O
using	O	O
a	O	O
phylogenetic	O	O
microarray	O	O
(	O	O
16S	O	O
rRNA	O	O
PhyloChip	O	O
)	O	O
.	O	O

Though	O	O
the	O	O
bacterial	O	O
burden	O	O
of	O	O
the	O	O
airway	O	O
was	O	O
significantly	O	O
lower	O	O
than	O	O
that	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
microbiota	O	O
in	O	O
both	O	O
niches	O	O
were	O	O
comparably	O	O
diverse	O	O
.	O	O

However	O	O
,	O	O
oral	O	O
and	O	O
airway	O	O
microbiota	O	O
exhibited	O	O
niche	O	O
specificity	O	O
.	O	O

Oral	O	O
microbiota	O	O
were	O	O
characterized	O	O
by	O	O
significantly	O	O
increased	O	O
relative	O	O
abundance	O	O
of	O	O
multiple	O	O
species	O	O
associated	O	O
with	O	O
the	O	O
mouth	O	O
,	O	O
including	O	O
members	O	O
of	O	O
the	O	O
Bacteroides	B-bacteria	B-bacteria
,	O	O
Firmicutes	B-bacteria	B-bacteria
,	O	O
and	O	O
TM7	B-bacteria	B-bacteria
phyla	E-bacteria	I-bacteria
,	O	O
while	O	O
airway	O	O
microbiota	O	O
were	O	O
primarily	O	O
characterized	O	O
by	O	O
a	O	O
relative	O	O
expansion	O	O
of	O	O
the	O	O
Proteobacteria	B-bacteria	B-bacteria
.	O	O

Twenty-two	O	O
taxa	O	O
were	O	O
detected	O	O
in	O	O
both	O	O
niches	O	O
,	O	O
including	O	O
Streptococcus	B-bacteria	B-bacteria
bovis	E-bacteria	I-bacteria
and	O	O
Chryseobacterium	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
pathogens	O	O
associated	O	O
with	O	O
HIV-infected	O	O
populations	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
we	O	O
compared	O	O
the	O	O
airway	O	O
microbiota	O	O
of	O	O
five	O	O
of	O	O
these	O	O
patients	O	O
to	O	O
those	O	O
of	O	O
five	O	O
non-HIV-infected	O	O
pneumonia	O	O
patients	O	O
from	O	O
a	O	O
previous	O	O
study	O	O
.	O	O

Compared	O	O
to	O	O
the	O	O
control	O	O
population	O	O
,	O	O
HIV-infected	O	O
patients	O	O
exhibited	O	O
relative	O	O
increased	O	O
abundance	O	O
of	O	O
a	O	O
large	O	O
number	O	O
of	O	O
phylogenetically	O	O
distinct	O	O
taxa	O	O
,	O	O
which	O	O
included	O	O
several	O	O
known	O	O
or	O	O
suspected	O	O
pathogenic	O	O
organisms	O	O
,	O	O
suggesting	O	O
that	O	O
recurrent	O	O
pneumonia	O	O
in	O	O
HIV-infected	O	O
populations	O	O
may	O	O
be	O	O
related	O	O
to	O	O
the	O	O
presence	O	O
of	O	O
these	O	O
species	O	O
.	O	O

Rothia	B-bacteria	B-bacteria
dentocariosa	E-bacteria	I-bacteria
is	O	O
an	O	O
indigenous	O	O
microbial	O	O
flora	O	O
of	O	O
dental	O	O
plaque	O	O
.	O	O

To	O	O
examine	O	O
the	O	O
bacterium	O	O
population	O	O
in	O	O
oral	O	O
cavities	O	O
,	O	O
a	O	O
novel	O	O
selective	O	O
medium	O	O
,	O	O
designated	O	O
RDSM	O	O
,	O	O
was	O	O
developed	O	O
for	O	O
the	O	O
isolation	O	O
of	O	O
R.	B-bacteria	B-bacteria
dentocariosa	E-bacteria	I-bacteria
.	O	O

RDSM	O	O
was	O	O
prepared	O	O
by	O	O
adding	O	O
0.5	O	O
mug/ml	O	O
of	O	O
lincomycin	O	O
,	O	O
10	O	O
mug/ml	O	O
of	O	O
colistin	O	O
,	O	O
and	O	O
40	O	O
%	O	O
sucrose	O	O
to	O	O
Heart	O	O
Infusion	O	O
(	O	O
HI	O	O
)	O	O
.	O	O

Average	O	O
growth	O	O
recovery	O	O
of	O	O
R.	B-bacteria	B-bacteria
dentocariosa	E-bacteria	I-bacteria
on	O	O
RDSM	O	O
was	O	O
93.8	O	O
%	O	O
that	O	O
of	O	O
HI	O	O
medium	O	O
.	O	O

Growth	O	O
of	O	O
other	O	O
bacteria	O	O
including	O	O
Rothia	B-bacteria	B-bacteria
mucilaginosa	E-bacteria	I-bacteria
,	O	O
Neisseria	B-bacteria	B-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
,	O	O
or	O	O
streptococci	B-bacteria	B-bacteria
was	O	O
remarkably	O	O
inhibited	O	O
on	O	O
the	O	O
selective	O	O
medium	O	O
.	O	O

Clinical	O	O
efficacy	O	O
was	O	O
evaluated	O	O
by	O	O
the	O	O
recovery	O	O
of	O	O
R.	B-bacteria	B-bacteria
dentocariosa	E-bacteria	I-bacteria
on	O	O
RDSM	O	O
from	O	O
the	O	O
stimulated	O	O
saliva	O	O
samples	O	O
of	O	O
8	O	O
volunteers	O	O
.	O	O

R.	B-bacteria	B-bacteria
dentocariosa	E-bacteria	I-bacteria
was	O	O
detected	O	O
at	O	O
2.6	O	O
(	O	O
range	O	O
:	O	O
1.0-4.6	O	O
)	O	O
%	O	O
to	O	O
total	O	O
bacteria	O	O
of	O	O
8.0x10	O	O
(	O	O
7	O	O
)	O	O
CFU/ml	O	O
on	O	O
BHI	O	O
in	O	O
their	O	O
oral	O	O
cavities	O	O
.	O	O

The	O	O
new	O	O
selective	O	O
medium	O	O
,	O	O
RDSM	O	O
,	O	O
was	O	O
highly	O	O
selective	O	O
for	O	O
R.	B-bacteria	B-bacteria
dentocariosa	E-bacteria	I-bacteria
and	O	O
was	O	O
useful	O	O
for	O	O
the	O	O
isolation	O	O
of	O	O
R.	B-bacteria	B-bacteria
dentocariosa	E-bacteria	I-bacteria
from	O	O
clinical	O	O
samples	O	O
.	O	O

Although	O	O
it	O	O
is	O	O
well-known	O	O
that	O	O
variations	O	O
of	O	O
the	O	O
microbial	O	O
community	O	O
in	O	O
a	O	O
specific	O	O
location	O	O
of	O	O
human	O	O
body	O	O
may	O	O
be	O	O
associated	O	O
with	O	O
some	O	O
diseases	O	O
,	O	O
the	O	O
developing	O	O
change	O	O
of	O	O
the	O	O
oral	O	O
microbiota	O	O
related	O	O
to	O	O
oral	O	O
diseases	O	O
before	O	O
and	O	O
after	O	O
wearing	O	O
the	O	O
removable	O	O
partial	O	O
dentures	O	O
(	O	O
RPD	O	O
)	O	O
is	O	O
not	O	O
completely	O	O
understood	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
three	O	O
kinds	O	O
of	O	O
samples	O	O
(	O	O
saliva	O	O
,	O	O
supra-	O	O
and	O	O
subgingival	O	O
plaque	O	O
,	O	O
and	O	O
oral	O	O
mucosal	O	O
surfaces	O	O
)	O	O
were	O	O
collected	O	O
from	O	O
the	O	O
10-patients	O	O
group	O	O
at	O	O
three	O	O
different	O	O
times	O	O
:	O	O
before	O	O
,	O	O
1-month	O	O
and	O	O
6-months	O	O
after	O	O
the	O	O
treatment	O	O
.	O	O

Ten	O	O
healthy	O	O
adults	O	O
were	O	O
also	O	O
selected	O	O
as	O	O
the	O	O
control	O	O
group	O	O
.	O	O

Denaturing	O	O
gradient	O	O
gel	O	O
electrophoresis	O	O
was	O	O
applied	O	O
to	O	O
identify	O	O
the	O	O
bacterial	O	O
profiles	O	O
and	O	O
to	O	O
analyze	O	O
the	O	O
dynamics	O	O
of	O	O
the	O	O
oral	O	O
microbial	O	O
population	O	O
in	O	O
the	O	O
pre-	O	O
and	O	O
post-therapy	O	O
.	O	O

The	O	O
ANOVA	O	O
of	O	O
Repeated	O	O
Measurement	O	O
Data	O	O
indicated	O	O
that	O	O
,	O	O
in	O	O
the	O	O
saliva	O	O
and	O	O
mucosal	O	O
surfaces	O	O
,	O	O
wearing	O	O
RPDs	O	O
caused	O	O
significant	O	O
change	O	O
of	O	O
numbers	O	O
of	O	O
amplicons	O	O
.	O	O

As	O	O
many	O	O
as	O	O
607	O	O
amplicons	O	O
were	O	O
chosen	O	O
to	O	O
cut	O	O
out	O	O
and	O	O
re-amplify	O	O
by	O	O
PCR	O	O
.	O	O

After	O	O
cloning	O	O
and	O	O
sequencing	O	O
,	O	O
a	O	O
total	O	O
of	O	O
16	O	O
bacterial	O	O
genera	O	O
were	O	O
identified	O	O
.	O	O

The	O	O
health-associated	O	O
genera	O	O
such	O	O
as	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Neisseria	B-bacteria	B-bacteria
,	O	O
Rothia	B-bacteria	B-bacteria
,	O	O
Corynebacterium	B-bacteria	B-bacteria
,	O	O
Leptotrichia	B-bacteria	B-bacteria
,	O	O
Gemella	B-bacteria	B-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
Selenomona	B-bacteria	B-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
tended	O	O
to	O	O
decrease	O	O
,	O	O
whereas	O	O
the	O	O
disease-associated	O	O
species	O	O
including	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
tended	O	O
to	O	O
increase	O	O
.	O	O

In	O	O
general	O	O
,	O	O
wearing	O	O
RPDs	O	O
influenced	O	O
the	O	O
diversity	O	O
of	O	O
the	O	O
bacterial	O	O
species	O	O
in	O	O
the	O	O
oral	O	O
microbial	O	O
ecosystem	O	O
.	O	O

It	O	O
is	O	O
noteworthy	O	O
that	O	O
the	O	O
oral	O	O
environment	O	O
will	O	O
be	O	O
changed	O	O
from	O	O
the	O	O
healthy	O	O
status	O	O
towards	O	O
the	O	O
disease	O	O
status	O	O
after	O	O
the	O	O
treatment	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
analyze	O	O
the	O	O
association	O	O
of	O	O
maternal	O	O
antenatal	O	O
therapy	O	O
on	O	O
initial	O	O
preterm	O	O
infant	O	O
oral	O	O
microbial	O	O
acquisition	O	O
of	O	O
gut	O	O
metabolically	O	O
important	O	O
bacteria	O	O
:	O	O
Firmicutes	B-bacteria	B-bacteria
,	O	O
Bacteroidetes	B-bacteria	B-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
,	O	O
Bifidobacterium	B-bacteria	B-bacteria
,	O	O
and	O	O
Bacteroides	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

Infant	O	O
oral	O	O
samples	O	O
were	O	O
collected	O	O
prefeeding	O	O
at	O	O
24	O	O
hours	O	O
and	O	O
analyzed	O	O
using	O	O
group-specific	O	O
primers	O	O
by	O	O
real-time	O	O
16S	O	O
rRNA	O	O
quantitative	O	O
polymerase	O	O
chain	O	O
reaction	O	O
with	O	O
analysis	O	O
of	O	O
variance	O	O
and	O	O
logistic	O	O
regression	O	O
to	O	O
evaluate	O	O
effect	O	O
of	O	O
antenatal	O	O
exposure	O	O
.	O	O

Sixty-five	O	O
infants	O	O
<	O	O
34	O	O
weeks	O	O
'	O	O
gestational	O	O
age	O	O
(	O	O
GA	O	O
)	O	O
were	O	O
evaluated	O	O
;	O	O
mean	O	O
GA	O	O
was	O	O
28.6	O	O
+/-	O	O
2.6	O	O
(	O	O
standard	O	O
deviation	O	O
)	O	O
weeks	O	O
.	O	O

Infants	O	O
unexposed	O	O
to	O	O
antenatal	O	O
treatment	O	O
(	O	O
n	O	O
=	O	O
5	O	O
)	O	O
acquired	O	O
<	O	O
1	O	O
%	O	O
Firmicutes	B-bacteria	B-bacteria
,	O	O
which	O	O
was	O	O
composed	O	O
of	O	O
100	O	O
%	O	O
Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
with	O	O
no	O	O
detectable	O	O
Bifidobacterium	B-bacteria	B-bacteria
,	O	O
Bacteroidetes	B-bacteria	B-bacteria
,	O	O
or	O	O
Bacteroides	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

Infants	O	O
exposed	O	O
to	O	O
antibiotics	O	O
(	O	O
n	O	O
=	O	O
7	O	O
)	O	O
,	O	O
acquired	O	O
fivefold	O	O
less	O	O
total	O	O
bacterial	O	O
density	O	O
(	O	O
TBD	O	O
)	O	O
with	O	O
45	O	O
%	O	O
Firmicutes	B-bacteria	B-bacteria
1.3	O	O
%	O	O
Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
23.5	O	O
%	O	O
Bacteroidetes	B-bacteria	B-bacteria
and	O	O
rare	O	O
Bacteroides	B-bacteria	B-bacteria
.	O	O

Compared	O	O
with	O	O
unexposed	O	O
infants	O	O
,	O	O
steroids	O	O
(	O	O
n	O	O
=	O	O
26	O	O
)	O	O
or	O	O
steroid	O	O
and	O	O
antibiotics	O	O
(	O	O
n	O	O
=	O	O
27	O	O
)	O	O
exposure	O	O
led	O	O
to	O	O
an	O	O
eightfold	O	O
increase	O	O
in	O	O
TBD	O	O
with	O	O
<	O	O
1	O	O
%	O	O
Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
and	O	O
Bacteroides	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
100	O	O
%	O	O
and	O	O
30	O	O
%	O	O
,	O	O
respectively	O	O
(	O	O
p	O	O
<	O	O
0.04	O	O
)	O	O
.	O	O

Bifidobacterium	B-bacteria	B-bacteria
was	O	O
undetectable	O	O
in	O	O
all	O	O
groups	O	O
.	O	O

Preterm	O	O
infant	O	O
exposure	O	O
to	O	O
routine	O	O
maternal	O	O
antenatal	O	O
treatments	O	O
influence	O	O
early	O	O
oral	O	O
microbial	O	O
acquisition	O	O
during	O	O
the	O	O
primary	O	O
hours	O	O
related	O	O
to	O	O
establishment	O	O
of	O	O
gut	B-bacteria	B-bacteria
commensal	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

Bacterial	O	O
infections	O	O
have	O	O
been	O	O
linked	O	O
to	O	O
malignancies	O	O
due	O	O
to	O	O
their	O	O
ability	O	O
to	O	O
induce	O	O
chronic	O	O
inflammation	O	O
.	O	O

We	O	O
investigated	O	O
the	O	O
association	O	O
of	O	O
oral	O	O
bacteria	O	O
in	O	O
oral	O	O
squamous	O	O
cell	O	O
carcinoma	O	O
(	O	O
OSCC/tumor	O	O
)	O	O
tissues	O	O
and	O	O
compared	O	O
with	O	O
adjacent	O	O
non-tumor	O	O
mucosa	O	O
sampled	O	O
5	O	O
cm	O	O
distant	O	O
from	O	O
the	O	O
same	O	O
patient	O	O
(	O	O
n	O	O
=	O	O
10	O	O
)	O	O
.	O	O

By	O	O
using	O	O
culture-independent	O	O
16S	O	O
rRNA	O	O
approaches	O	O
,	O	O
denaturing	O	O
gradient	O	O
gel	O	O
electrophoresis	O	O
(	O	O
DGGE	O	O
)	O	O
and	O	O
cloning	O	O
and	O	O
sequencing	O	O
,	O	O
we	O	O
assessed	O	O
the	O	O
total	O	O
bacterial	O	O
diversity	O	O
in	O	O
these	O	O
clinical	O	O
samples	O	O
.	O	O

DGGE	O	O
fingerprints	O	O
showed	O	O
variations	O	O
in	O	O
the	O	O
band	O	O
intensity	O	O
profiles	O	O
within	O	O
non-tumor	O	O
and	O	O
tumor	O	O
tissues	O	O
of	O	O
the	O	O
same	O	O
patient	O	O
and	O	O
among	O	O
the	O	O
two	O	O
groups	O	O
.	O	O

The	O	O
clonal	O	O
analysis	O	O
indicated	O	O
that	O	O
from	O	O
a	O	O
total	O	O
of	O	O
1200	O	O
sequences	O	O
characterized	O	O
,	O	O
80	O	O
bacterial	O	O
species/phylotypes	O	O
were	O	O
detected	O	O
representing	O	O
six	O	O
phyla	O	O
,	O	O
Firmicutes	B-bacteria	B-bacteria
,	O	O
Bacteroidetes	B-bacteria	B-bacteria
,	O	O
Proteobacteria	B-bacteria	B-bacteria
,	O	O
Fusobacteria	B-bacteria	B-bacteria
,	O	O
Actinobacteria	B-bacteria	B-bacteria
and	O	O
uncultivated	O	O
TM7	B-bacteria	B-bacteria
in	O	O
non-tumor	O	O
and	O	O
tumor	O	O
libraries	O	O
.	O	O

In	O	O
combined	O	O
library	O	O
,	O	O
12	O	O
classes	O	O
,	O	O
16	O	O
order	O	O
,	O	O
26	O	O
families	O	O
and	O	O
40	O	O
genera	O	O
were	O	O
observed	O	O
.	O	O

Bacterial	O	O
species	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

oral	O	O
taxon	B-bacteria	B-bacteria
058	I-bacteria	I-bacteria
,	O	O
Peptostreptococcus	B-bacteria	B-bacteria
stomatis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
Gemella	B-bacteria	B-bacteria
haemolysans	E-bacteria	I-bacteria
,	O	O
Gemella	B-bacteria	B-bacteria
morbillorum	E-bacteria	I-bacteria
,	O	O
Johnsonella	B-bacteria	B-bacteria
ignava	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
parasanguinis	I-bacteria	I-bacteria
I	E-bacteria	I-bacteria
were	O	O
highly	O	O
associated	O	O
with	O	O
tumor	O	O
site	O	O
where	O	O
as	O	O
Granulicatella	B-bacteria	B-bacteria
adiacens	E-bacteria	I-bacteria
was	O	O
prevalent	O	O
at	O	O
non-tumor	O	O
site	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
intermedius	E-bacteria	I-bacteria
was	O	O
present	O	O
in	O	O
70	O	O
%	O	O
of	O	O
both	O	O
non-tumor	O	O
and	O	O
tumor	O	O
sites	O	O
.	O	O

The	O	O
underlying	O	O
changes	O	O
in	O	O
the	O	O
bacterial	O	O
diversity	O	O
in	O	O
the	O	O
oral	O	O
mucosal	O	O
tissues	O	O
from	O	O
non-tumor	O	O
and	O	O
tumor	O	O
sites	O	O
of	O	O
OSCC	O	O
subjects	O	O
indicated	O	O
a	O	O
shift	O	O
in	O	O
bacterial	O	O
colonization	O	O
.	O	O

These	O	O
most	O	O
prevalent	O	O
or	O	O
unique	O	O
bacterial	O	O
species/phylotypes	O	O
present	O	O
in	O	O
tumor	O	O
tissues	O	O
may	O	O
be	O	O
associated	O	O
with	O	O
OSCC	O	O
and	O	O
needs	O	O
to	O	O
be	O	O
further	O	O
investigated	O	O
with	O	O
a	O	O
larger	O	O
sample	O	O
size	O	O
.	O	O

Over	O	O
the	O	O
past	O	O
decade	O	O
,	O	O
advances	O	O
in	O	O
cancer	O	O
treatments	O	O
have	O	O
been	O	O
counterbalanced	O	O
by	O	O
a	O	O
rising	O	O
number	O	O
of	O	O
immunosuppressed	O	O
patients	O	O
with	O	O
a	O	O
multitude	O	O
of	O	O
new	O	O
risk	O	O
factors	O	O
for	O	O
infection	O	O
.	O	O

Hence	O	O
,	O	O
the	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
risk	O	O
factors	O	O
,	O	O
infectious	O	O
pathogens	O	O
in	O	O
blood	O	O
and	O	O
oral	O	O
cavity	O	O
of	O	O
oral	O	O
cancer	O	O
patients	O	O
undergoing	O	O
different	O	O
treatment	O	O
procedures	O	O
.	O	O

The	O	O
present	O	O
prospective	O	O
cohort	O	O
analysis	O	O
was	O	O
conducted	O	O
on	O	O
the	O	O
patients	O	O
undergoing	O	O
treatment	O	O
in	O	O
the	O	O
radiotherapy	O	O
unit	O	O
of	O	O
Regional	O	O
Cancer	O	O
Institute	O	O
,	O	O
Pt	O	O
.	O	O

B.D	O	O
.	O	O

Sharma	O	O
University	O	O
of	O	O
Health	O	O
Sciences	O	O
,	O	O
Rohtak	O	O
,	O	O
Haryana	O	O
,	O	O
during	O	O
the	O	O
period	O	O
of	O	O
January	O	O
2007	O	O
to	O	O
October	O	O
2009	O	O
.	O	O

Total	O	O
186	O	O
patients	O	O
with	O	O
squamous	O	O
cell	O	O
carcinoma	O	O
of	O	O
oral	O	O
cavity	O	O
were	O	O
analyzed	O	O
in	O	O
the	O	O
study	O	O
.	O	O

Based	O	O
on	O	O
treatment	O	O
procedures	O	O
patients	O	O
were	O	O
divided	O	O
into	O	O
three	O	O
groups	O	O
,	O	O
group	O	O
I	O	O
were	O	O
under	O	O
radiotherapy	O	O
,	O	O
group	O	O
II	O	O
under	O	O
chemotherapy	O	O
and	O	O
group	O	O
III	O	O
were	O	O
of	O	O
radio	O	O
chemotherapy	O	O
together	O	O
.	O	O

Clinical	O	O
isolates	O	O
from	O	O
blood	O	O
and	O	O
oral	O	O
cavity	O	O
were	O	O
identified	O	O
by	O	O
following	O	O
general	O	O
microbiological	O	O
,	O	O
staining	O	O
and	O	O
biochemical	O	O
methods	O	O
.	O	O

The	O	O
absolute	O	O
neutrophile	O	O
counts	O	O
were	O	O
done	O	O
by	O	O
following	O	O
the	O	O
standard	O	O
methods	O	O
.	O	O

Prevalent	O	O
bacterial	O	O
pathogens	O	O
isolated	O	O
were	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
,	O	O
Klebsiella	B-bacteria	B-bacteria
pneumonia	E-bacteria	I-bacteria
,	O	O
Proteus	B-bacteria	B-bacteria
mirabilis	E-bacteria	I-bacteria
,	O	O
Proteus	B-bacteria	B-bacteria
vulgaris	E-bacteria	I-bacteria
and	O	O
the	O	O
fungal	O	O
pathogens	O	O
were	O	O
Candida	O	O
albicans	O	O
,	O	O
Aspergillus	O	O
fumigatus	O	O
.	O	O

The	O	O
predominant	O	O
gram	B-bacteria	B-bacteria
negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
and	O	O
Klebsiella	B-bacteria	B-bacteria
pneumonia	E-bacteria	I-bacteria
were	O	O
isolated	O	O
from	O	O
blood	O	O
of	O	O
radiotherapy	O	O
and	O	O
oral	O	O
cavity	O	O
of	O	O
chemotherapy	O	O
treated	O	O
cases	O	O
respectively	O	O
.	O	O

The	O	O
predominance	O	O
of	O	O
gram	B-bacteria	B-bacteria
positive	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
and	O	O
Staphylococcus	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
)	O	O
were	O	O
observed	O	O
in	O	O
blood	O	O
of	O	O
chemotherapy	O	O
,	O	O
radio	O	O
chemotherapy	O	O
cases	O	O
and	O	O
oral	O	O
cavity	O	O
of	O	O
radiotherapy	O	O
,	O	O
radio	O	O
chemotherapy	O	O
treated	O	O
cases	O	O
.	O	O

Our	O	O
study	O	O
also	O	O
revealed	O	O
the	O	O
presence	O	O
of	O	O
C.	O	O
albicans	O	O
fungi	O	O
as	O	O
most	O	O
significant	O	O
oral	O	O
cavity	O	O
pathogens	O	O
in	O	O
radiotherapy	O	O
and	O	O
radio	O	O
chemotherapy	O	O
cases	O	O
.	O	O

Gram	B-bacteria	B-bacteria
positive	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
Gram	B-bacteria	B-bacteria
negative	E-bacteria	I-bacteria
were	O	O
reported	O	O
from	O	O
the	O	O
blood	O	O
of	O	O
all	O	O
the	O	O
three	O	O
groups	O	O
of	O	O
patients	O	O
.	O	O

Oral	O	O
mucositis	O	O
played	O	O
a	O	O
significant	O	O
role	O	O
in	O	O
oral	O	O
cavity	O	O
infection	O	O
and	O	O
make	O	O
patients	O	O
more	O	O
prone	O	O
to	O	O
C.	O	O
albicans	O	O
infection	O	O
.	O	O

Despite	O	O
the	O	O
role	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
as	O	O
a	O	O
reservoir	O	O
of	O	O
opportunistic	O	O
pathogens	O	O
for	O	O
infection	O	O
in	O	O
patients	O	O
following	O	O
stroke	O	O
,	O	O
the	O	O
evaluation	O	O
of	O	O
the	O	O
effects	O	O
of	O	O
oral	O	O
hygiene	O	O
interventions	O	O
has	O	O
been	O	O
largely	O	O
neglected	O	O
.	O	O

This	O	O
randomized	O	O
clinical	O	O
trial	O	O
included	O	O
102	O	O
patients	O	O
undergoing	O	O
hospital-based	O	O
rehabilitation	O	O
for	O	O
stroke	O	O
.	O	O

Patients	O	O
were	O	O
randomized	O	O
to	O	O
one	O	O
of	O	O
3	O	O
groups	O	O
:	O	O
oral	O	O
hygiene	O	O
instruction	O	O
(	O	O
OHI	O	O
)	O	O
only	O	O
;	O	O
OHI	O	O
and	O	O
0.2	O	O
%	O	O
chlorhexidine	O	O
mouth	O	O
rinse	O	O
twice	O	O
daily	O	O
;	O	O
or	O	O
OHI	O	O
,	O	O
0.2	O	O
%	O	O
chlorhexidine	O	O
mouth	O	O
rinse	O	O
twice	O	O
daily	O	O
,	O	O
and	O	O
assisted	O	O
brushing	O	O
twice	O	O
weekly	O	O
.	O	O

Oral	O	O
samples	O	O
were	O	O
obtained	O	O
at	O	O
baseline	O	O
and	O	O
after	O	O
3	O	O
weeks	O	O
for	O	O
detection	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
aerobic	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
facultatively	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
gram-negative	I-bacteria	I-bacteria
bacilli	E-bacteria	I-bacteria
,	O	O
and	O	O
yeasts	O	O
.	O	O

Almost	O	O
three-quarters	O	O
(	O	O
72.8	O	O
%	O	O
)	O	O
of	O	O
the	O	O
patients	O	O
harbored	O	O
oral	O	O
anaerobic	B-bacteria	B-bacteria
gram-negative	I-bacteria	I-bacteria
bacilli	E-bacteria	I-bacteria
at	O	O
baseline	O	O
,	O	O
and	O	O
more	O	O
than	O	O
half	O	O
had	O	O
detectable	O	O
S	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
56.8	O	O
%	O	O
)	O	O
and	O	O
yeasts	O	O
(	O	O
59.3	O	O
%	O	O
)	O	O
.	O	O

Percentage	O	O
frequencies	O	O
and	O	O
viable	O	O
counts	O	O
of	O	O
pathogens	O	O
remained	O	O
relatively	O	O
stable	O	O
during	O	O
the	O	O
course	O	O
of	O	O
the	O	O
clinical	O	O
trial	O	O
,	O	O
and	O	O
no	O	O
significant	O	O
differences	O	O
were	O	O
observed	O	O
among	O	O
the	O	O
3	O	O
patient	O	O
groups	O	O
.	O	O

In	O	O
our	O	O
study	O	O
cohort	O	O
,	O	O
there	O	O
was	O	O
no	O	O
significant	O	O
difference	O	O
in	O	O
the	O	O
effectiveness	O	O
of	O	O
the	O	O
3	O	O
different	O	O
oral	O	O
hygiene	O	O
interventions	O	O
on	O	O
the	O	O
prevalence	O	O
or	O	O
viable	O	O
counts	O	O
of	O	O
oral	O	O
opportunistic	O	O
pathogens	O	O
.	O	O

Endodontic	O	O
infections	O	O
are	O	O
a	O	O
leading	O	O
cause	O	O
of	O	O
oro-facial	O	O
pain	O	O
and	O	O
tooth	O	O
loss	O	O
in	O	O
western	O	O
countries	O	O
,	O	O
and	O	O
may	O	O
lead	O	O
to	O	O
severe	O	O
life-threatening	O	O
infections	O	O
.	O	O

These	O	O
infections	O	O
are	O	O
polymicrobial	O	O
with	O	O
high	O	O
bacterial	O	O
diversity	O	O
.	O	O

Understanding	O	O
the	O	O
spatial	O	O
transition	O	O
of	O	O
microbiota	O	O
from	O	O
normal	O	O
oral	O	O
cavities	O	O
through	O	O
the	O	O
infected	O	O
root	O	O
canal	O	O
to	O	O
the	O	O
acute	O	O
periapical	O	O
abscess	O	O
can	O	O
improve	O	O
our	O	O
knowledge	O	O
of	O	O
the	O	O
pathogenesis	O	O
of	O	O
endodontic	O	O
infections	O	O
and	O	O
lead	O	O
to	O	O
more	O	O
effective	O	O
treatment	O	O
.	O	O

We	O	O
obtained	O	O
samples	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
infected	O	O
root	O	O
canal	O	O
and	O	O
periapical	O	O
abscess	O	O
of	O	O
8	O	O
patients	O	O
(	O	O
5	O	O
with	O	O
localized	O	O
and	O	O
3	O	O
with	O	O
systemic	O	O
infections	O	O
)	O	O
.	O	O

Microbial	O	O
populations	O	O
in	O	O
these	O	O
samples	O	O
were	O	O
analyzed	O	O
using	O	O
next-generation	O	O
sequencing	O	O
of	O	O
16S	O	O
rRNA	O	O
amplicons	O	O
.	O	O

Bioinformatics	O	O
tools	O	O
and	O	O
statistical	O	O
tests	O	O
with	O	O
rigorous	O	O
criteria	O	O
were	O	O
used	O	O
to	O	O
elucidate	O	O
the	O	O
spatial	O	O
transition	O	O
of	O	O
the	O	O
microbiota	O	O
from	O	O
normal	O	O
to	O	O
diseased	O	O
sites	O	O
.	O	O

On	O	O
average	O	O
,	O	O
10,000	O	O
partial	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
were	O	O
obtained	O	O
from	O	O
each	O	O
sample	O	O
.	O	O

All	O	O
sequences	O	O
fell	O	O
into	O	O
11	O	O
different	O	O
bacterial	O	O
phyla	O	O
.	O	O

The	O	O
microbial	O	O
diversity	O	O
in	O	O
root	O	O
canal	O	O
and	O	O
abscess	O	O
samples	O	O
was	O	O
significantly	O	O
lower	O	O
than	O	O
in	O	O
the	O	O
oral	O	O
samples	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
was	O	O
the	O	O
most	O	O
abundant	O	O
genus	O	O
in	O	O
oral	O	O
cavities	O	O
while	O	O
Prevotella	B-bacteria	B-bacteria
and	O	O
Fusobacterium	B-bacteria	B-bacteria
were	O	O
most	O	O
abundant	O	O
in	O	O
diseased	O	O
samples	O	O
.	O	O

The	O	O
microbiota	O	O
community	O	O
structures	O	O
of	O	O
root	O	O
canal	O	O
and	O	O
abscess	O	O
samples	O	O
were	O	O
,	O	O
however	O	O
,	O	O
more	O	O
similar	O	O
to	O	O
each	O	O
other	O	O
than	O	O
to	O	O
the	O	O
oral	O	O
cavity	O	O
microbiota	O	O
.	O	O

Using	O	O
rigorous	O	O
criteria	O	O
and	O	O
novel	O	O
bioinformatics	O	O
tools	O	O
,	O	O
we	O	O
found	O	O
that	O	O
Granulicatella	B-bacteria	B-bacteria
adiacens	E-bacteria	I-bacteria
,	O	O
Eubacterium	B-bacteria	B-bacteria
yurii	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
melaninogenica	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
salivae	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
and	O	O
Atopobium	B-bacteria	B-bacteria
rimae	E-bacteria	I-bacteria
were	O	O
over-represented	O	O
in	O	O
diseased	O	O
samples	O	O
.	O	O

We	O	O
used	O	O
a	O	O
novel	O	O
approach	O	O
and	O	O
high-throughput	O	O
methodologies	O	O
to	O	O
characterize	O	O
the	O	O
microbiota	O	O
associated	O	O
normal	O	O
and	O	O
diseased	O	O
oral	O	O
sites	O	O
in	O	O
the	O	O
same	O	O
individuals	O	O
.	O	O

The	O	O
salivary	O	O
glands	O	O
of	O	O
adults	O	O
concentrate	O	O
nitrate	O	O
from	O	O
plasma	O	O
into	O	O
saliva	O	O
where	O	O
it	O	O
is	O	O
converted	O	O
to	O	O
nitrite	O	O
by	O	O
bacterial	O	O
nitrate	O	O
reductases	O	O
.	O	O

Nitrite	O	O
can	O	O
play	O	O
a	O	O
beneficial	O	O
role	O	O
in	O	O
adult	O	O
gastrointestinal	O	O
and	O	O
cardiovascular	O	O
physiology	O	O
.	O	O

When	O	O
nitrite	O	O
is	O	O
swallowed	O	O
,	O	O
some	O	O
of	O	O
it	O	O
is	O	O
converted	O	O
to	O	O
nitric	O	O
oxide	O	O
(	O	O
NO	O	O
)	O	O
in	O	O
the	O	O
stomach	O	O
and	O	O
may	O	O
then	O	O
exert	O	O
protective	O	O
effects	O	O
in	O	O
the	O	O
gastrointestinal	O	O
tract	O	O
and	O	O
throughout	O	O
the	O	O
body	O	O
.	O	O

It	O	O
has	O	O
yet	O	O
to	O	O
be	O	O
determined	O	O
either	O	O
when	O	O
newborn	O	O
infants	O	O
acquire	O	O
oral	O	O
nitrate	O	O
reducing	O	O
bacteria	O	O
or	O	O
what	O	O
the	O	O
effects	O	O
of	O	O
antimicrobial	O	O
therapy	O	O
or	O	O
premature	O	O
birth	O	O
may	O	O
be	O	O
on	O	O
the	O	O
bacterial	O	O
processing	O	O
of	O	O
nitrate	O	O
to	O	O
nitrite	O	O
.	O	O

We	O	O
measured	O	O
nitrate	O	O
and	O	O
nitrite	O	O
levels	O	O
in	O	O
the	O	O
saliva	O	O
of	O	O
adults	O	O
and	O	O
both	O	O
preterm	O	O
and	O	O
term	O	O
human	O	O
infants	O	O
in	O	O
the	O	O
early	O	O
weeks	O	O
of	O	O
life	O	O
.	O	O

We	O	O
also	O	O
measured	O	O
oral	O	O
bacterial	O	O
reductase	O	O
activity	O	O
in	O	O
the	O	O
saliva	O	O
of	O	O
both	O	O
infants	O	O
and	O	O
adults	O	O
,	O	O
and	O	O
characterized	O	O
the	O	O
species	O	O
of	O	O
nitrate	O	O
reducing	O	O
bacteria	O	O
present	O	O
.	O	O

Oral	O	O
bacterial	O	O
conversion	O	O
of	O	O
nitrate	O	O
to	O	O
nitrite	O	O
in	O	O
infants	O	O
was	O	O
either	O	O
undetectable	O	O
or	O	O
markedly	O	O
lower	O	O
than	O	O
the	O	O
conversion	O	O
rates	O	O
of	O	O
adults	O	O
.	O	O

No	O	O
measurable	O	O
reductase	O	O
activity	O	O
was	O	O
found	O	O
in	O	O
infants	O	O
within	O	O
the	O	O
first	O	O
two	O	O
weeks	O	O
of	O	O
life	O	O
,	O	O
despite	O	O
the	O	O
presence	O	O
of	O	O
oral	O	O
nitrate	O	O
reducing	O	O
bacteria	O	O
such	O	O
as	O	O
Actinomyces	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
atypica	E-bacteria	I-bacteria
,	O	O
and	O	O
Rothia	B-bacteria	B-bacteria
mucilaginosa	E-bacteria	I-bacteria
.	O	O

We	O	O
conclude	O	O
that	O	O
relatively	O	O
little	O	O
nitrite	O	O
reaches	O	O
the	O	O
infant	O	O
gastrointestinal	O	O
tract	O	O
due	O	O
to	O	O
the	O	O
lack	O	O
of	O	O
oral	O	O
bacterial	O	O
nitrate	O	O
reductase	O	O
activity	O	O
.	O	O

Given	O	O
the	O	O
importance	O	O
of	O	O
the	O	O
nitrate-nitrite-NO	O	O
axis	O	O
in	O	O
adults	O	O
,	O	O
the	O	O
lack	O	O
of	O	O
oral	O	O
nitrate-reducing	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
infants	O	O
may	O	O
be	O	O
relevant	O	O
to	O	O
the	O	O
vulnerability	O	O
of	O	O
newborns	O	O
to	O	O
hypoxic	O	O
stress	O	O
and	O	O
gastrointestinal	O	O
tract	O	O
pathologies	O	O
.	O	O

A	O	O
strictly	O	O
anaerobic	O	O
Gram-stain-variable	O	O
but	O	O
positive	O	O
by	O	O
structure	O	O
,	O	O
non-spore-forming	O	O
bacterium	O	O
designated	O	O
Lachnospiraceae	B-bacteria	B-bacteria
bacterium	I-bacteria	I-bacteria
ACC2	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
DSM	I-bacteria	I-bacteria
24645	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
was	O	O
isolated	O	O
from	O	O
human	O	O
subgingival	O	O
dental	O	O
plaque	O	O
.	O	O

Bacterial	O	O
cells	O	O
were	O	O
4-40	O	O
microm	O	O
long	O	O
non-motile	O	O
rods	O	O
,	O	O
often	O	O
swollen	O	O
and	O	O
forming	O	O
curved	O	O
filaments	O	O
up	O	O
to	O	O
200	O	O
microm	O	O
.	O	O

Cells	O	O
contained	O	O
intracellular	O	O
,	O	O
poorly	O	O
crystalline	O	O
,	O	O
nanometre-sized	O	O
iron-	O	O
and	O	O
sulfur-rich	O	O
particles	O	O
.	O	O

The	O	O
micro-organism	O	O
was	O	O
able	O	O
to	O	O
grow	O	O
on	O	O
yeast	O	O
extract	O	O
,	O	O
trypticase	O	O
peptone	O	O
,	O	O
milk	O	O
,	O	O
some	O	O
sugars	O	O
and	O	O
organic	O	O
acids	O	O
.	O	O

The	O	O
major	O	O
metabolic	O	O
end-products	O	O
of	O	O
glucose	O	O
fermentation	O	O
were	O	O
butyrate	O	O
,	O	O
lactate	O	O
,	O	O
isovalerate	O	O
and	O	O
acetate	O	O
.	O	O

The	O	O
growth	O	O
temperature	O	O
and	O	O
pH	O	O
ranges	O	O
were	O	O
30-42	O	O
degrees	O	O
C	O	O
and	O	O
4.9-7.5	O	O
,	O	O
respectively	O	O
.	O	O

Major	O	O
fatty	O	O
acids	O	O
were	O	O
C14	O	O
:	O	O
0	O	O
,	O	O
C14	O	O
:	O	O
0	O	O
DMA	O	O
(	O	O
dimethyl	O	O
aldehyde	O	O
)	O	O
,	O	O
C16	O	O
:	O	O
0	O	O
,	O	O
C16	O	O
:	O	O
1omega7c	O	O
DMA	O	O
.	O	O

The	O	O
whole-cell	O	O
hydrolysate	O	O
contained	O	O
meso-diaminopimelic	O	O
acid	O	O
,	O	O
indicating	O	O
peptidoglycan	O	O
type	O	O
A1gamma	O	O
.	O	O

The	O	O
DNA	O	O
G+C	O	O
content	O	O
was	O	O
calculated	O	O
to	O	O
be	O	O
55.05	O	O
mol	O	O
%	O	O
from	O	O
the	O	O
whole-genome	O	O
sequence	O	O
and	O	O
55.3	O	O
mol	O	O
%	O	O
as	O	O
determined	O	O
by	O	O
HPLC	O	O
.	O	O

There	O	O
were	O	O
no	O	O
predicted	O	O
genes	O	O
responsible	O	O
for	O	O
biosynthesis	O	O
of	O	O
respiratory	O	O
lipoquinones	O	O
,	O	O
mycolic	O	O
acids	O	O
and	O	O
lipopolysaccharides	O	O
.	O	O

Genes	O	O
associated	O	O
with	O	O
synthesis	O	O
of	O	O
teichoic	O	O
and	O	O
lipoteichoic	O	O
acids	O	O
,	O	O
diaminopimelic	O	O
acid	O	O
,	O	O
polar	O	O
lipids	O	O
and	O	O
polyamines	O	O
were	O	O
present	O	O
.	O	O

According	O	O
to	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
phylogeny	O	O
,	O	O
strain	B-bacteria	B-bacteria
DSM	I-bacteria	I-bacteria
24645	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
formed	O	O
,	O	O
together	O	O
with	O	O
several	O	O
uncultured	O	O
oral	O	O
clones	O	O
,	O	O
a	O	O
separate	O	O
branch	O	O
within	O	O
the	O	O
family	O	O
Lachnospiraceae	B-bacteria	B-bacteria
,	O	O
with	O	O
the	O	O
highest	O	O
sequence	O	O
similarity	O	O
to	O	O
the	O	O
type	O	O
strain	O	O
of	O	O
Moryella	B-bacteria	B-bacteria
indoligenes	E-bacteria	I-bacteria
at	O	O
94.2	O	O
%	O	O
.	O	O

Based	O	O
on	O	O
distinct	O	O
phenotypic	O	O
and	O	O
genotypic	O	O
characteristics	O	O
,	O	O
we	O	O
suggest	O	O
that	O	O
strain	B-bacteria	B-bacteria
DSM	I-bacteria	I-bacteria
24645	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
represents	O	O
a	O	O
novel	O	O
species	O	O
in	O	O
a	O	O
new	O	O
genus	O	O
,	O	O
for	O	O
which	O	O
the	O	O
name	O	O
Stomatobaculum	B-bacteria	B-bacteria
longum	I-bacteria	I-bacteria
gen.	I-bacteria	I-bacteria
nov.	E-bacteria	I-bacteria
,	O	O
sp	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria

nov.	E-bacteria	I-bacteria
is	O	O
proposed	O	O
.	O	O

The	O	O
type	O	O
strain	O	O
of	O	O
Stomatobaculum	B-bacteria	B-bacteria
longum	E-bacteria	I-bacteria
is	O	O
DSM	B-bacteria	B-bacteria
24645	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
(	O	O
=	O	O
HM-480	B-bacteria	B-bacteria
(	O	O
T	O	O
)	O	O
;	O	O
deposited	O	O
in	O	O
BEI	O	O
Resources	O	O
,	O	O
an	O	O
NIH	O	O
collection	O	O
managed	O	O
by	O	O
the	O	O
ATCC	B-bacteria	B-bacteria
)	O	O
.	O	O

Tobacco	O	O
use	O	O
has	O	O
been	O	O
identified	O	O
as	O	O
the	O	O
most	O	O
important	O	O
environmental	O	O
risk	O	O
factor	O	O
for	O	O
periodontitis	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
effect	O	O
of	O	O
green	O	O
tea	O	O
epigallocatechin-3-gallate	O	O
on	O	O
the	O	O
nicotine-induced	O	O
toxic	O	O
and	O	O
inflammatory	O	O
responses	O	O
in	O	O
oral	O	O
epithelial	O	O
cells	O	O
and	O	O
gingival	O	O
fibroblasts	O	O
.	O	O

The	O	O
effect	O	O
of	O	O
nicotine	O	O
,	O	O
alone	O	O
and	O	O
in	O	O
combination	O	O
with	O	O
the	O	O
lipopolysaccharide	O	O
of	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
on	O	O
the	O	O
viability	O	O
of	O	O
oral	O	O
epithelial	O	O
cells	O	O
and	O	O
fibroblasts	O	O
was	O	O
evaluated	O	O
using	O	O
a	O	O
3-	O	O
(	O	O
4,5-dimethylthiazol-2-yl	O	O
)	O	O
-2,5-diphenyltetrazolium	O	O
bromide	O	O
colorimetric	O	O
assay	O	O
.	O	O

The	O	O
ability	O	O
of	O	O
epigallocatechin-3-gallate	O	O
to	O	O
neutralize	O	O
the	O	O
nicotine-induced	O	O
cytotoxicity	O	O
was	O	O
then	O	O
investigated	O	O
.	O	O

The	O	O
nicotine-induced	O	O
cytokine	O	O
secretion	O	O
in	O	O
epithelial	O	O
cells	O	O
and	O	O
the	O	O
inhibitory	O	O
effect	O	O
of	O	O
epigallocatechin-3-gallate	O	O
were	O	O
determined	O	O
by	O	O
enzyme-linked	O	O
immunosorbent	O	O
assay	O	O
.	O	O

Our	O	O
results	O	O
indicated	O	O
that	O	O
nicotine	O	O
caused	O	O
a	O	O
dose-dependent	O	O
loss	O	O
of	O	O
viability	O	O
in	O	O
both	O	O
epithelial	O	O
cells	O	O
and	O	O
fibroblasts	O	O
.	O	O

A	O	O
mixture	O	O
of	O	O
nicotine	O	O
and	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
lipopolysaccharide	O	O
demonstrated	O	O
additive	O	O
instead	O	O
of	O	O
synergistic	O	O
effects	O	O
on	O	O
loss	O	O
of	O	O
cell	O	O
viability	O	O
.	O	O

Pretreatment	O	O
of	O	O
cells	O	O
with	O	O
epigallocatechin-3-gallate	O	O
efficiently	O	O
neutralized	O	O
the	O	O
nicotine-induced	O	O
toxic	O	O
effects	O	O
in	O	O
epithelial	O	O
cells	O	O
and	O	O
fibroblasts	O	O
.	O	O

It	O	O
also	O	O
dose	O	O
dependently	O	O
inhibited	O	O
the	O	O
nicotine-induced	O	O
secretion	O	O
of	O	O
chemokine	O	O
(	O	O
C-C	O	O
motif	O	O
)	O	O
ligand	O	O
5	O	O
by	O	O
epithelial	O	O
cells	O	O
.	O	O

The	O	O
present	O	O
study	O	O
suggests	O	O
that	O	O
epigallocatechin-3-gallate	O	O
,	O	O
the	O	O
major	O	O
polyphenol	O	O
in	O	O
green	O	O
tea	O	O
,	O	O
may	O	O
represent	O	O
a	O	O
novel	O	O
preventive/therapeutic	O	O
agent	O	O
for	O	O
smoking-related	O	O
periodontitis	O	O
.	O	O

Chronic	O	O
periodontal	O	O
diseases	O	O
are	O	O
characterised	O	O
by	O	O
a	O	O
dysregulated	O	O
and	O	O
exaggerated	O	O
inflammatory/immune	O	O
response	O	O
to	O	O
plaque	O	O
bacteria	O	O
.	O	O

We	O	O
have	O	O
demonstrated	O	O
previously	O	O
that	O	O
oral	O	O
keratinocytes	O	O
up-regulate	O	O
key	O	O
molecular	O	O
markers	O	O
of	O	O
inflammation	O	O
,	O	O
including	O	O
NF-kappaB	O	O
and	O	O
cytokine	O	O
signalling	O	O
,	O	O
when	O	O
exposed	O	O
to	O	O
the	O	O
periodontal	O	O
bacteria	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
in	O	O
vitro	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
the	O	O
current	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
whether	O	O
alpha-lipoic	O	O
acid	O	O
was	O	O
able	O	O
to	O	O
abrogate	O	O
bacterially-induced	O	O
pro-inflammatory	O	O
changes	O	O
in	O	O
the	O	O
H400	O	O
oral	O	O
epithelial	O	O
cell	O	O
line	O	O
.	O	O

Initial	O	O
studies	O	O
indicated	O	O
that	O	O
alpha-lipoic	O	O
acid	O	O
supplementation	O	O
(	O	O
1-4	O	O
mM	O	O
)	O	O
significantly	O	O
reduced	O	O
cell	O	O
attachment	O	O
;	O	O
lower	O	O
concentrations	O	O
(	O	O
<	O	O
0.5	O	O
mM	O	O
)	O	O
enabled	O	O
>	O	O
85	O	O
%	O	O
cell	O	O
adhesion	O	O
at	O	O
24	O	O
h.	O	O
While	O	O
a	O	O
pro-inflammatory	O	O
response	O	O
,	O	O
demonstrable	O	O
by	O	O
NF-kappaB	O	O
translocation	O	O
,	O	O
gene	O	O
expression	O	O
and	O	O
protein	O	O
production	O	O
was	O	O
evident	O	O
in	O	O
H400	O	O
cells	O	O
following	O	O
exposure	O	O
to	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
pre-incubation	O	O
of	O	O
cells	O	O
with	O	O
0.5	O	O
mM	O	O
alpha-lipoic	O	O
acid	O	O
modulated	O	O
this	O	O
response	O	O
.	O	O

alpha-Lipoic	O	O
acid	O	O
pre-treatment	O	O
significantly	O	O
decreased	O	O
levels	O	O
of	O	O
bacterially-induced	O	O
NF-kappaB	O	O
activation	O	O
and	O	O
IL-8	O	O
protein	O	O
production	O	O
,	O	O
and	O	O
differentially	O	O
modulated	O	O
transcript	O	O
levels	O	O
for	O	O
IL-8	O	O
,	O	O
IL-1beta	O	O
,	O	O
TNF-alpha	O	O
and	O	O
GM-CSF	O	O
,	O	O
TLR2	O	O
,	O	O
4	O	O
,	O	O
9	O	O
,	O	O
S100A8	O	O
,	O	O
S100A9	O	O
,	O	O
lysyl	O	O
oxidase	O	O
,	O	O
NF-kappaB1	O	O
,	O	O
HMOX	O	O
,	O	O
and	O	O
SOD2	O	O
.	O	O

Overall	O	O
,	O	O
the	O	O
data	O	O
indicate	O	O
that	O	O
alpha-lipoic	O	O
acid	O	O
exerts	O	O
an	O	O
anti-inflammatory	O	O
effect	O	O
on	O	O
oral	O	O
epithelial	O	O
cells	O	O
exposed	O	O
to	O	O
periodontal	O	O
bacteria	O	O
and	O	O
thus	O	O
may	O	O
provide	O	O
a	O	O
novel	O	O
adjunctive	O	O
treatment	O	O
for	O	O
periodontal	O	O
diseases	O	O
.	O	O

To	O	O
determine	O	O
if	O	O
a	O	O
novel	O	O
formulation	O	O
is	O	O
effective	O	O
in	O	O
killing	O	O
oral	O	O
biofilm	O	O
streptococci	B-bacteria	B-bacteria
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo	O	O
.	O	O

Efficacy	O	O
of	O	O
0.5	O	O
%	O	O
levulinic	O	O
acid	O	O
and	O	O
0.05	O	O
%	O	O
sodium	O	O
dodecyl	O	O
sulfate	O	O
(	O	O
SDS	O	O
)	O	O
in	O	O
killing	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
CH1	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
DL1	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
NCTC10712	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	I-bacteria	I-bacteria
KS32AR	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
BM71	E-bacteria	I-bacteria
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
GS5	E-bacteria	I-bacteria
in	O	O
their	O	O
biofilm	O	O
form	O	O
was	O	O
measured	O	O
in	O	O
vitro	O	O
,	O	O
using	O	O
microtiter	O	O
plates	O	O
and	O	O
subsequent	O	O
counts	O	O
on	O	O
Mitis-Salivarius	O	O
agar	O	O
plates	O	O
.	O	O

The	O	O
safety	O	O
and	O	O
efficacy	O	O
in	O	O
vivo	O	O
were	O	O
evaluated	O	O
using	O	O
a	O	O
mouse	O	O
model	O	O
.	O	O

Our	O	O
anti-microbial	O	O
formulation	O	O
completely	O	O
eliminated	O	O
all	O	O
the	O	O
biofilm	O	O
streptococcal	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
tested	O	O
within	O	O
30	O	O
seconds	O	O
(	O	O
a	O	O
reduction	O	O
of	O	O
10	O	O
(	O	O
7	O	O
)	O	O
CFU/ml	O	O
)	O	O
,	O	O
whereas	O	O
the	O	O
positive	O	O
control	O	O
Listerine	O	O
only	O	O
demonstrated	O	O
moderate	O	O
reduction	O	O
in	O	O
vitro	O	O
.	O	O

Application	O	O
of	O	O
the	O	O
formulation	O	O
twice	O	O
a	O	O
day	O	O
for	O	O
7	O	O
days	O	O
in	O	O
the	O	O
murine	O	O
oral	O	O
cavity	O	O
resulted	O	O
in	O	O
significantly	O	O
more	O	O
reduction	O	O
of	O	O
established	O	O
S.	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
DL1	I-bacteria	I-bacteria
oral	I-bacteria	I-bacteria
biofilm	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
than	O	O
Listerine	O	O
.	O	O

The	O	O
formulation	O	O
did	O	O
not	O	O
cause	O	O
any	O	O
adverse	O	O
effect	O	O
in	O	O
murine	O	O
oral	O	O
cavity	O	O
within	O	O
a	O	O
2-week	O	O
period	O	O
.	O	O

We	O	O
have	O	O
demonstrated	O	O
that	O	O
the	O	O
novel	O	O
mouth	O	O
rinse	O	O
exhibits	O	O
high	O	O
efficacy	O	O
in	O	O
killing	O	O
oral	O	O
bacteria	O	O
in	O	O
their	O	O
biofilm	O	O
forms	O	O
,	O	O
results	O	O
in	O	O
no	O	O
adverse	O	O
effect	O	O
in	O	O
vivo	O	O
,	O	O
and	O	O
contains	O	O
alcohol-free	O	O
components	O	O
.	O	O

This	O	O
study	O	O
compared	O	O
the	O	O
antimicrobial	O	O
effects	O	O
of	O	O
three	O	O
commercial	O	O
dentifrice	O	O
formulations	O	O
:	O	O
sodium	O	O
fluoride/triclosan/copolymer	O	O
(	O	O
TCN/C	O	O
)	O	O
,	O	O
stannous	O	O
fluoride/sodium	O	O
hexametaphosphate/zinc	O	O
lactate	O	O
(	O	O
SnF	O	O
(	O	O
2	O	O
)	O	O
/SHMP	O	O
)	O	O
and	O	O
sodium	O	O
fluoride	O	O
(	O	O
NaF	O	O
)	O	O
.	O	O


adults	O	O
(	O	O
15	O	O
men	O	O
and	O	O
20	O	O
women	O	O
;	O	O
average	O	O
age	O	O
33	O	O
years	O	O
and	O	O
pockets	O	O
<	O	O
5	O	O
mm	O	O
)	O	O
completed	O	O
this	O	O
double-blind	O	O
,	O	O
triple-crossover	O	O
study	O	O
.	O	O

After	O	O
washout	O	O
,	O	O
baseline	O	O
samples	O	O
from	O	O
four	O	O
sites	O	O
,	O	O
plaque	O	O
,	O	O
saliva	O	O
,	O	O
tongue	O	O
and	O	O
buccal	O	O
mucosa	O	O
,	O	O
were	O	O
collected	O	O
and	O	O
evaluated	O	O
for	O	O
six	O	O
microbial	O	O
types	O	O
,	O	O
anaerobes	B-bacteria	B-bacteria
,	O	O
Streptococci	B-bacteria	B-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
,	O	O
hydrogen-sulphide	O	O
(	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S	O	O
)	O	O
-producing	O	O
bacteria	O	O
,	O	O
Fusobacteria	B-bacteria	B-bacteria
and	O	O
Veillonella	B-bacteria	B-bacteria
.	O	O

A	O	O
specific	O	O
dentifrice	O	O
was	O	O
randomly	O	O
assigned	O	O
for	O	O
twice-daily	O	O
use	O	O
for	O	O
13	O	O
days	O	O
.	O	O

On	O	O
day	O	O
14	O	O
,	O	O
12	O	O
h	O	O
after	O	O
brushing	O	O
,	O	O
samples	O	O
were	O	O
collected	O	O
for	O	O
microbiological	O	O
evaluations	O	O
.	O	O

Alternate	O	O
dentifrices	O	O
followed	O	O
this	O	O
identical	O	O
protocol	O	O
.	O	O

For	O	O
all	O	O
four	O	O
oral	O	O
sites	O	O
and	O	O
six	O	O
organisms	O	O
evaluated	O	O
in	O	O
each	O	O
site	O	O
,	O	O
the	O	O
TCN/C	O	O
demonstrated	O	O
significant	O	O
reductions	O	O
(	O	O
49-83	O	O
%	O	O
)	O	O
as	O	O
compared	O	O
with	O	O
the	O	O
other	O	O
treatments	O	O
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

The	O	O
SnF	O	O
(	O	O
2	O	O
)	O	O
/SHMP	O	O
group	O	O
showed	O	O
significant	O	O
reductions	O	O
of	O	O
14-43	O	O
%	O	O
for	O	O
14	O	O
of	O	O
24	O	O
outcomes	O	O
as	O	O
compared	O	O
with	O	O
the	O	O
NaF	O	O
group	O	O
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
,	O	O
with	O	O
no	O	O
differences	O	O
in	O	O
10	O	O
outcomes	O	O
.	O	O

The	O	O
TCN/C	O	O
dentifrice	O	O
formulation	O	O
consistently	O	O
demonstrated	O	O
significant	O	O
reductions	O	O
for	O	O
a	O	O
range	O	O
of	O	O
microorganisms	O	O
in	O	O
diverse	O	O
oral	O	O
sites	O	O
in	O	O
comparison	O	O
with	O	O
the	O	O
NaF	O	O
,	O	O
or	O	O
the	O	O
SnF	O	O
(	O	O
2	O	O
)	O	O
/SHMP	O	O
dentifrice	O	O
formulations	O	O
as	O	O
seen	O	O
12	O	O
h	O	O
after	O	O
brushing	O	O
.	O	O

The	O	O
University	O	O
of	O	O
Nevada	O	O
,	O	O
Las	O	O
Vegas	O	O
School	O	O
of	O	O
Dental	O	O
Medicine	O	O
recently	O	O
opened	O	O
an	O	O
orthodontic	O	O
treatment	O	O
clinic	O	O
to	O	O
address	O	O
the	O	O
needs	O	O
of	O	O
the	O	O
racially	O	O
and	O	O
ethnically	O	O
diverse	O	O
population	O	O
of	O	O
Southern	O	O
Nevada	O	O
,	O	O
primarily	O	O
focusing	O	O
on	O	O
the	O	O
treatment	O	O
and	O	O
care	O	O
of	O	O
low-income	O	O
and	O	O
minority	O	O
patients	O	O
.	O	O

Although	O	O
orthodontic	O	O
treatment	O	O
and	O	O
therapy	O	O
has	O	O
been	O	O
shown	O	O
to	O	O
induce	O	O
changes	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
much	O	O
of	O	O
this	O	O
evidence	O	O
was	O	O
collected	O	O
from	O	O
traditional	O	O
White	O	O
,	O	O
teenage	O	O
orthodontic	O	O
clinic	O	O
populations	O	O
.	O	O

The	O	O
primary	O	O
goal	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
describe	O	O
the	O	O
microbial	O	O
burden	O	O
of	O	O
the	O	O
cariogenic	O	O
and	O	O
periodontal	O	O
pathogens	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
within	O	O
the	O	O
UNLV-SDM	O	O
patient	O	O
population	O	O
.	O	O

Representative	O	O
saliva	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
healthy	O	O
adult	O	O
patients	O	O
for	O	O
DNA	O	O
isolation	O	O
.	O	O

Relative	O	O
endpoint	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
RE-PCR	O	O
)	O	O
was	O	O
performed	O	O
to	O	O
ascertain	O	O
the	O	O
presence	O	O
and	O	O
relative	O	O
microbial	O	O
burden	O	O
of	O	O
these	O	O
oral	O	O
pathogens	O	O
.	O	O

Nearly	O	O
one	O	O
quarter	O	O
(	O	O
13/56	O	O
)	O	O
or	O	O
23.3	O	O
%	O	O
of	O	O
these	O	O
patients	O	O
had	O	O
elevated	O	O
levels	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
while	O	O
(	O	O
10/56	O	O
)	O	O
and	O	O
17.8	O	O
%	O	O
of	O	O
these	O	O
samples	O	O
were	O	O
found	O	O
to	O	O
have	O	O
elevated	O	O
levels	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
-	O	O
with	O	O
(	O	O
90	O	O
%	O	O
)	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis-positive	E-bacteria	I-bacteria
samples	O	O
from	O	O
minority	O	O
patients	O	O
(	O	O
X2=17.921	O	O
,	O	O
d.f	O	O
.	O	O

=	O	O
1	O	O
;	O	O
p	O	O
<	O	O
0.0001	O	O
)	O	O
.	O	O

These	O	O
findings	O	O
of	O	O
elevated	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
levels	O	O
,	O	O
primarily	O	O
among	O	O
minority	O	O
patients	O	O
,	O	O
may	O	O
suggest	O	O
underlying	O	O
oral	O	O
health	O	O
practices	O	O
contributing	O	O
to	O	O
adverse	O	O
oral	O	O
health	O	O
conditions	O	O
within	O	O
this	O	O
population	O	O
.	O	O

Oral	O	O
health	O	O
knowledge	O	O
and	O	O
practices	O	O
among	O	O
minority	O	O
patients	O	O
may	O	O
be	O	O
strongly	O	O
influenced	O	O
by	O	O
other	O	O
factors	O	O
,	O	O
including	O	O
education	O	O
and	O	O
socioeconomic	O	O
status	O	O
,	O	O
suggesting	O	O
additional	O	O
research	O	O
may	O	O
be	O	O
needed	O	O
to	O	O
accurately	O	O
determine	O	O
the	O	O
most	O	O
appropriate	O	O
standards	O	O
for	O	O
care	O	O
and	O	O
oral	O	O
health	O	O
education	O	O
within	O	O
this	O	O
patient	O	O
population	O	O
.	O	O

To	O	O
compare	O	O
the	O	O
oral	O	O
prevalence	O	O
and	O	O
antimicrobial	O	O
susceptibility	O	O
of	O	O
candida	O	O
spp.	O	O
,	O	O
staphylococci	B-bacteria	B-bacteria
,	O	O
enterobacteriaceae	B-bacteria	B-bacteria
,	O	O
and	O	O
pseudomonas	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

from	O	O
ankylosing	O	O
spondylitis	O	O
(	O	O
AS	O	O
)	O	O
patients	O	O
receiving	O	O
conventional	O	O
and	O	O
anti-TNF-alpha	O	O
therapy	O	O
.	O	O

The	O	O
study	O	O
included	O	O
70	O	O
AS	O	O
patients	O	O
,	O	O
diagnosed	O	O
according	O	O
to	O	O
the	O	O
modified	O	O
New	O	O
York	O	O
criteria	O	O
(	O	O
1984	O	O
)	O	O
.	O	O

The	O	O
volunteers	O	O
were	O	O
divided	O	O
into	O	O
2	O	O
groups	O	O
:	O	O
a	O	O
biological	O	O
group	O	O
(	O	O
AS	O	O
BioG	O	O
)	O	O
(	O	O
n=35	O	O
)	O	O
(	O	O
on	O	O
anti-TNF-alpha	O	O
therapy	O	O
)	O	O
and	O	O
a	O	O
conventional	O	O
group	O	O
(	O	O
AS	O	O
ConvG	O	O
)	O	O
(	O	O
n=35	O	O
)	O	O
.	O	O

The	O	O
control	O	O
group	O	O
(	O	O
ContG	O	O
)	O	O
(	O	O
n=70	O	O
)	O	O
was	O	O
made	O	O
up	O	O
of	O	O
healthy	O	O
individuals	O	O
matched	O	O
for	O	O
age	O	O
,	O	O
gender	O	O
,	O	O
and	O	O
oral	O	O
conditions	O	O
.	O	O

After	O	O
clinical	O	O
examination	O	O
,	O	O
oral	O	O
rinse	O	O
samples	O	O
were	O	O
collected	O	O
and	O	O
plated	O	O
in	O	O
specific	O	O
culture	O	O
media	O	O
.	O	O

The	O	O
number	O	O
of	O	O
colony-forming	O	O
units	O	O
per	O	O
milliliter	O	O
(	O	O
cfu/ml	O	O
)	O	O
was	O	O
obtained	O	O
,	O	O
and	O	O
isolates	O	O
were	O	O
identified	O	O
using	O	O
the	O	O
API	O	O
system	O	O
.	O	O

Antimicrobial	O	O
susceptibility	O	O
tests	O	O
were	O	O
performed	O	O
according	O	O
to	O	O
the	O	O
NCCLS	O	O
guidelines	O	O
.	O	O

Prevalence	O	O
and	O	O
counts	O	O
of	O	O
microorganisms	O	O
were	O	O
statistically	O	O
compared	O	O
between	O	O
the	O	O
3	O	O
groups	O	O
,	O	O
using	O	O
the	O	O
Mann-Whitney	O	O
and	O	O
Chi-square	O	O
tests	O	O
.	O	O

Significance	O	O
level	O	O
was	O	O
set	O	O
at	O	O
5	O	O
%	O	O
.	O	O

In	O	O
both	O	O
the	O	O
AS	O	O
BioG	O	O
and	O	O
the	O	O
AS	O	O
ConvG	O	O
,	O	O
staphylococci	B-bacteria	B-bacteria
counts	O	O
were	O	O
higher	O	O
than	O	O
that	O	O
in	O	O
the	O	O
ContG	O	O
(	O	O
p	O	O
<	O	O
0.0001	O	O
)	O	O
.	O	O

Candida	O	O
albicans	O	O
and	O	O
staphylococcus	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
were	O	O
the	O	O
most	O	O
commonly	O	O
found	O	O
species	O	O
in	O	O
all	O	O
the	O	O
groups	O	O
.	O	O

Serratia	B-bacteria	B-bacteria
marcescens	E-bacteria	I-bacteria
and	O	O
klebsiella	B-bacteria	B-bacteria
oxytoca	E-bacteria	I-bacteria
were	O	O
more	O	O
prevalent	O	O
in	O	O
the	O	O
AS	O	O
BioG	O	O
and	O	O
the	O	O
AS	O	O
ConvG	O	O
,	O	O
respectively	O	O
.	O	O

Two	O	O
candida	O	O
isolates	O	O
(	O	O
2.8	O	O
%	O	O
)	O	O
from	O	O
the	O	O
AS	O	O
BioG	O	O
and	O	O
5	O	O
(	O	O
10.8	O	O
%	O	O
)	O	O
from	O	O
the	O	O
AS	O	O
ConvG	O	O
were	O	O
resistant	O	O
to	O	O
amphotericin	O	O
B	O	O
and	O	O
5-fluorocytosine	O	O
.	O	O

A	O	O
low	O	O
percentage	O	O
of	O	O
staphylococci	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
was	O	O
resistant	O	O
to	O	O
amoxicillin	O	O
,	O	O
ciprofloxacin	O	O
,	O	O
and	O	O
doxycycline	O	O
.	O	O

Higher	O	O
counts	O	O
of	O	O
staphylococci	B-bacteria	B-bacteria
were	O	O
observed	O	O
in	O	O
both	O	O
AS	O	O
groups	O	O
,	O	O
regardless	O	O
of	O	O
the	O	O
current	O	O
therapy	O	O
,	O	O
age	O	O
,	O	O
sex	O	O
,	O	O
and	O	O
oral	O	O
conditions	O	O
.	O	O

Anti-TNF-alpha	O	O
therapy	O	O
could	O	O
not	O	O
be	O	O
correlated	O	O
with	O	O
increased	O	O
counts	O	O
of	O	O
microorganisms	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
evaluate	O	O
the	O	O
capacity	O	O
of	O	O
whole-genome	O	O
DNA	O	O
probes	O	O
prepared	O	O
from	O	O
human	O	O
oral	O	O
bacteria	O	O
to	O	O
cross-react	O	O
with	O	O
bacteria	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
rats	O	O
,	O	O
and	O	O
to	O	O
assess	O	O
the	O	O
influence	O	O
of	O	O
alcohol	O	O
ingestion	O	O
on	O	O
the	O	O
animals	O	O
'	O	O
oral	O	O
biofilm	O	O
.	O	O

Twenty	O	O
four	O	O
mature	O	O
Wistar	O	O
rats	O	O
were	O	O
equally	O	O
divided	O	O
in	O	O
two	O	O
groups	O	O
.	O	O

One	O	O
group	O	O
(	O	O
control	O	O
)	O	O
was	O	O
fed	O	O
balanced	O	O
diet	O	O
of	O	O
rat	O	O
pellets	O	O
and	O	O
water	O	O
.	O	O

The	O	O
alcohol-treated	O	O
group	O	O
(	O	O
AT	O	O
)	O	O
received	O	O
the	O	O
same	O	O
diet	O	O
and	O	O
20	O	O
%	O	O
ethanol	O	O
solution	O	O
.	O	O

Upon	O	O
euthanasia	O	O
after	O	O
30	O	O
days	O	O
,	O	O
bacterial	O	O
samples	O	O
from	O	O
the	O	O
oral	O	O
biofilm	O	O
covering	O	O
the	O	O
animals	O	O
'	O	O
teeth	O	O
were	O	O
collected	O	O
using	O	O
microbrushes	O	O
.	O	O

Bacteria	O	O
identification	O	O
and	O	O
quantification	O	O
were	O	O
performed	O	O
using	O	O
the	O	O
DNA	O	O
checkerboard	O	O
hybridization	O	O
method	O	O
with	O	O
33	O	O
probes	O	O
prepared	O	O
from	O	O
human	O	O
oral	O	O
bacteria	O	O
.	O	O

Signals	O	O
corresponding	O	O
to	O	O
bacterial	O	O
genome	O	O
counts	O	O
and	O	O
percentages	O	O
were	O	O
compared	O	O
using	O	O
a	O	O
Mann-Whitney	O	O
U	O	O
test	O	O
with	O	O
a	O	O
significance	O	O
level	O	O
<	O	O
0.05	O	O
.	O	O

Cross-reaction	O	O
for	O	O
all	O	O
targeted	O	O
species	O	O
,	O	O
except	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
mitis-like	O	O
species	O	O
,	O	O
occurred	O	O
in	O	O
the	O	O
control	O	O
group	O	O
.	O	O

Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
endodontalis	E-bacteria	I-bacteria
,	O	O
and	O	O
Veillonella	B-bacteria	B-bacteria
parvula-like	O	O
species	O	O
only	O	O
produced	O	O
detectable	O	O
signals	O	O
in	O	O
the	O	O
AT	O	O
group	O	O
.	O	O

Significantly	O	O
more	O	O
signals	O	O
were	O	O
detected	O	O
in	O	O
the	O	O
control	O	O
group	O	O
compared	O	O
to	O	O
the	O	O
AT	O	O
group	O	O
(	O	O
p=0.001	O	O
)	O	O
.	O	O

The	O	O
percentage	O	O
of	O	O
E.	B-bacteria	B-bacteria
coli-like	E-bacteria	I-bacteria
species	O	O
was	O	O
highest	O	O
in	O	O
both	O	O
groups	O	O
.	O	O

Whole-genome	O	O
DNA	O	O
probes	O	O
prepared	O	O
from	O	O
human	O	O
oral	O	O
bacteria	O	O
can	O	O
cross-react	O	O
with	O	O
rats	O	O
'	O	O
oral	O	O
bacterial	O	O
species	O	O
.	O	O

Alcohol	O	O
consumption	O	O
is	O	O
associated	O	O
with	O	O
lower	O	O
levels	O	O
and	O	O
diversity	O	O
of	O	O
bacterial	O	O
species	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
rats	O	O
.	O	O

Little	O	O
is	O	O
known	O	O
about	O	O
the	O	O
effect	O	O
of	O	O
diet	O	O
on	O	O
the	O	O
oral	O	O
microbiota	O	O
of	O	O
infants	O	O
,	O	O
although	O	O
diet	O	O
is	O	O
known	O	O
to	O	O
affect	O	O
the	O	O
gut	O	O
microbiota	O	O
.	O	O

The	O	O
aims	O	O
of	O	O
the	O	O
present	O	O
study	O	O
were	O	O
to	O	O
compare	O	O
the	O	O
oral	O	O
microbiota	O	O
in	O	O
breast-fed	O	O
and	O	O
formula-fed	O	O
infants	O	O
,	O	O
and	O	O
investigate	O	O
growth	O	O
inhibition	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
by	O	O
infant-isolated	B-bacteria	B-bacteria
lactobacilli	E-bacteria	I-bacteria
.	O	O

A	O	O
total	O	O
of	O	O
207	O	O
mothers	O	O
consented	O	O
to	O	O
participation	O	O
of	O	O
their	O	O
3-month-old	O	O
infants	O	O
.	O	O

A	O	O
total	O	O
of	O	O
146	O	O
(	O	O
70.5	O	O
%	O	O
)	O	O
infants	O	O
were	O	O
exclusively	O	O
and	O	O
38	O	O
(	O	O
18.4	O	O
%	O	O
)	O	O
partially	O	O
breast-fed	O	O
,	O	O
and	O	O
23	O	O
(	O	O
11.1	O	O
%	O	O
)	O	O
were	O	O
exclusively	O	O
formula-fed	O	O
.	O	O

Saliva	O	O
from	O	O
all	O	O
of	O	O
their	O	O
infants	O	O
was	O	O
cultured	O	O
for	O	O
Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
with	O	O
isolate	O	O
identifications	O	O
from	O	O
21	O	O
infants	O	O
.	O	O

Lactobacillus	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
were	O	O
tested	O	O
for	O	O
their	O	O
ability	O	O
to	O	O
suppress	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
.	O	O

Oral	O	O
swabs	O	O
from	O	O
73	O	O
infants	O	O
were	O	O
analysed	O	O
by	O	O
the	O	O
Human	O	O
Oral	O	O
Microbe	O	O
Identification	O	O
Microarray	O	O
(	O	O
HOMIM	O	O
)	O	O
and	O	O
by	O	O
quantitative	O	O
polymerase	O	O
chain	O	O
reaction	O	O
for	O	O
Lactobacillus	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
.	O	O

Lactobacilli	B-bacteria	B-bacteria
were	O	O
cultured	O	O
from	O	O
27.8	O	O
%	O	O
of	O	O
exclusively	O	O
and	O	O
partially	O	O
breast-fed	O	O
infants	O	O
,	O	O
but	O	O
not	O	O
from	O	O
formula-fed	O	O
infants	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
14	O	O
HOMIM-detected	O	O
taxa	O	O
,	O	O
and	O	O
total	O	O
salivary	B-bacteria	B-bacteria
lactobacilli	E-bacteria	I-bacteria
counts	O	O
differed	O	O
by	O	O
feeding	O	O
method	O	O
.	O	O

Multivariate	O	O
modelling	O	O
of	O	O
HOMIM-detected	O	O
bacteria	O	O
and	O	O
possible	O	O
confounders	O	O
clustered	O	O
samples	O	O
from	O	O
breast-fed	O	O
infants	O	O
separately	O	O
from	O	O
formula-fed	O	O
infants	O	O
.	O	O

The	O	O
microbiota	O	O
of	O	O
breast-fed	O	O
infants	O	O
differed	O	O
based	O	O
on	O	O
vaginal	O	O
or	O	O
C-section	O	O
delivery	O	O
.	O	O

Isolates	O	O
of	O	O
L	B-bacteria	B-bacteria
plantarum	E-bacteria	I-bacteria
,	O	O
L	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
,	O	O
and	O	O
L	B-bacteria	B-bacteria
vaginalis	E-bacteria	I-bacteria
inhibited	O	O
growth	O	O
of	O	O
the	O	O
cariogenic	B-bacteria	B-bacteria
S	I-bacteria	I-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
the	O	O
commensal	O	O
S	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
:	O	O
L	B-bacteria	B-bacteria
plantarum	E-bacteria	I-bacteria
>	O	O
L	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
>	O	O
L	B-bacteria	B-bacteria
vaginalis	E-bacteria	I-bacteria
.	O	O

The	O	O
microbiota	O	O
of	O	O
the	O	O
mouth	O	O
differs	O	O
between	O	O
3-month-old	O	O
breast-fed	O	O
and	O	O
formula-fed	O	O
infants	O	O
.	O	O

Possible	O	O
mechanisms	O	O
for	O	O
microbial	O	O
differences	O	O
observed	O	O
include	O	O
species	O	O
suppression	O	O
by	O	O
lactobacilli	B-bacteria	B-bacteria
indigenous	E-bacteria	I-bacteria
to	O	O
breast	O	O
milk	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
analyze	O	O
the	O	O
improvement	O	O
in	O	O
oral	O	O
function	O	O
and	O	O
environment	O	O
in	O	O
high-risk	O	O
elderly	O	O
persons	O	O
participating	O	O
in	O	O
a	O	O
program	O	O
to	O	O
improve	O	O
oral	O	O
function	O	O
organized	O	O
by	O	O
their	O	O
local	O	O
government	O	O
.	O	O

Participants	O	O
comprised	O	O
36	O	O
high-risk	O	O
elderly	O	O
and	O	O
the	O	O
mean	O	O
age	O	O
was	O	O
77.11	O	O
+/-	O	O
7.24	O	O
years	O	O
.	O	O

The	O	O
program	O	O
involved	O	O
training	O	O
sessions	O	O
carried	O	O
out	O	O
five	O	O
or	O	O
six	O	O
times	O	O
every	O	O
2-3	O	O
weeks	O	O
for	O	O
3	O	O
months	O	O
.	O	O

Oral	O	O
function	O	O
and	O	O
environment	O	O
was	O	O
evaluated	O	O
before	O	O
and	O	O
after	O	O
the	O	O
program	O	O
.	O	O

The	O	O
research	O	O
period	O	O
extended	O	O
from	O	O
2008	O	O
to	O	O
2010	O	O
.	O	O

The	O	O
effects	O	O
of	O	O
intervention	O	O
were	O	O
clearly	O	O
observed	O	O
in	O	O
oral	O	O
diadochokinesis	O	O
score	O	O
in	O	O
the	O	O
high-risk	O	O
elderly	O	O
.	O	O

Persons	O	O
with	O	O
a	O	O
lower	O	O
repetitive	O	O
saliva	O	O
swallowing	O	O
test	O	O
(	O	O
RSST	O	O
)	O	O
and	O	O
oral	O	O
diadochokinesis	O	O
score	O	O
before	O	O
intervention	O	O
showed	O	O
a	O	O
tendency	O	O
toward	O	O
even	O	O
greater	O	O
improvement	O	O
.	O	O

No	O	O
significant	O	O
changes	O	O
were	O	O
observed	O	O
in	O	O
saliva	O	O
secretion	O	O
or	O	O
total	O	O
amounts	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Lactobacilli	B-bacteria	B-bacteria
,	O	O
Candida	O	O
or	O	O
total	O	O
microorganisms	O	O
.	O	O

The	O	O
effects	O	O
of	O	O
intervention	O	O
were	O	O
clearly	O	O
recognized	O	O
in	O	O
regards	O	O
to	O	O
oral	O	O
diadochokinesis	O	O
.	O	O

Improvement	O	O
in	O	O
RSST	O	O
and	O	O
oral	O	O
diadochokinesis	O	O
scores	O	O
was	O	O
marked	O	O
in	O	O
those	O	O
persons	O	O
showing	O	O
a	O	O
lower	O	O
number	O	O
of	O	O
articulations	O	O
before	O	O
intervention	O	O
.	O	O

Salvadora	O	O
persica	O	O
L.	O	O
(	O	O
miswak	O	O
)	O	O
is	O	O
traditionally	O	O
used	O	O
to	O	O
ensure	O	O
oral	O	O
hygiene	O	O
Muslim	O	O
people	O	O
in	O	O
developing	O	O
countries	O	O
where	O	O
it	O	O
is	O	O
growing	O	O
.	O	O

The	O	O
antibacterial	O	O
properties	O	O
of	O	O
Salvadora	O	O
persica	O	O
L.	O	O
originating	O	O
from	O	O
various	O	O
geographic	O	O
areas	O	O
have	O	O
already	O	O
been	O	O
reported	O	O
.	O	O

However	O	O
,	O	O
they	O	O
have	O	O
never	O	O
been	O	O
tested	O	O
for	O	O
samples	O	O
originating	O	O
from	O	O
Hoggar	O	O
,	O	O
where	O	O
extreme	O	O
weather	O	O
conditions	O	O
could	O	O
lead	O	O
to	O	O
different	O	O
properties	O	O
for	O	O
this	O	O
Salvadora	O	O
persica	O	O
L.	O	O
ecotype	O	O
.	O	O

To	O	O
assess	O	O
the	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo	O	O
antimicrobial	O	O
activities	O	O
of	O	O
methanolic	O	O
extract	O	O
of	O	O
Algerian	O	O
Hoggar	O	O
Salvadora	O	O
persica	O	O
L.	O	O
(	O	O
miswak	O	O
)	O	O
on	O	O
some	O	O
isolated	O	O
and	O	O
identified	O	O
strains	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
school	O	O
children	O	O
aged	O	O
from	O	O
6	O	O
to	O	O
12	O	O
with	O	O
(	O	O
n=20	O	O
)	O	O
and	O	O
without	O	O
(	O	O
n=20	O	O
)	O	O
caries	O	O
.	O	O

After	O	O
a	O	O
qualitative	O	O
and	O	O
quantitative	O	O
analysis	O	O
of	O	O
dental	O	O
plaque	O	O
samples	O	O
from	O	O
the	O	O
selected	O	O
children	O	O
,	O	O
the	O	O
effect	O	O
of	O	O
methanolic	O	O
extract	O	O
of	O	O
Hoggar	O	O
miswak	O	O
against	O	O
oral	O	O
bacterial	O	O
and	O	O
fungal	O	O
strains	O	O
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
children	O	O
with	O	O
caries	O	O
was	O	O
tested	O	O
by	O	O
both	O	O
agar	O	O
disc	O	O
diffusion	O	O
and	O	O
microdilution	O	O
methods	O	O
.	O	O

The	O	O
stability	O	O
and	O	O
physicochemical	O	O
parameters	O	O
of	O	O
Hoggar	O	O
Salvadora	O	O
persica	O	O
L.	O	O
mouthwash	O	O
were	O	O
also	O	O
assessed	O	O
compared	O	O
.	O	O

The	O	O
in	O	O
vivo	O	O
antimicrobial	O	O
effect	O	O
of	O	O
Hoggar	O	O
miswak	O	O
rinse	O	O
on	O	O
dental	O	O
plaque	O	O
samples	O	O
was	O	O
also	O	O
tested	O	O
over	O	O
a	O	O
week	O	O
.	O	O

Four	O	O
bacterial	O	O
genera	O	O
(	O	O
Staphylococcus	B-bacteria	B-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
)	O	O
were	O	O
commonly	O	O
identified	O	O
in	O	O
all	O	O
subjects	O	O
at	O	O
different	O	O
colonization	O	O
levels	O	O
.	O	O

A	O	O
statistically	O	O
significant	O	O
difference	O	O
in	O	O
colonization	O	O
levels	O	O
between	O	O
the	O	O
two	O	O
groups	O	O
of	O	O
children	O	O
was	O	O
recorded	O	O
.	O	O

Hoggar	O	O
miswak	O	O
extract	O	O
more	O	O
significantly	O	O
inhibited	O	O
the	O	O
growth	O	O
of	O	O
Gram	B-bacteria	B-bacteria
negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
from	O	O
the	O	O
dental	O	O
plaque	O	O
than	O	O
Gram	O	O
positive	O	O
ones	O	O
.	O	O

Hoggar	O	O
Salvadora	O	O
persica	O	O
L.	O	O
mouthwash	O	O
was	O	O
stable	O	O
at	O	O
4	O	O
degrees	O	O
C	O	O
and	O	O
25	O	O
degrees	O	O
C	O	O
over	O	O
the	O	O
period	O	O
of	O	O
conservation	O	O
(	O	O
one	O	O
week	O	O
)	O	O
while	O	O
a	O	O
temperature	O	O
of	O	O
40	O	O
degrees	O	O
C	O	O
induced	O	O
variations	O	O
in	O	O
the	O	O
physicochemical	O	O
parameters	O	O
and	O	O
considered	O	O
not	O	O
suitable	O	O
for	O	O
preservation	O	O
.	O	O

The	O	O
in	O	O
vivo	O	O
study	O	O
revealed	O	O
a	O	O
significant	O	O
reduction	O	O
in	O	O
bacteria	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
using	O	O
miswak	O	O
mouthwash	O	O
as	O	O
compared	O	O
to	O	O
placebo	O	O
.	O	O

Hoggar	O	O
miswak	O	O
extract	O	O
displayed	O	O
a	O	O
strong	O	O
antimicrobial	O	O
effect	O	O
both	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo	O	O
.	O	O

Its	O	O
use	O	O
as	O	O
a	O	O
mouthrinse	O	O
could	O	O
therefore	O	O
be	O	O
recommended	O	O
as	O	O
a	O	O
preventive	O	O
measure	O	O
to	O	O
preserve	O	O
from	O	O
tooth	O	O
decay	O	O
.	O	O

Examine	O	O
the	O	O
relationship	O	O
between	O	O
antibodies	O	O
to	O	O
25	O	O
oral	O	O
bacteria	O	O
and	O	O
pancreatic	O	O
cancer	O	O
risk	O	O
in	O	O
a	O	O
prospective	O	O
cohort	O	O
study	O	O
.	O	O

We	O	O
measured	O	O
antibodies	O	O
to	O	O
oral	O	O
bacteria	O	O
in	O	O
prediagnosis	O	O
blood	O	O
samples	O	O
from	O	O
405	O	O
pancreatic	O	O
cancer	O	O
cases	O	O
and	O	O
416	O	O
matched	O	O
controls	O	O
,	O	O
nested	O	O
within	O	O
the	O	O
European	O	O
Prospective	O	O
Investigation	O	O
into	O	O
Cancer	O	O
and	O	O
Nutrition	O	O
study	O	O
.	O	O

Analyses	O	O
were	O	O
conducted	O	O
using	O	O
conditional	O	O
logistic	O	O
regression	O	O
and	O	O
additionally	O	O
adjusted	O	O
for	O	O
smoking	O	O
status	O	O
and	O	O
body	O	O
mass	O	O
index	O	O
.	O	O

Individuals	O	O
with	O	O
high	O	O
levels	O	O
of	O	O
antibodies	O	O
against	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
ATTC	I-bacteria	I-bacteria
53978	E-bacteria	I-bacteria
,	O	O
a	O	O
pathogenic	O	O
periodontal	O	O
bacteria	O	O
,	O	O
had	O	O
a	O	O
twofold	O	O
higher	O	O
risk	O	O
of	O	O
pancreatic	O	O
cancer	O	O
than	O	O
individuals	O	O
with	O	O
lower	O	O
levels	O	O
of	O	O
these	O	O
antibodies	O	O
(	O	O
OR	O	O
2.14	O	O
;	O	O
95	O	O
%	O	O
CI	O	O
1.05	O	O
to	O	O
4.36	O	O
;	O	O
>	O	O
200	O	O
ng/ml	O	O
vs	O	O
<	O	O
/=200	O	O
ng/ml	O	O
)	O	O
.	O	O

To	O	O
explore	O	O
the	O	O
association	O	O
with	O	O
commensal	O	O
(	O	O
non-pathogenic	O	O
)	O	O
oral	O	O
bacteria	O	O
,	O	O
we	O	O
performed	O	O
a	O	O
cluster	O	O
analysis	O	O
and	O	O
identified	O	O
two	O	O
groups	O	O
of	O	O
individuals	O	O
,	O	O
based	O	O
on	O	O
their	O	O
antibody	O	O
profiles	O	O
.	O	O

A	O	O
cluster	O	O
with	O	O
overall	O	O
higher	O	O
levels	O	O
of	O	O
antibodies	O	O
had	O	O
a	O	O
45	O	O
%	O	O
lower	O	O
risk	O	O
of	O	O
pancreatic	O	O
cancer	O	O
than	O	O
a	O	O
cluster	O	O
with	O	O
overall	O	O
lower	O	O
levels	O	O
of	O	O
antibodies	O	O
(	O	O
OR	O	O
0.55	O	O
;	O	O
95	O	O
%	O	O
CI	O	O
0.36	O	O
to	O	O
0.83	O	O
)	O	O
.	O	O

Periodontal	O	O
disease	O	O
might	O	O
increase	O	O
the	O	O
risk	O	O
for	O	O
pancreatic	O	O
cancer	O	O
.	O	O

Moreover	O	O
,	O	O
increased	O	O
levels	O	O
of	O	O
antibodies	O	O
against	O	O
specific	O	O
commensal	O	O
oral	O	O
bacteria	O	O
,	O	O
which	O	O
can	O	O
inhibit	O	O
growth	O	O
of	O	O
pathogenic	O	O
bacteria	O	O
,	O	O
might	O	O
reduce	O	O
the	O	O
risk	O	O
of	O	O
pancreatic	O	O
cancer	O	O
.	O	O

Studies	O	O
are	O	O
needed	O	O
to	O	O
determine	O	O
whether	O	O
oral	O	O
bacteria	O	O
have	O	O
direct	O	O
effects	O	O
on	O	O
pancreatic	O	O
cancer	O	O
pathogenesis	O	O
or	O	O
serve	O	O
as	O	O
markers	O	O
of	O	O
the	O	O
immune	O	O
response	O	O
.	O	O

Oral	O	O
microbial	O	O
flora	O	O
and	O	O
a	O	O
damaged	O	O
oral	O	O
mucosa	O	O
may	O	O
increase	O	O
the	O	O
risk	O	O
of	O	O
bacteriemia	O	O
,	O	O
fungemia	O	O
and	O	O
complications	O	O
in	O	O
immunocompromised	O	O
patients	O	O
.	O	O


Assessment	O	O
of	O	O
presence	O	O
:	O	O
bacteria	O	O
and	O	O
Candida	O	O
spp	O	O
.	O	O

in	O	O
different	O	O
oral	O	O
lesions	O	O
,	O	O
and	O	O
the	O	O
incidence	O	O
of	O	O
bacteremia	O	O
in	O	O
the	O	O
case	O	O
of	O	O
a	O	O
damaged	O	O
mucosa	O	O
in	O	O
transplant	O	O
recipients	O	O
and	O	O
patients	O	O
receiving	O	O
anti-tumour	O	O
chemotherapy	O	O
.	O	O


Forty-five	O	O
patients	O	O
-	O	O
18	O	O
months	O	O
to	O	O
18	O	O
years	O	O
of	O	O
life	O	O
,	O	O
were	O	O
included	O	O
(	O	O
20	O	O
-	O	O
organ	O	O
recipients	O	O
,	O	O
14-	O	O
anti-tumour	O	O
chemotherapy	O	O
,	O	O
11	O	O
-	O	O
control	O	O
group	O	O
)	O	O
.	O	O

Clinical	O	O
,	O	O
oral	O	O
mucosa	O	O
examination	O	O
focused	O	O
on	O	O
the	O	O
type	O	O
,	O	O
severity	O	O
and	O	O
site	O	O
of	O	O
lesions	O	O
,	O	O
and	O	O
microbiology	O	O
assessed	O	O
the	O	O
presence	O	O
of	O	O
bacteria	O	O
and	O	O
fungi	O	O
in	O	O
the	O	O
material	O	O
from	O	O
lesions	O	O
.	O	O

Blood	O	O
cultures	O	O
were	O	O
performed	O	O
in	O	O
ten	O	O
immunocompromised	O	O
patients	O	O
with	O	O
manifestations	O	O
of	O	O
systemic	O	O
infection	O	O
.	O	O

The	O	O
control	O	O
material	O	O
consisted	O	O
of	O	O
blood	O	O
cultures	O	O
made	O	O
prior	O	O
to	O	O
the	O	O
onset	O	O
of	O	O
oral	O	O
lesions	O	O
and	O	O
after	O	O
4-6	O	O
weeks	O	O
following	O	O
their	O	O
remission	O	O
in	O	O
a	O	O
diagnosed	O	O
bacteremia	O	O
.	O	O

The	O	O
statistical	O	O
analysis	O	O
was	O	O
performed	O	O
.	O	O

In	O	O
the	O	O
subjects	O	O
with	O	O
secondary	O	O
immunodeficiency	O	O
,	O	O
among	O	O
other	O	O
coagulase-negative	B-bacteria	B-bacteria
Staphylococcus	E-bacteria	I-bacteria
(	O	O
CoNS	B-bacteria	B-bacteria
)	O	O
,	O	O
Candidia	O	O
spp	O	O
.	O	O

were	O	O
more	O	O
frequent	O	O
.	O	O

In	O	O
cancer	O	O
patients	O	O
,	O	O
mucositis	O	O
was	O	O
associated	O	O
with	O	O
Candida	O	O
spp.	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

Organ	O	O
recipients	O	O
with	O	O
stomatitis	O	O
exhibited	O	O
the	O	O
presence	O	O
of	O	O
CoNS	B-bacteria	B-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
viridians	E-bacteria	I-bacteria
and	O	O
other	O	O
.	O	O

Oral	O	O
lesions	O	O
in	O	O
the	O	O
control	O	O
group	O	O
contained	O	O
Haemophilus	B-bacteria	B-bacteria
parainfluenzae	E-bacteria	I-bacteria
,	O	O
Neisseria	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

and	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
.	O	O

In	O	O
30	O	O
%	O	O
of	O	O
immunocompromised	O	O
patients	O	O
,	O	O
oral	O	O
lesions	O	O
were	O	O
accompanied	O	O
by	O	O
bacteremia	O	O
.	O	O

A	O	O
correlation	O	O
has	O	O
been	O	O
found	O	O
between	O	O
oral	O	O
lesions	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
in	O	O
patients	O	O
without	O	O
secondary	O	O
immunodeficiency	O	O
,	O	O
and	O	O
of	O	O
CoNS	B-bacteria	B-bacteria
,	O	O
Enterococcus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Candida	O	O
spp	O	O
.	O	O

in	O	O
immunocompromised	O	O
patients	O	O
.	O	O

Infants	O	O
with	O	O
moderate	O	O
to	O	O
severe	O	O
congenital	O	O
heart	O	O
disease	O	O
(	O	O
CHD	O	O
)	O	O
are	O	O
at	O	O
a	O	O
higher	O	O
risk	O	O
for	O	O
growth	O	O
failure	O	O
and	O	O
malnutrition	O	O
due	O	O
to	O	O
increased	O	O
metabolic	O	O
demands	O	O
and	O	O
inadequate	O	O
energy	O	O
intake	O	O
.	O	O

This	O	O
state	O	O
requires	O	O
meals	O	O
that	O	O
are	O	O
more	O	O
frequent	O	O
and	O	O
a	O	O
special	O	O
enriched	O	O
diet	O	O
,	O	O
which	O	O
may	O	O
have	O	O
negative	O	O
implications	O	O
on	O	O
oral	O	O
health	O	O
.	O	O

To	O	O
examine	O	O
the	O	O
oral	O	O
colonisation	O	O
of	O	O
some	O	O
bacteria	O	O
associated	O	O
with	O	O
caries	O	O
development	O	O
during	O	O
infancy	O	O
;	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
MS	B-bacteria	B-bacteria
)	O	O
and	O	O
lactobacilli	B-bacteria	B-bacteria
(	O	O
LCB	B-bacteria	B-bacteria
)	O	O
in	O	O
infants	O	O
with	O	O
CHD	O	O
and	O	O
whether	O	O
their	O	O
dietary	O	O
intake	O	O
had	O	O
an	O	O
impact	O	O
on	O	O
the	O	O
bacterial	O	O
levels	O	O
.	O	O

This	O	O
was	O	O
a	O	O
prospective	O	O
case-control	O	O
study	O	O
.	O	O

11	O	O
infants	O	O
with	O	O
CHD	O	O
and	O	O
22	O	O
healthy	O	O
,	O	O
age-matched	O	O
infants	O	O
were	O	O
enrolled	O	O
.	O	O

Saliva	O	O
samples	O	O
and	O	O
food	O	O
diaries	O	O
were	O	O
collected	O	O
at	O	O
6	O	O
,	O	O
9	O	O
,	O	O
and	O	O
12	O	O
months	O	O
of	O	O
age	O	O
.	O	O

The	O	O
total	O	O
viable	O	O
counts	O	O
of	O	O
MS	B-bacteria	B-bacteria
and	O	O
LCB	B-bacteria	B-bacteria
in	O	O
saliva	O	O
were	O	O
determined	O	O
,	O	O
and	O	O
energy	O	O
intake	O	O
,	O	O
meal	O	O
frequency	O	O
,	O	O
intake	O	O
of	O	O
proteins	O	O
,	O	O
fat	O	O
,	O	O
carbohydrates	O	O
and	O	O
sucrose	O	O
were	O	O
calculated	O	O
.	O	O

At	O	O
12	O	O
months	O	O
of	O	O
age	O	O
,	O	O
the	O	O
MS	B-bacteria	B-bacteria
count	O	O
was	O	O
higher	O	O
in	O	O
the	O	O
CHD	O	O
group	O	O
than	O	O
in	O	O
the	O	O
controls	O	O
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
,	O	O
and	O	O
MS	B-bacteria	B-bacteria
constituted	O	O
a	O	O
higher	O	O
ratio	O	O
of	O	O
the	O	O
total	O	O
viable	O	O
count	O	O
of	O	O
oral	O	O
bacteria	O	O
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

Meal	O	O
frequency	O	O
was	O	O
higher	O	O
in	O	O
the	O	O
CHD	O	O
group	O	O
at	O	O
6	O	O
and	O	O
9	O	O
months	O	O
of	O	O
age	O	O
than	O	O
in	O	O
the	O	O
controls	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
intake	O	O
of	O	O
sucrose	O	O
did	O	O
not	O	O
differ	O	O
between	O	O
the	O	O
groups	O	O
,	O	O
while	O	O
the	O	O
total	O	O
carbohydrate	O	O
intake	O	O
was	O	O
higher	O	O
in	O	O
the	O	O
control	O	O
group	O	O
at	O	O
6	O	O
and	O	O
12	O	O
months	O	O
of	O	O
age	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Compared	O	O
with	O	O
the	O	O
control	O	O
group	O	O
,	O	O
which	O	O
had	O	O
six	O	O
courses	O	O
of	O	O
antibiotic	O	O
administration	O	O
,	O	O
the	O	O
CHD	O	O
infants	O	O
had	O	O
21	O	O
courses	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Infants	O	O
with	O	O
severe	O	O
CHD	O	O
have	O	O
higher	O	O
levels	O	O
of	O	O
MS	B-bacteria	B-bacteria
at	O	O
12	O	O
months	O	O
of	O	O
age	O	O
than	O	O
the	O	O
healthy	O	O
controls	O	O
.	O	O

A	O	O
higher	O	O
meal	O	O
frequency	O	O
and	O	O
use	O	O
of	O	O
diuretic	O	O
medication	O	O
and	O	O
antibiotics	O	O
may	O	O
have	O	O
influenced	O	O
MS	B-bacteria	B-bacteria
colonisation	O	O
.	O	O

A	O	O
total	O	O
of	O	O
550	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
:	O	O
270	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
110	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	B-bacteria	B-bacteria
,	O	O
90	O	O
Streptococcus	B-bacteria	B-bacteria
anginosus	E-bacteria	I-bacteria
,	O	O
50	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
30	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
were	O	O
isolated	O	O
from	O	O
dental	O	O
plaque	O	O
and	O	O
gengival	O	O
crevices	O	O
of	O	O
patients	O	O
and	O	O
tested	O	O
for	O	O
their	O	O
susceptibility	O	O
to	O	O
12	O	O
beta-lactam	O	O
antibiotics	O	O
and	O	O
to	O	O
5	O	O
non-beta-lactam	O	O
antibiotics	O	O
,	O	O
using	O	O
the	O	O
microdiluition	O	O
method	O	O
.	O	O

Overall	O	O
,	O	O
a	O	O
reduced	O	O
susceptibility	O	O
to	O	O
penicillin	O	O
was	O	O
recorded	O	O
in	O	O
13.4	O	O
%	O	O
of	O	O
cases	O	O
.	O	O

The	O	O
percentage	O	O
of	O	O
strains	O	O
resistant	O	O
to	O	O
penicillin	O	O
appeared	O	O
significantly	O	O
higher	O	O
in	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
(	O	O
24	O	O
%	O	O
)	O	O
than	O	O
in	O	O
S.	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
(	O	O
19	O	O
%	O	O
)	O	O
,	O	O
in	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
14	O	O
%	O	O
)	O	O
and	O	O
in	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
(	O	O
10	O	O
%	O	O
)	O	O
.	O	O

No	O	O
levels	O	O
of	O	O
penicillin	O	O
resistance	O	O
were	O	O
shown	O	O
by	O	O
90	O	O
strains	O	O
of	O	O
S.	B-bacteria	B-bacteria
anginosus	E-bacteria	I-bacteria
.	O	O

In	O	O
susceptibility	O	O
test	O	O
to	O	O
antibiotics	O	O
,	O	O
imipenem	O	O
was	O	O
the	O	O
most	O	O
active	O	O
molecule	O	O
tested	O	O
,	O	O
confirming	O	O
its	O	O
general	O	O
good	O	O
activity	O	O
against	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Also	O	O
third	O	O
generation	O	O
cephalosporins	O	O
such	O	O
as	O	O
ceftriaxone	O	O
and	O	O
fourth	O	O
generation	O	O
cephalosporins	O	O
such	O	O
as	O	O
cefepime	O	O
,	O	O
showed	O	O
good	O	O
activity	O	O
.	O	O

Chinolones	O	O
,	O	O
glycopeptides	O	O
and	O	O
rifampicin	O	O
confirmed	O	O
a	O	O
good	O	O
activity	O	O
against	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

To	O	O
compare	O	O
the	O	O
virulence	O	O
genotype	O	O
(	O	O
cagA	O	O
and	O	O
vacA	O	O
ml	O	O
genes	O	O
)	O	O
of	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
obtained	O	O
simultaneously	O	O
from	O	O
gastric	O	O
mucosa	O	O
and	O	O
oral	O	O
cavity	O	O
.	O	O

Gastric	O	O
samples	O	O
of	O	O
18	O	O
patients	O	O
were	O	O
obtained	O	O
by	O	O
endoscopic	O	O
biopsies	O	O
.	O	O

Oral	O	O
samples	O	O
of	O	O
these	O	O
patients	O	O
were	O	O
obtained	O	O
from	O	O
dental	O	O
plaque	O	O
and	O	O
saliva	O	O
swabs	O	O
from	O	O
the	O	O
floor	O	O
of	O	O
the	O	O
mouth	O	O
and	O	O
the	O	O
base	O	O
of	O	O
the	O	O
tongue	O	O
.	O	O

All	O	O
samples	O	O
were	O	O
studied	O	O
by	O	O
conventional	O	O
PCR	O	O
and	O	O
real-time	O	O
PCR	O	O
(	O	O
RT-PCR	O	O
)	O	O
.	O	O

Virulence	O	O
genes	O	O
cagA	O	O
and	O	O
vacA	O	O
ml	O	O
were	O	O
studied	O	O
by	O	O
RT-	O	O
PCR	O	O
.	O	O

According	O	O
to	O	O
presence	O	O
and/or	O	O
absence	O	O
of	O	O
cagA	O	O
and	O	O
vacAm1	O	O
genes	O	O
,	O	O
seven	O	O
different	O	O
combinations	O	O
were	O	O
observed	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
there	O	O
is	O	O
a	O	O
variety	O	O
of	O	O
genetic	O	O
profiles	O	O
of	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
stomach	O	O
and	O	O
oral	O	O
cavity	O	O
,	O	O
with	O	O
a	O	O
predominance	O	O
of	O	O
less	O	O
virulent	O	O
genotypes	O	O
in	O	O
the	O	O
patients	O	O
included	O	O
in	O	O
this	O	O
study	O	O
(	O	O
cagA-	O	O
,	O	O
vacA	O	O
m1-	O	O
)	O	O
.	O	O

In	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
we	O	O
can	O	O
find	O	O
a	O	O
complex	O	O
mixture	O	O
of	O	O
microorganisms	O	O
,	O	O
commensals	O	O
,	O	O
and	O	O
pathogens	O	O
.	O	O

The	O	O
studies	O	O
of	O	O
normal	O	O
oral	O	O
microbiota	O	O
,	O	O
as	O	O
well	O	O
as	O	O
the	O	O
studies	O	O
of	O	O
much	O	O
oral	O	O
pathology	O	O
(	O	O
e.g.	O	O
,	O	O
caries	O	O
,	O	O
periodontitis	O	O
)	O	O
,	O	O
involve	O	O
the	O	O
isolation	O	O
and	O	O
cultivation	O	O
of	O	O
these	O	O
microorganisms	O	O
and	O	O
their	O	O
molecular	O	O
analysis	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
validate	O	O
a	O	O
quick	O	O
,	O	O
easy	O	O
,	O	O
efficient	O	O
,	O	O
and	O	O
inexpensive	O	O
DNA	O	O
extraction	O	O
method	O	O
for	O	O
the	O	O
recovery	O	O
of	O	O
genomic	O	O
DNA	O	O
from	O	O
gram-positive	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
gram-negative	I-bacteria	I-bacteria
oral	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
to	O	O
be	O	O
used	O	O
in	O	O
polymerase	O	O
chain	O	O
reaction	O	O
amplification	O	O
.	O	O

This	O	O
method	O	O
worked	O	O
great	O	O
with	O	O
all	O	O
samples	O	O
analyzed	O	O
,	O	O
providing	O	O
an	O	O
approach	O	O
to	O	O
extract	O	O
DNA	O	O
for	O	O
different	O	O
microorganisms	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
)	O	O
is	O	O
the	O	O
prime	O	O
pathogen	O	O
of	O	O
dental	O	O
caries	O	O
.	O	O

There	O	O
are	O	O
few	O	O
reports	O	O
that	O	O
studied	O	O
the	O	O
relationship	O	O
between	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
bacteria	O	O
and	O	O
dental	O	O
caries	O	O
in	O	O
permanent	O	O
teeth	O	O
when	O	O
compared	O	O
to	O	O
those	O	O
in	O	O
primary	O	O
teeth	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
detect	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
bacteria	O	O
of	O	O
dental	O	O
caries	O	O
and	O	O
non-caries	O	O
groups	O	O
in	O	O
permanent	O	O
teeth	O	O
from	O	O
a	O	O
north	O	O
China	O	O
population	O	O
by	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
and	O	O
compare	O	O
the	O	O
relationship	O	O
between	O	O
the	O	O
number	O	O
of	O	O
these	O	O
bacteria	O	O
and	O	O
the	O	O
prevalence	O	O
of	O	O
dental	O	O
caries	O	O
in	O	O
permanent	O	O
teeth	O	O
.	O	O

Human	O	O
saliva	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
142	O	O
subjects	O	O
with	O	O
permanent	O	O
teeth	O	O
.	O	O

According	O	O
to	O	O
their	O	O
dental	O	O
tooth	O	O
(	O	O
DT	O	O
)	O	O
,	O	O
142	O	O
subjects	O	O
were	O	O
divided	O	O
into	O	O
a	O	O
dental	O	O
caries	O	O
group	O	O
(	O	O
DT	O	O
>	O	O
/=	O	O
1	O	O
)	O	O
and	O	O
a	O	O
non-caries	O	O
group	O	O
(	O	O
DT	O	O
=	O	O
0	O	O
)	O	O
.	O	O

With	O	O
specific	O	O
primers	O	O
for	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
16S	O	O
rRNA	O	O
,	O	O
the	O	O
total	O	O
number	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
total	O	O
bacteria	O	O
of	O	O
142	O	O
saliva	O	O
samples	O	O
were	O	O
detected	O	O
by	O	O
real-time	O	O
PCR	O	O
and	O	O
statistically	O	O
analyzed	O	O
.	O	O

There	O	O
was	O	O
no	O	O
significant	O	O
difference	O	O
between	O	O
the	O	O
detection	O	O
rates	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
P	O	O
=	O	O
0.118	O	O
)	O	O
and	O	O
medians	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
P	O	O
=	O	O
0.115	O	O
)	O	O
.	O	O

The	O	O
ratio	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
to	O	O
total	O	O
bacteria	O	O
in	O	O
people	O	O
with	O	O
dental	O	O
caries	O	O
was	O	O
significantly	O	O
higher	O	O
than	O	O
in	O	O
those	O	O
without	O	O
caries	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
,	O	O
but	O	O
the	O	O
total	O	O
number	O	O
of	O	O
bacteria	O	O
in	O	O
people	O	O
with	O	O
dental	O	O
caries	O	O
was	O	O
significantly	O	O
lower	O	O
than	O	O
in	O	O
those	O	O
without	O	O
caries	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
had	O	O
different	O	O
effects	O	O
on	O	O
caries	O	O
in	O	O
the	O	O
permanent	O	O
teeth	O	O
of	O	O
several	O	O
individuals	O	O
from	O	O
a	O	O
north	O	O
China	O	O
population	O	O
.	O	O

The	O	O
ratios	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
to	O	O
total	O	O
bacteria	O	O
in	O	O
saliva	O	O
detected	O	O
by	O	O
real-time	O	O
PCR	O	O
with	O	O
Sm479F/R	O	O
and	O	O
16S	O	O
RNA	O	O
primers	O	O
were	O	O
closely	O	O
associated	O	O
with	O	O
the	O	O
prevalence	O	O
of	O	O
dental	O	O
caries	O	O
in	O	O
the	O	O
same	O	O
population	O	O
.	O	O

These	O	O
assays	O	O
may	O	O
be	O	O
useful	O	O
for	O	O
the	O	O
assessment	O	O
of	O	O
an	O	O
individual	O	O
's	O	O
risk	O	O
of	O	O
dental	O	O
caries	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
whether	O	O
measurements	O	O
of	O	O
volatile	O	O
sulfur	O	O
compounds	O	O
(	O	O
VSCs	O	O
)	O	O
are	O	O
useful	O	O
to	O	O
predict	O	O
colonization	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
.	O	O

For	O	O
this	O	O
purpose	O	O
,	O	O
we	O	O
assessed	O	O
the	O	O
relationships	O	O
among	O	O
distributions	O	O
of	O	O
4	O	O
species	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
in	O	O
tongue	O	O
coating	O	O
and	O	O
dental	O	O
plaque	O	O
,	O	O
oral	O	O
conditions	O	O
including	O	O
VSC	O	O
concentration	O	O
in	O	O
mouth	O	O
air	O	O
,	O	O
and	O	O
smoking	O	O
habit	O	O
of	O	O
periodontal	O	O
healthy	O	O
young	O	O
subjects	O	O
.	O	O

The	O	O
subjects	O	O
were	O	O
108	O	O
young	O	O
adults	O	O
(	O	O
mean	O	O
age	O	O
,	O	O
23.5+/-2.56	O	O
years	O	O
)	O	O
without	O	O
clinical	O	O
periodontal	O	O
pockets	O	O
.	O	O

Information	O	O
regarding	O	O
smoking	O	O
habit	O	O
was	O	O
obtained	O	O
by	O	O
interview	O	O
.	O	O

After	O	O
VSC	O	O
concentration	O	O
in	O	O
mouth	O	O
,	O	O
air	O	O
was	O	O
measured	O	O
with	O	O
a	O	O
portable	O	O
sulfide	O	O
monitor	O	O
(	O	O
Halimeter	O	O
(	O	O
(	O	O
R	O	O
)	O	O
)	O	O
)	O	O
,	O	O
non-stimulated	O	O
saliva	O	O
flow	O	O
and	O	O
dental	O	O
caries	O	O
status	O	O
were	O	O
assessed	O	O
,	O	O
and	O	O
tongue	O	O
coating	O	O
and	O	O
dental	O	O
plaque	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
the	O	O
subjects	O	O
.	O	O

The	O	O
tongue	O	O
coating	O	O
samples	O	O
were	O	O
weighed	O	O
to	O	O
determine	O	O
the	O	O
amount	O	O
.	O	O

The	O	O
colonization	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
in	O	O
both	O	O
tongue	O	O
coating	O	O
and	O	O
plaque	O	O
samples	O	O
was	O	O
investigated	O	O
using	O	O
species-specific	O	O
polymerase	O	O
chain	O	O
reaction	O	O
assays	O	O
.	O	O

Significant	O	O
relationships	O	O
were	O	O
observed	O	O
between	O	O
the	O	O
colonization	O	O
of	O	O
periodontopathic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
tongue	O	O
coating	O	O
and	O	O
plaque	O	O
samples	O	O
,	O	O
especially	O	O
that	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

VSC	O	O
concentration	O	O
showed	O	O
the	O	O
most	O	O
significant	O	O
association	O	O
with	O	O
colonization	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
in	O	O
both	O	O
tongue	O	O
coating	O	O
and	O	O
dental	O	O
plaque	O	O
.	O	O

Logistic	O	O
regression	O	O
analysis	O	O
demonstrated	O	O
that	O	O
the	O	O
adjusted	O	O
partial	O	O
correlation	O	O
coefficient	O	O
[	O	O
Exp	O	O
(	O	O
B	O	O
)	O	O
]	O	O
values	O	O
for	O	O
VSC	O	O
concentration	O	O
with	O	O
the	O	O
colonization	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
and	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
in	O	O
dental	O	O
plaque	O	O
were	O	O
135	O	O
,	O	O
35.4	O	O
and	O	O
10.4	O	O
,	O	O
respectively	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
smoking	O	O
habit	O	O
was	O	O
also	O	O
shown	O	O
to	O	O
be	O	O
a	O	O
significant	O	O
variable	O	O
in	O	O
regression	O	O
models	O	O
[	O	O
Exp	O	O
(	O	O
B	O	O
)	O	O
=6.19	O	O
,	O	O
8.92	O	O
and	O	O
2.53	O	O
,	O	O
respectively	O	O
]	O	O
.	O	O

Therefore	O	O
,	O	O
receiver	O	O
operating	O	O
characteristic	O	O
analysis	O	O
was	O	O
performed	O	O
to	O	O
predict	O	O
the	O	O
colonization	O	O
of	O	O
periodontal	O	O
bacteria	O	O
in	O	O
dental	O	O
plaque	O	O
in	O	O
the	O	O
subjects	O	O
divided	O	O
by	O	O
smoking	O	O
habit	O	O
.	O	O

Based	O	O
on	O	O
our	O	O
results	O	O
,	O	O
we	O	O
found	O	O
cut-off	O	O
values	O	O
that	O	O
indicated	O	O
likelihood	O	O
ratios	O	O
(	O	O
LR	O	O
)	O	O
within	O	O
the	O	O
efficient	O	O
range	O	O
for	O	O
positive	O	O
findings	O	O
in	O	O
both	O	O
groups	O	O
.	O	O

The	O	O
present	O	O
results	O	O
demonstrated	O	O
that	O	O
measurement	O	O
of	O	O
VSC	O	O
concentration	O	O
in	O	O
mouth	O	O
air	O	O
is	O	O
a	O	O
useful	O	O
method	O	O
to	O	O
predict	O	O
the	O	O
presence	O	O
of	O	O
colonization	O	O
of	O	O
some	O	O
periodontopathic	O	O
bacteria	O	O
in	O	O
dental	O	O
plaque	O	O
.	O	O

Numerous	O	O
publications	O	O
have	O	O
reported	O	O
the	O	O
presence	O	O
of	O	O
periodontopathogenic	O	O
bacteria	O	O
in	O	O
peripheral	O	O
and	O	O
central	O	O
vascular	O	O
lesions	O	O
.	O	O

However	O	O
,	O	O
it	O	O
is	O	O
unclear	O	O
how	O	O
this	O	O
bacterial	O	O
translocation	O	O
occurs	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
whether	O	O
periodontopathic	O	O
bacteria	O	O
are	O	O
translocated	O	O
to	O	O
lymph	O	O
nodes	O	O
proximal	O	O
to	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Obtaining	O	O
lymph	O	O
node	O	O
samples	O	O
is	O	O
not	O	O
ethically	O	O
feasible	O	O
unless	O	O
they	O	O
are	O	O
excised	O	O
as	O	O
part	O	O
of	O	O
the	O	O
surgical	O	O
management	O	O
of	O	O
patients	O	O
with	O	O
cancer	O	O
.	O	O

This	O	O
study	O	O
analyzed	O	O
formalin-fixed	O	O
and	O	O
paraffin-embedded	O	O
lymph	O	O
nodes	O	O
,	O	O
histologically	O	O
negative	O	O
for	O	O
cancer	O	O
cell	O	O
invasion	O	O
,	O	O
that	O	O
were	O	O
excised	O	O
from	O	O
66	O	O
patients	O	O
with	O	O
histories	O	O
of	O	O
head	O	O
and	O	O
neck	O	O
cancer	O	O
.	O	O

Real-time	O	O
PCR	O	O
was	O	O
performed	O	O
to	O	O
amplify	O	O
the	O	O
16S	O	O
ribosomal	O	O
DNA	O	O
fragments	O	O
from	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
.	O	O

The	O	O
relationship	O	O
between	O	O
bacterial	O	O
detection	O	O
and	O	O
cancer	O	O
severity	O	O
,	O	O
gender	O	O
,	O	O
and	O	O
the	O	O
use	O	O
of	O	O
anti-cancer	O	O
therapy	O	O
was	O	O
examined	O	O
by	O	O
Fisher	O	O
's	O	O
exact	O	O
test	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
and	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
were	O	O
present	O	O
in	O	O
17	O	O
%	O	O
,	O	O
8	O	O
%	O	O
,	O	O
and	O	O
8	O	O
%	O	O
of	O	O
the	O	O
samples	O	O
of	O	O
submandibular	O	O
and	O	O
submental	O	O
lymph	O	O
nodes	O	O
,	O	O
respectively	O	O
.	O	O

There	O	O
were	O	O
no	O	O
significant	O	O
relationships	O	O
between	O	O
bacterial	O	O
detection	O	O
and	O	O
the	O	O
cancer	O	O
disease	O	O
status	O	O
,	O	O
patient	O	O
gender	O	O
or	O	O
use	O	O
of	O	O
anticancer	O	O
therapy	O	O
.	O	O

According	O	O
to	O	O
these	O	O
data	O	O
,	O	O
it	O	O
appears	O	O
that	O	O
the	O	O
translocation	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
may	O	O
occur	O	O
via	O	O
lymphatic	O	O
drainage	O	O
,	O	O
irrespective	O	O
of	O	O
the	O	O
cancer	O	O
disease	O	O
status	O	O
,	O	O
gender	O	O
or	O	O
anticancer	O	O
therapy	O	O
.	O	O

We	O	O
aim	O	O
to	O	O
develop	O	O
antibacterial	O	O
peptide	O	O
mimics	O	O
resistant	O	O
to	O	O
protease	O	O
degradation	O	O
,	O	O
with	O	O
broad-spectrum	O	O
activity	O	O
at	O	O
sites	O	O
of	O	O
infection	O	O
.	O	O

The	O	O
bactericidal	O	O
activities	O	O
of	O	O
LL-37	O	O
,	O	O
ceragenins	O	O
CSA-13	O	O
,	O	O
CSA-90	O	O
and	O	O
CSA-92	O	O
and	O	O
the	O	O
spermine-conjugated	O	O
dexamethasone	O	O
derivative	O	O
D2S	O	O
were	O	O
evaluated	O	O
using	O	O
MIC	O	O
and	O	O
MBC	O	O
measurements	O	O
.	O	O

Gingival	O	O
fibroblast	O	O
counting	O	O
,	O	O
interleukin-8	O	O
(	O	O
IL-8	O	O
)	O	O
and	O	O
lactate	O	O
dehydrogenase	O	O
(	O	O
LDH	O	O
)	O	O
release	O	O
from	O	O
keratinocytes	O	O
(	O	O
HaCat	O	O
)	O	O
were	O	O
used	O	O
to	O	O
determine	O	O
effects	O	O
on	O	O
cell	O	O
growth	O	O
,	O	O
pro-inflammatory	O	O
response	O	O
and	O	O
toxicity	O	O
.	O	O

All	O	O
tested	O	O
cationic	O	O
lipids	O	O
showed	O	O
stronger	O	O
bactericidal	O	O
activity	O	O
than	O	O
LL-37	O	O
.	O	O

Incubation	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
with	O	O
half	O	O
the	O	O
MIC	O	O
of	O	O
LL-37	O	O
led	O	O
to	O	O
the	O	O
appearance	O	O
of	O	O
bacteria	O	O
resistant	O	O
to	O	O
its	O	O
bactericidal	O	O
effects	O	O
,	O	O
but	O	O
identical	O	O
incubations	O	O
with	O	O
CSA-13	O	O
or	O	O
D2S	O	O
did	O	O
not	O	O
produce	O	O
resistant	O	O
bacteria	O	O
.	O	O

Cathelicidin	O	O
LL-37	O	O
significantly	O	O
increased	O	O
the	O	O
total	O	O
number	O	O
of	O	O
gingival	O	O
fibroblasts	O	O
,	O	O
but	O	O
ceragenins	O	O
and	O	O
D2S	O	O
did	O	O
not	O	O
alter	O	O
gingival	O	O
fibroblast	O	O
growth	O	O
.	O	O

Cationic	O	O
lipids	O	O
showed	O	O
no	O	O
toxicity	O	O
to	O	O
HaCat	O	O
cells	O	O
at	O	O
concentrations	O	O
resulting	O	O
in	O	O
bacterial	O	O
killing	O	O
.	O	O

These	O	O
data	O	O
suggest	O	O
that	O	O
cationic	O	O
lipids	O	O
such	O	O
as	O	O
ceragenins	O	O
warrant	O	O
further	O	O
testing	O	O
as	O	O
potential	O	O
novel	O	O
antibacterial	O	O
agents	O	O
.	O	O

Beta-lactam	O	O
antibiotics	O	O
prescribed	O	O
in	O	O
periodontal	O	O
therapy	O	O
are	O	O
vulnerable	O	O
to	O	O
degradation	O	O
by	O	O
bacterial	O	O
beta-lactamases	O	O
.	O	O

This	O	O
study	O	O
evaluated	O	O
the	O	O
occurrence	O	O
of	O	O
beta-lactamase-positive	B-bacteria	B-bacteria
subgingival	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
chronic	O	O
periodontitis	O	O
subjects	O	O
of	O	O
USA	O	O
origin	O	O
,	O	O
and	O	O
assessed	O	O
their	O	O
in	O	O
vitro	O	O
resistance	O	O
to	O	O
metronidazole	O	O
at	O	O
a	O	O
breakpoint	O	O
concentration	O	O
of	O	O
4	O	O
mug/mL	O	O
.	O	O

Subgingival	O	O
plaque	O	O
specimens	O	O
from	O	O
deep	O	O
periodontal	O	O
pockets	O	O
with	O	O
bleeding	O	O
on	O	O
probing	O	O
were	O	O
removed	O	O
from	O	O
564	O	O
adults	O	O
with	O	O
severe	O	O
chronic	O	O
periodontitis	O	O
before	O	O
treatment	O	O
.	O	O

The	O	O
samples	O	O
were	O	O
transported	O	O
in	O	O
VMGA	O	O
III	O	O
and	O	O
then	O	O
plated	O	O
onto	O	O
:	O	O
(	O	O
i	O	O
)	O	O
nonselective	O	O
enriched	O	O
Brucella	O	O
blood	O	O
agar	O	O
(	O	O
EBBA	O	O
)	O	O
and	O	O
incubated	O	O
anaerobically	O	O
for	O	O
7	O	O
d	O	O
;	O	O
and	O	O
(	O	O
ii	O	O
)	O	O
selective	O	O
trypticase	O	O
soy-bacitracin-vancomycin	O	O
(	O	O
TSBV	O	O
)	O	O
and	O	O
incubated	O	O
for	O	O
3	O	O
d	O	O
in	O	O
air	O	O
+	O	O
5	O	O
%	O	O
CO2	O	O
.	O	O

At	O	O
the	O	O
end	O	O
of	O	O
the	O	O
incubation	O	O
periods	O	O
,	O	O
the	O	O
bacterial	O	O
test	O	O
species	O	O
were	O	O
identified	O	O
and	O	O
quantified	O	O
.	O	O

Specimen	O	O
dilutions	O	O
were	O	O
also	O	O
plated	O	O
onto	O	O
EBBA	O	O
plates	O	O
supplemented	O	O
with	O	O
2	O	O
mug/mL	O	O
of	O	O
amoxicillin	O	O
,	O	O
a	O	O
combination	O	O
of	O	O
2	O	O
mug/mL	O	O
of	O	O
amoxicillin	O	O
plus	O	O
2	O	O
mug/mL	O	O
of	O	O
the	O	O
beta-lactamase	O	O
inhibitor	O	O
clavulanic	O	O
acid	O	O
,	O	O
or	O	O
4	O	O
mug/mL	O	O
of	O	O
metronidazole	O	O
,	O	O
followed	O	O
by	O	O
anaerobic	O	O
incubation	O	O
for	O	O
7	O	O
d.	O	O
Bacterial	O	O
test	O	O
species	O	O
presumptively	O	O
positive	O	O
for	O	O
beta-lactamase	O	O
production	O	O
were	O	O
identified	O	O
by	O	O
growth	O	O
on	O	O
EBBA	O	O
primary	O	O
isolation	O	O
plates	O	O
supplemented	O	O
with	O	O
amoxicillin	O	O
alone	O	O
and	O	O
no	O	O
growth	O	O
on	O	O
EBBA	O	O
primary	O	O
isolation	O	O
plates	O	O
containing	O	O
both	O	O
amoxicillin	O	O
plus	O	O
clavulanic	O	O
acid	O	O
.	O	O

A	O	O
subset	O	O
of	O	O
such	O	O
isolates	O	O
was	O	O
subjected	O	O
to	O	O
nitrocefin-based	O	O
chromogenic	O	O
disk	O	O
testing	O	O
to	O	O
confirm	O	O
the	O	O
presence	O	O
of	O	O
beta-lactamase	O	O
activity	O	O
.	O	O

In	O	O
vitro	O	O
resistance	O	O
to	O	O
4	O	O
mug/mL	O	O
of	O	O
metronidazole	O	O
was	O	O
noted	O	O
when	O	O
growth	O	O
of	O	O
test	O	O
species	O	O
occurred	O	O
on	O	O
metronidazole-supplemented	O	O
EBBA	O	O
culture	O	O
plates	O	O
.	O	O

Two-hundred	O	O
and	O	O
ninety-four	O	O
(	O	O
52.1	O	O
%	O	O
)	O	O
of	O	O
the	O	O
study	O	O
subjects	O	O
yielded	O	O
beta-lactamase-producing	O	O
subgingival	O	O
bacterial	O	O
test	O	O
species	O	O
,	O	O
with	O	O
Prevotella	B-bacteria	B-bacteria
intermedia/nigrescens	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
other	O	O
Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
most	O	O
frequently	O	O
identified	O	O
as	O	O
beta-lactamase-producing	O	O
organisms	O	O
.	O	O

Of	O	O
the	O	O
beta-lactamase-producing	O	O
bacterial	O	O
test	O	O
species	O	O
strains	O	O
recovered	O	O
,	O	O
98.9	O	O
%	O	O
were	O	O
susceptible	O	O
in	O	O
vitro	O	O
to	O	O
metronidazole	O	O
at	O	O
4	O	O
mug/mL	O	O
.	O	O

The	O	O
occurrence	O	O
of	O	O
beta-lactamase-positive	B-bacteria	B-bacteria
subgingival	I-bacteria	I-bacteria
bacterial	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
in	O	O
more	O	O
than	O	O
half	O	O
of	O	O
the	O	O
subjects	O	O
with	O	O
severe	O	O
chronic	O	O
periodontitis	O	O
raises	O	O
questions	O	O
about	O	O
the	O	O
therapeutic	O	O
potential	O	O
of	O	O
single-drug	O	O
regimens	O	O
with	O	O
beta-lactam	O	O
antibiotics	O	O
in	O	O
periodontal	O	O
therapy	O	O
.	O	O

The	O	O
in	O	O
vitro	O	O
effectiveness	O	O
of	O	O
metronidazole	O	O
against	O	O
nearly	O	O
all	O	O
recovered	O	O
beta-lactamase-producing	O	O
subgingival	O	O
bacterial	O	O
species	O	O
further	O	O
supports	O	O
clinical	O	O
periodontitis	O	O
treatment	O	O
strategies	O	O
involving	O	O
the	O	O
combination	O	O
of	O	O
systemic	O	O
amoxicillin	O	O
plus	O	O
metronidazole	O	O
.	O	O

Circulating	O	O
nitrate	O	O
(	O	O
NO	O	O
(	O	O
3	O	O
)	O	O
(	O	O
-	O	O
)	O	O
)	O	O
,	O	O
derived	O	O
from	O	O
dietary	O	O
sources	O	O
or	O	O
endogenous	O	O
nitric	O	O
oxide	O	O
production	O	O
,	O	O
is	O	O
extracted	O	O
from	O	O
blood	O	O
by	O	O
the	O	O
salivary	O	O
glands	O	O
,	O	O
accumulates	O	O
in	O	O
saliva	O	O
,	O	O
and	O	O
is	O	O
then	O	O
reduced	O	O
to	O	O
nitrite	O	O
(	O	O
NO	O	O
(	O	O
2	O	O
)	O	O
(	O	O
-	O	O
)	O	O
)	O	O
by	O	O
the	O	O
oral	O	O
microflora	O	O
.	O	O

This	O	O
process	O	O
has	O	O
historically	O	O
been	O	O
viewed	O	O
as	O	O
harmful	O	O
,	O	O
because	O	O
nitrite	O	O
can	O	O
promote	O	O
formation	O	O
of	O	O
potentially	O	O
carcinogenic	O	O
N-nitrosamines	O	O
.	O	O

More	O	O
recent	O	O
research	O	O
,	O	O
however	O	O
,	O	O
suggests	O	O
that	O	O
nitrite	O	O
can	O	O
also	O	O
serve	O	O
as	O	O
a	O	O
precursor	O	O
for	O	O
systemic	O	O
generation	O	O
of	O	O
vasodilatory	O	O
nitric	O	O
oxide	O	O
,	O	O
and	O	O
exogenous	O	O
administration	O	O
of	O	O
nitrate	O	O
reduces	O	O
blood	O	O
pressure	O	O
in	O	O
humans	O	O
.	O	O

However	O	O
,	O	O
whether	O	O
oral	O	O
nitrate-reducing	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
participate	O	O
in	O	O
``	O	O
setting	O	O
''	O	O
blood	O	O
pressure	O	O
is	O	O
unknown	O	O
.	O	O

We	O	O
investigated	O	O
whether	O	O
suppression	O	O
of	O	O
the	O	O
oral	O	O
microflora	O	O
affects	O	O
systemic	O	O
nitrite	O	O
levels	O	O
and	O	O
hence	O	O
blood	O	O
pressure	O	O
in	O	O
healthy	O	O
individuals	O	O
.	O	O

We	O	O
measured	O	O
blood	O	O
pressure	O	O
(	O	O
clinic	O	O
,	O	O
home	O	O
,	O	O
and	O	O
24-h	O	O
ambulatory	O	O
)	O	O
in	O	O
19	O	O
healthy	O	O
volunteers	O	O
during	O	O
an	O	O
initial	O	O
7-day	O	O
control	O	O
period	O	O
followed	O	O
by	O	O
a	O	O
7-day	O	O
treatment	O	O
period	O	O
with	O	O
a	O	O
chlorhexidine-based	O	O
antiseptic	O	O
mouthwash	O	O
.	O	O

Oral	O	O
nitrate-reducing	O	O
capacity	O	O
and	O	O
nitrite	O	O
levels	O	O
were	O	O
measured	O	O
after	O	O
each	O	O
study	O	O
period	O	O
.	O	O

Antiseptic	O	O
mouthwash	O	O
treatment	O	O
reduced	O	O
oral	O	O
nitrite	O	O
production	O	O
by	O	O
90	O	O
%	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
and	O	O
plasma	O	O
nitrite	O	O
levels	O	O
by	O	O
25	O	O
%	O	O
(	O	O
p	O	O
=	O	O
0.001	O	O
)	O	O
compared	O	O
to	O	O
the	O	O
control	O	O
period	O	O
.	O	O

Systolic	O	O
and	O	O
diastolic	O	O
blood	O	O
pressure	O	O
increased	O	O
by	O	O
2-3	O	O
.5mmHg	O	O
,	O	O
increases	O	O
correlated	O	O
to	O	O
a	O	O
decrease	O	O
in	O	O
circulating	O	O
nitrite	O	O
concentrations	O	O
(	O	O
r	O	O
(	O	O
2	O	O
)	O	O
=	O	O
0.56	O	O
,	O	O
p	O	O
=	O	O
0.002	O	O
)	O	O
.	O	O

The	O	O
blood	O	O
pressure	O	O
effect	O	O
appeared	O	O
within	O	O
1	O	O
day	O	O
of	O	O
disruption	O	O
of	O	O
the	O	O
oral	O	O
microflora	O	O
and	O	O
was	O	O
sustained	O	O
during	O	O
the	O	O
7-day	O	O
mouthwash	O	O
intervention	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
recycling	O	O
of	O	O
endogenous	O	O
nitrate	O	O
by	O	O
oral	O	O
bacteria	O	O
plays	O	O
an	O	O
important	O	O
role	O	O
in	O	O
determination	O	O
of	O	O
plasma	O	O
nitrite	O	O
levels	O	O
and	O	O
thereby	O	O
in	O	O
the	O	O
physiological	O	O
control	O	O
of	O	O
blood	O	O
pressure	O	O
.	O	O

The	O	O
human	O	O
mouth	O	O
harbours	O	O
one	O	O
of	O	O
the	O	O
most	O	O
diverse	O	O
microbiomes	O	O
in	O	O
the	O	O
human	O	O
body	O	O
,	O	O
including	O	O
viruses	O	O
,	O	O
fungi	O	O
,	O	O
protozoa	O	O
,	O	O
archaea	O	O
and	O	O
bacteria	O	O
.	O	O

The	O	O
bacteria	O	O
are	O	O
responsible	O	O
for	O	O
the	O	O
two	O	O
commonest	O	O
bacterial	O	O
diseases	O	O
of	O	O
man	O	O
:	O	O
dental	O	O
caries	O	O
(	O	O
tooth	O	O
decay	O	O
)	O	O
and	O	O
the	O	O
periodontal	O	O
(	O	O
gum	O	O
)	O	O
diseases	O	O
.	O	O

Archaea	O	O
are	O	O
restricted	O	O
to	O	O
a	O	O
small	O	O
number	O	O
of	O	O
species	O	O
of	O	O
methanogens	O	O
while	O	O
around	O	O
1000	O	O
bacterial	O	O
species	O	O
have	O	O
been	O	O
found	O	O
,	O	O
with	O	O
representatives	O	O
from	O	O
the	O	O
phyla	B-bacteria	B-bacteria
Actinobacteria	E-bacteria	I-bacteria
,	O	O
Bacteroidetes	B-bacteria	B-bacteria
,	O	O
Firmicutes	B-bacteria	B-bacteria
,	O	O
Proteobacteria	B-bacteria	B-bacteria
,	O	O
Spirochaetes	B-bacteria	B-bacteria
,	O	O
Synergistetes	B-bacteria	B-bacteria
and	O	O
Tenericutes	B-bacteria	B-bacteria
and	O	O
the	O	O
uncultured	O	O
divisions	O	O
GN02	O	O
,	O	O
SR1	O	O
and	O	O
TM7	O	O
.	O	O

Around	O	O
half	O	O
of	O	O
oral	O	O
bacteria	O	O
are	O	O
as	O	O
yet	O	O
uncultured	O	O
and	O	O
culture-independent	O	O
methods	O	O
have	O	O
been	O	O
successfully	O	O
used	O	O
to	O	O
comprehensively	O	O
describe	O	O
the	O	O
oral	O	O
bacterial	O	O
community	O	O
.	O	O

The	O	O
human	O	O
oral	O	O
microbiome	O	O
database	O	O
(	O	O
HOMD	O	O
,	O	O
www.homd.org	O	O
)	O	O
provides	O	O
a	O	O
comprehensive	O	O
resource	O	O
consisting	O	O
of	O	O
descriptions	O	O
of	O	O
oral	O	O
bacterial	O	O
taxa	O	O
,	O	O
a	O	O
16S	O	O
rRNA	O	O
identification	O	O
tool	O	O
and	O	O
a	O	O
repository	O	O
of	O	O
oral	O	O
bacterial	O	O
genome	O	O
sequences	O	O
.	O	O

Individuals	O	O
'	O	O
oral	O	O
microbiomes	O	O
are	O	O
highly	O	O
specific	O	O
at	O	O
the	O	O
species	O	O
level	O	O
,	O	O
although	O	O
overall	O	O
the	O	O
human	O	O
oral	O	O
microbiome	O	O
shows	O	O
few	O	O
geographical	O	O
differences	O	O
.	O	O

Although	O	O
caries	O	O
and	O	O
periodontitis	O	O
are	O	O
clearly	O	O
bacterial	O	O
diseases	O	O
,	O	O
they	O	O
are	O	O
not	O	O
infectious	O	O
diseases	O	O
in	O	O
the	O	O
classical	O	O
sense	O	O
because	O	O
they	O	O
result	O	O
from	O	O
a	O	O
complex	O	O
interaction	O	O
between	O	O
the	O	O
commensal	O	O
microbiota	O	O
,	O	O
host	O	O
susceptibility	O	O
and	O	O
environmental	O	O
factors	O	O
such	O	O
as	O	O
diet	O	O
and	O	O
smoking	O	O
.	O	O

Periodontitis	O	O
,	O	O
in	O	O
particular	O	O
,	O	O
appears	O	O
to	O	O
result	O	O
from	O	O
an	O	O
inappropriate	O	O
inflammatory	O	O
reaction	O	O
to	O	O
the	O	O
normal	O	O
microbiota	O	O
,	O	O
exacerbated	O	O
by	O	O
the	O	O
presence	O	O
of	O	O
some	O	O
disease-associated	O	O
bacterial	O	O
species	O	O
.	O	O

In	O	O
functional	O	O
terms	O	O
,	O	O
there	O	O
appears	O	O
to	O	O
considerable	O	O
redundancy	O	O
among	O	O
the	O	O
oral	O	O
microbiota	O	O
and	O	O
a	O	O
focus	O	O
on	O	O
functional	O	O
rather	O	O
than	O	O
phylogenetic	O	O
diversity	O	O
may	O	O
be	O	O
required	O	O
in	O	O
order	O	O
to	O	O
fully	O	O
understand	O	O
host-microbiome	O	O
interactions	O	O
.	O	O

Lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
LAB	B-bacteria	B-bacteria
)	O	O
have	O	O
become	O	O
increasingly	O	O
studied	O	O
over	O	O
the	O	O
last	O	O
two	O	O
decades	O	O
as	O	O
potential	O	O
delivery	O	O
systems	O	O
for	O	O
various	O	O
biological	O	O
molecules	O	O
to	O	O
the	O	O
gastrointestinal	O	O
tract	O	O
.	O	O

This	O	O
article	O	O
presents	O	O
an	O	O
overview	O	O
of	O	O
characteristics	O	O
of	O	O
LAB	B-bacteria	B-bacteria
as	O	O
delivery	O	O
systems	O	O
and	O	O
of	O	O
the	O	O
applications	O	O
which	O	O
have	O	O
already	O	O
been	O	O
developed	O	O
.	O	O

The	O	O
majority	O	O
of	O	O
LAB	B-bacteria	B-bacteria
strains	O	O
are	O	O
able	O	O
to	O	O
survive	O	O
the	O	O
intestinal	O	O
passage	O	O
and	O	O
some	O	O
are	O	O
also	O	O
able	O	O
to	O	O
persist	O	O
and	O	O
colonize	O	O
the	O	O
intestine	O	O
.	O	O

Several	O	O
strains	O	O
were	O	O
in	O	O
fact	O	O
described	O	O
as	O	O
members	O	O
of	O	O
the	O	O
human	O	O
commensal	O	O
flora	O	O
.	O	O

They	O	O
can	O	O
interact	O	O
with	O	O
their	O	O
host	O	O
and	O	O
are	O	O
able	O	O
to	O	O
deliver	O	O
large	O	O
molecular	O	O
weight	O	O
biomolecules	O	O
across	O	O
the	O	O
epithelium	O	O
via	O	O
M-cells	O	O
or	O	O
dendritic	O	O
cells	O	O
.	O	O

The	O	O
most	O	O
widely	O	O
applied	O	O
LAB	B-bacteria	B-bacteria
species	O	O
has	O	O
been	O	O
Lactococcus	B-bacteria	B-bacteria
lactis	E-bacteria	I-bacteria
;	O	O
however	O	O
species	O	O
from	O	O
genus	O	O
Lactobacillus	B-bacteria	B-bacteria
are	O	O
gaining	O	O
popularity	O	O
and	O	O
the	O	O
first	O	O
examples	O	O
from	O	O
genus	B-bacteria	B-bacteria
Bifidobacterium	E-bacteria	I-bacteria
are	O	O
starting	O	O
to	O	O
emerge	O	O
.	O	O

Bacteria	O	O
are	O	O
mostly	O	O
applied	O	O
live	O	O
and	O	O
enable	O	O
continuous	O	O
delivery	O	O
of	O	O
the	O	O
biomolecules	O	O
.	O	O

However	O	O
,	O	O
killed	O	O
bacteria	O	O
(	O	O
e.g	O	O
.	O	O

gram-positive	B-bacteria	B-bacteria
enhancer	I-bacteria	I-bacteria
matrix	E-bacteria	I-bacteria
)	O	O
,	O	O
with	O	O
bound	O	O
biomolecules	O	O
or	O	O
as	O	O
adjuvants	O	O
,	O	O
are	O	O
also	O	O
being	O	O
developed	O	O
.	O	O

The	O	O
techniques	O	O
for	O	O
genetic	O	O
modification	O	O
of	O	O
LAB	B-bacteria	B-bacteria
are	O	O
well	O	O
known	O	O
.	O	O

This	O	O
review	O	O
focuses	O	O
on	O	O
the	O	O
delivery	O	O
of	O	O
recombinant	O	O
proteins	O	O
and	O	O
DNA	O	O
,	O	O
which	O	O
can	O	O
cause	O	O
either	O	O
local	O	O
or	O	O
systemic	O	O
effects	O	O
.	O	O

We	O	O
divide	O	O
recombinant	O	O
proteins	O	O
into	O	O
antigens	O	O
and	O	O
therapeutic	O	O
proteins	O	O
.	O	O

Delivery	O	O
of	O	O
antigens	O	O
for	O	O
the	O	O
purpose	O	O
of	O	O
vaccination	O	O
represents	O	O
the	O	O
most	O	O
abundant	O	O
application	O	O
with	O	O
numerous	O	O
successful	O	O
demonstrations	O	O
of	O	O
the	O	O
efficacy	O	O
on	O	O
the	O	O
animal	O	O
model	O	O
.	O	O

Therapeutic	O	O
proteins	O	O
have	O	O
mostly	O	O
been	O	O
developed	O	O
for	O	O
the	O	O
treatment	O	O
of	O	O
the	O	O
inflammatory	O	O
bowel	O	O
disease	O	O
,	O	O
by	O	O
the	O	O
delivery	O	O
of	O	O
anti-inflammatory	O	O
cytokines	O	O
,	O	O
or	O	O
downregulation	O	O
of	O	O
proinflammatory	O	O
cytokines	O	O
.	O	O

Delivery	O	O
of	O	O
allergens	O	O
for	O	O
the	O	O
modulation	O	O
of	O	O
allergic	O	O
disorders	O	O
represents	O	O
the	O	O
second	O	O
most	O	O
popular	O	O
application	O	O
of	O	O
therapeutic	O	O
proteins	O	O
.	O	O

The	O	O
delivery	O	O
of	O	O
DNA	O	O
by	O	O
LAB	B-bacteria	B-bacteria
was	O	O
demonstrated	O	O
and	O	O
offers	O	O
exciting	O	O
opportunities	O	O
,	O	O
especially	O	O
as	O	O
a	O	O
vaccine	O	O
.	O	O

New	O	O
discoveries	O	O
may	O	O
eventually	O	O
lead	O	O
to	O	O
the	O	O
transition	O	O
of	O	O
LAB	B-bacteria	B-bacteria
as	O	O
delivery	O	O
systems	O	O
in	O	O
clinical	O	O
practice	O	O
.	O	O

Efficient	O	O
characterization	O	O
of	O	O
the	O	O
canine	O	O
oral	O	O
microbiome	O	O
is	O	O
critical	O	O
for	O	O
understanding	O	O
the	O	O
role	O	O
of	O	O
oral	O	O
bacteria	O	O
in	O	O
health	O	O
and	O	O
for	O	O
providing	O	O
insight	O	O
into	O	O
early	O	O
diagnosis	O	O
and	O	O
treatment	O	O
strategies	O	O
against	O	O
periodontal	O	O
disease	O	O
.	O	O

To	O	O
date	O	O
,	O	O
characterization	O	O
has	O	O
been	O	O
limited	O	O
to	O	O
cloning-based	O	O
sequencing	O	O
and	O	O
conventional	O	O
culture-based	O	O
studies	O	O
,	O	O
which	O	O
generally	O	O
underestimate	O	O
community	O	O
diversity	O	O
as	O	O
a	O	O
result	O	O
of	O	O
inherent	O	O
biases	O	O
in	O	O
their	O	O
methodologies	O	O
.	O	O

Pyrosequencing	O	O
,	O	O
a	O	O
cloning-	O	O
and	O	O
culture-independent	O	O
sequencing	O	O
approach	O	O
,	O	O
eliminates	O	O
these	O	O
elements	O	O
of	O	O
bias	O	O
from	O	O
the	O	O
analysis	O	O
and	O	O
enables	O	O
extensive	O	O
sequencing	O	O
of	O	O
microbial	O	O
populations	O	O
.	O	O

In	O	O
this	O	O
report	O	O
,	O	O
pyrosequencing	O	O
of	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
was	O	O
used	O	O
to	O	O
examine	O	O
oral	O	O
samples	O	O
from	O	O
six	O	O
healthy	O	O
dogs	O	O
in	O	O
an	O	O
effort	O	O
to	O	O
determine	O	O
community	O	O
membership	O	O
,	O	O
diversity	O	O
,	O	O
and	O	O
zoonotic	O	O
implications	O	O
.	O	O

Pyrosequencing	O	O
revealed	O	O
a	O	O
mean	O	O
(	O	O
SD	O	O
)	O	O
of	O	O
226	O	O
(	O	O
59	O	O
)	O	O
operational	O	O
taxonomic	O	O
units	O	O
(	O	O
OTUs	O	O
,	O	O
97	O	O
%	O	O
similarity	O	O
)	O	O
,	O	O
representing	O	O
181	O	O
genera	O	O
from	O	O
13	O	O
bacterial	O	O
phyla	O	O
.	O	O

The	O	O
phyla	B-bacteria	B-bacteria
Bacteroidetes	E-bacteria	I-bacteria
(	O	O
60.2	O	O
%	O	O
)	O	O
,	O	O
Proteobacteria	B-bacteria	B-bacteria
(	O	O
20.8	O	O
%	O	O
)	O	O
,	O	O
Firmicutes	B-bacteria	B-bacteria
(	O	O
11.4	O	O
%	O	O
)	O	O
,	O	O
Fusobacteria	B-bacteria	B-bacteria
(	O	O
4.7	O	O
%	O	O
)	O	O
,	O	O
and	O	O
Spirochaetes	B-bacteria	B-bacteria
(	O	O
1.7	O	O
%	O	O
)	O	O
predominated	O	O
.	O	O

The	O	O
most	O	O
commonly	O	O
identified	O	O
genera	O	O
were	O	O
Porphyromonas	B-bacteria	B-bacteria
(	O	O
39.2	O	O
%	O	O
of	O	O
sequences	O	O
)	O	O
,	O	O
Fusobacterium	B-bacteria	B-bacteria
(	O	O
4.5	O	O
%	O	O
)	O	O
,	O	O
Capnocytophaga	B-bacteria	B-bacteria
(	O	O
3.8	O	O
%	O	O
)	O	O
,	O	O
Derxia	B-bacteria	B-bacteria
(	O	O
3.7	O	O
%	O	O
)	O	O
,	O	O
Moraxella	B-bacteria	B-bacteria
(	O	O
3.3	O	O
%	O	O
)	O	O
,	O	O
and	O	O
Bergeyella	B-bacteria	B-bacteria
(	O	O
2.7	O	O
%	O	O
)	O	O
.	O	O

Fifty-six	O	O
OTUs	O	O
,	O	O
corresponding	O	O
to	O	O
38	O	O
unique	O	O
genus-level	O	O
identifications	O	O
,	O	O
were	O	O
present	O	O
in	O	O
all	O	O
samples	O	O
,	O	O
which	O	O
supports	O	O
the	O	O
concept	O	O
of	O	O
a	O	O
stable	O	O
core	O	O
microbiome	O	O
existing	O	O
between	O	O
healthy	O	O
dogs	O	O
.	O	O

Potentially	O	O
zoonotic	O	O
and	O	O
periodontal	O	O
bacteria	O	O
were	O	O
detected	O	O
in	O	O
all	O	O
dogs	O	O
,	O	O
and	O	O
highlights	O	O
the	O	O
zoonotic	O	O
and	O	O
disease	O	O
potential	O	O
of	O	O
the	O	O
oral	O	O
microflora	O	O
.	O	O

Results	O	O
suggest	O	O
that	O	O
the	O	O
canine	O	O
oral	O	O
cavity	O	O
harbors	O	O
a	O	O
rich	O	O
and	O	O
diverse	O	O
bacterial	O	O
community	O	O
,	O	O
and	O	O
exceeds	O	O
estimates	O	O
by	O	O
previous	O	O
culture-	O	O
and	O	O
cloning-based	O	O
studies	O	O
.	O	O

Children	O	O
born	O	O
extremely	O	O
preterm	O	O
often	O	O
suffer	O	O
from	O	O
medical	O	O
complications	O	O
that	O	O
have	O	O
been	O	O
shown	O	O
to	O	O
affect	O	O
their	O	O
oral	O	O
health	O	O
as	O	O
toddlers	O	O
and	O	O
school	O	O
children	O	O
.	O	O
The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
oral	O	O
health	O	O
and	O	O
possible	O	O
risk	O	O
indicators	O	O
for	O	O
poor	O	O
oral	O	O
health	O	O
in	O	O
adolescents	O	O
born	O	O
extremely	O	O
preterm	O	O
compared	O	O
with	O	O
a	O	O
control	O	O
group	O	O
and	O	O
relate	O	O
the	O	O
findings	O	O
to	O	O
medical	O	O
diagnoses	O	O
at	O	O
the	O	O
clinical	O	O
examination	O	O
.	O	O

Also	O	O
in	O	O
the	O	O
same	O	O
groups	O	O
,	O	O
compare	O	O
the	O	O
frequency	O	O
of	O	O
mineralization	O	O
disturbances	O	O
and	O	O
its	O	O
relation	O	O
to	O	O
postnatal	O	O
morbidity	O	O
and	O	O
treatments	O	O
.	O	O

The	O	O
medical	O	O
records	O	O
postnatally	O	O
,	O	O
was	O	O
noted	O	O
in	O	O
45	O	O
extremely	O	O
preterm	O	O
infants	O	O
with	O	O
a	O	O
gestational	O	O
age	O	O
(	O	O
GA	O	O
)	O	O
of	O	O
<	O	O
29	O	O
weeks	O	O
,	O	O
at	O	O
12	O	O
-	O	O
16	O	O
years	O	O
of	O	O
age	O	O
and	O	O
in	O	O
age	O	O
and	O	O
gender	O	O
matched	O	O
fullterm	O	O
controls	O	O
with	O	O
37-43	O	O
weeks	O	O
GA.	O	O
A	O	O
dental	O	O
clinical	O	O
examination	O	O
was	O	O
performed	O	O
including	O	O
a	O	O
salivary	O	O
examination	O	O
.	O	O

Medical	O	O
diagnoses	O	O
were	O	O
noted	O	O
at	O	O
the	O	O
time	O	O
of	O	O
the	O	O
survey	O	O
.	O	O

Data	O	O
from	O	O
the	O	O
patient	O	O
dental	O	O
records	O	O
at	O	O
3	O	O
,	O	O
6	O	O
,	O	O
and	O	O
9	O	O
years	O	O
of	O	O
age	O	O
was	O	O
compiled	O	O
.	O	O

The	O	O
findings	O	O
were	O	O
related	O	O
to	O	O
gestational	O	O
age	O	O
,	O	O
birth	O	O
weight	O	O
,	O	O
neonatal	O	O
and	O	O
postnatal	O	O
medical	O	O
diagnoses	O	O
treatments	O	O
and	O	O
medical	O	O
diagnoses	O	O
at	O	O
the	O	O
clinical	O	O
examination	O	O
.	O	O

The	O	O
result	O	O
showed	O	O
that	O	O
the	O	O
prevalence	O	O
of	O	O
plaque	O	O
,	O	O
gingivitis	O	O
and	O	O
the	O	O
occurrence	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
were	O	O
higher	O	O
among	O	O
adolescents	O	O
born	O	O
extremely	O	O
preterm	O	O
compared	O	O
to	O	O
matched	O	O
controls	O	O
,	O	O
and	O	O
the	O	O
saliva	O	O
secretion	O	O
was	O	O
lower	O	O
in	O	O
the	O	O
extremely	O	O
preterm	O	O
infants	O	O
.	O	O

The	O	O
frequency	O	O
of	O	O
caries	O	O
did	O	O
not	O	O
differ	O	O
between	O	O
the	O	O
groups	O	O
.	O	O

Mineralization	O	O
disturbances	O	O
were	O	O
more	O	O
frequent	O	O
in	O	O
the	O	O
primary	O	O
dentition	O	O
and	O	O
more	O	O
severe	O	O
in	O	O
the	O	O
permanent	O	O
dentition	O	O
among	O	O
the	O	O
children	O	O
born	O	O
extremely	O	O
preterm	O	O
.	O	O

No	O	O
association	O	O
between	O	O
dental	O	O
pathology	O	O
,	O	O
neonatal	O	O
and	O	O
postnatal	O	O
morbidity	O	O
and	O	O
treatments	O	O
was	O	O
found	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
adolescents	O	O
born	O	O
extremely	O	O
preterm	O	O
have	O	O
an	O	O
increased	O	O
number	O	O
of	O	O
risk	O	O
indicators	O	O
for	O	O
a	O	O
poorer	O	O
oral	O	O
outcome	O	O
compared	O	O
with	O	O
the	O	O
controls	O	O
and	O	O
more	O	O
severe	O	O
mineralization	O	O
disturbances	O	O
.	O	O

These	O	O
findings	O	O
may	O	O
imply	O	O
an	O	O
increased	O	O
vulnerability	O	O
for	O	O
poorer	O	O
oral	O	O
health	O	O
later	O	O
in	O	O
life	O	O
.	O	O

The	O	O
occurrence	O	O
of	O	O
bacteria	O	O
belonging	O	O
to	O	O
Pasteurellaceae	B-bacteria	B-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
captive	O	O
marine	O	O
mammals	O	O
was	O	O
investigated	O	O
using	O	O
culture	O	O
and	O	O
subsequent	O	O
geno-	O	O
and	O	O
phenotypic	O	O
characterization	O	O
and	O	O
phylogenetic	O	O
analyses	O	O
.	O	O

A	O	O
total	O	O
of	O	O
89	O	O
bacterial	O	O
isolates	O	O
from	O	O
pinnipeds	O	O
tentatively	O	O
classified	O	O
with	O	O
the	O	O
family	O	O
Pasteurellaceae	B-bacteria	B-bacteria
were	O	O
further	O	O
characterized	O	O
by	O	O
phylogenetic	O	O
analysis	O	O
of	O	O
rpoB	O	O
gene	O	O
sequences	O	O
,	O	O
which	O	O
showed	O	O
that	O	O
the	O	O
isolates	O	O
investigated	O	O
formed	O	O
five	O	O
distinct	O	O
groups	O	O
.	O	O

Four	O	O
strains	O	O
from	O	O
California	O	O
sea	O	O
lions	O	O
(	O	O
Zalophus	O	O
californianus	O	O
)	O	O
made	O	O
up	O	O
group	O	O
I	O	O
,	O	O
which	O	O
was	O	O
classified	O	O
with	O	O
Pasteurella	B-bacteria	B-bacteria
canis	E-bacteria	I-bacteria
.	O	O

Group	O	O
II	O	O
comprised	O	O
four	O	O
strains	O	O
from	O	O
harbor	O	O
seals	O	O
(	O	O
Phoca	O	O
vitulina	O	O
)	O	O
and	O	O
grey	O	O
seals	O	O
(	O	O
Halichoerus	O	O
grypus	O	O
)	O	O
classified	O	O
with	O	O
Pasteurella	B-bacteria	B-bacteria
stomatis	E-bacteria	I-bacteria
.	O	O

Group	O	O
III	O	O
consisted	O	O
of	O	O
28	O	O
strains	O	O
,	O	O
isolated	O	O
from	O	O
harbor	O	O
and	O	O
gray	O	O
seals	O	O
and	O	O
represented	O	O
Bisgaardia	B-bacteria	B-bacteria
genomospecies	I-bacteria	I-bacteria
1	E-bacteria	I-bacteria
.	O	O

Two	O	O
strains	O	O
from	O	O
a	O	O
harbor	O	O
and	O	O
a	O	O
grey	O	O
seal	O	O
,	O	O
group	O	O
IV	O	O
,	O	O
were	O	O
classified	O	O
with	O	O
Bisgaardia	B-bacteria	B-bacteria
hudsonensis	E-bacteria	I-bacteria
.	O	O

Fifty-two	O	O
strains	O	O
from	O	O
northern	O	O
fur	O	O
seals	O	O
(	O	O
Callorhinus	O	O
ursinus	O	O
)	O	O
,	O	O
walruses	O	O
(	O	O
Odobenus	O	O
rosmarus	O	O
)	O	O
,	O	O
and	O	O
California	O	O
and	O	O
Steller	O	O
sea	O	O
lions	O	O
(	O	O
Eumetopias	O	O
jubatus	O	O
)	O	O
formed	O	O
group	O	O
V	O	O
and	O	O
represented	O	O
Otariodibacter	O	O
oris	O	O
.	O	O

No	O	O
Pasteurellaceae	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
were	O	O
obtained	O	O
from	O	O
cetaceans	O	O
,	O	O
but	O	O
Pasteurellaceae	B-bacteria	B-bacteria
were	O	O
isolated	O	O
from	O	O
all	O	O
sampled	O	O
pinnipeds	O	O
.	O	O

On	O	O
the	O	O
basis	O	O
of	O	O
these	O	O
results	O	O
,	O	O
it	O	O
is	O	O
very	O	O
likely	O	O
that	O	O
Pasteurellaceae	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
represent	O	O
a	O	O
part	O	O
of	O	O
the	O	O
normal	O	O
oral	O	O
flora	O	O
in	O	O
pinnipeds	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
:	O	O
(	O	O
i	O	O
)	O	O
to	O	O
evaluate	O	O
whether	O	O
an	O	O
endodontic	O	O
pathology	O	O
on	O	O
the	O	O
extracted	O	O
tooth	O	O
or	O	O
adjacent	O	O
teeth	O	O
of	O	O
an	O	O
implant	O	O
site	O	O
has	O	O
an	O	O
influence	O	O
on	O	O
the	O	O
emergence	O	O
of	O	O
a	O	O
periapical	O	O
lesion	O	O
,	O	O
(	O	O
ii	O	O
)	O	O
to	O	O
retrospectively	O	O
analyse	O	O
the	O	O
outcome	O	O
of	O	O
different	O	O
treatment	O	O
strategies	O	O
,	O	O
(	O	O
iii	O	O
)	O	O
to	O	O
determine	O	O
which	O	O
bacteria	O	O
were	O	O
present	O	O
in	O	O
periapical	O	O
lesions	O	O
.	O	O

The	O	O
endodontic	O	O
status	O	O
of	O	O
the	O	O
tooth	O	O
at	O	O
the	O	O
implant	O	O
site	O	O
and	O	O
the	O	O
adjacent	O	O
teeth	O	O
was	O	O
explored	O	O
and	O	O
linked	O	O
to	O	O
the	O	O
periapical	O	O
status	O	O
of	O	O
the	O	O
implant	O	O
.	O	O

For	O	O
all	O	O
the	O	O
lesions	O	O
treated	O	O
since	O	O
2000	O	O
,	O	O
their	O	O
survival	O	O
was	O	O
assessed	O	O
.	O	O

Finally	O	O
,	O	O
microbial	O	O
samples	O	O
(	O	O
culturing	O	O
)	O	O
from	O	O
the	O	O
periapical	O	O
lesions	O	O
,	O	O
were	O	O
analysed	O	O
.	O	O

If	O	O
an	O	O
endodontic	O	O
treatment	O	O
or	O	O
a	O	O
periapical	O	O
lesion	O	O
at	O	O
the	O	O
apex	O	O
of	O	O
a	O	O
tooth	O	O
is	O	O
present	O	O
,	O	O
a	O	O
periapical	O	O
lesion	O	O
around	O	O
the	O	O
implant	O	O
can	O	O
be	O	O
detected	O	O
in	O	O
8.2	O	O
%	O	O
up	O	O
to	O	O
13.6	O	O
%	O	O
(	O	O
OR	O	O
7.2	O	O
)	O	O
.	O	O

For	O	O
periapical	O	O
pathology	O	O
at	O	O
the	O	O
adjacent	O	O
teeth	O	O
,	O	O
the	O	O
percentage	O	O
rises	O	O
to	O	O
25	O	O
%	O	O
(	O	O
OR	O	O
8.0	O	O
)	O	O
.	O	O

The	O	O
best	O	O
treatment	O	O
option	O	O
could	O	O
not	O	O
be	O	O
found	O	O
.	O	O

Bacteria	O	O
were	O	O
found	O	O
in	O	O
9/21	O	O
lesions	O	O
.	O	O

The	O	O
most	O	O
prominent	O	O
species	O	O
was	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

When	O	O
an	O	O
endodontic	O	O
pathology	O	O
is	O	O
present	O	O
on	O	O
the	O	O
extracted	O	O
or	O	O
neighbouring	O	O
teeth	O	O
,	O	O
it	O	O
is	O	O
significantly	O	O
more	O	O
likely	O	O
that	O	O
a	O	O
periapical	O	O
lesion	O	O
will	O	O
develop	O	O
around	O	O
a	O	O
future	O	O
implant	O	O
.	O	O

Feline	O	O
chronic	O	O
gingivostomatitis	O	O
(	O	O
FCGS	O	O
)	O	O
is	O	O
an	O	O
inflammatory	O	O
disease	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
that	O	O
causes	O	O
severe	O	O
pain	O	O
and	O	O
distress	O	O
in	O	O
affected	O	O
cats	O	O
.	O	O

Treatment	O	O
methods	O	O
are	O	O
currently	O	O
very	O	O
limited	O	O
.	O	O

The	O	O
aims	O	O
of	O	O
this	O	O
study	O	O
were	O	O
to	O	O
assess	O	O
the	O	O
feline	O	O
innate	O	O
immune	O	O
response	O	O
by	O	O
investigating	O	O
the	O	O
levels	O	O
of	O	O
cytokine	O	O
and	O	O
Toll-like	O	O
receptor	O	O
(	O	O
TLR	O	O
)	O	O
mRNAs	O	O
in	O	O
tissue	O	O
biopsies	O	O
of	O	O
cats	O	O
with	O	O
and	O	O
without	O	O
FCGS	O	O
,	O	O
and	O	O
to	O	O
relate	O	O
this	O	O
to	O	O
the	O	O
presence	O	O
or	O	O
absence	O	O
of	O	O
putative	O	O
oral	O	O
pathogens	O	O
identified	O	O
previously	O	O
within	O	O
these	O	O
cats	O	O
.	O	O

Mucosal	O	O
biopsies	O	O
were	O	O
collected	O	O
from	O	O
28	O	O
cats	O	O
with	O	O
FCGS	O	O
and	O	O
eight	O	O
healthy	O	O
cats	O	O
.	O	O

The	O	O
levels	O	O
of	O	O
TLR	O	O
(	O	O
TLR2	O	O
,	O	O
TLR3	O	O
,	O	O
TLR4	O	O
,	O	O
TLR7	O	O
,	O	O
TLR9	O	O
)	O	O
and	O	O
cytokine	O	O
(	O	O
IL-1beta	O	O
,	O	O
IL-4	O	O
,	O	O
IL-6	O	O
,	O	O
IL-10	O	O
,	O	O
IL-12	O	O
,	O	O
TNF-alpha	O	O
,	O	O
IFN-gamma	O	O
)	O	O
mRNA	O	O
was	O	O
determined	O	O
using	O	O
quantitative	O	O
PCR	O	O
.	O	O

In	O	O
the	O	O
FCGS	O	O
group	O	O
a	O	O
statistically	O	O
significant	O	O
increase	O	O
was	O	O
seen	O	O
in	O	O
TLR2	O	O
,	O	O
TLR7	O	O
,	O	O
TNF-alpha	O	O
,	O	O
IFN-gamma	O	O
,	O	O
IL-1beta	O	O
and	O	O
IL-6	O	O
mRNA	O	O
levels	O	O
compared	O	O
to	O	O
the	O	O
healthy	O	O
group	O	O
.	O	O

In	O	O
cats	O	O
where	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
was	O	O
present	O	O
,	O	O
statistically	O	O
significant	O	O
increases	O	O
were	O	O
seen	O	O
in	O	O
TLR2	O	O
,	O	O
TLR4	O	O
,	O	O
TLR7	O	O
,	O	O
TLR9	O	O
,	O	O
TNF-alpha	O	O
and	O	O
IL-1beta	O	O
mRNA	O	O
levels	O	O
compared	O	O
to	O	O
cats	O	O
where	O	O
this	O	O
putative	O	O
pathogen	O	O
was	O	O
absent	O	O
.	O	O

Statistically	O	O
significant	O	O
increases	O	O
in	O	O
mRNA	O	O
expression	O	O
were	O	O
also	O	O
seen	O	O
in	O	O
cats	O	O
harbouring	O	O
feline	O	O
calicivirus	O	O
(	O	O
FCV	O	O
)	O	O
(	O	O
TLR2	O	O
,	O	O
IL-1beta	O	O
,	O	O
IL-6	O	O
,	O	O
IFN-gamma	O	O
)	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
circumdentaria	E-bacteria	I-bacteria
(	O	O
TLR2	O	O
,	O	O
TLR3	O	O
)	O	O
compared	O	O
to	O	O
cats	O	O
where	O	O
these	O	O
putative	O	O
pathogens	O	O
were	O	O
absent	O	O
.	O	O

Pasteurella	I-bacteria	I-bacteria
multocida	I-bacteria	I-bacteria
subsp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

multocida	E-bacteria	I-bacteria
and	O	O
Pseudomonas	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

did	O	O
not	O	O
significantly	O	O
alter	O	O
the	O	O
expression	O	O
of	O	O
any	O	O
TLR	O	O
or	O	O
cytokine	O	O
mRNAs	O	O
when	O	O
compared	O	O
to	O	O
animals	O	O
who	O	O
tested	O	O
negative	O	O
for	O	O
these	O	O
species	O	O
,	O	O
while	O	O
cats	O	O
colonised	O	O
with	O	O
P.	B-bacteria	B-bacteria
multocida	I-bacteria	I-bacteria
subsp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

septica	E-bacteria	I-bacteria
demonstrated	O	O
a	O	O
statistically	O	O
significant	O	O
reduction	O	O
in	O	O
the	O	O
expression	O	O
of	O	O
TLR7	O	O
,	O	O
TNF-alpha	O	O
and	O	O
IFN-gamma	O	O
mRNAs	O	O
compared	O	O
to	O	O
cats	O	O
free	O	O
of	O	O
this	O	O
species	O	O
.	O	O

The	O	O
expression	O	O
of	O	O
mRNA	O	O
for	O	O
several	O	O
TLRs	O	O
and	O	O
cytokines	O	O
is	O	O
elevated	O	O
in	O	O
FCGS	O	O
.	O	O

A	O	O
positive	O	O
correlation	O	O
was	O	O
observed	O	O
between	O	O
clinical	O	O
disease	O	O
severity	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
FCV	O	O
(	O	O
p=0.001	O	O
;	O	O
Rho=0.58	O	O
)	O	O
.	O	O

Although	O	O
the	O	O
number	O	O
of	O	O
cats	O	O
harbouring	O	O
T.	O	O
forsythia	O	O
was	O	O
low	O	O
by	O	O
comparison	O	O
,	O	O
80	O	O
%	O	O
of	O	O
samples	O	O
in	O	O
which	O	O
it	O	O
was	O	O
present	O	O
were	O	O
from	O	O
cases	O	O
with	O	O
the	O	O
highest	O	O
clinical	O	O
disease	O	O
severity	O	O
.	O	O

Positive	O	O
correlations	O	O
with	O	O
clinical	O	O
disease	O	O
severity	O	O
were	O	O
seen	O	O
for	O	O
TLR2	O	O
(	O	O
p=0.00086	O	O
)	O	O
,	O	O
TLR7	O	O
(	O	O
p=0.049	O	O
)	O	O
,	O	O
TNF-alpha	O	O
(	O	O
p=0.027	O	O
)	O	O
,	O	O
IFN-gamma	O	O
(	O	O
p=0.0015	O	O
)	O	O
,	O	O
IL-1beta	O	O
(	O	O
p=0.004	O	O
)	O	O
and	O	O
IL-6	O	O
(	O	O
p=0.00001	O	O
)	O	O
mRNAs	O	O
.	O	O

The	O	O
putative	O	O
pathogens	O	O
FCV	O	O
and	O	O
T.	O	O
forsythia	O	O
may	O	O
be	O	O
important	O	O
in	O	O
stimulating	O	O
a	O	O
host	O	O
immune	O	O
response	O	O
to	O	O
FCGS	O	O
and	O	O
may	O	O
play	O	O
a	O	O
role	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
this	O	O
disease	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
compare	O	O
the	O	O
antimicrobial	O	O
activity	O	O
of	O	O
a	O	O
mouth	O	O
rinse	O	O
containing	O	O
chlorhexidine	O	O
and	O	O
cetylpyridinium	O	O
chloride	O	O
(	O	O
MR1	O	O
)	O	O
with	O	O
a	O	O
stannous	O	O
fluoride-based	O	O
mouth	O	O
rinse	O	O
(	O	O
MR2	O	O
)	O	O
in	O	O
vitro	O	O
.	O	O

Samples	O	O
of	O	O
the	O	O
tongues	O	O
from	O	O
10	O	O
subjects	O	O
with	O	O
and	O	O
10	O	O
subjects	O	O
without	O	O
halitosis	O	O
were	O	O
inoculated	O	O
on	O	O
blood	O	O
agar	O	O
plates	O	O
.	O	O

The	O	O
agar	O	O
was	O	O
perforated	O	O
,	O	O
and	O	O
the	O	O
cylindrical	O	O
holes	O	O
were	O	O
filled	O	O
either	O	O
with	O	O
mouth	O	O
rinse	O	O
MR1	O	O
or	O	O
with	O	O
mouth	O	O
rinse	O	O
MR2	O	O
.	O	O

After	O	O
incubation	O	O
,	O	O
inhibition	O	O
zones	O	O
of	O	O
the	O	O
whole	O	O
tongue	O	O
microbiota	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
were	O	O
measured	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
MR1	O	O
and	O	O
MR2	O	O
were	O	O
applied	O	O
in	O	O
a	O	O
short	O	O
interval	O	O
killing	O	O
test	O	O
(	O	O
SIKT	O	O
)	O	O
on	O	O
four	O	O
oral	O	O
pathogens	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
.	O	O

Total	O	O
viable	O	O
cell	O	O
counts	O	O
were	O	O
made	O	O
after	O	O
two	O	O
minutes	O	O
of	O	O
incubation	O	O
with	O	O
increasing	O	O
concentrations	O	O
of	O	O
MR1	O	O
and	O	O
MR2	O	O
.	O	O

MR1	O	O
showed	O	O
a	O	O
significantly	O	O
higher	O	O
in	O	O
vitro	O	O
antimicrobial	O	O
activity	O	O
against	O	O
the	O	O
whole	O	O
tongue	O	O
microbiota	O	O
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
than	O	O
MR2	O	O
in	O	O
both	O	O
groups	O	O
of	O	O
subjects	O	O
.	O	O

In	O	O
the	O	O
SIK	O	O
test	O	O
,	O	O
MR1	O	O
showed	O	O
a	O	O
significantly	O	O
greater	O	O
killing	O	O
capacity	O	O
than	O	O
MR2	O	O
.	O	O

The	O	O
results	O	O
show	O	O
that	O	O
a	O	O
mouth	O	O
rinse	O	O
with	O	O
low	O	O
concentrations	O	O
of	O	O
chlorhexidine	O	O
and	O	O
0.05	O	O
%	O	O
cetylpyridinium	O	O
chloride	O	O
appears	O	O
to	O	O
be	O	O
more	O	O
effective	O	O
in	O	O
inhibiting	O	O
growth	O	O
of	O	O
the	O	O
human	O	O
tongue	O	O
microbiota	O	O
in	O	O
vitro	O	O
than	O	O
a	O	O
fluoride/stannous	O	O
fluoride-containing	O	O
mouth	O	O
rinse	O	O
.	O	O

This	O	O
in	O	O
vitro	O	O
observation	O	O
supports	O	O
the	O	O
use	O	O
of	O	O
chlorhexidine	O	O
and	O	O
cetylpyridinium	O	O
chloride	O	O
in	O	O
the	O	O
treatment	O	O
of	O	O
oral	O	O
halitosis	O	O
.	O	O

Dental	O	O
caries	O	O
and	O	O
periodontal	O	O
disease	O	O
are	O	O
widespread	O	O
diseases	O	O
for	O	O
which	O	O
microorganism	O	O
infections	O	O
have	O	O
been	O	O
identified	O	O
as	O	O
the	O	O
main	O	O
etiology	O	O
.	O	O

Silver	O	O
nanoparticles	O	O
(	O	O
Ag	O	O
Nps	O	O
)	O	O
were	O	O
considered	O	O
as	O	O
potential	O	O
control	O	O
oral	O	O
bacteria	O	O
infection	O	O
agent	O	O
due	O	O
to	O	O
its	O	O
excellent	O	O
antimicrobial	O	O
activity	O	O
and	O	O
non	O	O
acute	O	O
toxic	O	O
effects	O	O
on	O	O
human	O	O
cells	O	O
.	O	O

In	O	O
this	O	O
work	O	O
,	O	O
stable	O	O
Ag	O	O
Nps	O	O
with	O	O
different	O	O
sizes	O	O
(	O	O
~5	O	O
,	O	O
15	O	O
and	O	O
55	O	O
nm	O	O
mean	O	O
values	O	O
)	O	O
were	O	O
synthesized	O	O
by	O	O
using	O	O
a	O	O
simple	O	O
reduction	O	O
method	O	O
or	O	O
hydrothermal	O	O
method	O	O
.	O	O

The	O	O
Nps	O	O
were	O	O
characterized	O	O
by	O	O
powder	O	O
X-ray	O	O
diffraction	O	O
,	O	O
transmission	O	O
electron	O	O
microscopy	O	O
and	O	O
UV-vis	O	O
absorption	O	O
spectroscopy	O	O
.	O	O

The	O	O
antibacterial	O	O
activities	O	O
were	O	O
evaluated	O	O
by	O	O
colony	O	O
counting	O	O
assay	O	O
and	O	O
growth	O	O
inhibition	O	O
curve	O	O
method	O	O
,	O	O
and	O	O
corresponding	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
against	O	O
five	O	O
anaerobic	O	O
oral	O	O
pathogenic	O	O
bacteria	O	O
and	O	O
aerobic	B-bacteria	B-bacteria
bacteria	I-bacteria	I-bacteria
E.	I-bacteria	I-bacteria
coli	E-bacteria	I-bacteria
were	O	O
determined	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
that	O	O
Ag	O	O
Nps	O	O
had	O	O
apparent	O	O
antibacterial	O	O
effects	O	O
against	O	O
the	O	O
anaerobic	O	O
oral	O	O
pathogenic	O	O
bacteria	O	O
and	O	O
aerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

The	O	O
MIC	O	O
values	O	O
of	O	O
5-nm	O	O
Ag	O	O
against	O	O
anaerobic	O	O
oral	O	O
pathogenic	O	O
bacteria	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
F.	B-bacteria	B-bacteria
nuceatum	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
were	O	O
25	O	O
,	O	O
25	O	O
,	O	O
25	O	O
,	O	O
50	O	O
and	O	O
50	O	O
mug/mL	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
aerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
more	O	O
susceptible	O	O
to	O	O
Ag	O	O
NPs	O	O
than	O	O
the	O	O
anaerobic	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
pathogenic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

In	O	O
the	O	O
mean	O	O
time	O	O
,	O	O
Ag	O	O
NPs	O	O
displayed	O	O
an	O	O
obvious	O	O
size-dependent	O	O
antibacterial	O	O
activity	O	O
against	O	O
the	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

The	O	O
5-nm	O	O
Ag	O	O
presents	O	O
the	O	O
highest	O	O
antibacterial	O	O
activity	O	O
.	O	O

The	O	O
results	O	O
of	O	O
this	O	O
work	O	O
indicated	O	O
a	O	O
potential	O	O
application	O	O
of	O	O
Ag	O	O
Nps	O	O
in	O	O
the	O	O
inhibition	O	O
of	O	O
oral	O	O
microorganism	O	O
infections	O	O
.	O	O

Autologous	O	O
platelet	O	O
concentrates	O	O
(	O	O
PCs	O	O
)	O	O
have	O	O
been	O	O
extensively	O	O
used	O	O
in	O	O
a	O	O
variety	O	O
of	O	O
medical	O	O
fields	O	O
to	O	O
promote	O	O
soft	O	O
and	O	O
hard	O	O
tissue	O	O
regeneration	O	O
.	O	O

The	O	O
significance	O	O
behind	O	O
their	O	O
use	O	O
lies	O	O
in	O	O
the	O	O
abundance	O	O
of	O	O
growth	O	O
factors	O	O
in	O	O
platelets	O	O
alpha-granules	O	O
that	O	O
promotes	O	O
wound	O	O
healing	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
antibacterial	O	O
properties	O	O
of	O	O
PCs	O	O
against	O	O
various	O	O
bacteria	O	O
have	O	O
been	O	O
recently	O	O
pointed	O	O
out	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
the	O	O
antimicrobial	O	O
effect	O	O
of	O	O
pure	O	O
platelet-rich	O	O
plasma	O	O
(	O	O
P-PRP	O	O
)	O	O
was	O	O
evaluated	O	O
against	O	O
oral	O	O
cavity	O	O
microorganisms	O	O
such	O	O
as	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
Candida	O	O
albicans	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
agalactiae	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
and	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
.	O	O

Blood	O	O
samples	O	O
were	O	O
obtained	O	O
from	O	O
17	O	O
patients	O	O
who	O	O
underwent	O	O
oral	O	O
surgery	O	O
procedures	O	O
involving	O	O
the	O	O
use	O	O
of	O	O
P-PRP	O	O
.	O	O

The	O	O
antibacterial	O	O
activity	O	O
of	O	O
P-PRP	O	O
,	O	O
evaluated	O	O
as	O	O
the	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
,	O	O
was	O	O
determined	O	O
through	O	O
the	O	O
microdilution	O	O
twofold	O	O
serial	O	O
method	O	O
.	O	O

P-PRP	O	O
inhibited	O	O
the	O	O
growth	O	O
of	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
Candida	O	O
albicans	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
agalactiae	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
but	O	O
not	O	O
of	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
.	O	O

P-PRP	O	O
is	O	O
a	O	O
potentially	O	O
useful	O	O
substance	O	O
in	O	O
the	O	O
fight	O	O
against	O	O
postoperative	O	O
infections	O	O
.	O	O

This	O	O
might	O	O
represent	O	O
a	O	O
valuable	O	O
property	O	O
in	O	O
adjunct	O	O
to	O	O
the	O	O
enhancement	O	O
of	O	O
tissue	O	O
regeneration	O	O
.	O	O

To	O	O
compare	O	O
via	O	O
a	O	O
split-mouth	O	O
randomized	O	O
clinical	O	O
trial	O	O
the	O	O
efficacy	O	O
of	O	O
1	O	O
%	O	O
chlorhexidine	O	O
gel	O	O
,	O	O
calcium	O	O
hydroxide/camphorated	O	O
paramonochlorophenol	O	O
(	O	O
Callen	O	O
PMCC	O	O
)	O	O
,	O	O
and	O	O
a	O	O
one-visit	O	O
endodontic	O	O
treatment	O	O
against	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
found	O	O
in	O	O
primary	O	O
molars	O	O
with	O	O
necrotic	O	O
pulps	O	O
and	O	O
to	O	O
assess	O	O
clinical	O	O
success	O	O
rates	O	O
after	O	O
12	O	O
months	O	O
.	O	O

Pre-	O	O
and	O	O
posttreatment	O	O
intracanal	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
37	O	O
teeth	O	O
(	O	O
from	O	O
21	O	O
children	O	O
)	O	O
for	O	O
analysis	O	O
of	O	O
the	O	O
number	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

Clinical	O	O
and	O	O
radiographic	O	O
criteria	O	O
were	O	O
analyzed	O	O
to	O	O
determine	O	O
treatment	O	O
outcome	O	O
.	O	O

Chlorhexidine	O	O
gel	O	O
significantly	O	O
reduced	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
levels	O	O
(	O	O
P	O	O
=	O	O
.010	O	O
)	O	O
,	O	O
whereas	O	O
Callen	O	O
PMCC	O	O
significantly	O	O
reduced	O	O
the	O	O
levels	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
P	O	O
=	O	O
.002	O	O
)	O	O
.	O	O

No	O	O
differences	O	O
in	O	O
the	O	O
reduction	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
P	O	O
=	O	O
.187	O	O
)	O	O
and	O	O
anaerobes	B-bacteria	B-bacteria
(	O	O
P	O	O
=	O	O
.564	O	O
)	O	O
were	O	O
observed	O	O
between	O	O
groups	O	O
.	O	O

The	O	O
clinical	O	O
success	O	O
rates	O	O
were	O	O
85.71	O	O
%	O	O
(	O	O
Callen	O	O
PMCC	O	O
)	O	O
,	O	O
78.57	O	O
%	O	O
(	O	O
chlorexidine	O	O
gel	O	O
)	O	O
,	O	O
and	O	O
77.77	O	O
%	O	O
(	O	O
one-visit	O	O
treatment	O	O
)	O	O
.	O	O

Teeth	O	O
treated	O	O
with	O	O
Callen	O	O
PMCC	O	O
presented	O	O
the	O	O
highest	O	O
clinical	O	O
success	O	O
rate	O	O
.	O	O

The	O	O
1	O	O
%	O	O
chlorhexidine	O	O
gel	O	O
,	O	O
as	O	O
well	O	O
as	O	O
calcium	O	O
hydroxide/camphorated	O	O
paramonochlorophenol	O	O
,	O	O
presented	O	O
limited	O	O
efficacy	O	O
in	O	O
reducing	O	O
bacteria	O	O
from	O	O
necrotic	O	O
primary	O	O
root	O	O
canals	O	O
.	O	O

The	O	O
levels	O	O
of	O	O
compounds	O	O
in	O	O
exhaled	O	O
mouth	O	O
air	O	O
do	O	O
not	O	O
necessarily	O	O
reflect	O	O
levels	O	O
in	O	O
the	O	O
systemic	O	O
circulation	O	O
as	O	O
bacteria	O	O
can	O	O
bio-transform	O	O
substrates	O	O
to	O	O
produce	O	O
compounds	O	O
within	O	O
the	O	O
mouth	O	O
.	O	O

This	O	O
should	O	O
be	O	O
of	O	O
concern	O	O
to	O	O
researchers	O	O
measuring	O	O
breath	O	O
volatiles	O	O
with	O	O
the	O	O
aim	O	O
of	O	O
diagnosing	O	O
systemic	O	O
or	O	O
metabolic	O	O
conditions	O	O
as	O	O
very	O	O
little	O	O
is	O	O
known	O	O
about	O	O
the	O	O
origin	O	O
of	O	O
many	O	O
compounds	O	O
detected	O	O
on	O	O
the	O	O
breath	O	O
.	O	O

This	O	O
pilot	O	O
study	O	O
investigated	O	O
the	O	O
production	O	O
of	O	O
volatile	O	O
compounds	O	O
by	O	O
bacterial	O	O
communities	O	O
present	O	O
within	O	O
the	O	O
mouth	O	O
.	O	O

Solid-phase	O	O
micro-extraction	O	O
was	O	O
used	O	O
to	O	O
extract	O	O
volatiles	O	O
from	O	O
the	O	O
headspace	O	O
gas	O	O
of	O	O
two	O	O
Gram-positive	O	O
and	O	O
two	O	O
Gram-negative	O	O
bacterial	O	O
cultures	O	O
known	O	O
to	O	O
be	O	O
present	O	O
within	O	O
the	O	O
mouth	O	O
and	O	O
from	O	O
tongue	O	O
biofilm	O	O
microflora	O	O
.	O	O

Analyses	O	O
were	O	O
undertaken	O	O
using	O	O
gas	O	O
chromatography	O	O
mass	O	O
spectrometry	O	O
.	O	O

Between	O	O
64	O	O
and	O	O
82	O	O
volatile	O	O
compounds	O	O
were	O	O
detected	O	O
from	O	O
sampling	O	O
the	O	O
headspace	O	O
gas	O	O
above	O	O
each	O	O
of	O	O
the	O	O
cultures	O	O
.	O	O

Gram-negative	B-bacteria	B-bacteria
anaerobes	E-bacteria	I-bacteria
were	O	O
found	O	O
to	O	O
produce	O	O
more	O	O
volatile	O	O
sulfur	O	O
compounds	O	O
(	O	O
VSCs	O	O
)	O	O
and	O	O
amines	O	O
.	O	O

Solobacterium	B-bacteria	B-bacteria
moorei	E-bacteria	I-bacteria
,	O	O
a	O	O
Gram-positive	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
was	O	O
however	O	O
found	O	O
to	O	O
produce	O	O
higher	O	O
levels	O	O
of	O	O
acids	O	O
,	O	O
hydrocarbons	O	O
,	O	O
alcohols	O	O
and	O	O
aldehydes	O	O
than	O	O
the	O	O
other	O	O
species	O	O
studied	O	O
.	O	O

Tongue-scrape	O	O
biofilm	O	O
systems	O	O
at	O	O
lower	O	O
pH	O	O
gave	O	O
more	O	O
hydrocarbons	O	O
,	O	O
ketones	O	O
and	O	O
fatty	O	O
acids	O	O
whilst	O	O
at	O	O
higher	O	O
pH	O	O
more	O	O
alcohols	O	O
,	O	O
aldehydes	O	O
,	O	O
VSCs	O	O
and	O	O
amines	O	O
were	O	O
detected	O	O
in	O	O
the	O	O
headspace	O	O
.	O	O

The	O	O
results	O	O
show	O	O
that	O	O
a	O	O
number	O	O
of	O	O
compounds	O	O
detected	O	O
in	O	O
mouth	O	O
breath	O	O
are	O	O
produced	O	O
by	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
tongue	O	O
biofilms	O	O
.	O	O

Thus	O	O
,	O	O
the	O	O
contribution	O	O
of	O	O
volatiles	O	O
from	O	O
oral	O	O
anaerobes	B-bacteria	B-bacteria
can	O	O
not	O	O
be	O	O
ignored	O	O
and	O	O
more	O	O
research	O	O
is	O	O
required	O	O
to	O	O
identify	O	O
the	O	O
major	O	O
source	O	O
of	O	O
breath	O	O
compounds	O	O
as	O	O
this	O	O
will	O	O
help	O	O
determine	O	O
their	O	O
clinical	O	O
significance	O	O
as	O	O
indicators	O	O
of	O	O
systemic	O	O
disease	O	O
or	O	O
metabolic	O	O
disorders	O	O
in	O	O
the	O	O
body	O	O
.	O	O

Traditional	O	O
Chinese	O	O
medicine	O	O
(	O	O
TCM	O	O
)	O	O
,	O	O
used	O	O
in	O	O
clinical	O	O
practice	O	O
for	O	O
thousands	O	O
of	O	O
years	O	O
,	O	O
has	O	O
been	O	O
taken	O	O
as	O	O
a	O	O
new	O	O
way	O	O
to	O	O
tackle	O	O
chronic	O	O
diseases	O	O
.	O	O

In	O	O
Chinese	O	O
medicine	O	O
,	O	O
many	O	O
ingredients	O	O
which	O	O
are	O	O
known	O	O
to	O	O
have	O	O
biological	O	O
effects	O	O
just	O	O
pass	O	O
through	O	O
the	O	O
gut	O	O
,	O	O
they	O	O
do	O	O
not	O	O
get	O	O
into	O	O
the	O	O
bloodstream	O	O
.	O	O

Study	O	O
on	O	O
interactions	O	O
of	O	O
these	O	O
active	O	O
ingredients	O	O
with	O	O
the	O	O
intestinal	O	O
bacteria	O	O
is	O	O
very	O	O
helpful	O	O
to	O	O
unravel	O	O
how	O	O
TCM	O	O
works	O	O
.	O	O

AIM	O	O
OF	O	O
THE	O	O
STUDY	O	O
:	O	O
Hyperoside	O	O
is	O	O
a	O	O
major	O	O
active	O	O
constituent	O	O
in	O	O
many	O	O
medicinal	O	O
plants	O	O
which	O	O
are	O	O
traditionally	O	O
used	O	O
in	O	O
Chinese	O	O
medicines	O	O
for	O	O
their	O	O
neuroprotective	O	O
,	O	O
anti-inflammatory	O	O
and	O	O
anti-oxidative	O	O
effects	O	O
.	O	O

It	O	O
would	O	O
be	O	O
metabolized	O	O
by	O	O
intestinal	O	O
bacteria	O	O
after	O	O
oral	O	O
administration	O	O
which	O	O
leads	O	O
to	O	O
the	O	O
variation	O	O
of	O	O
ethnopharmacological	O	O
profile	O	O
of	O	O
these	O	O
traditional	O	O
medicines	O	O
.	O	O

Thus	O	O
,	O	O
it	O	O
is	O	O
necessary	O	O
to	O	O
investigate	O	O
the	O	O
metabolic	O	O
routes	O	O
and	O	O
metabolites	O	O
of	O	O
hyperoside	O	O
produced	O	O
by	O	O
human	O	O
intestinal	O	O
bacteria	O	O
.	O	O

MATERIALS	O	O
AND	O	O
Ultra	O	O
performance	O	O
liquid	O	O
chromatography/quadrupole-time-of-flight	O	O
mass	O	O
spectrometry	O	O
(	O	O
UPLC/QTOF-MS	O	O
)	O	O
technique	O	O
combined	O	O
with	O	O
Metabolynx	O	O
(	O	O
)	O	O
software	O	O
was	O	O
used	O	O
for	O	O
analysis	O	O
of	O	O
the	O	O
metabolic	O	O
profile	O	O
of	O	O
hyperoside	O	O
by	O	O
the	O	O
isolated	O	O
human	O	O
intestinal	O	O
bacteria	O	O
from	O	O
the	O	O
human	O	O
feces	O	O
.	O	O

Parent	O	O
compound	O	O
and	O	O
6	O	O
metabolites	O	O
(	O	O
M1-M7	O	O
)	O	O
were	O	O
detected	O	O
in	O	O
the	O	O
isolated	O	O
bacterial	O	O
samples	O	O
compared	O	O
with	O	O
blank	O	O
samples	O	O
.	O	O

Quercetin	O	O
,	O	O
3	O	O
,	O	O
4-dihydroxyphenylacetic	O	O
acid	O	O
and	O	O
3	O	O
,	O	O
4-dihydroxyphenylbenzoic	O	O
acid	O	O
(	O	O
M2-M4	O	O
)	O	O
were	O	O
only	O	O
found	O	O
in	O	O
the	O	O
sample	O	O
of	O	O
Bacteroides	O	O
sp	O	O
.	O	O

45	O	O
.	O	O

Dehydroxylation	O	O
of	O	O
hyperoside	O	O
and	O	O
the	O	O
conjugates	O	O
:	O	O
acetylation	O	O
and	O	O
hydroxylation	O	O
of	O	O
hyperoside	O	O
(	O	O
M5-M7	O	O
)	O	O
were	O	O
identified	O	O
in	O	O
the	O	O
majority	O	O
of	O	O
isolated	O	O
intestinal	O	O
bacterial	O	O
samples	O	O
.	O	O

Only	O	O
Bacteroides	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

45	E-bacteria	I-bacteria
could	O	O
metabolize	O	O
hyperoside	O	O
to	O	O
form	O	O
its	O	O
aglycone	O	O
quercetin	O	O
,	O	O
thereafter	O	O
,	O	O
quercetin	O	O
was	O	O
further	O	O
metabolized	O	O
to	O	O
3,4-dihydroxyphenylacetic	O	O
acid	O	O
and	O	O
3,4-dihydroxyphenylacetic	O	O
acid	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
majority	O	O
of	O	O
bacteria	O	O
could	O	O
metabolize	O	O
hyperoside	O	O
to	O	O
dehydroxylation	O	O
of	O	O
hyperoside	O	O
and	O	O
the	O	O
conjugates	O	O
:	O	O
hydroxylation	O	O
and	O	O
acetylation	O	O
of	O	O
hyperoside	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
the	O	O
metabolic	O	O
routes	O	O
and	O	O
metabolites	O	O
of	O	O
hyperoside	O	O
produced	O	O
by	O	O
the	O	O
different	O	O
intestinal	O	O
bacteria	O	O
were	O	O
investigated	O	O
for	O	O
the	O	O
first	O	O
time	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
production	O	O
of	O	O
metabolites	O	O
of	O	O
hyperoside	O	O
might	O	O
influence	O	O
the	O	O
effects	O	O
of	O	O
traditional	O	O
medicines	O	O
.	O	O

Thus	O	O
,	O	O
the	O	O
study	O	O
on	O	O
the	O	O
metabolism	O	O
of	O	O
hyperoside	O	O
by	O	O
human	O	O
intestinal	O	O
bacteria	O	O
is	O	O
of	O	O
great	O	O
importance	O	O
to	O	O
an	O	O
understanding	O	O
of	O	O
the	O	O
effects	O	O
of	O	O
traditional	O	O
medicines	O	O
.	O	O

In	O	O
leprosy	O	O
,	O	O
the	O	O
nasal	O	O
mucosa	O	O
is	O	O
considered	O	O
as	O	O
the	O	O
principal	O	O
route	O	O
of	O	O
transmission	O	O
for	O	O
the	O	O
bacillus	B-bacteria	B-bacteria
Mycobacterium	I-bacteria	I-bacteria
leprae	E-bacteria	I-bacteria
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
identify	O	O
M.	B-bacteria	B-bacteria
leprae	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
mucosa	O	O
of	O	O
50	O	O
untreated	O	O
leprosy	O	O
patients	O	O
,	O	O
including	O	O
21	O	O
paucibacillary	O	O
(	O	O
PB	O	O
)	O	O
and	O	O
29	O	O
multibacillary	O	O
(	O	O
MB	O	O
)	O	O
patients	O	O
,	O	O
using	O	O
immunohistochemistry	O	O
(	O	O
IHC	O	O
)	O	O
,	O	O
with	O	O
antibodies	O	O
against	O	O
bacillus	B-bacteria	B-bacteria
Calmette-Guerin	E-bacteria	I-bacteria
(	O	O
BCG	B-bacteria	B-bacteria
)	O	O
and	O	O
phenolic	O	O
glycolipid	O	O
antigen-1	O	O
(	O	O
PGL-1	O	O
)	O	O
,	O	O
and	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
,	O	O
with	O	O
MntH-specific	O	O
primers	O	O
for	O	O
M.	B-bacteria	B-bacteria
leprae	E-bacteria	I-bacteria
,	O	O
and	O	O
to	O	O
compare	O	O
the	O	O
results	O	O
.	O	O

The	O	O
material	O	O
was	O	O
represented	O	O
by	O	O
163	O	O
paraffin	O	O
blocks	O	O
containing	O	O
biopsy	O	O
samples	O	O
obtained	O	O
from	O	O
clinically	O	O
normal	O	O
sites	O	O
(	O	O
including	O	O
the	O	O
tongue	O	O
,	O	O
buccal	O	O
mucosa	O	O
and	O	O
soft	O	O
palate	O	O
)	O	O
and	O	O
visible	O	O
lesions	O	O
anywhere	O	O
in	O	O
the	O	O
oral	O	O
mucosa	O	O
.	O	O

All	O	O
patients	O	O
and	O	O
158	O	O
available	O	O
samples	O	O
were	O	O
included	O	O
for	O	O
IHC	O	O
study	O	O
.	O	O

Among	O	O
the	O	O
161	O	O
available	O	O
samples	O	O
for	O	O
PCR	O	O
,	O	O
110	O	O
had	O	O
viable	O	O
DNA	O	O
.	O	O

There	O	O
was	O	O
viable	O	O
DNA	O	O
in	O	O
at	O	O
least	O	O
one	O	O
area	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
for	O	O
47	O	O
patients	O	O
.	O	O

M.	B-bacteria	B-bacteria
leprae	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
70	O	O
%	O	O
and	O	O
78	O	O
%	O	O
of	O	O
patients	O	O
using	O	O
IHC	O	O
and	O	O
PCR	O	O
,	O	O
respectively	O	O
,	O	O
and	O	O
in	O	O
94	O	O
%	O	O
of	O	O
the	O	O
patients	O	O
by	O	O
at	O	O
least	O	O
one	O	O
of	O	O
the	O	O
two	O	O
diagnostic	O	O
methods	O	O
.	O	O

There	O	O
were	O	O
no	O	O
differences	O	O
in	O	O
detection	O	O
of	O	O
M.	B-bacteria	B-bacteria
leprae	E-bacteria	I-bacteria
between	O	O
MB	O	O
and	O	O
PB	O	O
patients	O	O
.	O	O

Similar	O	O
results	O	O
were	O	O
obtained	O	O
using	O	O
anti-BCG	O	O
and	O	O
anti-PGL-1	O	O
antibodies	O	O
,	O	O
and	O	O
immunoreactivity	O	O
occurred	O	O
predominantly	O	O
on	O	O
free-living	O	O
bacteria	O	O
on	O	O
the	O	O
epithelial	O	O
surface	O	O
,	O	O
with	O	O
a	O	O
predilection	O	O
for	O	O
the	O	O
tongue	O	O
.	O	O

Conversely	O	O
,	O	O
there	O	O
was	O	O
no	O	O
area	O	O
of	O	O
predilection	O	O
according	O	O
to	O	O
the	O	O
PCR	O	O
results	O	O
.	O	O

M.	B-bacteria	B-bacteria
leprae	E-bacteria	I-bacteria
is	O	O
present	O	O
in	O	O
the	O	O
oral	O	O
mucosa	O	O
at	O	O
a	O	O
high	O	O
frequency	O	O
,	O	O
implicating	O	O
this	O	O
site	O	O
as	O	O
a	O	O
potential	O	O
means	O	O
of	O	O
leprosy	O	O
transmission	O	O
.	O	O

Results	O	O
from	O	O
16S	O	O
rDNA-encoding	O	O
gene	O	O
sequence-based	O	O
,	O	O
culture-independent	O	O
techniques	O	O
have	O	O
led	O	O
to	O	O
conflicting	O	O
conclusions	O	O
about	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
lower	O	O
respiratory	O	O
tract	O	O
microbiome	O	O
.	O	O

To	O	O
compare	O	O
the	O	O
microbiome	O	O
of	O	O
the	O	O
upper	O	O
and	O	O
lower	O	O
respiratory	O	O
tract	O	O
in	O	O
healthy	O	O
HIV-uninfected	O	O
nonsmokers	O	O
and	O	O
smokers	O	O
in	O	O
a	O	O
multicenter	O	O
cohort	O	O
.	O	O

Participants	O	O
were	O	O
nonsmokers	O	O
and	O	O
smokers	O	O
without	O	O
significant	O	O
comorbidities	O	O
.	O	O

Oral	O	O
washes	O	O
and	O	O
bronchoscopic	O	O
alveolar	O	O
lavages	O	O
were	O	O
collected	O	O
in	O	O
a	O	O
standardized	O	O
manner	O	O
.	O	O

Sequence	O	O
analysis	O	O
of	O	O
bacterial	O	O
16S	O	O
rRNA-encoding	O	O
genes	O	O
was	O	O
performed	O	O
,	O	O
and	O	O
the	O	O
neutral	O	O
model	O	O
in	O	O
community	O	O
ecology	O	O
was	O	O
used	O	O
to	O	O
identify	O	O
bacteria	O	O
that	O	O
were	O	O
the	O	O
most	O	O
plausible	O	O
members	O	O
of	O	O
a	O	O
lung	O	O
microbiome	O	O
.	O	O

Sixty-four	O	O
participants	O	O
were	O	O
enrolled	O	O
.	O	O

Most	O	O
bacteria	O	O
identified	O	O
in	O	O
the	O	O
lung	O	O
were	O	O
also	O	O
in	O	O
the	O	O
mouth	O	O
,	O	O
but	O	O
specific	O	O
bacteria	O	O
such	O	O
as	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
,	O	O
Haemophilus	B-bacteria	B-bacteria
,	O	O
Methylobacterium	B-bacteria	B-bacteria
,	O	O
and	O	O
Ralstonia	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
were	O	O
disproportionally	O	O
represented	O	O
in	O	O
the	O	O
lungs	O	O
compared	O	O
with	O	O
values	O	O
predicted	O	O
by	O	O
the	O	O
neutral	O	O
model	O	O
.	O	O

Tropheryma	B-bacteria	B-bacteria
was	O	O
also	O	O
in	O	O
the	O	O
lung	O	O
,	O	O
but	O	O
not	O	O
the	O	O
mouth	O	O
.	O	O

Mouth	O	O
communities	O	O
differed	O	O
between	O	O
nonsmokers	O	O
and	O	O
smokers	O	O
in	O	O
species	O	O
such	O	O
as	O	O
Porphyromonas	B-bacteria	B-bacteria
,	O	O
Neisseria	B-bacteria	B-bacteria
,	O	O
and	O	O
Gemella	B-bacteria	B-bacteria
,	O	O
but	O	O
lung	O	O
bacterial	O	O
populations	O	O
did	O	O
not	O	O
.	O	O

This	O	O
study	O	O
is	O	O
the	O	O
largest	O	O
to	O	O
examine	O	O
composition	O	O
of	O	O
the	O	O
lower	O	O
respiratory	O	O
tract	O	O
microbiome	O	O
in	O	O
healthy	O	O
individuals	O	O
and	O	O
the	O	O
first	O	O
to	O	O
use	O	O
the	O	O
neutral	O	O
model	O	O
to	O	O
compare	O	O
the	O	O
lung	O	O
to	O	O
the	O	O
mouth	O	O
.	O	O

Specific	O	O
bacteria	O	O
appear	O	O
in	O	O
significantly	O	O
higher	O	O
abundance	O	O
in	O	O
the	O	O
lungs	O	O
than	O	O
would	O	O
be	O	O
expected	O	O
if	O	O
they	O	O
originated	O	O
from	O	O
the	O	O
mouth	O	O
,	O	O
demonstrating	O	O
that	O	O
the	O	O
lung	O	O
microbiome	O	O
does	O	O
not	O	O
derive	O	O
entirely	O	O
from	O	O
the	O	O
mouth	O	O
.	O	O

The	O	O
mouth	O	O
microbiome	O	O
differs	O	O
in	O	O
nonsmokers	O	O
and	O	O
smokers	O	O
,	O	O
but	O	O
lung	O	O
communities	O	O
were	O	O
not	O	O
significantly	O	O
altered	O	O
by	O	O
smoking	O	O
.	O	O

The	O	O
composition	O	O
of	O	O
the	O	O
human	O	O
microbiota	O	O
is	O	O
recognized	O	O
as	O	O
an	O	O
important	O	O
factor	O	O
in	O	O
human	O	O
health	O	O
and	O	O
disease	O	O
.	O	O

Many	O	O
of	O	O
our	O	O
cohabitating	O	O
microbes	O	O
belong	O	O
to	O	O
phylum-level	O	O
divisions	O	O
for	O	O
which	O	O
there	O	O
are	O	O
no	O	O
cultivated	O	O
representatives	O	O
and	O	O
are	O	O
only	O	O
represented	O	O
by	O	O
small	O	O
subunit	O	O
rRNA	O	O
sequences	O	O
.	O	O

For	O	O
one	O	O
such	O	O
taxon	O	O
(	O	O
SR1	B-bacteria	B-bacteria
)	O	O
,	O	O
which	O	O
includes	O	O
bacteria	O	O
with	O	O
elevated	O	O
abundance	O	O
in	O	O
periodontitis	O	O
,	O	O
we	O	O
provide	O	O
a	O	O
single-cell	O	O
genome	O	O
sequence	O	O
from	O	O
a	O	O
healthy	O	O
oral	O	O
sample	O	O
.	O	O

SR1	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
use	O	O
a	O	O
unique	O	O
genetic	O	O
code	O	O
.	O	O

In-frame	O	O
TGA	O	O
(	O	O
opal	O	O
)	O	O
codons	O	O
are	O	O
found	O	O
in	O	O
most	O	O
genes	O	O
(	O	O
85	O	O
%	O	O
)	O	O
,	O	O
often	O	O
at	O	O
loci	O	O
normally	O	O
encoding	O	O
conserved	O	O
glycine	O	O
residues	O	O
.	O	O

UGA	O	O
appears	O	O
not	O	O
to	O	O
function	O	O
as	O	O
a	O	O
stop	O	O
codon	O	O
and	O	O
is	O	O
in	O	O
equilibrium	O	O
with	O	O
the	O	O
canonical	O	O
GGN	O	O
glycine	O	O
codons	O	O
,	O	O
displaying	O	O
strain-specific	O	O
variation	O	O
across	O	O
the	O	O
human	O	O
population	O	O
.	O	O

SR1	B-bacteria	B-bacteria
encodes	O	O
a	O	O
divergent	O	O
tRNA	O	O
(	O	O
Gly	O	O
)	O	O
UCA	O	O
with	O	O
an	O	O
opal-decoding	O	O
anticodon	O	O
.	O	O

SR1	B-bacteria	B-bacteria
glycyl-tRNA	O	O
synthetase	O	O
acylates	O	O
tRNA	O	O
(	O	O
Gly	O	O
)	O	O
UCA	O	O
with	O	O
glycine	O	O
in	O	O
vitro	O	O
with	O	O
similar	O	O
activity	O	O
compared	O	O
with	O	O
normal	O	O
tRNA	O	O
(	O	O
Gly	O	O
)	O	O
UCC	O	O
.	O	O

Coexpression	O	O
of	O	O
SR1	B-bacteria	B-bacteria
glycyl-tRNA	O	O
synthetase	O	O
and	O	O
tRNA	O	O
(	O	O
Gly	O	O
)	O	O
UCA	O	O
in	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
yields	O	O
significant	O	O
beta-galactosidase	O	O
activity	O	O
in	O	O
vivo	O	O
from	O	O
a	O	O
lacZ	O	O
gene	O	O
containing	O	O
an	O	O
in-frame	O	O
TGA	O	O
codon	O	O
.	O	O

Comparative	O	O
genomic	O	O
analysis	O	O
with	O	O
Human	O	O
Microbiome	O	O
Project	O	O
data	O	O
revealed	O	O
that	O	O
the	O	O
human	O	O
body	O	O
harbors	O	O
a	O	O
striking	O	O
diversity	O	O
of	O	O
SR1	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

This	O	O
is	O	O
a	O	O
surprising	O	O
finding	O	O
because	O	O
SR1	B-bacteria	B-bacteria
is	O	O
most	O	O
closely	O	O
related	O	O
to	O	O
bacteria	O	O
that	O	O
live	O	O
in	O	O
anoxic	O	O
and	O	O
thermal	O	O
environments	O	O
.	O	O

Some	O	O
of	O	O
these	O	O
bacteria	O	O
share	O	O
common	O	O
genetic	O	O
and	O	O
metabolic	O	O
features	O	O
with	O	O
SR1	B-bacteria	B-bacteria
,	O	O
including	O	O
UGA	O	O
to	O	O
glycine	O	O
reassignment	O	O
and	O	O
an	O	O
archaeal-type	O	O
ribulose-1,5-bisphosphate	O	O
carboxylase	O	O
(	O	O
RubisCO	O	O
)	O	O
involved	O	O
in	O	O
AMP	O	O
recycling	O	O
.	O	O

UGA	O	O
codon	O	O
reassignment	O	O
renders	O	O
SR1	B-bacteria	B-bacteria
genes	O	O
untranslatable	O	O
by	O	O
other	O	O
bacteria	O	O
,	O	O
which	O	O
impacts	O	O
horizontal	O	O
gene	O	O
transfer	O	O
within	O	O
the	O	O
human	O	O
microbiota	O	O
.	O	O

To	O	O
study	O	O
the	O	O
preventive	O	O
effects	O	O
of	O	O
chlorhexidine	O	O
against	O	O
root	O	O
caries	O	O
under	O	O
oral	O	O
biofilm	O	O
in	O	O
an	O	O
artificial	O	O
mouth	O	O
.	O	O

Sixteen	O	O
human	O	O
tooth-root	O	O
disks	O	O
were	O	O
inoculated	O	O
with	O	O
a	O	O
salivary	O	O
sample	O	O
that	O	O
was	O	O
produced	O	O
by	O	O
mixing	O	O
the	O	O
unstimulated	O	O
saliva	O	O
of	O	O
three	O	O
adults	O	O
who	O	O
had	O	O
no	O	O
untreated	O	O
caries	O	O
.	O	O

The	O	O
disks	O	O
were	O	O
incubated	O	O
in	O	O
an	O	O
artificial	O	O
mouth	O	O
fed	O	O
with	O	O
a	O	O
5	O	O
%	O	O
sucrose	O	O
solution	O	O
three	O	O
times	O	O
daily	O	O
for	O	O
one	O	O
week	O	O
.	O	O

Eight	O	O
disks	O	O
received	O	O
a	O	O
twice	O	O
daily	O	O
rinse	O	O
of	O	O
0.12	O	O
%	O	O
chlorhexidine	O	O
(	O	O
test	O	O
group	O	O
)	O	O
.	O	O

The	O	O
other	O	O
eight	O	O
disks	O	O
were	O	O
rinsed	O	O
in	O	O
distilled	O	O
water	O	O
(	O	O
control	O	O
)	O	O
.	O	O

The	O	O
biofilm	O	O
was	O	O
then	O	O
studied	O	O
with	O	O
three	O	O
techniques	O	O
:	O	O
colony	O	O
forming	O	O
unit	O	O
(	O	O
CFU	O	O
)	O	O
counting	O	O
,	O	O
scanning	O	O
electron	O	O
microscopy	O	O
(	O	O
SEM	O	O
)	O	O
and	O	O
confocal	O	O
laser	O	O
scanning	O	O
microscopy	O	O
(	O	O
CLSM	O	O
)	O	O
.	O	O

The	O	O
changes	O	O
in	O	O
the	O	O
chemical	O	O
structure	O	O
of	O	O
the	O	O
root	O	O
surface	O	O
were	O	O
studied	O	O
using	O	O
Fourier	O	O
transform	O	O
infra-Red	O	O
spectroscopy	O	O
.	O	O

Type-I	O	O
collagen	O	O
and	O	O
proteoglycans	O	O
on	O	O
the	O	O
root	O	O
surface	O	O
were	O	O
quantified	O	O
using	O	O
immunocytochemical	O	O
staining	O	O
.	O	O

The	O	O
log	O	O
CFU	O	O
for	O	O
the	O	O
test	O	O
and	O	O
control	O	O
groups	O	O
were	O	O
4.21	O	O
and	O	O
8.27	O	O
,	O	O
respectively	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

The	O	O
CFU	O	O
count	O	O
of	O	O
Streptococci	B-bacteria	B-bacteria
and	O	O
Lactobacilli	B-bacteria	B-bacteria
were	O	O
negligible	O	O
.	O	O

Both	O	O
the	O	O
SEM	O	O
and	O	O
the	O	O
CLSM	O	O
showed	O	O
suppressed	O	O
bacteria	O	O
growth	O	O
in	O	O
the	O	O
test	O	O
group	O	O
.	O	O

The	O	O
log	O	O
[	O	O
amide-I	O	O
:	O	O
HPO	O	O
(	O	O
4	O	O
)	O	O
(	O	O
2-	O	O
)	O	O
]	O	O
of	O	O
the	O	O
test	O	O
and	O	O
control	O	O
groups	O	O
were	O	O
1.11	O	O
and	O	O
1.93	O	O
,	O	O
respectively	O	O
(	O	O
p=0.02	O	O
)	O	O
.	O	O

The	O	O
mean	O	O
counts	O	O
of	O	O
sound	O	O
type-I	O	O
collagen	O	O
in	O	O
the	O	O
test	O	O
and	O	O
control	O	O
groups	O	O
were	O	O
16.8/mum	O	O
(	O	O
2	O	O
)	O	O
and	O	O
13.0/mum	O	O
(	O	O
2	O	O
)	O	O
,	O	O
respectively	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
,	O	O
whereas	O	O
the	O	O
mean	O	O
counts	O	O
of	O	O
intact	O	O
proteoglycans	O	O
were	O	O
5.6/mum	O	O
(	O	O
2	O	O
)	O	O
and	O	O
3.5/mum	O	O
(	O	O
2	O	O
)	O	O
,	O	O
respectively	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

Chlorhexidine	O	O
suppressed	O	O
the	O	O
growth	O	O
of	O	O
selected	O	O
cariogenic	O	O
bacteria	O	O
in	O	O
oral	O	O
biofilm	O	O
on	O	O
the	O	O
root	O	O
surface	O	O
and	O	O
thus	O	O
protected	O	O
tooth-root	O	O
from	O	O
cariogenic	O	O
challenge	O	O
.	O	O

Despite	O	O
a	O	O
long	O	O
history	O	O
of	O	O
investigation	O	O
,	O	O
many	O	O
bacteria	O	O
associated	O	O
with	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
have	O	O
yet	O	O
to	O	O
be	O	O
cultured	O	O
.	O	O

Studies	O	O
that	O	O
correlate	O	O
the	O	O
presence	O	O
or	O	O
abundance	O	O
of	O	O
uncultured	O	O
species	O	O
with	O	O
oral	O	O
health	O	O
or	O	O
disease	O	O
highlight	O	O
the	O	O
importance	O	O
of	O	O
these	O	O
community	O	O
members	O	O
.	O	O

Thus	O	O
,	O	O
we	O	O
sequenced	O	O
several	O	O
single-cell	O	O
genomic	O	O
amplicons	O	O
from	O	O
Desulfobulbus	B-bacteria	B-bacteria
and	O	O
Desulfovibrio	B-bacteria	B-bacteria
(	O	O
class	B-bacteria	B-bacteria
Deltaproteobacteria	E-bacteria	I-bacteria
)	O	O
to	O	O
better	O	O
understand	O	O
their	O	O
function	O	O
within	O	O
the	O	O
human	O	O
oral	O	O
community	O	O
and	O	O
their	O	O
association	O	O
with	O	O
periodontitis	O	O
,	O	O
as	O	O
well	O	O
as	O	O
other	O	O
systemic	O	O
diseases	O	O
.	O	O

Genomic	O	O
data	O	O
from	O	O
oral	O	O
Desulfobulbus	B-bacteria	B-bacteria
and	O	O
Desulfovibrio	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
were	O	O
compared	O	O
to	O	O
other	O	O
available	O	O
deltaproteobacterial	O	O
genomes	O	O
,	O	O
including	O	O
from	O	O
a	O	O
subset	O	O
of	O	O
host-associated	O	O
species	O	O
.	O	O

While	O	O
both	O	O
groups	O	O
share	O	O
a	O	O
large	O	O
number	O	O
of	O	O
genes	O	O
with	O	O
other	O	O
environmental	O	O
Deltaproteobacteria	B-bacteria	B-bacteria
genomes	O	O
,	O	O
they	O	O
encode	O	O
a	O	O
wide	O	O
array	O	O
of	O	O
unique	O	O
genes	O	O
that	O	O
appear	O	O
to	O	O
function	O	O
in	O	O
survival	O	O
in	O	O
a	O	O
host	O	O
environment	O	O
.	O	O

Many	O	O
of	O	O
these	O	O
genes	O	O
are	O	O
similar	O	O
to	O	O
virulence	O	O
and	O	O
host	O	O
adaptation	O	O
factors	O	O
of	O	O
known	O	O
human	O	O
pathogens	O	O
,	O	O
suggesting	O	O
that	O	O
the	O	O
oral	O	O
Deltaproteobacteria	B-bacteria	B-bacteria
have	O	O
the	O	O
potential	O	O
to	O	O
play	O	O
a	O	O
role	O	O
in	O	O
the	O	O
etiology	O	O
of	O	O
periodontal	O	O
disease	O	O
.	O	O

To	O	O
test	O	O
the	O	O
hypothesis	O	O
that	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
a	O	O
potential	O	O
source	O	O
for	O	O
implantable	O	O
pacemaker	O	O
and	O	O
cardioverter	O	O
defibrillators	O	O
infections	O	O
,	O	O
the	O	O
bacterial	O	O
diversity	O	O
on	O	O
explanted	O	O
rhythm	O	O
heart	O	O
management	O	O
devices	O	O
was	O	O
investigated	O	O
and	O	O
compared	O	O
to	O	O
the	O	O
oral	O	O
microbiome	O	O
.	O	O

A	O	O
metagenomic	O	O
approach	O	O
was	O	O
used	O	O
to	O	O
analyze	O	O
the	O	O
bacterial	O	O
diversity	O	O
on	O	O
the	O	O
surfaces	O	O
of	O	O
non-infected	O	O
and	O	O
infected	O	O
pacemakers	O	O
.	O	O

The	O	O
DNA	O	O
from	O	O
surfaces	O	O
swaps	O	O
of	O	O
24	O	O
non-infected	O	O
and	O	O
23	O	O
infected	O	O
pacemaker	O	O
were	O	O
isolated	O	O
and	O	O
subjected	O	O
to	O	O
bacterial-specific	O	O
DNA	O	O
amplification	O	O
,	O	O
single	O	O
strand	O	O
conformation	O	O
polymorphism-	O	O
(	O	O
SSCP	O	O
)	O	O
and	O	O
sequencing	O	O
analysis	O	O
.	O	O

Species-specific	O	O
primer	O	O
sets	O	O
were	O	O
used	O	O
to	O	O
analyze	O	O
for	O	O
any	O	O
correlation	O	O
between	O	O
bacterial	O	O
diversity	O	O
on	O	O
pacemakers	O	O
and	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

DNA	O	O
of	O	O
bacterial	O	O
origin	O	O
was	O	O
detected	O	O
in	O	O
21	O	O
cases	O	O
on	O	O
infected	O	O
pacemakers	O	O
and	O	O
assigned	O	O
to	O	O
the	O	O
bacterial	O	O
phylotypes	O	O
Staphylococcus	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
,	O	O
Propionibacterium	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
schleiferi	E-bacteria	I-bacteria
and	O	O
Stapyhlococcus	B-bacteria	B-bacteria
.	O	O

In	O	O
17	O	O
cases	O	O
bacterial	O	O
DNA	O	O
was	O	O
found	O	O
on	O	O
pacemakers	O	O
with	O	O
no	O	O
clinical	O	O
signs	O	O
of	O	O
infections	O	O
.	O	O

On	O	O
the	O	O
basis	O	O
of	O	O
the	O	O
obtained	O	O
sequence	O	O
data	O	O
,	O	O
the	O	O
phylotypes	O	O
Propionibacterium	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
and	O	O
an	O	O
uncultured	O	O
bacterium	O	O
were	O	O
identified	O	O
.	O	O

Propionibacterium	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
and	O	O
Staphylococcus	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
were	O	O
the	O	O
only	O	O
bacteria	O	O
detected	O	O
in	O	O
pacemeaker	O	O
(	O	O
n	O	O
=	O	O
25	O	O
)	O	O
and	O	O
oral	O	O
samples	O	O
(	O	O
n	O	O
=	O	O
11	O	O
)	O	O
.	O	O

The	O	O
frequency	O	O
of	O	O
the	O	O
coincidental	O	O
detection	O	O
of	O	O
bacteria	O	O
on	O	O
infected	O	O
devices	O	O
and	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
low	O	O
and	O	O
the	O	O
detected	O	O
bacteria	O	O
are	O	O
highly	O	O
abundant	O	O
colonizers	O	O
of	O	O
non-oral	O	O
human	O	O
niches	O	O
.	O	O

The	O	O
transmission	O	O
of	O	O
oral	O	O
bacteria	O	O
to	O	O
the	O	O
lead	O	O
or	O	O
device	O	O
of	O	O
implantable	O	O
pacemaker	O	O
or	O	O
cardioverter	O	O
defibrillators	O	O
is	O	O
unlikely	O	O
relevant	O	O
for	O	O
the	O	O
pathogenesis	O	O
of	O	O
pacemaker	O	O
or	O	O
cardioverter	O	O
defibrillators	O	O
infections	O	O
.	O	O

Tea	O	O
has	O	O
been	O	O
suggested	O	O
to	O	O
promote	O	O
oral	O	O
health	O	O
by	O	O
inhibiting	O	O
bacterial	O	O
attachment	O	O
to	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Most	O	O
studies	O	O
have	O	O
focused	O	O
on	O	O
prevention	O	O
of	O	O
bacterial	O	O
attachment	O	O
to	O	O
hard	O	O
surfaces	O	O
such	O	O
as	O	O
enamel	O	O
.	O	O

This	O	O
study	O	O
investigated	O	O
the	O	O
effect	O	O
of	O	O
five	O	O
commercial	O	O
tea	O	O
(	O	O
green	O	O
,	O	O
oolong	O	O
,	O	O
black	O	O
,	O	O
pu-erh	O	O
and	O	O
chrysanthemum	O	O
)	O	O
extracts	O	O
and	O	O
tea	O	O
components	O	O
(	O	O
epigallocatechin	O	O
gallate	O	O
and	O	O
gallic	O	O
acid	O	O
)	O	O
on	O	O
the	O	O
attachment	O	O
of	O	O
five	O	O
oral	O	O
pathogens	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25175	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
35668	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
49456	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
13419	E-bacteria	I-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
51655	E-bacteria	I-bacteria
)	O	O
to	O	O
the	O	O
HGF-1	O	O
gingival	O	O
cell	O	O
line	O	O
.	O	O

Extracts	O	O
of	O	O
two	O	O
of	O	O
the	O	O
teas	O	O
(	O	O
pu-erh	O	O
and	O	O
chrysanthemum	O	O
)	O	O
significantly	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
reduced	O	O
attachment	O	O
of	O	O
all	O	O
the	O	O
Streptococcus	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
by	O	O
up	O	O
to	O	O
4	O	O
log	O	O
CFU/well	O	O
but	O	O
effects	O	O
of	O	O
other	O	O
teas	O	O
and	O	O
components	O	O
were	O	O
small	O	O
.	O	O

Pu-erh	O	O
and	O	O
chrysanthemum	O	O
tea	O	O
may	O	O
have	O	O
the	O	O
potential	O	O
to	O	O
reduce	O	O
attachment	O	O
of	O	O
oral	O	O
pathogens	O	O
to	O	O
gingival	O	O
tissue	O	O
and	O	O
improve	O	O
the	O	O
health	O	O
of	O	O
oral	O	O
soft	O	O
tissues	O	O
.	O	O

Laminaria	O	O
japonica	O	O
is	O	O
a	O	O
brown	O	O
alga	O	O
,	O	O
which	O	O
is	O	O
consumed	O	O
widely	O	O
in	O	O
Korea	O	O
,	O	O
Japan	O	O
,	O	O
and	O	O
China	O	O
.	O	O

This	O	O
study	O	O
investigated	O	O
the	O	O
antimicrobial	O	O
activity	O	O
of	O	O
ethanol	O	O
extracts	O	O
of	O	O
L.	O	O
japonica	O	O
against	O	O
oral	O	O
microbial	O	O
species	O	O
to	O	O
assess	O	O
the	O	O
possible	O	O
application	O	O
of	O	O
L.	O	O
japonica	O	O
extracts	O	O
in	O	O
dental	O	O
care	O	O
products	O	O
.	O	O

The	O	O
minimal	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
and	O	O
minimal	O	O
bactericidal	O	O
concentration	O	O
(	O	O
MBC	O	O
)	O	O
were	O	O
determined	O	O
in	O	O
culture	O	O
medium	O	O
using	O	O
a	O	O
microdilution	O	O
method	O	O
.	O	O

The	O	O
MICs	O	O
of	O	O
ethanol	O	O
extracts	O	O
of	O	O
L.	O	O
japonica	O	O
with	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
were	O	O
62.5-500	O	O
mug/ml	O	O
and	O	O
the	O	O
MBCs	O	O
were	O	O
125-1000	O	O
mug/ml	O	O
.	O	O

The	O	O
MICs	O	O
of	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
were	O	O
250	O	O
and	O	O
62.5	O	O
mug/ml	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
MBCs	O	O
of	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
and	O	O
A.	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
were	O	O
500	O	O
and	O	O
250	O	O
mug/ml	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
MICs	O	O
were	O	O
250	O	O
and	O	O
62.5	O	O
mug/ml	O	O
for	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
respectively	O	O
.	O	O

The	O	O
killing	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
dependent	O	O
on	O	O
the	O	O
incubation	O	O
time	O	O
.	O	O

The	O	O
killing	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
,	O	O
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
significantly	O	O
dependent	O	O
on	O	O
the	O	O
extract	O	O
concentration	O	O
.	O	O

Bacterial	O	O
treatment	O	O
with	O	O
L.	O	O
japonica	O	O
extracts	O	O
changed	O	O
the	O	O
cell	O	O
surface	O	O
texture	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
,	O	O
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

The	O	O
results	O	O
of	O	O
this	O	O
study	O	O
suggest	O	O
that	O	O
L.	O	O
japonica	O	O
extracts	O	O
may	O	O
be	O	O
useful	O	O
for	O	O
the	O	O
development	O	O
of	O	O
antimicrobial	O	O
agents	O	O
to	O	O
combat	O	O
oral	O	O
pathogens	O	O
.	O	O

The	O	O
human	O	O
oral	O	O
cavity	O	O
has	O	O
an	O	O
indigenous	B-bacteria	B-bacteria
microbiota	E-bacteria	I-bacteria
known	O	O
to	O	O
include	O	O
a	O	O
robust	O	O
community	O	O
of	O	O
viruses	O	O
.	O	O

Very	O	O
little	O	O
is	O	O
known	O	O
about	O	O
how	O	O
oral	O	O
viruses	O	O
are	O	O
spread	O	O
throughout	O	O
the	O	O
environment	O	O
or	O	O
to	O	O
which	O	O
viruses	O	O
individuals	O	O
are	O	O
exposed	O	O
.	O	O

We	O	O
sought	O	O
to	O	O
determine	O	O
whether	O	O
shared	O	O
living	O	O
environment	O	O
is	O	O
associated	O	O
with	O	O
the	O	O
composition	O	O
of	O	O
human	O	O
oral	O	O
viral	O	O
communities	O	O
by	O	O
examining	O	O
the	O	O
saliva	O	O
of	O	O
21	O	O
human	O	O
subjects	O	O
;	O	O
11	O	O
subjects	O	O
from	O	O
different	O	O
households	O	O
and	O	O
10	O	O
unrelated	O	O
subjects	O	O
comprising	O	O
4	O	O
separate	O	O
households	O	O
.	O	O

Although	O	O
there	O	O
were	O	O
many	O	O
viral	O	O
homologues	O	O
shared	O	O
among	O	O
all	O	O
subjects	O	O
studied	O	O
,	O	O
there	O	O
were	O	O
significant	O	O
patterns	O	O
of	O	O
shared	O	O
homologues	O	O
in	O	O
three	O	O
of	O	O
the	O	O
four	O	O
households	O	O
that	O	O
suggest	O	O
shared	O	O
living	O	O
environment	O	O
affects	O	O
viral	O	O
community	O	O
composition	O	O
.	O	O

We	O	O
also	O	O
examined	O	O
CRISPR	O	O
(	O	O
clustered	O	O
regularly	O	O
interspaced	O	O
short	O	O
palindromic	O	O
repeat	O	O
)	O	O
loci	O	O
,	O	O
which	O	O
are	O	O
involved	O	O
in	O	O
acquired	O	O
bacterial	O	O
and	O	O
archaeal	O	O
resistance	O	O
against	O	O
invading	O	O
viruses	O	O
by	O	O
acquiring	O	O
short	O	O
viral	O	O
sequences	O	O
.	O	O

We	O	O
analyzed	O	O
2	O	O
065	O	O
246	O	O
CRISPR	O	O
spacers	O	O
from	O	O
5	O	O
separate	O	O
repeat	O	O
motifs	O	O
found	O	O
in	O	O
oral	O	O
bacterial	O	O
species	O	O
of	O	O
Gemella	B-bacteria	B-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
Leptotrichia	B-bacteria	B-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
to	O	O
determine	O	O
whether	O	O
individuals	O	O
from	O	O
shared	O	O
living	O	O
environments	O	O
may	O	O
have	O	O
been	O	O
exposed	O	O
to	O	O
similar	O	O
viruses	O	O
.	O	O

A	O	O
significant	O	O
proportion	O	O
of	O	O
CRISPR	O	O
spacers	O	O
were	O	O
shared	O	O
within	O	O
subjects	O	O
from	O	O
the	O	O
same	O	O
households	O	O
,	O	O
suggesting	O	O
either	O	O
shared	O	O
ancestry	O	O
of	O	O
their	O	O
oral	O	O
microbiota	O	O
or	O	O
similar	O	O
viral	O	O
exposures	O	O
.	O	O

Many	O	O
CRISPR	O	O
spacers	O	O
matched	O	O
virome	O	O
sequences	O	O
from	O	O
different	O	O
subjects	O	O
,	O	O
but	O	O
no	O	O
pattern	O	O
specific	O	O
to	O	O
any	O	O
household	O	O
was	O	O
found	O	O
.	O	O

Our	O	O
data	O	O
on	O	O
viromes	O	O
and	O	O
CRISPR	O	O
content	O	O
indicate	O	O
that	O	O
shared	O	O
living	O	O
environment	O	O
may	O	O
have	O	O
a	O	O
significant	O	O
role	O	O
in	O	O
determining	O	O
the	O	O
ecology	O	O
of	O	O
human	O	O
oral	O	O
viruses	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
since	O	O
Marshall	O	O
and	O	O
Warren	O	O
's	O	O
discovery	O	O
has	O	O
been	O	O
an	O	O
object	O	O
of	O	O
interest	O	O
of	O	O
gastroenterologists	O	O
and	O	O
many	O	O
researchers	O	O
of	O	O
other	O	O
specialties	O	O
.	O	O

What	O	O
needs	O	O
to	O	O
be	O	O
highlighted	O	O
is	O	O
also	O	O
the	O	O
growing	O	O
interest	O	O
of	O	O
dentists	O	O
in	O	O
the	O	O
role	O	O
of	O	O
oral	O	O
residue	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
oral	O	O
pathologies	O	O
such	O	O
as	O	O
burning	O	O
mouth	O	O
syndrome	O	O
,	O	O
periodontitis	O	O
and	O	O
gingivitis	O	O
.	O	O

With	O	O
the	O	O
development	O	O
of	O	O
medical	O	O
techniques	O	O
more	O	O
studies	O	O
using	O	O
highly	O	O
specific	O	O
diagnostic	O	O
methods	O	O
are	O	O
performed	O	O
in	O	O
order	O	O
to	O	O
determine	O	O
the	O	O
transmission	O	O
pattern	O	O
of	O	O
bacterial	O	O
infection	O	O
.	O	O

Suggested	O	O
faecal-oral	O	O
and	O	O
oral-oral	O	O
routes	O	O
of	O	O
bacterial	O	O
transmission	O	O
raised	O	O
interest	O	O
in	O	O
molecular	O	O
biology	O	O
methods	O	O
as	O	O
tools	O	O
for	O	O
the	O	O
study	O	O
of	O	O
these	O	O
environments	O	O
.	O	O

Additionally	O	O
,	O	O
co-existence	O	O
of	O	O
helical	O	O
and	O	O
coccoidal	O	O
forms	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
mentioned	O	O
niches	O	O
raised	O	O
the	O	O
question	O	O
whether	O	O
the	O	O
latter	O	O
is	O	O
potentially	O	O
pathogenic	O	O
.	O	O

This	O	O
is	O	O
why	O	O
molecular	O	O
biology	O	O
is	O	O
now	O	O
giving	O	O
a	O	O
great	O	O
opportunity	O	O
to	O	O
explore	O	O
parts	O	O
of	O	O
the	O	O
human	O	O
body	O	O
that	O	O
could	O	O
not	O	O
have	O	O
been	O	O
diagnosed	O	O
before	O	O
using	O	O
only	O	O
gold	O	O
standard	O	O
diagnostic	O	O
methods	O	O
.	O	O

Molecular	O	O
techniques	O	O
have	O	O
shown	O	O
their	O	O
usefulness	O	O
in	O	O
examining	O	O
the	O	O
potential	O	O
virulence	O	O
of	O	O
coccoid	B-bacteria	B-bacteria
forms	I-bacteria	I-bacteria
of	I-bacteria	I-bacteria
bacterium	E-bacteria	I-bacteria
.	O	O

This	O	O
review	O	O
was	O	O
created	O	O
also	O	O
to	O	O
summarize	O	O
the	O	O
knowledge	O	O
about	O	O
molecular	O	O
methods	O	O
,	O	O
especially	O	O
different	O	O
PCR	O	O
techniques	O	O
,	O	O
as	O	O
diagnostic	O	O
tools	O	O
that	O	O
can	O	O
help	O	O
medical	O	O
teams	O	O
during	O	O
regular	O	O
diagnosis	O	O
of	O	O
gastritis	O	O
.	O	O

The	O	O
link	O	O
between	O	O
oral	O	O
infections	O	O
and	O	O
adverse	O	O
systemic	O	O
conditions	O	O
has	O	O
attracted	O	O
much	O	O
attention	O	O
in	O	O
the	O	O
research	O	O
community	O	O
.	O	O

Several	O	O
mechanisms	O	O
have	O	O
been	O	O
proposed	O	O
,	O	O
including	O	O
spread	O	O
of	O	O
the	O	O
oral	O	O
infection	O	O
due	O	O
to	O	O
transient	O	O
bacteremia	O	O
resulting	O	O
in	O	O
bacterial	O	O
colonization	O	O
in	O	O
extra-oral	O	O
sites	O	O
,	O	O
systemic	O	O
injury	O	O
by	O	O
free	O	O
toxins	O	O
of	O	O
oral	O	O
pathogens	O	O
,	O	O
and	O	O
systemic	O	O
inflammation	O	O
caused	O	O
by	O	O
soluble	O	O
antigens	O	O
of	O	O
oral	O	O
pathogens	O	O
.	O	O

Mounting	O	O
evidence	O	O
supports	O	O
a	O	O
major	O	O
role	O	O
of	O	O
the	O	O
systemic	O	O
spread	O	O
of	O	O
oral	O	O
commensals	O	O
and	O	O
pathogens	O	O
to	O	O
distant	O	O
body	O	O
sites	O	O
causing	O	O
extra-oral	O	O
infections	O	O
and	O	O
inflammation	O	O
.	O	O

We	O	O
review	O	O
here	O	O
the	O	O
most	O	O
recent	O	O
findings	O	O
on	O	O
systemic	O	O
infections	O	O
and	O	O
inflammation	O	O
complicated	O	O
by	O	O
oral	O	O
bacteria	O	O
,	O	O
including	O	O
cardiovascular	O	O
disease	O	O
,	O	O
adverse	O	O
pregnancy	O	O
outcomes	O	O
,	O	O
rheumatoid	O	O
arthritis	O	O
,	O	O
inflammatory	O	O
bowel	O	O
disease	O	O
and	O	O
colorectal	O	O
cancer	O	O
,	O	O
respiratory	O	O
tract	O	O
infections	O	O
,	O	O
and	O	O
organ	O	O
inflammations	O	O
and	O	O
abscesses	O	O
.	O	O

The	O	O
recently	O	O
identified	O	O
virulence	O	O
mechanisms	O	O
of	O	O
oral	O	O
species	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
and	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
are	O	O
also	O	O
reviewed	O	O
.	O	O

A	O	O
pattern	O	O
emerges	O	O
indicating	O	O
that	O	O
only	O	O
select	O	O
subtype	O	O
(	O	O
s	O	O
)	O	O
of	O	O
a	O	O
given	O	O
species	O	O
,	O	O
e.g.	O	O
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
subspecies	O	O
animalis	O	O
and	O	O
polymorphum	O	O
and	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
non-c	O	O
serotypes	O	O
,	O	O
are	O	O
prone	O	O
to	O	O
extra-oral	O	O
translocation	O	O
.	O	O

These	O	O
findings	O	O
advocate	O	O
the	O	O
importance	O	O
of	O	O
identification	O	O
and	O	O
quantification	O	O
of	O	O
potential	O	O
pathogens	O	O
at	O	O
the	O	O
subtype	O	O
levels	O	O
for	O	O
accurate	O	O
prediction	O	O
of	O	O
disease	O	O
potential	O	O
.	O	O

Ethanol	O	O
consumption	O	O
and	O	O
poor	O	O
oral	O	O
hygiene	O	O
are	O	O
risk	O	O
factors	O	O
for	O	O
oral	O	O
and	O	O
oesophageal	O	O
cancers	O	O
.	O	O

Although	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
have	O	O
been	O	O
found	O	O
to	O	O
produce	O	O
excessive	O	O
acetaldehyde	O	O
from	O	O
ethanol	O	O
,	O	O
little	O	O
is	O	O
known	O	O
about	O	O
the	O	O
mechanism	O	O
by	O	O
which	O	O
this	O	O
carcinogen	O	O
is	O	O
produced	O	O
.	O	O

By	O	O
screening	O	O
52	O	O
strains	O	O
of	O	O
diverse	O	O
oral	O	O
streptococcal	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
we	O	O
identified	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
V2016	E-bacteria	I-bacteria
that	O	O
produced	O	O
the	O	O
most	O	O
acetaldehyde	O	O
from	O	O
ethanol	O	O
.	O	O

We	O	O
then	O	O
constructed	O	O
gene	O	O
deletion	O	O
mutants	O	O
in	O	O
this	O	O
strain	O	O
and	O	O
analysed	O	O
them	O	O
for	O	O
alcohol	O	O
and	O	O
acetaldehyde	O	O
dehydrogenases	O	O
by	O	O
zymograms	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
that	O	O
S.	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
V2016	E-bacteria	I-bacteria
expressed	O	O
three	O	O
primary	O	O
alcohol	O	O
dehydrogenases	O	O
,	O	O
AdhA	O	O
,	O	O
AdhB	O	O
and	O	O
AdhE	O	O
,	O	O
which	O	O
all	O	O
oxidize	O	O
ethanol	O	O
to	O	O
acetaldehyde	O	O
,	O	O
but	O	O
their	O	O
preferred	O	O
substrates	O	O
were	O	O
1-propanol	O	O
,	O	O
1-butanol	O	O
and	O	O
ethanol	O	O
,	O	O
respectively	O	O
.	O	O

Two	O	O
additional	O	O
dehydrogenases	O	O
,	O	O
S-AdhA	O	O
and	O	O
TdhA	O	O
,	O	O
were	O	O
identified	O	O
with	O	O
specificities	O	O
to	O	O
the	O	O
secondary	O	O
alcohol	O	O
2-propanol	O	O
and	O	O
threonine	O	O
,	O	O
respectively	O	O
,	O	O
but	O	O
not	O	O
to	O	O
ethanol	O	O
.	O	O

S.	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
V2016	E-bacteria	I-bacteria
did	O	O
not	O	O
show	O	O
a	O	O
detectable	O	O
acetaldehyde	O	O
dehydrogenase	O	O
even	O	O
though	O	O
its	O	O
adhE	O	O
gene	O	O
encodes	O	O
a	O	O
putative	O	O
bifunctional	O	O
acetaldehyde/alcohol	O	O
dehydrogenase	O	O
.	O	O

Mutants	O	O
with	O	O
adhE	O	O
deletion	O	O
showed	O	O
greater	O	O
tolerance	O	O
to	O	O
ethanol	O	O
in	O	O
comparison	O	O
with	O	O
the	O	O
wild-type	O	O
and	O	O
mutant	O	O
with	O	O
adhA	O	O
or	O	O
adhB	O	O
deletion	O	O
,	O	O
indicating	O	O
that	O	O
AdhE	O	O
is	O	O
the	O	O
major	O	O
alcohol	O	O
dehydrogenase	O	O
in	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
.	O	O

Analysis	O	O
of	O	O
19	O	O
additional	O	O
strains	O	O
of	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
showed	O	O
expressions	O	O
of	O	O
up	O	O
to	O	O
three	O	O
alcohol	O	O
dehydrogenases	O	O
,	O	O
but	O	O
none	O	O
showed	O	O
detectable	O	O
acetaldehyde	O	O
dehydrogenase	O	O
,	O	O
except	O	O
one	O	O
strain	O	O
that	O	O
showed	O	O
a	O	O
novel	O	O
ALDH	O	O
.	O	O

Therefore	O	O
,	O	O
expression	O	O
of	O	O
multiple	O	O
alcohol	O	O
dehydrogenases	O	O
but	O	O
no	O	O
functional	O	O
acetaldehyde	O	O
dehydrogenase	O	O
may	O	O
contribute	O	O
to	O	O
excessive	O	O
production	O	O
of	O	O
acetaldehyde	O	O
from	O	O
ethanol	O	O
by	O	O
certain	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
current	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
presence	O	O
of	O	O
sulphate-reducing	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
SRB	B-bacteria	B-bacteria
)	O	O
in	O	O
human	O	O
saliva	O	O
and	O	O
correlate	O	O
with	O	O
oral	O	O
and	O	O
systemic	O	O
conditions	O	O
.	O	O

Saliva	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
118	O	O
patients	O	O
and	O	O
inoculated	O	O
in	O	O
2	O	O
ml	O	O
of	O	O
modified	O	O
Postgate	O	O
's	O	O
E	O	O
medium	O	O
culture	O	O
.	O	O

After	O	O
28	O	O
days	O	O
of	O	O
incubation	O	O
at	O	O
30	O	O
degrees	O	O
C	O	O
the	O	O
presence	O	O
of	O	O
SRB	B-bacteria	B-bacteria
was	O	O
identified	O	O
by	O	O
the	O	O
production	O	O
of	O	O
sulphide	O	O
.	O	O

Of	O	O
118	O	O
saliva	O	O
samples	O	O
collected	O	O
,	O	O
35	O	O
were	O	O
positive	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
SRB	B-bacteria	B-bacteria
.	O	O

Three	O	O
positive	O	O
samples	O	O
were	O	O
randomly	O	O
chosen	O	O
to	O	O
identify	O	O
the	O	O
species	O	O
of	O	O
SRB	O	O
by	O	O
PCR	O	O
and	O	O
sequenced	O	O
.	O	O

The	O	O
three	O	O
selected	O	O
samples	O	O
were	O	O
identified	O	O
as	O	O
Desulfovibrio	B-bacteria	B-bacteria
fairfieldensis	E-bacteria	I-bacteria
,	O	O
Desulfovibrio	B-bacteria	B-bacteria
desulfuricans	E-bacteria	I-bacteria
and	O	O
Raoultella	B-bacteria	B-bacteria
ornithinolytic	E-bacteria	I-bacteria
.	O	O

Gastritis	O	O
(	O	O
14.4	O	O
%	O	O
)	O	O
was	O	O
the	O	O
most	O	O
prevalent	O	O
systemic	O	O
disease	O	O
,	O	O
followed	O	O
by	O	O
diabetes	O	O
(	O	O
3.4	O	O
%	O	O
)	O	O
,	O	O
while	O	O
periodontitis	O	O
(	O	O
11	O	O
%	O	O
)	O	O
and	O	O
traumatic	O	O
fibroma	O	O
(	O	O
4.2	O	O
%	O	O
)	O	O
were	O	O
the	O	O
oral	O	O
manifestations	O	O
most	O	O
frequently	O	O
found	O	O
.	O	O

A	O	O
bivariate	O	O
analysis	O	O
was	O	O
performed	O	O
to	O	O
examine	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
SRB	O	O
and	O	O
the	O	O
most	O	O
prevalent	O	O
systemic	O	O
and	O	O
oral	O	O
manifestations	O	O
.	O	O

Only	O	O
periodontitis	O	O
showed	O	O
a	O	O
statistically	O	O
significant	O	O
association	O	O
(	O	O
p	O	O
=	O	O
0.0003	O	O
)	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
SRB	B-bacteria	B-bacteria
can	O	O
be	O	O
found	O	O
in	O	O
oral	O	O
microbiota	O	O
of	O	O
healthy	O	O
patients	O	O
.	O	O

Regarding	O	O
the	O	O
several	O	O
conditions	O	O
studied	O	O
,	O	O
there	O	O
was	O	O
a	O	O
higher	O	O
prevalence	O	O
of	O	O
SRB	B-bacteria	B-bacteria
in	O	O
patients	O	O
with	O	O
gastritis	O	O
and	O	O
patients	O	O
with	O	O
periodontal	O	O
disease	O	O
,	O	O
with	O	O
a	O	O
possible	O	O
correlation	O	O
between	O	O
the	O	O
presence	O	O
of	O	O
SRB	B-bacteria	B-bacteria
in	O	O
the	O	O
oral	O	O
microbiota	O	O
and	O	O
periodontal	O	O
disease	O	O
.	O	O

Oral	O	O
cavity	O	O
has	O	O
been	O	O
proposed	O	O
as	O	O
an	O	O
important	O	O
reservoir	O	O
of	O	O
H.pylori	B-bacteria	B-bacteria
,	O	O
being	O	O
implicated	O	O
in	O	O
bacterial	O	O
transmission	O	O
through	O	O
oral-oral	O	O
route	O	O
.	O	O

However	O	O
,	O	O
some	O	O
investigators	O	O
believe	O	O
that	O	O
the	O	O
newborn	O	O
acquires	O	O
H.pylori	B-bacteria	B-bacteria
from	O	O
mother	O	O
through	O	O
vaginal	O	O
delivery	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
oral	O	O
and	O	O
vaginal	O	O
yeasts	O	O
were	O	O
examined	O	O
for	O	O
the	O	O
intracellular	O	O
occurrence	O	O
of	O	O
H.pylori	B-bacteria	B-bacteria
and	O	O
their	O	O
possible	O	O
role	O	O
in	O	O
bacterial	O	O
transmission	O	O
.	O	O

Sixty	O	O
nine	O	O
oral	O	O
and	O	O
vaginal	O	O
yeasts	O	O
from	O	O
expecting	O	O
mothers	O	O
(	O	O
39	O	O
oral	O	O
and	O	O
30	O	O
vaginal	O	O
)	O	O
and	O	O
seven	O	O
oral	O	O
yeasts	O	O
from	O	O
neonates	O	O
(	O	O
6/46	O	O
vaginal	O	O
delivery	O	O
,	O	O
1/43	O	O
cesarean	O	O
)	O	O
were	O	O
identified	O	O
and	O	O
studied	O	O
by	O	O
light	O	O
and	O	O
fluorescent	O	O
microscopy	O	O
for	O	O
observing	O	O
the	O	O
intracellular	O	O
bacterium-like	O	O
bodies	O	O
(	O	O
BLBs	O	O
)	O	O
.	O	O

Whole	O	O
DNAs	O	O
of	O	O
yeasts	O	O
were	O	O
recruited	O	O
for	O	O
detection	O	O
of	O	O
H.pylori-specific	O	O
genes	O	O
.	O	O

Urea	O	O
breath	O	O
test	O	O
(	O	O
UBT	O	O
)	O	O
was	O	O
performed	O	O
for	O	O
detection	O	O
of	O	O
H.pylori	B-bacteria	B-bacteria
infection	O	O
in	O	O
mothers	O	O
.	O	O

Stool	O	O
antigen	O	O
test	O	O
(	O	O
SAT	O	O
)	O	O
was	O	O
used	O	O
for	O	O
detection	O	O
of	O	O
H.pylori	B-bacteria	B-bacteria
antigens	O	O
in	O	O
infants	O	O
'	O	O
stool	O	O
at	O	O
birth	O	O
and	O	O
six	O	O
months	O	O
of	O	O
age	O	O
.	O	O

Oral	O	O
yeasts	O	O
were	O	O
isolated	O	O
more	O	O
frequently	O	O
from	O	O
normally-delivered	O	O
neonates	O	O
.	O	O

The	O	O
frequency	O	O
of	O	O
H.pylori	B-bacteria	B-bacteria
genes	O	O
in	O	O
mothers	O	O
'	O	O
vaginal	O	O
yeasts	O	O
was	O	O
significantly	O	O
higher	O	O
than	O	O
in	O	O
mothers	O	O
'	O	O
oral	O	O
yeasts	O	O
.	O	O

A	O	O
significant	O	O
correlation	O	O
was	O	O
found	O	O
between	O	O
the	O	O
occurrence	O	O
of	O	O
H.pylori	B-bacteria	B-bacteria
genes	O	O
in	O	O
vaginal	O	O
yeasts	O	O
and	O	O
that	O	O
in	O	O
neonates	O	O
'	O	O
oral	O	O
yeasts	O	O
,	O	O
occurrence	O	O
of	O	O
H.pylori	B-bacteria	B-bacteria
genes	O	O
in	O	O
mothers	O	O
'	O	O
vaginal	O	O
yeasts	O	O
or	O	O
neonates	O	O
'	O	O
oral	O	O
yeasts	O	O
,	O	O
and	O	O
UBT+	O	O
results	O	O
in	O	O
mothers	O	O
.	O	O

C.albicans	O	O
which	O	O
colonizes	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
neonates	O	O
through	O	O
vaginal	O	O
delivery	O	O
or	O	O
contact	O	O
with	O	O
environment	O	O
or	O	O
healthcare	O	O
workers	O	O
could	O	O
be	O	O
an	O	O
important	O	O
reservoir	O	O
of	O	O
H.pylori	B-bacteria	B-bacteria
.	O	O

Vaginal	O	O
yeasts	O	O
are	O	O
more	O	O
potent	O	O
in	O	O
accommodating	O	O
H.pylori	B-bacteria	B-bacteria
than	O	O
oral	O	O
yeasts	O	O
.	O	O

Accordingly	O	O
,	O	O
vaginal	O	O
yeast	O	O
is	O	O
proposed	O	O
as	O	O
the	O	O
primary	O	O
reservoir	O	O
of	O	O
H.pylori	B-bacteria	B-bacteria
which	O	O
facilitates	O	O
H.pylori	B-bacteria	B-bacteria
transmission	O	O
to	O	O
neonates	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
assess	O	O
the	O	O
red	O	O
autofluorescence	O	O
from	O	O
bacterial	O	O
species	O	O
related	O	O
to	O	O
dental	O	O
caries	O	O
and	O	O
periodontitis	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
different	O	O
nutrients	O	O
in	O	O
the	O	O
growth	O	O
medium	O	O
.	O	O

Bacteria	O	O
were	O	O
grown	O	O
anaerobically	O	O
on	O	O
tryptic	O	O
soy	O	O
agar	O	O
(	O	O
TSA	O	O
)	O	O
supplemented	O	O
with	O	O
nutrients	O	O
,	O	O
including	O	O
magnesium-porphyrins	O	O
from	O	O
spinach	O	O
and	O	O
iron-porphyrins	O	O
from	O	O
heme	O	O
.	O	O

The	O	O
autofluorescence	O	O
was	O	O
then	O	O
assessed	O	O
at	O	O
405	O	O
nm	O	O
excitation	O	O
.	O	O

On	O	O
the	O	O
TSA	O	O
without	O	O
additives	O	O
,	O	O
no	O	O
autofluorescence	O	O
was	O	O
observed	O	O
from	O	O
any	O	O
of	O	O
the	O	O
species	O	O
tested	O	O
.	O	O

On	O	O
the	O	O
TSA	O	O
containing	O	O
sheep	O	O
blood	O	O
,	O	O
red	O	O
autofluorescence	O	O
was	O	O
observed	O	O
only	O	O
from	O	O
Parvimonas	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
.	O	O

When	O	O
the	O	O
TSA	O	O
was	O	O
supplemented	O	O
with	O	O
blood	O	O
,	O	O
hemin	O	O
,	O	O
and	O	O
vitamin	O	O
K	O	O
,	O	O
red	O	O
autofluorescence	O	O
was	O	O
observed	O	O
from	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
Bifidobacterium	B-bacteria	B-bacteria
dentium	E-bacteria	I-bacteria
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Finally	O	O
,	O	O
on	O	O
the	O	O
TSA	O	O
supplemented	O	O
with	O	O
spinach	O	O
extract	O	O
,	O	O
red	O	O
autofluorescence	O	O
was	O	O
observed	O	O
from	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
and	O	O
Veillonella	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
.	O	O

We	O	O
conclude	O	O
that	O	O
the	O	O
bacteria	O	O
related	O	O
to	O	O
dental	O	O
caries	O	O
and	O	O
periodontal	O	O
disease	O	O
exhibit	O	O
red	O	O
autofluorescence	O	O
.	O	O

The	O	O
autofluorescence	O	O
characteristics	O	O
of	O	O
the	O	O
tested	O	O
strains	O	O
depended	O	O
on	O	O
the	O	O
nutrients	O	O
present	O	O
,	O	O
such	O	O
as	O	O
metalloporphyrins	O	O
,	O	O
suggesting	O	O
that	O	O
the	O	O
metabolic	O	O
products	O	O
of	O	O
the	O	O
oral	O	O
biofilm	O	O
could	O	O
be	O	O
responsible	O	O
for	O	O
red	O	O
autofluorescence	O	O
.	O	O

Approximately	O	O
15	O	O
%	O	O
of	O	O
human	O	O
deaths	O	O
from	O	O
cancer	O	O
are	O	O
associated	O	O
with	O	O
chronic	O	O
viral	O	O
or	O	O
bacterial	O	O
infections	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
(	O	O
HP	B-bacteria	B-bacteria
)	O	O
,	O	O
a	O	O
flagellated	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
spiral	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
microaerophilic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
is	O	O
considered	O	O
to	O	O
be	O	O
the	O	O
most	O	O
common	O	O
chronic	O	O
bacterial	O	O
infection	O	O
in	O	O
humans	O	O
.	O	O

Toll-like	O	O
receptor	O	O
5	O	O
(	O	O
TLR5	O	O
)	O	O
is	O	O
involved	O	O
in	O	O
recognition	O	O
of	O	O
bacterial	O	O
flagella	O	O
and	O	O
is	O	O
thought	O	O
to	O	O
promote	O	O
tumour	O	O
growth	O	O
through	O	O
inflammation-dependent	O	O
mechanisms	O	O
in	O	O
epithelial	O	O
cells	O	O
.	O	O

Expression	O	O
of	O	O
HP	B-bacteria	B-bacteria
and	O	O
TLR5	O	O
was	O	O
analysed	O	O
in	O	O
OSCC	O	O
specimen	O	O
(	O	O
n	O	O
=	O	O
191	O	O
)	O	O
by	O	O
immunohistochemistry	O	O
.	O	O

TLR5	O	O
expression	O	O
specificity	O	O
was	O	O
conducted	O	O
by	O	O
Western	O	O
blotting	O	O
in	O	O
cancer	O	O
cell	O	O
lines	O	O
(	O	O
BICR3	O	O
,	O	O
BICR56	O	O
)	O	O
.	O	O

TLR5-stained	O	O
sections	O	O
were	O	O
scanned	O	O
and	O	O
digitally	O	O
analysed	O	O
using	O	O
ImageJ	O	O
and	O	O
the	O	O
immunomembrane	O	O
plug-in	O	O
.	O	O

HP	B-bacteria	B-bacteria
expression	O	O
and	O	O
TLR5	O	O
expression	O	O
were	O	O
associated	O	O
with	O	O
clinicopathological	O	O
characteristics	O	O
and	O	O
impact	O	O
on	O	O
survival	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
detection	O	O
was	O	O
significantly	O	O
associated	O	O
with	O	O
recurrence	O	O
of	O	O
the	O	O
tumour	O	O
,	O	O
whereas	O	O
TLR5	O	O
expression	O	O
was	O	O
not	O	O
.	O	O

Multivariate	O	O
analysis	O	O
demonstrated	O	O
HP	B-bacteria	B-bacteria
expression	O	O
as	O	O
an	O	O
independent	O	O
prognostic	O	O
factor	O	O
(	O	O
P	O	O
=	O	O
0.0260	O	O
)	O	O
.	O	O

TLR5	O	O
specificity	O	O
was	O	O
confirmed	O	O
by	O	O
Western	O	O
blot	O	O
analysis	O	O
.	O	O

For	O	O
the	O	O
first	O	O
time	O	O
,	O	O
this	O	O
study	O	O
provides	O	O
evidence	O	O
that	O	O
immunohistochemically	O	O
detected	O	O
HP	B-bacteria	B-bacteria
expression	O	O
in	O	O
OSCC	O	O
is	O	O
associated	O	O
with	O	O
reduced	O	O
disease-free	O	O
survival	O	O
in	O	O
a	O	O
large	O	O
patient	O	O
cohort	O	O
.	O	O

Although	O	O
TLR5	O	O
was	O	O
not	O	O
associated	O	O
with	O	O
any	O	O
clinicopathological	O	O
characteristics	O	O
or	O	O
impact	O	O
on	O	O
survival	O	O
,	O	O
investigation	O	O
of	O	O
the	O	O
TLR	O	O
family	O	O
seems	O	O
to	O	O
be	O	O
reasonable	O	O
due	O	O
to	O	O
the	O	O
possible	O	O
existence	O	O
of	O	O
other	O	O
pathogenic	O	O
bacterial	O	O
or	O	O
viral	O	O
compounds	O	O
in	O	O
oral	O	O
cavity	O	O
cancer	O	O
.	O	O

There	O	O
is	O	O
a	O	O
paucity	O	O
of	O	O
data	O	O
in	O	O
relation	O	O
to	O	O
the	O	O
possible	O	O
emergence	O	O
of	O	O
triclosan	O	O
(	O	O
TCS	O	O
)	O	O
-resistant	O	O
bacteria	O	O
following	O	O
long-term	O	O
exposure	O	O
to	O	O
TCS	O	O
toothpaste	O	O
.	O	O

Therefore	O	O
,	O	O
this	O	O
study	O	O
investigated	O	O
whether	O	O
long-term	O	O
continuous	O	O
exposure	O	O
to	O	O
TCS	O	O
in	O	O
toothpaste	O	O
selects	O	O
for	O	O
TCS-resistant	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
within	O	O
the	O	O
oral	O	O
biofilm	O	O
.	O	O

Dental	O	O
plaque	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
40	O	O
individuals	O	O
during	O	O
year	O	O
5	O	O
of	O	O
a	O	O
randomised	O	O
controlled	O	O
trial	O	O
.	O	O

Participants	O	O
had	O	O
been	O	O
randomly	O	O
assigned	O	O
to	O	O
use	O	O
TCS	O	O
(	O	O
3000	O	O
mug/mL	O	O
TCS	O	O
)	O	O
(	O	O
n	O	O
=	O	O
18	O	O
)	O	O
or	O	O
placebo	O	O
toothpaste	O	O
(	O	O
n	O	O
=	O	O
22	O	O
)	O	O
.	O	O

Diluted	O	O
plaque	O	O
samples	O	O
were	O	O
plated	O	O
on	O	O
to	O	O
Wilkins-Chalgren	O	O
agar	O	O
plates	O	O
containing	O	O
5	O	O
%	O	O
(	O	O
v/v	O	O
)	O	O
laked	O	O
sheep	O	O
red	O	O
blood	O	O
cells	O	O
and	O	O
TCS	O	O
(	O	O
concentrations	O	O
ranging	O	O
from	O	O
25	O	O
to	O	O
150	O	O
mug/mL	O	O
)	O	O
and	O	O
incubated	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
under	O	O
microaerophilic	O	O
and	O	O
anaerobic	O	O
conditions	O	O
for	O	O
2-10	O	O
d.	O	O
Selected	O	O
bacterial	O	O
isolates	O	O
were	O	O
identified	O	O
by	O	O
partial	O	O
16S	O	O
rDNA	O	O
sequencing	O	O
and	O	O
TCS	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
determined	O	O
for	O	O
each	O	O
isolate	O	O
.	O	O

At	O	O
3000	O	O
mug/mL	O	O
TCS	O	O
no	O	O
growth	O	O
was	O	O
observed	O	O
under	O	O
microaerophilic	O	O
or	O	O
anaerobic	O	O
conditions	O	O
in	O	O
either	O	O
group	O	O
.	O	O

The	O	O
MICs	O	O
of	O	O
TCS	O	O
for	O	O
all	O	O
isolates	O	O
ranged	O	O
from	O	O
125	O	O
to	O	O
1000	O	O
mug/mL	O	O
in	O	O
both	O	O
groups	O	O
.	O	O

Species	O	O
common	O	O
to	O	O
both	O	O
groups	O	O
had	O	O
similar	O	O
MICs	O	O
.	O	O

Veillonella	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
and	O	O
Campylobacter	B-bacteria	B-bacteria
gracilis	E-bacteria	I-bacteria
were	O	O
the	O	O
most	O	O
frequent	O	O
isolates	O	O
from	O	O
both	O	O
groups	O	O
,	O	O
with	O	O
similar	O	O
MICs	O	O
in	O	O
both	O	O
groups	O	O
.	O	O

The	O	O
use	O	O
of	O	O
TCS-containing	O	O
toothpaste	O	O
did	O	O
not	O	O
appear	O	O
to	O	O
lead	O	O
to	O	O
an	O	O
increase	O	O
in	O	O
MIC	O	O
of	O	O
TCS	O	O
of	O	O
oral	O	O
bacterial	O	O
isolates	O	O
.	O	O

Molecular	O	O
biological	O	O
modalities	O	O
with	O	O
better	O	O
detection	O	O
rates	O	O
have	O	O
been	O	O
applied	O	O
to	O	O
identify	O	O
the	O	O
bacteria	O	O
causing	O	O
infectious	O	O
diseases	O	O
.	O	O

Approximately	O	O
10-48	O	O
%	O	O
of	O	O
bacterial	O	O
pathogens	O	O
causing	O	O
community-acquired	O	O
pneumonia	O	O
are	O	O
not	O	O
identified	O	O
using	O	O
conventional	O	O
cultivation	O	O
methods	O	O
.	O	O

This	O	O
study	O	O
evaluated	O	O
the	O	O
bacteriological	O	O
causes	O	O
of	O	O
community-acquired	O	O
pneumonia	O	O
using	O	O
a	O	O
cultivation-independent	O	O
clone	O	O
library	O	O
analysis	O	O
of	O	O
the	O	O
16S	O	O
ribosomal	O	O
RNA	O	O
gene	O	O
of	O	O
bronchoalveolar	O	O
lavage	O	O
specimens	O	O
,	O	O
and	O	O
compared	O	O
the	O	O
results	O	O
with	O	O
those	O	O
of	O	O
conventional	O	O
cultivation	O	O
methods	O	O
.	O	O

Patients	O	O
with	O	O
community-acquired	O	O
pneumonia	O	O
were	O	O
enrolled	O	O
based	O	O
on	O	O
their	O	O
clinical	O	O
and	O	O
radiological	O	O
findings	O	O
.	O	O

Bronchoalveolar	O	O
lavage	O	O
specimens	O	O
were	O	O
collected	O	O
from	O	O
pulmonary	O	O
pathological	O	O
lesions	O	O
using	O	O
bronchoscopy	O	O
and	O	O
evaluated	O	O
by	O	O
both	O	O
a	O	O
culture-independent	O	O
molecular	O	O
method	O	O
and	O	O
conventional	O	O
cultivation	O	O
methods	O	O
.	O	O

For	O	O
the	O	O
culture-independent	O	O
molecular	O	O
method	O	O
,	O	O
approximately	O	O
600	O	O
base	O	O
pairs	O	O
of	O	O
16S	O	O
ribosomal	O	O
RNA	O	O
genes	O	O
were	O	O
amplified	O	O
using	O	O
polymerase	O	O
chain	O	O
reaction	O	O
with	O	O
universal	O	O
primers	O	O
,	O	O
followed	O	O
by	O	O
the	O	O
construction	O	O
of	O	O
clone	O	O
libraries	O	O
.	O	O

The	O	O
nucleotide	O	O
sequences	O	O
of	O	O
96	O	O
clones	O	O
randomly	O	O
chosen	O	O
for	O	O
each	O	O
specimen	O	O
were	O	O
determined	O	O
,	O	O
and	O	O
bacterial	O	O
homology	O	O
was	O	O
searched	O	O
.	O	O

Conventional	O	O
cultivation	O	O
methods	O	O
,	O	O
including	O	O
anaerobic	O	O
cultures	O	O
,	O	O
were	O	O
also	O	O
performed	O	O
using	O	O
the	O	O
same	O	O
specimens	O	O
.	O	O

In	O	O
addition	O	O
to	O	O
known	O	O
common	O	O
pathogens	O	O
of	O	O
community-acquired	O	O
pneumonia	O	O
[	O	O
Streptococcus	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
(	O	O
18.8	O	O
%	O	O
)	O	O
,	O	O
Haemophilus	B-bacteria	B-bacteria
influenzae	E-bacteria	I-bacteria
(	O	O
18.8	O	O
%	O	O
)	O	O
,	O	O
Mycoplasma	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
(	O	O
17.2	O	O
%	O	O
)	O	O
]	O	O
,	O	O
molecular	O	O
analysis	O	O
of	O	O
specimens	O	O
from	O	O
64	O	O
patients	O	O
with	O	O
community-acquired	O	O
pneumonia	O	O
showed	O	O
relatively	O	O
higher	O	O
rates	O	O
of	O	O
anaerobes	B-bacteria	B-bacteria
(	O	O
15.6	O	O
%	O	O
)	O	O
and	O	O
oral	O	O
bacteria	O	O
(	O	O
15.6	O	O
%	O	O
)	O	O
than	O	O
previous	O	O
reports	O	O
.	O	O

Our	O	O
findings	O	O
suggest	O	O
that	O	O
anaerobes	B-bacteria	B-bacteria
and	O	O
oral	O	O
bacteria	O	O
are	O	O
more	O	O
frequently	O	O
detected	O	O
in	O	O
patients	O	O
with	O	O
community-acquired	O	O
pneumonia	O	O
than	O	O
previously	O	O
believed	O	O
.	O	O

It	O	O
is	O	O
possible	O	O
that	O	O
these	O	O
bacteria	O	O
may	O	O
play	O	O
more	O	O
important	O	O
roles	O	O
in	O	O
community-acquired	O	O
pneumonia	O	O
.	O	O

We	O	O
aimed	O	O
to	O	O
determine	O	O
the	O	O
bacterial	O	O
diversity	O	O
of	O	O
different	O	O
oral	O	O
micro-niches	O	O
and	O	O
to	O	O
assess	O	O
whether	O	O
saliva	O	O
and	O	O
plaque	O	O
samples	O	O
are	O	O
representative	O	O
of	O	O
oral	O	O
microbial	O	O
composition	O	O
.	O	O

We	O	O
took	O	O
minute	O	O
samples	O	O
from	O	O
each	O	O
surface	O	O
of	O	O
the	O	O
individual	O	O
teeth	O	O
and	O	O
gingival	O	O
crevices	O	O
of	O	O
two	O	O
healthy	O	O
volunteers	O	O
(	O	O
112	O	O
samples	O	O
per	O	O
donor	O	O
)	O	O
,	O	O
as	O	O
well	O	O
as	O	O
samples	O	O
from	O	O
the	O	O
tongue	O	O
dorsum	O	O
and	O	O
non-stimulated	O	O
and	O	O
stimulated	O	O
saliva	O	O
.	O	O

DNA	O	O
was	O	O
extracted	O	O
from	O	O
67	O	O
selected	O	O
samples	O	O
of	O	O
each	O	O
donor	O	O
,	O	O
and	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
was	O	O
amplified	O	O
by	O	O
PCR	O	O
and	O	O
pyrosequenced	O	O
to	O	O
obtain	O	O
,	O	O
on	O	O
average	O	O
,	O	O
over	O	O
2,700	O	O
reads	O	O
per	O	O
sample	O	O
,	O	O
which	O	O
were	O	O
taxonomically	O	O
assigned	O	O
to	O	O
obtain	O	O
a	O	O
geographic	O	O
map	O	O
of	O	O
bacterial	O	O
diversity	O	O
at	O	O
each	O	O
tooth	O	O
and	O	O
sulcus	O	O
location	O	O
.	O	O

Analysis	O	O
of	O	O
the	O	O
data	O	O
shows	O	O
considerable	O	O
differences	O	O
in	O	O
bacterial	O	O
composition	O	O
between	O	O
teeth	O	O
at	O	O
different	O	O
intra-oral	O	O
locations	O	O
and	O	O
between	O	O
surfaces	O	O
of	O	O
the	O	O
same	O	O
tooth	O	O
.	O	O

The	O	O
most	O	O
pronounced	O	O
differences	O	O
were	O	O
observed	O	O
in	O	O
incisors	O	O
and	O	O
canines	O	O
,	O	O
where	O	O
genera	O	O
like	O	O
Streptococcus	B-bacteria	B-bacteria
were	O	O
found	O	O
at	O	O
40	O	O
%	O	O
to	O	O
70	O	O
%	O	O
on	O	O
the	O	O
vestibular	O	O
surfaces	O	O
but	O	O
were	O	O
almost	O	O
absent	O	O
on	O	O
the	O	O
lingual	O	O
sides	O	O
.	O	O

Saliva	O	O
samples	O	O
,	O	O
especially	O	O
non-stimulated	O	O
saliva	O	O
,	O	O
were	O	O
not	O	O
representative	O	O
of	O	O
supra-and	O	O
subgingival	O	O
plaque	O	O
in	O	O
the	O	O
two	O	O
individuals	O	O
tested	O	O
.	O	O

We	O	O
suggest	O	O
that	O	O
more	O	O
precise	O	O
sampling	O	O
is	O	O
required	O	O
for	O	O
the	O	O
proper	O	O
determination	O	O
of	O	O
oral	O	O
microbial	O	O
composition	O	O
and	O	O
to	O	O
relate	O	O
that	O	O
diversity	O	O
to	O	O
epidemiological	O	O
,	O	O
clinical	O	O
,	O	O
and	O	O
etiological	O	O
parameters	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
can	O	O
aggravate	O	O
colitis	O	O
in	O	O
mice	O	O
.	O	O

We	O	O
evaluated	O	O
the	O	O
virulence	O	O
of	O	O
colitis	O	O
using	O	O
type	O	O
strains	O	O
as	O	O
well	O	O
as	O	O
blood	O	O
isolates	O	O
of	O	O
several	O	O
oral	O	O
streptococcal	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

We	O	O
investigated	O	O
the	O	O
susceptibility	O	O
of	O	O
blood	O	O
isolates	O	O
of	O	O
several	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
to	O	O
phagocytosis	O	O
,	O	O
adhesion	O	O
to	O	O
and	O	O
invasion	O	O
of	O	O
hepatic	O	O
cells	O	O
and	O	O
interferon-gamma	O	O
secretion	O	O
.	O	O

A	O	O
mouse	O	O
model	O	O
of	O	O
dextran	O	O
sodium	O	O
sulphate-induced	O	O
colitis	O	O
was	O	O
used	O	O
to	O	O
evaluate	O	O
bacterial	O	O
aggravation	O	O
of	O	O
colitis	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
interferon-gamma	O	O
antibody	O	O
was	O	O
administered	O	O
to	O	O
mice	O	O
with	O	O
prominent	O	O
aggravation	O	O
of	O	O
colitis	O	O
.	O	O

In	O	O
vitro	O	O
analyses	O	O
showed	O	O
that	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
10556	E-bacteria	I-bacteria
was	O	O
a	O	O
possible	O	O
virulent	O	O
strain	O	O
among	O	O
type	O	O
strains	O	O
of	O	O
several	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
and	O	O
that	O	O
analysis	O	O
of	O	O
blood	O	O
isolates	O	O
of	O	O
S.	B-bacteria	B-bacteria
sanguinis	I-bacteria	I-bacteria
TW289	E-bacteria	I-bacteria
revealed	O	O
a	O	O
potential	O	O
virulent	O	O
strain	O	O
.	O	O

Intravenous	O	O
administration	O	O
of	O	O
ATCC	B-bacteria	B-bacteria
10556	E-bacteria	I-bacteria
and	O	O
TW289	B-bacteria	B-bacteria
caused	O	O
prominent	O	O
aggravation	O	O
of	O	O
dextran	O	O
sodium	O	O
sulphate-induced	O	O
colitis	O	O
,	O	O
and	O	O
histopathological	O	O
examinations	O	O
showed	O	O
that	O	O
interferon-gamma	O	O
secretion	O	O
due	O	O
to	O	O
infection	O	O
of	O	O
hepatic	O	O
cells	O	O
caused	O	O
colitis	O	O
aggravation	O	O
.	O	O

Administration	O	O
of	O	O
interferon-gamma	O	O
antibody	O	O
suppressed	O	O
TW289-induced	O	O
colitis	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
some	O	O
virulent	O	O
oral	O	O
streptococcal	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
are	O	O
associated	O	O
with	O	O
the	O	O
aggravation	O	O
of	O	O
colitis	O	O
induced	O	O
by	O	O
enhanced	O	O
secretion	O	O
of	O	O
interferon-gamma	O	O
when	O	O
they	O	O
invade	O	O
the	O	O
bloodstream	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
introduced	O	O
species-specific	O	O
quantitative	O	O
real-time	O	O
PCR	O	O
(	O	O
qPCR	O	O
)	O	O
primers	O	O
designed	O	O
based	O	O
on	O	O
a	O	O
DNA-dependent	O	O
RNA	O	O
polymerase	O	O
beta-subunit	O	O
gene	O	O
(	O	O
rpoB	O	O
)	O	O
for	O	O
detecting	O	O
42	O	O
oral	O	O
bacterial	O	O
species	O	O
.	O	O

The	O	O
specificity	O	O
of	O	O
the	O	O
qPCR	O	O
primers	O	O
was	O	O
confirmed	O	O
by	O	O
conventional	O	O
PCR	O	O
with	O	O
the	O	O
genomic	O	O
DNAs	O	O
of	O	O
73-79	O	O
strains	O	O
regarding	O	O
73-75	O	O
bacterial	O	O
species	O	O
including	O	O
the	O	O
type	O	O
strain	O	O
for	O	O
the	O	O
target	O	O
species	O	O
.	O	O

The	O	O
standard	O	O
curves	O	O
revealed	O	O
the	O	O
lower	O	O
detection	O	O
limits	O	O
of	O	O
42	O	O
bacterial	O	O
species-specific	O	O
qPCR	O	O
primers	O	O
ranged	O	O
from	O	O
4	O	O
to	O	O
40	O	O
fg	O	O
below	O	O
a	O	O
cycle	O	O
threshold	O	O
(	O	O
C	O	O
T	O	O
)	O	O
value	O	O
of	O	O
35	O	O
,	O	O
except	O	O
Atopobium	B-bacteria	B-bacteria
rimae	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Neisseria	B-bacteria	B-bacteria
meningitidis	E-bacteria	I-bacteria
,	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
asaccharolytica	E-bacteria	I-bacteria
which	O	O
were	O	O
400	O	O
fg	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
42	O	O
bacterial	O	O
species-specific	O	O
qPCR	O	O
primers	O	O
are	O	O
suitable	O	O
for	O	O
applications	O	O
in	O	O
epidemiological	O	O
studies	O	O
related	O	O
to	O	O
oral	O	O
infectious	O	O
diseases	O	O
such	O	O
as	O	O
periodontal	O	O
diseases	O	O
,	O	O
endodontic	O	O
infection	O	O
,	O	O
and	O	O
dental	O	O
caries	O	O
.	O	O

Oral	O	O
health	O	O
is	O	O
influenced	O	O
by	O	O
the	O	O
mouth	O	O
's	O	O
resident	O	O
microorganisms	O	O
.	O	O

Dental	O	O
caries	O	O
and	O	O
periodontitis	O	O
are	O	O
oral	O	O
disorders	O	O
caused	O	O
by	O	O
imbalances	O	O
in	O	O
the	O	O
oral	O	O
microbiota	O	O
.	O	O

Probiotics	B-bacteria	B-bacteria
have	O	O
potential	O	O
for	O	O
the	O	O
prevention	O	O
and	O	O
treatment	O	O
of	O	O
oral	O	O
disorders	O	O
.	O	O

Current	O	O
formulations	O	O
,	O	O
including	O	O
supplements	O	O
and	O	O
foods	O	O
,	O	O
have	O	O
limitations	O	O
for	O	O
oral	O	O
delivery	O	O
including	O	O
short	O	O
storage	O	O
time	O	O
,	O	O
low	O	O
residence	O	O
time	O	O
in	O	O
the	O	O
mouth	O	O
,	O	O
effects	O	O
on	O	O
food	O	O
consistency	O	O
,	O	O
and	O	O
low	O	O
patient	O	O
compliance	O	O
.	O	O

Oral	O	O
thin	O	O
films	O	O
(	O	O
OTFs	O	O
)	O	O
may	O	O
be	O	O
efficient	O	O
in	O	O
delivering	O	O
probiotics	O	O
to	O	O
the	O	O
mouth	O	O
.	O	O

This	O	O
research	O	O
aims	O	O
to	O	O
develop	O	O
a	O	O
novel	O	O
carboxymethyl	O	O
cellulose	O	O
(	O	O
CMC	O	O
)	O	O
-probiotic-OTF	O	O
to	O	O
deliver	O	O
probiotics	B-bacteria	B-bacteria
for	O	O
the	O	O
treatment/prevention	O	O
of	O	O
oral	O	O
disorders	O	O
.	O	O

CMC-OTFs	O	O
were	O	O
developed	O	O
with	O	O
varying	O	O
CMC	O	O
concentration	O	O
(	O	O
1.25	O	O
-	O	O
10	O	O
mg/mL	O	O
)	O	O
,	O	O
weight	O	O
(	O	O
5	O	O
-	O	O
40	O	O
g	O	O
)	O	O
,	O	O
thickness	O	O
(	O	O
16	O	O
-	O	O
262	O	O
mum	O	O
)	O	O
,	O	O
hygroscopicity	O	O
(	O	O
30.8	O	O
-	O	O
78.9	O	O
mg/cm	O	O
(	O	O
2	O	O
)	O	O
film	O	O
)	O	O
,	O	O
and	O	O
dissolving	O	O
time	O	O
(	O	O
135	O	O
-	O	O
600	O	O
s	O	O
)	O	O
.	O	O

The	O	O
10	O	O
g	O	O
5	O	O
mg/mL	O	O
CMC-OTF	O	O
was	O	O
selected	O	O
and	O	O
used	O	O
to	O	O
incorporate	O	O
Lactobacillus	B-bacteria	B-bacteria
fermentum	I-bacteria	I-bacteria
NCIMB	I-bacteria	I-bacteria
5221	E-bacteria	I-bacteria
(	O	O
6.75	O	O
x	O	O
10	O	O
(	O	O
8	O	O
)	O	O
cells/film	O	O
)	O	O
,	O	O
a	O	O
probiotic	B-bacteria	B-bacteria
with	O	O
anti-inflammatory	O	O
potential	O	O
for	O	O
periodontitis	O	O
treatment	O	O
and	O	O
capable	O	O
of	O	O
inhibiting	O	O
microorganisms	O	O
responsible	O	O
for	O	O
dental	O	O
caries	O	O
and	O	O
oral	O	O
candidiasis	O	O
.	O	O

The	O	O
CMC-OTF	O	O
maintained	O	O
probiotic	O	O
viability	O	O
and	O	O
antioxidant	O	O
activity	O	O
following	O	O
150	O	O
days	O	O
of	O	O
storage	O	O
with	O	O
a	O	O
production	O	O
of	O	O
549.52	O	O
+/-	O	O
26.08	O	O
muM	O	O
Trolox	O	O
equivalents	O	O
.	O	O

This	O	O
research	O	O
shows	O	O
the	O	O
successful	O	O
development	O	O
and	O	O
characterization	O	O
of	O	O
a	O	O
novel	O	O
probiotic-CMC-OTF	B-bacteria	B-bacteria
with	O	O
potential	O	O
as	O	O
an	O	O
oral	O	O
health	O	O
biotherapeutic	O	O
.	O	O

Coeliac	O	O
disease	O	O
is	O	O
characterized	O	O
by	O	O
intestinal	O	O
inflammation	O	O
caused	O	O
by	O	O
gluten	O	O
,	O	O
proteins	O	O
which	O	O
are	O	O
widely	O	O
contained	O	O
in	O	O
the	O	O
Western	O	O
diet	O	O
.	O	O

Mammalian	O	O
digestive	O	O
enzymes	O	O
are	O	O
only	O	O
partly	O	O
capable	O	O
of	O	O
cleaving	O	O
gluten	O	O
,	O	O
and	O	O
fragments	O	O
remain	O	O
that	O	O
induce	O	O
toxic	O	O
responses	O	O
in	O	O
patients	O	O
with	O	O
coeliac	O	O
disease	O	O
.	O	O

We	O	O
found	O	O
that	O	O
the	O	O
oral	O	O
microbiome	O	O
is	O	O
a	O	O
novel	O	O
and	O	O
rich	O	O
source	O	O
of	O	O
gluten-degrading	O	O
organisms	O	O
.	O	O

Here	O	O
we	O	O
report	O	O
on	O	O
the	O	O
isolation	O	O
and	O	O
characterization	O	O
of	O	O
the	O	O
cultivable	O	O
resident	O	O
oral	O	O
microbes	O	O
that	O	O
are	O	O
capable	O	O
of	O	O
cleaving	O	O
gluten	O	O
,	O	O
with	O	O
special	O	O
emphasis	O	O
on	O	O
the	O	O
immunogenic	O	O
domains	O	O
.	O	O

Bacteria	O	O
were	O	O
obtained	O	O
by	O	O
a	O	O
selective	O	O
culturing	O	O
approach	O	O
and	O	O
enzyme	O	O
activities	O	O
were	O	O
characterized	O	O
by	O	O
:	O	O
(	O	O
i	O	O
)	O	O
hydrolysis	O	O
of	O	O
paranitroanilide-derivatized	O	O
gliadin-derived	O	O
tripeptide	O	O
substrates	O	O
;	O	O
(	O	O
ii	O	O
)	O	O
gliadin	O	O
degradation	O	O
in-gel	O	O
(	O	O
gliadin	O	O
zymography	O	O
)	O	O
;	O	O
(	O	O
iii	O	O
)	O	O
gliadin	O	O
degradation	O	O
in	O	O
solution	O	O
;	O	O
(	O	O
iv	O	O
)	O	O
proteolysis	O	O
of	O	O
the	O	O
highly	O	O
immunogenic	O	O
alpha-gliadin-derived	O	O
33-mer	O	O
peptide	O	O
.	O	O

For	O	O
selected	O	O
strains	O	O
pH	O	O
activity	O	O
profiles	O	O
were	O	O
determined	O	O
.	O	O

The	O	O
culturing	O	O
strategy	O	O
yielded	O	O
87	O	O
aerobic	O	O
and	O	O
63	O	O
anaerobic	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
.	O	O

Species	O	O
with	O	O
activity	O	O
in	O	O
at	O	O
least	O	O
two	O	O
of	O	O
the	O	O
four	O	O
assays	O	O
were	O	O
typed	O	O
as	O	O
:	O	O
Rothia	B-bacteria	B-bacteria
mucilaginosa	I-bacteria	I-bacteria
HOT-681	E-bacteria	I-bacteria
,	O	O
Rothia	B-bacteria	B-bacteria
aeria	I-bacteria	I-bacteria
HOT-188	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
odontolyticus	I-bacteria	I-bacteria
HOT-701	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
HOT-677	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria
HOT-071	E-bacteria	I-bacteria
,	O	O
Neisseria	B-bacteria	B-bacteria
mucosa	I-bacteria	I-bacteria
HOT-682	E-bacteria	I-bacteria
and	O	O
Capnocytophaga	B-bacteria	B-bacteria
sputigena	I-bacteria	I-bacteria
HOT-775	E-bacteria	I-bacteria
,	O	O
with	O	O
Rothia	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
being	O	O
active	O	O
in	O	O
all	O	O
four	O	O
assays	O	O
.	O	O

Cleavage	O	O
specificities	O	O
and	O	O
substrate	O	O
preferences	O	O
differed	O	O
among	O	O
the	O	O
strains	O	O
identified	O	O
.	O	O

The	O	O
approximate	O	O
molecular	O	O
weights	O	O
of	O	O
the	O	O
enzymes	O	O
were	O	O
~75	O	O
kD	O	O
(	O	O
Rothia	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

)	O	O
,	O	O
~60	O	O
kD	O	O
(	O	O
A.	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
)	O	O
and	O	O
~150	O	O
kD	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
)	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
this	O	O
study	O	O
identified	O	O
new	O	O
gluten-degrading	O	O
microorganisms	O	O
in	O	O
the	O	O
upper	O	O
gastrointestinal	O	O
tract	O	O
.	O	O

A	O	O
cocktail	O	O
of	O	O
the	O	O
most	O	O
active	O	O
oral	O	O
bacteria	O	O
,	O	O
or	O	O
their	O	O
isolated	O	O
enzymes	O	O
,	O	O
may	O	O
offer	O	O
promising	O	O
new	O	O
treatment	O	O
modalities	O	O
for	O	O
coeliac	O	O
disease	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
the	O	O
prevalence	O	O
of	O	O
oral	O	O
microflora	O	O
and	O	O
association	O	O
of	O	O
oral	O	O
candidiasis	O	O
and	O	O
multiple	O	O
risk	O	O
factors	O	O
in	O	O
HIV	O	O
(	O	O
+	O	O
)	O	O
patients	O	O
.	O	O

The	O	O
present	O	O
study	O	O
included	O	O
100	O	O
HIV-infected	O	O
patients	O	O
participated	O	O
in	O	O
Imam	O	O
Khomeini	O	O
Hospital	O	O
,	O	O
Tehran	O	O
,	O	O
Iran	O	O
for	O	O
Oropharyngeal	O	O
candidiasis	O	O
(	O	O
OPC	O	O
)	O	O
and	O	O
HIV	O	O
.	O	O

We	O	O
assessed	O	O
the	O	O
presence	O	O
or	O	O
absence	O	O
of	O	O
OPC	O	O
,	O	O
and	O	O
samples	O	O
were	O	O
obtained	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
direct	O	O
microscopic	O	O
examination	O	O
,	O	O
gram	O	O
staining	O	O
and	O	O
culture	O	O
on	O	O
standard	O	O
microbiological	O	O
media	O	O
were	O	O
performed	O	O
in	O	O
all	O	O
patients	O	O
.	O	O

CD4	O	O
(	O	O
+	O	O
)	O	O
cell	O	O
count/CD4	O	O
(	O	O
+	O	O
)	O	O
percentage	O	O
were	O	O
also	O	O
calculated	O	O
.	O	O

The	O	O
demographic	O	O
characteristics	O	O
showed	O	O
that	O	O
the	O	O
patients	O	O
had	O	O
a	O	O
mean	O	O
age	O	O
of	O	O
32.3	O	O
years	O	O
old	O	O
,	O	O
78	O	O
%	O	O
male	O	O
and	O	O
22	O	O
%	O	O
female	O	O
.	O	O

Patients	O	O
belonging	O	O
to	O	O
'O	O	O
(	O	O
+	O	O
)	O	O
'	O	O
blood	O	O
group	O	O
(	O	O
27	O	O
%	O	O
)	O	O
were	O	O
more	O	O
prone	O	O
to	O	O
develop	O	O
OPC	O	O
.	O	O

A	O	O
total	O	O
of	O	O
460	O	O
bacterial	O	O
colonies	O	O
were	O	O
obtained	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	B-bacteria	B-bacteria
(	O	O
15.4	O	O
%	O	O
)	O	O
was	O	O
the	O	O
most	O	O
frequently	O	O
isolated	O	O
species	O	O
in	O	O
the	O	O
HIV	O	O
(	O	O
+	O	O
)	O	O
patients	O	O
,	O	O
followed	O	O
by	O	O
Staphylococcus	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
(	O	O
12.8	O	O
%	O	O
)	O	O
and	O	O
Corynebacterium	B-bacteria	B-bacteria
(	O	O
8.7	O	O
%	O	O
)	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
254	O	O
yeasts	O	O
(	O	O
from	O	O
four	O	O
different	O	O
genera	O	O
)	O	O
were	O	O
isolated	O	O
from	O	O
the	O	O
patient	O	O
under	O	O
study	O	O
.	O	O

Candida	O	O
species	O	O
(	O	O
94.4	O	O
%	O	O
)	O	O
were	O	O
the	O	O
most	O	O
frequently	O	O
obtained	O	O
genera	O	O
,	O	O
followed	O	O
by	O	O
Saccharomyces	O	O
(	O	O
2.4	O	O
%	O	O
)	O	O
,	O	O
Kluyveromyces	O	O
and	O	O
Cryptococcus	O	O
(	O	O
1.6	O	O
%	O	O
for	O	O
both	O	O
)	O	O
species	O	O
.	O	O

Candida	O	O
albicans	O	O
(	O	O
37.2	O	O
%	O	O
)	O	O
was	O	O
the	O	O
most	O	O
common	O	O
species	O	O
isolated	O	O
from	O	O
HIV	O	O
(	O	O
+	O	O
)	O	O
patients	O	O
with	O	O
OPC	O	O
and	O	O
its	O	O
frequency	O	O
was	O	O
significantly	O	O
higher	O	O
than	O	O
that	O	O
of	O	O
other	O	O
Candida	O	O
species	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Candida	O	O
glabrata	O	O
,	O	O
C.	O	O
dubliniensis	O	O
,	O	O
C.	O	O
tropicalis	O	O
,	O	O
C.	O	O
parapsilosis	O	O
,	O	O
C.	O	O
krusei	O	O
,	O	O
C.	O	O
lusitaniae	O	O
,	O	O
C.	O	O
guilliermondii	O	O
and	O	O
C.	O	O
norvegensis	O	O
were	O	O
also	O	O
identified	O	O
.	O	O

Forty	O	O
percent	O	O
of	O	O
the	O	O
patients	O	O
had	O	O
angular	O	O
cheilitis	O	O
as	O	O
the	O	O
most	O	O
frequent	O	O
clinical	O	O
variant	O	O
.	O	O

The	O	O
mean	O	O
CD4	O	O
(	O	O
+	O	O
)	O	O
cell	O	O
counts	O	O
were	O	O
154.5	O	O
cells/muL	O	O
,	O	O
with	O	O
a	O	O
range	O	O
of	O	O
8	O	O
to	O	O
611	O	O
cells/muL	O	O
.	O	O

Thirty	O	O
percent	O	O
patients	O	O
had	O	O
a	O	O
CD4	O	O
(	O	O
+	O	O
)	O	O
cell	O	O
count	O	O
between	O	O
101	O	O
and	O	O
200	O	O
cells/muL	O	O
(	O	O
28.7	O	O
%	O	O
of	O	O
total	O	O
yeasts	O	O
isolated	O	O
)	O	O
.	O	O

Yeast	O	O
and	O	O
bacteria	O	O
counts	O	O
did	O	O
not	O	O
differ	O	O
statistically	O	O
among	O	O
HIV	O	O
(	O	O
+	O	O
)	O	O
patients	O	O
'	O	O
subgroups	O	O
with	O	O
different	O	O
levels	O	O
of	O	O
CD4	O	O
(	O	O
+	O	O
)	O	O
cells	O	O
counts	O	O
.	O	O

Our	O	O
results	O	O
showed	O	O
that	O	O
yeasts	O	O
of	O	O
the	O	O
genus	O	O
Candida	O	O
were	O	O
isolated	O	O
at	O	O
a	O	O
comparable	O	O
rate	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
HIV	O	O
(	O	O
+	O	O
)	O	O
patients	O	O
and	O	O
there	O	O
was	O	O
no	O	O
significant	O	O
difference	O	O
of	O	O
the	O	O
variables	O	O
CD4	O	O
(	O	O
+	O	O
)	O	O
cell	O	O
count	O	O
and	O	O
yeast	O	O
counts	O	O
.	O	O

The	O	O
findings	O	O
of	O	O
this	O	O
study	O	O
would	O	O
be	O	O
helpful	O	O
in	O	O
any	O	O
further	O	O
study	O	O
,	O	O
which	O	O
,	O	O
if	O	O
done	O	O
prospectively	O	O
on	O	O
a	O	O
large	O	O
cohort	O	O
,	O	O
can	O	O
be	O	O
confirmatory	O	O
.	O	O

Experimental	O	O
infection	O	O
systems	O	O
are	O	O
important	O	O
for	O	O
studying	O	O
antagonistic	O	O
interactions	O	O
and	O	O
coevolution	O	O
between	O	O
hosts	O	O
and	O	O
their	O	O
pathogens	O	O
.	O	O

The	O	O
red	O	O
flour	O	O
beetle	O	O
Tribolium	O	O
castaneum	O	O
and	O	O
the	O	O
spore-forming	O	O
bacterial	O	O
insect	O	O
pathogen	O	O
Bacillus	B-bacteria	B-bacteria
thuringiensis	E-bacteria	I-bacteria
(	O	O
Bt	B-bacteria	B-bacteria
)	O	O
are	O	O
widely	O	O
used	O	O
and	O	O
tractable	O	O
model	O	O
organisms	O	O
.	O	O

However	O	O
,	O	O
they	O	O
have	O	O
not	O	O
been	O	O
employed	O	O
yet	O	O
as	O	O
an	O	O
efficient	O	O
experimental	O	O
system	O	O
to	O	O
study	O	O
host-pathogen	O	O
interactions	O	O
.	O	O

We	O	O
used	O	O
a	O	O
high	O	O
throughput	O	O
oral	O	O
infection	O	O
protocol	O	O
to	O	O
infect	O	O
T.	O	O
castaneum	O	O
insects	O	O
with	O	O
coleopteran	O	O
specific	O	O
B.	B-bacteria	B-bacteria
thuringiensis	I-bacteria	I-bacteria
bv	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria

tenebrionis	I-bacteria	I-bacteria
(	O	O
Btt	I-bacteria	I-bacteria
)	O	O
bacteria	E-bacteria	I-bacteria
.	O	O

We	O	O
found	O	O
that	O	O
larval	O	O
mortality	O	O
depends	O	O
on	O	O
the	O	O
dietary	O	O
spore	O	O
concentration	O	O
and	O	O
on	O	O
the	O	O
duration	O	O
of	O	O
exposure	O	O
to	O	O
the	O	O
spores	O	O
.	O	O

Furthermore	O	O
,	O	O
differential	O	O
susceptibility	O	O
of	O	O
larvae	O	O
from	O	O
different	O	O
T.	O	O
castaneum	O	O
populations	O	O
indicates	O	O
that	O	O
the	O	O
host	O	O
genetic	O	O
background	O	O
influences	O	O
infection	O	O
success	O	O
.	O	O

The	O	O
recovery	O	O
of	O	O
high	O	O
numbers	O	O
of	O	O
infectious	O	O
spores	O	O
from	O	O
the	O	O
cadavers	O	O
indicates	O	O
successful	O	O
replication	O	O
of	O	O
bacteria	O	O
in	O	O
the	O	O
host	O	O
and	O	O
suggests	O	O
that	O	O
Btt	B-bacteria	B-bacteria
could	O	O
establish	O	O
infectious	O	O
cycles	O	O
in	O	O
T.	O	O
castaneum	O	O
in	O	O
nature	O	O
.	O	O

We	O	O
were	O	O
able	O	O
to	O	O
transfer	O	O
plasmids	O	O
from	O	O
Btt	B-bacteria	B-bacteria
to	O	O
a	O	O
non-pathogenic	O	O
but	O	O
genetically	O	O
well-characterised	O	O
Bt	B-bacteria	B-bacteria
strain	E-bacteria	I-bacteria
,	O	O
which	O	O
was	O	O
thereafter	O	O
able	O	O
to	O	O
successfully	O	O
infect	O	O
T.	O	O
castaneum	O	O
,	O	O
suggesting	O	O
that	O	O
factors	O	O
residing	O	O
on	O	O
the	O	O
plasmids	O	O
are	O	O
important	O	O
for	O	O
the	O	O
virulence	O	O
of	O	O
Btt	B-bacteria	B-bacteria
.	O	O

The	O	O
availability	O	O
of	O	O
a	O	O
genetically	O	O
accessible	O	O
strain	O	O
will	O	O
provide	O	O
an	O	O
ideal	O	O
model	O	O
for	O	O
more	O	O
in-depth	O	O
analyses	O	O
of	O	O
pathogenicity	O	O
factors	O	O
during	O	O
oral	O	O
infections	O	O
.	O	O

Combined	O	O
with	O	O
the	O	O
availability	O	O
of	O	O
the	O	O
full	O	O
genome	O	O
sequence	O	O
of	O	O
T.	O	O
castaneum	O	O
,	O	O
this	O	O
system	O	O
will	O	O
enable	O	O
analyses	O	O
of	O	O
host	O	O
responses	O	O
during	O	O
infection	O	O
,	O	O
as	O	O
well	O	O
as	O	O
addressing	O	O
basic	O	O
questions	O	O
concerning	O	O
host-parasite	O	O
coevolution	O	O
.	O	O

Drug-resistant	O	O
opportunistic	O	O
infections	O	O
may	O	O
cause	O	O
health	O	O
problems	O	O
in	O	O
immunocompromised	O	O
hosts	O	O
.	O	O

Representative	O	O
microorganisms	O	O
in	O	O
opportunistic	O	O
infections	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
are	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
,	O	O
and	O	O
Candida	O	O
albicans	O	O
.	O	O

We	O	O
investigated	O	O
the	O	O
prevalence	O	O
of	O	O
drug-resistant	O	O
opportunistic	O	O
microorganisms	O	O
in	O	O
elderly	O	O
adults	O	O
receiving	O	O
follow-up	O	O
examinations	O	O
after	O	O
primary	O	O
treatment	O	O
of	O	O
oral	O	O
cancer	O	O
.	O	O

Oral	O	O
microorganisms	O	O
were	O	O
collected	O	O
from	O	O
patients	O	O
satisfactorily	O	O
treated	O	O
for	O	O
oral	O	O
cancer	O	O
(	O	O
defined	O	O
as	O	O
good	O	O
outcomes	O	O
to	O	O
date	O	O
)	O	O
and	O	O
a	O	O
group	O	O
of	O	O
healthy	O	O
adults	O	O
(	O	O
controls	O	O
)	O	O
.	O	O

After	O	O
identification	O	O
of	O	O
microorganisms	O	O
,	O	O
the	O	O
prevalence	O	O
of	O	O
drug-resistant	O	O
microorganisms	O	O
was	O	O
studied	O	O
.	O	O

Pulsed-field	O	O
gel	O	O
electrophoresis	O	O
(	O	O
PFGE	O	O
)	O	O
and	O	O
staphylococcal	O	O
cassette	O	O
chromosome	O	O
mec	O	O
(	O	O
SCCmec	O	O
)	O	O
typing	O	O
were	O	O
also	O	O
performed	O	O
for	O	O
methicillin-resistant	B-bacteria	B-bacteria
S	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
MRSA	B-bacteria	B-bacteria
)	O	O
.	O	O

Statistical	O	O
analysis	O	O
revealed	O	O
no	O	O
significant	O	O
differences	O	O
in	O	O
the	O	O
prevalences	O	O
of	O	O
the	O	O
three	O	O
microorganisms	O	O
between	O	O
the	O	O
groups	O	O
.	O	O

Surprisingly	O	O
,	O	O
69.2	O	O
%	O	O
of	O	O
S	B-bacteria	B-bacteria
aureus	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
showed	O	O
oxacillin	O	O
resistance	O	O
,	O	O
suggesting	O	O
that	O	O
MRSA	B-bacteria	B-bacteria
colonization	O	O
is	O	O
increasing	O	O
among	O	O
older	O	O
Japanese	O	O
.	O	O

These	O	O
MRSA	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
possessed	O	O
SCCmec	O	O
types	O	O
II	O	O
and	O	O
IV	O	O
but	O	O
no	O	O
representative	O	O
toxin	O	O
genes	O	O
.	O	O

Our	O	O
results	O	O
indicate	O	O
that	O	O
a	O	O
basic	O	O
infection	O	O
control	O	O
strategy	O	O
,	O	O
including	O	O
standard	O	O
precautions	O	O
against	O	O
MRSA	B-bacteria	B-bacteria
,	O	O
is	O	O
important	O	O
for	O	O
elderly	O	O
adults	O	O
,	O	O
particularly	O	O
after	O	O
treatment	O	O
for	O	O
oral	O	O
cancer	O	O
.	O	O

To	O	O
compare	O	O
early	O	O
bacterial	O	O
adhesion	O	O
and	O	O
biofilm	O	O
formation	O	O
in	O	O
vitro	O	O
by	O	O
different	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
on	O	O
a	O	O
variety	O	O
of	O	O
commercial	O	O
brackets	O	O
.	O	O

Adhesion	O	O
and	O	O
biofilm	O	O
formation	O	O
in	O	O
vitro	O	O
of	O	O
6	O	O
Streptococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

on	O	O
15	O	O
different	O	O
commercial	O	O
brackets	O	O
,	O	O
in	O	O
standard	O	O
culture	O	O
medium	O	O
and	O	O
in	O	O
human	O	O
saliva	O	O
were	O	O
evaluated	O	O
by	O	O
the	O	O
MTT	O	O
reduction	O	O
assay	O	O
.	O	O

Significant	O	O
differences	O	O
were	O	O
evidenced	O	O
in	O	O
both	O	O
early	O	O
adhesion	O	O
and	O	O
biofilm	O	O
formation	O	O
among	O	O
the	O	O
studied	O	O
brackets	O	O
and	O	O
between	O	O
the	O	O
two	O	O
conditions	O	O
of	O	O
growth	O	O
.	O	O

Gold	O	O
brackets	O	O
resulted	O	O
less	O	O
prone	O	O
to	O	O
colonisation	O	O
compared	O	O
to	O	O
composite	O	O
brackets	O	O
.	O	O

The	O	O
growth	O	O
rates	O	O
of	O	O
the	O	O
tested	O	O
species	O	O
on	O	O
the	O	O
different	O	O
tested	O	O
materials	O	O
were	O	O
significantly	O	O
different	O	O
.	O	O

The	O	O
adopted	O	O
experimental	O	O
plan	O	O
,	O	O
dissecting	O	O
the	O	O
two	O	O
phases	O	O
of	O	O
plaque	O	O
formation	O	O
on	O	O
different	O	O
brackets	O	O
in	O	O
different	O	O
conditions	O	O
,	O	O
showed	O	O
that	O	O
composite	O	O
brackets	O	O
are	O	O
more	O	O
susceptible	O	O
to	O	O
adhesion	O	O
and	O	O
colonisation	O	O
by	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
while	O	O
the	O	O
remaining	O	O
tested	O	O
brackets	O	O
did	O	O
not	O	O
show	O	O
differences	O	O
that	O	O
could	O	O
be	O	O
clinically	O	O
relevant	O	O
.	O	O

Data	O	O
suggest	O	O
that	O	O
different	O	O
personal	O	O
behaviours	O	O
affecting	O	O
the	O	O
oral	O	O
environment	O	O
could	O	O
significantly	O	O
affect	O	O
colonisation	O	O
of	O	O
brackets	O	O
by	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Patients	O	O
with	O	O
ruptured	O	O
saccular	O	O
intracranial	O	O
aneurysms	O	O
have	O	O
excess	O	O
long-term	O	O
mortality	O	O
due	O	O
to	O	O
cerebrovascular	O	O
and	O	O
cardiovascular	O	O
diseases	O	O
compared	O	O
with	O	O
general	O	O
population	O	O
.	O	O

Chronic	O	O
inflammation	O	O
is	O	O
detected	O	O
in	O	O
ruptured	O	O
intracranial	O	O
aneurysms	O	O
,	O	O
abdominal	O	O
aortic	O	O
aneurysms	O	O
and	O	O
coronary	O	O
artery	O	O
plaques	O	O
.	O	O

Bacterial	O	O
infections	O	O
have	O	O
been	O	O
suggested	O	O
to	O	O
have	O	O
a	O	O
role	O	O
in	O	O
the	O	O
aetiology	O	O
of	O	O
atherosclerosis	O	O
.	O	O

Bacteria	O	O
have	O	O
been	O	O
detected	O	O
both	O	O
in	O	O
abdominal	O	O
and	O	O
coronary	O	O
arteries	O	O
but	O	O
their	O	O
presence	O	O
in	O	O
intracranial	O	O
aneurysms	O	O
has	O	O
not	O	O
yet	O	O
been	O	O
properly	O	O
studied	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
preliminary	O	O
study	O	O
was	O	O
to	O	O
assess	O	O
the	O	O
presence	O	O
of	O	O
oral	O	O
and	O	O
pharyngeal	O	O
bacterial	O	O
genome	O	O
in	O	O
ruptured	O	O
intracranial	O	O
aneurysms	O	O
and	O	O
to	O	O
ascertain	O	O
if	O	O
dental	O	O
infection	O	O
is	O	O
a	O	O
previously	O	O
unknown	O	O
risk	O	O
factor	O	O
for	O	O
subarachnoid	O	O
haemorrhage	O	O
.	O	O

A	O	O
total	O	O
of	O	O
36	O	O
ruptured	O	O
aneurysm	O	O
specimens	O	O
were	O	O
obtained	O	O
perioperatively	O	O
in	O	O
aneurysm	O	O
clipping	O	O
operations	O	O
(	O	O
n=29	O	O
)	O	O
and	O	O
by	O	O
autopsy	O	O
(	O	O
n=7	O	O
)	O	O
.	O	O

Aneurysmal	O	O
sac	O	O
tissue	O	O
was	O	O
analysed	O	O
by	O	O
real	O	O
time	O	O
quantitative	O	O
PCR	O	O
with	O	O
specific	O	O
primers	O	O
and	O	O
probes	O	O
to	O	O
detect	O	O
bacterial	O	O
DNA	O	O
from	O	O
several	O	O
oral	O	O
species	O	O
.	O	O

Immunohistochemical	O	O
staining	O	O
for	O	O
bacterial	O	O
receptors	O	O
(	O	O
CD14	O	O
and	O	O
toll-like	O	O
receptor-2	O	O
(	O	O
TLR-2	O	O
)	O	O
)	O	O
was	O	O
performed	O	O
from	O	O
four	O	O
autopsy	O	O
cases	O	O
.	O	O

Bacterial	O	O
DNA	O	O
was	O	O
detected	O	O
in	O	O
21/36	O	O
(	O	O
58	O	O
%	O	O
)	O	O
of	O	O
specimens	O	O
.	O	O

A	O	O
third	O	O
of	O	O
the	O	O
positive	O	O
samples	O	O
contained	O	O
DNA	O	O
from	O	O
both	O	O
endodontic	O	O
and	O	O
periodontal	O	O
bacteria	O	O
.	O	O

DNA	O	O
from	O	O
endodontic	O	O
bacteria	O	O
were	O	O
detected	O	O
in	O	O
20/36	O	O
(	O	O
56	O	O
%	O	O
)	O	O
and	O	O
from	O	O
periodontal	O	O
bacteria	O	O
in	O	O
17/36	O	O
(	O	O
47	O	O
%	O	O
)	O	O
of	O	O
samples	O	O
.	O	O

Bacterial	O	O
DNA	O	O
of	O	O
the	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
group	O	O
was	O	O
found	O	O
to	O	O
be	O	O
most	O	O
common	O	O
.	O	O

Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatu	E-bacteria	I-bacteria
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
were	O	O
the	O	O
three	O	O
most	O	O
common	O	O
periodontal	O	O
pathogens	O	O
.	O	O

The	O	O
highly	O	O
intensive	O	O
staining	O	O
of	O	O
CD14	O	O
and	O	O
TLR-2	O	O
in	O	O
ruptured	O	O
aneurysms	O	O
was	O	O
observed	O	O
.	O	O

This	O	O
is	O	O
the	O	O
first	O	O
report	O	O
showing	O	O
evidence	O	O
that	O	O
dental	O	O
infection	O	O
could	O	O
be	O	O
a	O	O
part	O	O
of	O	O
pathophysiology	O	O
in	O	O
intracranial	O	O
aneurysm	O	O
disease	O	O
.	O	O

Bacteriocin-producing	B-bacteria	B-bacteria
probiotic	I-bacteria	I-bacteria
Streptococcus	I-bacteria	I-bacteria
salivarius	I-bacteria	I-bacteria
M18	E-bacteria	I-bacteria
offers	O	O
beneficial	O	O
modulatory	O	O
capabilities	O	O
within	O	O
the	O	O
oral	O	O
microbiome	O	O
,	O	O
apparently	O	O
through	O	O
potent	O	O
inhibitory	O	O
activity	O	O
against	O	O
potentially	O	O
deleterious	O	O
bacteria	O	O
,	O	O
such	O	O
as	O	O
Streptococcus	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
.	O	O

The	O	O
oral	O	O
cavity	O	O
persistence	O	O
of	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
M18	E-bacteria	I-bacteria
was	O	O
investigated	O	O
in	O	O
75	O	O
subjects	O	O
receiving	O	O
four	O	O
different	O	O
doses	O	O
for	O	O
28	O	O
days	O	O
.	O	O

Sixty	O	O
per	O	O
cent	O	O
of	O	O
the	O	O
subjects	O	O
already	O	O
had	O	O
some	O	O
inhibitor-producing	B-bacteria	B-bacteria
S.	I-bacteria	I-bacteria
salivarius	E-bacteria	I-bacteria
in	O	O
their	O	O
saliva	O	O
prior	O	O
to	O	O
probiotic	O	O
intervention	O	O
.	O	O

Strain	B-bacteria	B-bacteria
M18	E-bacteria	I-bacteria
's	O	O
persistence	O	O
was	O	O
dependent	O	O
upon	O	O
the	O	O
dose	O	O
,	O	O
but	O	O
not	O	O
the	O	O
period	O	O
of	O	O
administration	O	O
.	O	O

Culture	O	O
analysis	O	O
indicated	O	O
that	O	O
in	O	O
some	O	O
individuals	O	O
the	O	O
introduced	O	O
strain	O	O
had	O	O
almost	O	O
entirely	O	O
replaced	O	O
the	O	O
indigenous	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
though	O	O
the	O	O
total	O	O
numbers	O	O
of	O	O
the	O	O
species	O	O
did	O	O
not	O	O
increase	O	O
.	O	O

Selected	O	O
subjects	O	O
showing	O	O
either	O	O
high	O	O
or	O	O
low	O	O
probiotic	O	O
persistence	O	O
had	O	O
their	O	O
salivary	O	O
populations	O	O
profiled	O	O
using	O	O
Illumina	O	O
sequencing	O	O
of	O	O
the	O	O
V6	O	O
region	O	O
of	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
.	O	O

Analysis	O	O
indicated	O	O
that	O	O
while	O	O
certain	O	O
bacterial	O	O
phenotypes	O	O
were	O	O
markedly	O	O
modulated	O	O
,	O	O
the	O	O
overall	O	O
composition	O	O
of	O	O
the	O	O
oral	O	O
microbiome	O	O
was	O	O
not	O	O
modified	O	O
by	O	O
the	O	O
probiotic	O	O
treatment	O	O
.	O	O

Megaplasmids	O	O
encoding	O	O
bacteriocins	O	O
and	O	O
adhesion	O	O
factors	O	O
were	O	O
transferred	O	O
in	O	O
vitro	O	O
to	O	O
generate	O	O
a	O	O
transconjugant	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
exhibiting	O	O
enhanced	O	O
antimicrobial	O	O
production	O	O
and	O	O
binding	O	O
capabilities	O	O
to	O	O
HEp-2	O	O
cells	O	O
.	O	O

Since	O	O
no	O	O
widespread	O	O
perturbation	O	O
of	O	O
the	O	O
existing	O	O
indigenous	O	O
microbiota	O	O
was	O	O
associated	O	O
with	O	O
oral	O	O
instillation	O	O
and	O	O
given	O	O
its	O	O
antimicrobial	O	O
activity	O	O
against	O	O
potentially	O	O
pathogenic	O	O
streptococci	O	O
,	O	O
it	O	O
appears	O	O
that	O	O
application	O	O
of	O	O
probiotic	B-bacteria	B-bacteria
strain	I-bacteria	I-bacteria
M18	E-bacteria	I-bacteria
offers	O	O
potential	O	O
low	O	O
impact	O	O
alternative	O	O
to	O	O
classical	O	O
antibiotic	O	O
prophylaxis	O	O
.	O	O

For	O	O
candidate	B-bacteria	B-bacteria
probiotic	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
having	O	O
relatively	O	O
poor	O	O
antimicrobial	O	O
or	O	O
adhesive	O	O
properties	O	O
,	O	O
unique	O	O
derivatives	O	O
displaying	O	O
improved	O	O
probiotic	O	O
performance	O	O
may	O	O
be	O	O
engineered	O	O
in	O	O
vitro	O	O
by	O	O
megaplasmid	O	O
transfer	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
prospective	O	O
clinical	O	O
study	O	O
was	O	O
to	O	O
identify	O	O
the	O	O
bacterial	O	O
spectra	O	O
on	O	O
the	O	O
surface	O	O
of	O	O
oral	O	O
squamous	O	O
cell	O	O
carcinomas	O	O
(	O	O
OSCC	O	O
)	O	O
in	O	O
comparison	O	O
to	O	O
oral	O	O
mucosa	O	O
of	O	O
patients	O	O
with	O	O
a	O	O
higher	O	O
risk	O	O
to	O	O
emerge	O	O
an	O	O
OSCC	O	O
and	O	O
a	O	O
control	O	O
group	O	O
to	O	O
determine	O	O
their	O	O
susceptibility	O	O
to	O	O
various	O	O
common	O	O
antibiotics	O	O
.	O	O

Swabs	O	O
from	O	O
90	O	O
patients	O	O
,	O	O
30	O	O
patients	O	O
of	O	O
each	O	O
group	O	O
,	O	O
were	O	O
cultured	O	O
on	O	O
media	O	O
for	O	O
aerobes	B-bacteria	B-bacteria
and	O	O
anaerobes	B-bacteria	B-bacteria
and	O	O
tested	O	O
with	O	O
agar	O	O
diffusion	O	O
and	O	O
Etest	O	O
.	O	O

The	O	O
predominant	O	O
pathogens	O	O
of	O	O
the	O	O
normal	O	O
healthy	O	O
oral	O	O
mucosa	O	O
were	O	O
aerobes	B-bacteria	B-bacteria
.	O	O

The	O	O
ratio	O	O
between	O	O
aerobes	B-bacteria	B-bacteria
and	O	O
anaerobes	B-bacteria	B-bacteria
was	O	O
2:1	O	O
,	O	O
balanced	O	O
in	O	O
risk	O	O
patients	O	O
and	O	O
inverted	O	O
in	O	O
the	O	O
OSCC	O	O
group	O	O
.	O	O

Altogether	O	O
,	O	O
1,006	O	O
isolates	O	O
were	O	O
cultured	O	O
.	O	O

The	O	O
most	O	O
frequent	O	O
strains	O	O
were	O	O
47	O	O
viridans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
30	O	O
Staphylococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
14	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
36	O	O
Neisseria	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
14	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
and	O	O
23	O	O
other	O	O
aerobes	B-bacteria	B-bacteria
,	O	O
66	O	O
Peptostreptococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
39	O	O
Fusobacterium	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
and	O	O
34	O	O
Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

The	O	O
resistance	O	O
rates	O	O
in	O	O
the	O	O
OSCC	O	O
group	O	O
were	O	O
penicillin	O	O
40	O	O
%	O	O
,	O	O
ampicillin	O	O
57	O	O
%	O	O
,	O	O
doxycycline	O	O
23	O	O
%	O	O
,	O	O
clindamycin	O	O
47	O	O
%	O	O
,	O	O
and	O	O
amoxicillin/clavulanic	O	O
acid	O	O
20	O	O
%	O	O
,	O	O
but	O	O
up	O	O
to	O	O
100	O	O
%	O	O
of	O	O
pathogens	O	O
were	O	O
susceptible	O	O
to	O	O
azithromycin	O	O
,	O	O
telithromycin	O	O
,	O	O
levofloxacin	O	O
,	O	O
and	O	O
moxifloxacin	O	O
.	O	O

Gram-negative	B-bacteria	B-bacteria
anaerobes	E-bacteria	I-bacteria
play	O	O
a	O	O
decisive	O	O
role	O	O
in	O	O
the	O	O
development	O	O
of	O	O
postoperative	O	O
infections	O	O
in	O	O
patients	O	O
with	O	O
OSCC	O	O
.	O	O

This	O	O
tumor	O	O
special	O	O
type	O	O
of	O	O
colonization	O	O
does	O	O
not	O	O
agree	O	O
with	O	O
the	O	O
normal	O	O
flora	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Biofilms	O	O
on	O	O
OSCC	O	O
surfaces	O	O
provide	O	O
an	O	O
important	O	O
reservoir	O	O
for	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

As	O	O
a	O	O
consequence	O	O
,	O	O
a	O	O
proposal	O	O
for	O	O
an	O	O
antibiotic	O	O
prophylactic	O	O
regime	O	O
should	O	O
be	O	O
given	O	O
.	O	O

Epithelial	O	O
cells	O	O
in	O	O
oral	O	O
cavities	O	O
can	O	O
be	O	O
considered	O	O
reservoirs	O	O
for	O	O
a	O	O
variety	O	O
of	O	O
bacterial	O	O
species	O	O
.	O	O

A	O	O
polymicrobial	O	O
intracellular	O	O
flora	O	O
associated	O	O
with	O	O
periodontal	O	O
disease	O	O
has	O	O
been	O	O
demonstrated	O	O
in	O	O
buccal	O	O
cells	O	O
.	O	O

Important	O	O
aetiological	O	O
agents	O	O
of	O	O
systemic	O	O
and	O	O
nosocomial	O	O
infections	O	O
have	O	O
been	O	O
detected	O	O
in	O	O
the	O	O
microbiota	O	O
of	O	O
subgingival	O	O
biofilm	O	O
,	O	O
especially	O	O
in	O	O
individuals	O	O
with	O	O
periodontal	O	O
disease	O	O
.	O	O

However	O	O
,	O	O
non-oral	O	O
pathogens	O	O
internalized	O	O
in	O	O
oral	O	O
epithelial	O	O
cells	O	O
and	O	O
their	O	O
relationship	O	O
with	O	O
periodontal	O	O
status	O	O
are	O	O
poorly	O	O
understood	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
detect	O	O
opportunistic	O	O
species	O	O
within	O	O
buccal	O	O
and	O	O
gingival	O	O
crevice	O	O
epithelial	O	O
cells	O	O
collected	O	O
from	O	O
subjects	O	O
with	O	O
periodontitis	O	O
or	O	O
individuals	O	O
with	O	O
good	O	O
periodontal	O	O
health	O	O
,	O	O
and	O	O
to	O	O
associate	O	O
their	O	O
prevalence	O	O
with	O	O
periodontal	O	O
clinical	O	O
status	O	O
.	O	O

Quantitative	O	O
detection	O	O
of	O	O
total	O	O
bacteria	O	O
and	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
and	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
in	O	O
oral	O	O
epithelial	O	O
cells	O	O
was	O	O
determined	O	O
by	O	O
quantitative	O	O
real-time	O	O
PCR	O	O
using	O	O
universal	O	O
and	O	O
species-specific	O	O
primer	O	O
sets	O	O
.	O	O

Intracellular	O	O
bacteria	O	O
were	O	O
visualized	O	O
by	O	O
confocal	O	O
microscopy	O	O
and	O	O
fluorescence	O	O
in	O	O
situ	O	O
hybridization	O	O
.	O	O

Overall	O	O
,	O	O
33	O	O
%	O	O
of	O	O
cell	O	O
samples	O	O
from	O	O
patients	O	O
with	O	O
periodontitis	O	O
contained	O	O
at	O	O
least	O	O
one	O	O
opportunistic	O	O
species	O	O
,	O	O
compared	O	O
with	O	O
15	O	O
%	O	O
of	O	O
samples	O	O
from	O	O
healthy	O	O
individuals	O	O
.	O	O

E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
prevalent	O	O
species	O	O
found	O	O
in	O	O
oral	O	O
epithelial	O	O
cells	O	O
(	O	O
detected	O	O
in	O	O
20.6	O	O
%	O	O
of	O	O
patients	O	O
with	O	O
periodontitis	O	O
,	O	O
P	O	O
=	O	O
0.03	O	O
versus	O	O
healthy	O	O
individuals	O	O
)	O	O
and	O	O
was	O	O
detected	O	O
only	O	O
in	O	O
cells	O	O
from	O	O
patients	O	O
with	O	O
periodontitis	O	O
.	O	O

Quantitative	O	O
real-time	O	O
PCR	O	O
showed	O	O
that	O	O
high	O	O
levels	O	O
of	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
were	O	O
present	O	O
in	O	O
both	O	O
the	O	O
periodontitis	O	O
and	O	O
healthy	O	O
groups	O	O
.	O	O

However	O	O
,	O	O
the	O	O
proportion	O	O
of	O	O
these	O	O
species	O	O
was	O	O
significantly	O	O
higher	O	O
in	O	O
epithelial	O	O
cells	O	O
of	O	O
subjects	O	O
with	O	O
periodontitis	O	O
compared	O	O
with	O	O
healthy	O	O
individuals	O	O
(	O	O
P	O	O
=	O	O
0.016	O	O
for	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
and	O	O
P	O	O
=	O	O
0.047	O	O
for	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
)	O	O
.	O	O

Although	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
were	O	O
detected	O	O
in	O	O
57	O	O
%	O	O
and	O	O
50	O	O
%	O	O
of	O	O
patients	O	O
,	O	O
respectively	O	O
,	O	O
with	O	O
probing	O	O
depth	O	O
and	O	O
clinical	O	O
attachment	O	O
level	O	O
>	O	O
/=6	O	O
mm	O	O
,	O	O
no	O	O
correlation	O	O
was	O	O
found	O	O
with	O	O
age	O	O
,	O	O
sex	O	O
,	O	O
bleeding	O	O
on	O	O
probing	O	O
or	O	O
the	O	O
presence	O	O
of	O	O
supragingival	O	O
biofilm	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
these	O	O
pathogens	O	O
in	O	O
epithelial	O	O
cells	O	O
is	O	O
correlated	O	O
with	O	O
the	O	O
state	O	O
of	O	O
periodontal	O	O
disease	O	O
.	O	O

It	O	O
has	O	O
been	O	O
speculated	O	O
that	O	O
the	O	O
oral	O	O
flora	O	O
of	O	O
the	O	O
Komodo	O	O
dragon	O	O
(	O	O
Varanus	O	O
komodoensis	O	O
)	O	O
exerts	O	O
a	O	O
lethal	O	O
effect	O	O
on	O	O
its	O	O
prey	O	O
;	O	O
yet	O	O
,	O	O
scant	O	O
information	O	O
about	O	O
their	O	O
specific	O	O
oral	O	O
flora	O	O
bacteriology	O	O
,	O	O
especially	O	O
anaerobes	B-bacteria	B-bacteria
,	O	O
exists	O	O
.	O	O

Consequently	O	O
,	O	O
the	O	O
aerobic	O	O
and	O	O
anaerobic	O	O
oral	O	O
bacteriology	O	O
of	O	O
16	O	O
captive	O	O
Komodo	O	O
dragons	O	O
(	O	O
10	O	O
adults	O	O
and	O	O
six	O	O
neonates	O	O
)	O	O
,	O	O
aged	O	O
2-17	O	O
yr	O	O
for	O	O
adults	O	O
and	O	O
7-10	O	O
days	O	O
for	O	O
neonates	O	O
,	O	O
from	O	O
three	O	O
U.S.	O	O
zoos	O	O
were	O	O
studied	O	O
.	O	O

Saliva	O	O
and	O	O
gingival	O	O
samples	O	O
were	O	O
collected	O	O
by	O	O
zoo	O	O
personnel	O	O
,	O	O
inoculated	O	O
into	O	O
anaerobic	O	O
transport	O	O
media	O	O
,	O	O
and	O	O
delivered	O	O
by	O	O
courier	O	O
to	O	O
a	O	O
reference	O	O
laboratory	O	O
.	O	O

Samples	O	O
were	O	O
cultured	O	O
for	O	O
aerobes	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
anaerobes	E-bacteria	I-bacteria
.	O	O

Strains	O	O
were	O	O
identified	O	O
by	O	O
standard	O	O
methods	O	O
and	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
when	O	O
required	O	O
.	O	O

The	O	O
oral	O	O
flora	O	O
consisted	O	O
of	O	O
39	O	O
aerobic	O	O
and	O	O
21	O	O
anaerobic	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
with	O	O
some	O	O
variation	O	O
by	O	O
zoo	O	O
.	O	O

Adult	O	O
dragons	O	O
grew	O	O
128	O	O
isolates	O	O
,	O	O
including	O	O
37	O	O
aerobic	B-bacteria	B-bacteria
gram-negative	I-bacteria	I-bacteria
rods	E-bacteria	I-bacteria
(	O	O
one	O	O
to	O	O
eight	O	O
per	O	O
specimen	O	O
)	O	O
,	O	O
especially	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
;	O	O
50	O	O
aerobic	B-bacteria	B-bacteria
gram-positive	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
two	O	O
to	O	O
nine	O	O
per	O	O
specimen	O	O
)	O	O
,	O	O
especially	O	O
Staphylococcus	B-bacteria	B-bacteria
sciuri	E-bacteria	I-bacteria
and	O	O
Enterococcusfaecalis	B-bacteria	B-bacteria
,	O	O
present	O	O
in	O	O
eight	O	O
of	O	O
10	O	O
and	O	O
nine	O	O
of	O	O
10	O	O
dragons	O	O
,	O	O
respectively	O	O
;	O	O
and	O	O
41	O	O
anaerobes	B-bacteria	B-bacteria
(	O	O
one	O	O
to	O	O
six	O	O
per	O	O
specimen	O	O
)	O	O
,	O	O
especially	O	O
clostridia	B-bacteria	B-bacteria
.	O	O

All	O	O
hatchlings	O	O
grew	O	O
aerobes	B-bacteria	B-bacteria
but	O	O
none	O	O
grew	O	O
anaerobes	B-bacteria	B-bacteria
.	O	O

No	O	O
virulent	O	O
species	O	O
were	O	O
isolated	O	O
.	O	O

As	O	O
with	O	O
other	O	O
carnivores	O	O
,	O	O
captive	O	O
Komodo	O	O
oral	O	O
flora	O	O
is	O	O
simply	O	O
reflective	O	O
of	O	O
the	O	O
gut	O	O
and	O	O
skin	O	O
flora	O	O
of	O	O
their	O	O
recent	O	O
meals	O	O
and	O	O
environment	O	O
and	O	O
is	O	O
unlikely	O	O
to	O	O
cause	O	O
rapid	O	O
fatal	O	O
infection	O	O
.	O	O

Bacteria	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
grow	O	O
in	O	O
the	O	O
form	O	O
of	O	O
biofilms	O	O
;	O	O
these	O	O
structures	O	O
are	O	O
subject	O	O
to	O	O
constant	O	O
saliva	O	O
or	O	O
gingival	O	O
crevicular	O	O
fluid	O	O
flow	O	O
conditions	O	O
.	O	O

The	O	O
aims	O	O
of	O	O
this	O	O
study	O	O
were	O	O
:	O	O
(	O	O
i	O	O
)	O	O
to	O	O
develop	O	O
and	O	O
to	O	O
characterize	O	O
an	O	O
in-vitro	O	O
biofilm	O	O
model	O	O
with	O	O
oral	O	O
bacteria	O	O
growing	O	O
under	O	O
flow	O	O
and	O	O
shear	O	O
conditions	O	O
;	O	O
and	O	O
(	O	O
ii	O	O
)	O	O
to	O	O
demonstrate	O	O
the	O	O
usefulness	O	O
of	O	O
the	O	O
model	O	O
for	O	O
evaluating	O	O
the	O	O
activity	O	O
of	O	O
three	O	O
antiplaque	O	O
agents	O	O
.	O	O

We	O	O
used	O	O
a	O	O
bioreactor	O	O
to	O	O
grow	O	O
the	O	O
oral	O	O
bacteria	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
under	O	O
planktonic	O	O
conditions	O	O
.	O	O

Biofilms	O	O
were	O	O
established	O	O
using	O	O
a	O	O
modified	O	O
Robbins	O	O
device	O	O
on	O	O
hydroxyapatite	O	O
(	O	O
HAP	O	O
)	O	O
discs	O	O
.	O	O

Three-	O	O
to	O	O
7-d-old	O	O
biofilms	O	O
were	O	O
analysed	O	O
using	O	O
culture	O	O
methods	O	O
,	O	O
scanning	O	O
electron	O	O
microscopy	O	O
,	O	O
Live/Dead	O	O
staining	O	O
and	O	O
fluorescence	O	O
in-situ	O	O
hybridization	O	O
(	O	O
confocal	O	O
laser	O	O
scanning	O	O
microscopy	O	O
)	O	O
.	O	O

Finally	O	O
,	O	O
we	O	O
assessed	O	O
the	O	O
antimicrobial	O	O
activity	O	O
of	O	O
three	O	O
mouthrinses	O	O
[	O	O
0.12	O	O
%	O	O
chlorhexidine	O	O
(	O	O
CHX	O	O
)	O	O
,	O	O
0.12	O	O
%	O	O
chlorhexidine	O	O
and	O	O
sodium	O	O
fluoride	O	O
(	O	O
CHX+NaF	O	O
)	O	O
and	O	O
0.12	O	O
%	O	O
chlorhexidine	O	O
and	O	O
0.05	O	O
%	O	O
cetylpyridinium	O	O
chloride	O	O
(	O	O
CHX+CPC	O	O
)	O	O
]	O	O
using	O	O
a	O	O
planktonic	O	O
test	O	O
(	O	O
short	O	O
interval-killing	O	O
test	O	O
)	O	O
and	O	O
in	O	O
our	O	O
4-d	O	O
biofilm	O	O
model	O	O
.	O	O

The	O	O
viable	O	O
cell	O	O
counts	O	O
showed	O	O
that	O	O
each	O	O
species	O	O
was	O	O
consistently	O	O
found	O	O
in	O	O
the	O	O
biofilms	O	O
throughout	O	O
the	O	O
study	O	O
.	O	O

The	O	O
architecture	O	O
and	O	O
cell	O	O
distribution	O	O
were	O	O
similar	O	O
to	O	O
those	O	O
described	O	O
for	O	O
biofilms	O	O
in	O	O
situ	O	O
,	O	O
with	O	O
the	O	O
exception	O	O
of	O	O
a	O	O
thin	O	O
layer	O	O
of	O	O
living	O	O
cells	O	O
that	O	O
was	O	O
found	O	O
close	O	O
to	O	O
the	O	O
HAP	O	O
.	O	O

The	O	O
effectiveness	O	O
test	O	O
of	O	O
the	O	O
mouthwashes	O	O
demonstrated	O	O
that	O	O
cells	O	O
in	O	O
biofilms	O	O
showed	O	O
more	O	O
tolerance	O	O
compared	O	O
with	O	O
planktonic	O	O
cells	O	O
.	O	O

Moreover	O	O
,	O	O
it	O	O
was	O	O
observed	O	O
that	O	O
in	O	O
4-d	O	O
biofilm	O	O
formed	O	O
in	O	O
vitro	O	O
,	O	O
CHX+CPC	O	O
caused	O	O
significantly	O	O
higher	O	O
mortality	O	O
compared	O	O
with	O	O
CHX	O	O
(	O	O
p	O	O
=	O	O
0.003	O	O
)	O	O
and	O	O
CHX+NaF	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

Our	O	O
results	O	O
suggest	O	O
that	O	O
we	O	O
have	O	O
a	O	O
highly	O	O
reproducible	O	O
system	O	O
for	O	O
multispecies	O	O
oral	O	O
biofilm	O	O
formation	O	O
and	O	O
that	O	O
it	O	O
is	O	O
a	O	O
useful	O	O
tool	O	O
for	O	O
assessing	O	O
antibacterial	O	O
molecules	O	O
before	O	O
their	O	O
clinical	O	O
evaluation	O	O
.	O	O

It	O	O
also	O	O
has	O	O
great	O	O
potential	O	O
to	O	O
be	O	O
used	O	O
in	O	O
basic	O	O
research	O	O
on	O	O
supragingival	O	O
and	O	O
subgingival	O	O
biofilms	O	O
.	O	O

Mucosal	O	O
surfaces	O	O
such	O	O
as	O	O
the	O	O
gut	O	O
,	O	O
vagina	O	O
and	O	O
oral	O	O
cavity	O	O
are	O	O
colonized	O	O
by	O	O
microbiota	O	O
that	O	O
are	O	O
an	O	O
integral	O	O
component	O	O
of	O	O
the	O	O
healthy	O	O
ecosystem	O	O
.	O	O

Recent	O	O
molecular	O	O
techniques	O	O
make	O	O
it	O	O
feasible	O	O
to	O	O
correlate	O	O
antimicrobial	O	O
dosing	O	O
levels	O	O
with	O	O
changes	O	O
in	O	O
microbiome	O	O
composition	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
characterize	O	O
the	O	O
rat	O	O
oral	O	O
plaque	O	O
microbiome	O	O
composition	O	O
at	O	O
doses	O	O
of	O	O
ciprofloxacin	O	O
that	O	O
were	O	O
considerably	O	O
above	O	O
and	O	O
below	O	O
nominal	O	O
in	O	O
vitro	O	O
minimal	O	O
inhibitory	O	O
concentrations	O	O
of	O	O
a	O	O
variety	O	O
of	O	O
gram-positive	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
commensal	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

We	O	O
exposed	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
rats	O	O
to	O	O
relatively	O	O
low	O	O
(	O	O
0.1	O	O
mug	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
)	O	O
and	O	O
high	O	O
(	O	O
20	O	O
mug	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
)	O	O
doses	O	O
of	O	O
ciprofloxacin	O	O
in	O	O
the	O	O
drinking	O	O
water	O	O
over	O	O
a	O	O
3-day	O	O
period	O	O
.	O	O

Plaque	O	O
microbiota	O	O
were	O	O
characterized	O	O
using	O	O
454	O	O
pyrosequencing	O	O
.	O	O

The	O	O
rat	O	O
indigenous	O	O
community	O	O
was	O	O
dominated	O	O
by	O	O
the	O	O
genera	O	O
Rothia	O	O
(	O	O
74.4	O	O
%	O	O
)	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
(	O	O
4.7	O	O
%	O	O
)	O	O
.	O	O

Dosing	O	O
at	O	O
0.1	O	O
mug	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
was	O	O
associated	O	O
with	O	O
changes	O	O
in	O	O
Rothia	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
that	O	O
were	O	O
not	O	O
significant	O	O
,	O	O
whereas	O	O
dosing	O	O
at	O	O
20	O	O
mug	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
caused	O	O
a	O	O
pronounced	O	O
(	O	O
significant	O	O
)	O	O
reduction	O	O
in	O	O
the	O	O
relative	O	O
abundance	O	O
of	O	O
the	O	O
Streptococcus	B-bacteria	B-bacteria
genus	E-bacteria	I-bacteria
.	O	O

Taxonomic	O	O
independent	O	O
analysis	O	O
indicated	O	O
that	O	O
the	O	O
perturbation	O	O
in	O	O
the	O	O
overall	O	O
community	O	O
structure	O	O
attributed	O	O
to	O	O
dosing	O	O
with	O	O
ciprofloxacin	O	O
at	O	O
either	O	O
the	O	O
low	O	O
or	O	O
high	O	O
dose	O	O
was	O	O
relatively	O	O
low	O	O
.	O	O

The	O	O
results	O	O
suggest	O	O
that	O	O
it	O	O
is	O	O
feasible	O	O
to	O	O
use	O	O
an	O	O
antimicrobial	O	O
dosing	O	O
regimen	O	O
to	O	O
selectively	O	O
target	O	O
a	O	O
specific	O	O
subset	O	O
of	O	O
a	O	O
mucosal	O	O
microbiome	O	O
for	O	O
elimination	O	O
with	O	O
minimal	O	O
perturbation	O	O
of	O	O
the	O	O
entire	O	O
community	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	O	O
are	O	O
associated	O	O
with	O	O
the	O	O
development	O	O
of	O	O
dental	O	O
caries	O	O
in	O	O
humans	O	O
.	O	O

However	O	O
,	O	O
previous	O	O
diagnostic	O	O
systems	O	O
are	O	O
unsuitable	O	O
for	O	O
monitoring	O	O
viable	O	O
cell	O	O
numbers	O	O
in	O	O
oral	O	O
specimens	O	O
.	O	O

Assessing	O	O
the	O	O
relationship	O	O
between	O	O
the	O	O
numbers	O	O
of	O	O
viable	O	O
and	O	O
dead	O	O
bacterial	O	O
cells	O	O
and	O	O
oral	O	O
status	O	O
is	O	O
important	O	O
for	O	O
understanding	O	O
oral	O	O
infectious	O	O
diseases	O	O
.	O	O

Propidium	O	O
monoazide	O	O
(	O	O
PMA	O	O
)	O	O
has	O	O
been	O	O
reported	O	O
to	O	O
penetrate	O	O
dead	O	O
cells	O	O
following	O	O
membrane	O	O
damage	O	O
and	O	O
to	O	O
cross-link	O	O
DNA	O	O
,	O	O
thereby	O	O
inhibiting	O	O
DNA	O	O
amplification	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
we	O	O
established	O	O
an	O	O
assay	O	O
for	O	O
selective	O	O
analysis	O	O
of	O	O
two	O	O
viable	O	O
human	O	O
cariogenic	O	O
pathogens	O	O
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
using	O	O
PMA	O	O
combined	O	O
with	O	O
real-time	O	O
PCR	O	O
(	O	O
PMA-qPCR	O	O
)	O	O
.	O	O

We	O	O
designed	O	O
species-specific	O	O
primer	O	O
sets	O	O
for	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
generated	O	O
standard	O	O
curves	O	O
for	O	O
measuring	O	O
cell	O	O
numbers	O	O
,	O	O
and	O	O
evaluated	O	O
the	O	O
dynamic	O	O
range	O	O
of	O	O
the	O	O
assay	O	O
.	O	O

To	O	O
determine	O	O
the	O	O
effectiveness	O	O
of	O	O
the	O	O
assay	O	O
,	O	O
PMA	O	O
was	O	O
added	O	O
to	O	O
viable	O	O
and	O	O
autoclave-killed	O	O
cell	O	O
mixtures	O	O
.	O	O

PMA	O	O
treatment	O	O
effectively	O	O
prevented	O	O
DNA	O	O
amplification	O	O
from	O	O
dead	O	O
cells	O	O
.	O	O

No	O	O
amplification	O	O
of	O	O
DNA	O	O
from	O	O
dead	O	O
cells	O	O
was	O	O
observed	O	O
in	O	O
these	O	O
organisms	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
we	O	O
applied	O	O
this	O	O
assay	O	O
to	O	O
analyze	O	O
viable	O	O
cell	O	O
numbers	O	O
in	O	O
oral	O	O
specimens	O	O
.	O	O

A	O	O
significant	O	O
correlation	O	O
was	O	O
found	O	O
between	O	O
the	O	O
number	O	O
of	O	O
viable	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
cells	O	O
in	O	O
saliva	O	O
and	O	O
that	O	O
in	O	O
plaque	O	O
among	O	O
caries-free	O	O
patients	O	O
,	O	O
whereas	O	O
no	O	O
correlation	O	O
was	O	O
observed	O	O
between	O	O
saliva	O	O
and	O	O
carious	O	O
dentin	O	O
.	O	O

The	O	O
total	O	O
and	O	O
viable	O	O
cell	O	O
numbers	O	O
in	O	O
caries-positive	O	O
saliva	O	O
were	O	O
significantly	O	O
higher	O	O
than	O	O
those	O	O
in	O	O
caries-free	O	O
saliva	O	O
.	O	O

Finally	O	O
,	O	O
we	O	O
analyzed	O	O
the	O	O
usefulness	O	O
of	O	O
this	O	O
assay	O	O
for	O	O
in	O	O
vitro	O	O
oral	O	O
biofilm	O	O
analysis	O	O
.	O	O

We	O	O
applied	O	O
PMA-qPCR	O	O
for	O	O
monitoring	O	O
viable	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
cell	O	O
numbers	O	O
in	O	O
vitro	O	O
in	O	O
planktonic	O	O
cells	O	O
and	O	O
oral	O	O
biofilm	O	O
treated	O	O
with	O	O
hydrogen	O	O
peroxide	O	O
(	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
)	O	O
.	O	O

In	O	O
planktonic	O	O
cells	O	O
,	O	O
the	O	O
number	O	O
of	O	O
viable	O	O
cells	O	O
decreased	O	O
significantly	O	O
with	O	O
increasing	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
concentration	O	O
,	O	O
whereas	O	O
only	O	O
a	O	O
small	O	O
decrease	O	O
was	O	O
observed	O	O
in	O	O
biofilm	O	O
cell	O	O
numbers	O	O
.	O	O

PMA-qPCR	O	O
is	O	O
potentially	O	O
useful	O	O
for	O	O
quantifying	O	O
viable	O	O
cariogenic	O	O
pathogens	O	O
in	O	O
oral	O	O
specimens	O	O
and	O	O
is	O	O
applicable	O	O
to	O	O
oral	O	O
biofilm	O	O
experiments	O	O
.	O	O

This	O	O
assay	O	O
will	O	O
help	O	O
to	O	O
elucidate	O	O
the	O	O
relationship	O	O
between	O	O
the	O	O
number	O	O
of	O	O
viable	O	O
cells	O	O
in	O	O
oral	O	O
specimens	O	O
and	O	O
the	O	O
oral	O	O
status	O	O
.	O	O

From	O	O
oral	O	O
cavity	O	O
we	O	O
isolated	O	O
and	O	O
characterized	O	O
probiotic	B-bacteria	B-bacteria
lactobacilli	E-bacteria	I-bacteria
that	O	O
could	O	O
probability	O	O
be	O	O
applied	O	O
to	O	O
therapy	O	O
and	O	O
prevention	O	O
of	O	O
oral	O	O
diseases	O	O
.	O	O

Lactobacillus	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
were	O	O
isolated	O	O
by	O	O
plating	O	O
the	O	O
saliva	O	O
and	O	O
dental	O	O
plaque	O	O
of	O	O
healthy	O	O
donors	O	O
on	O	O
selective	O	O
medium	O	O
.	O	O

Then	O	O
the	O	O
target	O	O
strains	O	O
were	O	O
tested	O	O
for	O	O
inhibiting	O	O
the	O	O
growth	O	O
of	O	O
a	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
belonging	O	O
to	O	O
cariogenic	O	O
pathogen	O	O
species	O	O
.	O	O

Other	O	O
properties	O	O
such	O	O
as	O	O
production	O	O
of	O	O
extracellular	O	O
polysaccharide	O	O
and	O	O
resistance	O	O
to	O	O
the	O	O
antibacterial	O	O
substances	O	O
were	O	O
also	O	O
investigated	O	O
.	O	O

Lactobacillus	B-bacteria	B-bacteria
fermentum	I-bacteria	I-bacteria
Y29	E-bacteria	I-bacteria
,	O	O
a	O	O
strain	O	O
with	O	O
antimicrobial	O	O
activity	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
was	O	O
obtained	O	O
from	O	O
dental	O	O
plaque	O	O
.	O	O

This	O	O
strain	O	O
was	O	O
an	O	O
extracellular	O	O
polysaccharide	O	O
producer	O	O
,	O	O
which	O	O
corresponds	O	O
to	O	O
its	O	O
aggregation	O	O
ability	O	O
.	O	O

Moreover	O	O
,	O	O
L.	B-bacteria	B-bacteria
fermentum	I-bacteria	I-bacteria
Y29	E-bacteria	I-bacteria
showed	O	O
resistance	O	O
to	O	O
1.0	O	O
mg/mL	O	O
lysozyme	O	O
and	O	O
140	O	O
microg/g	O	O
hydrogen	O	O
peroxide	O	O
that	O	O
may	O	O
guarantee	O	O
its	O	O
persistence	O	O
in	O	O
the	O	O
complex	O	O
oral	O	O
niche	O	O
.	O	O

Probiotic	O	O
properties	O	O
were	O	O
characterized	O	O
of	O	O
an	O	O
oral	O	O
isolate	O	O
L.	B-bacteria	B-bacteria
fermentum	I-bacteria	I-bacteria
Y29	E-bacteria	I-bacteria
,	O	O
which	O	O
provided	O	O
a	O	O
possibility	O	O
for	O	O
its	O	O
application	O	O
in	O	O
prevention	O	O
and	O	O
treatment	O	O
of	O	O
oral	O	O
diseases	O	O
.	O	O

Oral	O	O
mucosal	O	O
and	O	O
salivary	O	O
lipids	O	O
exhibit	O	O
potent	O	O
antimicrobial	O	O
activity	O	O
for	O	O
a	O	O
variety	O	O
of	O	O
Gram-positive	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
;	O	O
however	O	O
,	O	O
little	O	O
is	O	O
known	O	O
about	O	O
their	O	O
spectrum	O	O
of	O	O
antimicrobial	O	O
activity	O	O
or	O	O
mechanisms	O	O
of	O	O
action	O	O
against	O	O
oral	O	O
bacteria	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
examine	O	O
the	O	O
activity	O	O
of	O	O
two	O	O
fatty	O	O
acids	O	O
and	O	O
three	O	O
sphingoid	O	O
bases	O	O
against	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
an	O	O
important	O	O
colonizer	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
implicated	O	O
in	O	O
periodontitis	O	O
.	O	O

Minimal	O	O
inhibitory	O	O
concentrations	O	O
,	O	O
minimal	O	O
bactericidal	O	O
concentrations	O	O
,	O	O
and	O	O
kill	O	O
kinetics	O	O
revealed	O	O
variable	O	O
,	O	O
but	O	O
potent	O	O
,	O	O
activity	O	O
of	O	O
oral	O	O
mucosal	O	O
and	O	O
salivary	O	O
lipids	O	O
against	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
indicating	O	O
that	O	O
lipid	O	O
structure	O	O
may	O	O
be	O	O
an	O	O
important	O	O
determinant	O	O
in	O	O
lipid	O	O
mechanisms	O	O
of	O	O
activity	O	O
against	O	O
bacteria	O	O
,	O	O
although	O	O
specific	O	O
components	O	O
of	O	O
bacterial	O	O
membranes	O	O
are	O	O
also	O	O
likely	O	O
important	O	O
.	O	O

Electron	O	O
micrographs	O	O
showed	O	O
ultrastructural	O	O
damage	O	O
induced	O	O
by	O	O
sapienic	O	O
acid	O	O
and	O	O
phytosphingosine	O	O
and	O	O
confirmed	O	O
disruption	O	O
of	O	O
the	O	O
bacterial	O	O
plasma	O	O
membrane	O	O
.	O	O

This	O	O
information	O	O
,	O	O
coupled	O	O
with	O	O
the	O	O
association	O	O
of	O	O
treatment	O	O
lipids	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
lipids	O	O
revealed	O	O
via	O	O
thin	O	O
layer	O	O
chromatography	O	O
,	O	O
suggests	O	O
that	O	O
the	O	O
plasma	O	O
membrane	O	O
is	O	O
a	O	O
likely	O	O
target	O	O
of	O	O
lipid	O	O
antibacterial	O	O
activity	O	O
.	O	O

Utilizing	O	O
a	O	O
combination	O	O
of	O	O
two-dimensional	O	O
in-gel	O	O
electrophoresis	O	O
and	O	O
Western	O	O
blot	O	O
followed	O	O
by	O	O
mass	O	O
spectroscopy	O	O
and	O	O
N-terminus	O	O
degradation	O	O
sequencing	O	O
we	O	O
also	O	O
show	O	O
that	O	O
treatment	O	O
with	O	O
sapienic	O	O
acid	O	O
induces	O	O
upregulation	O	O
of	O	O
a	O	O
set	O	O
of	O	O
proteins	O	O
comprising	O	O
a	O	O
unique	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
stress	O	O
response	O	O
,	O	O
including	O	O
proteins	O	O
important	O	O
in	O	O
fatty	O	O
acid	O	O
biosynthesis	O	O
,	O	O
metabolism	O	O
and	O	O
energy	O	O
production	O	O
,	O	O
protein	O	O
processing	O	O
,	O	O
cell	O	O
adhesion	O	O
and	O	O
virulence	O	O
.	O	O

Prophylactic	O	O
or	O	O
therapeutic	O	O
lipid	O	O
treatments	O	O
may	O	O
be	O	O
beneficial	O	O
for	O	O
intervention	O	O
of	O	O
infection	O	O
by	O	O
supplementing	O	O
the	O	O
natural	O	O
immune	O	O
function	O	O
of	O	O
endogenous	O	O
lipids	O	O
on	O	O
mucosal	O	O
surfaces	O	O
.	O	O

Adhesion	O	O
to	O	O
oral	O	O
soft	O	O
and	O	O
hard	O	O
tissue	O	O
is	O	O
crucial	O	O
for	O	O
bacterial	O	O
colonisation	O	O
in	O	O
the	O	O
mouth	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
work	O	O
was	O	O
to	O	O
select	O	O
strains	O	O
of	O	O
oral	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
that	O	O
could	O	O
be	O	O
used	O	O
as	O	O
probiotics	O	O
for	O	O
oral	O	O
health	O	O
.	O	O

To	O	O
this	O	O
end	O	O
,	O	O
the	O	O
adhesive	O	O
properties	O	O
of	O	O
some	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
investigated	O	O
.	O	O

Seventeen	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
including	O	O
two	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
strains	O	O
were	O	O
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
healthy	O	O
children	O	O
,	O	O
while	O	O
other	O	O
strains	O	O
were	O	O
isolated	O	O
from	O	O
fermented	O	O
meat	O	O
products	O	O
.	O	O

The	O	O
bacterial	O	O
strains	O	O
were	O	O
applied	O	O
to	O	O
teeth	O	O
surfaces	O	O
covered	O	O
with	O	O
saliva	O	O
or	O	O
without	O	O
saliva	O	O
.	O	O

A	O	O
significant	O	O
diversity	O	O
in	O	O
adhesion	O	O
capacity	O	O
to	O	O
teeth	O	O
surfaces	O	O
among	O	O
the	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
was	O	O
observed	O	O
.	O	O

Lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
adhered	O	O
the	O	O
best	O	O
to	O	O
teeth	O	O
surfaces	O	O
covered	O	O
with	O	O
saliva	O	O
,	O	O
whereas	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
isolated	O	O
from	O	O
fermented	O	O
meat	O	O
samples	O	O
adhered	O	O
the	O	O
best	O	O
to	O	O
tooth	O	O
surface	O	O
without	O	O
saliva	O	O
.	O	O

All	O	O
strains	O	O
of	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
able	O	O
to	O	O
reduce	O	O
the	O	O
number	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
cells	O	O
,	O	O
in	O	O
particular	O	O
on	O	O
saliva-coated	O	O
tooth	O	O
surface	O	O
.	O	O

Therefore	O	O
,	O	O
they	O	O
might	O	O
have	O	O
potential	O	O
as	O	O
probiotics	O	O
for	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
our	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
relationship	O	O
between	O	O
halitosis	O	O
and	O	O
oral	O	O
bacteria	O	O
in	O	O
tongue	O	O
coating	O	O
(	O	O
TC	O	O
)	O	O
and	O	O
saliva	O	O
samples	O	O
from	O	O
patients	O	O
with	O	O
halitosis	O	O
,	O	O
and	O	O
to	O	O
evaluate	O	O
the	O	O
effect	O	O
of	O	O
tongue	O	O
cleaning	O	O
on	O	O
halitosis	O	O
.	O	O

Ninety-four	O	O
participants	O	O
complaining	O	O
of	O	O
oral	O	O
malodour	O	O
were	O	O
included	O	O
in	O	O
the	O	O
study	O	O
.	O	O

Organoleptic	O	O
(	O	O
OR	O	O
)	O	O
values	O	O
,	O	O
volatile	O	O
sulphur	O	O
compound	O	O
(	O	O
VSC	O	O
)	O	O
concentrations	O	O
determined	O	O
by	O	O
gas	O	O
chromatography	O	O
and	O	O
TC	O	O
scores	O	O
were	O	O
used	O	O
as	O	O
clinical	O	O
parameters	O	O
of	O	O
halitosis	O	O
.	O	O

Quantitative	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reactions	O	O
were	O	O
used	O	O
to	O	O
determine	O	O
the	O	O
numbers	O	O
of	O	O
periodontal	O	O
disease-associated	O	O
oral	O	O
bacteria	O	O
.	O	O

There	O	O
was	O	O
a	O	O
significant	O	O
correlation	O	O
between	O	O
TC	O	O
scores	O	O
and	O	O
OR	O	O
values	O	O
,	O	O
methylmercaptan	O	O
(	O	O
CH3	O	O
SH	O	O
)	O	O
concentrations	O	O
and	O	O
VSC	O	O
concentrations	O	O
(	O	O
Spearman	O	O
's	O	O
rank-correlation	O	O
coefficient	O	O
test	O	O
,	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

There	O	O
was	O	O
also	O	O
a	O	O
positive	O	O
correlation	O	O
between	O	O
the	O	O
clinical	O	O
parameters	O	O
of	O	O
halitosis	O	O
and	O	O
total	O	O
bacterial	O	O
numbers	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
concentrations	O	O
in	O	O
the	O	O
TC	O	O
samples	O	O
.	O	O

However	O	O
,	O	O
there	O	O
was	O	O
no	O	O
similar	O	O
correlation	O	O
with	O	O
respect	O	O
to	O	O
the	O	O
saliva	O	O
samples	O	O
.	O	O

The	O	O
participants	O	O
were	O	O
sub-divided	O	O
into	O	O
two	O	O
groups	O	O
based	O	O
on	O	O
whether	O	O
they	O	O
had	O	O
the	O	O
habit	O	O
of	O	O
tongue	O	O
cleaning	O	O
or	O	O
not	O	O
.	O	O

The	O	O
participants	O	O
with	O	O
the	O	O
habit	O	O
of	O	O
tongue	O	O
cleaning	O	O
had	O	O
significantly	O	O
lower	O	O
OR	O	O
scores	O	O
,	O	O
VSC	O	O
concentrations	O	O
and	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
levels	O	O
than	O	O
the	O	O
other	O	O
participants	O	O
(	O	O
Mann-Whitney	O	O
U-test	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

These	O	O
results	O	O
suggested	O	O
that	O	O
periodontal	O	O
disease-associated	O	O
oral	O	O
bacteria	O	O
in	O	O
TCs	O	O
are	O	O
closely	O	O
related	O	O
to	O	O
halitosis	O	O
and	O	O
that	O	O
tongue	O	O
cleaning	O	O
may	O	O
be	O	O
an	O	O
effective	O	O
method	O	O
for	O	O
improving	O	O
halitosis	O	O
.	O	O

The	O	O
in	O	O
vitro	O	O
effect	O	O
of	O	O
a	O	O
novel	O	O
,	O	O
oligosaccharide	O	O
nanomedicine	O	O
OligoG	O	O
against	O	O
oral	O	O
pathogen-related	O	O
biofilms	O	O
,	O	O
both	O	O
alone	O	O
and	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
conventional	O	O
anti-bacterial	O	O
agent	O	O
triclosan	O	O
,	O	O
was	O	O
evaluated	O	O
.	O	O

The	O	O
effect	O	O
of	O	O
OligoG+/-triclosan	O	O
was	O	O
assessed	O	O
against	O	O
established	O	O
Streptococcus	O	O
mutans	O	O
and	O	O
Porphyromonas	O	O
gingivalis	O	O
biofilms	O	O
by	O	O
bacterial	O	O
counts	O	O
and	O	O
image	O	O
analysis	O	O
using	O	O
LIVE/DEAD	O	O
(	O	O
(	O	O
R	O	O
)	O	O
)	O	O
staining	O	O
and	O	O
atomic	O	O
force	O	O
microscopy	O	O
(	O	O
AFM	O	O
)	O	O
.	O	O

The	O	O
effect	O	O
of	O	O
triclosan	O	O
and	O	O
OligoG	O	O
surface	O	O
pre-treatments	O	O
on	O	O
bacterial	O	O
attachment	O	O
to	O	O
titanium	O	O
and	O	O
polymethylmethacrylate	O	O
was	O	O
also	O	O
studied	O	O
.	O	O

OligoG	O	O
potentiated	O	O
the	O	O
antimicrobial	O	O
effect	O	O
of	O	O
triclosan	O	O
,	O	O
particularly	O	O
when	O	O
used	O	O
in	O	O
combination	O	O
at	O	O
0.3	O	O
%	O	O
against	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
grown	O	O
in	O	O
artificial	O	O
saliva	O	O
.	O	O

OligoG	O	O
was	O	O
less	O	O
effective	O	O
against	O	O
established	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
biofilms	O	O
.	O	O

However	O	O
,	O	O
attachment	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
to	O	O
titanium	O	O
in	O	O
particular	O	O
,	O	O
was	O	O
significantly	O	O
reduced	O	O
after	O	O
surface	O	O
pre-treatment	O	O
with	O	O
OligoG	O	O
and	O	O
triclosan	O	O
at	O	O
0.01	O	O
%	O	O
when	O	O
compared	O	O
to	O	O
controls	O	O
.	O	O

Light	O	O
microscopy	O	O
and	O	O
AFM	O	O
showed	O	O
that	O	O
OligoG	O	O
was	O	O
biocidal	O	O
to	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
but	O	O
not	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

OligoG	O	O
and	O	O
triclosan	O	O
when	O	O
used	O	O
in	O	O
combination	O	O
produced	O	O
an	O	O
enhanced	O	O
antimicrobial	O	O
effect	O	O
against	O	O
two	O	O
important	O	O
oral	O	O
pathogens	O	O
and	O	O
reduced	O	O
bacterial	O	O
attachment	O	O
to	O	O
dental	O	O
materials	O	O
such	O	O
as	O	O
titanium	O	O
,	O	O
even	O	O
at	O	O
reduced	O	O
triclosan	O	O
concentrations	O	O
.	O	O

Whilst	O	O
the	O	O
use	O	O
of	O	O
triclosan	O	O
against	O	O
oral	O	O
bacteria	O	O
has	O	O
been	O	O
widely	O	O
documented	O	O
,	O	O
its	O	O
synergistic	O	O
use	O	O
with	O	O
OligoG	O	O
described	O	O
here	O	O
,	O	O
has	O	O
not	O	O
previously	O	O
been	O	O
reported	O	O
.	O	O

The	O	O
use	O	O
of	O	O
lower	O	O
concentrations	O	O
of	O	O
triclosan	O	O
,	O	O
if	O	O
used	O	O
in	O	O
combination	O	O
therapy	O	O
with	O	O
OligoG	O	O
,	O	O
could	O	O
have	O	O
environmental	O	O
benefits	O	O
.	O	O

The	O	O
potentiation	O	O
of	O	O
antimicrobial	O	O
agents	O	O
by	O	O
naturally	O	O
occurring	O	O
oligomers	O	O
such	O	O
as	O	O
OligoG	O	O
may	O	O
represent	O	O
a	O	O
novel	O	O
,	O	O
safe	O	O
adjunct	O	O
to	O	O
conventional	O	O
oral	O	O
hygiene	O	O
and	O	O
periodontal	O	O
therapy	O	O
.	O	O

The	O	O
ability	O	O
of	O	O
OligoG	O	O
to	O	O
inhibit	O	O
the	O	O
growth	O	O
and	O	O
impair	O	O
bacterial	O	O
adherence	O	O
highlights	O	O
its	O	O
potential	O	O
in	O	O
the	O	O
management	O	O
of	O	O
peri-implantitis	O	O
.	O	O

'Broken	O	O
mouth	O	O
'	O	O
periodontitis	O	O
(	O	O
BMP	O	O
)	O	O
is	O	O
a	O	O
painful	O	O
condition	O	O
of	O	O
sheep	O	O
grazed	O	O
on	O	O
rough	O	O
pasture	O	O
and	O	O
involves	O	O
periodontal	O	O
infection	O	O
of	O	O
the	O	O
incisor	O	O
teeth	O	O
and	O	O
progressive	O	O
tooth	O	O
loss	O	O
.	O	O

This	O	O
can	O	O
reduce	O	O
the	O	O
efficiency	O	O
of	O	O
grazing	O	O
of	O	O
sheep	O	O
,	O	O
which	O	O
contributes	O	O
to	O	O
malnutrition	O	O
,	O	O
weight	O	O
loss	O	O
,	O	O
systemic	O	O
health	O	O
problems	O	O
,	O	O
poor	O	O
quality	O	O
of	O	O
life	O	O
and	O	O
early	O	O
culling	O	O
from	O	O
flocks	O	O
.	O	O

Consequently	O	O
,	O	O
this	O	O
condition	O	O
is	O	O
a	O	O
major	O	O
economic	O	O
problem	O	O
to	O	O
sheep	O	O
farmers	O	O
.	O	O

However	O	O
,	O	O
there	O	O
are	O	O
no	O	O
treatment	O	O
or	O	O
control	O	O
methods	O	O
available	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
identify	O	O
the	O	O
bacteria	O	O
associated	O	O
with	O	O
BMP	O	O
and	O	O
oral	O	O
health	O	O
in	O	O
sheep	O	O
.	O	O

Swabs	O	O
were	O	O
collected	O	O
from	O	O
the	O	O
gingival	O	O
pockets	O	O
of	O	O
three	O	O
sheep	O	O
with	O	O
BMP	O	O
and	O	O
from	O	O
the	O	O
gingival	O	O
margin	O	O
of	O	O
three	O	O
orally	O	O
healthy	O	O
(	O	O
normal	O	O
)	O	O
sheep	O	O
.	O	O

Bacteria	O	O
were	O	O
identified	O	O
using	O	O
culture-independent	O	O
(	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
)	O	O
methods	O	O
.	O	O

In	O	O
the	O	O
normal	O	O
samples	O	O
,	O	O
26	O	O
phylotypes	O	O
were	O	O
identified	O	O
.	O	O

The	O	O
most	O	O
prevalent	O	O
species	O	O
were	O	O
Enterobacter	B-bacteria	B-bacteria
hormaechei	E-bacteria	I-bacteria
(	O	O
21.3	O	O
%	O	O
of	O	O
analysed	O	O
clones	O	O
)	O	O
and	O	O
Hafnia	B-bacteria	B-bacteria
alvei	E-bacteria	I-bacteria
(	O	O
21.3	O	O
%	O	O
)	O	O
,	O	O
with	O	O
uncultured	O	O
(	O	O
4.4	O	O
%	O	O
)	O	O
and	O	O
novel	O	O
(	O	O
5.0	O	O
%	O	O
)	O	O
phylotypes	O	O
also	O	O
being	O	O
identified	O	O
.	O	O

For	O	O
the	O	O
BMP	O	O
samples	O	O
,	O	O
24	O	O
phylotypes	O	O
were	O	O
identified	O	O
.	O	O

The	O	O
most	O	O
prevalent	O	O
species	O	O
were	O	O
Mannheimia	B-bacteria	B-bacteria
ruminalis	E-bacteria	I-bacteria
(	O	O
28.4	O	O
%	O	O
)	O	O
and	O	O
Moraxella	B-bacteria	B-bacteria
caprae	E-bacteria	I-bacteria
(	O	O
13.5	O	O
%	O	O
)	O	O
,	O	O
with	O	O
uncultured	O	O
(	O	O
2.6	O	O
%	O	O
)	O	O
and	O	O
novel	O	O
(	O	O
24.5	O	O
%	O	O
)	O	O
phylotypes	O	O
also	O	O
being	O	O
identified	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
a	O	O
distinct	O	O
microflora	O	O
is	O	O
associated	O	O
with	O	O
BMP	O	O
and	O	O
oral	O	O
health	O	O
in	O	O
sheep	O	O
and	O	O
M.	B-bacteria	B-bacteria
ruminalis	E-bacteria	I-bacteria
may	O	O
be	O	O
involved	O	O
in	O	O
the	O	O
aetiology	O	O
of	O	O
BMP	O	O
.	O	O

Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
can	O	O
contribute	O	O
positively	O	O
to	O	O
general	O	O
and	O	O
oral	O	O
health	O	O
and	O	O
are	O	O
frequently	O	O
acquired	O	O
by	O	O
breastfeeding	O	O
in	O	O
infancy	O	O
.	O	O

The	O	O
present	O	O
study	O	O
aimed	O	O
to	O	O
identify	O	O
oral	O	O
lactobacilli	B-bacteria	B-bacteria
in	O	O
breast	O	O
and	O	O
formula-fed	O	O
4	O	O
month-old	O	O
infants	O	O
and	O	O
to	O	O
evaluate	O	O
potential	O	O
probiotic	O	O
properties	O	O
of	O	O
the	O	O
dominant	O	O
Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
detected	O	O
.	O	O

Saliva	O	O
and	O	O
oral	O	O
swab	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
133	O	O
infants	O	O
who	O	O
were	O	O
enrolled	O	O
in	O	O
a	O	O
longitudinal	O	O
study	O	O
(	O	O
n=240	O	O
)	O	O
examining	O	O
the	O	O
effect	O	O
of	O	O
a	O	O
new	O	O
infant	O	O
formula	O	O
on	O	O
child	O	O
growth	O	O
and	O	O
development	O	O
.	O	O

Saliva	O	O
was	O	O
cultured	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
isolates	O	O
were	O	O
identified	O	O
from	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
.	O	O

Five	O	O
L.	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
isolates	O	O
that	O	O
differed	O	O
in	O	O
16S	O	O
rRNA	O	O
sequence	O	O
were	O	O
tested	O	O
for	O	O
their	O	O
ability	O	O
to	O	O
inhibit	O	O
growth	O	O
of	O	O
selected	O	O
oral	O	O
bacteria	O	O
and	O	O
for	O	O
adhesion	O	O
to	O	O
oral	O	O
tissues	O	O
.	O	O

Oral	O	O
swab	O	O
samples	O	O
were	O	O
analyzed	O	O
by	O	O
qPCR	O	O
for	O	O
Lactobacillus	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
.	O	O

43	O	O
(	O	O
32.3	O	O
%	O	O
)	O	O
infants	O	O
were	O	O
breastfed	O	O
and	O	O
90	O	O
(	O	O
67.7	O	O
%	O	O
)	O	O
were	O	O
formula-fed	O	O
with	O	O
either	O	O
a	O	O
standard	O	O
formula	O	O
(	O	O
43	O	O
out	O	O
of	O	O
90	O	O
)	O	O
or	O	O
formula	O	O
supplemented	O	O
with	O	O
a	O	O
milk	O	O
fat	O	O
globule	O	O
membrane	O	O
(	O	O
MFGM	O	O
)	O	O
fraction	O	O
(	O	O
47	O	O
out	O	O
of	O	O
90	O	O
)	O	O
.	O	O

lactobacilli	B-bacteria	B-bacteria
were	O	O
cultured	O	O
from	O	O
saliva	O	O
of	O	O
34.1	O	O
%	O	O
breastfed	O	O
infants	O	O
,	O	O
but	O	O
only	O	O
in	O	O
4.7	O	O
%	O	O
of	O	O
the	O	O
standard	O	O
and	O	O
9.3	O	O
%	O	O
of	O	O
the	O	O
MFGM	O	O
supplemented	O	O
formula-fed	O	O
infants	O	O
.	O	O

L.	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
prevalent	O	O
(	O	O
88	O	O
%	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
positive	O	O
infants	O	O
)	O	O
of	O	O
six	O	O
Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
detected	O	O
.	O	O

L.	B-bacteria	B-bacteria
gasseri	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
inhibited	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
binding	O	O
to	O	O
saliva-coated	O	O
hydroxyapatite	O	O
,	O	O
and	O	O
inhibited	O	O
growth	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
oris	E-bacteria	I-bacteria
,	O	O
Candida	O	O
albicans	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
in	O	O
a	O	O
concentration	O	O
dependent	O	O
fashion	O	O
.	O	O

L.	B-bacteria	B-bacteria
gasseri	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
bound	O	O
to	O	O
parotid	O	O
and	O	O
submandibular	O	O
saliva	O	O
,	O	O
salivary	O	O
gp340	O	O
and	O	O
MUC7	O	O
,	O	O
and	O	O
purified	O	O
MFGM	O	O
,	O	O
and	O	O
adhered	O	O
to	O	O
epithelial	O	O
cells	O	O
.	O	O

L.	O	O
gasseri	O	O
was	O	O
detected	O	O
by	O	O
qPCR	O	O
in	O	O
29.7	O	O
%	O	O
of	O	O
the	O	O
oral	O	O
swabs	O	O
.	O	O

Breastfed	O	O
infants	O	O
had	O	O
significantly	O	O
higher	O	O
mean	O	O
DNA	O	O
levels	O	O
of	O	O
L.	O	O
gasseri	O	O
(	O	O
2.14	O	O
pg/uL	O	O
)	O	O
than	O	O
infants	O	O
fed	O	O
the	O	O
standard	O	O
(	O	O
0.363	O	O
pg/uL	O	O
)	O	O
or	O	O
MFGM	O	O
(	O	O
0.697	O	O
pg/uL	O	O
)	O	O
formula	O	O
.	O	O

lactobacilli	B-bacteria	B-bacteria
colonized	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
breastfed	O	O
infants	O	O
significantly	O	O
more	O	O
frequently	O	O
than	O	O
formula-fed	O	O
infants	O	O
.	O	O

The	O	O
dominant	O	O
Lactobacillus	B-bacteria	B-bacteria
was	O	O
L.	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
,	O	O
which	O	O
was	O	O
detected	O	O
at	O	O
higher	O	O
levels	O	O
in	O	O
breastfed	O	O
than	O	O
formula-fed	O	O
infants	O	O
and	O	O
displayed	O	O
probiotic	O	O
traits	O	O
in	O	O
vitro	O	O
.	O	O

Oral	O	O
infection	O	O
may	O	O
be	O	O
a	O	O
source	O	O
of	O	O
bacteremia	O	O
in	O	O
patients	O	O
undergoing	O	O
hematopoietic	O	O
stem	O	O
cell	O	O
transplant	O	O
(	O	O
HSCT	O	O
)	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
relationship	O	O
between	O	O
patients	O	O
with	O	O
poor	O	O
periodontal	O	O
status	O	O
and	O	O
complications	O	O
after	O	O
HSCT	O	O
.	O	O

A	O	O
cohort	O	O
of	O	O
patients	O	O
with	O	O
hematological	O	O
malignancies	O	O
candidates	O	O
for	O	O
autologous	O	O
HSCT	O	O
was	O	O
observed	O	O
before	O	O
and	O	O
during	O	O
the	O	O
neutropenic	O	O
phase	O	O
of	O	O
HSCT	O	O
.	O	O

A	O	O
primary	O	O
evaluation	O	O
was	O	O
performed	O	O
before	O	O
the	O	O
HSCT	O	O
procedure	O	O
,	O	O
including	O	O
medical	O	O
and	O	O
socio-demographic	O	O
data	O	O
and	O	O
physical	O	O
examination	O	O
(	O	O
number	O	O
of	O	O
teeth	O	O
and	O	O
decayed	O	O
,	O	O
missing	O	O
and	O	O
filled	O	O
teeth	O	O
index	O	O
(	O	O
DMFT	O	O
)	O	O
,	O	O
oral	O	O
mucosa	O	O
,	O	O
and	O	O
full	O	O
mouth	O	O
periodontal	O	O
assessment	O	O
)	O	O
.	O	O

During	O	O
the	O	O
neutropenic	O	O
phase	O	O
,	O	O
data	O	O
regarding	O	O
the	O	O
development	O	O
of	O	O
febrile	O	O
neutropenia	O	O
,	O	O
bacteremia	O	O
,	O	O
and	O	O
mucositis	O	O
were	O	O
also	O	O
prospectively	O	O
obtained	O	O
.	O	O

Forty-eight	O	O
patients	O	O
were	O	O
included	O	O
.	O	O

The	O	O
most	O	O
common	O	O
baseline	O	O
disease	O	O
was	O	O
multiple	O	O
myeloma	O	O
(	O	O
70	O	O
%	O	O
)	O	O
.	O	O

In	O	O
the	O	O
primary	O	O
evaluations	O	O
,	O	O
the	O	O
median	O	O
DMFT	O	O
was	O	O
13	O	O
(	O	O
ranging	O	O
0-27	O	O
)	O	O
,	O	O
and	O	O
periodontitis	O	O
and	O	O
gingivitis	O	O
were	O	O
present	O	O
in	O	O
29	O	O
and	O	O
60	O	O
%	O	O
of	O	O
the	O	O
patients	O	O
,	O	O
respectively	O	O
.	O	O

During	O	O
the	O	O
neutropenic	O	O
phase	O	O
of	O	O
HSCT	O	O
,	O	O
fever	O	O
occurred	O	O
in	O	O
96	O	O
%	O	O
of	O	O
patients	O	O
,	O	O
and	O	O
bacteremia	O	O
was	O	O
documented	O	O
in	O	O
29	O	O
%	O	O
.	O	O

Coagulase-negative	B-bacteria	B-bacteria
Staphylococcus	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
common	O	O
isolated	O	O
bacteria	O	O
.	O	O

Patients	O	O
who	O	O
developed	O	O
bacteremia	O	O
had	O	O
a	O	O
higher	O	O
frequency	O	O
of	O	O
oral	O	O
disorders	O	O
compared	O	O
with	O	O
those	O	O
without	O	O
bacteremia	O	O
,	O	O
but	O	O
it	O	O
was	O	O
not	O	O
statistically	O	O
significant	O	O
.	O	O

Oral	O	O
mucositis	O	O
affected	O	O
89.6	O	O
%	O	O
of	O	O
the	O	O
patients	O	O
,	O	O
and	O	O
patients	O	O
with	O	O
gingivitis	O	O
or	O	O
periodontal	O	O
disorders	O	O
had	O	O
a	O	O
high	O	O
frequency	O	O
of	O	O
mucositis	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
oral	O	O
pathologic	O	O
conditions	O	O
previous	O	O
to	O	O
HSCT	O	O
procedures	O	O
was	O	O
very	O	O
high	O	O
in	O	O
the	O	O
studied	O	O
population	O	O
.	O	O

A	O	O
possible	O	O
association	O	O
was	O	O
noted	O	O
between	O	O
previous	O	O
gingivitis	O	O
and	O	O
the	O	O
development	O	O
of	O	O
mucositis	O	O
during	O	O
the	O	O
neutropenia	O	O
of	O	O
HSCT	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
DNA	O	O
sequence	O	O
variations	O	O
of	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavities	O	O
and	O	O
stomachs	O	O
of	O	O
children	O	O
with	O	O
chronic	O	O
gastritis	O	O
.	O	O

Dental	O	O
plaques	O	O
and	O	O
gargle	O	O
on	O	O
235	O	O
patients	O	O
were	O	O
obtained	O	O
before	O	O
gastroscopy	O	O
.	O	O

Gastric	O	O
H.	O	O
pylori	O	O
infection	O	O
was	O	O
diagnosed	O	O
using	O	O
rapid	O	O
urease	O	O
test	O	O
or	O	O
Giemsa	O	O
staining	O	O
.	O	O

H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
16S	O	O
rDNA	O	O
and	O	O
CagA	O	O
gene	O	O
were	O	O
analyzed	O	O
using	O	O
PCR	O	O
methods	O	O
.	O	O

Thymine	O	O
adenine	O	O
cloning-based	O	O
sequencing	O	O
was	O	O
performed	O	O
in	O	O
patients	O	O
with	O	O
CagA	O	O
gene	O	O
positive	O	O
from	O	O
oral	O	O
cavities	O	O
.	O	O

The	O	O
sequence	O	O
alignments	O	O
and	O	O
V1	O	O
variable	O	O
region	O	O
were	O	O
evaluated	O	O
by	O	O
comparison	O	O
with	O	O
the	O	O
sequence	O	O
of	O	O
the	O	O
standard	O	O
H.	B-bacteria	B-bacteria
pylori	I-bacteria	I-bacteria
26695	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
.	O	O

Totally	O	O
,	O	O
46	O	O
out	O	O
of	O	O
the	O	O
235	O	O
patients	O	O
were	O	O
positive	O	O
for	O	O
gastric	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
.	O	O

Of	O	O
the	O	O
46	O	O
patients	O	O
,	O	O
26	O	O
cases	O	O
had	O	O
amplified	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
16S	O	O
rDNA	O	O
in	O	O
both	O	O
oral	O	O
(	O	O
plaque	O	O
and	O	O
gargle	O	O
)	O	O
and	O	O
gastric	O	O
samples	O	O
.	O	O

Of	O	O
the	O	O
26	O	O
cases	O	O
,	O	O
12	O	O
patients	O	O
(	O	O
46.1	O	O
%	O	O
)	O	O
were	O	O
positive	O	O
for	O	O
the	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
CagA	O	O
gene	O	O
in	O	O
the	O	O
oral	O	O
samples	O	O
,	O	O
which	O	O
was	O	O
significantly	O	O
lower	O	O
than	O	O
that	O	O
in	O	O
the	O	O
gastric	O	O
mucosa	O	O
(	O	O
80.8	O	O
%	O	O
;	O	O
P	O	O
=	O	O
0.010	O	O
)	O	O
.	O	O

The	O	O
homology	O	O
of	O	O
the	O	O
complete	O	O
sequence	O	O
alignment	O	O
ranged	O	O
from	O	O
74.0	O	O
%	O	O
to	O	O
92.1	O	O
%	O	O
in	O	O
the	O	O
oral	O	O
and	O	O
gastric	O	O
samples	O	O
.	O	O

The	O	O
V1	O	O
region	O	O
alleles	O	O
(	O	O
positions	O	O
75-99	O	O
)	O	O
had	O	O
7-22	O	O
polymorphisms	O	O
(	O	O
homology	O	O
from	O	O
12.0	O	O
%	O	O
to	O	O
72.0	O	O
%	O	O
)	O	O
in	O	O
11	O	O
patients	O	O
between	O	O
the	O	O
oral	O	O
and	O	O
gastric	O	O
samples	O	O
,	O	O
but	O	O
had	O	O
100	O	O
%	O	O
homology	O	O
in	O	O
1	O	O
patient	O	O
.	O	O

Our	O	O
study	O	O
found	O	O
that	O	O
distinct	O	O
H.	B-bacteria	B-bacteria
pylori	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
exist	O	O
in	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
children	O	O
,	O	O
but	O	O
we	O	O
would	O	O
not	O	O
support	O	O
the	O	O
hypothesis	O	O
that	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavities	O	O
is	O	O
an	O	O
important	O	O
reservoir	O	O
of	O	O
gastric	O	O
H.	O	O
pylori	O	O
infections	O	O
in	O	O
children	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
association	O	O
of	O	O
dry	O	O
mouth	O	O
with	O	O
denture	O	O
plaque	O	O
microflora	O	O
in	O	O
patients	O	O
with	O	O
palatal	O	O
obturator	O	O
prostheses	O	O
from	O	O
the	O	O
viewpoint	O	O
of	O	O
infection	O	O
control	O	O
.	O	O

Thirty	O	O
palatal	O	O
obturator	O	O
prosthesis	O	O
wearers	O	O
were	O	O
compared	O	O
with	O	O
30	O	O
healthy	O	O
maxillary	O	O
complete	O	O
denture	O	O
wearers	O	O
.	O	O

Dry	O	O
mouth	O	O
was	O	O
examined	O	O
using	O	O
a	O	O
moisture-checking	O	O
device	O	O
and	O	O
was	O	O
diagnosed	O	O
by	O	O
the	O	O
measured	O	O
moisture	O	O
levels	O	O
.	O	O

Denture	O	O
plaque	O	O
was	O	O
collected	O	O
by	O	O
rubbing	O	O
the	O	O
mucosal	O	O
surface	O	O
of	O	O
the	O	O
denture	O	O
with	O	O
a	O	O
swab	O	O
;	O	O
collected	O	O
microorganisms	O	O
were	O	O
cultured	O	O
and	O	O
identified	O	O
using	O	O
culture-dependent	O	O
methods	O	O
.	O	O

The	O	O
number	O	O
of	O	O
colonising	O	O
microorganisms	O	O
and	O	O
prevalence	O	O
of	O	O
microorganisms	O	O
were	O	O
examined	O	O
according	O	O
to	O	O
the	O	O
type	O	O
of	O	O
prostheses	O	O
and	O	O
presence	O	O
of	O	O
dry	O	O
mouth	O	O
using	O	O
nonparametric	O	O
tests	O	O
and	O	O
frequency	O	O
analysis	O	O
(	O	O
alpha	O	O
=	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
Candida	O	O
spp	O	O
.	O	O

and	O	O
Staphylococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

in	O	O
palatal	O	O
obturator	O	O
prostheses	O	O
was	O	O
significantly	O	O
higher	O	O
than	O	O
that	O	O
in	O	O
complete	O	O
dentures	O	O
.	O	O

In	O	O
palatal	O	O
obturator	O	O
prostheses	O	O
,	O	O
the	O	O
total	O	O
number	O	O
of	O	O
colonising	O	O
microorganisms	O	O
showed	O	O
no	O	O
significant	O	O
differences	O	O
between	O	O
the	O	O
groups	O	O
with	O	O
and	O	O
without	O	O
dry	O	O
mouth	O	O
on	O	O
each	O	O
side	O	O
of	O	O
the	O	O
prostheses	O	O
.	O	O

However	O	O
,	O	O
the	O	O
prevalence	O	O
of	O	O
Candida	O	O
spp	O	O
.	O	O

and	O	O
Staphylococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

in	O	O
the	O	O
group	O	O
with	O	O
dry	O	O
mouth	O	O
was	O	O
significantly	O	O
higher	O	O
than	O	O
that	O	O
in	O	O
the	O	O
group	O	O
without	O	O
dry	O	O
mouth	O	O
.	O	O

The	O	O
number	O	O
of	O	O
microorganisms	O	O
and	O	O
moisture	O	O
levels	O	O
of	O	O
palatal	O	O
obturator	O	O
prosthesis	O	O
wearers	O	O
showed	O	O
a	O	O
significantly	O	O
negative	O	O
correlation	O	O
with	O	O
Candida	O	O
spp	O	O
.	O	O

and	O	O
Staphylococcus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
but	O	O
a	O	O
positive	O	O
correlation	O	O
with	O	O
Neisseria	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	O	O

It	O	O
was	O	O
concluded	O	O
that	O	O
palatal	O	O
obturator	O	O
prosthesis	O	O
wearers	O	O
with	O	O
a	O	O
dry	O	O
mouth	O	O
have	O	O
greater	O	O
colonisation	O	O
by	O	O
Candida	O	O
spp	O	O
.	O	O

and	O	O
Staphylococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

than	O	O
do	O	O
complete	O	O
denture	O	O
wearers	O	O
.	O	O

To	O	O
detect	O	O
predominant	O	O
bacteria	O	O
associated	O	O
with	O	O
radicular	O	O
cysts	O	O
and	O	O
discuss	O	O
in	O	O
light	O	O
of	O	O
the	O	O
literature	O	O
.	O	O

Clinical	O	O
materials	O	O
were	O	O
obtained	O	O
from	O	O
35	O	O
radicular	O	O
cysts	O	O
by	O	O
aspiration	O	O
.	O	O

Cultures	O	O
were	O	O
made	O	O
from	O	O
clinical	O	O
materials	O	O
by	O	O
modern	O	O
laboratory	O	O
techniques	O	O
,	O	O
they	O	O
underwent	O	O
microbiologic	O	O
analysis	O	O
.	O	O

The	O	O
following	O	O
are	O	O
microorganisms	O	O
isolated	O	O
from	O	O
cultures	O	O
:	O	O
Streptococcus	B-bacteria	B-bacteria
milleri	I-bacteria	I-bacteria
Group	E-bacteria	I-bacteria
(	O	O
SMG	O	O
)	O	O
(	O	O
23.8	O	O
%	O	O
)	O	O
[	O	O
Streptococcus	B-bacteria	B-bacteria
constellatus	E-bacteria	I-bacteria
(	O	O
19.1	O	O
%	O	O
)	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
anginosus	E-bacteria	I-bacteria
(	O	O
4.7	O	O
%	O	O
)	O	O
]	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
(	O	O
14.3	O	O
%	O	O
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
(	O	O
4.7	O	O
%	O	O
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
cremoris	E-bacteria	I-bacteria
(	O	O
4.7	O	O
%	O	O
)	O	O
,	O	O
Peptostreptococcus	B-bacteria	B-bacteria
pevotii	E-bacteria	I-bacteria
(	O	O
4.7	O	O
%	O	O
)	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
buccae	E-bacteria	I-bacteria
(	O	O
4.7	O	O
%	O	O
)	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
(	O	O
4.7	O	O
%	O	O
)	O	O
,	O	O
Actinomyces	B-bacteria	B-bacteria
meyeri	E-bacteria	I-bacteria
(	O	O
4.7	O	O
%	O	O
)	O	O
,	O	O
Actinomyces	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
(	O	O
4.7	O	O
%	O	O
)	O	O
,	O	O
Propionibacterium	B-bacteria	B-bacteria
propionicum	E-bacteria	I-bacteria
(	O	O
4.7	O	O
%	O	O
)	O	O
,	O	O
Bacteroides	B-bacteria	B-bacteria
capillosus	E-bacteria	I-bacteria
(	O	O
4.7	O	O
%	O	O
)	O	O
,	O	O
Staphylococcus	B-bacteria	B-bacteria
hominis	E-bacteria	I-bacteria
(	O	O
4.7	O	O
%	O	O
)	O	O
,	O	O
Rothia	B-bacteria	B-bacteria
denticariosa	E-bacteria	I-bacteria
(	O	O
4.7	O	O
%	O	O
)	O	O
,	O	O
Gemella	B-bacteria	B-bacteria
haemolysans	E-bacteria	I-bacteria
(	O	O
4.7	O	O
%	O	O
)	O	O
,	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
4.7	O	O
%	O	O
)	O	O
.	O	O

Results	O	O
of	O	O
this	O	O
study	O	O
demonstrated	O	O
that	O	O
radicular	O	O
cysts	O	O
show	O	O
a	O	O
great	O	O
variety	O	O
of	O	O
anaerobic	O	O
and	O	O
facultative	O	O
anaerobic	O	O
bacterial	O	O
flora	O	O
.	O	O

It	O	O
was	O	O
observed	O	O
that	O	O
all	O	O
isolated	O	O
microorganisms	O	O
were	O	O
the	O	O
types	O	O
commonly	O	O
found	O	O
in	O	O
oral	O	O
flora	O	O
.	O	O

Although	O	O
no	O	O
specific	O	O
microorganism	O	O
was	O	O
found	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
47.5	O	O
%	O	O
)	O	O
-	O	O
especially	O	O
SMG	B-bacteria	B-bacteria
(	O	O
23.8	O	O
%	O	O
)	O	O
-	O	O
were	O	O
predominantly	O	O
found	O	O
in	O	O
the	O	O
microorganisms	O	O
isolated	O	O
.	O	O

Furthermore	O	O
,	O	O
radicular	O	O
cysts	O	O
might	O	O
be	O	O
polymicrobial	O	O
originated	O	O
.	O	O

Although	O	O
radicular	O	O
cyst	O	O
is	O	O
an	O	O
inflammatory	O	O
cyst	O	O
,	O	O
some	O	O
radicular	O	O
cyst	O	O
fluids	O	O
might	O	O
be	O	O
sterile	O	O
.	O	O

Gingivitis	O	O
and	O	O
lumpy	O	O
jaw	O	O
are	O	O
diseases	O	O
of	O	O
polymicrobial	O	O
aetiology	O	O
.	O	O

Although	O	O
Fusobacterium	B-bacteria	B-bacteria
necrophorum	E-bacteria	I-bacteria
has	O	O
been	O	O
associated	O	O
with	O	O
these	O	O
diseases	O	O
in	O	O
macropods	O	O
,	O	O
little	O	O
is	O	O
known	O	O
about	O	O
other	O	O
organisms	O	O
associated	O	O
with	O	O
these	O	O
diseases	O	O
in	O	O
this	O	O
animal	O	O
species	O	O
.	O	O

PCR-DGGE	O	O
analysis	O	O
revealed	O	O
the	O	O
potential	O	O
pathogens	O	O
associated	O	O
with	O	O
gingivitis	O	O
and	O	O
lumpy	O	O
jaw	O	O
in	O	O
macropods	O	O
.	O	O

PCR-DGGE	O	O
profile	O	O
comparison	O	O
between	O	O
the	O	O
healthy	O	O
and	O	O
disease	O	O
groups	O	O
indicated	O	O
a	O	O
shift	O	O
in	O	O
the	O	O
oral	O	O
bacterial	O	O
community	O	O
structures	O	O
with	O	O
similarity	O	O
coefficients	O	O
of	O	O
48	O	O
%	O	O
and	O	O
35	O	O
%	O	O
for	O	O
gingivitis	O	O
and	O	O
lumpy	O	O
jaw	O	O
respectively	O	O
.	O	O

Moreover	O	O
,	O	O
gingivitis	O	O
was	O	O
associated	O	O
with	O	O
increase	O	O
in	O	O
bacterial	O	O
diversity	O	O
(	O	O
Shannon	O	O
index	O	O
=	O	O
2.87	O	O
;	O	O
PL	O	O
curve	O	O
=	O	O
45	O	O
%	O	O
)	O	O
while	O	O
lumpy	O	O
jaw	O	O
resulted	O	O
in	O	O
a	O	O
decline	O	O
in	O	O
bacterial	O	O
diversity	O	O
(	O	O
Shannon	O	O
index	O	O
=	O	O
2.47	O	O
;	O	O
PL	O	O
curve	O	O
=	O	O
74	O	O
%	O	O
)	O	O
.	O	O

This	O	O
study	O	O
suggest	O	O
that	O	O
the	O	O
establishment	O	O
of	O	O
gingivitis	O	O
and	O	O
lumpy	O	O
jaw	O	O
diseases	O	O
follows	O	O
the	O	O
ecological	O	O
plaque	O	O
hypothesis	O	O
.	O	O

This	O	O
forms	O	O
the	O	O
basis	O	O
for	O	O
an	O	O
expanded	O	O
investigation	O	O
in	O	O
an	O	O
epidemiological	O	O
scale	O	O
and	O	O
suggests	O	O
the	O	O
need	O	O
for	O	O
the	O	O
appropriate	O	O
choice	O	O
of	O	O
antimicrobial	O	O
agent	O	O
(	O	O
s	O	O
)	O	O
and	O	O
for	O	O
the	O	O
effective	O	O
management	O	O
and	O	O
control	O	O
of	O	O
polymicrobial	O	O
diseases	O	O
.	O	O

Induced	O	O
plant	O	O
defenses	O	O
in	O	O
response	O	O
to	O	O
herbivore	O	O
attack	O	O
are	O	O
modulated	O	O
by	O	O
cross-talk	O	O
between	O	O
jasmonic	O	O
acid	O	O
(	O	O
JA	O	O
)	O	O
-	O	O
and	O	O
salicylic	O	O
acid	O	O
(	O	O
SA	O	O
)	O	O
-signaling	O	O
pathways	O	O
.	O	O

Oral	O	O
secretions	O	O
from	O	O
some	O	O
insect	O	O
herbivores	O	O
contain	O	O
effectors	O	O
that	O	O
overcome	O	O
these	O	O
antiherbivore	O	O
defenses	O	O
.	O	O

Herbivores	O	O
possess	O	O
diverse	O	O
microbes	O	O
in	O	O
their	O	O
digestive	O	O
systems	O	O
and	O	O
these	O	O
microbial	O	O
symbionts	O	O
can	O	O
modify	O	O
plant-insect	O	O
interactions	O	O
;	O	O
however	O	O
,	O	O
the	O	O
specific	O	O
role	O	O
of	O	O
herbivore-associated	O	O
microbes	O	O
in	O	O
manipulating	O	O
plant	O	O
defenses	O	O
remains	O	O
unclear	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
demonstrate	O	O
that	O	O
Colorado	O	O
potato	O	O
beetle	O	O
(	O	O
Leptinotarsa	O	O
decemlineata	O	O
)	O	O
larvae	O	O
exploit	O	O
bacteria	O	O
in	O	O
their	O	O
oral	O	O
secretions	O	O
to	O	O
suppress	O	O
antiherbivore	O	O
defenses	O	O
in	O	O
tomato	O	O
(	O	O
Solanum	O	O
lycopersicum	O	O
)	O	O
.	O	O

We	O	O
found	O	O
that	O	O
antibiotic-untreated	O	O
larvae	O	O
decreased	O	O
production	O	O
of	O	O
JA	O	O
and	O	O
JA-responsive	O	O
antiherbivore	O	O
defenses	O	O
,	O	O
but	O	O
increased	O	O
SA	O	O
accumulation	O	O
and	O	O
SA-responsive	O	O
gene	O	O
expression	O	O
.	O	O

Beetles	O	O
benefit	O	O
from	O	O
down-regulating	O	O
plant	O	O
defenses	O	O
by	O	O
exhibiting	O	O
enhanced	O	O
larval	O	O
growth	O	O
.	O	O

In	O	O
SA-deficient	O	O
plants	O	O
,	O	O
suppression	O	O
was	O	O
not	O	O
observed	O	O
,	O	O
indicating	O	O
that	O	O
suppression	O	O
of	O	O
JA-regulated	O	O
defenses	O	O
depends	O	O
on	O	O
the	O	O
SA-signaling	O	O
pathway	O	O
.	O	O

Applying	O	O
bacteria	O	O
isolated	O	O
from	O	O
larval	O	O
oral	O	O
secretions	O	O
to	O	O
wounded	O	O
plants	O	O
confirmed	O	O
that	O	O
three	O	O
microbial	O	O
symbionts	O	O
belonging	O	O
to	O	O
the	O	O
genera	O	O
Stenotrophomonas	B-bacteria	B-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
,	O	O
and	O	O
Enterobacter	B-bacteria	B-bacteria
are	O	O
responsible	O	O
for	O	O
defense	O	O
suppression	O	O
.	O	O

Additionally	O	O
,	O	O
reinoculation	O	O
of	O	O
these	O	O
bacteria	O	O
to	O	O
antibiotic-treated	O	O
larvae	O	O
restored	O	O
their	O	O
ability	O	O
to	O	O
suppress	O	O
defenses	O	O
.	O	O

Flagellin	O	O
isolated	O	O
from	O	O
Pseudomonas	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

was	O	O
associated	O	O
with	O	O
defense	O	O
suppression	O	O
.	O	O

Our	O	O
findings	O	O
show	O	O
that	O	O
the	O	O
herbivore	O	O
exploits	O	O
symbiotic	O	O
bacteria	O	O
as	O	O
a	O	O
decoy	O	O
to	O	O
deceive	O	O
plants	O	O
into	O	O
incorrectly	O	O
perceiving	O	O
the	O	O
threat	O	O
as	O	O
microbial	O	O
.	O	O

By	O	O
interfering	O	O
with	O	O
the	O	O
normal	O	O
perception	O	O
of	O	O
herbivory	O	O
,	O	O
beetles	O	O
can	O	O
evade	O	O
antiherbivore	O	O
defenses	O	O
of	O	O
its	O	O
host	O	O
.	O	O

To	O	O
examine	O	O
the	O	O
histopathological	O	O
characteristics	O	O
of	O	O
inflammatory	O	O
lesions	O	O
containing	O	O
Actinomyces	B-bacteria	B-bacteria
based	O	O
on	O	O
DNA	O	O
sequencing	O	O
.	O	O

Furthermore	O	O
,	O	O
case	O	O
reports	O	O
of	O	O
actinomycosis	O	O
in	O	O
the	O	O
maxillofacial	O	O
region	O	O
are	O	O
summarized	O	O
by	O	O
a	O	O
review	O	O
of	O	O
the	O	O
literature	O	O
.	O	O

The	O	O
study	O	O
comprised	O	O
12	O	O
cases	O	O
of	O	O
inflammatory	O	O
lesions	O	O
containing	O	O
Actinomyces	B-bacteria	B-bacteria
as	O	O
diagnosed	O	O
by	O	O
DNA	O	O
analysis	O	O
.	O	O

The	O	O
average	O	O
age	O	O
of	O	O
the	O	O
subjects	O	O
was	O	O
59	O	O
+/-	O	O
15	O	O
years	O	O
(	O	O
6	O	O
males	O	O
;	O	O
6	O	O
females	O	O
)	O	O
.	O	O

The	O	O
distribution	O	O
of	O	O
causative	O	O
bacteria	O	O
was	O	O
:	O	O
Actinomyces	B-bacteria	B-bacteria
israelii	E-bacteria	I-bacteria
in	O	O
9	O	O
cases	O	O
,	O	O
Actinomyces	B-bacteria	B-bacteria
gerencseriae	E-bacteria	I-bacteria
in	O	O
2	O	O
cases	O	O
,	O	O
and	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
in	O	O
1	O	O
case	O	O
.	O	O

Four	O	O
cases	O	O
diagnosed	O	O
by	O	O
DNA	O	O
sequencing	O	O
were	O	O
positive	O	O
for	O	O
``	O	O
Druse	O	O
,	O	O
''	O	O
a	O	O
known	O	O
morphological	O	O
diagnostic	O	O
characteristic	O	O
of	O	O
actinomycosis	O	O
,	O	O
and	O	O
8	O	O
cases	O	O
lacked	O	O
typical	O	O
colony	O	O
formation	O	O
.	O	O

DNA	O	O
analysis	O	O
using	O	O
paraffin-embedded	O	O
samples	O	O
is	O	O
effective	O	O
for	O	O
both	O	O
early	O	O
and	O	O
accurate	O	O
diagnosis	O	O
of	O	O
oral	O	O
lesions	O	O
containing	O	O
Actinomyces	B-bacteria	B-bacteria
.	O	O

The	O	O
antimicrobial	O	O
activity	O	O
of	O	O
isothiocyanates	O	O
(	O	O
ITCs	O	O
)	O	O
extracted	O	O
from	O	O
horseradish	O	O
root	O	O
was	O	O
investigated	O	O
against	O	O
oral	O	O
microorganisms	O	O
:	O	O
6	O	O
strains	O	O
of	O	O
facultative	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
and	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
;	O	O
one	O	O
strain	O	O
of	O	O
yeast	O	O
,	O	O
Candida	O	O
albicans	O	O
,	O	O
and	O	O
3	O	O
strains	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
and	O	O
Clostridium	B-bacteria	B-bacteria
perfringens	E-bacteria	I-bacteria
.	O	O

The	O	O
ITCs	O	O
extracted	O	O
from	O	O
horseradish	O	O
root	O	O
showed	O	O
antimicrobial	O	O
activity	O	O
against	O	O
all	O	O
oral	O	O
microorganisms	O	O
by	O	O
the	O	O
paper	O	O
disk	O	O
method	O	O
.	O	O

The	O	O
minimum	O	O
bactericidal	O	O
concentration	O	O
(	O	O
MBC	O	O
)	O	O
of	O	O
the	O	O
ITCs	O	O
extracted	O	O
from	O	O
horseradish	O	O
root	O	O
ranged	O	O
from	O	O
1.25	O	O
to	O	O
5.00	O	O
mg/ml	O	O
against	O	O
6	O	O
strains	O	O
of	O	O
facultative	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
one	O	O
strain	O	O
of	O	O
yeast	O	O
,	O	O
and	O	O
4.17	O	O
to	O	O
16.67	O	O
mg/ml	O	O
against	O	O
3	O	O
strains	O	O
of	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

The	O	O
ITCs	O	O
extracted	O	O
from	O	O
horseradish	O	O
root	O	O
showed	O	O
the	O	O
strongest	O	O
antimicrobial	O	O
activity	O	O
,	O	O
with	O	O
a	O	O
MBC	O	O
of	O	O
1.25	O	O
mg/ml	O	O
,	O	O
against	O	O
C.	O	O
albicans	O	O
among	O	O
facultative	O	O
microorganisms	O	O
,	O	O
and	O	O
4.17	O	O
mg/ml	O	O
against	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
among	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
ITCs	O	O
extracted	O	O
from	O	O
horseradish	O	O
root	O	O
may	O	O
be	O	O
a	O	O
candidate	O	O
for	O	O
use	O	O
as	O	O
an	O	O
antimicrobial	O	O
agent	O	O
against	O	O
oral	O	O
microorganisms	O	O
.	O	O

Filamentous	B-bacteria	B-bacteria
multicellular	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
are	O	O
among	O	O
the	O	O
most	O	O
ancient	O	O
multicellular	O	O
organisms	O	O
.	O	O

They	O	O
inhabit	O	O
a	O	O
great	O	O
variety	O	O
of	O	O
environments	O	O
and	O	O
are	O	O
present	O	O
in	O	O
the	O	O
human	O	O
body	O	O
,	O	O
including	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Beside	O	O
the	O	O
selective	O	O
advantages	O	O
related	O	O
to	O	O
the	O	O
larger	O	O
size	O	O
achieved	O	O
through	O	O
filamentation	O	O
,	O	O
the	O	O
development	O	O
of	O	O
multicellular	O	O
bacteria	O	O
can	O	O
be	O	O
also	O	O
driven	O	O
by	O	O
simple	O	O
ecological	O	O
factors	O	O
such	O	O
as	O	O
birth	O	O
and	O	O
death	O	O
rates	O	O
at	O	O
the	O	O
cellular	O	O
level	O	O
.	O	O

In	O	O
order	O	O
to	O	O
extend	O	O
earlier	O	O
results	O	O
obtained	O	O
in	O	O
aquatic	O	O
species	O	O
,	O	O
we	O	O
investigate	O	O
the	O	O
filamentation	O	O
process	O	O
of	O	O
four	O	O
different	O	O
strains	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
namely	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
anginosus	E-bacteria	I-bacteria
.	O	O

The	O	O
results	O	O
indicate	O	O
differences	O	O
in	O	O
the	O	O
capacities	O	O
of	O	O
different	O	O
streptococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
to	O	O
form	O	O
filaments	O	O
,	O	O
manifested	O	O
in	O	O
terms	O	O
of	O	O
length	O	O
and	O	O
the	O	O
time-scale	O	O
of	O	O
filament	O	O
elongation	O	O
.	O	O

The	O	O
filamentation	O	O
pattern	O	O
of	O	O
these	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
resembles	O	O
that	O	O
of	O	O
aquatic	O	O
bacteria	O	O
,	O	O
whereby	O	O
filaments	O	O
reach	O	O
a	O	O
peak	O	O
length	O	O
during	O	O
exponential	O	O
growth	O	O
and	O	O
become	O	O
short	O	O
when	O	O
the	O	O
population	O	O
reaches	O	O
a	O	O
steady	O	O
state	O	O
.	O	O

Hence	O	O
,	O	O
this	O	O
study	O	O
validates	O	O
that	O	O
multicellularity	O	O
can	O	O
be	O	O
an	O	O
emergent	O	O
property	O	O
of	O	O
filamentous	O	O
bacteria	O	O
of	O	O
different	O	O
ecological	O	O
niches	O	O
,	O	O
and	O	O
that	O	O
phenotypic	O	O
differences	O	O
in	O	O
filamentation	O	O
can	O	O
occur	O	O
within	O	O
species	O	O
of	O	O
the	O	O
same	O	O
genus	O	O
,	O	O
in	O	O
this	O	O
case	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Moreover	O	O
,	O	O
given	O	O
the	O	O
role	O	O
that	O	O
specific	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
can	O	O
play	O	O
in	O	O
the	O	O
etiology	O	O
of	O	O
oral	O	O
diseases	O	O
,	O	O
these	O	O
results	O	O
can	O	O
possibly	O	O
open	O	O
new	O	O
perspectives	O	O
in	O	O
the	O	O
study	O	O
of	O	O
the	O	O
virulence	O	O
properties	O	O
of	O	O
these	O	O
species	O	O
.	O	O

Filifactor	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
is	O	O
a	O	O
gram	B-bacteria	B-bacteria
positive	I-bacteria	I-bacteria
anaerobe	E-bacteria	I-bacteria
that	O	O
is	O	O
emerging	O	O
as	O	O
an	O	O
important	O	O
periodontal	O	O
pathogen	O	O
.	O	O

In	O	O
the	O	O
oral	O	O
cavity	O	O
F.	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
colonizes	O	O
polymicrobial	O	O
biofilm	O	O
communities	O	O
;	O	O
however	O	O
,	O	O
little	O	O
is	O	O
known	O	O
regarding	O	O
the	O	O
nature	O	O
of	O	O
the	O	O
interactions	O	O
between	O	O
F.	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
and	O	O
other	O	O
oral	O	O
biofilm	O	O
bacteria	O	O
.	O	O

Here	O	O
we	O	O
investigate	O	O
the	O	O
community	O	O
interactions	O	O
of	O	O
two	O	O
strains	O	O
of	O	O
F.	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
with	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
organisms	O	O
with	O	O
differing	O	O
pathogenic	O	O
potential	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

In	O	O
an	O	O
in	O	O
vitro	O	O
community	O	O
development	O	O
model	O	O
,	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
was	O	O
antagonistic	O	O
to	O	O
the	O	O
accumulation	O	O
of	O	O
F.	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
into	O	O
a	O	O
dual	O	O
species	O	O
community	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
the	O	O
type	O	O
strain	O	O
of	O	O
F.	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
formed	O	O
a	O	O
synergistic	O	O
partnership	O	O
.	O	O

Accumulation	O	O
of	O	O
a	O	O
low	O	O
passage	O	O
isolate	O	O
of	O	O
F.	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
was	O	O
also	O	O
enhanced	O	O
by	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

In	O	O
three	O	O
species	O	O
communities	O	O
of	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
,	O	O
the	O	O
antagonistic	O	O
effects	O	O
of	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
superseded	O	O
the	O	O
synergistic	O	O
effects	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
toward	O	O
F.	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
.	O	O

The	O	O
interaction	O	O
between	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
was	O	O
strain	O	O
specific	O	O
and	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
could	O	O
either	O	O
stimulate	O	O
F.	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
accumulation	O	O
or	O	O
have	O	O
no	O	O
effect	O	O
depending	O	O
on	O	O
the	O	O
strain	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
formed	O	O
heterotypic	O	O
communities	O	O
with	O	O
the	O	O
amount	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
greater	O	O
than	O	O
in	O	O
the	O	O
absence	O	O
of	O	O
F.	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
.	O	O

However	O	O
,	O	O
while	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
benefited	O	O
from	O	O
the	O	O
relationship	O	O
,	O	O
levels	O	O
of	O	O
F.	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
in	O	O
the	O	O
dual	O	O
species	O	O
community	O	O
were	O	O
lower	O	O
compared	O	O
to	O	O
F.	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
alone	O	O
.	O	O

The	O	O
inhibitory	O	O
effect	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
toward	O	O
F.	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
was	O	O
dependent	O	O
,	O	O
at	O	O
least	O	O
partially	O	O
,	O	O
on	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
Mfa1	O	O
fimbrial	O	O
subunit	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
AI-2	O	O
production	O	O
by	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
helped	O	O
maintain	O	O
levels	O	O
of	O	O
F.	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
.	O	O

Collectively	O	O
,	O	O
these	O	O
results	O	O
show	O	O
that	O	O
the	O	O
pattern	O	O
of	O	O
F.	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
colonization	O	O
will	O	O
be	O	O
dictated	O	O
by	O	O
the	O	O
spatial	O	O
composition	O	O
of	O	O
microbial	O	O
microenvironments	O	O
,	O	O
and	O	O
that	O	O
the	O	O
organism	O	O
may	O	O
preferentially	O	O
accumulate	O	O
at	O	O
sites	O	O
rich	O	O
in	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

To	O	O
better	O	O
understand	O	O
the	O	O
microbial	O	O
basis	O	O
of	O	O
oral	O	O
malodor	O	O
development	O	O
in	O	O
humans	O	O
,	O	O
we	O	O
used	O	O
a	O	O
cross-sectional	O	O
and	O	O
longitudinal	O	O
study	O	O
design	O	O
and	O	O
the	O	O
pyrosequencing	O	O
approach	O	O
to	O	O
track	O	O
and	O	O
compare	O	O
the	O	O
tongue	O	O
microbiota	O	O
associated	O	O
with	O	O
oral	O	O
malodor	O	O
in	O	O
29	O	O
Chinese	O	O
adults	O	O
who	O	O
underwent	O	O
a	O	O
consecutive	O	O
three-day	O	O
evaluation	O	O
for	O	O
the	O	O
amount	O	O
of	O	O
H2S	O	O
excreted	O	O
orally	O	O
.	O	O

Three	O	O
levels	O	O
of	O	O
the	O	O
oral	O	O
malodor	O	O
state	O	O
(	O	O
healthy	O	O
,	O	O
oral	O	O
malodor	O	O
,	O	O
and	O	O
severe	O	O
oral	O	O
malodor	O	O
)	O	O
were	O	O
defined	O	O
based	O	O
on	O	O
the	O	O
H2S	O	O
level	O	O
.	O	O

Community	O	O
structure	O	O
of	O	O
the	O	O
tongue	O	O
plaques	O	O
was	O	O
more	O	O
sensitive	O	O
to	O	O
changes	O	O
of	O	O
malodor	O	O
state	O	O
than	O	O
to	O	O
interpersonal	O	O
variations	O	O
or	O	O
differences	O	O
in	O	O
sampling	O	O
times	O	O
.	O	O

Within	O	O
each	O	O
individual	O	O
,	O	O
the	O	O
structure	O	O
of	O	O
microbiota	O	O
was	O	O
relatively	O	O
stable	O	O
,	O	O
while	O	O
their	O	O
variations	O	O
were	O	O
correlated	O	O
with	O	O
the	O	O
change	O	O
in	O	O
the	O	O
H2S	O	O
level	O	O
.	O	O

Severe	O	O
oral	O	O
malodor	O	O
microbiota	O	O
were	O	O
the	O	O
most	O	O
conserved	O	O
in	O	O
community	O	O
structure	O	O
,	O	O
whereas	O	O
the	O	O
healthy	O	O
ones	O	O
were	O	O
relatively	O	O
varied	O	O
.	O	O

Oral-malodor-associated	O	O
bacteria	O	O
were	O	O
identified	O	O
.	O	O

The	O	O
relative	O	O
abundance	O	O
of	O	O
Leptotrichia	B-bacteria	B-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
was	O	O
positively	O	O
correlated	O	O
with	O	O
oral	O	O
malodor	O	O
severity	O	O
,	O	O
whereas	O	O
Hemophilus	B-bacteria	B-bacteria
and	O	O
Gemella	B-bacteria	B-bacteria
exhibited	O	O
a	O	O
negative	O	O
relationship	O	O
with	O	O
oral	O	O
malodor	O	O
severity	O	O
.	O	O

Our	O	O
study	O	O
provides	O	O
one	O	O
of	O	O
the	O	O
first	O	O
landscapes	O	O
of	O	O
oral	O	O
microbiota	O	O
changes	O	O
associated	O	O
with	O	O
oral	O	O
malodor	O	O
development	O	O
and	O	O
reveals	O	O
microbes	O	O
potentially	O	O
useful	O	O
to	O	O
the	O	O
evaluation	O	O
and	O	O
control	O	O
of	O	O
oral	O	O
malodor	O	O
.	O	O

Actinomyces	B-bacteria	B-bacteria
are	O	O
predominant	O	O
oral	O	O
bacteria	O	O
;	O	O
however	O	O
,	O	O
their	O	O
cariogenic	O	O
potential	O	O
in	O	O
terms	O	O
of	O	O
acid	O	O
production	O	O
and	O	O
fluoride	O	O
sensitivity	O	O
has	O	O
not	O	O
been	O	O
elucidated	O	O
in	O	O
detail	O	O
and	O	O
compared	O	O
with	O	O
that	O	O
of	O	O
other	O	O
caries-associated	O	O
oral	O	O
bacteria	O	O
,	O	O
such	O	O
as	O	O
Streptococcus	B-bacteria	B-bacteria
.	O	O

Therefore	O	O
,	O	O
this	O	O
study	O	O
aimed	O	O
to	O	O
elucidate	O	O
and	O	O
compare	O	O
the	O	O
acid	O	O
production	O	O
and	O	O
growth	O	O
of	O	O
Actinomyces	B-bacteria	B-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
in	O	O
the	O	O
presence	O	O
of	O	O
bicarbonate	O	O
and	O	O
fluoride	O	O
to	O	O
mimic	O	O
conditions	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Acid	O	O
production	O	O
from	O	O
glucose	O	O
was	O	O
measured	O	O
by	O	O
pH-stat	O	O
at	O	O
pH	O	O
5.5	O	O
and	O	O
7.0	O	O
under	O	O
anaerobic	O	O
conditions	O	O
.	O	O

Growth	O	O
rate	O	O
was	O	O
assessed	O	O
by	O	O
optical	O	O
density	O	O
in	O	O
anaerobic	O	O
culture	O	O
.	O	O

Although	O	O
Actinomyces	B-bacteria	B-bacteria
produced	O	O
acid	O	O
at	O	O
a	O	O
lower	O	O
rate	O	O
than	O	O
did	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
their	O	O
acid	O	O
production	O	O
was	O	O
more	O	O
tolerant	O	O
of	O	O
fluoride	O	O
(	O	O
IDacid	O	O
production	O	O
50	O	O
=	O	O
110-170	O	O
ppm	O	O
at	O	O
pH	O	O
7.0	O	O
and	O	O
10-13	O	O
ppm	O	O
at	O	O
pH	O	O
5.5	O	O
)	O	O
than	O	O
that	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
(	O	O
IDacid	O	O
production	O	O
50	O	O
=	O	O
36-53	O	O
ppm	O	O
at	O	O
pH	O	O
7.0	O	O
and	O	O
6.3-6.5	O	O
ppm	O	O
at	O	O
pH	O	O
5.5	O	O
)	O	O
.	O	O

Bicarbonate	O	O
increased	O	O
acid	O	O
production	O	O
by	O	O
Actinomyces	B-bacteria	B-bacteria
with	O	O
prominent	O	O
succinate	O	O
production	O	O
and	O	O
enhanced	O	O
their	O	O
fluoride	O	O
tolerance	O	O
(	O	O
IDacid	O	O
production	O	O
50	O	O
=	O	O
220-320	O	O
ppm	O	O
at	O	O
pH	O	O
7.0	O	O
and	O	O
33-52	O	O
ppm	O	O
at	O	O
pH	O	O
5.5	O	O
)	O	O
.	O	O

Bicarbonate	O	O
had	O	O
no	O	O
effect	O	O
on	O	O
these	O	O
variables	O	O
in	O	O
Streptococcus	B-bacteria	B-bacteria
.	O	O

In	O	O
addition	O	O
,	O	O
although	O	O
the	O	O
growth	O	O
rate	O	O
of	O	O
Actinomyces	B-bacteria	B-bacteria
was	O	O
lower	O	O
than	O	O
that	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
growth	O	O
was	O	O
more	O	O
tolerant	O	O
of	O	O
fluoride	O	O
(	O	O
IDgrowth	O	O
50	O	O
=	O	O
130-160	O	O
ppm	O	O
)	O	O
than	O	O
was	O	O
that	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
(	O	O
IDgrowth	O	O
50	O	O
=	O	O
27-36	O	O
ppm	O	O
)	O	O
.	O	O

These	O	O
results	O	O
indicate	O	O
that	O	O
oral	O	O
Actinomyces	B-bacteria	B-bacteria
are	O	O
more	O	O
tolerant	O	O
of	O	O
fluoride	O	O
than	O	O
oral	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
and	O	O
bicarbonate	O	O
enhances	O	O
the	O	O
fluoride	O	O
tolerance	O	O
of	O	O
oral	O	O
Actinomyces	B-bacteria	B-bacteria
.	O	O

Because	O	O
of	O	O
the	O	O
limited	O	O
number	O	O
of	O	O
species	O	O
tested	O	O
here	O	O
,	O	O
further	O	O
study	O	O
is	O	O
needed	O	O
to	O	O
generalize	O	O
these	O	O
findings	O	O
to	O	O
the	O	O
genus	O	O
level	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
distribution	O	O
of	O	O
bacteria	O	O
within	O	O
the	O	O
dentine	O	O
tubular	O	O
network	O	O
in	O	O
a	O	O
two-chamber	O	O
model	O	O
in	O	O
order	O	O
to	O	O
determine	O	O
a	O	O
possible	O	O
route	O	O
of	O	O
penetration	O	O
.	O	O

Root	O	O
canals	O	O
of	O	O
teeth	O	O
in	O	O
the	O	O
experimental	O	O
group	O	O
(	O	O
n	O	O
=	O	O
16	O	O
)	O	O
were	O	O
instrumented	O	O
and	O	O
root	O	O
filled	O	O
using	O	O
AH26	O	O
and	O	O
gutta-percha	O	O
.	O	O

Canals	O	O
in	O	O
the	O	O
teeth	O	O
serving	O	O
as	O	O
positive	O	O
(	O	O
n	O	O
=	O	O
1	O	O
)	O	O
and	O	O
negative	O	O
(	O	O
n	O	O
=	O	O
1	O	O
)	O	O
controls	O	O
were	O	O
instrumented	O	O
,	O	O
but	O	O
not	O	O
root	O	O
filled	O	O
.	O	O

A	O	O
two-chamber	O	O
model	O	O
was	O	O
fabricated	O	O
for	O	O
each	O	O
root	O	O
-	O	O
upper	O	O
chambers	O	O
were	O	O
inoculated	O	O
weekly	O	O
with	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
in	O	O
brain-heart	O	O
infusion	O	O
broth	O	O
over	O	O
90	O	O
days	O	O
.	O	O

Turbidity	O	O
of	O	O
the	O	O
lower	O	O
chamber	O	O
was	O	O
checked	O	O
daily	O	O
.	O	O

Samples	O	O
that	O	O
showed	O	O
turbidity	O	O
during	O	O
the	O	O
experimental	O	O
period	O	O
and	O	O
samples	O	O
that	O	O
showed	O	O
no	O	O
signs	O	O
of	O	O
turbidity	O	O
at	O	O
90	O	O
days	O	O
were	O	O
fractured	O	O
and	O	O
prepared	O	O
for	O	O
SEM	O	O
examination	O	O
.	O	O

SEM	O	O
examination	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
bacteria	O	O
within	O	O
the	O	O
dentinal	O	O
tubules	O	O
was	O	O
performed	O	O
in	O	O
the	O	O
cervical	O	O
,	O	O
middle	O	O
and	O	O
apical	O	O
root	O	O
thirds	O	O
.	O	O

In	O	O
each	O	O
root	O	O
third	O	O
,	O	O
the	O	O
depth	O	O
of	O	O
bacterial	O	O
penetration	O	O
was	O	O
recorded	O	O
as	O	O
inner	O	O
,	O	O
middle	O	O
or	O	O
outer	O	O
dentine	O	O
.	O	O

Bacteria	O	O
were	O	O
most	O	O
commonly	O	O
detected	O	O
in	O	O
the	O	O
cervical	O	O
third	O	O
(	O	O
14	O	O
of	O	O
30	O	O
areas	O	O
)	O	O
.	O	O

Irrespective	O	O
of	O	O
the	O	O
root	O	O
third	O	O
examined	O	O
,	O	O
bacteria	O	O
were	O	O
most	O	O
commonly	O	O
detected	O	O
in	O	O
the	O	O
inner	O	O
dentine	O	O
(	O	O
i.e	O	O
.	O	O

adjacent	O	O
to	O	O
the	O	O
root	O	O
canal	O	O
)	O	O
.	O	O

Only	O	O
two	O	O
samples	O	O
demonstrated	O	O
bacterial	O	O
penetration	O	O
in	O	O
the	O	O
outer	O	O
dentine	O	O
.	O	O

The	O	O
dentine	O	O
tubular	O	O
network	O	O
provides	O	O
a	O	O
potential	O	O
pathway	O	O
for	O	O
bacteria	O	O
to	O	O
penetrate	O	O
tooth	O	O
roots	O	O
in	O	O
a	O	O
two-chamber	O	O
model	O	O
.	O	O

For	O	O
selective	O	O
detection	O	O
of	O	O
viable	O	O
bacteria	O	O
with	O	O
molecular	O	O
methods	O	O
,	O	O
propidium	O	O
monoazide	O	O
(	O	O
PMA	O	O
)	O	O
treatment	O	O
has	O	O
been	O	O
successfully	O	O
applied	O	O
to	O	O
a	O	O
wide	O	O
range	O	O
of	O	O
bacteria	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
compare	O	O
the	O	O
quantity	O	O
of	O	O
live	O	O
cells	O	O
with	O	O
the	O	O
total	O	O
amounts	O	O
of	O	O
both	O	O
live	O	O
and	O	O
dead	O	O
cells	O	O
before	O	O
and	O	O
after	O	O
chemomechanical	O	O
preparation	O	O
by	O	O
using	O	O
PMA	O	O
in	O	O
combination	O	O
with	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
qPCR	O	O
)	O	O
.	O	O

Twenty-one	O	O
teeth	O	O
with	O	O
pulp	O	O
necrosis	O	O
and	O	O
a	O	O
periapical	O	O
lesion	O	O
were	O	O
included	O	O
.	O	O

Bacterial	O	O
sampling	O	O
of	O	O
the	O	O
root	O	O
canals	O	O
was	O	O
performed	O	O
before	O	O
(	O	O
S1	O	O
)	O	O
and	O	O
after	O	O
(	O	O
S2	O	O
)	O	O
chemomechanical	O	O
root	O	O
canal	O	O
treatment	O	O
.	O	O

Each	O	O
sample	O	O
was	O	O
separated	O	O
into	O	O
2	O	O
different	O	O
tubes	O	O
.	O	O

PMA	O	O
was	O	O
added	O	O
to	O	O
one	O	O
of	O	O
the	O	O
tubes	O	O
,	O	O
and	O	O
the	O	O
other	O	O
was	O	O
left	O	O
untreated	O	O
.	O	O

Then	O	O
,	O	O
DNA	O	O
extraction	O	O
and	O	O
qPCR	O	O
were	O	O
performed	O	O
.	O	O

To	O	O
evaluate	O	O
the	O	O
validity	O	O
of	O	O
the	O	O
PMA	O	O
treatment	O	O
,	O	O
the	O	O
defined	O	O
mixtures	O	O
containing	O	O
different	O	O
ratios	O	O
of	O	O
live	O	O
and	O	O
dead	O	O
cell	O	O
suspensions	O	O
of	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
were	O	O
either	O	O
subjected	O	O
to	O	O
PMA	O	O
treatment	O	O
or	O	O
not	O	O
subjected	O	O
to	O	O
PMA	O	O
treatment	O	O
,	O	O
followed	O	O
by	O	O
qPCR	O	O
quantification	O	O
.	O	O

A	O	O
paired	O	O
t	O	O
test	O	O
showed	O	O
a	O	O
highly	O	O
significant	O	O
difference	O	O
in	O	O
the	O	O
mean	O	O
threshold	O	O
cycle	O	O
values	O	O
between	O	O
S1	O	O
with	O	O
and	O	O
without	O	O
PMA	O	O
(	O	O
P	O	O
=	O	O
.0002	O	O
)	O	O
,	O	O
and	O	O
this	O	O
difference	O	O
(	O	O
0.89	O	O
)	O	O
was	O	O
similar	O	O
to	O	O
that	O	O
(	O	O
0.96	O	O
)	O	O
obtained	O	O
from	O	O
the	O	O
samples	O	O
consisting	O	O
of	O	O
80	O	O
%	O	O
live	O	O
cell	O	O
suspension	O	O
and	O	O
20	O	O
%	O	O
dead	O	O
cell	O	O
suspension	O	O
of	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
.	O	O

The	O	O
threshold	O	O
cycle	O	O
values	O	O
between	O	O
the	O	O
S2	O	O
samples	O	O
with	O	O
and	O	O
without	O	O
PMA	O	O
were	O	O
also	O	O
significantly	O	O
different	O	O
(	O	O
P	O	O
=	O	O
.0134	O	O
)	O	O
,	O	O
and	O	O
this	O	O
difference	O	O
(	O	O
0.37	O	O
)	O	O
was	O	O
similar	O	O
to	O	O
that	O	O
obtained	O	O
from	O	O
the	O	O
100	O	O
%	O	O
live	O	O
cell	O	O
suspension	O	O
of	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
(	O	O
0.42	O	O
)	O	O
.	O	O

PMA	O	O
in	O	O
conjunction	O	O
with	O	O
qPCR	O	O
appeared	O	O
to	O	O
be	O	O
useful	O	O
in	O	O
analyzing	O	O
the	O	O
primary	O	O
infections	O	O
of	O	O
root	O	O
canals	O	O
because	O	O
there	O	O
were	O	O
significant	O	O
amounts	O	O
of	O	O
dead	O	O
bacteria	O	O
in	O	O
the	O	O
root	O	O
canals	O	O
.	O	O

Although	O	O
the	O	O
use	O	O
of	O	O
PMA	O	O
treatment	O	O
in	O	O
post-preparation	O	O
samples	O	O
significantly	O	O
reduced	O	O
the	O	O
detection	O	O
of	O	O
dead	O	O
bacteria	O	O
,	O	O
this	O	O
difference	O	O
was	O	O
still	O	O
small	O	O
,	O	O
so	O	O
further	O	O
studies	O	O
should	O	O
be	O	O
carried	O	O
out	O	O
to	O	O
confirm	O	O
the	O	O
necessity	O	O
of	O	O
PMA	O	O
treatment	O	O
.	O	O

The	O	O
acquisition	O	O
and	O	O
development	O	O
of	O	O
the	O	O
complex	O	O
oral	O	O
microbiome	O	O
remain	O	O
ill	O	O
defined	O	O
.	O	O

While	O	O
selected	O	O
species	O	O
of	O	O
oral	O	O
bacteria	O	O
have	O	O
been	O	O
examined	O	O
in	O	O
relation	O	O
to	O	O
their	O	O
initial	O	O
colonization	O	O
in	O	O
neonates	O	O
,	O	O
a	O	O
more	O	O
detailed	O	O
understanding	O	O
of	O	O
the	O	O
dynamics	O	O
of	O	O
the	O	O
microbiome	O	O
has	O	O
been	O	O
developed	O	O
only	O	O
in	O	O
adults	O	O
.	O	O

The	O	O
current	O	O
investigation	O	O
used	O	O
a	O	O
nonhuman	O	O
primate	O	O
model	O	O
to	O	O
document	O	O
the	O	O
kinetics	O	O
of	O	O
colonization	O	O
of	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
newborns	O	O
and	O	O
infants	O	O
by	O	O
a	O	O
range	O	O
of	O	O
oral	O	O
commensals	O	O
and	O	O
pathogens	O	O
.	O	O

Differences	O	O
in	O	O
colonization	O	O
were	O	O
evaluated	O	O
in	O	O
newborns	O	O
from	O	O
mothers	O	O
who	O	O
were	O	O
maintained	O	O
on	O	O
an	O	O
oral	O	O
hygiene	O	O
regimen	O	O
pre-	O	O
and	O	O
postparturition	O	O
with	O	O
those	O	O
displaying	O	O
naturally	O	O
acquired	O	O
gingivitis/periodontitis	O	O
.	O	O

The	O	O
results	O	O
demonstrate	O	O
distinct	O	O
profiles	O	O
of	O	O
acquisition	O	O
of	O	O
selected	O	O
oral	O	O
bacteria	O	O
,	O	O
with	O	O
the	O	O
transmission	O	O
of	O	O
targeted	O	O
pathogens	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
being	O	O
passed	O	O
on	O	O
primarily	O	O
from	O	O
mothers	O	O
with	O	O
gingivitis/periodontitis	O	O
.	O	O

This	O	O
colonization	O	O
resulted	O	O
in	O	O
defined	O	O
patterns	O	O
of	O	O
systemic	O	O
antibody	O	O
responses	O	O
in	O	O
the	O	O
infants	O	O
.	O	O

The	O	O
significant	O	O
relative	O	O
risk	O	O
measures	O	O
for	O	O
infection	O	O
with	O	O
the	O	O
pathogens	O	O
,	O	O
as	O	O
well	O	O
as	O	O
the	O	O
relationship	O	O
of	O	O
oral	O	O
infection	O	O
and	O	O
blood	O	O
serum	O	O
antibody	O	O
levels	O	O
,	O	O
were	O	O
consistent	O	O
with	O	O
those	O	O
of	O	O
the	O	O
newborns	O	O
from	O	O
mothers	O	O
with	O	O
gingivitis/periodontitis	O	O
.	O	O

These	O	O
findings	O	O
indicate	O	O
that	O	O
the	O	O
early	O	O
acquisition	O	O
of	O	O
potentially	O	O
pathogenic	O	O
oral	O	O
bacterial	O	O
species	O	O
might	O	O
impact	O	O
the	O	O
development	O	O
of	O	O
mucosal	O	O
responses	O	O
in	O	O
the	O	O
gingiva	O	O
and	O	O
may	O	O
provide	O	O
an	O	O
enhanced	O	O
risk	O	O
for	O	O
the	O	O
development	O	O
of	O	O
periodontitis	O	O
later	O	O
in	O	O
life	O	O
.	O	O

Oropharyngeal	O	O
candidiasis	O	O
(	O	O
OPC	O	O
)	O	O
is	O	O
caused	O	O
by	O	O
the	O	O
opportunistic	O	O
fungi	O	O
Candida	O	O
albicans	O	O
and	O	O
is	O	O
prevalent	O	O
in	O	O
immunocompromised	O	O
patients	O	O
,	O	O
individuals	O	O
with	O	O
dry	O	O
mouth	O	O
,	O	O
or	O	O
patients	O	O
with	O	O
prolonged	O	O
antibiotic	O	O
therapies	O	O
that	O	O
reduce	O	O
oral	O	O
commensal	O	O
bacteria	O	O
.	O	O

Human	O	O
salivary	O	O
histatins	O	O
,	O	O
including	O	O
histatin	O	O
5	O	O
(	O	O
Hst	O	O
5	O	O
)	O	O
,	O	O
are	O	O
small	O	O
cationic	O	O
proteins	O	O
that	O	O
are	O	O
the	O	O
major	O	O
source	O	O
of	O	O
fungicidal	O	O
activity	O	O
of	O	O
saliva	O	O
.	O	O

However	O	O
,	O	O
Hsts	O	O
are	O	O
rapidly	O	O
degraded	O	O
in	O	O
vivo	O	O
,	O	O
limiting	O	O
their	O	O
usefulness	O	O
as	O	O
therapeutic	O	O
agents	O	O
despite	O	O
their	O	O
lack	O	O
of	O	O
toxicity	O	O
.	O	O

We	O	O
constructed	O	O
a	O	O
conjugate	O	O
peptide	O	O
using	O	O
spermidine	O	O
(	O	O
Spd	O	O
)	O	O
linked	O	O
to	O	O
the	O	O
active	O	O
fragment	O	O
of	O	O
Hst	O	O
5	O	O
(	O	O
Hst	O	O
54-15	O	O
)	O	O
,	O	O
based	O	O
upon	O	O
our	O	O
findings	O	O
that	O	O
C.	O	O
albicans	O	O
spermidine	O	O
transporters	O	O
are	O	O
required	O	O
for	O	O
Hst	O	O
5	O	O
uptake	O	O
and	O	O
fungicidal	O	O
activity	O	O
.	O	O

We	O	O
found	O	O
that	O	O
Hst	O	O
54-15-Spd	O	O
was	O	O
significantly	O	O
more	O	O
effective	O	O
in	O	O
killing	O	O
C.	O	O
albicans	O	O
and	O	O
Candida	O	O
glabrata	O	O
than	O	O
Hst	O	O
5	O	O
alone	O	O
in	O	O
both	O	O
planktonic	O	O
and	O	O
biofilm	O	O
growth	O	O
and	O	O
that	O	O
Hst	O	O
54-15-Spd	O	O
retained	O	O
high	O	O
activity	O	O
in	O	O
both	O	O
serum	O	O
and	O	O
saliva	O	O
.	O	O

Hst	O	O
54-15-Spd	O	O
was	O	O
not	O	O
bactericidal	O	O
against	O	O
streptococcal	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
commensal	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
had	O	O
no	O	O
hemolytic	O	O
activity	O	O
.	O	O

We	O	O
tested	O	O
the	O	O
effectiveness	O	O
of	O	O
Hst	O	O
54-15-Spd	O	O
in	O	O
vivo	O	O
by	O	O
topical	O	O
application	O	O
to	O	O
tongue	O	O
surfaces	O	O
of	O	O
immunocompromised	O	O
mice	O	O
with	O	O
OPC	O	O
.	O	O

Mice	O	O
treated	O	O
with	O	O
Hst	O	O
54-15-Spd	O	O
had	O	O
significant	O	O
clearance	O	O
of	O	O
candidal	O	O
tongue	O	O
lesions	O	O
macroscopically	O	O
,	O	O
which	O	O
was	O	O
confirmed	O	O
by	O	O
a	O	O
3-	O	O
to	O	O
5-log	O	O
fold	O	O
reduction	O	O
of	O	O
C.	O	O
albicans	O	O
colonies	O	O
recovered	O	O
from	O	O
tongue	O	O
tissues	O	O
.	O	O

Hst	O	O
54-15-Spd	O	O
conjugates	O	O
are	O	O
a	O	O
new	O	O
class	O	O
of	O	O
peptide-based	O	O
drugs	O	O
with	O	O
high	O	O
selectivity	O	O
for	O	O
fungi	O	O
and	O	O
potential	O	O
as	O	O
topical	O	O
therapeutic	O	O
agents	O	O
for	O	O
oral	O	O
candidiasis	O	O
.	O	O

Previous	O	O
findings	O	O
of	O	O
an	O	O
association	O	O
between	O	O
25-hydroxyvitamin	O	O
D	O	O
[	O	O
25	O	O
(	O	O
OH	O	O
)	O	O
D	O	O
]	O	O
concentrations	O	O
and	O	O
periodontal	O	O
disease	O	O
may	O	O
be	O	O
partially	O	O
explained	O	O
by	O	O
the	O	O
antimicrobial	O	O
properties	O	O
of	O	O
vitamin	O	O
D.	O	O
To	O	O
the	O	O
best	O	O
of	O	O
the	O	O
authors	O	O
'	O	O
knowledge	O	O
,	O	O
no	O	O
study	O	O
has	O	O
investigated	O	O
the	O	O
association	O	O
between	O	O
25	O	O
(	O	O
OH	O	O
)	O	O
D	O	O
and	O	O
pathogenic	O	O
oral	O	O
bacteria	O	O
,	O	O
a	O	O
putative	O	O
cause	O	O
of	O	O
periodontal	O	O
disease	O	O
.	O	O

The	O	O
association	O	O
between	O	O
plasma	O	O
25	O	O
(	O	O
OH	O	O
)	O	O
D	O	O
concentrations	O	O
and	O	O
pathogenic	O	O
oral	O	O
bacteria	O	O
was	O	O
examined	O	O
among	O	O
postmenopausal	O	O
females	O	O
in	O	O
the	O	O
Buffalo	O	O
Osteoporosis	O	O
and	O	O
Periodontal	O	O
Disease	O	O
Study	O	O
(	O	O
1997	O	O
to	O	O
2000	O	O
)	O	O
,	O	O
an	O	O
ancillary	O	O
study	O	O
of	O	O
the	O	O
Women	O	O
's	O	O
Health	O	O
Initiative	O	O
Observational	O	O
Study	O	O
.	O	O

Subgingival	O	O
plaque	O	O
samples	O	O
were	O	O
assessed	O	O
using	O	O
immunofluorescence	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
and	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
.	O	O

Logistic	O	O
regression	O	O
was	O	O
used	O	O
to	O	O
calculate	O	O
odds	O	O
ratios	O	O
(	O	O
ORs	O	O
)	O	O
and	O	O
95	O	O
%	O	O
confidence	O	O
intervals	O	O
(	O	O
CIs	O	O
)	O	O
for	O	O
prevalent	O	O
bacteria	O	O
by	O	O
quintile	O	O
(	O	O
Q	O	O
)	O	O
of	O	O
25	O	O
(	O	O
OH	O	O
)	O	O
D	O	O
concentrations	O	O
,	O	O
adjusting	O	O
for	O	O
age	O	O
and	O	O
body	O	O
mass	O	O
index	O	O
.	O	O

Of	O	O
the	O	O
855	O	O
participants	O	O
,	O	O
288	O	O
(	O	O
34	O	O
%	O	O
)	O	O
had	O	O
deficient/inadequate	O	O
(	O	O
<	O	O
50	O	O
nmol/L	O	O
)	O	O
25	O	O
(	O	O
OH	O	O
)	O	O
D	O	O
concentrations	O	O
,	O	O
and	O	O
496	O	O
(	O	O
58	O	O
%	O	O
)	O	O
had	O	O
at	O	O
least	O	O
one	O	O
species	O	O
of	O	O
pathogenic	O	O
bacteria	O	O
.	O	O

No	O	O
significant	O	O
association	O	O
was	O	O
found	O	O
between	O	O
25	O	O
(	O	O
OH	O	O
)	O	O
D	O	O
and	O	O
presence	O	O
of	O	O
any	O	O
of	O	O
these	O	O
bacteria	O	O
(	O	O
adjusted	O	O
OR	O	O
for	O	O
high	O	O
[	O	O
Q5	O	O
]	O	O
compared	O	O
to	O	O
low	O	O
[	O	O
Q1	O	O
]	O	O
25	O	O
(	O	O
OH	O	O
)	O	O
D	O	O
=	O	O
0.96	O	O
;	O	O
95	O	O
%	O	O
CI	O	O
:	O	O
0.61	O	O
to	O	O
1.50	O	O
;	O	O
P	O	O
for	O	O
trend	O	O
=	O	O
0.50	O	O
)	O	O
.	O	O

Inverse	O	O
,	O	O
although	O	O
not	O	O
statistically	O	O
significant	O	O
,	O	O
associations	O	O
were	O	O
found	O	O
between	O	O
25	O	O
(	O	O
OH	O	O
)	O	O
D	O	O
and	O	O
more	O	O
than	O	O
one	O	O
species	O	O
of	O	O
pathogenic	O	O
bacteria	O	O
(	O	O
adjusted	O	O
OR	O	O
for	O	O
adequate	O	O
compared	O	O
to	O	O
deficient/inadequate	O	O
25	O	O
(	O	O
OH	O	O
)	O	O
D	O	O
=	O	O
0.85	O	O
;	O	O
95	O	O
%	O	O
CI	O	O
:	O	O
0.60	O	O
to	O	O
1.19	O	O
)	O	O
.	O	O

No	O	O
association	O	O
was	O	O
observed	O	O
between	O	O
pathogenic	O	O
oral	O	O
bacteria	O	O
and	O	O
25	O	O
(	O	O
OH	O	O
)	O	O
D	O	O
concentrations	O	O
in	O	O
postmenopausal	O	O
females	O	O
.	O	O

This	O	O
may	O	O
be	O	O
attributable	O	O
to	O	O
the	O	O
species	O	O
of	O	O
bacteria	O	O
assessed	O	O
,	O	O
small	O	O
effect	O	O
size	O	O
,	O	O
or	O	O
a	O	O
true	O	O
absence	O	O
of	O	O
an	O	O
association	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
is	O	O
one	O	O
of	O	O
the	O	O
first	O	O
colonizers	O	O
of	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
and	O	O
gut	O	O
after	O	O
birth	O	O
and	O	O
therefore	O	O
may	O	O
contribute	O	O
to	O	O
the	O	O
establishment	O	O
of	O	O
immune	O	O
homeostasis	O	O
and	O	O
regulation	O	O
of	O	O
host	O	O
inflammatory	O	O
responses	O	O
.	O	O

The	O	O
anti-inflammatory	O	O
potential	O	O
of	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
was	O	O
first	O	O
evaluated	O	O
in	O	O
vitro	O	O
on	O	O
human	O	O
intestinal	O	O
epithelial	O	O
cells	O	O
and	O	O
human	O	O
peripheral	O	O
blood	O	O
mononuclear	O	O
cells	O	O
.	O	O

We	O	O
show	O	O
that	O	O
live	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
inhibited	O	O
in	O	O
vitro	O	O
the	O	O
activation	O	O
of	O	O
the	O	O
NF-kappaB	O	O
pathway	O	O
on	O	O
intestinal	O	O
epithelial	O	O
cells	O	O
.	O	O

We	O	O
also	O	O
demonstrate	O	O
that	O	O
the	O	O
live	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
JIM8772	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
significantly	O	O
inhibited	O	O
inflammation	O	O
in	O	O
severe	O	O
and	O	O
moderate	O	O
colitis	O	O
mouse	O	O
models	O	O
.	O	O

These	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo	O	O
anti-inflammatory	O	O
properties	O	O
were	O	O
not	O	O
found	O	O
with	O	O
heat-killed	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
suggesting	O	O
a	O	O
protective	O	O
response	O	O
exclusively	O	O
with	O	O
metabolically	O	O
active	O	O
bacteria	O	O
.	O	O

Salivary	O	O
contamination	O	O
of	O	O
surgical	O	O
wounds	O	O
in	O	O
clean-contaminated	O	O
head	O	O
and	O	O
neck	O	O
surgery	O	O
with	O	O
free	O	O
flap	O	O
reconstruction	O	O
remains	O	O
a	O	O
major	O	O
cause	O	O
of	O	O
infection	O	O
and	O	O
leads	O	O
to	O	O
significant	O	O
morbidity	O	O
.	O	O

This	O	O
study	O	O
investigates	O	O
the	O	O
correlation	O	O
between	O	O
intraoral	O	O
flora	O	O
and	O	O
surgical	O	O
site	O	O
infections	O	O
(	O	O
SSIs	O	O
)	O	O
among	O	O
high-risk	O	O
head	O	O
and	O	O
neck	O	O
cancer	O	O
patients	O	O
undergoing	O	O
resection	O	O
and	O	O
free	O	O
flap	O	O
reconstruction	O	O
.	O	O

One	O	O
hundred	O	O
twenty-nine	O	O
patients	O	O
were	O	O
identified	O	O
as	O	O
being	O	O
at	O	O
high	O	O
risk	O	O
for	O	O
infective	O	O
complications	O	O
based	O	O
on	O	O
cancer	O	O
stage	O	O
,	O	O
tumor	O	O
size	O	O
,	O	O
comorbid	O	O
factors	O	O
,	O	O
and	O	O
extent	O	O
of	O	O
reconstruction	O	O
.	O	O

All	O	O
patients	O	O
had	O	O
intraoral	O	O
swab	O	O
cultures	O	O
before	O	O
surgery	O	O
.	O	O

Patients	O	O
with	O	O
culture-confirmed	O	O
SSI	O	O
after	O	O
surgery	O	O
were	O	O
chosen	O	O
for	O	O
analysis	O	O
,	O	O
using	O	O
the	O	O
kappa	O	O
index	O	O
and	O	O
its	O	O
95	O	O
%	O	O
confidence	O	O
interval	O	O
for	O	O
concordance	O	O
analysis	O	O
.	O	O

All	O	O
patients	O	O
received	O	O
clindamycin	O	O
and	O	O
gentamicin	O	O
for	O	O
antibiotic	O	O
prophylaxis	O	O
for	O	O
5	O	O
days	O	O
.	O	O

Antibiotic	O	O
susceptibility	O	O
testing	O	O
of	O	O
all	O	O
isolates	O	O
was	O	O
obtained	O	O
and	O	O
analyzed	O	O
.	O	O

Thirty-seven	O	O
patients	O	O
experienced	O	O
SSI	O	O
,	O	O
or	O	O
an	O	O
infection	O	O
rate	O	O
of	O	O
28.3	O	O
%	O	O
,	O	O
occurring	O	O
at	O	O
a	O	O
mean	O	O
of	O	O
9.3	O	O
postoperative	O	O
days	O	O
.	O	O

The	O	O
overall	O	O
concordance	O	O
between	O	O
oral	O	O
flora	O	O
and	O	O
SSI	O	O
was	O	O
fair	O	O
to	O	O
moderate	O	O
(	O	O
kappa	O	O
index	O	O
of	O	O
0.25	O	O
)	O	O
,	O	O
but	O	O
detailed	O	O
analysis	O	O
shows	O	O
a	O	O
higher	O	O
concordance	O	O
for	O	O
known	O	O
and	O	O
opportunistic	O	O
pathogens	O	O
,	O	O
such	O	O
as	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
and	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
compared	O	O
to	O	O
typical	O	O
oral	O	O
commensals	O	O
.	O	O

Antibiotic	O	O
susceptibility	O	O
tests	O	O
show	O	O
rapid	O	O
and	O	O
significant	O	O
increases	O	O
in	O	O
resistance	O	O
to	O	O
clindamycin	O	O
,	O	O
indicating	O	O
a	O	O
need	O	O
for	O	O
a	O	O
more	O	O
effective	O	O
alternative	O	O
.	O	O

Predicting	O	O
pathogens	O	O
in	O	O
SSI	O	O
using	O	O
preoperative	O	O
oral	O	O
swabs	O	O
did	O	O
not	O	O
demonstrate	O	O
a	O	O
good	O	O
concordance	O	O
in	O	O
general	O	O
for	O	O
patients	O	O
undergoing	O	O
clean-contaminated	O	O
head	O	O
and	O	O
neck	O	O
surgery	O	O
,	O	O
although	O	O
concordance	O	O
for	O	O
certain	O	O
pathogenic	O	O
species	O	O
seem	O	O
to	O	O
be	O	O
higher	O	O
than	O	O
for	O	O
typical	O	O
intraoral	O	O
commensals	O	O
.	O	O

The	O	O
rapid	O	O
development	O	O
of	O	O
resistance	O	O
to	O	O
clindamycin	O	O
precludes	O	O
its	O	O
use	O	O
as	O	O
a	O	O
prophylactic	O	O
agent	O	O
.	O	O

Oral	O	O
ulcerations	O	O
often	O	O
arise	O	O
as	O	O
a	O	O
side	O	O
effect	O	O
from	O	O
chemo-	O	O
and	O	O
radiation	O	O
therapy	O	O
.	O	O

In	O	O
a	O	O
previous	O	O
clinical	O	O
study	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
identified	O	O
as	O	O
a	O	O
positive	O	O
predictor	O	O
for	O	O
oral	O	O
ulcerations	O	O
after	O	O
hematopoetic	O	O
stem	O	O
cell	O	O
transplantation	O	O
,	O	O
possibly	O	O
incriminating	O	O
P.	O	O
gingivalis	O	O
in	O	O
delayed	O	O
healing	O	O
of	O	O
the	O	O
ulcerations	O	O
.	O	O

Therefore	O	O
,	O	O
it	O	O
was	O	O
tested	O	O
whether	O	O
P.	O	O
gingivalis	O	O
and	O	O
its	O	O
secreted	O	O
products	O	O
could	O	O
inhibit	O	O
the	O	O
migration	O	O
of	O	O
oral	O	O
epithelial	O	O
cells	O	O
in	O	O
an	O	O
in	O	O
vitro	O	O
scratch	O	O
assay	O	O
.	O	O

To	O	O
compare	O	O
,	O	O
the	O	O
oral	O	O
bacteria	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
were	O	O
included	O	O
.	O	O

A	O	O
standardized	O	O
scratch	O	O
was	O	O
made	O	O
in	O	O
a	O	O
confluent	O	O
layer	O	O
of	O	O
human	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

The	O	O
epithelial	O	O
cells	O	O
were	O	O
challenged	O	O
with	O	O
bacterial	O	O
cells	O	O
and	O	O
with	O	O
medium	O	O
containing	O	O
secretions	O	O
of	O	O
these	O	O
bacteria	O	O
.	O	O

Closure	O	O
of	O	O
the	O	O
scratch	O	O
was	O	O
measured	O	O
after	O	O
17	O	O
h	O	O
using	O	O
a	O	O
phase	O	O
contrast	O	O
microscope	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
and	O	O
secretions	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
strongly	O	O
inhibited	O	O
cell	O	O
migration	O	O
.	O	O

A	O	O
challenge	O	O
with	O	O
1000	O	O
heat-killed	O	O
bacteria	O	O
versus	O	O
1	O	O
epithelial	O	O
cell	O	O
resulted	O	O
in	O	O
a	O	O
relative	O	O
closure	O	O
of	O	O
the	O	O
scratch	O	O
of	O	O
25	O	O
%	O	O
for	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
20	O	O
%	O	O
for	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
.	O	O

Weaker	O	O
inhibitory	O	O
effects	O	O
were	O	O
found	O	O
for	O	O
the	O	O
other	O	O
bacteria	O	O
.	O	O

The	O	O
results	O	O
confirmed	O	O
our	O	O
hypothesis	O	O
that	O	O
the	O	O
oral	O	O
bacteria	O	O
may	O	O
be	O	O
involved	O	O
in	O	O
delayed	O	O
wound	O	O
healing	O	O
.	O	O

Modern	O	O
dentistry	O	O
emphasizes	O	O
the	O	O
importance	O	O
of	O	O
dental	O	O
plaque	O	O
control	O	O
to	O	O
improve	O	O
oral	O	O
health	O	O
.	O	O

To	O	O
that	O	O
end	O	O
the	O	O
development	O	O
of	O	O
oral	O	O
care	O	O
formulations	O	O
has	O	O
been	O	O
geared	O	O
toward	O	O
the	O	O
incorporation	O	O
of	O	O
antiplaque	O	O
agents	O	O
that	O	O
may	O	O
play	O	O
a	O	O
crucial	O	O
role	O	O
in	O	O
oral	O	O
health	O	O
maintenance	O	O
.	O	O

In	O	O
later	O	O
years	O	O
the	O	O
research	O	O
into	O	O
antiplaque	O	O
agents	O	O
has	O	O
led	O	O
to	O	O
the	O	O
discovery	O	O
of	O	O
compounds	O	O
with	O	O
significant	O	O
capability	O	O
to	O	O
affect	O	O
biofilm	O	O
formation	O	O
.	O	O

Among	O	O
these	O	O
compounds	O	O
was	O	O
chitosan	O	O
,	O	O
a	O	O
polysaccharide	O	O
which	O	O
showed	O	O
great	O	O
ability	O	O
to	O	O
interfere	O	O
with	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilm	O	O
formation	O	O
.	O	O

As	O	O
such	O	O
the	O	O
aim	O	O
of	O	O
this	O	O
work	O	O
was	O	O
to	O	O
incorporate	O	O
chitosan	O	O
into	O	O
a	O	O
mouthwash	O	O
matrix	O	O
and	O	O
assess	O	O
its	O	O
effect	O	O
upon	O	O
biofilm	O	O
formation	O	O
of	O	O
oral	O	O
microorganisms	O	O
.	O	O

This	O	O
assessment	O	O
was	O	O
performed	O	O
via	O	O
study	O	O
of	O	O
the	O	O
impact	O	O
the	O	O
mouthwash	O	O
upon	O	O
microbial	O	O
adherence	O	O
,	O	O
biofilm	O	O
formation	O	O
and	O	O
mature	O	O
biofilms	O	O
.	O	O

Additionally	O	O
,	O	O
the	O	O
action	O	O
of	O	O
the	O	O
chitosan	O	O
mouthwash	O	O
was	O	O
compared	O	O
with	O	O
two	O	O
commercially	O	O
available	O	O
mouthwashes	O	O
.	O	O

The	O	O
results	O	O
here	O	O
obtained	O	O
show	O	O
that	O	O
only	O	O
the	O	O
chitosan	O	O
containing	O	O
mouthwash	O	O
was	O	O
capable	O	O
of	O	O
interfering	O	O
with	O	O
all	O	O
microorganisms	O	O
'	O	O
adherence	O	O
,	O	O
biofilm	O	O
formation	O	O
and	O	O
mature	O	O
biofilms	O	O
while	O	O
at	O	O
the	O	O
same	O	O
time	O	O
showing	O	O
vastly	O	O
superior	O	O
activity	O	O
than	O	O
both	O	O
commercial	O	O
mouthwashes	O	O
assayed	O	O
.	O	O

As	O	O
such	O	O
a	O	O
chitosan	O	O
mouthwash	O	O
shows	O	O
great	O	O
potential	O	O
as	O	O
a	O	O
natural	O	O
and	O	O
efficient	O	O
alternative	O	O
to	O	O
traditional	O	O
mouthwashes	O	O
.	O	O

The	O	O
study	O	O
was	O	O
carried	O	O
out	O	O
to	O	O
see	O	O
the	O	O
diversity	O	O
of	O	O
oral	O	O
microflora	O	O
and	O	O
its	O	O
antibiotic	O	O
sensitivity	O	O
test	O	O
in	O	O
children	O	O
of	O	O
age	O	O
group	O	O
6	O	O
to	O	O
12	O	O
years	O	O
was	O	O
carried	O	O
.	O	O

Total	O	O
50	O	O
patients	O	O
of	O	O
age	O	O
group	O	O
6	O	O
to	O	O
12	O	O
years	O	O
were	O	O
analyzed	O	O
for	O	O
their	O	O
oral	O	O
microflora	O	O
and	O	O
then	O	O
checked	O	O
for	O	O
the	O	O
antibiotic	O	O
susceptibility	O	O
test	O	O
.	O	O

The	O	O
samples	O	O
that	O	O
were	O	O
collected	O	O
were	O	O
incubated	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
for	O	O
48	O	O
hours	O	O
.	O	O

Once	O	O
dispersed	O	O
samples	O	O
were	O	O
taken	O	O
and	O	O
Gram	O	O
staining	O	O
was	O	O
done	O	O
,	O	O
also	O	O
they	O	O
were	O	O
spread	O	O
on	O	O
to	O	O
a	O	O
number	O	O
of	O	O
freshly	O	O
prepared	O	O
agar	O	O
plates	O	O
and	O	O
incubated	O	O
to	O	O
allow	O	O
cells	O	O
to	O	O
form	O	O
microbial	O	O
colony	O	O
.	O	O

The	O	O
result	O	O
showed	O	O
microflora	O	O
common	O	O
in	O	O
all	O	O
types	O	O
,	O	O
Gram-positive	B-bacteria	B-bacteria
facultative	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
rods	E-bacteria	I-bacteria
and	O	O
cocci	B-bacteria	B-bacteria
.	O	O

In	O	O
normal	O	O
children	O	O
Gram-positive	B-bacteria	B-bacteria
facultative	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
and	I-bacteria	I-bacteria
fermenting	I-bacteria	I-bacteria
cocci	E-bacteria	I-bacteria
were	O	O
predominant	O	O
where	O	O
as	O	O
in	O	O
children	O	O
with	O	O
caries	O	O
growth	O	O
of	O	O
microbiota	O	O
that	O	O
were	O	O
Gram-negative	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
positive	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
capnophilic	I-bacteria	I-bacteria
,	I-bacteria	I-bacteria
motile	I-bacteria	I-bacteria
and	I-bacteria	I-bacteria
anaerobic	I-bacteria	I-bacteria
rods	E-bacteria	I-bacteria
and	O	O
cocci	B-bacteria	B-bacteria
belonging	O	O
to	O	O
members	O	O
of	O	O
genera	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
was	O	O
seen	O	O
.	O	O

By	O	O
the	O	O
present	O	O
study	O	O
it	O	O
has	O	O
been	O	O
concluded	O	O
that	O	O
the	O	O
number	O	O
of	O	O
bacteria	O	O
determined	O	O
by	O	O
microscopic	O	O
counts	O	O
was	O	O
twice	O	O
as	O	O
high	O	O
in	O	O
caries	O	O
patients	O	O
as	O	O
in	O	O
healthy	O	O
sites	O	O
,	O	O
and	O	O
also	O	O
recommended	O	O
that	O	O
amoxicillin	O	O
,	O	O
ampicillin	O	O
and	O	O
amikacin	O	O
are	O	O
the	O	O
most	O	O
effective	O	O
antibacterial	O	O
drugs	O	O
for	O	O
the	O	O
treatment	O	O
of	O	O
dental	O	O
caries	O	O
.	O	O

To	O	O
study	O	O
and	O	O
compare	O	O
the	O	O
number	O	O
of	O	O
colony	O	O
forming	O	O
units	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
milleri	E-bacteria	I-bacteria
in	O	O
dentulous	O	O
,	O	O
edentulous	O	O
and	O	O
in	O	O
those	O	O
wearing	O	O
partial	O	O
and	O	O
complete	O	O
dentures	O	O
by	O	O
using	O	O
semi-quantitative	O	O
culture	O	O
method	O	O
of	O	O
saliva	O	O
samples	O	O
with	O	O
calibrated	O	O
standard	O	O
loop	O	O
.	O	O

Sterile	O	O
specimen	O	O
collection	O	O
bottles	O	O
,	O	O
Mitis	O	O
salivarius	O	O
agar	O	O
plates	O	O
,	O	O
Standard	O	O
loop	O	O
,	O	O
Candle	O	O
jar	O	O
,	O	O
Incubator	O	O
,	O	O
Colony	O	O
counter	O	O
.	O	O

Study	O	O
population	O	O
consisted	O	O
of	O	O
100	O	O
subjects	O	O
with	O	O
25	O	O
in	O	O
each	O	O
group	O	O
,	O	O
with	O	O
an	O	O
age	O	O
range	O	O
of	O	O
40	O	O
to	O	O
80	O	O
years	O	O
,	O	O
who	O	O
were	O	O
attending	O	O
the	O	O
Department	O	O
of	O	O
Community	O	O
Dentistry	O	O
and	O	O
Prosthodontics	O	O
at	O	O
MNR	O	O
Dental	O	O
College	O	O
,	O	O
Sangareddy	O	O
,	O	O
Hyderabad	O	O
.	O	O

Unstimulated	O	O
saliva	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
patients	O	O
and	O	O
inoculated	O	O
on	O	O
to	O	O
Mitis	O	O
salivarius	O	O
agar	O	O
plates	O	O
using	O	O
calibrated	O	O
standard	O	O
loop	O	O
.	O	O

The	O	O
plates	O	O
were	O	O
then	O	O
incubated	O	O
anaerobically	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
for	O	O
24	O	O
hours	O	O
and	O	O
left	O	O
at	O	O
room	O	O
temperature	O	O
for	O	O
further	O	O
24	O	O
hours	O	O
.	O	O

Using	O	O
a	O	O
colony	O	O
counter	O	O
,	O	O
the	O	O
number	O	O
of	O	O
colonies	O	O
of	O	O
each	O	O
species	O	O
was	O	O
counted	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
predominates	O	O
in	O	O
the	O	O
dentulous	O	O
group	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
in	O	O
complete	O	O
denture	O	O
group	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
in	O	O
edentulous	O	O
group	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
milleri	E-bacteria	I-bacteria
in	O	O
removable	O	O
partial	O	O
denture	O	O
group	O	O
.	O	O

The	O	O
results	O	O
of	O	O
our	O	O
study	O	O
are	O	O
in	O	O
accordance	O	O
with	O	O
the	O	O
previous	O	O
studies	O	O
,	O	O
which	O	O
have	O	O
sought	O	O
to	O	O
differentiate	O	O
different	O	O
groups	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
using	O	O
a	O	O
simple	O	O
calibrated	O	O
standard	O	O
loop	O	O
.	O	O

A	O	O
majority	O	O
of	O	O
individuals	O	O
infected	O	O
with	O	O
human	O	O
immunodeficiency	O	O
virus	O	O
(	O	O
HIV	O	O
)	O	O
have	O	O
inadequate	O	O
access	O	O
to	O	O
antiretroviral	O	O
therapy	O	O
and	O	O
ultimately	O	O
develop	O	O
debilitating	O	O
oral	O	O
infections	O	O
that	O	O
often	O	O
correlate	O	O
with	O	O
disease	O	O
progression	O	O
.	O	O

Due	O	O
to	O	O
the	O	O
impracticalities	O	O
of	O	O
conducting	O	O
host-microbe	O	O
systems-based	O	O
studies	O	O
in	O	O
HIV	O	O
infected	O	O
patients	O	O
,	O	O
we	O	O
have	O	O
evaluated	O	O
the	O	O
potential	O	O
of	O	O
simian	O	O
immunodeficiency	O	O
virus	O	O
(	O	O
SIV	O	O
)	O	O
infected	O	O
rhesus	O	O
macaques	O	O
to	O	O
serve	O	O
as	O	O
a	O	O
non-human	O	O
primate	O	O
model	O	O
for	O	O
oral	O	O
manifestations	O	O
of	O	O
HIV	O	O
disease	O	O
.	O	O

We	O	O
present	O	O
the	O	O
first	O	O
description	O	O
of	O	O
the	O	O
rhesus	O	O
macaque	O	O
oral	O	O
microbiota	O	O
and	O	O
show	O	O
that	O	O
a	O	O
mixture	O	O
of	O	O
human	O	O
commensal	O	O
bacteria	O	O
and	O	O
``	O	O
macaque	O	O
versions	O	O
''	O	O
of	O	O
human	O	O
commensals	O	O
colonize	O	O
the	O	O
tongue	O	O
dorsum	O	O
and	O	O
dental	O	O
plaque	O	O
.	O	O

Our	O	O
findings	O	O
indicate	O	O
that	O	O
SIV	O	O
infection	O	O
results	O	O
in	O	O
chronic	O	O
activation	O	O
of	O	O
antiviral	O	O
and	O	O
inflammatory	O	O
responses	O	O
in	O	O
the	O	O
tongue	O	O
mucosa	O	O
that	O	O
may	O	O
collectively	O	O
lead	O	O
to	O	O
repression	O	O
of	O	O
epithelial	O	O
development	O	O
and	O	O
impact	O	O
the	O	O
microbiome	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
we	O	O
show	O	O
that	O	O
dysbiosis	O	O
of	O	O
the	O	O
lingual	O	O
microbiome	O	O
in	O	O
SIV	O	O
infection	O	O
is	O	O
characterized	O	O
by	O	O
outgrowth	O	O
of	O	O
Gemella	O	O
morbillorum	O	O
that	O	O
may	O	O
result	O	O
from	O	O
impaired	O	O
macrophage	O	O
function	O	O
.	O	O

Finally	O	O
,	O	O
we	O	O
provide	O	O
evidence	O	O
that	O	O
the	O	O
increased	O	O
capacity	O	O
of	O	O
opportunistic	O	O
pathogens	O	O
(	O	O
e.g	O	O
.	O	O

E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
)	O	O
to	O	O
colonize	O	O
the	O	O
microbiome	O	O
is	O	O
associated	O	O
with	O	O
reduced	O	O
production	O	O
of	O	O
antimicrobial	O	O
peptides	O	O
.	O	O

This	O	O
study	O	O
compared	O	O
the	O	O
oral	O	O
hygiene	O	O
and	O	O
caries	O	O
risk	O	O
of	O	O
patients	O	O
treated	O	O
with	O	O
labial	O	O
and	O	O
lingual	O	O
orthodontic	O	O
appliances	O	O
throughout	O	O
a	O	O
prospective	O	O
evaluation	O	O
of	O	O
the	O	O
status	O	O
of	O	O
the	O	O
oral	O	O
environment	O	O
before	O	O
and	O	O
after	O	O
bracket	O	O
placement	O	O
.	O	O

A	O	O
total	O	O
of	O	O
20	O	O
orthodontic	O	O
patients	O	O
aged	O	O
19	O	O
to	O	O
23	O	O
years	O	O
were	O	O
included	O	O
in	O	O
the	O	O
study	O	O
and	O	O
were	O	O
divided	O	O
into	O	O
two	O	O
groups	O	O
:	O	O
10	O	O
patients	O	O
wore	O	O
Roth	O	O
labial	O	O
appliance	O	O
(	O	O
American	O	O
Orthodontics	O	O
,	O	O
Sheboygan	O	O
,	O	O
WI	O	O
,	O	O
USA	O	O
)	O	O
and	O	O
10	O	O
patients	O	O
wore	O	O
STb	O	O
lingual	O	O
appliance	O	O
(	O	O
Ormco	O	O
Corporation	O	O
,	O	O
Glendora	O	O
,	O	O
CA	O	O
,	O	O
USA	O	O
)	O	O
.	O	O

Plaque	O	O
index	O	O
(	O	O
PI	O	O
)	O	O
,	O	O
gingival	O	O
bleeding	O	O
index	O	O
(	O	O
GBI	O	O
)	O	O
,	O	O
salivary	O	O
flow	O	O
rate	O	O
,	O	O
saliva	O	O
buffer	O	O
capacity	O	O
,	O	O
salivary	O	O
pH	O	O
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
counts	O	O
in	O	O
saliva	O	O
were	O	O
determined	O	O
at	O	O
three	O	O
time	O	O
points	O	O
:	O	O
before	O	O
orthodontic	O	O
appliance	O	O
placement	O	O
(	O	O
T0	O	O
)	O	O
,	O	O
4	O	O
weeks	O	O
after	O	O
bonding	O	O
(	O	O
T1	O	O
)	O	O
,	O	O
and	O	O
8	O	O
weeks	O	O
after	O	O
bonding	O	O
(	O	O
T2	O	O
)	O	O
.	O	O

After	O	O
appliance	O	O
placement	O	O
,	O	O
all	O	O
patients	O	O
were	O	O
periodically	O	O
educated	O	O
to	O	O
the	O	O
oral	O	O
hygiene	O	O
procedures	O	O
.	O	O

Wilcoxon	O	O
rank	O	O
and	O	O
Mann-Whitney	O	O
U	O	O
tests	O	O
were	O	O
used	O	O
to	O	O
determine	O	O
intragroup	O	O
and	O	O
intergroup	O	O
differences	O	O
as	O	O
regards	O	O
qualitative	O	O
data	O	O
.	O	O

To	O	O
compare	O	O
quantitative	O	O
data	O	O
between	O	O
the	O	O
groups	O	O
,	O	O
chi-square	O	O
and	O	O
Fisher	O	O
's	O	O
exact	O	O
tests	O	O
were	O	O
undertaken	O	O
,	O	O
while	O	O
intragroup	O	O
differences	O	O
were	O	O
tested	O	O
with	O	O
McNemar	O	O
test	O	O
.	O	O

The	O	O
level	O	O
of	O	O
statistical	O	O
significance	O	O
was	O	O
set	O	O
at	O	O
p	O	O
<	O	O
0.05	O	O
.	O	O

Statistical	O	O
analysis	O	O
of	O	O
the	O	O
data	O	O
obtained	O	O
revealed	O	O
a	O	O
statistically	O	O
significant	O	O
difference	O	O
between	O	O
the	O	O
data	O	O
of	O	O
T0	O	O
and	O	O
T1	O	O
and	O	O
the	O	O
data	O	O
of	O	O
T0	O	O
and	O	O
T2	O	O
of	O	O
the	O	O
PI	O	O
scores	O	O
and	O	O
between	O	O
T0	O	O
and	O	O
T2	O	O
of	O	O
the	O	O
GBI	O	O
scores	O	O
in	O	O
the	O	O
group	O	O
treated	O	O
with	O	O
the	O	O
lingual	O	O
appliance	O	O
.	O	O

The	O	O
GBI	O	O
value	O	O
increased	O	O
significantly	O	O
between	O	O
T0	O	O
and	O	O
T1	O	O
but	O	O
decreased	O	O
significantly	O	O
between	O	O
T1	O	O
and	O	O
T2	O	O
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
in	O	O
the	O	O
group	O	O
treated	O	O
with	O	O
labial	O	O
appliance	O	O
.	O	O

S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
counts	O	O
increased	O	O
significantly	O	O
between	O	O
T0	O	O
and	O	O
T2	O	O
in	O	O
the	O	O
saliva	O	O
samples	O	O
of	O	O
patients	O	O
treated	O	O
with	O	O
lingual	O	O
appliance	O	O
.	O	O

No	O	O
statistically	O	O
significant	O	O
differences	O	O
were	O	O
found	O	O
between	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
counts	O	O
at	O	O
the	O	O
three	O	O
terms	O	O
of	O	O
saliva	O	O
collection	O	O
in	O	O
patients	O	O
treated	O	O
with	O	O
labial	O	O
appliance	O	O
.	O	O

No	O	O
statistically	O	O
significant	O	O
differences	O	O
were	O	O
found	O	O
between	O	O
the	O	O
two	O	O
groups	O	O
at	O	O
the	O	O
three	O	O
time	O	O
points	O	O
as	O	O
regards	O	O
the	O	O
salivary	O	O
flow	O	O
rate	O	O
and	O	O
saliva	O	O
buffer	O	O
capacity	O	O
.	O	O

Lingual	O	O
and	O	O
labial	O	O
orthodontic	O	O
appliances	O	O
showed	O	O
a	O	O
different	O	O
potential	O	O
in	O	O
modifying	O	O
the	O	O
investigated	O	O
clinical	O	O
parameters	O	O
:	O	O
patients	O	O
wearing	O	O
STb	O	O
lingual	O	O
orthodontic	O	O
appliance	O	O
had	O	O
more	O	O
plaque	O	O
retention	O	O
4	O	O
and	O	O
8	O	O
weeks	O	O
after	O	O
bonding	O	O
,	O	O
while	O	O
there	O	O
were	O	O
more	O	O
gingival	O	O
inflammation	O	O
and	O	O
more	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
counts	O	O
8	O	O
weeks	O	O
after	O	O
bonding	O	O
.	O	O

No	O	O
differences	O	O
were	O	O
found	O	O
between	O	O
the	O	O
two	O	O
groups	O	O
as	O	O
regards	O	O
the	O	O
Lactobacillus	B-bacteria	B-bacteria
counts	O	O
,	O	O
the	O	O
salivary	O	O
flow	O	O
rate	O	O
,	O	O
and	O	O
saliva	O	O
buffer	O	O
capacity	O	O
.	O	O

A	O	O
significant	O	O
portion	O	O
of	O	O
the	O	O
bacteria	O	O
taking	O	O
part	O	O
of	O	O
the	O	O
microbiome	O	O
associated	O	O
with	O	O
apical	O	O
periodontitis	O	O
still	O	O
remain	O	O
to	O	O
be	O	O
cultivated	O	O
and	O	O
phenotypically	O	O
characterized	O	O
.	O	O

This	O	O
molecular	O	O
study	O	O
evaluated	O	O
the	O	O
prevalence	O	O
of	O	O
selected	O	O
as-yet-uncultivated	O	O
and	O	O
difficult-to-culture	O	O
bacterial	O	O
taxa	O	O
in	O	O
infected	O	O
root	O	O
canals	O	O
and	O	O
their	O	O
susceptibility	O	O
to	O	O
chemomechanical	O	O
procedures	O	O
.	O	O

Root	O	O
canals	O	O
of	O	O
single-rooted	O	O
teeth	O	O
with	O	O
apical	O	O
periodontitis	O	O
were	O	O
prepared	O	O
using	O	O
rotary	O	O
nickel-titanium	O	O
instruments	O	O
and	O	O
2.5	O	O
%	O	O
sodium	O	O
hypochlorite	O	O
as	O	O
the	O	O
irrigant	O	O
.	O	O

DNA	O	O
extracts	O	O
from	O	O
samples	O	O
taken	O	O
before	O	O
(	O	O
S1	O	O
)	O	O
and	O	O
after	O	O
(	O	O
S2	O	O
)	O	O
chemomechanical	O	O
preparation	O	O
were	O	O
surveyed	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
7	O	O
as-yet-uncultivated	O	O
phylotypes	O	O
and	O	O
1	O	O
difficult-to-culture	O	O
species	O	O
using	O	O
end-point	O	O
polymerase	O	O
chain	O	O
reaction	O	O
.	O	O

Samples	O	O
were	O	O
also	O	O
subjected	O	O
to	O	O
quantitative	O	O
analysis	O	O
of	O	O
total	O	O
bacteria	O	O
and	O	O
levels	O	O
of	O	O
the	O	O
2	O	O
most	O	O
prevalent	O	O
taxa	O	O
.	O	O

Bacteroidaceae	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

HOT-272	O	O
(	O	O
24	O	O
%	O	O
)	O	O
and	O	O
Fretibacterium	B-bacteria	B-bacteria
fastidiosum	E-bacteria	I-bacteria
(	O	O
20	O	O
%	O	O
)	O	O
were	O	O
the	O	O
most	O	O
prevalent	O	O
taxa	O	O
in	O	O
S1	O	O
.	O	O

Their	O	O
mean	O	O
counts	O	O
in	O	O
S1	O	O
were	O	O
8.25	O	O
x	O	O
10	O	O
(	O	O
3	O	O
)	O	O
and	O	O
2.13	O	O
x	O	O
10	O	O
(	O	O
3	O	O
)	O	O
rRNA	O	O
gene	O	O
copies	O	O
,	O	O
corresponding	O	O
to	O	O
0.18	O	O
%	O	O
and	O	O
0.55	O	O
%	O	O
of	O	O
the	O	O
total	O	O
bacteria	O	O
.	O	O

Chemomechanical	O	O
debridement	O	O
promoted	O	O
a	O	O
highly	O	O
statistically	O	O
significant	O	O
reduction	O	O
in	O	O
total	O	O
bacterial	O	O
counts	O	O
(	O	O
P	O	O
<	O	O
.001	O	O
)	O	O
,	O	O
but	O	O
64	O	O
%	O	O
of	O	O
the	O	O
canals	O	O
were	O	O
still	O	O
positive	O	O
for	O	O
bacterial	O	O
presence	O	O
.	O	O

Of	O	O
the	O	O
target	O	O
taxa	O	O
,	O	O
only	O	O
Bacteroidaceae	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

HOT-272	O	O
and	O	O
F.	B-bacteria	B-bacteria
fastidiosum	E-bacteria	I-bacteria
were	O	O
detected	O	O
in	O	O
S2	O	O
(	O	O
each	O	O
one	O	O
in	O	O
1	O	O
sample	O	O
)	O	O
.	O	O

The	O	O
reduction	O	O
in	O	O
counts	O	O
of	O	O
both	O	O
taxa	O	O
was	O	O
also	O	O
highly	O	O
significant	O	O
(	O	O
P	O	O
<	O	O
.001	O	O
)	O	O
.	O	O

Findings	O	O
confirmed	O	O
that	O	O
several	O	O
as-yet-uncultivated	O	O
and	O	O
difficult-to-grow	O	O
bacterial	O	O
taxa	O	O
can	O	O
participate	O	O
in	O	O
the	O	O
microbiome	O	O
associated	O	O
with	O	O
apical	O	O
periodontitis	O	O
.	O	O

Two	O	O
of	O	O
them	O	O
were	O	O
found	O	O
in	O	O
relatively	O	O
high	O	O
prevalence	O	O
but	O	O
rarely	O	O
as	O	O
a	O	O
dominant	O	O
species	O	O
.	O	O

Chemomechanical	O	O
procedures	O	O
were	O	O
highly	O	O
effective	O	O
in	O	O
completely	O	O
eliminating	O	O
these	O	O
taxa	O	O
or	O	O
at	O	O
least	O	O
substantially	O	O
reducing	O	O
their	O	O
numbers	O	O
.	O	O

One	O	O
of	O	O
the	O	O
most	O	O
important	O	O
factors	O	O
implicated	O	O
in	O	O
preterm	O	O
birth	O	O
(	O	O
PTB	O	O
)	O	O
is	O	O
acute	O	O
genitourinary	O	O
tract	O	O
infection	O	O
.	O	O

The	O	O
bacteria	O	O
causing	O	O
chronic	O	O
periodontal	O	O
inflammation	O	O
include	O	O
Gram-negative	B-bacteria	B-bacteria
rods	E-bacteria	I-bacteria
and	O	O
anaerobes	B-bacteria	B-bacteria
similar	O	O
to	O	O
those	O	O
found	O	O
in	O	O
women	O	O
with	O	O
bacterial	O	O
vaginosis	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
prospective	O	O
study	O	O
is	O	O
to	O	O
investigate	O	O
the	O	O
relationship	O	O
between	O	O
oral	O	O
and	O	O
vaginal	O	O
microflora	O	O
and	O	O
preterm	O	O
low	O	O
birth	O	O
weight	O	O
.	O	O

Real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
was	O	O
used	O	O
to	O	O
detect	O	O
both	O	O
the	O	O
presence	O	O
and	O	O
level	O	O
of	O	O
six	O	O
periodontitis-related	O	O
species	O	O
:	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
Aa	B-bacteria	B-bacteria
)	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
Pg	B-bacteria	B-bacteria
)	O	O
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
(	O	O
Tf	B-bacteria	B-bacteria
)	O	O
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
(	O	O
Td	B-bacteria	B-bacteria
)	O	O
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
ssp	E-bacteria	I-bacteria
(	O	O
Fn	B-bacteria	B-bacteria
)	O	O
,	O	O
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
(	O	O
Pi	B-bacteria	B-bacteria
)	O	O
for	O	O
both	O	O
oral	O	O
samples	O	O
of	O	O
subgingival	O	O
plaque	O	O
and	O	O
cervical	O	O
samples	O	O
,	O	O
obtained	O	O
from	O	O
80	O	O
patients	O	O
,	O	O
during	O	O
gynaecological	O	O
examinations	O	O
.	O	O

The	O	O
more	O	O
representative	O	O
oral	O	O
pathogen	O	O
(	O	O
less	O	O
than	O	O
60	O	O
percent	O	O
)	O	O
species	O	O
in	O	O
oral	O	O
samples	O	O
of	O	O
preterm	O	O
and	O	O
term	O	O
group	O	O
were	O	O
Tf	B-bacteria	B-bacteria
,	O	O
Td	B-bacteria	B-bacteria
,	O	O
and	O	O
Fn	B-bacteria	B-bacteria
.	O	O

24.4	O	O
percent	O	O
of	O	O
pregnant	O	O
women	O	O
presented	O	O
periodontal	O	O
pathogens	O	O
in	O	O
vaginal	O	O
swab	O	O
;	O	O
the	O	O
most	O	O
representative	O	O
species	O	O
with	O	O
a	O	O
percentage	O	O
over	O	O
0.1	O	O
percent	O	O
of	O	O
total	O	O
bacteria	O	O
in	O	O
genital	O	O
tract	O	O
of	O	O
preterm	O	O
group	O	O
were	O	O
Tf	B-bacteria	B-bacteria
,	O	O
Td	B-bacteria	B-bacteria
,	O	O
and	O	O
Pi	B-bacteria	B-bacteria
with	O	O
a	O	O
positive	O	O
correlation	O	O
(	O	O
less	O	O
than	O	O
0.5	O	O
)	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
the	O	O
bacterium	B-bacteria	B-bacteria
T.	I-bacteria	I-bacteria
denticolain	E-bacteria	I-bacteria
the	O	O
vagina	O	O
,	O	O
regardless	O	O
of	O	O
the	O	O
amount	O	O
,	O	O
adversely	O	O
affects	O	O
preterm	O	O
delivery	O	O
.	O	O

Astilbin	O	O
,	O	O
mainly	O	O
isolated	O	O
from	O	O
a	O	O
commonly	O	O
used	O	O
herbal	O	O
medicine	O	O
,	O	O
Smilax	O	O
glabra	O	O
Roxb	O	O
(	O	O
SGR	O	O
)	O	O
,	O	O
exhibits	O	O
a	O	O
variety	O	O
of	O	O
pharmacological	O	O
activities	O	O
and	O	O
biological	O	O
effects	O	O
.	O	O

It	O	O
is	O	O
metabolized	O	O
by	O	O
intestinal	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
after	O	O
oral	O	O
administration	O	O
which	O	O
leads	O	O
to	O	O
the	O	O
variation	O	O
of	O	O
ethnopharmacological	O	O
profile	O	O
of	O	O
this	O	O
traditional	O	O
medicine	O	O
.	O	O

However	O	O
,	O	O
little	O	O
is	O	O
known	O	O
on	O	O
the	O	O
interactions	O	O
of	O	O
this	O	O
active	O	O
compound	O	O
with	O	O
intestinal	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
which	O	O
would	O	O
be	O	O
very	O	O
helpful	O	O
in	O	O
unravelling	O	O
how	O	O
SGR	O	O
works	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
different	O	O
pure	O	O
bacteria	O	O
from	O	O
human	O	O
feces	O	O
were	O	O
isolated	O	O
and	O	O
were	O	O
used	O	O
to	O	O
investigate	O	O
their	O	O
conversion	O	O
capability	O	O
of	O	O
astilbin	O	O
.	O	O

Ultra-performance	O	O
liquid	O	O
chromatography/quadrupole-time-of-flight	O	O
mass	O	O
spectrometry	O	O
(	O	O
UPLC-Q-TOF/MS	O	O
)	O	O
technique	O	O
combined	O	O
with	O	O
Metabolynx	O	O
(	O	O
TM	O	O
)	O	O
software	O	O
was	O	O
used	O	O
to	O	O
analyze	O	O
astilbin	O	O
and	O	O
its	O	O
metabolites	O	O
.	O	O

The	O	O
parent	O	O
compound	O	O
and	O	O
two	O	O
metabolites	O	O
(	O	O
quercetin	O	O
and	O	O
eriodictyol	O	O
)	O	O
were	O	O
detected	O	O
in	O	O
the	O	O
isolated	O	O
bacterial	O	O
samples	O	O
compared	O	O
with	O	O
blank	O	O
samples	O	O
.	O	O

Quercetin	O	O
was	O	O
present	O	O
in	O	O
Enterococcus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

8B	O	O
,	O	O
8-2	O	O
and	O	O
9-2	O	O
samples	O	O
.	O	O

Eriodictyol	O	O
was	O	O
only	O	O
identified	O	O
in	O	O
Enterococcus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

8B	O	O
sample	O	O
.	O	O

The	O	O
metabolic	O	O
routes	O	O
and	O	O
metabolites	O	O
of	O	O
astilbin	O	O
produced	O	O
by	O	O
the	O	O
different	O	O
intestinal	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
are	O	O
reported	O	O
for	O	O
the	O	O
first	O	O
time	O	O
.	O	O

This	O	O
will	O	O
be	O	O
useful	O	O
for	O	O
the	O	O
investigation	O	O
of	O	O
the	O	O
pharmacokinetic	O	O
study	O	O
of	O	O
astilbin	O	O
in	O	O
vivo	O	O
and	O	O
the	O	O
role	O	O
of	O	O
different	O	O
intestinal	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
the	O	O
metabolism	O	O
of	O	O
natural	O	O
compounds	O	O
.	O	O

Periodontitis	O	O
is	O	O
a	O	O
common	O	O
dental	O	O
disease	O	O
which	O	O
results	O	O
in	O	O
irreversible	O	O
alveolar	O	O
bone	O	O
loss	O	O
around	O	O
teeth	O	O
,	O	O
and	O	O
subsequent	O	O
tooth	O	O
loss	O	O
.	O	O

Previous	O	O
studies	O	O
have	O	O
focused	O	O
on	O	O
bacteria	O	O
that	O	O
damage	O	O
the	O	O
host	O	O
and	O	O
the	O	O
roles	O	O
of	O	O
commensals	O	O
to	O	O
facilitate	O	O
their	O	O
colonization	O	O
.	O	O

Although	O	O
some	O	O
immune	O	O
responses	O	O
targeting	O	O
oral	O	O
bacteria	O	O
protect	O	O
the	O	O
host	O	O
from	O	O
alveolar	O	O
bone	O	O
loss	O	O
,	O	O
recent	O	O
studies	O	O
show	O	O
that	O	O
particular	O	O
host	O	O
defense	O	O
responses	O	O
to	O	O
oral	O	O
bacteria	O	O
can	O	O
induce	O	O
alveolar	O	O
bone	O	O
loss	O	O
.	O	O

Host-damaging	O	O
and	O	O
immunostimulatory	O	O
oral	O	O
bacteria	O	O
cooperatively	O	O
induce	O	O
bone	O	O
loss	O	O
by	O	O
inducing	O	O
gingival	O	O
damage	O	O
followed	O	O
by	O	O
immunostimulation	O	O
.	O	O

In	O	O
mouse	O	O
models	O	O
of	O	O
experimental	O	O
periodontitis	O	O
induced	O	O
by	O	O
either	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
or	O	O
ligature	O	O
,	O	O
gamma-proteobacteria	B-bacteria	B-bacteria
accumulate	O	O
and	O	O
stimulate	O	O
host	O	O
immune	O	O
responses	O	O
to	O	O
induce	O	O
host	O	O
damage	O	O
.	O	O

Here	O	O
we	O	O
review	O	O
the	O	O
differential	O	O
roles	O	O
of	O	O
individual	O	O
bacterial	O	O
groups	O	O
in	O	O
promoting	O	O
bone	O	O
loss	O	O
through	O	O
the	O	O
induction	O	O
of	O	O
host	O	O
damage	O	O
and	O	O
immunostimulation	O	O
.	O	O

Oral	O	O
biofilms	O	O
harbor	O	O
several	O	O
hundreds	O	O
of	O	O
species	O	O
of	O	O
bacteria	O	O
as	O	O
well	O	O
as	O	O
spirochetes	B-bacteria	B-bacteria
,	O	O
protozoa	O	O
,	O	O
fungi	O	O
and	O	O
viruses	O	O
.	O	O

The	O	O
composition	O	O
of	O	O
the	O	O
oral	O	O
biofilm	O	O
varies	O	O
from	O	O
health	O	O
to	O	O
disease	O	O
.	O	O

It	O	O
is	O	O
the	O	O
source	O	O
of	O	O
microorganisms	O	O
that	O	O
cause	O	O
dental	O	O
and	O	O
periodontal	O	O
infections	O	O
.	O	O

Oral	O	O
infections	O	O
and	O	O
periodontal	O	O
disease	O	O
have	O	O
been	O	O
implicated	O	O
in	O	O
the	O	O
etiopathogenesis	O	O
of	O	O
several	O	O
important	O	O
chronic	O	O
systemic	O	O
diseases	O	O
.	O	O

It	O	O
is	O	O
now	O	O
clear	O	O
that	O	O
the	O	O
most	O	O
common	O	O
oral	O	O
diseases	O	O
,	O	O
dental	O	O
caries	O	O
and	O	O
periodontitis	O	O
,	O	O
are	O	O
caused	O	O
by	O	O
mixed-species	O	O
communities	O	O
rather	O	O
than	O	O
by	O	O
individual	O	O
pathogens	O	O
working	O	O
in	O	O
isolation	O	O
.	O	O

Oral	O	O
streptococci	B-bacteria	B-bacteria
are	O	O
central	O	O
to	O	O
these	O	O
disease	O	O
processes	O	O
since	O	O
they	O	O
are	O	O
frequently	O	O
the	O	O
first	O	O
microorganisms	O	O
to	O	O
colonize	O	O
oral	O	O
surfaces	O	O
and	O	O
they	O	O
are	O	O
numerically	O	O
the	O	O
dominant	O	O
microorganisms	O	O
in	O	O
the	O	O
human	O	O
mouth	O	O
.	O	O

Numerous	O	O
interactions	O	O
between	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
other	O	O
bacteria	O	O
have	O	O
been	O	O
documented	O	O
.	O	O

These	O	O
are	O	O
thought	O	O
to	O	O
be	O	O
critical	O	O
for	O	O
the	O	O
development	O	O
of	O	O
mixed-species	O	O
oral	O	O
microbial	O	O
communities	O	O
and	O	O
for	O	O
the	O	O
transition	O	O
from	O	O
oral	O	O
health	O	O
to	O	O
disease	O	O
.	O	O

Recent	O	O
metagenomic	O	O
studies	O	O
are	O	O
beginning	O	O
to	O	O
shed	O	O
light	O	O
on	O	O
the	O	O
co-occurrence	O	O
patterns	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
with	O	O
other	O	O
oral	O	O
bacteria	O	O
.	O	O

Refinements	O	O
in	O	O
microscopy	O	O
techniques	O	O
and	O	O
biofilm	O	O
models	O	O
are	O	O
providing	O	O
detailed	O	O
insights	O	O
into	O	O
the	O	O
spatial	O	O
distribution	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
in	O	O
oral	O	O
biofilms	O	O
.	O	O

Targeted	O	O
genetic	O	O
manipulation	O	O
is	O	O
increasingly	O	O
being	O	O
applied	O	O
for	O	O
the	O	O
analysis	O	O
of	O	O
specific	O	O
genes	O	O
and	O	O
networks	O	O
that	O	O
modulate	O	O
interspecies	O	O
interactions	O	O
.	O	O

From	O	O
this	O	O
work	O	O
,	O	O
it	O	O
is	O	O
clear	O	O
that	O	O
streptococci	B-bacteria	B-bacteria
produce	O	O
a	O	O
range	O	O
of	O	O
extracellular	O	O
factors	O	O
that	O	O
promote	O	O
their	O	O
integration	O	O
into	O	O
mixed-species	O	O
communities	O	O
and	O	O
enable	O	O
them	O	O
to	O	O
form	O	O
social	O	O
networks	O	O
with	O	O
neighboring	O	O
taxa	O	O
.	O	O

These	O	O
``	O	O
community	O	O
integration	O	O
factors	O	O
''	O	O
include	O	O
coaggregation-mediating	O	O
adhesins	O	O
and	O	O
receptors	O	O
,	O	O
small	O	O
signaling	O	O
molecules	O	O
such	O	O
as	O	O
peptides	O	O
or	O	O
autoinducer-2	O	O
,	O	O
bacteriocins	O	O
,	O	O
by-products	O	O
of	O	O
metabolism	O	O
including	O	O
hydrogen	O	O
peroxide	O	O
and	O	O
lactic	O	O
acid	O	O
,	O	O
and	O	O
a	O	O
range	O	O
of	O	O
extracellular	O	O
enzymes	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
provide	O	O
an	O	O
overview	O	O
of	O	O
various	O	O
types	O	O
of	O	O
community	O	O
interactions	O	O
between	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
other	O	O
microorganisms	O	O
,	O	O
and	O	O
we	O	O
consider	O	O
the	O	O
possibilities	O	O
for	O	O
the	O	O
development	O	O
of	O	O
new	O	O
technologies	O	O
to	O	O
interfere	O	O
with	O	O
these	O	O
interactions	O	O
to	O	O
help	O	O
control	O	O
oral	O	O
biofilms	O	O
.	O	O

Wounded	O	O
tissue	O	O
offers	O	O
opportunity	O	O
to	O	O
microflora	O	O
to	O	O
adhere	O	O
,	O	O
colonize	O	O
,	O	O
invade	O	O
and	O	O
infect	O	O
surrounding	O	O
healthy	O	O
tissue	O	O
.	O	O

The	O	O
bacteria	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
have	O	O
the	O	O
potential	O	O
to	O	O
alter	O	O
the	O	O
wound	O	O
healing	O	O
process	O	O
by	O	O
interacting	O	O
with	O	O
keratinocytes	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
mechanisms	O	O
through	O	O
which	O	O
oral	O	O
bacteria	O	O
may	O	O
influence	O	O
re-epithelialization	O	O
by	O	O
interacting	O	O
with	O	O
gingival	O	O
keratinocytes	O	O
.	O	O

By	O	O
an	O	O
in	O	O
vitro	O	O
scratch	O	O
assay	O	O
we	O	O
demonstrate	O	O
that	O	O
primary	O	O
gingival	O	O
keratinocytes	O	O
have	O	O
impaired	O	O
closure	O	O
when	O	O
exposed	O	O
to	O	O
two	O	O
well	O	O
characterized	O	O
oral	O	O
bacteria	O	O
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
to	O	O
a	O	O
lesser	O	O
extent	O	O
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
reduced	O	O
wound	O	O
closure	O	O
by	O	O
approximately	O	O
40	O	O
%	O	O
,	O	O
which	O	O
was	O	O
partially	O	O
dependent	O	O
on	O	O
proteolytic	O	O
activity	O	O
,	O	O
and	O	O
bacteria	O	O
was	O	O
still	O	O
present	O	O
within	O	O
infected	O	O
cells	O	O
9	O	O
days	O	O
later	O	O
despite	O	O
exposure	O	O
to	O	O
bacteria	O	O
for	O	O
only	O	O
24	O	O
h.	O	O
Both	O	O
oral	O	O
bacteria	O	O
caused	O	O
keratinocyte	O	O
apoptosis	O	O
at	O	O
the	O	O
wound	O	O
site	O	O
with	O	O
cell	O	O
death	O	O
being	O	O
greatest	O	O
at	O	O
the	O	O
wound	O	O
edge	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
adversely	O	O
affected	O	O
cell	O	O
proliferation	O	O
and	O	O
the	O	O
effect	O	O
also	O	O
had	O	O
a	O	O
spatial	O	O
component	O	O
being	O	O
most	O	O
striking	O	O
at	O	O
the	O	O
edge	O	O
.	O	O

The	O	O
impact	O	O
of	O	O
the	O	O
bacteria	O	O
was	O	O
long	O	O
lasting	O	O
even	O	O
when	O	O
exposure	O	O
was	O	O
brief	O	O
.	O	O

Cell	O	O
migration	O	O
was	O	O
compromised	O	O
in	O	O
bacteria	O	O
challenged	O	O
keratinocytes	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
having	O	O
more	O	O
severe	O	O
effect	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
than	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

Quantitative	O	O
real	O	O
time	O	O
PCR	O	O
of	O	O
bacteria	O	O
challenged	O	O
cells	O	O
showed	O	O
that	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
to	O	O
a	O	O
lesser	O	O
extent	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
significantly	O	O
downregulated	O	O
cell	O	O
cycle	O	O
genes	O	O
cyclin1	O	O
,	O	O
CDK1	O	O
,	O	O
and	O	O
CDK4	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
that	O	O
are	O	O
critical	O	O
for	O	O
GI/S	O	O
transition	O	O
.	O	O

Further	O	O
,	O	O
genes	O	O
associated	O	O
with	O	O
cell	O	O
migration	O	O
such	O	O
as	O	O
integrin	O	O
beta-3	O	O
and	O	O
-6	O	O
were	O	O
significantly	O	O
downregulated	O	O
by	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

We	O	O
investigated	O	O
the	O	O
response	O	O
of	O	O
oral	O	O
cancer	O	O
cells	O	O
to	O	O
intracellular	O	O
invasion	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
to	O	O
define	O	O
changes	O	O
in	O	O
the	O	O
biological	O	O
characteristics	O	O
of	O	O
oral	O	O
cancer	O	O
cells	O	O
evoked	O	O
by	O	O
the	O	O
presence	O	O
of	O	O
oral	O	O
pathogenic	O	O
bacteria	O	O
within	O	O
a	O	O
tumour	O	O
microenvironment	O	O
.	O	O

The	O	O
proliferative	O	O
activity	O	O
,	O	O
cell	O	O
cycle	O	O
,	O	O
and	O	O
autophagic	O	O
response	O	O
were	O	O
evaluated	O	O
in	O	O
oral	O	O
cancer	O	O
cells	O	O
infected	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
381	E-bacteria	I-bacteria
.	O	O

ROS	O	O
generation	O	O
was	O	O
detected	O	O
in	O	O
these	O	O
cells	O	O
by	O	O
DCFDA	O	O
assay	O	O
,	O	O
and	O	O
its	O	O
role	O	O
in	O	O
the	O	O
responses	O	O
of	O	O
oral	O	O
cancer	O	O
cells	O	O
to	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
infection	O	O
was	O	O
further	O	O
investigated	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
inhibited	O	O
proliferation	O	O
of	O	O
oral	O	O
cancer	O	O
cells	O	O
by	O	O
inducing	O	O
G1	O	O
cell	O	O
cycle	O	O
arrest	O	O
,	O	O
but	O	O
had	O	O
no	O	O
effect	O	O
on	O	O
apoptosis	O	O
.	O	O

Following	O	O
infection	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
the	O	O
expression	O	O
of	O	O
cyclin	O	O
D1	O	O
and	O	O
cdk4	O	O
was	O	O
decreased	O	O
in	O	O
oral	O	O
cancer	O	O
cells	O	O
,	O	O
whereas	O	O
p21	O	O
,	O	O
a	O	O
Cdk	O	O
inhibitor	O	O
,	O	O
was	O	O
upregulated	O	O
,	O	O
in	O	O
comparison	O	O
with	O	O
non-infected	O	O
controls	O	O
.	O	O

Autophagy	O	O
was	O	O
prominently	O	O
enhanced	O	O
in	O	O
these	O	O
infected	O	O
cells	O	O
,	O	O
presumably	O	O
contributing	O	O
to	O	O
the	O	O
suppressed	O	O
proliferation	O	O
.	O	O

Further	O	O
experiments	O	O
revealed	O	O
that	O	O
such	O	O
autophagic	O	O
response	O	O
was	O	O
activated	O	O
by	O	O
the	O	O
formation	O	O
of	O	O
reactive	O	O
oxygen	O	O
species	O	O
,	O	O
as	O	O
evidenced	O	O
by	O	O
the	O	O
lack	O	O
of	O	O
autophagic	O	O
response	O	O
and	O	O
cell	O	O
proliferation	O	O
upon	O	O
removal	O	O
of	O	O
reactive	O	O
oxygen	O	O
species	O	O
.	O	O

These	O	O
findings	O	O
provide	O	O
a	O	O
novel	O	O
insight	O	O
into	O	O
the	O	O
mechanism	O	O
by	O	O
which	O	O
cancer	O	O
cells	O	O
are	O	O
influenced	O	O
by	O	O
tumour	O	O
microenvironment	O	O
including	O	O
oral	O	O
bacteria	O	O
.	O	O

Titanium	O	O
and	O	O
stainless	O	O
steel	O	O
wires	O	O
used	O	O
for	O	O
retainers	O	O
in	O	O
orthodontic	O	O
procedures	O	O
were	O	O
coated	O	O
with	O	O
Ag	O	O
ions	O	O
and	O	O
the	O	O
effects	O	O
of	O	O
the	O	O
coating	O	O
on	O	O
common	O	O
oral	O	O
pathogens	O	O
and	O	O
their	O	O
pathogenicity	O	O
were	O	O
investigated	O	O
.	O	O

Two	O	O
species	O	O
of	O	O
cariogenic	O	O
and	O	O
three	O	O
species	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
were	O	O
assessed	O	O
.	O	O

Biofilms	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
and	O	O
two	O	O
VSC	O	O
gases	O	O
produced	O	O
by	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
were	O	O
also	O	O
examined	O	O
.	O	O

Ag	O	O
ion-coated	O	O
wires	O	O
showed	O	O
marked	O	O
antibacterial	O	O
activities	O	O
compared	O	O
with	O	O
uncoated	O	O
wires	O	O
;	O	O
in	O	O
most	O	O
cases	O	O
,	O	O
the	O	O
differences	O	O
were	O	O
statistically	O	O
significant	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

All	O	O
Ag	O	O
ion-coated	O	O
wires	O	O
(	O	O
Ti+	O	O
and	O	O
SS+	O	O
wires	O	O
)	O	O
displayed	O	O
more	O	O
than	O	O
2-mm	O	O
diameter	O	O
bacteria	O	O
growth-resistant	O	O
zones	O	O
around	O	O
them	O	O
in	O	O
radial	O	O
diffusion	O	O
tests	O	O
.	O	O

Ag	O	O
ion	O	O
release	O	O
was	O	O
0.043+/-0.005	O	O
ppm	O	O
in	O	O
24	O	O
h	O	O
that	O	O
did	O	O
n't	O	O
show	O	O
cytotoxicity	O	O
.	O	O

Thus	O	O
,	O	O
these	O	O
results	O	O
suggest	O	O
that	O	O
a	O	O
simple	O	O
Ag	O	O
ion	O	O
coating	O	O
on	O	O
pure	O	O
titanium	O	O
and	O	O
stainless	O	O
steel	O	O
wires	O	O
can	O	O
restrict	O	O
growth	O	O
and	O	O
pathogenic	O	O
activities	O	O
of	O	O
oral	O	O
pathogenic	O	O
bacteria	O	O
,	O	O
even	O	O
in	O	O
the	O	O
early	O	O
stages	O	O
of	O	O
culture	O	O
.	O	O

Mycoplasma	B-bacteria	B-bacteria
salivarium	E-bacteria	I-bacteria
belongs	O	O
to	O	O
the	O	O
class	O	O
of	O	O
the	O	O
smallest	O	O
self-replicating	B-bacteria	B-bacteria
Tenericutes	E-bacteria	I-bacteria
and	O	O
is	O	O
predominantly	O	O
found	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
humans	O	O
.	O	O

In	O	O
general	O	O
it	O	O
is	O	O
considered	O	O
as	O	O
a	O	O
non-pathogenic	O	O
commensal	O	O
.	O	O

However	O	O
,	O	O
some	O	O
reports	O	O
point	O	O
to	O	O
an	O	O
association	O	O
with	O	O
human	O	O
diseases	O	O
.	O	O

M.	B-bacteria	B-bacteria
salivarium	E-bacteria	I-bacteria
was	O	O
found	O	O
e.g	O	O
.	O	O

as	O	O
causative	O	O
agent	O	O
of	O	O
a	O	O
submasseteric	O	O
abscess	O	O
,	O	O
in	O	O
necrotic	O	O
dental	O	O
pulp	O	O
,	O	O
in	O	O
brain	O	O
abscess	O	O
and	O	O
clogged	O	O
biliary	O	O
stent	O	O
.	O	O

Here	O	O
we	O	O
describe	O	O
the	O	O
detection	O	O
of	O	O
M.	B-bacteria	B-bacteria
salivarium	E-bacteria	I-bacteria
on	O	O
the	O	O
surface	O	O
of	O	O
a	O	O
squamous	O	O
cell	O	O
carcinoma	O	O
of	O	O
the	O	O
tongue	O	O
of	O	O
a	O	O
patient	O	O
with	O	O
Fanconi	O	O
anaemia	O	O
(	O	O
FA	O	O
)	O	O
.	O	O

FA	O	O
is	O	O
an	O	O
inherited	O	O
bone	O	O
marrow	O	O
failure	O	O
syndrome	O	O
based	O	O
on	O	O
defective	O	O
DNA-repair	O	O
that	O	O
increases	O	O
the	O	O
risk	O	O
of	O	O
carcinomas	O	O
especially	O	O
oral	O	O
squamous	O	O
cell	O	O
carcinoma	O	O
.	O	O

Employing	O	O
high	O	O
coverage	O	O
,	O	O
massive	O	O
parallel	O	O
Roche/454-next-generation-sequencing	O	O
of	O	O
16S	O	O
rRNA	O	O
gene	O	O
amplicons	O	O
we	O	O
analysed	O	O
the	O	O
oral	O	O
microbiome	O	O
of	O	O
this	O	O
FA	O	O
patient	O	O
in	O	O
comparison	O	O
to	O	O
that	O	O
of	O	O
an	O	O
FA	O	O
patient	O	O
with	O	O
a	O	O
benign	O	O
leukoplakia	O	O
and	O	O
five	O	O
healthy	O	O
individuals	O	O
.	O	O

The	O	O
microbiota	O	O
of	O	O
the	O	O
FA	O	O
patient	O	O
with	O	O
leukoplakia	O	O
correlated	O	O
well	O	O
with	O	O
that	O	O
of	O	O
the	O	O
healthy	O	O
controls	O	O
.	O	O

A	O	O
dominance	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
and	O	O
Neisseria	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
was	O	O
typically	O	O
observed	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
the	O	O
microbiome	O	O
of	O	O
the	O	O
cancer	O	O
bearing	O	O
FA	O	O
patient	O	O
was	O	O
dominated	O	O
by	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
at	O	O
the	O	O
healthy	O	O
sites	O	O
,	O	O
which	O	O
changed	O	O
to	O	O
a	O	O
predominance	O	O
of	O	O
98	O	O
%	O	O
M.	B-bacteria	B-bacteria
salivarium	E-bacteria	I-bacteria
on	O	O
the	O	O
tumour	O	O
surface	O	O
.	O	O

Quantification	O	O
of	O	O
the	O	O
mycoplasma	O	O
load	O	O
in	O	O
five	O	O
healthy	O	O
,	O	O
two	O	O
tumour-	O	O
and	O	O
two	O	O
leukoplakia-FA	O	O
patients	O	O
by	O	O
TaqMan-PCR	O	O
confirmed	O	O
the	O	O
prevalence	O	O
of	O	O
M.	O	O
salivarium	O	O
at	O	O
the	O	O
tumour	O	O
sites	O	O
.	O	O

These	O	O
new	O	O
findings	O	O
suggest	O	O
that	O	O
this	O	O
mycoplasma	O	O
species	O	O
with	O	O
its	O	O
reduced	O	O
coding	O	O
capacity	O	O
found	O	O
ideal	O	O
breeding	O	O
grounds	O	O
at	O	O
the	O	O
tumour	O	O
sites	O	O
.	O	O

Interestingly	O	O
,	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
all	O	O
FA	O	O
patients	O	O
and	O	O
especially	O	O
samples	O	O
at	O	O
the	O	O
tumour	O	O
sites	O	O
were	O	O
in	O	O
addition	O	O
positive	O	O
for	O	O
Candida	O	O
albicans	O	O
.	O	O

It	O	O
remains	O	O
to	O	O
be	O	O
elucidated	O	O
in	O	O
further	O	O
studies	O	O
whether	O	O
M.	B-bacteria	B-bacteria
salivarium	E-bacteria	I-bacteria
can	O	O
be	O	O
used	O	O
as	O	O
a	O	O
predictive	O	O
biomarker	O	O
for	O	O
tumour	O	O
development	O	O
in	O	O
these	O	O
patients	O	O
.	O	O

The	O	O
microbiota	O	O
of	O	O
the	O	O
human	O	O
lower	O	O
intestinal	O	O
tract	O	O
helps	O	O
maintain	O	O
healthy	O	O
host	O	O
physiology	O	O
,	O	O
for	O	O
example	O	O
through	O	O
nutrient	O	O
acquisition	O	O
and	O	O
bile	O	O
acid	O	O
recycling	O	O
,	O	O
but	O	O
specific	O	O
positive	O	O
contributions	O	O
of	O	O
the	O	O
oral	O	O
microbiota	O	O
to	O	O
host	O	O
health	O	O
are	O	O
not	O	O
well	O	O
established	O	O
.	O	O

Nitric	O	O
oxide	O	O
(	O	O
NO	O	O
)	O	O
homeostasis	O	O
is	O	O
crucial	O	O
to	O	O
mammalian	O	O
physiology	O	O
.	O	O

The	O	O
recently	O	O
described	O	O
entero-salivary	O	O
nitrate-nitrite-nitric	O	O
oxide	O	O
pathway	O	O
has	O	O
been	O	O
shown	O	O
to	O	O
provide	O	O
bioactive	O	O
NO	O	O
from	O	O
dietary	O	O
nitrate	O	O
sources	O	O
.	O	O

Interestingly	O	O
,	O	O
this	O	O
pathway	O	O
is	O	O
dependent	O	O
upon	O	O
oral	O	O
nitrate-reducing	O	O
bacteria	O	O
,	O	O
since	O	O
humans	O	O
lack	O	O
this	O	O
enzyme	O	O
activity	O	O
.	O	O

This	O	O
pathway	O	O
appears	O	O
to	O	O
represent	O	O
a	O	O
newly	O	O
recognized	O	O
symbiosis	O	O
between	O	O
oral	O	O
nitrate-reducing	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
their	O	O
human	O	O
hosts	O	O
in	O	O
which	O	O
the	O	O
bacteria	O	O
provide	O	O
nitrite	O	O
and	O	O
nitric	O	O
oxide	O	O
from	O	O
nitrate	O	O
reduction	O	O
.	O	O

Here	O	O
we	O	O
measure	O	O
the	O	O
nitrate-reducing	O	O
capacity	O	O
of	O	O
tongue-scraping	O	O
samples	O	O
from	O	O
six	O	O
healthy	O	O
human	O	O
volunteers	O	O
,	O	O
and	O	O
analyze	O	O
metagenomes	O	O
of	O	O
the	O	O
bacterial	O	O
communities	O	O
to	O	O
identify	O	O
bacteria	O	O
contributing	O	O
to	O	O
nitrate	O	O
reduction	O	O
.	O	O

We	O	O
identified	O	O
14	O	O
candidate	O	O
species	O	O
,	O	O
seven	O	O
of	O	O
which	O	O
were	O	O
not	O	O
previously	O	O
believed	O	O
to	O	O
contribute	O	O
to	O	O
nitrate	O	O
reduction	O	O
.	O	O

We	O	O
cultivated	O	O
isolates	O	O
of	O	O
four	O	O
candidate	O	O
species	O	O
in	O	O
single-	O	O
and	O	O
mixed-species	O	O
biofilms	O	O
,	O	O
revealing	O	O
that	O	O
they	O	O
have	O	O
substantial	O	O
nitrate-	O	O
and	O	O
nitrite-reduction	O	O
capabilities	O	O
.	O	O

Colonization	O	O
by	O	O
specific	O	O
oral	O	O
bacteria	O	O
may	O	O
thus	O	O
contribute	O	O
to	O	O
host	O	O
NO	O	O
homeostasis	O	O
by	O	O
providing	O	O
nitrite	O	O
and	O	O
nitric	O	O
oxide	O	O
.	O	O

Conversely	O	O
,	O	O
the	O	O
lack	O	O
of	O	O
specific	O	O
nitrate-reducing	O	O
communities	O	O
may	O	O
disrupt	O	O
the	O	O
nitrate-nitrite-nitric	O	O
oxide	O	O
pathway	O	O
and	O	O
lead	O	O
to	O	O
a	O	O
state	O	O
of	O	O
NO	O	O
insufficiency	O	O
.	O	O

These	O	O
findings	O	O
may	O	O
also	O	O
provide	O	O
mechanistic	O	O
evidence	O	O
for	O	O
the	O	O
oral	O	O
systemic	O	O
link	O	O
.	O	O

Our	O	O
results	O	O
provide	O	O
a	O	O
possible	O	O
new	O	O
therapeutic	O	O
target	O	O
and	O	O
paradigm	O	O
for	O	O
NO	O	O
restoration	O	O
in	O	O
humans	O	O
by	O	O
specific	O	O
oral	O	O
bacteria	O	O
.	O	O

Knowledge	O	O
of	O	O
the	O	O
microbial	O	O
composition	O	O
of	O	O
deciduous	O	O
endodontic	O	O
infections	O	O
is	O	O
limited	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
evaluate	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
10	O	O
oral	O	O
bacterial	O	O
species	O	O
in	O	O
samples	O	O
from	O	O
primary	O	O
tooth	O	O
root	O	O
canals	O	O
by	O	O
using	O	O
microarray	O	O
technology	O	O
and	O	O
to	O	O
determine	O	O
the	O	O
association	O	O
of	O	O
these	O	O
organisms	O	O
with	O	O
clinical	O	O
conditions	O	O
.	O	O

The	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
30	O	O
root	O	O
canals	O	O
of	O	O
primary	O	O
teeth	O	O
with	O	O
primer	O	O
infection	O	O
.	O	O

The	O	O
bacterial	O	O
composition	O	O
of	O	O
the	O	O
samples	O	O
was	O	O
semi-quantitatively	O	O
defined	O	O
using	O	O
a	O	O
microarray	O	O
system	O	O
(	O	O
Parocheck	O	O
)	O	O
.	O	O

All	O	O
the	O	O
tested	O	O
species	O	O
were	O	O
detected	O	O
in	O	O
the	O	O
samples	O	O
.	O	O

Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
frequently	O	O
isolated	O	O
bacterium	O	O
(	O	O
96.7	O	O
%	O	O
)	O	O
,	O	O
followed	O	O
by	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
(	O	O
86.7	O	O
%	O	O
)	O	O
,	O	O
Parvimonas	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
(	O	O
83.3	O	O
%	O	O
)	O	O
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
(	O	O
76.7	O	O
%	O	O
)	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
(	O	O
66.7	O	O
%	O	O
)	O	O
.	O	O

These	O	O
bacteria	O	O
were	O	O
also	O	O
present	O	O
in	O	O
high	O	O
levels	O	O
.	O	O

All	O	O
pairs	O	O
of	O	O
bacterial	O	O
species	O	O
were	O	O
positively	O	O
associated	O	O
(	O	O
RR	O	O
>	O	O
1	O	O
)	O	O
,	O	O
except	O	O
Pintermedia	O	O
and	O	O
P	O	O
>	O	O
micra	O	O
.	O	O

On	O	O
average	O	O
,	O	O
five	O	O
species	O	O
(	O	O
range:3-8	O	O
)	O	O
were	O	O
detected	O	O
per	O	O
amplified	O	O
sample	O	O
.	O	O

Root	O	O
canals	O	O
of	O	O
teeth	O	O
with	O	O
>	O	O
5	O	O
different	O	O
species	O	O
were	O	O
statistically	O	O
associated	O	O
with	O	O
periapical	O	O
radiolucency	O	O
(	O	O
P	O	O
=	O	O
0.049	O	O
)	O	O
.	O	O

Primary	O	O
teeth	O	O
with	O	O
endodontic	O	O
infections	O	O
show	O	O
a	O	O
highly	O	O
diverse	O	O
variety	O	O
of	O	O
bacteria	O	O
,	O	O
in	O	O
which	O	O
the	O	O
most	O	O
prevalent	O	O
specie	O	O
are	O	O
present	O	O
in	O	O
high	O	O
proportions	O	O
.	O	O

The	O	O
well-directed	O	O
use	O	O
of	O	O
the	O	O
improved	O	O
microarray	O	O
technology	O	O
will	O	O
provide	O	O
additional	O	O
valuable	O	O
information	O	O
for	O	O
causative	O	O
factors	O	O
associated	O	O
with	O	O
endodontic	O	O
diseases	O	O
,	O	O
helping	O	O
to	O	O
develop	O	O
more	O	O
successful	O	O
antibacterial	O	O
or	O	O
anti-inflammatory	O	O
treatment	O	O
strategies	O	O
.	O	O

Peanut	O	O
allergy	O	O
(	O	O
PNA	O	O
)	O	O
has	O	O
becoming	O	O
a	O	O
non-negligible	O	O
health	O	O
concern	O	O
worldwide	O	O
.	O	O

Thus	O	O
far	O	O
,	O	O
allergen-specific	O	O
immunotherapy	O	O
aimed	O	O
at	O	O
inducing	O	O
mucosal	O	O
tolerance	O	O
has	O	O
widely	O	O
been	O	O
regarded	O	O
as	O	O
a	O	O
major	O	O
management	O	O
strategy	O	O
for	O	O
PNA	O	O
.	O	O

The	O	O
safety	O	O
profiles	O	O
and	O	O
the	O	O
intrinsic	O	O
probiotic	B-bacteria	B-bacteria
properties	O	O
of	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	I-bacteria	I-bacteria
(	O	O
LAB	B-bacteria	B-bacteria
)	O	O
render	O	O
them	O	O
attractive	O	O
delivery	O	O
vehicles	O	O
for	O	O
mucosal	O	O
vaccines	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
we	O	O
exploited	O	O
genetically	O	O
modified	O	O
Lactococcus	B-bacteria	B-bacteria
lactis	E-bacteria	I-bacteria
to	O	O
produce	O	O
peanut	O	O
allergen	O	O
Ara	O	O
h	O	O
2	O	O
via	O	O
different	O	O
protein-targeting	O	O
systems	O	O
and	O	O
their	O	O
immunomodulatory	O	O
potency	O	O
for	O	O
allergic	O	O
immune	O	O
responses	O	O
in	O	O
mice	O	O
were	O	O
investigated	O	O
.	O	O

By	O	O
comparison	O	O
with	O	O
the	O	O
strain	O	O
expressing	O	O
the	O	O
cytoplasmic	O	O
form	O	O
of	O	O
Ara	O	O
h	O	O
2	O	O
(	O	O
LL1	O	O
)	O	O
,	O	O
the	O	O
strains	O	O
expressing	O	O
the	O	O
secreted	O	O
and	O	O
anchored	O	O
forms	O	O
of	O	O
Ara	O	O
h	O	O
2	O	O
(	O	O
LL2	O	O
and	O	O
LL3	O	O
)	O	O
were	O	O
more	O	O
potent	O	O
in	O	O
redirecting	O	O
a	O	O
Th2-polarized	O	O
to	O	O
a	O	O
non-allergic	O	O
Th1	O	O
immune	O	O
responses	O	O
.	O	O

Induction	O	O
of	O	O
SIgA	O	O
and	O	O
regulatory	O	O
T	O	O
cells	O	O
were	O	O
also	O	O
observed	O	O
at	O	O
the	O	O
local	O	O
levels	O	O
by	O	O
orally	O	O
administration	O	O
of	O	O
recombinant	O	O
L.	B-bacteria	B-bacteria
lactis	E-bacteria	I-bacteria
.	O	O

Our	O	O
results	O	O
indicate	O	O
that	O	O
allergen-producing	O	O
L.	B-bacteria	B-bacteria
lactis	E-bacteria	I-bacteria
strains	O	O
modulated	O	O
allergic	O	O
immune	O	O
responses	O	O
and	O	O
may	O	O
be	O	O
developed	O	O
as	O	O
promising	O	O
mucosal	O	O
vaccines	O	O
for	O	O
managing	O	O
allergic	O	O
diseases	O	O
.	O	O

Atherosclerotic	O	O
vascular	O	O
disease	O	O
is	O	O
a	O	O
leading	O	O
cause	O	O
of	O	O
myocardial	O	O
infarction	O	O
and	O	O
cerebrovascular	O	O
accident	O	O
,	O	O
and	O	O
independent	O	O
associations	O	O
with	O	O
periodontal	O	O
disease	O	O
(	O	O
PD	O	O
)	O	O
are	O	O
reported	O	O
.	O	O

PD	O	O
is	O	O
caused	O	O
by	O	O
polymicrobial	O	O
infections	O	O
and	O	O
aggressive	O	O
immune	O	O
responses	O	O
.	O	O

Genomic	O	O
DNA	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
the	O	O
best-studied	O	O
bacterial	O	O
pathogen	O	O
associated	O	O
with	O	O
severe	O	O
PD	O	O
,	O	O
is	O	O
detected	O	O
within	O	O
atherosclerotic	O	O
plaque	O	O
.	O	O

We	O	O
examined	O	O
causal	O	O
relationships	O	O
between	O	O
chronic	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
oral	O	O
infection	O	O
,	O	O
PD	O	O
,	O	O
and	O	O
atherosclerosis	O	O
in	O	O
hyperlipidemic	O	O
ApoEnull	O	O
mice	O	O
.	O	O

ApoEnull	O	O
mice	O	O
(	O	O
n	O	O
=	O	O
24	O	O
)	O	O
were	O	O
orally	O	O
infected	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
for	O	O
12	O	O
and	O	O
24	O	O
weeks	O	O
.	O	O

PD	O	O
was	O	O
assessed	O	O
by	O	O
standard	O	O
clinical	O	O
measurements	O	O
while	O	O
the	O	O
aorta	O	O
was	O	O
examined	O	O
for	O	O
atherosclerotic	O	O
lesions	O	O
and	O	O
inflammatory	O	O
markers	O	O
by	O	O
array	O	O
.	O	O

Systemic	O	O
inflammatory	O	O
markers	O	O
serum	O	O
amyloid	O	O
A	O	O
,	O	O
nitric	O	O
oxide	O	O
,	O	O
and	O	O
oxidized	O	O
low-density	O	O
lipoprotein	O	O
were	O	O
analyzed	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
infection	O	O
elicited	O	O
specific	O	O
antibodies	O	O
and	O	O
alveolar	O	O
bone	O	O
loss	O	O
.	O	O

Fluorescent	O	O
in	O	O
situ	O	O
hybridization	O	O
detected	O	O
viable	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
within	O	O
oral	O	O
epithelium	O	O
and	O	O
aorta	O	O
,	O	O
and	O	O
genomic	O	O
DNA	O	O
was	O	O
detected	O	O
within	O	O
systemic	O	O
organs	O	O
.	O	O

Aortic	O	O
plaque	O	O
area	O	O
was	O	O
significantly	O	O
increased	O	O
in	O	O
P.	B-bacteria	B-bacteria
gingivalis-infected	E-bacteria	I-bacteria
mice	O	O
at	O	O
24	O	O
weeks	O	O
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

Aortic	O	O
RNA	O	O
and	O	O
protein	O	O
arrays	O	O
indicated	O	O
a	O	O
strong	O	O
Th2	O	O
response	O	O
.	O	O

Chronic	O	O
oral	O	O
infection	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
results	O	O
in	O	O
a	O	O
specific	O	O
immune	O	O
response	O	O
,	O	O
significant	O	O
increases	O	O
in	O	O
oral	O	O
bone	O	O
resorption	O	O
,	O	O
aortic	O	O
inflammation	O	O
,	O	O
viable	O	O
bacteria	O	O
in	O	O
oral	O	O
epithelium	O	O
and	O	O
aorta	O	O
,	O	O
and	O	O
plaque	O	O
development	O	O
.	O	O

Individual	O	O
bacteria	O	O
and	O	O
shifts	O	O
in	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
microbiome	O	O
have	O	O
been	O	O
associated	O	O
with	O	O
human	O	O
diseases	O	O
including	O	O
cancer	O	O
.	O	O

To	O	O
investigate	O	O
changes	O	O
in	O	O
the	O	O
microbiome	O	O
associated	O	O
with	O	O
oral	O	O
cancers	O	O
,	O	O
we	O	O
profiled	O	O
cancers	O	O
and	O	O
anatomically	O	O
matched	O	O
contralateral	O	O
normal	O	O
tissue	O	O
from	O	O
the	O	O
same	O	O
patient	O	O
by	O	O
sequencing	O	O
16S	O	O
rDNA	O	O
hypervariable	O	O
region	O	O
amplicons	O	O
.	O	O

In	O	O
cancer	O	O
samples	O	O
from	O	O
both	O	O
a	O	O
discovery	O	O
and	O	O
a	O	O
subsequent	O	O
confirmation	O	O
cohort	O	O
,	O	O
abundance	O	O
of	O	O
Firmicutes	B-bacteria	B-bacteria
(	O	O
especially	O	O
Streptococcus	B-bacteria	B-bacteria
)	O	O
and	O	O
Actinobacteria	B-bacteria	B-bacteria
(	O	O
especially	O	O
Rothia	B-bacteria	B-bacteria
)	O	O
was	O	O
significantly	O	O
decreased	O	O
relative	O	O
to	O	O
contralateral	O	O
normal	O	O
samples	O	O
from	O	O
the	O	O
same	O	O
patient	O	O
.	O	O

Significant	O	O
decreases	O	O
in	O	O
abundance	O	O
of	O	O
these	O	O
phyla	O	O
were	O	O
observed	O	O
for	O	O
pre-cancers	O	O
,	O	O
but	O	O
not	O	O
when	O	O
comparing	O	O
samples	O	O
from	O	O
contralateral	O	O
sites	O	O
(	O	O
tongue	O	O
and	O	O
floor	O	O
of	O	O
mouth	O	O
)	O	O
from	O	O
healthy	O	O
individuals	O	O
.	O	O

Weighted	O	O
UniFrac	O	O
principal	O	O
coordinates	O	O
analysis	O	O
based	O	O
on	O	O
12	O	O
taxa	O	O
separated	O	O
most	O	O
cancers	O	O
from	O	O
other	O	O
samples	O	O
with	O	O
greatest	O	O
separation	O	O
of	O	O
node	O	O
positive	O	O
cases	O	O
.	O	O

These	O	O
studies	O	O
begin	O	O
to	O	O
develop	O	O
a	O	O
framework	O	O
for	O	O
exploiting	O	O
the	O	O
oral	O	O
microbiome	O	O
for	O	O
monitoring	O	O
oral	O	O
cancer	O	O
development	O	O
,	O	O
progression	O	O
and	O	O
recurrence	O	O
.	O	O

Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
is	O	O
a	O	O
ubiquitous	O	O
member	O	O
of	O	O
the	O	O
human	O	O
oral	O	O
flora	O	O
and	O	O
is	O	O
associated	O	O
with	O	O
the	O	O
development	O	O
of	O	O
periodontitis	O	O
and	O	O
a	O	O
variety	O	O
of	O	O
other	O	O
types	O	O
of	O	O
polymicrobial	O	O
infections	O	O
of	O	O
the	O	O
mucosa	O	O
.	O	O

In	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
this	O	O
species	O	O
is	O	O
one	O	O
of	O	O
the	O	O
few	O	O
that	O	O
is	O	O
prevalent	O	O
in	O	O
both	O	O
healthy	O	O
and	O	O
diseased	O	O
subgingival	O	O
plaque	O	O
.	O	O

Using	O	O
microarray	O	O
analysis	O	O
,	O	O
we	O	O
examined	O	O
the	O	O
transcriptional	O	O
response	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
subspecies	I-bacteria	I-bacteria
nucleatum	E-bacteria	I-bacteria
to	O	O
whole	O	O
blood	O	O
in	O	O
order	O	O
to	O	O
identify	O	O
some	O	O
of	O	O
the	O	O
genetic	O	O
responses	O	O
that	O	O
might	O	O
occur	O	O
during	O	O
the	O	O
transition	O	O
from	O	O
health	O	O
to	O	O
disease	O	O
.	O	O

From	O	O
these	O	O
studies	O	O
,	O	O
we	O	O
identified	O	O
a	O	O
sialic	O	O
acid	O	O
catabolism	O	O
operon	O	O
that	O	O
was	O	O
induced	O	O
by	O	O
the	O	O
presence	O	O
of	O	O
blood	O	O
.	O	O

We	O	O
subsequently	O	O
confirmed	O	O
that	O	O
this	O	O
operon	O	O
was	O	O
inducible	O	O
by	O	O
the	O	O
presence	O	O
of	O	O
synthetic	O	O
sialic	O	O
acid	O	O
,	O	O
but	O	O
we	O	O
found	O	O
no	O	O
evidence	O	O
suggesting	O	O
sialic	O	O
acid	O	O
was	O	O
used	O	O
as	O	O
a	O	O
major	O	O
carbon	O	O
source	O	O
.	O	O

However	O	O
,	O	O
this	O	O
organism	O	O
was	O	O
found	O	O
to	O	O
possess	O	O
a	O	O
de	O	O
novo	O	O
synthesized	O	O
surface	O	O
sialylation	O	O
ability	O	O
that	O	O
is	O	O
widely	O	O
conserved	O	O
among	O	O
the	O	O
various	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
subspecies	E-bacteria	I-bacteria
as	O	O
well	O	O
as	O	O
in	O	O
F.	B-bacteria	B-bacteria
periodonticum	E-bacteria	I-bacteria
.	O	O

We	O	O
provide	O	O
evidence	O	O
that	O	O
fusobacterial	O	O
sialylation	O	O
does	O	O
occur	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
irrespective	O	O
of	O	O
health	O	O
status	O	O
.	O	O

Interestingly	O	O
,	O	O
only	O	O
a	O	O
minority	O	O
of	O	O
fusobacterial	O	O
cells	O	O
exhibit	O	O
surface	O	O
sialylation	O	O
within	O	O
dental	O	O
plaque	O	O
,	O	O
whereas	O	O
most	O	O
cells	O	O
are	O	O
uniformly	O	O
sialylated	O	O
when	O	O
grown	O	O
in	O	O
pure	O	O
culture	O	O
.	O	O

The	O	O
implications	O	O
of	O	O
these	O	O
results	O	O
are	O	O
discussed	O	O
.	O	O

Many	O	O
viruses	O	O
,	O	O
fungi	O	O
and	O	O
bacteria	O	O
inhabit	O	O
the	O	O
mouth	O	O
.	O	O

Most	O	O
of	O	O
these	O	O
microorganisms	O	O
can	O	O
be	O	O
easily	O	O
cultured	O	O
and	O	O
identified	O	O
by	O	O
classical	O	O
microbiological	O	O
tests	O	O
,	O	O
but	O	O
some	O	O
of	O	O
them	O	O
,	O	O
such	O	O
as	O	O
human	O	O
papilloma	O	O
virus	O	O
,	O	O
can	O	O
only	O	O
be	O	O
identified	O	O
by	O	O
the	O	O
methods	O	O
of	O	O
molecular	O	O
biology	O	O
.	O	O

Some	O	O
microorganisms	O	O
are	O	O
present	O	O
in	O	O
a	O	O
very	O	O
small	O	O
amount	O	O
and	O	O
can	O	O
not	O	O
be	O	O
detected	O	O
by	O	O
classical	O	O
tests	O	O
;	O	O
therefore	O	O
,	O	O
in	O	O
this	O	O
case	O	O
,	O	O
molecular	O	O
diagnosis	O	O
is	O	O
also	O	O
a	O	O
logical	O	O
alternative	O	O
.	O	O

Molecular	O	O
biology	O	O
assays	O	O
are	O	O
sensitive	O	O
,	O	O
objective	O	O
,	O	O
easy	O	O
to	O	O
perform	O	O
and	O	O
less	O	O
demanding	O	O
than	O	O
conventional	O	O
microbiological	O	O
methods	O	O
in	O	O
terms	O	O
of	O	O
training	O	O
and	O	O
quality	O	O
assurance	O	O
.	O	O

This	O	O
paper	O	O
describes	O	O
the	O	O
molecular	O	O
methods	O	O
that	O	O
are	O	O
commonly	O	O
used	O	O
for	O	O
the	O	O
detection	O	O
of	O	O
microorganisms	O	O
that	O	O
colonize	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

In	O	O
leukemia	O	O
,	O	O
oral	O	O
manifestations	O	O
indicate	O	O
aberrations	O	O
in	O	O
oral	O	O
microbiota	O	O
.	O	O

Microbiota	O	O
structure	O	O
is	O	O
determined	O	O
by	O	O
both	O	O
host	O	O
and	O	O
environmental	O	O
factors	O	O
.	O	O

In	O	O
human	O	O
hosts	O	O
,	O	O
how	O	O
health	O	O
status	O	O
shapes	O	O
the	O	O
composition	O	O
of	O	O
oral	O	O
microbiota	O	O
is	O	O
largely	O	O
unknown	O	O
.	O	O

Taking	O	O
advantage	O	O
of	O	O
advances	O	O
in	O	O
high-throughput	O	O
sequencing	O	O
,	O	O
we	O	O
compared	O	O
the	O	O
composition	O	O
of	O	O
supragingival	O	O
plaque	O	O
microbiota	O	O
of	O	O
acute	O	O
lymphoblastic	O	O
leukemia	O	O
(	O	O
ALL	O	O
)	O	O
pediatric	O	O
patients	O	O
with	O	O
healthy	O	O
controls	O	O
.	O	O

The	O	O
oral	O	O
microbiota	O	O
of	O	O
leukemia	O	O
patients	O	O
had	O	O
lower	O	O
richness	O	O
and	O	O
less	O	O
diversity	O	O
compared	O	O
to	O	O
healthy	O	O
controls	O	O
.	O	O

Microbial	O	O
samples	O	O
clustered	O	O
into	O	O
two	O	O
major	O	O
groups	O	O
,	O	O
one	O	O
of	O	O
ALL	O	O
patients	O	O
and	O	O
another	O	O
of	O	O
healthy	O	O
children	O	O
,	O	O
with	O	O
different	O	O
structure	O	O
and	O	O
composition	O	O
.	O	O

Abundance	O	O
changes	O	O
of	O	O
certain	O	O
taxa	O	O
including	O	O
the	O	O
Phylum	B-bacteria	B-bacteria
Firmicutes	E-bacteria	I-bacteria
,	O	O
the	O	O
Class	B-bacteria	B-bacteria
Bacilli	E-bacteria	I-bacteria
,	O	O
the	O	O
Order	B-bacteria	B-bacteria
Lactobacillales	E-bacteria	I-bacteria
,	O	O
the	O	O
Family	B-bacteria	B-bacteria
Aerococcaceae	E-bacteria	I-bacteria
and	O	O
Carnobacteriaceae	B-bacteria	B-bacteria
,	O	O
as	O	O
well	O	O
as	O	O
the	O	O
Genus	B-bacteria	B-bacteria
Abiotrophia	E-bacteria	I-bacteria
and	O	O
Granulicatella	B-bacteria	B-bacteria
were	O	O
associated	O	O
with	O	O
leukemia	O	O
status	O	O
.	O	O

ALL	O	O
patients	O	O
demonstrated	O	O
a	O	O
structural	O	O
imbalance	O	O
of	O	O
the	O	O
oral	O	O
microbiota	O	O
,	O	O
characterized	O	O
by	O	O
reduced	O	O
diversity	O	O
and	O	O
abundance	O	O
alterations	O	O
,	O	O
possibly	O	O
involved	O	O
in	O	O
systemic	O	O
infections	O	O
,	O	O
indicating	O	O
the	O	O
importance	O	O
of	O	O
immune	O	O
status	O	O
in	O	O
shaping	O	O
the	O	O
structure	O	O
of	O	O
oral	O	O
microbiota	O	O
.	O	O

Nature	O	O
is	O	O
an	O	O
unexplored	O	O
reservoir	O	O
of	O	O
novel	O	O
phytopharmaceuticals	O	O
.	O	O

Since	O	O
biofilm-related	O	O
oral	O	O
diseases	O	O
often	O	O
correlate	O	O
with	O	O
antibiotic	O	O
resistance	O	O
,	O	O
plant-derived	O	O
antimicrobial	O	O
agents	O	O
could	O	O
enhance	O	O
existing	O	O
treatment	O	O
options	O	O
.	O	O

Therefore	O	O
,	O	O
the	O	O
rationale	O	O
of	O	O
the	O	O
present	O	O
report	O	O
was	O	O
to	O	O
examine	O	O
the	O	O
antimicrobial	O	O
impact	O	O
of	O	O
Mediterranean	O	O
natural	O	O
extracts	O	O
on	O	O
oral	O	O
microorganisms	O	O
.	O	O

Five	O	O
different	O	O
extracts	O	O
from	O	O
Olea	O	O
europaea	O	O
,	O	O
mastic	O	O
gum	O	O
,	O	O
and	O	O
Inula	O	O
viscosa	O	O
were	O	O
tested	O	O
against	O	O
ten	O	O
bacteria	O	O
and	O	O
one	O	O
Candida	O	O
albicans	O	O
strain	O	O
.	O	O

The	O	O
extraction	O	O
protocols	O	O
were	O	O
conducted	O	O
according	O	O
to	O	O
established	O	O
experimental	O	O
procedures	O	O
.	O	O

Two	O	O
antimicrobial	O	O
assays	O	O
--	O	O
the	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
assay	O	O
and	O	O
the	O	O
minimum	O	O
bactericidal	O	O
concentration	O	O
(	O	O
MBC	O	O
)	O	O
assay	O	O
--	O	O
were	O	O
applied	O	O
.	O	O

The	O	O
screened	O	O
extracts	O	O
were	O	O
found	O	O
to	O	O
be	O	O
active	O	O
against	O	O
each	O	O
of	O	O
the	O	O
tested	O	O
microorganisms	O	O
.	O	O

O.	O	O
europaea	O	O
presented	O	O
MIC	O	O
and	O	O
MBC	O	O
ranges	O	O
of	O	O
0.07-10.00	O	O
mg	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
and	O	O
0.60-10.00	O	O
mg	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
mean	O	O
MBC	O	O
values	O	O
for	O	O
mastic	O	O
gum	O	O
and	O	O
I.	O	O
viscosa	O	O
were	O	O
0.07-10.00	O	O
mg	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
and	O	O
0.15-10.00	O	O
mg	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
,	O	O
respectively	O	O
.	O	O

Extracts	O	O
were	O	O
less	O	O
effective	O	O
against	O	O
C.	O	O
albicans	O	O
and	O	O
exerted	O	O
bactericidal	O	O
effects	O	O
at	O	O
a	O	O
concentration	O	O
range	O	O
of	O	O
0.07-5.00	O	O
mg	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
on	O	O
strict	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
and	O	O
Parvimonas	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
)	O	O
.	O	O

Ethyl	O	O
acetate	O	O
I.	O	O
viscosa	O	O
extract	O	O
and	O	O
total	O	O
mastic	O	O
extract	O	O
showed	O	O
considerable	O	O
antimicrobial	O	O
activity	O	O
against	O	O
oral	O	O
microorganisms	O	O
and	O	O
could	O	O
therefore	O	O
be	O	O
considered	O	O
as	O	O
alternative	O	O
natural	O	O
anti-infectious	O	O
agents	O	O
.	O	O

Oral	O	O
bacteria	O	O
live	O	O
in	O	O
symbiosis	O	O
with	O	O
the	O	O
host	O	O
.	O	O

Therefore	O	O
,	O	O
when	O	O
mouthwashes	O	O
are	O	O
indicated	O	O
,	O	O
selective	O	O
inhibition	O	O
of	O	O
taxa	O	O
contributing	O	O
to	O	O
disease	O	O
is	O	O
preferred	O	O
instead	O	O
of	O	O
broad-spectrum	O	O
antimicrobials	O	O
.	O	O

The	O	O
potential	O	O
selectivity	O	O
of	O	O
an	O	O
oxygenating	O	O
mouthwash	O	O
,	O	O
Ardox-X	O	O
(	O	O
R	O	O
)	O	O
(	O	O
AX	O	O
)	O	O
,	O	O
has	O	O
not	O	O
been	O	O
assessed	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
the	O	O
antimicrobial	O	O
potential	O	O
of	O	O
AX	O	O
and	O	O
the	O	O
effects	O	O
of	O	O
a	O	O
twice-daily	O	O
oral	O	O
rinse	O	O
on	O	O
dental	O	O
plaque	O	O
composition	O	O
.	O	O

In	O	O
vitro	O	O
,	O	O
16	O	O
oral	O	O
bacterial	O	O
strains	O	O
were	O	O
tested	O	O
using	O	O
agar	O	O
diffusion	O	O
susceptibility	O	O
,	O	O
minimum	O	O
inhibitory	O	O
and	O	O
minimum	O	O
bactericidal	O	O
concentration	O	O
tests	O	O
.	O	O

A	O	O
pilot	O	O
clinical	O	O
study	O	O
was	O	O
performed	O	O
with	O	O
25	O	O
healthy	O	O
volunteers	O	O
.	O	O

Clinical	O	O
assessments	O	O
and	O	O
microbiological	O	O
sampling	O	O
of	O	O
supragingival	O	O
plaque	O	O
were	O	O
performed	O	O
at	O	O
1	O	O
month	O	O
before	O	O
the	O	O
experiment	O	O
(	O	O
Pre-exp	O	O
)	O	O
,	O	O
at	O	O
the	O	O
start	O	O
of	O	O
the	O	O
experiment	O	O
(	O	O
Baseline	O	O
)	O	O
and	O	O
after	O	O
the	O	O
one-week	O	O
experimental	O	O
period	O	O
(	O	O
Post-exp	O	O
)	O	O
.	O	O

During	O	O
the	O	O
experiment	O	O
individuals	O	O
used	O	O
AX	O	O
mouthwash	O	O
twice	O	O
daily	O	O
in	O	O
absence	O	O
of	O	O
other	O	O
oral	O	O
hygiene	O	O
measures	O	O
.	O	O

The	O	O
microbiological	O	O
composition	O	O
of	O	O
plaque	O	O
was	O	O
assessed	O	O
by	O	O
16S	O	O
rRNA	O	O
gene	O	O
amplicon	O	O
sequencing	O	O
.	O	O

AX	O	O
showed	O	O
high	O	O
inter-species	O	O
variation	O	O
in	O	O
microbial	O	O
growth	O	O
inhibition	O	O
.	O	O

The	O	O
tested	O	O
Prevotella	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
showed	O	O
the	O	O
highest	O	O
sensitivity	O	O
,	O	O
while	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
were	O	O
most	O	O
resistant	O	O
to	O	O
AX	O	O
.	O	O

Plaque	O	O
scores	O	O
at	O	O
Pre-exp	O	O
and	O	O
Baseline	O	O
visits	O	O
did	O	O
not	O	O
differ	O	O
significantly	O	O
(	O	O
p	O	O
=	O	O
0.193	O	O
)	O	O
,	O	O
nor	O	O
did	O	O
the	O	O
microbial	O	O
composition	O	O
of	O	O
plaque	O	O
.	O	O

During	O	O
a	O	O
period	O	O
of	O	O
7-days	O	O
non-brushing	O	O
but	O	O
twice	O	O
daily	O	O
rinsing	O	O
plaque	O	O
scores	O	O
increased	O	O
from	O	O
2.21	O	O
(	O	O
0.31	O	O
)	O	O
at	O	O
Baseline	O	O
to	O	O
2.43	O	O
(	O	O
0.39	O	O
)	O	O
Post-exp	O	O
.	O	O

A	O	O
significant	O	O
microbial	O	O
shift	O	O
in	O	O
composition	O	O
was	O	O
observed	O	O
:	O	O
genus	B-bacteria	B-bacteria
Streptococcus	E-bacteria	I-bacteria
and	O	O
Veillonella	B-bacteria	B-bacteria
increased	O	O
while	O	O
Corynebacterium	B-bacteria	B-bacteria
,	O	O
Haemophilus	B-bacteria	B-bacteria
,	O	O
Leptotrichia	B-bacteria	B-bacteria
,	O	O
Cardiobacterium	B-bacteria	B-bacteria
and	O	O
Capnocytophaga	B-bacteria	B-bacteria
decreased	O	O
(	O	O
p	O	O
<	O	O
/=	O	O
0.001	O	O
)	O	O
.	O	O

AX	O	O
has	O	O
the	O	O
potential	O	O
for	O	O
selective	O	O
inhibition	O	O
of	O	O
oral	O	O
bacteria	O	O
.	O	O

The	O	O
shift	O	O
in	O	O
oral	O	O
microbiome	O	O
after	O	O
1	O	O
week	O	O
of	O	O
rinsing	O	O
deserves	O	O
further	O	O
research	O	O
.	O	O

Sharks	O	O
possess	O	O
a	O	O
variety	O	O
of	O	O
pathogenic	O	O
bacteria	O	O
in	O	O
their	O	O
oral	O	O
cavity	O	O
that	O	O
may	O	O
potentially	O	O
be	O	O
transferred	O	O
into	O	O
humans	O	O
during	O	O
a	O	O
bite	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
presented	O	O
study	O	O
focused	O	O
on	O	O
the	O	O
identification	O	O
of	O	O
the	O	O
bacteria	O	O
present	O	O
in	O	O
the	O	O
mouths	O	O
of	O	O
live	O	O
blacktip	O	O
sharks	O	O
,	O	O
Carcharhinus	O	O
limbatus	O	O
,	O	O
and	O	O
the	O	O
extent	O	O
that	O	O
these	O	O
bacteria	O	O
possess	O	O
multi-drug	O	O
resistance	O	O
.	O	O

Swabs	O	O
were	O	O
taken	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
nineteen	O	O
live	O	O
blacktip	O	O
sharks	O	O
,	O	O
which	O	O
were	O	O
subsequently	O	O
released	O	O
.	O	O

The	O	O
average	O	O
fork	O	O
length	O	O
was	O	O
146	O	O
cm	O	O
(	O	O
+/-11	O	O
)	O	O
,	O	O
suggesting	O	O
the	O	O
blacktip	O	O
sharks	O	O
were	O	O
mature	O	O
adults	O	O
at	O	O
least	O	O
8	O	O
years	O	O
old	O	O
.	O	O

All	O	O
swabs	O	O
underwent	O	O
standard	O	O
microbiological	O	O
work-up	O	O
with	O	O
identification	O	O
of	O	O
organisms	O	O
and	O	O
reporting	O	O
of	O	O
antibiotic	O	O
susceptibilities	O	O
using	O	O
an	O	O
automated	O	O
microbiology	O	O
system	O	O
.	O	O

The	O	O
oral	O	O
samples	O	O
revealed	O	O
an	O	O
average	O	O
of	O	O
2.72	O	O
(	O	O
+/-1.4	O	O
)	O	O
bacterial	O	O
isolates	O	O
per	O	O
shark	O	O
.	O	O

Gram-negative	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
making	O	O
up	O	O
61	O	O
%	O	O
of	O	O
all	O	O
bacterial	O	O
isolates	O	O
,	O	O
were	O	O
significantly	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
more	O	O
common	O	O
than	O	O
gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
39	O	O
%	O	O
)	O	O
.	O	O

The	O	O
most	O	O
common	O	O
organisms	O	O
were	O	O
Vibrio	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
28	O	O
%	O	O
)	O	O
,	O	O
various	O	O
coagulase-negative	B-bacteria	B-bacteria
Staphylococcus	I-bacteria	I-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
16	O	O
%	O	O
)	O	O
,	O	O
and	O	O
Pasteurella	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

(	O	O
12	O	O
%	O	O
)	O	O
.	O	O

The	O	O
overall	O	O
resistance	O	O
rate	O	O
was	O	O
12	O	O
%	O	O
for	O	O
all	O	O
antibiotics	O	O
tested	O	O
with	O	O
nearly	O	O
43	O	O
%	O	O
of	O	O
bacteria	O	O
resistant	O	O
to	O	O
at	O	O
least	O	O
one	O	O
antibiotic	O	O
.	O	O

Multi-drug	O	O
resistance	O	O
was	O	O
seen	O	O
in	O	O
4	O	O
%	O	O
of	O	O
bacteria	O	O
.	O	O

No	O	O
association	O	O
between	O	O
shark	O	O
gender	O	O
or	O	O
fork	O	O
length	O	O
with	O	O
bacterial	O	O
density	O	O
or	O	O
antibiotic	O	O
resistance	O	O
was	O	O
observed	O	O
.	O	O

Antibiotics	O	O
with	O	O
the	O	O
highest	O	O
overall	O	O
susceptibility	O	O
rates	O	O
included	O	O
fluoroquinolones	O	O
,	O	O
3rd	O	O
generation	O	O
cephalosporins	O	O
and	O	O
sulfamethoxazole/trimethoprim	O	O
.	O	O

Recommended	O	O
empiric	O	O
antimicrobial	O	O
therapy	O	O
for	O	O
adult	O	O
blacktip	O	O
shark	O	O
bites	O	O
should	O	O
encompass	O	O
either	O	O
a	O	O
fluoroquinolone	O	O
or	O	O
combination	O	O
of	O	O
a	O	O
3rd	O	O
generation	O	O
cephalosporin	O	O
plus	O	O
doxycycline	O	O
.	O	O

Dental	O	O
caries	O	O
is	O	O
one	O	O
of	O	O
the	O	O
most	O	O
common	O	O
chronic	O	O
and	O	O
multifactorial	O	O
diseases	O	O
affecting	O	O
the	O	O
human	O	O
population	O	O
.	O	O

The	O	O
appearance	O	O
of	O	O
a	O	O
caries	O	O
lesion	O	O
is	O	O
determined	O	O
by	O	O
the	O	O
coexistence	O	O
of	O	O
three	O	O
main	O	O
factors	O	O
:	O	O
acidogenic	O	O
and	O	O
acidophilic	O	O
microorganisms	O	O
,	O	O
carbohydrates	O	O
derived	O	O
from	O	O
the	O	O
diet	O	O
,	O	O
and	O	O
host	O	O
factors	O	O
.	O	O

Socio-economic	O	O
and	O	O
behavioral	O	O
factors	O	O
also	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
etiology	O	O
of	O	O
the	O	O
disease	O	O
.	O	O

Caries	O	O
develops	O	O
as	O	O
a	O	O
result	O	O
of	O	O
an	O	O
ecological	O	O
imbalance	O	O
in	O	O
the	O	O
stable	O	O
oral	O	O
microbiom	O	O
.	O	O

Oral	O	O
microorganisms	O	O
form	O	O
dental	O	O
plaque	O	O
on	O	O
the	O	O
surfaces	O	O
of	O	O
teeth	O	O
,	O	O
which	O	O
is	O	O
the	O	O
cause	O	O
of	O	O
the	O	O
caries	O	O
process	O	O
,	O	O
and	O	O
shows	O	O
features	O	O
of	O	O
the	O	O
classic	O	O
biofilm	O	O
.	O	O

Biofilm	O	O
formation	O	O
appears	O	O
to	O	O
be	O	O
influenced	O	O
by	O	O
large	O	O
scale	O	O
changes	O	O
in	O	O
protein	O	O
expression	O	O
over	O	O
time	O	O
and	O	O
under	O	O
genetic	O	O
control	O	O
Cariogenic	O	O
microorganisms	O	O
produce	O	O
lactic	O	O
,	O	O
formic	O	O
,	O	O
acetic	O	O
and	O	O
propionic	O	O
acids	O	O
,	O	O
which	O	O
are	O	O
a	O	O
product	O	O
of	O	O
carbohydrate	O	O
metabolism	O	O
.	O	O

Their	O	O
presence	O	O
causes	O	O
a	O	O
decrease	O	O
in	O	O
pH	O	O
level	O	O
below	O	O
5.5	O	O
,	O	O
resulting	O	O
in	O	O
demineralization	O	O
of	O	O
enamel	O	O
hydroxyapatite	O	O
crystals	O	O
and	O	O
proteolytic	O	O
breakdown	O	O
of	O	O
the	O	O
structure	O	O
of	O	O
tooth	O	O
hard	O	O
tissues	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
other	O	O
streptococci	B-bacteria	B-bacteria
of	O	O
the	O	O
so-called	O	O
non-mutans	B-bacteria	B-bacteria
streptococci	I-bacteria	I-bacteria
group	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
play	O	O
a	O	O
key	O	O
role	O	O
in	O	O
this	O	O
process	O	O
.	O	O

Dental	O	O
biofilm	O	O
is	O	O
a	O	O
dynamic	O	O
,	O	O
constantly	O	O
active	O	O
metabolically	O	O
structure	O	O
.	O	O

The	O	O
alternating	O	O
processes	O	O
of	O	O
decrease	O	O
and	O	O
increase	O	O
of	O	O
biofilm	O	O
pH	O	O
occur	O	O
,	O	O
which	O	O
are	O	O
followed	O	O
by	O	O
the	O	O
respective	O	O
processes	O	O
of	O	O
de-	O	O
and	O	O
remineralisation	O	O
of	O	O
the	O	O
tooth	O	O
surface	O	O
.	O	O

In	O	O
healthy	O	O
conditions	O	O
,	O	O
these	O	O
processes	O	O
are	O	O
in	O	O
balance	O	O
and	O	O
no	O	O
permanent	O	O
damage	O	O
to	O	O
the	O	O
tooth	O	O
enamel	O	O
surface	O	O
occurs	O	O
.	O	O

High	O	O
throughput	O	O
sequencing	O	O
has	O	O
accelerated	O	O
knowledge	O	O
on	O	O
the	O	O
oral	O	O
microbiome	O	O
.	O	O

While	O	O
the	O	O
bacterial	O	O
component	O	O
of	O	O
oral	O	O
communities	O	O
has	O	O
been	O	O
extensively	O	O
characterized	O	O
,	O	O
the	O	O
role	O	O
of	O	O
the	O	O
fungal	O	O
microbiota	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
largely	O	O
unknown	O	O
.	O	O

Interactions	O	O
among	O	O
fungi	O	O
and	O	O
bacteria	O	O
are	O	O
likely	O	O
to	O	O
influence	O	O
oral	O	O
health	O	O
as	O	O
exemplified	O	O
by	O	O
the	O	O
synergistic	O	O
relationship	O	O
between	O	O
Candida	O	O
albicans	O	O
and	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

In	O	O
this	O	O
perspective	O	O
,	O	O
we	O	O
discuss	O	O
the	O	O
current	O	O
state	O	O
of	O	O
the	O	O
field	O	O
of	O	O
fungal-bacterial	O	O
interactions	O	O
in	O	O
the	O	O
context	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

We	O	O
highlight	O	O
the	O	O
need	O	O
to	O	O
conduct	O	O
longitudinal	O	O
clinical	O	O
studies	O	O
to	O	O
simultaneously	O	O
characterize	O	O
the	O	O
bacterial	O	O
and	O	O
fungal	O	O
components	O	O
of	O	O
the	O	O
human	O	O
oral	O	O
microbiome	O	O
in	O	O
health	O	O
and	O	O
during	O	O
disease	O	O
progression	O	O
.	O	O

Such	O	O
studies	O	O
need	O	O
to	O	O
be	O	O
coupled	O	O
with	O	O
investigations	O	O
using	O	O
disease-relevant	O	O
models	O	O
to	O	O
mechanistically	O	O
test	O	O
the	O	O
associations	O	O
observed	O	O
in	O	O
humans	O	O
and	O	O
eventually	O	O
identify	O	O
fungal-bacterial	O	O
interactions	O	O
that	O	O
could	O	O
serve	O	O
as	O	O
preventive	O	O
or	O	O
therapeutic	O	O
targets	O	O
for	O	O
oral	O	O
diseases	O	O
.	O	O

Antrodia	O	O
camphorata	O	O
(	O	O
A.	O	O
camphorata	O	O
)	O	O
is	O	O
a	O	O
unique	O	O
,	O	O
endemic	O	O
and	O	O
extremely	O	O
rare	O	O
mushroom	O	O
species	O	O
native	O	O
to	O	O
Taiwan	O	O
,	O	O
and	O	O
both	O	O
crude	O	O
extracts	O	O
of	O	O
and	O	O
purified	O	O
chemical	O	O
compounds	O	O
from	O	O
A.	O	O
camphorata	O	O
have	O	O
been	O	O
reported	O	O
to	O	O
have	O	O
a	O	O
variety	O	O
of	O	O
significant	O	O
beneficial	O	O
effects	O	O
,	O	O
such	O	O
as	O	O
anti-tumor	O	O
and	O	O
anti-inflammatory	O	O
activity	O	O
.	O	O

However	O	O
,	O	O
reports	O	O
on	O	O
the	O	O
effects	O	O
of	O	O
A.	O	O
camphorata	O	O
against	O	O
dental	O	O
pathogens	O	O
have	O	O
been	O	O
limited	O	O
.	O	O

Oral	O	O
health	O	O
is	O	O
now	O	O
recognized	O	O
as	O	O
important	O	O
for	O	O
overall	O	O
general	O	O
health	O	O
,	O	O
including	O	O
conditions	O	O
such	O	O
as	O	O
dental	O	O
caries	O	O
,	O	O
periodontal	O	O
disease	O	O
and	O	O
rheumatoid	O	O
arthritis	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
)	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
)	O	O
are	O	O
the	O	O
most	O	O
common	O	O
bacteria	O	O
associated	O	O
with	O	O
dental	O	O
plaque	O	O
and	O	O
periodontopathic	O	O
diseases	O	O
,	O	O
respectively	O	O
.	O	O

Thus	O	O
,	O	O
our	O	O
study	O	O
examined	O	O
the	O	O
ability	O	O
of	O	O
five	O	O
various	O	O
crude	O	O
extracts	O	O
of	O	O
A.	O	O
camphorata	O	O
to	O	O
inhibit	O	O
the	O	O
growth	O	O
of	O	O
dental	O	O
bacteria	O	O
and	O	O
anti-adherence	O	O
in	O	O
vitro	O	O
.	O	O

Among	O	O
the	O	O
extracts	O	O
,	O	O
the	O	O
ethanol	O	O
,	O	O
ethyl	O	O
acetate	O	O
and	O	O
chloroform	O	O
extracts	O	O
exhibited	O	O
the	O	O
lowest	O	O
MICs	O	O
against	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
MIC	O	O
=	O	O
4	O	O
approximately	O	O
16	O	O
microg/mL	O	O
)	O	O
.	O	O

The	O	O
MIC	O	O
of	O	O
the	O	O
aqueous	O	O
extract	O	O
was	O	O
greater	O	O
than	O	O
2048	O	O
microg/mL	O	O
against	O	O
both	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

In	O	O
vitro	O	O
adherence	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
significantly	O	O
inhibited	O	O
by	O	O
the	O	O
addition	O	O
of	O	O
either	O	O
the	O	O
ethyl	O	O
acetate	O	O
extract	O	O
or	O	O
chloroform	O	O
extract	O	O
(	O	O
MIC	O	O
=	O	O
16	O	O
approximately	O	O
24	O	O
microg/mL	O	O
)	O	O
,	O	O
while	O	O
the	O	O
ethanol	O	O
extract	O	O
(	O	O
MIC	O	O
=	O	O
32	O	O
approximately	O	O
64	O	O
microg/mL	O	O
)	O	O
exhibited	O	O
moderate	O	O
inhibitory	O	O
activity	O	O
.	O	O

Based	O	O
on	O	O
the	O	O
result	O	O
of	O	O
this	O	O
study	O	O
,	O	O
the	O	O
ethyl	O	O
acetate	O	O
and	O	O
chloroform	O	O
extracts	O	O
of	O	O
A.	O	O
camphorata	O	O
may	O	O
be	O	O
good	O	O
candidates	O	O
for	O	O
oral	O	O
hygiene	O	O
agents	O	O
to	O	O
control	O	O
dental	O	O
caries	O	O
and	O	O
periodontopathic	O	O
conditions	O	O
.	O	O

Chlorhexidine	O	O
(	O	O
CHX	O	O
)	O	O
is	O	O
a	O	O
widely	O	O
used	O	O
antimicrobial	O	O
agent	O	O
in	O	O
dentistry	O	O
.	O	O

Herein	O	O
,	O	O
we	O	O
report	O	O
the	O	O
synthesis	O	O
of	O	O
a	O	O
novel	O	O
mesoporous	O	O
silica	O	O
nanoparticle-encapsulated	O	O
pure	O	O
CHX	O	O
(	O	O
Nano-CHX	O	O
)	O	O
,	O	O
and	O	O
its	O	O
mechanical	O	O
profile	O	O
and	O	O
antimicrobial	O	O
properties	O	O
against	O	O
oral	O	O
biofilms	O	O
.	O	O

The	O	O
release	O	O
of	O	O
CHX	O	O
from	O	O
the	O	O
Nano-CHX	O	O
was	O	O
characterized	O	O
by	O	O
UV/visible	O	O
absorption	O	O
spectroscopy	O	O
.	O	O

The	O	O
antimicrobial	O	O
properties	O	O
of	O	O
Nano-CHX	O	O
were	O	O
evaluated	O	O
in	O	O
both	O	O
planktonic	O	O
and	O	O
biofilm	O	O
modes	O	O
of	O	O
representative	O	O
oral	O	O
pathogenic	O	O
bacteria	O	O
.	O	O

The	O	O
Nano-CHX	O	O
demonstrated	O	O
potent	O	O
antibacterial	O	O
effects	O	O
on	O	O
planktonic	O	O
bacteria	O	O
and	O	O
mono-species	O	O
biofilms	O	O
at	O	O
the	O	O
concentrations	O	O
of	O	O
50-200	O	O
microg/mL	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
Enterococccus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
.	O	O

Moreover	O	O
,	O	O
Nano-CHX	O	O
effectively	O	O
suppressed	O	O
multi-species	O	O
biofilms	O	O
such	O	O
as	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
up	O	O
to	O	O
72	O	O
h.	O	O
This	O	O
pioneering	O	O
study	O	O
demonstrates	O	O
the	O	O
potent	O	O
antibacterial	O	O
effects	O	O
of	O	O
the	O	O
Nano-CHX	O	O
on	O	O
oral	O	O
biofilms	O	O
,	O	O
and	O	O
it	O	O
may	O	O
be	O	O
developed	O	O
as	O	O
a	O	O
novel	O	O
and	O	O
promising	O	O
anti-biofilm	O	O
agent	O	O
for	O	O
clinical	O	O
use	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
infections	O	O
caused	O	O
by	O	O
Cefotaximase-Munich	O	O
(	O	O
CTX-M	O	O
)	O	O
-type	O	O
extended-spectrum	B-bacteria	B-bacteria
beta-lactamase-producing	I-bacteria	I-bacteria
Enterobacteriaceae	E-bacteria	I-bacteria
(	O	O
ESBL-E	B-bacteria	B-bacteria
)	O	O
has	O	O
rapidly	O	O
increased	O	O
during	O	O
the	O	O
past	O	O
15	O	O
years	O	O
.	O	O

Enterobacteriaceae	B-bacteria	B-bacteria
are	O	O
commonly	O	O
found	O	O
in	O	O
the	O	O
gastrointestinal	O	O
tract	O	O
and	O	O
long-term	O	O
intestinal	O	O
carriage	O	O
is	O	O
considered	O	O
important	O	O
for	O	O
the	O	O
spread	O	O
of	O	O
ESBL	O	O
and	O	O
as	O	O
a	O	O
source	O	O
of	O	O
clinical	O	O
infections	O	O
.	O	O

Oral	O	O
biofilm	O	O
such	O	O
as	O	O
supragingival	O	O
plaque	O	O
is	O	O
known	O	O
to	O	O
contain	O	O
numerous	O	O
antibiotic	O	O
resistance	O	O
determinants	O	O
and	O	O
may	O	O
also	O	O
represent	O	O
a	O	O
poorly	O	O
investigated	O	O
site	O	O
for	O	O
ESBL	O	O
carriage	O	O
and	O	O
further	O	O
spread	O	O
.	O	O

To	O	O
investigate	O	O
possible	O	O
carriage	O	O
of	O	O
ESBL-producing	O	O
bacteria	O	O
in	O	O
supragingival	O	O
plaque	O	O
of	O	O
known	O	O
fecal	O	O
carriers	O	O
of	O	O
these	O	O
bacteria	O	O
.	O	O

We	O	O
screened	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
aerobic	O	O
and	O	O
anaerobic	O	O
ESBL-producing	O	O
bacteria	O	O
and	O	O
bla	O	O
CTX-M	O	O
in	O	O
supragingival	O	O
plaque	O	O
samples	O	O
from	O	O
healthy	O	O
human	O	O
adults	O	O
with	O	O
culture-verified	O	O
fecal	O	O
carriage	O	O
of	O	O
CTX-M-producing	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
.	O	O

The	O	O
presence	O	O
or	O	O
absence	O	O
of	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
and	O	O
ESBL-producing	O	O
bacteria	O	O
in	O	O
plaque	O	O
samples	O	O
was	O	O
evaluated	O	O
using	O	O
culture-based	O	O
methods	O	O
and	O	O
consensus	O	O
CTX-M	O	O
PCR	O	O
.	O	O

Oral	O	O
samples	O	O
were	O	O
obtained	O	O
from	O	O
17	O	O
participants	O	O
with	O	O
known	O	O
previous	O	O
carriage	O	O
of	O	O
ESBL-producing	B-bacteria	B-bacteria
E.	I-bacteria	I-bacteria
coli	E-bacteria	I-bacteria
.	O	O

No	O	O
ESBL-producing	O	O
bacteria	O	O
or	O	O
ESBL	O	O
genes	O	O
were	O	O
detected	O	O
using	O	O
culture-based	O	O
and	O	O
molecular	O	O
methods	O	O
.	O	O

One	O	O
colony	O	O
of	O	O
Rahnella	B-bacteria	B-bacteria
aquatilis	E-bacteria	I-bacteria
harboring	O	O
the	O	O
class	O	O
A	O	O
ESBL	O	O
gene	O	O
bla	O	O
RAHN-1/2	O	O
was	O	O
identified	O	O
in	O	O
an	O	O
oral	O	O
sample	O	O
from	O	O
one	O	O
of	O	O
the	O	O
participants	O	O
.	O	O

This	O	O
pilot	O	O
study	O	O
supports	O	O
the	O	O
notion	O	O
that	O	O
the	O	O
presence	O	O
of	O	O
CTX-M-producing	O	O
bacteria	O	O
is	O	O
uncommon	O	O
in	O	O
oral	O	O
plaque	O	O
of	O	O
healthy	O	O
human	O	O
adult	O	O
fecal	O	O
carriers	O	O
.	O	O

Due	O	O
to	O	O
the	O	O
limited	O	O
number	O	O
of	O	O
persons	O	O
tested	O	O
,	O	O
a	O	O
low	O	O
prevalence	O	O
of	O	O
oral	O	O
ESBL-carriage	O	O
in	O	O
healthy	O	O
adults	O	O
or	O	O
carriage	O	O
in	O	O
selected	O	O
groups	O	O
of	O	O
patients	O	O
can	O	O
not	O	O
be	O	O
excluded	O	O
.	O	O

To	O	O
our	O	O
knowledge	O	O
,	O	O
this	O	O
is	O	O
the	O	O
first	O	O
description	O	O
of	O	O
an	O	O
R.	B-bacteria	B-bacteria
aquatilis	E-bacteria	I-bacteria
with	O	O
the	O	O
RAHN-1/2	O	O
gene	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Microorganisms	O	O
interact	O	O
with	O	O
each	O	O
other	O	O
within	O	O
a	O	O
community	O	O
.	O	O

Within	O	O
the	O	O
same	O	O
community	O	O
,	O	O
some	O	O
microorganisms	O	O
tend	O	O
to	O	O
co-exist	O	O
,	O	O
whereas	O	O
some	O	O
others	O	O
tend	O	O
to	O	O
avoid	O	O
each	O	O
other	O	O
.	O	O

The	O	O
association	O	O
among	O	O
microorganisms	O	O
can	O	O
be	O	O
revealed	O	O
by	O	O
computing	O	O
the	O	O
correlation	O	O
between	O	O
their	O	O
abundance	O	O
patterns	O	O
that	O	O
are	O	O
measured	O	O
through	O	O
metagenomic	O	O
sequencing	O	O
across	O	O
multiple	O	O
communities	O	O
.	O	O

In	O	O
this	O	O
paper	O	O
,	O	O
we	O	O
built	O	O
an	O	O
association	O	O
network	O	O
among	O	O
microorganisms	O	O
from	O	O
the	O	O
human	O	O
oral	O	O
microbiome	O	O
.	O	O

To	O	O
improve	O	O
its	O	O
accuracy	O	O
,	O	O
we	O	O
adopted	O	O
a	O	O
network	O	O
deconvolution	O	O
algorithm	O	O
to	O	O
filter	O	O
out	O	O
indirect	O	O
associations	O	O
,	O	O
and	O	O
we	O	O
used	O	O
an	O	O
ensemble	O	O
of	O	O
three	O	O
correlation	O	O
measures	O	O
to	O	O
filter	O	O
out	O	O
the	O	O
false-positive	O	O
associations	O	O
.	O	O

When	O	O
applying	O	O
on	O	O
the	O	O
metagenomic	O	O
data	O	O
from	O	O
human	O	O
oral	O	O
samples	O	O
,	O	O
experimental	O	O
results	O	O
showed	O	O
that	O	O
phylogenetically	O	O
close	O	O
microorganisms	O	O
formed	O	O
highly	O	O
correlated	O	O
network	O	O
clusters	O	O
.	O	O

Additionally	O	O
,	O	O
most	O	O
of	O	O
the	O	O
identified	O	O
mutually	O	O
exclusive	O	O
associations	O	O
were	O	O
related	O	O
to	O	O
the	O	O
order	O	O
Lactobacillales	B-bacteria	B-bacteria
.	O	O

Polycystic	O	O
ovary	O	O
syndrome	O	O
(	O	O
PCOS	O	O
)	O	O
is	O	O
a	O	O
hormonal	O	O
disorder	O	O
of	O	O
women	O	O
that	O	O
not	O	O
only	O	O
is	O	O
the	O	O
leading	O	O
cause	O	O
of	O	O
infertility	O	O
but	O	O
also	O	O
shows	O	O
a	O	O
reciprocal	O	O
link	O	O
with	O	O
oral	O	O
health	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
investigate	O	O
the	O	O
hypothesis	O	O
that	O	O
the	O	O
levels	O	O
of	O	O
putative	O	O
periodontal	O	O
pathogens	O	O
in	O	O
saliva	O	O
and	O	O
their	O	O
antibody	O	O
response	O	O
in	O	O
serum	O	O
are	O	O
elevated	O	O
in	O	O
PCOS	O	O
,	O	O
compared	O	O
to	O	O
systemic	O	O
health	O	O
.	O	O

A	O	O
total	O	O
of	O	O
125	O	O
women	O	O
were	O	O
included	O	O
in	O	O
four	O	O
groups	O	O
;	O	O
45	O	O
women	O	O
with	O	O
PCOS	O	O
and	O	O
healthy	O	O
periodontium	O	O
,	O	O
35	O	O
women	O	O
with	O	O
PCOS	O	O
and	O	O
gingivitis	O	O
,	O	O
25	O	O
systemically	O	O
and	O	O
periodontally	O	O
healthy	O	O
women	O	O
,	O	O
20	O	O
systemically	O	O
healthy	O	O
women	O	O
with	O	O
gingivitis	O	O
.	O	O

Salivary	O	O
levels	O	O
of	O	O
seven	O	O
putative	O	O
periodontal	O	O
pathogens	O	O
were	O	O
analyzed	O	O
by	O	O
quantitative	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
and	O	O
serum	O	O
antibody	O	O
levels	O	O
were	O	O
analyzed	O	O
by	O	O
ELISA	O	O
.	O	O

In	O	O
women	O	O
with	O	O
PCOS	O	O
,	O	O
salivary	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
levels	O	O
were	O	O
higher	O	O
than	O	O
matched	O	O
systemically	O	O
healthy	O	O
women	O	O
,	O	O
particularly	O	O
in	O	O
the	O	O
case	O	O
of	O	O
gingivitis	O	O
.	O	O

Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
levels	O	O
were	O	O
similar	O	O
among	O	O
study	O	O
groups	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
PCOS	O	O
also	O	O
enhanced	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
serum	O	O
antibody	O	O
levels	O	O
,	O	O
when	O	O
gingivitis	O	O
was	O	O
also	O	O
present	O	O
.	O	O

Gingival	O	O
inflammation	O	O
correlated	O	O
positively	O	O
with	O	O
levels	O	O
of	O	O
the	O	O
studied	O	O
taxa	O	O
in	O	O
saliva	O	O
,	O	O
particularly	O	O
in	O	O
PCOS	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
in	O	O
saliva	O	O
also	O	O
exhibited	O	O
a	O	O
strong	O	O
positive	O	O
correlation	O	O
with	O	O
the	O	O
corresponding	O	O
serum	O	O
antibody	O	O
levels	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
as	O	O
an	O	O
underlying	O	O
systemic	O	O
endocrine	O	O
condition	O	O
,	O	O
PCOS	O	O
may	O	O
quantitatively	O	O
affect	O	O
the	O	O
composition	O	O
of	O	O
oral	O	O
microbiota	O	O
and	O	O
the	O	O
raised	O	O
systemic	O	O
response	O	O
to	O	O
selective	O	O
members	O	O
of	O	O
this	O	O
microbial	O	O
community	O	O
,	O	O
exerting	O	O
a	O	O
confounding	O	O
role	O	O
in	O	O
resultant	O	O
gingival	O	O
inflammation	O	O
and	O	O
periodontal	O	O
health	O	O
.	O	O

The	O	O
most	O	O
consistent	O	O
effect	O	O
appeared	O	O
to	O	O
be	O	O
exerted	O	O
on	O	O
P.	B-bacteria	B-bacteria
gingivalis	B-bacteria	B-bacteria
.	O	O

Honey	O	O
is	O	O
an	O	O
ancient	O	O
natural	O	O
remedy	O	O
for	O	O
the	O	O
treatment	O	O
of	O	O
infected	O	O
wounds	O	O
.	O	O

It	O	O
has	O	O
regained	O	O
attention	O	O
in	O	O
the	O	O
medical	O	O
profession	O	O
,	O	O
as	O	O
it	O	O
has	O	O
recently	O	O
been	O	O
reported	O	O
to	O	O
have	O	O
a	O	O
broad-spectrum	O	O
inhibitory	O	O
effect	O	O
against	O	O
bacteria	O	O
.	O	O

Data	O	O
concerning	O	O
Manuka	O	O
honey	O	O
of	O	O
New	O	O
Zealand	O	O
origin	O	O
,	O	O
which	O	O
is	O	O
claimed	O	O
to	O	O
provide	O	O
additional	O	O
non-peroxide	O	O
antimicrobial	O	O
activity	O	O
(	O	O
so-called	O	O
standard	O	O
NPA	O	O
)	O	O
against	O	O
oral	O	O
pathogens	O	O
,	O	O
is	O	O
still	O	O
scarce	O	O
.	O	O

Therefore	O	O
,	O	O
this	O	O
study	O	O
aimed	O	O
to	O	O
screen	O	O
for	O	O
the	O	O
antibacterial	O	O
efficacy	O	O
of	O	O
different	O	O
Manuka	O	O
honey	O	O
products	O	O
against	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
(	I-bacteria	I-bacteria
OMZ	I-bacteria	I-bacteria
918	I-bacteria	I-bacteria
)	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
(	I-bacteria	I-bacteria
OMZ	I-bacteria	I-bacteria
925	I-bacteria	I-bacteria
)	E-bacteria	I-bacteria
and	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	I-bacteria	I-bacteria
(	I-bacteria	I-bacteria
OMZ	I-bacteria	I-bacteria
299	I-bacteria	I-bacteria
)	E-bacteria	I-bacteria
.	O	O

Chlorhexidine	O	O
and	O	O
saline	O	O
served	O	O
as	O	O
positive	O	O
and	O	O
negative	O	O
controls	O	O
,	O	O
respectively	O	O
,	O	O
whereas	O	O
a	O	O
Swiss	O	O
multifloral	O	O
honey	O	O
served	O	O
as	O	O
control	O	O
honey	O	O
without	O	O
intrinsic	O	O
non-peroxide	O	O
activity	O	O
.	O	O

Chlorhexidine	O	O
showed	O	O
the	O	O
highest	O	O
inhibiting	O	O
potential	O	O
against	O	O
all	O	O
specimens	O	O
tested	O	O
.	O	O

Manuka	O	O
honey	O	O
below	O	O
an	O	O
NPA	O	O
value	O	O
of	O	O
15	O	O
showed	O	O
the	O	O
least	O	O
bacterial	O	O
growth-inhibiting	O	O
potential	O	O
,	O	O
even	O	O
less	O	O
although	O	O
not	O	O
significantly	O	O
so	O	O
than	O	O
multifloral	O	O
Swiss	O	O
honey	O	O
.	O	O

Manuka	O	O
honey	O	O
above	O	O
an	O	O
NPA	O	O
value	O	O
of	O	O
15	O	O
showed	O	O
a	O	O
significantly	O	O
higher	O	O
antibacterial	O	O
effect	O	O
compared	O	O
to	O	O
the	O	O
other	O	O
honeys	O	O
tested	O	O
.	O	O

All	O	O
Manuka	O	O
honey	O	O
preparations	O	O
were	O	O
more	O	O
effective	O	O
in	O	O
inhibiting	O	O
the	O	O
growth	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
rather	O	O
than	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

In	O	O
conclusion	O	O
,	O	O
the	O	O
study	O	O
showed	O	O
an	O	O
NPA	O	O
dose-dependent	O	O
antibacterial	O	O
efficacy	O	O
of	O	O
Manuka	O	O
honey	O	O
.	O	O

Further	O	O
investigations	O	O
of	O	O
this	O	O
natural	O	O
product	O	O
are	O	O
now	O	O
open	O	O
for	O	O
scrutiny	O	O
.	O	O

A	O	O
complex	O	O
of	O	O
species	O	O
has	O	O
been	O	O
associated	O	O
with	O	O
dental	O	O
caries	O	O
under	O	O
the	O	O
ecological	O	O
hypothesis	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
develop	O	O
a	O	O
rapid	O	O
,	O	O
sensitive	O	O
PCR-dipstick	O	O
DNA	O	O
chromatography	O	O
assay	O	O
that	O	O
could	O	O
be	O	O
read	O	O
by	O	O
eye	O	O
for	O	O
multiplex	O	O
and	O	O
semiquantitative	O	O
analysis	O	O
of	O	O
plaque	O	O
bacteria	O	O
.	O	O

Parallel	O	O
oligonucleotides	O	O
were	O	O
immobilized	O	O
on	O	O
a	O	O
dipstick	O	O
strip	O	O
for	O	O
multiplex	O	O
analysis	O	O
of	O	O
target	O	O
DNA	O	O
sequences	O	O
of	O	O
the	O	O
caries-associated	O	O
bacteria	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
Scardovia	B-bacteria	B-bacteria
wiggsiae	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
and	O	O
Veillonella	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
.	O	O

Streptavidin-coated	O	O
blue-colored	O	O
latex	O	O
microspheres	O	O
were	O	O
to	O	O
generate	O	O
signal	O	O
.	O	O

Target	O	O
DNA	O	O
amplicons	O	O
with	O	O
an	O	O
oligonucleotide-tagged	O	O
terminus	O	O
and	O	O
a	O	O
biotinylated	O	O
terminus	O	O
were	O	O
coupled	O	O
with	O	O
latex	O	O
beads	O	O
through	O	O
a	O	O
streptavidin-biotin	O	O
interaction	O	O
and	O	O
then	O	O
hybridized	O	O
with	O	O
complementary	O	O
oligonucleotides	O	O
on	O	O
the	O	O
strip	O	O
.	O	O

The	O	O
accumulation	O	O
of	O	O
captured	O	O
latex	O	O
beads	O	O
on	O	O
the	O	O
test	O	O
and	O	O
control	O	O
lines	O	O
produced	O	O
blue	O	O
bands	O	O
,	O	O
enabling	O	O
visual	O	O
detection	O	O
with	O	O
the	O	O
naked	O	O
eye	O	O
.	O	O

The	O	O
PCR-dipstick	O	O
DNA	O	O
chromatography	O	O
detected	O	O
quantities	O	O
as	O	O
low	O	O
as	O	O
100	O	O
pg	O	O
of	O	O
DNA	O	O
amplicons	O	O
and	O	O
demonstrated	O	O
10-	O	O
to	O	O
1000-fold	O	O
higher	O	O
sensitivity	O	O
than	O	O
PCR-agarose	O	O
gel	O	O
electrophoresis	O	O
,	O	O
depending	O	O
on	O	O
the	O	O
target	O	O
bacterial	O	O
species	O	O
.	O	O

Semiquantification	O	O
of	O	O
bacteria	O	O
was	O	O
performed	O	O
by	O	O
obtaining	O	O
a	O	O
series	O	O
of	O	O
chromatograms	O	O
using	O	O
serial	O	O
10-fold	O	O
dilution	O	O
of	O	O
PCR-amplified	O	O
DNA	O	O
extracted	O	O
from	O	O
dental	O	O
plaque	O	O
samples	O	O
.	O	O

The	O	O
assay	O	O
time	O	O
was	O	O
less	O	O
than	O	O
3	O	O
h.	O	O
The	O	O
semiquantification	O	O
procedure	O	O
revealed	O	O
the	O	O
relative	O	O
amounts	O	O
of	O	O
each	O	O
test	O	O
species	O	O
in	O	O
dental	O	O
plaque	O	O
samples	O	O
,	O	O
indicating	O	O
that	O	O
this	O	O
disposable	O	O
device	O	O
has	O	O
great	O	O
potential	O	O
in	O	O
analysis	O	O
of	O	O
microbial	O	O
composition	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
intestinal	O	O
tract	O	O
,	O	O
as	O	O
well	O	O
as	O	O
in	O	O
point-of-care	O	O
diagnosis	O	O
of	O	O
microbiota-associated	O	O
diseases	O	O
.	O	O

Black	O	O
lion	O	O
tamarins	O	O
(	O	O
Leontopithecus	O	O
chrysopygus	O	O
)	O	O
are	O	O
endangered	O	O
callithrichids	O	O
.	O	O

Their	O	O
conservation	O	O
may	O	O
require	O	O
future	O	O
translocations	O	O
or	O	O
reintroductions	O	O
;	O	O
however	O	O
these	O	O
approaches	O	O
involve	O	O
risks	O	O
of	O	O
pathogen	O	O
introduction	O	O
in	O	O
the	O	O
environment	O	O
and	O	O
stress-related	O	O
opportunistic	O	O
infections	O	O
in	O	O
these	O	O
animals	O	O
.	O	O

In	O	O
order	O	O
to	O	O
screen	O	O
for	O	O
opportunistic	O	O
and	O	O
potential	O	O
pathogenic	O	O
bacterial	O	O
and	O	O
fungal	O	O
microbiota	O	O
,	O	O
ten	O	O
free-ranging	O	O
and	O	O
ten	O	O
captive	O	O
Black	O	O
lion	O	O
tamarins	O	O
were	O	O
studied	O	O
and	O	O
the	O	O
results	O	O
compared	O	O
.	O	O

Nasal	O	O
,	O	O
oral	O	O
and	O	O
rectal	O	O
swabs	O	O
were	O	O
collected	O	O
and	O	O
cultured	O	O
for	O	O
aerobic	O	O
and	O	O
facultative	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
and	O	O
fungi	O	O
,	O	O
and	O	O
a	O	O
total	O	O
203	O	O
bacterial	O	O
and	O	O
84	O	O
fungal	O	O
isolates	O	O
were	O	O
obtained	O	O
.	O	O

Overall	O	O
,	O	O
the	O	O
most	O	O
frequent	O	O
organisms	O	O
were	O	O
Staphylococcus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Bacillus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Candida	O	O
spp	O	O
.	O	O

and	O	O
Aspergillus	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	O	O

Microbiota	O	O
of	O	O
free-ranging	O	O
and	O	O
captive	O	O
animals	O	O
were	O	O
similar	O	O
in	O	O
composition	O	O
.	O	O

A	O	O
number	O	O
of	O	O
potentially	O	O
pathogenic	O	O
organisms	O	O
were	O	O
identified	O	O
,	O	O
emphasizing	O	O
the	O	O
importance	O	O
of	O	O
microbiological	O	O
screening	O	O
in	O	O
future	O	O
translocation	O	O
or	O	O
reintroduction	O	O
conservation	O	O
management	O	O
programs	O	O
.	O	O

Nonimmune	O	O
binding	O	O
of	O	O
immunoglobulins	O	O
via	O	O
the	O	O
Fc	O	O
fragment	O	O
may	O	O
reduce	O	O
opsonization	O	O
and	O	O
phagocytosis	O	O
of	O	O
bacteria	O	O
and	O	O
is	O	O
thus	O	O
considered	O	O
a	O	O
virulence	O	O
factor	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
a	O	O
wide	O	O
range	O	O
of	O	O
oral	O	O
bacterial	O	O
strains	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
human	O	O
immunoglobulin	O	O
G	O	O
(	O	O
IgG	O	O
)	O	O
Fc-binding	O	O
activity	O	O
.	O	O

A	O	O
total	O	O
of	O	O
132	O	O
strains	O	O
representing	O	O
40	O	O
different	O	O
gram-positive	B-bacteria	B-bacteria
and	I-bacteria	I-bacteria
gram	I-bacteria	I-bacteria
negative	I-bacteria	I-bacteria
bacterial	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
were	O	O
tested	O	O
for	O	O
IgG	O	O
Fc-binding	O	O
activity	O	O
by	O	O
using	O	O
a	O	O
fast	O	O
and	O	O
simple	O	O
dot	O	O
blot	O	O
procedure	O	O
with	O	O
horseradish	O	O
peroxidase-conjugated	O	O
Fc	O	O
fragments	O	O
from	O	O
human	O	O
IgG	O	O
.	O	O

Neither	O	O
the	O	O
human	O	O
nor	O	O
animal	O	O
biotype	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
possessed	O	O
IgG	O	O
Fc-binding	O	O
activity	O	O
.	O	O

The	O	O
strongest	O	O
positive	O	O
reaction	O	O
of	O	O
gram-negative	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
with	O	O
the	O	O
IgG	O	O
Fc	O	O
fragments	O	O
were	O	O
obtained	O	O
with	O	O
strains	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

Among	O	O
the	O	O
gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
tested	O	O
,	O	O
Peptostreptococcus	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
and	O	O
several	O	O
species	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
possessed	O	O
IgG	O	O
Fc-binding	O	O
activity	O	O
.	O	O

In	O	O
the	O	O
present	O	O
investigation	O	O
,	O	O
the	O	O
ability	O	O
of	O	O
several	O	O
oral	O	O
bacterial	O	O
species	O	O
to	O	O
bind	O	O
IgG	O	O
Fc	O	O
fragments	O	O
was	O	O
demonstrated	O	O
.	O	O

This	O	O
factor	O	O
represents	O	O
a	O	O
potential	O	O
virulence	O	O
determinant	O	O
as	O	O
it	O	O
may	O	O
help	O	O
pathogenic	O	O
oral	O	O
bacteria	O	O
escape	O	O
host	O	O
defense	O	O
mechanisms	O	O
.	O	O

Viable	O	O
counts	O	O
and	O	O
activities	O	O
of	O	O
sulfate-reducing	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
were	O	O
determined	O	O
in	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
12	O	O
healthy	O	O
volunteers	O	O
.	O	O

Of	O	O
these	O	O
,	O	O
10	O	O
harboured	O	O
viable	O	O
sulfate-reducing	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
populations	O	O
.	O	O

Six	O	O
separate	O	O
sites	O	O
were	O	O
sampled	O	O
:	O	O
the	O	O
posterior	O	O
tongue	O	O
,	O	O
anterior	O	O
tongue	O	O
,	O	O
mid	O	O
buccal	O	O
mucosa	O	O
,	O	O
vestibular	O	O
mucosa	O	O
,	O	O
supragingival	O	O
plaque	O	O
and	O	O
subgingival	O	O
plaque	O	O
.	O	O

Sulfate-reducing	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
occurred	O	O
in	O	O
all	O	O
areas	O	O
,	O	O
with	O	O
the	O	O
highest	O	O
incidence	O	O
in	O	O
supragingival	O	O
plaque	O	O
.	O	O

Viable	O	O
counts	O	O
and	O	O
sulfate-reducing	O	O
activities	O	O
in	O	O
each	O	O
of	O	O
the	O	O
regions	O	O
varied	O	O
from	O	O
0	O	O
to	O	O
10	O	O
(	O	O
8	O	O
)	O	O
cfu	O	O
(	O	O
g	O	O
wet	O	O
weight	O	O
)	O	O
-1	O	O
and	O	O
from	O	O
0	O	O
to	O	O
50	O	O
nmol	O	O
(	O	O
g	O	O
wet	O	O
weight	O	O
)	O	O
-1	O	O
h-1	O	O
,	O	O
respectively	O	O
.	O	O

As	O	O
sulfate-reducing	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
can	O	O
be	O	O
detected	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
they	O	O
may	O	O
potentially	O	O
be	O	O
involved	O	O
in	O	O
terminal	O	O
oxidative	O	O
processes	O	O
carried	O	O
out	O	O
by	O	O
the	O	O
microflora	O	O
of	O	O
the	O	O
mouth	O	O
.	O	O

The	O	O
expression	O	O
of	O	O
sialy-Lewis	O	O
(	O	O
x	O	O
)	O	O
(	O	O
sLe	O	O
(	O	O
x	O	O
)	O	O
;	O	O
Neu5Ac	O	O
alpha	O	O
2-3	O	O
Gal	O	O
beta	O	O
1-4	O	O
)	O	O
(	O	O
Fuc	O	O
alpha	O	O
1-3	O	O
)	O	O
GlcNAc-R	O	O
)	O	O
on	O	O
oral	O	O
bacteria	O	O
producing	O	O
infective	O	O
endocarditis	O	O
was	O	O
determined	O	O
by	O	O
a	O	O
whole-cell	O	O
enzyme	O	O
linked	O	O
immunosorbent	O	O
assay	O	O
and	O	O
an	O	O
immunoelectron	O	O
microscopy	O	O
using	O	O
the	O	O
well-characterized	O	O
anti-sLe	O	O
(	O	O
x	O	O
)	O	O
monoclonal	O	O
antibody	O	O
SNH-3	O	O
(	O	O
mAb	O	O
SNH-3	O	O
;	O	O
IgM	O	O
class	O	O
)	O	O
.	O	O

mAb	O	O
SNH-3	O	O
reacted	O	O
strongly	O	O
with	O	O
whole	O	O
cells	O	O
of	O	O
oral	O	O
bacteria	O	O
:	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
intermedius	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
constellatus	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
anginosus	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
,	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Eikenella	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

The	O	O
negatively	O	O
stained	O	O
immuno-electron	O	O
micrograph	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
showed	O	O
many	O	O
reactive	O	O
gold	O	O
particles	O	O
on	O	O
the	O	O
cell	O	O
surface	O	O
.	O	O

Our	O	O
findings	O	O
demonstrated	O	O
the	O	O
existence	O	O
of	O	O
immunologic	O	O
mimicry	O	O
between	O	O
the	O	O
sLe	O	O
(	O	O
x	O	O
)	O	O
oligosaccharide	O	O
and	O	O
cell	O	O
surface	O	O
antigens	O	O
of	O	O
many	O	O
species	O	O
associated	O	O
with	O	O
infective	O	O
endocarditis	O	O
.	O	O

We	O	O
propose	O	O
the	O	O
hypothesis	O	O
that	O	O
if	O	O
these	O	O
bacteria	O	O
escape	O	O
their	O	O
normal	O	O
habitats	O	O
,	O	O
the	O	O
surface	O	O
components	O	O
that	O	O
mimic	O	O
the	O	O
sLe	O	O
(	O	O
x	O	O
)	O	O
oligosaccharide	O	O
might	O	O
bind	O	O
to	O	O
host	O	O
antigens	O	O
of	O	O
the	O	O
selectin	O	O
family	O	O
which	O	O
could	O	O
promote	O	O
binding	O	O
to	O	O
endothelial	O	O
cells	O	O
and	O	O
,	O	O
consequently	O	O
,	O	O
initiation	O	O
of	O	O
the	O	O
events	O	O
leading	O	O
to	O	O
infective	O	O
endocarditis	O	O
.	O	O

In	O	O
order	O	O
to	O	O
examine	O	O
the	O	O
possible	O	O
implication	O	O
of	O	O
human	O	O
epithelial	O	O
and	O	O
endothelial	O	O
cells	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
various	O	O
diseases	O	O
associated	O	O
with	O	O
oral	O	O
viridans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
we	O	O
tested	O	O
the	O	O
immunomodulatory	O	O
effects	O	O
of	O	O
11	O	O
representative	O	O
strains	O	O
of	O	O
oral	O	O
viridans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
on	O	O
human	O	O
epithelial	O	O
cells	O	O
and	O	O
endothelial	O	O
cells	O	O
.	O	O

We	O	O
then	O	O
examined	O	O
the	O	O
possible	O	O
role	O	O
of	O	O
two	O	O
major	O	O
adhesins	O	O
from	O	O
oral	O	O
viridans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
protein	O	O
I/II	O	O
and	O	O
rhamnose-glucose	O	O
polymers	O	O
(	O	O
RGPs	O	O
)	O	O
,	O	O
in	O	O
this	O	O
process	O	O
.	O	O

In	O	O
this	O	O
study	O	O
we	O	O
demonstrate	O	O
that	O	O
oral	O	O
viridans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
are	O	O
potent	O	O
stimulators	O	O
of	O	O
interleukin-8	O	O
(	O	O
IL-8	O	O
)	O	O
production	O	O
from	O	O
KB	O	O
cells	O	O
and	O	O
of	O	O
IL-6	O	O
and	O	O
IL-8	O	O
production	O	O
from	O	O
endothelial	O	O
cells	O	O
.	O	O

The	O	O
ability	O	O
of	O	O
protein	O	O
I/II	O	O
and	O	O
RGPs	O	O
to	O	O
contribute	O	O
to	O	O
these	O	O
effects	O	O
was	O	O
then	O	O
examined	O	O
.	O	O

Using	O	O
biotinylated	O	O
protein	O	O
I/IIf	O	O
and	O	O
RGPs	O	O
from	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
OMZ	I-bacteria	I-bacteria
175	E-bacteria	I-bacteria
,	O	O
we	O	O
showed	O	O
that	O	O
these	O	O
adhesins	O	O
bind	O	O
to	O	O
KB	O	O
and	O	O
endothelial	O	O
cells	O	O
through	O	O
specific	O	O
interactions	O	O
and	O	O
that	O	O
the	O	O
binding	O	O
of	O	O
these	O	O
molecules	O	O
initiates	O	O
the	O	O
release	O	O
of	O	O
IL-8	O	O
from	O	O
KB	O	O
cells	O	O
and	O	O
of	O	O
IL-6	O	O
and	O	O
IL-8	O	O
from	O	O
endothelial	O	O
cells	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
protein	O	O
I/IIf	O	O
and	O	O
RGPs	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
interactions	O	O
between	O	O
bacteria	O	O
and	O	O
KB	O	O
and	O	O
endothelial	O	O
cells	O	O
in	O	O
that	O	O
similar	O	O
cytokine	O	O
profiles	O	O
are	O	O
obtained	O	O
when	O	O
cells	O	O
are	O	O
stimulated	O	O
with	O	O
bacteria	O	O
or	O	O
surface	O	O
components	O	O
.	O	O

We	O	O
also	O	O
provide	O	O
evidence	O	O
that	O	O
protein	O	O
I/IIf	O	O
binds	O	O
to	O	O
and	O	O
stimulates	O	O
KB	O	O
and	O	O
endothelial	O	O
cells	O	O
through	O	O
lectin	O	O
interactions	O	O
that	O	O
N-acetyl	O	O
neuraminic	O	O
acid	O	O
(	O	O
NANA	O	O
)	O	O
and	O	O
fucose	O	O
present	O	O
on	O	O
cell	O	O
surface	O	O
glycoproteins	O	O
may	O	O
form	O	O
the	O	O
recognition	O	O
site	O	O
since	O	O
binding	O	O
and	O	O
cytokine	O	O
release	O	O
can	O	O
be	O	O
inhibited	O	O
by	O	O
dispase	O	O
and	O	O
periodate	O	O
treatment	O	O
of	O	O
cells	O	O
and	O	O
by	O	O
NANA	O	O
and	O	O
fucose	O	O
.	O	O

These	O	O
results	O	O
demonstrate	O	O
that	O	O
ora	B-bacteria	B-bacteria
viridans	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
probably	O	O
by	O	O
engaging	O	O
two	O	O
cell	O	O
surface	O	O
adhesins	O	O
,	O	O
exert	O	O
immunomodulatory	O	O
effects	O	O
on	O	O
human	O	O
KB	O	O
and	O	O
endothelial	O	O
cells	O	O
.	O	O

This	O	O
study	O	O
compared	O	O
the	O	O
antimicrobial	O	O
effectiveness	O	O
of	O	O
nine	O	O
dental	O	O
materials	O	O
and	O	O
a	O	O
negative	O	O
control	O	O
agent	O	O
against	O	O
21	O	O
strains	O	O
or	O	O
species	O	O
of	O	O
bacteria	O	O
using	O	O
an	O	O
agar	O	O
diffusion	O	O
assay	O	O
.	O	O

The	O	O
materials	O	O
were	O	O
:	O	O
1	O	O
.	O	O

Camphorated	O	O
parachlorophenol	O	O
mixed	O	O
with	O	O
calcium	O	O
hydroxide	O	O
(	O	O
CPC	O	O
+	O	O
Ca	O	O
(	O	O
OH	O	O
)	O	O
2	O	O
)	O	O
.	O	O

2	O	O
.	O	O

CPC	O	O
mixed	O	O
with	O	O
zinc	O	O
oxide	O	O
(	O	O
CPC	O	O
+	O	O
ZnO	O	O
)	O	O
.	O	O

3	O	O
.	O	O

Formocresol	O	O
mixed	O	O
with	O	O
zinc	O	O
oxide	O	O
and	O	O
eugenol	O	O
(	O	O
FC	O	O
+	O	O
ZOE	O	O
)	O	O
.	O	O

4	O	O
.	O	O

Chlorhexidine	O	O
mixed	O	O
with	O	O
ZOE	O	O
(	O	O
CHX	O	O
+	O	O
ZOE	O	O
)	O	O
.	O	O

5	O	O
.	O	O

Kri	O	O
paste	O	O
.	O	O

6	O	O
.	O	O

ZOE	O	O
.	O	O

7	O	O
.	O	O

Zinc	O	O
oxide	O	O
mixed	O	O
with	O	O
sterile	O	O
water	O	O
(	O	O
ZnO	O	O
+	O	O
H2O	O	O
)	O	O
.	O	O

8	O	O
.	O	O

Calcium	O	O
hydroxide	O	O
mixed	O	O
with	O	O
sterile	O	O
water	O	O
(	O	O
Ca	O	O
(	O	O
OH	O	O
)	O	O
2	O	O
+	O	O
H2O	O	O
)	O	O
.	O	O

9	O	O
.	O	O

Vitapex	O	O
.	O	O

10	O	O
.	O	O

Vaseline	O	O
(	O	O
control	O	O
)	O	O
.	O	O

The	O	O
test	O	O
bacteria	O	O
represented	O	O
species	O	O
commonly	O	O
isolated	O	O
from	O	O
nonvital	O	O
primary	O	O
and	O	O
permanent	O	O
tooth	O	O
root	O	O
canals	O	O
.	O	O

The	O	O
antimicrobial	O	O
effectiveness	O	O
of	O	O
the	O	O
materials	O	O
was	O	O
divided	O	O
into	O	O
five	O	O
groups	O	O
based	O	O
on	O	O
the	O	O
diameters	O	O
of	O	O
the	O	O
zones	O	O
of	O	O
inhibition	O	O
against	O	O
all	O	O
test	O	O
bacteria	O	O
and	O	O
distribution	O	O
of	O	O
the	O	O
data	O	O
.	O	O

All	O	O
materials	O	O
except	O	O
Vaseline	O	O
showed	O	O
antimicrobial	O	O
activity	O	O
against	O	O
some	O	O
of	O	O
the	O	O
21	O	O
organisms	O	O
.	O	O

Generally	O	O
,	O	O
all	O	O
materials	O	O
inhibited	O	O
gram-negative	B-bacteria	B-bacteria
anaerobic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
more	O	O
effectively	O	O
than	O	O
aerotolerant	B-bacteria	B-bacteria
gram-negative	I-bacteria	I-bacteria
or	I-bacteria	I-bacteria
gram-positive	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

Materials	O	O
containing	O	O
CPC	O	O
or	O	O
FC	O	O
(	O	O
except	O	O
Kri	O	O
paste	O	O
)	O	O
produced	O	O
strong	O	O
or	O	O
medium	O	O
strong	O	O
inhibition	O	O
against	O	O
most	O	O
bacteria	O	O
.	O	O

CHX	O	O
+	O	O
ZOE	O	O
,	O	O
Kri	O	O
paste	O	O
,	O	O
ZnO	O	O
+	O	O
H2O	O	O
,	O	O
and	O	O
ZOE	O	O
inhibited	O	O
all	O	O
or	O	O
most	O	O
bacteria	O	O
,	O	O
but	O	O
to	O	O
lesser	O	O
extent	O	O
than	O	O
CPC	O	O
+	O	O
Ca	O	O
(	O	O
OH	O	O
)	O	O
2	O	O
,	O	O
CPC	O	O
+	O	O
ZnO	O	O
,	O	O
or	O	O
FC	O	O
+	O	O
ZOE	O	O
.	O	O

Ca	O	O
(	O	O
OH	O	O
)	O	O
2	O	O
+	O	O
H2O	O	O
,	O	O
Vitapex	O	O
,	O	O
and	O	O
Vaseline	O	O
generally	O	O
were	O	O
nonihibitory	O	O
.	O	O

The	O	O
findings	O	O
should	O	O
allow	O	O
a	O	O
comparative	O	O
evaluation	O	O
of	O	O
antimicrobial	O	O
effectiveness	O	O
to	O	O
be	O	O
made	O	O
of	O	O
materials	O	O
commonly	O	O
used	O	O
in	O	O
pulpectomy	O	O
procedures	O	O
with	O	O
primary	O	O
teeth	O	O
.	O	O

Extra	O	O
Parotid	O	O
Glycoprotein	O	O
(	O	O
EP-GP	O	O
)	O	O
is	O	O
a	O	O
glycoprotein	O	O
isolated	O	O
from	O	O
human	O	O
saliva	O	O
,	O	O
having	O	O
homologues	O	O
in	O	O
several	O	O
other	O	O
body	O	O
fluids	O	O
.	O	O

The	O	O
biological	O	O
role	O	O
of	O	O
EP-GP	O	O
and	O	O
its	O	O
homologues	O	O
is	O	O
unknown	O	O
.	O	O

Recently	O	O
,	O	O
EP-GP	O	O
was	O	O
shown	O	O
to	O	O
bind	O	O
in	O	O
vitro	O	O
to	O	O
the	O	O
bacterium	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
HB	E-bacteria	I-bacteria
.	O	O

In	O	O
contrast	O	O
,	O	O
no	O	O
binding	O	O
to	O	O
a	O	O
number	O	O
of	O	O
other	O	O
oral	O	O
microorganisms	O	O
could	O	O
be	O	O
demonstrated	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
we	O	O
have	O	O
determined	O	O
whether	O	O
binding	O	O
of	O	O
EP-GP	O	O
to	O	O
bacteria	O	O
occurs	O	O
in	O	O
vivo	O	O
in	O	O
saliva	O	O
and	O	O
in	O	O
other	O	O
EP-GP	O	O
containing	O	O
body	O	O
fluids	O	O
.	O	O

Therefore	O	O
the	O	O
presence	O	O
of	O	O
EP-GP	O	O
on	O	O
bacteria	O	O
in	O	O
vivo	O	O
was	O	O
determined	O	O
by	O	O
analyzing	O	O
oral	O	O
,	O	O
skin	O	O
and	O	O
ear	O	O
floras	O	O
by	O	O
confocal	O	O
fluoresence	O	O
microscopy	O	O
using	O	O
specific	O	O
antibodies	O	O
.	O	O

About	O	O
12	O	O
%	O	O
of	O	O
the	O	O
in	O	O
vivo	O	O
oral	O	O
flora	O	O
had	O	O
EP-GP	O	O
present	O	O
on	O	O
their	O	O
surface	O	O
,	O	O
while	O	O
approximately	O	O
5	O	O
%	O	O
of	O	O
the	O	O
bacteria	O	O
from	O	O
ear	O	O
canal	O	O
or	O	O
skin	O	O
was	O	O
positive	O	O
for	O	O
EP-GP	O	O
.	O	O

IgA	O	O
was	O	O
detected	O	O
on	O	O
approximately	O	O
65	O	O
%	O	O
of	O	O
the	O	O
salivary	O	O
bacteria	O	O
,	O	O
whereas	O	O
the	O	O
high-molecular	O	O
weight	O	O
mucin	O	O
(	O	O
MG1	O	O
)	O	O
and	O	O
cystatin	O	O
C	O	O
were	O	O
not	O	O
detectable	O	O
on	O	O
any	O	O
oral	O	O
bacterium	O	O
.	O	O

Using	O	O
a	O	O
replica-plate	O	O
assay	O	O
,	O	O
a	O	O
number	O	O
of	O	O
EP-GP	O	O
binding	O	O
strains	O	O
in	O	O
saliva	O	O
were	O	O
isolated	O	O
and	O	O
identified	O	O
as	O	O
Gemella	B-bacteria	B-bacteria
haemolysans	E-bacteria	I-bacteria
,	O	O
Gemella	B-bacteria	B-bacteria
morbillorium	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
acidominimus	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
parasanguis	E-bacteria	I-bacteria
.	O	O

Bacteria	O	O
from	O	O
the	O	O
ear	O	O
canal	O	O
and	O	O
skin	O	O
bacteria	O	O
were	O	O
identified	O	O
as	O	O
Staphylococcus	B-bacteria	B-bacteria
hominis	E-bacteria	I-bacteria
.	O	O

It	O	O
is	O	O
concluded	O	O
that	O	O
EP-GP	O	O
is	O	O
selectively	O	O
bound	O	O
in	O	O
vivo	O	O
to	O	O
several	O	O
oral	O	O
and	O	O
non-oral	O	O
bacterial	O	O
species	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
prevalence	O	O
of	O	O
the	O	O
microbiota	O	O
on	O	O
the	O	O
oral	O	O
mucosal	O	O
surfaces	O	O
and	O	O
in	O	O
the	O	O
peri-implant	O	O
pocket	O	O
in	O	O
edentulous	O	O
subjects	O	O
with	O	O
a	O	O
past	O	O
history	O	O
of	O	O
periodontitis	O	O
.	O	O

Twenty	O	O
edentulous	O	O
subjects	O	O
wearing	O	O
dental	O	O
implants	O	O
for	O	O
at	O	O
least	O	O
one	O	O
year	O	O
and	O	O
with	O	O
a	O	O
history	O	O
of	O	O
periodontitis	O	O
participated	O	O
in	O	O
this	O	O
study	O	O
.	O	O

Clinical	O	O
parameters	O	O
were	O	O
assessed	O	O
(	O	O
plaque	O	O
,	O	O
redness	O	O
,	O	O
swelling	O	O
,	O	O
peri-implant	O	O
probing	O	O
depth	O	O
[	O	O
PIPD	O	O
]	O	O
,	O	O
and	O	O
bleeding	O	O
on	O	O
probing	O	O
)	O	O
and	O	O
microbiological	O	O
samples	O	O
were	O	O
taken	O	O
(	O	O
oral	O	O
mucosal	O	O
surfaces	O	O
,	O	O
saliva	O	O
,	O	O
plaque	O	O
,	O	O
and	O	O
peri-implant	O	O
pocket	O	O
)	O	O
.	O	O

Based	O	O
on	O	O
the	O	O
clinical	O	O
results	O	O
,	O	O
the	O	O
group	O	O
as	O	O
a	O	O
whole	O	O
showed	O	O
healthy	O	O
peri-implant	O	O
tissues	O	O
.	O	O

A	O	O
mean	O	O
PIPD	O	O
of	O	O
3.6	O	O
mm	O	O
was	O	O
found	O	O
.	O	O

A	O	O
statistically	O	O
significant	O	O
correlation	O	O
was	O	O
found	O	O
between	O	O
the	O	O
PIPD	O	O
and	O	O
bleeding	O	O
upon	O	O
probing	O	O
,	O	O
plaque	O	O
scores	O	O
,	O	O
redness	O	O
,	O	O
and	O	O
swelling	O	O
.	O	O

Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
Porphyromonas	O	O
gingivalis	O	O
were	O	O
not	O	O
detected	O	O
.	O	O

The	O	O
subjects	O	O
harboring	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
showed	O	O
presence	O	O
of	O	O
PIPD	O	O
of	O	O
>	O	O
or	O	O
=	O	O
5	O	O
mm	O	O
.	O	O

All	O	O
subjects	O	O
harbored	O	O
Peptostreptococcus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
and	O	O
other	O	O
Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

Actinomyces	B-bacteria	B-bacteria
odontolyticus	E-bacteria	I-bacteria
,	O	O
Bacteroides	B-bacteria	B-bacteria
forsythus	E-bacteria	I-bacteria
,	O	O
Campylobacter	O	O
rectus	O	O
,	O	O
Pseudomonas	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
and	O	O
enterobacteria	B-bacteria	B-bacteria
were	O	O
detected	O	O
less	O	O
frequently	O	O
.	O	O

Three	O	O
subjects	O	O
showed	O	O
signs	O	O
of	O	O
overt	O	O
soft	O	O
tissue	O	O
inflammation	O	O
.	O	O

They	O	O
harbored	O	O
higher	O	O
proportions	O	O
of	O	O
Peptostreptococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

than	O	O
the	O	O
other	O	O
subjects	O	O
.	O	O

The	O	O
results	O	O
corroborate	O	O
the	O	O
suggestion	O	O
that	O	O
the	O	O
primary	O	O
source	O	O
of	O	O
colonization	O	O
for	O	O
dental	O	O
implants	O	O
in	O	O
edentulous	O	O
patients	O	O
are	O	O
the	O	O
oral	O	O
mucous	O	O
membranes	O	O
.	O	O

The	O	O
results	O	O
indicate	O	O
that	O	O
the	O	O
microbiota	O	O
of	O	O
subjects	O	O
wearing	O	O
dental	O	O
implants	O	O
with	O	O
a	O	O
past	O	O
history	O	O
of	O	O
periodontitis	O	O
are	O	O
composed	O	O
of	O	O
bacteria	O	O
associated	O	O
with	O	O
a	O	O
healthy	O	O
periodontium	O	O
or	O	O
gingivitis	O	O
.	O	O

It	O	O
is	O	O
suggested	O	O
that	O	O
elimination	O	O
of	O	O
the	O	O
subgingival	O	O
environment	O	O
by	O	O
extraction	O	O
of	O	O
all	O	O
natural	O	O
teeth	O	O
probably	O	O
initiates	O	O
the	O	O
disappearance	O	O
of	O	O
the	O	O
two	O	O
periodonta	O	O
bacteria	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

Various	O	O
oral	O	O
bacterial	O	O
species	O	O
were	O	O
found	O	O
to	O	O
inhibit	O	O
the	O	O
growth	O	O
of	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
.	O	O

The	O	O
growth	O	O
inhibitory	O	O
activities	O	O
of	O	O
most	O	O
of	O	O
these	O	O
oral	O	O
bacteria	O	O
were	O	O
adversely	O	O
affected	O	O
by	O	O
heating	O	O
at	O	O
80	O	O
degrees	O	O
C	O	O
for	O	O
60	O	O
min	O	O
or	O	O
by	O	O
protease	O	O
treatment	O	O
,	O	O
indicating	O	O
that	O	O
these	O	O
bacteria	O	O
produce	O	O
bacteriocin-like	O	O
inhibitory	O	O
proteins	O	O
against	O	O
H.	B-bacteria	B-bacteria
pylori	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
.	O	O

The	O	O
antagonistic	O	O
effects	O	O
of	O	O
oral	O	O
bacteria	O	O
against	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
may	O	O
restrain	O	O
colonization	O	O
by	O	O
this	O	O
organism	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Halitosis	O	O
is	O	O
most	O	O
often	O	O
caused	O	O
by	O	O
oral	O	O
conditions	O	O
.	O	O

Volatile	O	O
sulfur	O	O
compounds	O	O
(	O	O
VSC	O	O
)	O	O
,	O	O
constituting	O	O
the	O	O
major	O	O
components	O	O
of	O	O
oral	O	O
malodor	O	O
,	O	O
are	O	O
produced	O	O
by	O	O
anaerobic	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
gram-negative	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
retained	O	O
mainly	O	O
in	O	O
periodontal	O	O
pockets	O	O
or	O	O
on	O	O
the	O	O
tongue	O	O
dorsum	O	O
.	O	O

Sulfur-containing	O	O
amino	O	O
acids	O	O
serve	O	O
as	O	O
substrate	O	O
for	O	O
these	O	O
bacteria	O	O
.	O	O

VSC	O	O
have	O	O
also	O	O
been	O	O
found	O	O
to	O	O
have	O	O
unfavorable	O	O
effect	O	O
on	O	O
the	O	O
tissue	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
examine	O	O
whether	O	O
normal	O	O
,	O	O
healthy	O	O
individuals	O	O
with	O	O
no	O	O
history	O	O
of	O	O
halitosis	O	O
were	O	O
able	O	O
to	O	O
produce	O	O
VSC	O	O
from	O	O
cysteine	O	O
,	O	O
when	O	O
applied	O	O
as	O	O
a	O	O
mouthrinse	O	O
.	O	O

A	O	O
further	O	O
aim	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
and	O	O
compare	O	O
the	O	O
potential	O	O
of	O	O
other	O	O
Sulfur-containing	O	O
amino	O	O
acids	O	O
and	O	O
peptides	O	O
as	O	O
substrates	O	O
for	O	O
oral	O	O
VSC	O	O
production	O	O
and	O	O
to	O	O
localize	O	O
the	O	O
odor-production	O	O
sites	O	O
.	O	O

A	O	O
portable	O	O
sulfide	O	O
monitor	O	O
was	O	O
used	O	O
for	O	O
VSC	O	O
registration	O	O
.	O	O

Results	O	O
showed	O	O
that	O	O
all	O	O
test	O	O
subjects	O	O
produced	O	O
high	O	O
oral	O	O
concentrations	O	O
of	O	O
VSC	O	O
upon	O	O
rinses	O	O
with	O	O
cysteine	O	O
,	O	O
which	O	O
thus	O	O
seems	O	O
to	O	O
be	O	O
a	O	O
major	O	O
substrate	O	O
for	O	O
VSC	O	O
production	O	O
.	O	O

The	O	O
other	O	O
sulfur-containing	O	O
substrates	O	O
had	O	O
much	O	O
less	O	O
effect	O	O
.	O	O

It	O	O
was	O	O
found	O	O
that	O	O
the	O	O
tongue	O	O
was	O	O
the	O	O
major	O	O
site	O	O
for	O	O
VSC	O	O
production	O	O
,	O	O
and	O	O
that	O	O
saliva	O	O
per	O	O
se	O	O
caused	O	O
low	O	O
VSC	O	O
production	O	O
.	O	O

In	O	O
the	O	O
antimicrobial	O	O
therapy	O	O
of	O	O
denture	O	O
stomatitis	O	O
,	O	O
it	O	O
is	O	O
desirable	O	O
to	O	O
inhibit	O	O
the	O	O
growth	O	O
of	O	O
not	O	O
only	O	O
the	O	O
primary	O	O
causative	O	O
organism	O	O
,	O	O
Candida	O	O
albicans	O	O
,	O	O
but	O	O
also	O	O
other	O	O
oral	O	O
bacteria	O	O
closely	O	O
associated	O	O
with	O	O
the	O	O
condition	O	O
.	O	O

Three	O	O
synthetic	O	O
anti-candidal	O	O
chalcones	O	O
were	O	O
characterized	O	O
and	O	O
compared	O	O
for	O	O
their	O	O
additional	O	O
activity	O	O
in	O	O
inhibiting	O	O
these	O	O
causative	O	O
bacteria	O	O
.	O	O

Among	O	O
the	O	O
tested	O	O
chalcones	O	O
,	O	O
2,4,2'-trihydroxy-5'-methylchalcone	O	O
showed	O	O
the	O	O
highest	O	O
activity	O	O
for	O	O
different	O	O
Gram-positive	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
.	O	O

It	O	O
inhibited	O	O
the	O	O
growth	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
staphylococci	B-bacteria	B-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
at	O	O
25.0-50.0	O	O
micrograms/mL	O	O
which	O	O
was	O	O
lower	O	O
than	O	O
or	O	O
comparable	O	O
to	O	O
its	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
for	O	O
candida	O	O
.	O	O

It	O	O
functioned	O	O
with	O	O
a	O	O
bactericidal	O	O
action	O	O
and	O	O
leaked	O	O
260	O	O
nm-absorbing	O	O
substances	O	O
from	O	O
the	O	O
streptococcal	O	O
cells	O	O
.	O	O

The	O	O
antimicrobial	O	O
activity	O	O
of	O	O
2,4,2'-trihydroxy-5'-methylchalcone	O	O
against	O	O
both	O	O
primary	O	O
and	O	O
secondary	O	O
causative	O	O
agents	O	O
suggests	O	O
it	O	O
could	O	O
be	O	O
useful	O	O
as	O	O
a	O	O
potent	O	O
therapeutic	O	O
agent	O	O
in	O	O
denture	O	O
stomatitis	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
60-day	O	O
single-blind	O	O
,	O	O
parallel	O	O
trial	O	O
,	O	O
using	O	O
150	O	O
subjects	O	O
,	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
effect	O	O
of	O	O
a	O	O
20	O	O
%	O	O
sodium	O	O
bicarbonate	O	O
dentifrice	O	O
,	O	O
a	O	O
1.5	O	O
%	O	O
hydrogen	O	O
peroxide	O	O
solution	O	O
and	O	O
a	O	O
mouth	O	O
moisturizer	O	O
on	O	O
oral	O	O
tissues	O	O
and	O	O
microflora	O	O
.	O	O

Subjects	O	O
were	O	O
randomly	O	O
assigned	O	O
to	O	O
one	O	O
of	O	O
five	O	O
groups	O	O
.	O	O

The	O	O
treatments	O	O
were	O	O
:	O	O
1	O	O
)	O	O
Sage	O	O
dentifrice	O	O
(	O	O
sodium	O	O
bicarbonate	O	O
)	O	O
.	O	O

Toothette	O	O
Plus	O	O
containing	O	O
baking	O	O
soda	O	O
saturated	O	O
with	O	O
the	O	O
hydrogen	O	O
peroxide	O	O
solution	O	O
and	O	O
use	O	O
of	O	O
a	O	O
mouth	O	O
moisturizer	O	O
,	O	O
2	O	O
)	O	O
Crest	O	O
dentifrice	O	O
,	O	O
Toothette	O	O
Plus	O	O
containing	O	O
baking	O	O
soda	O	O
saturated	O	O
with	O	O
the	O	O
hydrogen	O	O
peroxide	O	O
solution	O	O
and	O	O
use	O	O
of	O	O
a	O	O
mouth	O	O
moisturizer	O	O
,	O	O
3	O	O
)	O	O
Crest	O	O
dentifrice	O	O
,	O	O
Toothette	O	O
Plus	O	O
containing	O	O
baking	O	O
soda	O	O
with	O	O
a	O	O
control	O	O
solution	O	O
and	O	O
no	O	O
mouth	O	O
moisturizer	O	O
,	O	O
4	O	O
)	O	O
Crest	O	O
dentifrice	O	O
,	O	O
Toothette	O	O
(	O	O
without	O	O
baking	O	O
soda	O	O
)	O	O
,	O	O
saturated	O	O
with	O	O
a	O	O
control	O	O
solution	O	O
and	O	O
no	O	O
mouth	O	O
moisturizer	O	O
,	O	O
and	O	O
5	O	O
)	O	O
Crest	O	O
dentifrice	O	O
,	O	O
Toothette	O	O
saturated	O	O
with	O	O
1.5	O	O
%	O	O
flavored	O	O
H2O2	O	O
and	O	O
no	O	O
mouth	O	O
moisturizer	O	O
.	O	O

From	O	O
a	O	O
subgroup	O	O
of	O	O
35	O	O
patients	O	O
(	O	O
seven	O	O
from	O	O
each	O	O
group	O	O
)	O	O
buccal	O	O
smears	O	O
for	O	O
exfoliative	O	O
cytology	O	O
were	O	O
taken	O	O
as	O	O
were	O	O
supragingival	O	O
microbiological	O	O
samples	O	O
from	O	O
the	O	O
mesial	O	O
aspect	O	O
of	O	O
first	O	O
molars	O	O
(	O	O
pooled	O	O
)	O	O
.	O	O

Buccal	O	O
smears	O	O
were	O	O
evaluated	O	O
for	O	O
signs	O	O
of	O	O
histopathological	O	O
changes	O	O
.	O	O

Microbiological	O	O
samples	O	O
from	O	O
supra-	O	O
and	O	O
subgingival	O	O
plaque	O	O
for	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
.	O	O

A	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
F.	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
and	O	O
C.	O	O
albicans	O	O
were	O	O
evaluated	O	O
.	O	O

Clinical	O	O
parameters	O	O
measured	O	O
were	O	O
a	O	O
stain	O	O
index	O	O
(	O	O
SI	O	O
)	O	O
,	O	O
the	O	O
modified	O	O
gingival	O	O
index	O	O
(	O	O
MGI	O	O
)	O	O
,	O	O
and	O	O
a	O	O
plaque	O	O
index	O	O
(	O	O
PI	O	O
)	O	O
.	O	O

There	O	O
were	O	O
no	O	O
adverse	O	O
changes	O	O
in	O	O
the	O	O
oral	O	O
microflora	O	O
and	O	O
no	O	O
anaplastic	O	O
or	O	O
other	O	O
pathological	O	O
changes	O	O
in	O	O
any	O	O
subjects	O	O
.	O	O

Clinical	O	O
parameters	O	O
showed	O	O
a	O	O
statistically	O	O
significant	O	O
reduction	O	O
in	O	O
the	O	O
MGI	O	O
ranging	O	O
from	O	O
26.7-29.9	O	O
%	O	O
with	O	O
no	O	O
significant	O	O
differences	O	O
among	O	O
the	O	O
groups	O	O
(	O	O
p	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
PI	O	O
showed	O	O
small	O	O
reductions	O	O
in	O	O
all	O	O
groups	O	O
except	O	O
group	O	O
2	O	O
,	O	O
but	O	O
the	O	O
differences	O	O
were	O	O
not	O	O
statistically	O	O
significant	O	O
from	O	O
each	O	O
other	O	O
or	O	O
baseline	O	O
(	O	O
p	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
SI	O	O
revealed	O	O
slight	O	O
increases	O	O
in	O	O
all	O	O
groups	O	O
and	O	O
no	O	O
differences	O	O
among	O	O
the	O	O
groups	O	O
.	O	O

It	O	O
can	O	O
be	O	O
concluded	O	O
that	O	O
use	O	O
of	O	O
Sage	O	O
dentifrice	O	O
,	O	O
Toothette	O	O
Plus	O	O
saturated	O	O
with	O	O
Perox-A-Mint	O	O
and	O	O
Sage	O	O
Mouth	O	O
Moisturizer	O	O
are	O	O
safe	O	O
to	O	O
oral	O	O
tissues	O	O
.	O	O

Using	O	O
these	O	O
components	O	O
did	O	O
not	O	O
result	O	O
in	O	O
clinically	O	O
noticeable	O	O
stain	O	O
formation	O	O
,	O	O
promote	O	O
plaque	O	O
formation	O	O
,	O	O
or	O	O
produce	O	O
any	O	O
significant	O	O
adverse	O	O
changes	O	O
in	O	O
the	O	O
oral	O	O
microflora	O	O
.	O	O

The	O	O
bactericidal	O	O
efficacy	O	O
of	O	O
two	O	O
types	O	O
of	O	O
Listerine	O	O
;	O	O
Listerine	O	O
and	O	O
Cool	O	O
Mint	O	O
Listerine	O	O
,	O	O
and	O	O
povidone	O	O
iodine	O	O
on	O	O
oral	O	O
microorganisms	O	O
,	O	O
methicillin-resistant	B-bacteria	B-bacteria
Staphylococcus	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
MRSA	B-bacteria	B-bacteria
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
,	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
and	O	O
Candida	O	O
albicans	O	O
were	O	O
examined	O	O
.	O	O

Most	O	O
of	O	O
the	O	O
oral	O	O
bacteria	O	O
were	O	O
killed	O	O
completely	O	O
by	O	O
a	O	O
10-sec	O	O
exposure	O	O
to	O	O
Listerine	O	O
or	O	O
Cool	O	O
Mint	O	O
Listerine	O	O
.	O	O

H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
,	O	O
MRSA	B-bacteria	B-bacteria
and	O	O
C.	O	O
albicans	O	O
were	O	O
also	O	O
reduced	O	O
by	O	O
a	O	O
30-sec	O	O
exposure	O	O
to	O	O
the	O	O
Listerine	O	O
mouth	O	O
rinse	O	O
.	O	O

Bacteria	O	O
in	O	O
dental	O	O
plaque	O	O
were	O	O
decreased	O	O
by	O	O
exposure	O	O
to	O	O
Listerine	O	O
,	O	O
Cool	O	O
Mint	O	O
Listerine	O	O
,	O	O
and	O	O
povidone	O	O
iodine	O	O
for	O	O
30	O	O
seconds	O	O
.	O	O

Mouthwashing	O	O
with	O	O
Listerine	O	O
for	O	O
30	O	O
seconds	O	O
resulted	O	O
in	O	O
a	O	O
decrease	O	O
to	O	O
approximately	O	O
1/100	O	O
of	O	O
the	O	O
viable	O	O
bacterial	O	O
counts	O	O
in	O	O
saliva	O	O
.	O	O

These	O	O
bactericidal	O	O
effects	O	O
against	O	O
bacteria	O	O
in	O	O
saliva	O	O
and	O	O
dental	O	O
plaque	O	O
indicated	O	O
that	O	O
Listerine	O	O
and	O	O
Cool	O	O
Mint	O	O
Listerine	O	O
antiseptic	O	O
are	O	O
useful	O	O
in	O	O
oral	O	O
cavity	O	O
as	O	O
antiseptic	O	O
mouth	O	O
rinses	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
if	O	O
endodontic	O	O
bacterial	O	O
act	O	O
in	O	O
vitro	O	O
on	O	O
human	O	O
gingival	O	O
fibroblast	O	O
functions	O	O
via	O	O
extracellular	O	O
products	O	O
.	O	O

The	O	O
bacteria	O	O
used	O	O
were	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
Capnocytophaga	B-bacteria	B-bacteria
ochracea	E-bacteria	I-bacteria
,	O	O
Peptostreptoccocus	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
and	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
.	O	O

Supernatants	O	O
were	O	O
collected	O	O
from	O	O
bacterial	O	O
cultures	O	O
at	O	O
the	O	O
beginning	O	O
of	O	O
the	O	O
stationary	O	O
phase	O	O
when	O	O
their	O	O
density	O	O
was	O	O
similar	O	O
.	O	O

Toxins	O	O
that	O	O
inhibited	O	O
fibroblast	O	O
proliferation	O	O
were	O	O
found	O	O
in	O	O
all	O	O
culture	O	O
supernatants	O	O
of	O	O
Gram-positive	B-bacteria	B-bacteria
or	I-bacteria	I-bacteria
Gram-negative	I-bacteria	I-bacteria
bacterial	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
,	O	O
except	O	O
for	O	O
Prev	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
nigrescens	E-bacteria	I-bacteria
.	O	O

The	O	O
cytotoxicity	O	O
of	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
supernatant	O	O
was	O	O
about	O	O
1000	O	O
fold	O	O
higher	O	O
than	O	O
the	O	O
others	O	O
.	O	O

This	O	O
supernatant	O	O
diluted	O	O
to	O	O
1/1000	O	O
led	O	O
to	O	O
total	O	O
fibroblast	O	O
growth	O	O
inhibition	O	O
whereas	O	O
only	O	O
25	O	O
%	O	O
growth	O	O
inhibition	O	O
was	O	O
obtained	O	O
with	O	O
Capn	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
ochracea	E-bacteria	I-bacteria
and	O	O
Pept	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
micros	E-bacteria	I-bacteria
diluted	O	O
to	O	O
1/10	O	O
.	O	O

Bacterial	O	O
supernatant	O	O
proteolytic	O	O
activity	O	O
was	O	O
investigated	O	O
in	O	O
confluent	O	O
fibroblast	O	O
cultures	O	O
that	O	O
were	O	O
incubated	O	O
for	O	O
48	O	O
hr	O	O
with	O	O
each	O	O
of	O	O
the	O	O
supernatants	O	O
diluted	O	O
to	O	O
1/2	O	O
except	O	O
for	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
supernatant	O	O
diluted	O	O
to	O	O
1/20	O	O
.	O	O

Indirect	O	O
immunofluorescence	O	O
studies	O	O
of	O	O
extracellular-matrix	O	O
molecules	O	O
,	O	O
followed	O	O
by	O	O
immunoelectrophoretic	O	O
analysis	O	O
of	O	O
extracts	O	O
of	O	O
whole-cell	O	O
layers	O	O
,	O	O
demonstrated	O	O
that	O	O
only	O	O
conditioned	O	O
medium	O	O
of	O	O
Prev	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
nigrescens	E-bacteria	I-bacteria
had	O	O
a	O	O
proteolytic	O	O
activity	O	O
capable	O	O
of	O	O
degrading	O	O
the	O	O
greater	O	O
part	O	O
of	O	O
type	O	O
I	O	O
collagen	O	O
and	O	O
fibronectin	O	O
fibres	O	O
in	O	O
the	O	O
extracellular	O	O
matrix	O	O
.	O	O

There	O	O
is	O	O
growing	O	O
public	O	O
recognition	O	O
of	O	O
the	O	O
importance	O	O
of	O	O
oral	O	O
health	O	O
,	O	O
as	O	O
symbolized	O	O
by	O	O
the	O	O
theme	O	O
.	O	O

``	O	O
Oral	O	O
Health	O	O
for	O	O
a	O	O
Healthy	O	O
Life	O	O
''	O	O
proposed	O	O
for	O	O
the	O	O
1994	O	O
World	O	O
Health	O	O
Day	O	O
.	O	O

In	O	O
this	O	O
report	O	O
,	O	O
the	O	O
efficacy	O	O
of	O	O
antimicrobial	O	O
mouth	O	O
rinses	O	O
,	O	O
mainly	O	O
Listerine	O	O
,	O	O
was	O	O
reviewed	O	O
by	O	O
three	O	O
investigators	O	O
who	O	O
are	O	O
working	O	O
as	O	O
a	O	O
microbiologist	O	O
,	O	O
a	O	O
microbiologist	O	O
,	O	O
a	O	O
dentist	O	O
,	O	O
and	O	O
a	O	O
dental	O	O
hygienist	O	O
participating	O	O
in	O	O
oral	O	O
health	O	O
care	O	O
.	O	O

Listerine	O	O
,	O	O
an	O	O
antimicrobial	O	O
mouth	O	O
rinse	O	O
,	O	O
completely	O	O
killed	O	O
microorganisms	O	O
in	O	O
10	O	O
to	O	O
30	O	O
seconds	O	O
;	O	O
the	O	O
microbes	O	O
includes	O	O
methicillin-resistant	B-bacteria	B-bacteria
Staphylococcus	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
pyogenes	E-bacteria	I-bacteria
,	O	O
Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
,	O	O
Candida	O	O
albicans	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
viscosus	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
and	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
.	O	O

Listerine	O	O
was	O	O
also	O	O
weakly	O	O
effective	O	O
in	O	O
inactivating	O	O
human	O	O
immunodeficiency	O	O
viruses	O	O
.	O	O

Bacteria	O	O
in	O	O
samples	O	O
collected	O	O
from	O	O
human	O	O
dental	O	O
plaque	O	O
and	O	O
saliva	O	O
were	O	O
completely	O	O
killed	O	O
within	O	O
30	O	O
seconds	O	O
when	O	O
exposed	O	O
to	O	O
Listerine	O	O
.	O	O

When	O	O
saliva	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
subjects	O	O
who	O	O
had	O	O
rinsed	O	O
their	O	O
mouths	O	O
with	O	O
20	O	O
ml	O	O
of	O	O
Listerine	O	O
or	O	O
1:50	O	O
diluted	O	O
povidone-iodine	O	O
,	O	O
levels	O	O
of	O	O
viable	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
the	O	O
samples	O	O
were	O	O
reduced	O	O
to	O	O
1	O	O
%	O	O
.	O	O

When	O	O
Listerine	O	O
was	O	O
used	O	O
for	O	O
oral	O	O
surgery	O	O
such	O	O
as	O	O
tooth	O	O
extraction	O	O
and	O	O
periodontal	O	O
surgery	O	O
,	O	O
the	O	O
agent	O	O
was	O	O
effective	O	O
in	O	O
relieving	O	O
toothache	O	O
.	O	O

This	O	O
was	O	O
probably	O	O
due	O	O
to	O	O
a	O	O
decrease	O	O
in	O	O
oral	O	O
bacteria	O	O
by	O	O
the	O	O
antimicrobial	O	O
action	O	O
of	O	O
Listerine	O	O
,	O	O
leading	O	O
to	O	O
lowering	O	O
the	O	O
inflammatory	O	O
response	O	O
of	O	O
the	O	O
host	O	O
.	O	O

The	O	O
use	O	O
of	O	O
antimicrobial	O	O
mouth	O	O
rinse	O	O
during	O	O
dental	O	O
treatments	O	O
such	O	O
as	O	O
endodontic	O	O
treatment	O	O
proved	O	O
effective	O	O
for	O	O
more	O	O
reliable	O	O
infection	O	O
control	O	O
.	O	O

In	O	O
Japan	O	O
,	O	O
there	O	O
are	O	O
an	O	O
increasing	O	O
number	O	O
of	O	O
elderly	O	O
and	O	O
medically	O	O
compromised	O	O
hosts	O	O
who	O	O
are	O	O
potentially	O	O
at	O	O
risk	O	O
for	O	O
developing	O	O
pneumonia	O	O
due	O	O
to	O	O
silent	O	O
aspiration	O	O
of	O	O
microbes	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
throat	O	O
.	O	O

For	O	O
the	O	O
aged	O	O
with	O	O
such	O	O
potential	O	O
risk	O	O
,	O	O
using	O	O
of	O	O
antimicrobial	O	O
mouth	O	O
rinse	O	O
may	O	O
be	O	O
effective	O	O
in	O	O
preventing	O	O
dental	O	O
plaque	O	O
accumulation	O	O
when	O	O
used	O	O
in	O	O
addition	O	O
to	O	O
the	O	O
mechanical	O	O
control	O	O
of	O	O
plaque	O	O
,	O	O
since	O	O
they	O	O
tend	O	O
to	O	O
have	O	O
difficulty	O	O
in	O	O
brushing	O	O
teeth	O	O
by	O	O
themselves	O	O
.	O	O

Indeed	O	O
,	O	O
the	O	O
use	O	O
of	O	O
antimicrobial	O	O
mouth	O	O
rinse	O	O
in	O	O
these	O	O
elderly	O	O
people	O	O
proved	O	O
useful	O	O
not	O	O
only	O	O
in	O	O
preventing	O	O
bacterial	O	O
pneumonia	O	O
,	O	O
but	O	O
also	O	O
in	O	O
improving	O	O
their	O	O
quality	O	O
of	O	O
life	O	O
by	O	O
preserving	O	O
their	O	O
oral	O	O
health	O	O
.	O	O

The	O	O
correlation	O	O
between	O	O
the	O	O
number	O	O
of	O	O
blood	O	O
polymorphonuclear	O	O
granulocytes	O	O
(	O	O
PMNs	O	O
)	O	O
and	O	O
the	O	O
counts	O	O
of	O	O
oral	O	O
bacteria	O	O
in	O	O
92	O	O
children	O	O
(	O	O
33	O	O
girls	O	O
and	O	O
59	O	O
boys	O	O
)	O	O
,	O	O
aged	O	O
4-15	O	O
was	O	O
investigated	O	O
.	O	O

The	O	O
groups	O	O
of	O	O
children	O	O
comprised	O	O
44	O	O
healthy	O	O
individuals	O	O
and	O	O
48	O	O
children	O	O
suffering	O	O
from	O	O
acute	O	O
lymphoblastic	O	O
leukaemia	O	O
who	O	O
were	O	O
given	O	O
intensive	O	O
antileukaemic	O	O
chemotherapy	O	O
.	O	O

It	O	O
was	O	O
found	O	O
that	O	O
while	O	O
the	O	O
number	O	O
of	O	O
PMNs	O	O
in	O	O
blood	O	O
decreased	O	O
,	O	O
the	O	O
counts	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
and	O	O
Actinomyces	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria

in	O	O
the	O	O
saliva	O	O
tended	O	O
to	O	O
increase	O	O
.	O	O

The	O	O
similar	O	O
reciprocal	O	O
correlation	O	O
between	O	O
the	O	O
number	O	O
of	O	O
blood	O	O
PMNs	O	O
and	O	O
the	O	O
counts	O	O
of	O	O
these	O	O
bacteria	O	O
in	O	O
the	O	O
saliva	O	O
was	O	O
found	O	O
in	O	O
the	O	O
group	O	O
of	O	O
healthy	O	O
children	O	O
.	O	O

We	O	O
concluded	O	O
that	O	O
the	O	O
blood	O	O
PMNs	O	O
,	O	O
by	O	O
influencing	O	O
the	O	O
number	O	O
of	O	O
oral	O	O
PMNs	O	O
which	O	O
control	O	O
bacteria	O	O
in	O	O
this	O	O
habitat	O	O
,	O	O
influence	O	O
also	O	O
the	O	O
number	O	O
of	O	O
some	O	O
groups	O	O
of	O	O
bacteria	O	O
there	O	O
.	O	O

Bacteriocin	O	O
production	O	O
has	O	O
been	O	O
studied	O	O
in	O	O
very	O	O
few	O	O
anaerobic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
and	O	O
no	O	O
report	O	O
is	O	O
available	O	O
for	O	O
Fusobacterium	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
a	O	O
total	O	O
of	O	O
167	O	O
Fusobacterium	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
were	O	O
tested	O	O
for	O	O
bacteriocin	O	O
production	O	O
:	O	O
70	O	O
isolates	O	O
were	O	O
obtained	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
patients	O	O
with	O	O
periodontal	O	O
disease	O	O
,	O	O
47	O	O
were	O	O
recovered	O	O
from	O	O
healthy	O	O
oral	O	O
sites	O	O
of	O	O
human	O	O
subjects	O	O
and	O	O
50	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
Callithrix	O	O
penicillata	O	O
.	O	O

Autoantagonism	O	O
and	O	O
isoantagonism	O	O
were	O	O
observed	O	O
when	O	O
the	O	O
bacteriocin-producing	O	O
isolates	O	O
were	O	O
tested	O	O
against	O	O
themselves	O	O
.	O	O

Heteroantagonism	O	O
was	O	O
detected	O	O
by	O	O
testing	O	O
the	O	O
Fusobacterium	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
against	O	O
14	O	O
reference	O	O
strains	O	O
and	O	O
2	O	O
strains	O	O
of	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
from	O	O
our	O	O
laboratory	O	O
collection	O	O
.	O	O

The	O	O
auto-	O	O
,	O	O
iso-	O	O
and	O	O
heteroantagonism	O	O
phenomena	O	O
observed	O	O
in	O	O
this	O	O
comparative	O	O
study	O	O
suggest	O	O
a	O	O
possible	O	O
ecological	O	O
role	O	O
for	O	O
this	O	O
(	O	O
these	O	O
)	O	O
antagonistic	O	O
substance	O	O
(	O	O
s	O	O
)	O	O
in	O	O
the	O	O
oral	O	O
environment	O	O
.	O	O

Competitive	O	O
PCR	O	O
was	O	O
used	O	O
to	O	O
monitor	O	O
the	O	O
survival	O	O
of	O	O
a	O	O
520-bp	O	O
DNA	O	O
target	O	O
sequence	O	O
from	O	O
a	O	O
recombinant	O	O
plasmid	O	O
,	O	O
pVACMC1	O	O
,	O	O
after	O	O
admixture	O	O
of	O	O
the	O	O
plasmid	O	O
with	O	O
freshly	O	O
sampled	O	O
human	O	O
saliva	O	O
.	O	O

The	O	O
fraction	O	O
of	O	O
the	O	O
target	O	O
remaining	O	O
amplifiable	O	O
ranged	O	O
from	O	O
40	O	O
to	O	O
65	O	O
%	O	O
after	O	O
10	O	O
min	O	O
of	O	O
exposure	O	O
to	O	O
saliva	O	O
samples	O	O
from	O	O
five	O	O
subjects	O	O
and	O	O
from	O	O
6	O	O
to	O	O
25	O	O
%	O	O
after	O	O
60	O	O
min	O	O
of	O	O
exposure	O	O
.	O	O

pVACMC1	O	O
plasmid	O	O
DNA	O	O
that	O	O
had	O	O
been	O	O
exposed	O	O
to	O	O
degradation	O	O
by	O	O
fresh	O	O
saliva	O	O
was	O	O
capable	O	O
of	O	O
transforming	O	O
naturally	O	O
competent	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
DL1	E-bacteria	I-bacteria
to	O	O
erythromycin	O	O
resistance	O	O
,	O	O
although	O	O
transforming	O	O
activity	O	O
decreased	O	O
rapidly	O	O
,	O	O
with	O	O
a	O	O
half-life	O	O
of	O	O
approximately	O	O
50	O	O
s.	O	O
S.	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
DL1	E-bacteria	I-bacteria
transformants	O	O
were	O	O
obtained	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
filter-sterilized	O	O
saliva	O	O
and	O	O
a	O	O
1-microg/ml	O	O
final	O	O
concentration	O	O
of	O	O
pVACMC1	O	O
DNA	O	O
.	O	O

Addition	O	O
of	O	O
filter-sterilized	O	O
saliva	O	O
instead	O	O
of	O	O
heat-inactivated	O	O
horse	O	O
serum	O	O
to	O	O
S.	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
DL1	E-bacteria	I-bacteria
cells	O	O
induced	O	O
competence	O	O
,	O	O
although	O	O
with	O	O
slightly	O	O
lower	O	O
efficiency	O	O
.	O	O

These	O	O
findings	O	O
indicate	O	O
that	O	O
DNA	O	O
released	O	O
from	O	O
bacteria	O	O
or	O	O
food	O	O
sources	O	O
within	O	O
the	O	O
mouth	O	O
has	O	O
the	O	O
potential	O	O
to	O	O
transform	O	O
naturally	O	O
competent	O	O
oral	O	O
bacteria	O	O
.	O	O

However	O	O
,	O	O
further	O	O
investigations	O	O
are	O	O
needed	O	O
to	O	O
establish	O	O
whether	O	O
transformation	O	O
of	O	O
oral	O	O
bacteria	O	O
can	O	O
occur	O	O
at	O	O
significant	O	O
frequencies	O	O
in	O	O
vivo	O	O
.	O	O

There	O	O
are	O	O
over	O	O
300	O	O
species	O	O
of	O	O
bacteria	O	O
forming	O	O
populations	O	O
of	O	O
several	O	O
hundred	O	O
billion	O	O
in	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
number	O	O
of	O	O
bacteria	O	O
reaches	O	O
a	O	O
thousand	O	O
billion	O	O
when	O	O
the	O	O
mouth	O	O
is	O	O
not	O	O
sufficiently	O	O
cleaned	O	O
.	O	O

Using	O	O
saliva	O	O
and	O	O
gingival	O	O
crevicular	O	O
fluid	O	O
as	O	O
their	O	O
main	O	O
nutrients	O	O
,	O	O
these	O	O
bacteria	O	O
create	O	O
their	O	O
ecological	O	O
niches	O	O
on	O	O
tooth	O	O
surfaces	O	O
,	O	O
gingival	O	O
crevices	O	O
,	O	O
saliva	O	O
,	O	O
dorsum	O	O
linguae	O	O
,	O	O
and	O	O
buccal	O	O
and	O	O
pharyngeal	O	O
mucosa	O	O
,	O	O
threatening	O	O
oral	O	O
and	O	O
systemic	O	O
health	O	O
.	O	O

It	O	O
is	O	O
known	O	O
that	O	O
primary	O	O
lesions	O	O
of	O	O
these	O	O
chronic	O	O
bacterial	O	O
infections	O	O
secondarily	O	O
cause	O	O
nephritis	O	O
,	O	O
rheumatoid	O	O
arthritis	O	O
,	O	O
and	O	O
dermatitis	O	O
.	O	O

Further	O	O
,	O	O
it	O	O
has	O	O
been	O	O
demonstrated	O	O
in	O	O
recent	O	O
years	O	O
that	O	O
bacteria	O	O
inhabiting	O	O
the	O	O
oral	O	O
cavity	O	O
can	O	O
cause	O	O
bacterial	O	O
pneumonia	O	O
and	O	O
endocarditis	O	O
and	O	O
that	O	O
the	O	O
periodontal-disease-associated	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
become	O	O
causative	O	O
agents	O	O
for	O	O
pregnancy	O	O
troubles	O	O
and	O	O
are	O	O
involved	O	O
in	O	O
blood	O	O
circulation	O	O
problem	O	O
and	O	O
coronary	O	O
heart	O	O
disease	O	O
.	O	O

Dentistry	O	O
reviewed	O	O
the	O	O
theme	O	O
of	O	O
World	O	O
Health	O	O
Day	O	O
,	O	O
Oral	O	O
Health	O	O
for	O	O
a	O	O
Healthy	O	O
Life	O	O
,	O	O
in	O	O
1994	O	O
.	O	O

The	O	O
8020	O	O
campaign	O	O
to	O	O
promote	O	O
tooth	O	O
care	O	O
is	O	O
also	O	O
becoming	O	O
established	O	O
in	O	O
Japan	O	O
;	O	O
however	O	O
,	O	O
the	O	O
authors	O	O
emphasized	O	O
that	O	O
this	O	O
achievement	O	O
is	O	O
not	O	O
the	O	O
goal	O	O
of	O	O
dental	O	O
health	O	O
care	O	O
.	O	O

In	O	O
this	O	O
article	O	O
,	O	O
we	O	O
explain	O	O
the	O	O
bases	O	O
supporting	O	O
the	O	O
concept	O	O
that	O	O
oral	O	O
health	O	O
care	O	O
,	O	O
primarily	O	O
mouth	O	O
cleaning	O	O
,	O	O
is	O	O
important	O	O
for	O	O
not	O	O
only	O	O
oral	O	O
disease	O	O
but	O	O
also	O	O
a	O	O
healthy	O	O
life	O	O
.	O	O

